0001193125-13-132519.txt : 20130328 0001193125-13-132519.hdr.sgml : 20130328 20130328165130 ACCESSION NUMBER: 0001193125-13-132519 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130328 DATE AS OF CHANGE: 20130328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Addus HomeCare Corp CENTRAL INDEX KEY: 0001468328 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 205340172 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34504 FILM NUMBER: 13724643 BUSINESS ADDRESS: STREET 1: 2401 SOUTH PLUM GROVE ROAD CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-303-5300 MAIL ADDRESS: STREET 1: 2401 SOUTH PLUM GROVE ROAD CITY: PALATINE STATE: IL ZIP: 60067 10-K 1 d468078d10k.htm 10-K 10-K
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-K

 

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2012

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 001-34504

 

 

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   20-5340172

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

2401 South Plum Grove Road

Palatine, Illinois 60067

(Address of principal executive offices)

(847) 303-5300

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Name of each Exchange on which Registered

Common Stock, par value $0.001   The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(b) of the Act:

None

 

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x.

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.    Yes  ¨    No  x.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer  ¨

  

Accelerated filer  ¨

Non-accelerated filer  ¨

  

Smaller reporting company  x

(Do not check if a smaller reporting company)

  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes  ¨    No  x

The aggregate market value of the voting and non-voting common stock held by non-affiliates of the registrant, based on the last sale price on The Nasdaq Global Market on June 30, 2012 (the last business day of the registrant’s most recently completed second fiscal quarter) was $28,927,673.

As of March 18, 2013, there were 10,883,632 shares of common stock outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the registrant’s Definitive Proxy Statement for its 2013 Annual Meeting of Stockholders (which is expected to be filed with the Commission within 120 days after the end of the registrant’s 2012 fiscal year) are incorporated by reference into Part III of this Annual Report on Form 10-K.

 

 

 


Table of Contents

TABLE OF CONTENTS

 

PART I

     2   

Item 1.

 

Business

     2   

Item 1A.

 

Risk Factors

     16   

Item 1B.

 

Unresolved Staff Comments

     35   

Item 2.

 

Properties

     35   

Item 3.

 

Legal Proceedings

     35   

Item 4.

 

Mine Safety Disclosures

     35   

PART II

     36   

Item 5.

 

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

     36   

Item 6.

 

Selected Financial Data

     37   

Item 7.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     42   

Item 7A.

 

Quantitative and Qualitative Disclosures about Market Risk

     62   

Item 8.

 

Financial Statements and Supplementary Data

     62   

Item 9.

 

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

     62   

Item 9A.

 

Controls and Procedures

     62   

Item 9B.

 

Other Information

     63   

PART III

     64   

Item 10.

 

Directors, Executive Officers and Corporate Governance

     64   

Item 11.

 

Executive Compensation

     64   

Item 12.

 

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

     64   

Item 13.

 

Certain Relationships and Related Transactions; and Director Independence

     64   

Item 14.

 

Principal Accountant Fees and Services

     64   
PART IV      65   

Item 15.

 

Exhibits and Financial Statement Schedules

     65   


Table of Contents

SPECIAL CAUTION CONCERNING FORWARD-LOOKING STATEMENTS

When included in this Annual Report on Form 10-K, or in other documents that we file with the Securities and Exchange Commission (“SEC”) or in statements made by or on behalf of the Company, words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should” and similar expressions are intended to identify forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a variety of risks and uncertainties that could cause actual results to differ materially from those described therein. These risks and uncertainties include, but are not limited to the following: changes in Medicaid, Medicare and other medical payment levels, changes in or our failure to comply with existing Federal and State laws or regulations or the inability to comply with new government regulations on a timely basis, competition in the home and community based service industry, changes in the case mix of consumers and payment methodologies, changes resulting from the assumption by managed care organizations of responsibility for managing and paying for home and community based services to consumers, changes in estimates and judgments associated with critical accounting policies, our ability to maintain or establish new referral sources, our ability to attract and retain qualified personnel, changes in payments and covered services due to the economic downturn and deficit spending by Federal and State governments, future cost containment initiatives undertaken by third party payors, our access to financing due to the volatility and disruption of the capital and credit markets, our ability to meet debt service requirements and comply with covenants in debt agreements, our ability to realize cost savings from the sale of our home health business, business disruptions due to natural disasters or acts of terrorism, our ability to integrate and manage our information systems, our expectations regarding the size and growth of the market for our services, the acceptance of privatized social services, our expectations regarding changes in reimbursement rates, authorized hours and eligibility standards of state governmental agencies, the potential to settle litigation, and the effect of those changes on our results of operations in 2012 or for periods thereafter, our ability to successfully implement our coordinated care model to grow our business, our ability to attract referrals, our ability to continue identifying and pursuing acquisition opportunities and expand into new geographic markets, the effectiveness, quality and cost of our services and various other matters, many of which are beyond our control.

Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on any forward-looking statement as a prediction of future events. We expressly disclaim any obligation or undertaking and we do not intend to release publicly any updates or changes in our expectations concerning the forward-looking statements or any changes in events, conditions or circumstances upon which any forward-looking statement may be based, except as required by law. For a discussion of some of the factors discussed above as well as additional factors, see Part I, Item 1A—“Risk Factors” and Part II, Item 7—“Critical Accounting Policies and Estimates” within “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.

Unless otherwise provided, “Addus,” “we,” “us,” “our,” and the “Company” refer to Addus HomeCare Corporation and our consolidated subsidiaries and “Holdings” refers to Addus HomeCare Corporation. When we refer to 2012, 2011 and 2010, we mean the twelve month period then ended December 31, unless otherwise provided.

A copy of this Annual Report on Form 10-K for the year ended December 31, 2012 as filed with the SEC, including all exhibits, is available on our internet website at http://www.addus.com on the “Investor Relations” page link. Information contained on, or accessible through, our website is not a part of, and is not incorporated by reference into, this Annual Report on Form 10-K.

 

1


Table of Contents

PART I

 

ITEM 1. BUSINESS

Overview

We are a comprehensive provider of home and community based services, which are primarily social in nature and are provided in the home, focused on the dual eligible population. Our services include personal care and assistance with activities of daily living, and adult day care. Our consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Our payor clients include federal, state and local governmental agencies, commercial insurers and private individuals. We provide home and community based services through over 96 locations across 19 states to over 25,000 consumers.

Effective March 1, 2013, we sold substantially all of the assets used in our home health business (the “Home Health Business”) in Arkansas, Nevada and South Carolina, and 90% of the Home Health Business in California and Illinois, to subsidiaries of LHC Group, Inc. (the “Purchasers”) for a cash purchase price of approximately $20 million. We retained a 10% ownership interest in the Home Health Business in California and Illinois. The assets sold included 19 home health agencies and two hospice agencies in five states. Through these home health agencies, we previously provided physical, occupational and speech therapy, as well as skilled nursing services, to pediatric, adult infirm and elderly patients. The results of the Home Health Business sold and two additional agencies held for sale are reflected as discontinued operations for all periods presented herein. Continuing operations include the results of operations previously included in our home & community segment and three agencies previously included in our home health segment. Following the sale of the Home Health Business, we manage and internally report our business in one segment.

We believe the sale of the Home Health Business substantially positions us for future growth. The sale allows us to focus both management and financial resources to address changes in the home and community based services industry and to address the needs of managed care organizations as they become responsible for state sponsored programs. We have improved our financial performance by lowering our administrative costs and concentrating our efforts on the business that is growing and providing all of our profitability while disposing of the business that was unprofitable. We have improved our overall financial position by eliminating our debt and adding substantial amounts in cash reserves to our balance sheet. A summary of our results for 2012 and 2011 are provided in the table below:

 

     2012     2011     Percent
Change
 

Net service revenues – continuing operations

   $ 244,315      $ 230,105        6.2

Net service revenues – discontinued operations

     38,822        42,995        (9.7 )% 

Net income from continuing operations

     9,288        8,412        10.4

(Loss) from discontinued operations

     (1,653     (10,393     N/A   
  

 

 

   

 

 

   

Net income (loss)

   $ 7,635      $ (1,981     N/A   
  

 

 

   

 

 

   

The home and community based services we provide are primarily social in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. We provide these services on a long-term, continuous basis, with an average duration of approximately 17 months per consumer. Our adult day centers provide a comprehensive program of skilled and support services and designated medical services for adults in a community-based group setting. Services provided by our adult day centers include social activities, transportation services to and from the centers, the provision of meals and snacks, personal care and therapeutic activities such as exercise and cognitive interaction.

We utilize a coordinated care model that is designed to enhance consumer outcomes and satisfaction as well as lower the cost of acute care treatment and reduce service duplication. Through our coordinated care model, we

 

2


Table of Contents

utilize our home care aides to observe and report changes in the condition of our consumers for the purpose of early intervention in the disease process, thereby preventing or reducing the cost of medical services by avoiding emergency room visits, and/or reducing the need for hospitalization. These changes in condition are evaluated by appropriately trained managers and referred to appropriate medical personnel including the primary care physicians and managed care plans for treatment and follow-up. We will coordinate the services provided by our team with those of selected health care agencies as appropriate. We believe this approach to the provision of care to our consumers and the integration of our services into the broader healthcare industry is particularly attractive to managed care providers and others who are ultimately responsible for the healthcare needs of our consumers and over time will increase our business with them.

Addus HomeCare Corporation was incorporated in Delaware in 2006 under the name Addus Holding Corporation for the purpose of acquiring Addus HealthCare, Inc. (“Addus HealthCare”). Addus HealthCare was founded in 1979. Our principal executive offices are located at 2401 South Plum Grove Road, Palatine, Illinois 60067. Our telephone number is (847) 303-5300.

Our Market and Opportunity

We provide home and community based services to the elderly and other adult infirm who need long-term care and assistance with essential, routine tasks of life. The Kaiser Commission report on Medicaid and the uninsured dated December 2011 estimated total Medicaid expenditures for home and community based services in 2008 to be over $45 billion annually. Home and community based services is the fastest growing segment within this overall homecare market, which includes home and community based services, home health and hospice services, with the program expenditures nearly doubling from $28 billion in 2003 to $45 billion in 2008, representing a compounded annual growth rate, or CAGR, of 10%.

In addition to the projected growth of government-sponsored home and community based services, the private duty market for our services is growing rapidly. We provide our private duty consumers with all of the services we provide to our home and community based consumers.

Historically, there were limited barriers to entry in the home and community based services industry. As a result, the home and community based services industry developed in a highly fragmented manner, with many small local providers. Few companies have a significant market share across multiple regions or states. According to the National Association for Home Care & Hospice, or NAHC, as of 2011, there were over 33,000 homecare and hospice agencies in the United States. Approximately 15,000 were Medicare-certified homecare and hospice agencies, while the remaining 18,000 represent the number of licensed home and community based services agencies in the United States providing services similar to those we provide. In addition, while difficult to estimate, there are many non-licensed, non-certified home and community based services agencies.

More recently, the home and community based services industry has been subject to increased regulation. In several states, providers are now required to obtain state licenses or registrations and must comply with laws and regulations governing standards of practice. Providers must dedicate substantial resources to ensure continuing compliance with all applicable regulations and significant expenditures may be necessary to offer new services or to expand into new markets. Any failure to comply with this growing and changing regulatory regime could lead to the termination of rights to participate in federal and state-sponsored programs and the suspension or revocation of licenses. We believe limitations on the availability of new licenses, the rising cost and complexity of operations and pressure on reimbursement rates due to constrained government resources create barriers for new providers and may encourage industry consolidation.

The Federal Coordinated Health Care Office was established to effectively integrate benefits for consumers who are enrolled in both Medicare and Medicaid, also known as dual eligibles, and improve coordination between the federal and state governments to ensure that dual eligibles have full access to items and services to which they are entitled. Stated goals of the Federal Coordinated Health Care Office are to ensure that the dual

 

3


Table of Contents

eligible population has full access to seamless high quality health care and to make the system as cost-effective as possible. The Federal Coordinated Health Care Office works with the Centers for Medicare and Medicaid Services (“CMS”), state Medicaid agencies, and other federal and state agencies, as well as physicians and others, to provide technical assistance and educational tools to improve care coordination between Medicare and Medicaid and to reduce costs, improve beneficiary experience and educate dual eligibles regarding care coverage. It also performs policy and program analysis and develops policy and program recommendations regarding dual eligibles.

The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, both laws are referred to herein as the “Health Reform Act”), encourages states to integrate the state managed Medicaid home and community based programs with managed Medicare programs. The objective of these initiatives is to enhance the coordination of benefits between the two programs and to lower overall costs. The integrated programs are being structured as three year pilots. States are also transitioning their Medicaid home and community based programs to managed care without including the integration of the Medicare programs. Nationally, 27 states have initiated efforts to pursue these programs, with 17 of the 19 states in which we provide services having initiated their efforts to transition to managed care.

We believe that our coordinated care program makes us well-suited to partner with managed care providers to address the needs of the dual eligible population. These programs will eliminate service duplication between home and community based programs and traditional Medicare home health. We believe our ability to identify changes in medical health and condition before the need for acute intervention will lower the overall cost of care and will be recognized as an added benefit of our services. We believe this approach to the provision of care to our consumers and the integration of our services into the broader healthcare industry is particularly attractive to managed care providers and others who are ultimately responsible for the healthcare needs of our consumers and over time will increase our business with them.

Our Growth Strategy

Our ability to grow our net service revenues is closely correlated with the number of consumers to whom we provide our services. Our continued growth depends on our ability to maintain our existing payor client relationships, establish relationships with new payors, enter into new contracts and increase our referral sources. Our continued growth is also dependent upon the authorization by state agencies of new consumers to receive our services. We believe there are several market opportunities for growth. The U.S. population of persons aged 65 and older is growing, and the U.S. Census Bureau estimates that this population will more than double by 2050. Additionally, we believe the overwhelming majority of individuals in need of care generally prefer to receive care in their homes or community-based settings. Finally, we believe the provision of home and community based services is more cost-effective than the provision of similar services in an institutional setting for long-term care. The following are the key elements of our growth strategy:

 

   

Drive growth in existing markets. We intend to drive growth in our existing markets by enhancing the breadth of our services, increasing the number of referral sources and leveraging and expanding our payor relationships in each market. We expect to achieve this growth by continuing to educate referral sources about the benefits of our services and maintaining our emphasis on high quality care for our consumers. To take advantage of the growing demand for quality and reputable home and community based services from private duty consumers, we are focusing on increasing and enhancing the private pay services we provide to consumers in all of our locations. By providing private duty services, we expect to increase our net service revenues without a corresponding increase in our operating costs.

 

   

Expand our coordinated care model. Our coordinated care model provides significant opportunities to effectively market to a wide range of payor clients and referral sources, many of whom are responsible for consumers with both social and medical service needs. We intend to extend this model to all of our markets. We are also seeking to partner with managed care providers to address the needs of the dual eligible population in light of governmental incentives for consumers to enroll in managed care plans. Our approach to the provision of care to our consumers and the integration of our services into the

 

4


Table of Contents
 

broader healthcare industry is particularly attractive to managed care providers and others who are ultimately responsible for the healthcare needs of our consumers and over time we believe will increase our business with them.

 

   

Growth through acquisitions. We intend to continue to grow with selective acquisitions. While entering new markets is a priority for our acquisitions, we are also looking for opportunities to expand within our existing markets.

 

   

Expand into new markets organically. We intend to offer our services in geographic markets contiguous to our existing markets through de novo agency development. We also anticipate we will have opportunities to develop new agencies in response to requests from managed care organizations.

Our Services

We deliver services to our consumers through 91 individual agencies located in 19 states and five adult day centers in Illinois. Our home and community based services assist consumers, who would otherwise be at risk of placement in a long-term care institution, with activities of daily living.

Services are primarily provided in consumers’ homes on an as-needed, hourly basis. We serve mostly to older adults and younger disabled persons. These services are generally provided by home and community based service aides, are of a social rather than medical nature, and include personal care, home support services and adult day care.

Personal care and home support services are provided to consumers who are unable to independently perform some or all of their activities of daily living. Our services are needed when assistance from family or community members is insufficient or where caregiver respite is needed. Personal care services include bathing, grooming, oral care, skin care, assistance with feeding and dressing and medication reminders. Home support services include meal planning and preparation, housekeeping and transportation services. Many consumers need such services on a long-term basis to address chronic or acute conditions. Each payor client establishes its own eligibility standards, determines the type, amount, duration and scope of services, and establishes the applicable reimbursement rate. The average duration of our provision of home and community based services is approximately 17 months per consumer.

We also operate five adult day centers in Illinois which provide a comprehensive program of skilled and support services and designated health services for adults in a community-based group setting. Services provided by our adult day centers include social activities, transportation services to and from the centers, the provision of meals and snacks, personal care and therapeutic activities such as exercise and cognitive interaction.

Most of our services are provided pursuant to agreements with state and local governmental social and aging service agencies. These agreements generally have a stated term of one to three years and may be terminated by the counterparty upon 60 days’ notice. They are typically renewed for one to five-year terms, provided we have complied with licensing, certification and program standards, and other regulatory requirements. Reimbursement rates and methods vary by state and service type, but are typically based on an hourly or unit-of-service basis. In 2012, approximately 94.9% of our net service revenues from continuing operations were derived from state and local government programs, while approximately 5.1% of net service revenues from continuing operations were derived from insurance programs and private duty consumers.

 

5


Table of Contents

The following table presents our locations (including the locations disposed of in connection with the sale of our Home Health Business), setting forth acquisitions, start-ups, divestitures and closures for the period January 1, 2011 to December 31, 2012:

 

     Total  

Total as previously reported December 31, 2010

     129   

Home health offices reported as discontinued operations in 2012

     (22
  

 

 

 

Adjusted total at December 31, 2010

     107   
  

 

 

 

Closed/Merged

     (11
  

 

 

 

Total at December 31, 2011

     96   
  

 

 

 

Start-up

     1   

Closed/Merged

     (1 )
  

 

 

 

Adjusted Total at December 31, 2012

     96   
  

 

 

 

Our payor clients are principally federal, state and local governmental agencies. The federal, state and local programs under which they operate are subject to legislative, budgetary and other risks that can influence reimbursement rates. Our commercial insurance carrier payor clients are typically for profit companies and are continuously seeking opportunities to control costs. We are seeking to grow our private duty business.

For 2012, 2011 and 2010, our revenue mix by payor type for continuing operations was as follows:

 

     Year Ended December 31,  
      2012     2011     2010  

State, local and other governmental programs

     94.9     93.5     92.7 %

Commercial

     1.0        1.3        1.2   

Private duty

     4.1        5.2        6.1   
  

 

 

   

 

 

   

 

 

 
     100.0     100.0     100.0
  

 

 

   

 

 

   

 

 

 

We derive a significant amount of our net service revenues from continuing operations from our operations in Illinois and California, which represented 64% and 7%; 58% and 8%; and 53% and 11% of our total net service revenues from continuing operations for the years ended December 31, 2012, 2011 and 2010, respectively.

A significant amount of our net service revenues from continuing operations are derived from one specific payor client, the Illinois Department on Aging, which accounted for 57%, 51% and 45% of our total net service revenues from continuing operations for the years ended December 31, 2012, 2011 and 2010, respectively.

We also measure the performance of our business through review of our billable hours, billable hours per business day, revenues per billable hour and the number of consumers served, or census.

Competition

The home and community based services industry is highly competitive, fragmented and market specific. Each local market has its own competitive profile and no single competitor has significant market share across all of our markets. Our competition consists of home and community based service providers, home health providers, private caregivers, larger publicly held companies, privately held companies, privately held single-site agencies, hospital-based agencies, not-for-profit organizations, community-based organizations, managed care

 

6


Table of Contents

organizations and self-directed care programs. In addition, certain governmental payors contract for services with independent providers such that our relationships with these payors are not exclusive. This is particularly true in California. We have experienced, and expect to continue to experience, competition from new entrants into our markets. Increased competition may result in pricing pressures, loss of or failure to gain market share or loss of consumers or payors, any of which could harm our business. In addition, some of our competitors may have greater financial, technical, political and marketing resources, name recognition on a larger number of consumers and payors than we do. We may also be subject to competition in connection with accountable care organization matters, as described below under the caption “Business—Government Regulation.”

Sales and Marketing

We focus on initiating and maintaining working relationships with state and local governmental agencies responsible for the provision of the services we offer. We target these agencies in our current markets and in geographical areas that we have identified as potential markets for expansion. We also seek to identify service needs or changes in the service delivery or reimbursement system of governmental entities and attempt to work with and provide input to the responsible government personnel, provider associations and consumer advocacy groups.

We receive substantially all of our consumers from third-party referrals. Generally, family members of potential consumers are made aware of available in-home or alternative living arrangements through a state or local case management system. These systems are operated by governmental or private agencies. We receive referrals from state departments on aging, rehabilitation, mental health and children’s services, county departments of social services, the Veterans Health Administration and city departments on aging.

We provide ongoing education and outreach to our target communities, both to inform residents about state and locally-subsidized care options and to communicate our role in providing quality home and community based services. We also utilize consumer-direct sales, marketing and advertising programs designed to attract consumers.

Payment for Services

We are compensated for substantially all of our services by federal, state and local government programs, such as Medicaid funded programs and Medicaid waiver programs, other state agencies, the Veterans Health Administration, commercial insurers and private duty consumers.

The following table sets forth net service revenues from continuing operations derived from each of our major payors during the indicated periods as a percentage of total net service revenues from continuing operations.

 

     Year Ended December 31,  

Payor Group

   2012     2011     2010  

Illinois Department on Aging

     57.3 %     51.2     44.7

Washington Department of Social and Health Services

     6.4        6.7        7.8   

Nevada Medicaid

     3.9        5.1        6.4   

Riverside County, CA Department of Public Social Services

     3.9        4.5        5.2   

Private duty

     4.1        5.2        6.1   

Commercial insurance

     1.0        1.3        1.2   

Other federal, state and local payors

     23.4        26.0        28.6   
  

 

 

   

 

 

   

 

 

 

Total

     100.0     100.0     100.0
  

 

 

   

 

 

   

 

 

 

 

7


Table of Contents

Illinois Department on Aging

We provide home and community based services pursuant to agreements with the Illinois Department on Aging, which is funded by Medicaid and general revenue funds of the State of Illinois. Consumers are identified by case managers contracted independently with the Illinois Department on Aging. Once a consumer has been evaluated and determined to be eligible for the program, the case manager refers the consumer to a list of authorized providers, from which the consumer selects the provider. We provide our services in accordance with a care plan developed by the case manager and under administrative directives from the Illinois Department on Aging. We are reimbursed on an hourly fee for service basis.

Due to its revenue deficiencies and financing issues, the State of Illinois is currently reimbursing us on a delayed basis with respect to these agreements. These payment delays have adversely impacted, and may further adversely impact, our liquidity, and may result in the need to increase borrowings under our credit facility. Other delayed payor reimbursements from the State of Illinois have also contributed to the increase in our receivables balances. Illinois and all other states benefited from an increase in the federal medical assistance percentage (“FMAP”) granted under the American Recovery and Reinvestment Act (“ARRA”), which increased the share of federal dollars paid to states for services to Medicaid beneficiaries. The increased FMAP payments generally terminated as of June 30, 2011.

Washington Department of Social and Health Services

We provide home and community based services pursuant to agreements with the Washington Department of Social and Health Services, which is funded by Medicaid and general revenue funds of the State of Washington. Consumers are identified by area Agency on Aging case managers contracted independently with the Washington Department of Social and Health Services. Once a consumer has been evaluated and determined to be eligible for the program, the case manager refers the consumer to a list of authorized providers, from which the consumer selects the provider. We provide our services in accordance with a care plan developed by the case manager and under administrative directives from the Washington Department of Social and Health Services. We are reimbursed on an hourly fee for service basis.

Nevada Medicaid

We provide services pursuant to an agreement with the State of Nevada Division of Health Care Financing and Policy under Nevada Medicaid’s Personal Care Options program. Under this agreement, we identify consumers through community outreach efforts, who are then qualified by the State of Nevada to receive services. We provide personal care and other in-home support services under this program. All services are reimbursed on an hourly fee for service basis. The FMAP for Nevada increased for fiscal year 2013 over the FMAP for 2012.

Riverside County Department of Public Social Services

We provide services pursuant to an agreement with the County of Riverside, California under its In-Home Support Services Program. Under this agreement, we serve consumers referred to us by county-employed social workers in accordance with the term and conditions of a Quality Assurance Work Plan. We provide personal care and other assistance with activities of daily living under this program. All services are reimbursed on an hourly fee for service basis. The current agreement has a one year term beginning July 1, 2012 with a one year renewal available before we are required to submit a new bid to the County Board of Supervisors. However, such renewal year is subject to approval by the county department that oversees our agreement. Our relationship with the County of Riverside, California may change before the end of the term of our agreement, including any renewal term, as the State of California and Riverside County are planning to enter into managed care demonstration plans whereby the services we provide to consumers in the county would become the responsibility of the contracted managed care plans. The current proposals would be implemented before the renewal date of our contract. There can be no assurance that we will be able to contract with managed care plans at rates comparable to our current contract with the County.

 

8


Table of Contents

Our arrangements with all of our California county payors are not exclusive in nature. Rather, each county is permitted to contract for services from independent providers with a registry of independent providers managed by the county authority. The independent provider programs represent a competitive threat to us but we believe independent providers do not provide the level of management or supervision that the counties or the individuals receiving services would have if the contract were with us.

Private Duty

Our private duty services are provided on an hourly basis. Our rates are established to achieve a pre-determined gross profit margin, and are competitive with those of other local providers. We bill our private duty consumers for services rendered either bi-monthly or monthly, and in certain circumstances we obtain a two-week deposit from the consumer. Other private duty payors include workers’ compensation programs/insurance, preferred provider organizations and other managed care companies and employers.

Commercial Insurance

Most long-term care insurance policies contain benefits for in-home services and adult day care. Policies are generally subject to dollar limitations on the amount of daily, weekly or monthly coverage provided. Depending on the type of service, coverage for services may be predicated on a physician or nurse determination that the care is necessary or on the development of a plan for care in the home.

Other Federal, State and Local Payors

Medicaid Funded Programs and Medicaid Waiver Programs

Medicaid is a state-administered program that provides certain social and medical services to qualified low-income individuals, and is jointly funded by the federal government and individual states. Reimbursement rates and methods vary by state and service type, but are typically based on an hourly or unit-of-service basis. Rates are subject to adjustment based on statutory and regulatory changes, administrative rulings, government funding limitations and interpretations of policy by individual state agencies. Within guidelines established by federal statutes and regulations, each state establishes its own eligibility standards, determines the type, amount, duration and scope of services, sets the rate of payment for services and administers its own program, subject to federal oversight. Most states cover Medicaid beneficiaries for intermittent home health services, as well as continuous services for children and young adults with complicated medical conditions, and certain states cover home and community-based services.

In an effort to control escalating Medicaid costs, states are increasingly requiring Medicaid beneficiaries to enroll in managed care plans. Under a health reform bill signed into law in January 2012, Illinois set a goal to increase the percentage of Medicaid beneficiaries in Medicaid managed care plans from the current 8% to 50% by 2015. The difficulty of getting healthcare providers to agree to sign up for the plans, however, has proved to be a stumbling block for increasing managed care enrollment.

Veterans Health Administration

The Veterans Health Administration operates the nation’s largest health care system, with more than 1,400 sites of care, and provides health care benefits, including home and community based services, to eligible military veterans. The Veterans Health Administration provides funding to regional and local offices and facilities that support the in-home care needs of eligible aged and disabled veterans by contracting directly with local in-home care providers, and to the aid and attendance pension, which pays veterans for their otherwise unreimbursed health and long-term care expenses. We currently have relationships and agreements with the Veterans Health Administration to provide home and community based services in Illinois, Arkansas and California.

 

9


Table of Contents

Other

Other sources of funding are available to support home and community based services in different states and localities. In addition, many states appropriate general funds or special use funds through targeted taxes or lotteries to finance home and community based services for senior citizens and people with disabilities. Depending on the state, these funds may be used to supplement existing Medicaid waiver programs or for distinct programs that serve non-Medicaid eligible consumers.

Exposure for Payments Previously Received

As described above under the caption “Business – Overview,” we sold our Home Health Business effective March 1, 2013, pursuant to an Asset Purchase Agreement, dated as of February 7, 2013 (the “Home Health Purchase Agreement”), with LHC Group, Inc. and the Purchasers identified therein. Pursuant to the Home Health Purchase Agreement, we retained a 10% ownership interest in the Home Health Business in California and Illinois. In addition, not included in the sale were four home health agencies in Delaware, Idaho, Indiana and Pennsylvania. The home health agencies in Idaho and Pennsylvania are assets being held for sale. Because regulatory requirements in Delaware and Indiana require the provision of home and community based services be provided by a licensed home health agency, we will continue to provide limited home health services reimbursable by Medicare in these agencies in order to maintain these licenses.

While we no longer receive substantial payments from Medicare for the home health services we continue to provide, pursuant to the Home Health Purchase Agreement, we are obligated to indemnify the Purchasers for, among other things, (i) penalties, fines, judgments and settlement amounts arising from a violation of certain specified statutes, including the False Claims Act, the Civil Monetary Penalties Law, the federal Anti-Kickback Statute, the Ethics in Patient Referral Act or any state law equivalent in connection with the operation of the Home Health Business prior to the consummation of the sale (the “Closing”), and (ii) any liability related to the failure of any reimbursement claim submitted to certain government programs for services rendered by the Home Health Business prior to the Closing to meet the requirements of such government programs, or any violation prior to the Closing of any health care laws. Such liabilities include amounts to be recouped by, or repaid to, such government programs as a result of improperly submitted claims for reimbursement or those discovered as a result of audits by investigative agencies. All services that we have provided that have been or may be reimbursed by Medicare are subject to retroactive adjustments and/or total denial of payments received from Medicare under various review and audit provisions included in the program regulations. The review period is generally described as six years from the date the services are provided but could be expanded to ten years under certain circumstances if fraud is found to have existed at the time of original billing. In the event that there are adjustments relating to the period prior to the Closing, we may be required to reimburse the Purchasers for the amount of such adjustments.

Medicare is the U.S. government’s health insurance program funded by the Social Security Administration for individuals aged 65 or older, individuals under the age of 65 with certain disabilities and individuals of all ages with end-stage renal disease. Eligibility for Medicare does not depend on income, and coverage is restricted to reasonable and medically-necessary treatment.

Medicare home health rates are based on a Medicare episodic rate set annually through federal legislation. The rate covers a 60-day episode of care. Payment for each patient’s episode of care is based on the severity of the consumer’s condition, his or her service needs and other factors relating to the cost of providing services and supplies.

In addition, Medicare payments can be adjusted through changes in the payment rate and recoveries of overpayments for, among other things, unusually costly care for a particular consumer, low utilization, transfers to another provider, the level of therapy services required, the number of episodes of care provided, and if the consumer is discharged but readmitted within the same 60-day episodic period. In addition, Medicare can also reduce levels of reimbursement if a provider is unable to produce appropriate billing documentation or acceptable medical authorizations.

 

10


Table of Contents

Insurance Programs and Costs

We maintain workers’ compensation, general and professional liability, automobile, directors’ and officers’ liability, fiduciary liability and excess liability insurance. We offer various health insurance plans to eligible full-time and part-time employees. We believe our insurance coverage and self-insurance reserves are adequate for our current operations. However, we cannot assure you that any potential losses or asserted claims will not exceed such insurance coverage and self-insurance reserves.

Employees

The following is a breakdown of our part- and full-time employees, as well as the employees in our National Support Center, as of December 31, 2012:

 

     Full-time      Part-time      Total  

Continuing Operations – Home and Community Based Services

     2,554         11,130         13,684   

Discontinued Operations – Home Health Business

     262         430         692   

National Support Center

     123         29         152   
  

 

 

    

 

 

    

 

 

 

Total

     2,939         11,589         14,528   
  

 

 

    

 

 

    

 

 

 

Our home and community based service aides provide substantially all of our services and comprise approximately 90% of our total workforce. In most cases, our home and community based services aides undergo a criminal background check, and are provided with pre-service training and orientation and an evaluation of their skills. In many cases, home and community based services aides are also required to attend ongoing in-services education. In certain states, our home and community based services aides are required to complete certified training programs and maintain a state certification; however, no state in which we operate requires home and community based services aides to maintain a license similar to that of a nurse or therapist. Approximately 73% of our total employees are represented by labor unions. We maintain strong working relationships with these labor unions. Our local labor agreements are renegotiated as they expire, which will occur at various times throughout 2013.

Our Technology

We have licensed the Horizon Homecare software solution from McKesson Information Solutions, LLC, or McKesson, to address our administrative, office, clinical and operating information system needs, including compliance with the Health Insurance Portability and Accountability Act, or HIPAA, requirements. Horizon Homecare assists our staff in gathering information to improve the quality of consumer care, optimize financial performance, adjust consumer mix, promote regulatory compliance and enhance staff efficiency. Horizon Homecare supports intake, personnel scheduling, office clinical and reimbursement management in an integrated database. The Horizon Homecare software is hosted by McKesson in a secure data center, which provides multiple redundancies for storage, power, bandwidth and security. Using this technology, we are able to standardize the care delivered across our network of locations and effectively monitor our performance and consumer outcomes. We have also leveraged this technology to implement a centralized billing and collections function at our national support center.

We have developed internally a highly scalable customized payroll management system. This system has been utilized to calculate and produce our payroll. This software is integrated with Horizon Homecare and other clinical data-management systems, and includes a feature for general ledger population, tax reporting, managing wage assignments and garnishments, on-site check printing, direct-deposit paychecks, and customizable heuristic analytical controls. Secure management reports are made available centrally and through our internal reporting module. This system was designed, and is continually maintained and updated, to satisfy our unique payroll and reporting needs with a minimum amount of operator training and labor.

 

11


Table of Contents

We utilize commercial vendors for electronic visit verification pursuant to which our home and community based service aids record their beginning and ending times for services provided through either an interactive voice recognition (IVR) system or cell phone based system.

Government Regulation

Overview

Our business is subject to extensive and increasing federal, state and local regulation. Changes in the law or new interpretations of existing laws may have a dramatic effect on the definition of permissible activities, the relative cost of doing business, and the methods and amounts of payment for care by both governmental and other payors. Departments of the federal government are currently considering how to implement programs and policy changes and mandated demonstration projects in the Health Reform Act. As a result of the Health Reform Act, it is expected that the number of Medicaid beneficiaries will increase (although several states in which we operate have declined to expand Medicaid eligibility) and in addition, there may be additional increases if employers terminate their employee health plans. It is impossible to know at this time what effect, if any, this will have on budgetary allocations for our services. The health care industry has experienced, and is expected to continue to experience, extensive and dynamic change. In addition, differences among state laws may impede our ability to expand into certain markets. If we fail to comply with applicable laws and regulations, we could suffer civil or criminal penalties, including the loss of our licenses to operate and our ability to participate in federal or state programs. See also “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Overview.”

Medicaid Participation

To participate in and qualify for reimbursement under Medicaid programs, we are subject to various requirements imposed by federal and state authorities. If we were to violate the applicable federal and state regulations, we could be excluded from participation in federal and state healthcare programs and be subject to substantial civil and criminal penalties.

Health Reform Act

The Health Reform Act, commonly referred to as Affordable Care Act, includes several provisions that may affect reimbursement for our services. The Health Reform Act is broad, sweeping reform, and is subject to change, including through the adoption of related regulations, the way in which its provisions are interpreted and the manner in which it is enforced. Although the Health Reform Act provides for expansion of eligibility for Medicaid enrollment, 14 states, including some in which we do business, have opted not to participate in Medicaid expansion. The Health Reform Act also creates within CMS a Center for Medicare and Medicaid Innovation, or CMMI, to test innovative payment and service delivery systems to reduce program expenditures while maintaining or enhancing quality. Among the issues that are to be addressed by CMMI are: allowing the states to test new models of care for individuals dually eligible for Medicare and Medicaid, supporting “continuing care hospitals” that offer post acute care during the 30 days following discharge, funding home health providers that offer chronic care management services, and establishing pilot programs that bundle acute care hospital services with physician services and post-acute care services, including home health services for patients with certain selected conditions. We may have difficulty negotiating for a fair share of the bundled payment. In addition, we may be unfairly penalized if a consumer is readmitted to the hospital within 30 days of discharge for reasons beyond our control.

It is difficult to predict the impact of the Health Reform Act due to its complexity, as well as our inability to foresee how individuals and businesses will respond to the choices afforded them by the law. We may be unable to mitigate any adverse effects resulting from the Health Reform Act. We cannot assure you that the provisions described above, or that any other provisions of the Health Reform Act, will not adversely impact our business, results of operations or financial position.

 

12


Table of Contents

Permits and Licensure

Our home and community based services are authorized and / or licensed under various state and county requirements. Our home and community based aides generally have no licensure requirements, although in certain states, they are required to complete training programs and maintain state certification. We believe we are currently licensed appropriately where required by the laws of the states in which we operate, but additional licensing requirements may be imposed upon us in existing markets or markets that we enter in the future.

Federal and State Anti-Kickback Laws

For purposes of the federal health care programs, including Medicaid and Medicare, the federal government enforces the federal Anti-Kickback Law that prohibits the offer, payment, solicitation or receipt of any remuneration to or from any person or entity to induce or in exchange for the referral of patients covered by federal health care programs. The federal Anti-Kickback Law also prohibits the purchasing, leasing, ordering or arranging for any item, facility or service covered by the government payment programs (or the recommendation thereof) in exchange for such referrals. In the absence of an applicable safe harbor that may be available, a violation of the Anti-Kickback Law may occur even if only one purpose of a payment arrangement is to induce patient referrals. The federal Anti-Kickback Law is very broad in scope and is subject to modifications and differing interpretations. Violations are punishable by criminal fines, civil penalties, imprisonment or exclusion from participation in reimbursement programs. States, including Illinois, Nevada and California also have similar laws proscribing kickbacks, some of which are not limited to services for which government-funded payment may be made. As a result of amendments to the Anti-Kickback Law in the Health Reform Act, it is not necessary to prove either knowledge of the law or the specific intent to violate it in order to prove liability.

Stark Laws

We may also be affected by the federal Ethics in Patient Referral Act or physician referral law, known as the “Stark Law.” The Stark Law prohibits physicians from making a referral for certain health care items or services, including home health services, if they, or their family members, have a financial relationship with the entity receiving the referral unless the financial relationship meets an exception in the Stark Law or its regulations. No bill may be submitted for reimbursement in connection with a prohibited referral. Violations are punishable by civil monetary penalties on both the person making the referral and the provider rendering the service. Such persons or entities are also subject to exclusion from federal and state healthcare programs. We believe our compensation agreements with physicians who served as medical directors in our home health agencies meet the requirements for the personal services exception and that our operations comply with the Stark Law.

Many states, including Illinois, Nevada and California, have also enacted statutes similar in scope and purpose to the Stark Law. These state laws may mirror the federal Stark Laws or may be broader in scope, as they generally apply regardless of payor and may apply to other licensed health care professionals in addition to physicians. The available guidance and enforcement activity associated with such state laws vary considerably. Some states also have laws that prohibit certain direct or indirect payments or fee-splitting arrangements between health care providers, if such arrangements are designed to induce or to encourage the referral of patients to a particular provider.

Beneficiary Inducement Prohibition

The federal Civil Monetary Penalties Law (“CMPL”) imposes substantial penalties for offering remuneration or other inducements to influence federal health care beneficiaries’ decisions to seek specific governmentally reimbursable items or services, or to choose particular providers. The CMPL also can be used for civil prosecution of the Anti-Kickback Law. Sanctions under the CMPL include substantial financial penalties as well as exclusion from participation in all federal and state health care programs.

 

13


Table of Contents

The False Claims Act

Under the federal False Claims Act, the government may fine any person, company or corporation that knowingly submits, or participates in submitting, claims for payment to the federal government which are false or fraudulent, or which contain false or misleading information. Any such person or entity that knowingly makes or uses a false record or statement to avoid paying the federal government may also be subject to fines under the False Claims Act. Private parties may initiate whistleblower lawsuits against any person or entity under the False Claims Act in the name of the government and may share in the proceeds of a successful suit. The penalty for violation of the False Claims Act is a minimum of $5,500 and a maximum of $11,000 for each fraudulent claim plus three times the amount of damages caused to the government as a result of each fraudulent claim. A False Claims Act violation may provide the basis for the imposition of administrative penalties as well as exclusion from participation in governmental health care programs, including Medicare and Medicaid. In addition to the False Claims Act, the federal government may use several criminal statutes to prosecute the submission of false or fraudulent claims for payment to the federal government.

The Fraud Enforcement and Recovery Act expanded the grounds for liability under the False Claims Act by providing for enforcement against any person or entity that knowingly makes, uses or causes to be made or used, a false record or statement material to a false or fraudulent claim. The statute’s definition of “claim” makes clear that this includes false records or claims made to the government or to contractors or other recipients of federal funds. Further, the new definition of “material” includes statements or records having a natural tendency to influence, or be capable of influencing, the payment or receipt of money or property. The recent amendments clarify that specific intent to defraud the government is not required for liability under the False Claims Act.

Amendments to the False Claims Act in the Health Reform Act provide that the government or a whistleblower may bring a False Claims Act case if an arrangement violates the Anti-Kickback Law. Other amendments provide that a provider must report and return overpayments within 60 days of identifying the overpayment or the claims for the services that generated the overpayments become false claims subject to the False Claims Act. Overpayments include payments for services for which the provider does not have proper documentation.

Many states, including Illinois, Nevada and California, have similar false claims statutes that impose additional liability for the types of acts prohibited by the False Claims Act.

Fraud Alerts and Advisory Opinions

From time to time, various federal and state agencies, such as the U.S. Department of Health and Human Services (“DHHS”), issue pronouncements that identify practices that may be subject to heightened scrutiny, as well as practices that may violate fraud and abuse laws. We believe, but cannot assure you, that our operations comply with the principles expressed by the Office of the Inspector General (the “OIG”) in these reports and special fraud alerts.

Combating health care fraud and abuse is a priority of President Obama’s administration. For example, in May 2009, the DHHS and the Department of Justice announced a new and aggressive interagency task force called the Health Care Fraud Prevention and Enforcement Action Team whose efforts will include, among other things, expansion of strike force teams, assistance with state Medicaid audits, and use of technology to analyze CMS data in real time.

Health Insurance Portability and Accountability Act

Health Information Privacy and Security Standards

HIPAA privacy regulations contain detailed requirements concerning the use and disclosure of individually identifiable health information by “HIPAA covered entities,” which includes our company. In addition to the

 

14


Table of Contents

privacy requirements, HIPAA covered entities must implement certain security standards to protect the integrity, confidentiality and availability of certain electronic health information. On July 14, 2010, the Office for Civil Rights of DHHS (the “OCR”) published proposed regulations to implement the Health Information Technology for Economic and Clinical Health Act (“HITECH Act”) provisions of the American Recovery and Reinvestment Act, or ARRA. The HITECH Act has imposed additional privacy and security requirements on health care providers and on their business associates. The HITECH Act also established certain health information security breach notification requirements which became effective February 22, 2010. A covered entity must notify any individual whose protected health information is “breached,” which means an unauthorized acquisition, access, use or disclosure that compromises the security or privacy of the protected health information. If the breach involves the information of 500 or more individuals in a single state or jurisdiction, the covered entity must also notify the media of the breach. If the breach involves the information of 500 or more individuals from any jurisdiction, the covered entity must also notify the Secretary of the DHHS, who will post notice of the breach on the DHHS website. Covered entities must make annual notification to the Secretary of the DHHS of all breaches of protected health information that occurred in the prior year. On January 25, 2013, the OCR issued long-awaited regulations implementing the HITECH Act requirements. The regulations become effective March 26, 2013, with a deferred compliance date of September 23, 2013. Failure to comply with the HITECH Act and its implementing regulations could result in fines and penalties that could have a material adverse effect on us.

Violations of the HIPAA privacy and security standards may result in civil or criminal penalties depending upon the nature of the violation. The HITECH Act provides for increased civil penalties for violations under HIPAA. Civil penalties are tiered according to conduct, from $100 to $50,000 per violation with a maximum penalty of $1.5 million per year for the identical violation. Criminal penalties can apply to employees of covered entities or other individuals who knowingly access, use or disclose protected health information for improper purposes with tiered fines of up to $250,000 and imprisonment for up to ten years. The OCR has stepped up enforcement of HIPAA violations and audits of covered entities and has imposed significant financial and other penalties on entities that have violated the law. Failure to comply with HIPAA could result in fines and penalties that could have a material adverse effect on us.

Most states, including Illinois, Nevada and California, also have laws that protect the privacy and security of confidential personal information. For example, California’s patient’s medical information regulation imposes penalties of up to $25,000 per patient for an initial occurrence and up to $17,500 per subsequent occurrence. These laws may be similar to or even more protective than the federal provisions. Not only may some of these state laws impose fines and penalties upon violators, but some may afford private rights of action to individuals who believe their personal information has been misused.

Anti-Fraud Provisions of HIPAA

HIPAA also defines new healthcare fraud crimes to include, among other things, knowingly and willfully attempting to defraud any health care benefit program, including as both government and private commercial plans, or knowingly and willfully falsifying or concealing a material fact or making a materially false or fraudulent statement in connection with claims for health care services. Violation of this statute is a felony and may result in fines, imprisonment and/or exclusion from governmental health care programs.

Civil Monetary Penalties

The DHHS may impose civil monetary penalties upon any person or entity that presents, or causes to be presented, certain ineligible claims for medical items or services. The amount of penalties varies, depending on the offense, from $2,000 to $50,000 per violation plus treble damages for the amount at issue and exclusion from federal health care programs, including Medicare and Medicaid. In addition, persons who have been excluded from the Medicare or Medicaid program may not retain ownership in a participating entity. Participating entities that permit continued ownership by excluded individuals, that contract with excluded individuals, and the

 

15


Table of Contents

excluded individuals themselves, may be penalized. Penalties are also applicable in certain other cases, including violations of the federal Anti-Kickback Law, payments to limit certain patient services and improper execution of statements of medical necessity.

Surveys and Audits

We are subject to routine and periodic surveys and audits by various governmental agencies and other payors. From time to time, we receive and respond to survey reports containing statements of deficiencies. Periodic and random audits conducted or directed by these agencies could result in a delay in receipt or an adjustment to the amount of reimbursements due or received under federal or state programs. Violation of the applicable federal and state health care regulations can result in excluding a health care provider from participating in the Medicare and/or Medicaid and other federal and state healthcare programs and can subject the provider to substantial civil and/or criminal penalties.

Pursuant to the Tax Relief and Health Care Act of 2006, the DHHS created a permanent and national recovery audit program to identify improper Medicare payments made on claims of health care services provided to Medicare beneficiaries. The program uses recovery audit contractors, or RACs, to identify the improper Medicare payments and protect the Medicare Trust Fund from fraud, waste and abuse. An initial demonstration project implemented in several states resulted in the return of over $900 million in overpayments to Medicare between 2005 and 2008. RACs are paid a contingent fee based on the improper payments identified. CMS also instituted Zone Program Integrity Contracts (“ZPICs”) for additional audit of Medicare providers, including home health agencies.

Environmental, Health and Safety Laws

We are subject to federal, state and local regulations governing the storage, transport, use and disposal of hazardous materials and waste products. In the event of an accident involving such hazardous materials, we could be held liable for any damages that result, and any liability could exceed the limits or fall outside the coverage of our insurance. We may not be able to maintain insurance on acceptable terms, or at all.

 

ITEM 1A. RISK FACTORS

The risks described below, and risks described elsewhere in this Form 10-K, could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows and the actual outcome of matters as to which forward-looking statements are made in this Form 10-K. The risk factors described below and elsewhere in this Form 10-K are not the only risks we face. Our business and consolidated financial condition, results of operations and cash flows may also be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions.

If any of the following risks are actually realized, our business and consolidated financial condition, results of operations and cash flows could be materially adversely affected. In that case, the trading price of our common stock could decline.

You should refer to the explanation of the qualifications and limitations on forward-looking statements under “Special Caution Concerning Forward-Looking Statements.” All forward-looking statements made by us are qualified by the risk factors described below.

 

16


Table of Contents

Changes to Medicaid, Medicaid waiver or other state and local medical and social programs could adversely affect our net service revenues and profitability.

For the year ended December 31, 2012, we derived approximately 95% of our net service revenues from continuing operations from agreements that are directly or indirectly paid for by state and local governmental agencies, such as Medicaid funded programs and Medicaid waiver programs. Governmental agencies generally condition their agreements with us upon a sufficient budgetary appropriation. If a governmental agency does not receive an appropriation sufficient to cover its contractual obligations with us, it may terminate an agreement or defer or reduce the amount of the reimbursement we receive. Almost all the states in which we operate are facing budgetary shortfalls due to the current economic downturn and the rising costs of health care, and as a result, have made, are considering or may consider making changes in their Medicaid, Medicaid waiver or other state and local medical and social programs. The Deficit Reduction Act of 2005 permits states to make benefit cuts to their Medicaid programs, which could affect the services for which states contract with us. Changes that states have made or may consider making to address their budget deficits include:

 

   

limiting increases in, or decreasing, reimbursement rates;

 

   

redefining eligibility standards or coverage criteria for social and medical programs or the receipt of home and community based services under those programs;

 

   

increasing the consumer’s share of costs or co-payment requirements;

 

   

decreasing the number of authorized hours for recipients;

 

   

slowing payments to providers;

 

   

increasing utilization of self-directed care alternatives or “all inclusive” programs; or

 

   

shifting beneficiaries to managed care programs.

Certain of these measures have been implemented by, or are proposed in, states in which we operate. For example, California has considered a number of proposals, including potential changes in eligibility standards or hours utilization and Illinois has delayed payments to providers. In 2012, we derived approximately 64% of our total net service revenues from continuing operations from services provided in Illinois, 7% of our total net service revenues from continuing operations from services provided in California and, 7% of our total net service revenues from continuing operations from services provided in Washington. Because a substantial portion of our business is concentrated in these states, any significant reduction in expenditures that pay for our services in these states and other states in which we do business may have a disproportionately negative impact on our future operating results. Provisions in the Health Reform Act increase eligibility for Medicaid, which may cause a reallocation of Medicaid funding. It is difficult to predict at this time what the effect of these changes would be on our business. If changes in Medicaid policy result in a reduction in available funds for the services we offer, our net service revenues could be negatively impacted.

Further, in an effort to control escalating Medicaid costs, states are increasingly requiring Medicaid beneficiaries to enroll in managed care plans. Under a health reform bill signed into law in January 2012, Illinois set a goal to increase the percentage of Medicaid beneficiaries in Medicaid managed care plans from the current 8% to 50% by 2015. The difficulty of getting healthcare providers to agree to sign up for the plans, however, has proved to be a stumbling block to managed care enrollment. States are also increasingly requiring Medicaid beneficiaries to work with case managers.

The Governor of Illinois has reported that state revenue is not sufficient to keep up with pension and Medicaid obligations. On February 22, 2012, the Governor of Illinois released his proposed budget for fiscal year 2013. He called for a $2.7 billion cut to the state’s $14 billion Medicaid program. Options to reach that goal include rate reduction and reform, eliminating some services, implementing utilization controls, and restricting Medicaid eligibility so that fewer people can qualify. On March 7, 2013 the Illinois Department on Aging released a letter to all providers notifying them that it was projecting it would run out of appropriations for home

 

17


Table of Contents

and community based services by March 15, 2013. We were notified shortly thereafter that substantially all billings for our services beginning on March 1, 2013 would be held for approval pending additional appropriations. While there are bills drafted to provide supplemental appropriation to the Illinois Department on Aging, those bills have not been introduced. The Governor’s budget for fiscal year 2014 was introduced on March 6, 2013 and included funding for the Illinois Department on Aging. It is not clear whether fiscal year 2013 bills will be payable with fiscal year 2014 appropriations. Absent passage of the supplemental appropriation or approval of the fiscal year 2014 budget by the General Assembly, we are at risk of not being reimbursed for services provided from March 1, 2013 through June 30, 2013. Because a substantial portion of our business is concentrated in these programs, any significant reduction in expenditures that pay for our services would have a disproportionately negative impact on our future operating results.

In February 2012, CMS agreed to allow Illinois to move forward on at least one of two efforts to combat Medicaid fraud. In January 2013, Illinois began a program to verify annually the income and residency of Medicaid beneficiaries. If Illinois identifies non-resident Medicaid beneficiaries and removes them from the Medicaid rolls or prevents non-resident individuals from becoming Medicaid beneficiaries, or if Illinois identifies Medicaid applicants or Medicaid beneficiaries who do not meet income requirements and prevents them from becoming Medicaid beneficiaries or removes beneficiaries from the Medicaid rolls, the number of consumers we serve in Illinois could be reduced, which could negatively affect our business and results of operations.

The federal government implemented in March 2013 certain budgetary reductions commonly known as sequestration. Reimbursement or authorizations for services under our programs with federal and state contracts may be reduced as a result of these actions, which could negatively impact our business and the results of operations.

State efforts to transition their home and community based programs to being administered by managed care plans could adversely affect our net service revenues and our profitability.

The Health Reform Act encourages states to integrate the state managed Medicaid home and community based programs with managed Medicare programs. The objective of these initiatives is to enhance the coordination of benefits between the two programs and to lower overall costs. The integrated programs are being structured as three year pilots. States are also transitioning their Medicaid home and community based programs to managed care without including the integration of the Medicare programs. Nationally, 27 states have initiated efforts to pursue these programs, with 17 of the 19 states in which we provide services having initiated their efforts to transition to managed care.

The timing for approval and implementation of these demonstration projects is unknown at this time. Delaware, New Jersey and New Mexico have already transitioned their home and community based services programs to managed care plans, but have not yet integrated the programs with Medicare benefit plans. Illinois, California, and Washington are in the process of implementing plans for the dual eligible population with effective dates in late 2013 and early 2014. Idaho, Oregon, Nevada, Indiana, Missouri, Pennsylvania, Alabama, North Carolina and South Carolina are pursuing some form of managed home and community based services programs and / or Medicare dual eligible programs. We cannot assure you that; we will be able to secure favorable contracts with all or some of the managed care organizations; our reimbursement under these programs will remain at current levels; the authorizations for services will remain at current levels or that our profitability will remain at levels consistent with past performance. If states in which we provide services transition their home and community based programs to managed care plans and we are not able to participate through contracts with managed care organization or otherwise, we could lose revenue generated in those states, even in states in which we currently have contracts to provide home and community based services.

The implementation of Accountable Care Organizations (ACOs) may limit our ability to increase our market share and could adversely affect our revenues.

CMS published final ACO regulations in October 2011, which established a shared savings program to facilitate coordination and cooperation among providers to improve the quality of care for Medicare fee-for-

 

18


Table of Contents

service beneficiaries and reduce unnecessary costs. CMS is encouraging healthcare providers to work together to better coordinate care for consumers. These programs are focused on efforts by hospitals and physician groups to organize the medical providers and are not directed toward home and community based service providers. If we are not included in development of these programs, or if the ACOs establish similar services to include home and community based service programs for their participants, we are at risk for losing market share. Other cost savings initiatives may be presented by the government and commercial payors to control costs and reduce hospital admissions / readmissions in which we could be financially at risk. We cannot predict at this time what effect ACOs or similar organizations may have on our company.

Changes to eligibility requirements or methods of reimbursement for home and community based services in the Illinois Department on Aging program could adversely affect our net service revenues and profitability.

We derive approximately 57% of our revenue from continuing operations from the Illinois Department on Aging programs. Since 2011 the State of Illinois has proposed various initiatives to reduce the costs of the Illinois Department on Aging program. The Governor of Illinois and department directors introduced in their fiscal year 2014 budget several initiatives to increase federal financial participation enhancement for the Medicaid programs under which we are a provider. In addition to these revenue enhancement proposals, cost savings measures were proposed to be achieved through the mandated utilization of an electronic visit verification system by all providers, changes to rules related to payments, and the establishment of parameters utilized in the authorization of hours based on specific care plan tasks. It is difficult to ascertain what impact, if any, these proposed rule changes will have on our business or if the proposed budget will be approved by the General Assembly. If these changes are implemented and have an impact on the number of hours authorized or services provided to existing consumers, our service revenues and profitability would be adversely affected.

Delays in reimbursement due to state budget deficits or otherwise have decreased, and may in the future further decrease our liquidity.

There is generally a delay between the time that we provide services and the time that we receive reimbursement or payment for these services. The majority of the 19 states in which we operate are operating with budget deficits for their current fiscal year. These and other states may in the future delay reimbursement, which would adversely affect our liquidity. Specifically, the State of Illinois is currently reimbursing us on a delayed basis, including with respect to our agreements with the Illinois Department on Aging, our largest payor. Our reimbursements from the State of Illinois could be further delayed. In addition, from time to time, procedural issues require us to resubmit claims before payment is remitted, which contributes to our aged receivables. Additionally, unanticipated delays in receiving reimbursement from state programs due to changes in their policies or billing or audit procedures may adversely impact our liquidity and working capital. Because we fund our operations primarily through the collection of accounts receivable, any delays in reimbursement would result in the need to increase borrowings under our credit facility.

Our revenue may be negatively impacted by a failure to appropriately document services, resulting delays in reimbursement and related indemnification obligations.

Reimbursement to us is conditioned upon providing the correct administrative and billing codes and properly documenting the services themselves, including the level of service provided, and the necessity for the services. If incorrect or incomplete documentation is provided or inaccurate reimbursement codes are utilized, this could result in nonpayment for services rendered and could lead to allegations of billing fraud. This could subsequently lead to civil and criminal penalties, including exclusion from government healthcare programs, such as Medicare and Medicaid. In addition, third-party payors may disallow, in whole or in part, requests for reimbursement based on determinations that certain amounts are not covered, services provided were not medically necessary, or supporting documentation was not adequate. Pursuant to the Home Health Purchase Agreement, we are obligated to indemnify the Purchasers for, among other things, (i) penalties, fines, judgments and settlement amounts arising from a violation of certain specified statutes, including the False Claims Act, the

 

19


Table of Contents

Civil Monetary Penalties Law, the federal Anti-Kickback Statute, the Ethics in Patient Referral Act or any state law equivalent in connection with the operation of the Home Health Business prior to the Closing, and (ii) any liability related to the failure of any reimbursement claim submitted to certain government programs for services rendered by the Home Health Business prior to the Closing to meet the requirements of such government programs, or any violation prior to the Closing of any health care laws. Such liabilities include amounts to be recouped by, or repaid to, such government programs as a result of improperly submitted claims for reimbursement or those discovered as a result of audits by investigative agencies. All services that we have provided that have been or may be reimbursed by Medicare are subject to retroactive adjustments and/or total denial of payments received from Medicare under various review and audit provisions included in the program regulations. The review period is generally described as six years from the date the services are provided but could be expanded to ten years under certain circumstances if fraud is found to have existed at the time of original billing. In the event that there are adjustments relating to the period prior to the Closing, we may be required to reimburse the Purchasers or the government for the amount of such adjustments, which could adversely affect our business and financial condition. In addition, timing delays may cause working capital shortages. Working capital management, including prompt and diligent billing and collection, is an important factor in achieving our financial results and maintaining liquidity. It is possible that documentation support, system problems, provider issues or industry trends may extend our collection period, which may materially adversely affect our working capital, and our working capital management procedures may not successfully mitigate this risk.

The implementation or expansion of self-directed care programs in states in which we operate may limit our ability to increase our market share and could adversely affect our revenue.

Self-directed care programs are funded by Medicaid and state and local agencies and allow the consumer to exercise discretion in selecting home and community based service providers. Consumers may hire family members, friends or neighbors to provide services that might otherwise be provided by a home and community based service agency provider, such as our company. Most states and the District of Columbia have implemented self-directed care programs, to varying degrees and for different types of consumers. States are under pressure from the federal government and certain advocacy groups to expand these programs. CMS has provided states with specific Medicaid waiver options for programs that offer person-centered planning, individual budgeting or self-directed services and support as part of the CMS Independence Plus initiative introduced in 2002 under an Executive Order of the President. Certain private foundations have also granted resources to states to develop and study programs that provide financial accounts to consumers for their long-term care needs, and counseling services to help prepare a plan of care that will help meet those needs. Expansion of these self-directed programs may erode our Medicaid consumer base and could adversely affect our net service revenues.

Failure to renew a significant agreement or group of related agreements may materially impact our revenue.

In 2012, we derived approximately 57.3% of our net service revenues from continuing operations under agreements with the Illinois Department on Aging, 3.9% of our net service revenues from continuing operations under an agreement with Nevada Medicaid and 3.9% of our net service revenues from continuing operations under an agreement with the Riverside County (California) Department of Public Social Services. Each of our agreements are generally in effect for a specific term. For example, the services we provide to the Illinois Department on Aging are provided under a number of agreements that expire at various times through 2015, while our agreement with the Riverside County Department of Public Social Services is reevaluated and subject to renewal annually. In addition, our relationship with Riverside County may change before the end of the term of our agreement, including any renewal terms, as the State of California and Riverside County are planning to enter into managed care demonstration plans whereby the services we provide to consumers in the county would become the responsibility of the contracted managed care plans. Even though our agreements are stated to be for a specific term, they are generally terminable by the counterparty upon 60 days’ notice. Our ability to renew or retain our agreements depends on our quality of service and reputation, as well as other factors over which we

 

20


Table of Contents

have little or no control, such as state appropriations and changes in provider eligibility requirements. Additionally, failure to satisfy any of the numerous technical renewal requirements in connection with our proposals for agreements could result in a proposal being rejected even if it contains favorable pricing terms. Failure to obtain, renew or retain agreements with major payors may negatively impact our results of operations and revenue. We can give no assurance these agreements will be renewed on commercially reasonable terms or at all.

Our industry is highly competitive, fragmented and market-specific, with limited barriers to entry.

We compete with home and community based service providers, home health providers, private caregivers, larger publicly held companies, privately held companies, privately held single-site agencies, hospital-based agencies, not-for-profit organizations, community-based organizations and self-directed care programs. In addition, certain governmental payors contract for services with independent providers such that our relationships with these payors are not exclusive, particularly in California. Our competition consists of home and community based service providers, home health providers, private caregivers, larger publicly traded companies, privately held companies, privately held single-site agencies, hospital-based agencies, non-for-profit organizations, community-based organizations, managed care organizations and self-directed care programs. Some of our competitors have greater financial, technical, political and marketing resources, name recognition or a larger number of consumers and payors than we do. In addition, some of these organizations offer more services than we do in the markets in which we operate. Consumers or referral sources may perceive that local service providers and not-for-profit agencies deliver higher quality services or are more responsive. These competitive advantages may limit our ability to attract and retain referrals in local markets and to increase our overall market share.

There are limited barriers to entry in providing home-based social and medical services, and the trend has been for states to eliminate many of the barriers that historically existed. For example, Illinois changed the way in which it procures home and community based service providers in 2009, allowing all providers that are willing and capable to obtain state approval and provide services. This may increase competition in that state, and because we derived approximately 64% of our net service revenues from continuing operations from services provided in Illinois in 2012, this increased competition could negatively impact our business.

Local competitors may develop strategic relationships with referral sources and payors. This could result in pricing pressures, loss of or failure to gain market share or loss of consumers or payors, any of which could harm our business. In addition, existing competitors may offer new or enhanced services that we do not provide, or be viewed by consumers as a more desirable local alternative. The introduction of new and enhanced service offerings, in combination with the development of strategic relationships by our competitors, could cause a decline in revenue, a loss of market acceptance of our services and a negative impact on our results of operations.

Our profitability could be negatively affected by a reduction in reimbursement from payors.

States such as Illinois and California are experiencing large budget deficits, which may result in lower Medicaid payments. In addition, private payors, including commercial insurance companies, could also reduce reimbursement. Any reduction in Medicaid reimbursements or imposition of copayments that dissuade the use of our services, or any reduction in reimbursement from private payors, would materially adversely affect our profitability.

 

21


Table of Contents

We are subject to extensive government regulation. Changes to the laws and regulations governing our business could negatively impact our profitability and any failure to comply with these regulations could adversely affect our business.

The federal government and the states in which we operate regulate our industry extensively. The laws and regulations governing our operations, along with the terms of participation in various government programs, impose certain requirements on the way in which we do business, the services we offer, and our interactions with consumers and the public. These requirements include matters related to:

 

   

licensure and certification;

 

   

adequacy and quality of services;

 

   

qualifications and training of personnel;

 

   

confidentiality, maintenance and security issues associated with medical records and claims processing;

 

   

relationships with physicians and other referral sources;

 

   

operating policies and procedures;

 

   

addition of facilities and services; and

 

   

billing for services.

These laws and regulations, and their interpretations, are subject to frequent change. These changes could reduce our profitability by increasing our liability, increasing our administrative and other costs, increasing or decreasing mandated services, forcing us to restructure our relationships with referral sources and providers or requiring us to implement additional or different programs and systems. Failure to comply could lead to the termination of rights to participate in federal and state-sponsored programs, the suspension or revocation of licenses and other civil and criminal penalties and a delay in our ability to bill and collect for services provided.

The Health Reform Act amended the False Claims Act to provide that a provider must report and return overpayments within 60 days of identifying the overpayment or the claims for the services that generated the overpayments become false claims subject to the False Claims Act. Overpayments include payments for services for which the provider does not have proper documentation. If we were to identify documentation failures that could not be corrected we could be required to return payments received for those claims within the mandated 60-day time period. If we fail to identify and return overpayments within the required 60-day period we could be subject to suits under the False Claims Act by the government or relators (whistleblowers). Any of these could have a material adverse impact on our business and operations.

The Health Reform Act is broad, sweeping reform, and is subject to change, including through the adoption of related regulations, the way in which its provisions are interpreted and the manner in which it is enforced. It is difficult to predict the impact of the Health Reform Act due to its complexity, lack of implementing regulations or interpretive guidance, gradual or potentially delayed implementation, court challenges and possible amendment or repeal, as well as our inability to foresee how individuals and businesses will respond to the choices afforded them by the law. We cannot assure you, however, that the provisions described above, or that any other provisions of the Health Reform Act, will not adversely impact our business, results of operations or financial results. We may be unable to mitigate any adverse effects resulting from the Health Reform Act.

While we believe that we protect individuals’ health information, if our information systems are breached, we may experience reputational harm that could adversely affect our business. Recently, the OCR, which is charged with enforcement of HIPAA, has imposed substantial fines and compliance requirements on covered entities whose employees improperly disclosed individuals’ health information.

 

22


Table of Contents

We are subject to federal and state laws that govern our employment practices. Failure to comply with these laws, or changes to these laws that increase our employment-related expenses, could adversely impact our operations.

We are required to comply with all applicable federal and state laws and regulations relating to employment, including occupational safety and health requirements, wage and hour requirements, employment insurance and equal employment opportunity laws. These laws can vary significantly among states and can be highly technical. Costs and expenses related to these requirements are a significant operating expense and may increase as a result of, among other things, changes in federal or state laws or regulations requiring employers to provide specified benefits to employees, increases in the minimum wage and local living wage ordinances, increases in the level of existing benefits or the lengthening of periods for which unemployment benefits are available. We may not be able to offset any increased costs and expenses. Furthermore, any failure to comply with these laws, including even a seemingly minor infraction, can result in significant penalties which could harm our reputation and have a material adverse effect on our business.

In addition, certain individuals and entities, known as excluded persons, are prohibited from receiving payment for their services rendered to Medicaid, Medicare and other federal and state healthcare program beneficiaries. If we inadvertently hire or contract with an excluded person, or if any of our current employees or contractors becomes an excluded person in the future without our knowledge, we may be subject to substantial civil penalties, including up to $10,000 for each item or service furnished by the excluded individual to a federal or state healthcare program beneficiary, an assessment of up to three times the amount claimed and exclusion from the program.

Under the Health Reform Act, beginning in 2014, if we continue to provide a medical plan, we will be required to provide a minimum level of coverage for all full-time employees. Should any full-time employee receive subsidized coverage through an exchange, we could be liable for an annual penalty equal to the lesser of $3,000 for each full-time employee receiving subsidized coverage or $2,000 for each of our full-time employees. The impact of these penalties may have a significant impact on our profitability. Many of our employees are not provided any medical coverage. If we determine that we will provide medical coverage for these employees, the costs could be material and have a significant effect on our profitability.

We are subject to reviews, compliance audits and investigations that could result in adverse findings that negatively affect our net service revenues and profitability.

As a result of our participation in Medicaid, Medicaid waiver, Medicare programs, Veterans Health Administration programs and other state and local governmental programs, and pursuant to certain of our contractual relationships, we are subject to various reviews, audits and investigations by governmental authorities and other third parties to verify our compliance with these programs and agreements as well as applicable laws, regulations and conditions of participation. Pursuant to the Home Health Purchase Agreement, we are obligated to indemnify the Purchasers for, among other things, (i) penalties, fines, judgments and settlement amounts arising from a violation of certain specified statutes, including the False Claims Act, the Civil Monetary Penalties Law, the federal Anti-Kickback Statute, the Ethics in Patient Referral Act or any state law equivalent in connection with the operation of the Home Health Business prior to the Closing, and (ii) any liability related to the failure of any reimbursement claim submitted to certain government programs for services rendered by the Home Health Business prior to the Closing to meet the requirements of such government programs, or any violation prior to the Closing of any health care laws. Such liabilities include amounts to be recouped by, or repaid to, such government programs as a result of improperly submitted claims for reimbursement or those discovered as a result of audits by investigative agencies. All services that we have provided that have been or may be reimbursed by Medicare are subject to retroactive adjustments and/or total denial of payments received from Medicare under various review and audit provisions included in the program regulations. The review period is generally described as six years from the date the services are provided but could be expanded to ten years under certain circumstances if fraud is found to have existed at the time of original billing. In the event that there

 

23


Table of Contents

are adjustments relating to the period prior to the Closing, we may be required to reimburse the Purchasers for the amount of such adjustments, which could adversely affect our business and financial condition. Payments we receive in respect of Medicaid and Medicare can be retroactively adjusted after a new examination during the claims settlement process or as a result of pre- or post-payment audits. Federal, state and local government payors may disallow our requests for reimbursement based on determinations that certain costs are not reimbursable because proper documentation was not provided or because certain services were not covered or deemed necessary. In addition, other third-party payors may reserve rights to conduct audits and make reimbursement adjustments in connection with or exclusive of audit activities. Significant adjustments as a result of these audits could adversely affect our revenues and profitability.

If we fail to meet any of the conditions of participation or coverage with respect to state licensure or our participation in Medicaid, Medicaid waiver, Medicare programs, Veterans Health Administration programs and other state and local governmental programs, we may receive a notice of deficiency from the applicable surveyor or authority. Failure to institute a plan of action to correct the deficiency within the period provided by the surveyor or authority could result in civil or criminal penalties, the imposition of fines or other sanctions, damage to our reputation, cancellation of our agreements, suspension or revocation of our licenses or disqualification from federal and state reimbursement programs. These actions may adversely affect our ability to provide certain services, to receive payments from other payors and to continue to operate. Additionally, actions taken against one of our locations may subject our other locations to adverse consequences. We may also fail to discover all instances of noncompliance by our acquisition targets, which could subject us to adverse remedies once those acquisitions are complete. Any termination of one or more of our locations from any federal, state or local program for failure to satisfy such program’s conditions of participation could adversely affect our net service revenues and profitability.

In 2006, the federal government launched a national pilot program utilizing independent contractors known as recovery audit contractors, or RACs, to identify and recoup Medicare overpayments. RACs are paid a contingent fee based on amounts recouped. An initial demonstration project implemented in several states resulted in the return of over $900 million in overpayments to Medicare between 2005 and 2008 from various provider types. California was the only state in which we operate that participated in the initial pilot program. The RAC program is now permanently implemented in all 50 states. This expansion may lead to an increase in the number of overpayment reviews, more aggressive audits and more claims for recoupment. If future Medicare RAC reviews result in significant refund payments, it would have an adverse effect on our financial results.

Under the RAC program, third party firms engaged by CMS conduct extensive reviews of claims data and non-medical and other records to identify potential improper payments under Medicare. In recent years, federal and state civil and criminal enforcement agencies have heightened and coordinated their oversight efforts related to the healthcare industry, including with respect to referral practices, cost reporting, billing practices, joint ventures and other financial relationships among health care providers. Medicare added the ZPIC program for audits.

Although we have invested substantial time and effort in implementing policies and procedures to comply with laws and regulations, we could be subject to liabilities arising from violations. A violation of the laws governing our operations, or changes in the interpretation of those laws, could result in the imposition of fines, civil or criminal penalties, the termination of our rights to participate in federal and state-sponsored programs or the suspension or revocation of our licenses to operate or could trigger substantial liability under our indemnification obligations described above. If we become subject to material fines or if other sanctions or other corrective actions are imposed upon us, we may suffer a substantial reduction in revenues.

Negative publicity or changes in public perception of our services may adversely affect our ability to receive referrals, obtain new agreements and renew existing agreements.

Our success in receiving referrals, obtaining new agreements and renewing our existing agreements depends upon maintaining our reputation as a quality service provider among governmental authorities, physicians,

 

24


Table of Contents

hospitals, discharge planning departments, case managers, nursing homes, rehabilitation centers, advocacy groups, consumers and their families, other referral sources and the public. While we believe that the services that we provide are of high quality, if studies mandated by Congress in the Health Reform Act to make public quality measures are implemented and if our quality measures are deemed to be not of the highest value, our reputation could be negatively affected. Negative publicity, changes in public perceptions of our services or government investigations of our operations could damage our reputation and hinder our ability to receive referrals, retain agreements or obtain new agreements. Increased government scrutiny may also contribute to an increase in compliance costs and could discourage consumers from using our services. Any of these events could have a negative effect on our business, financial condition and operating results.

In addition, in connection with the sale of our Home Health Business, we granted a license to the Purchasers that allows them to use certain of our intellectual property, including the Addus name, for the provision of skilled nursing and related physical therapy healthcare services to individuals in their homes and hospice services in California, Illinois, Arkansas, South Carolina and Nevada. Although the use of the intellectual property is required to be consistent and at least equal to the level of quality and brand perception prior to the sale, we do not have operational control over the Purchasers. As a result, home health agencies operated by the Purchasers may not be operated in a manner consistent with the standards we uphold at our agencies. If such agencies do not maintain operational standards consistent with the standards we demand of our agencies, the image and brand reputation of Addus may suffer and our business may be materially affected.

Our growth strategy depends on our ability to manage growing and changing operations and we may not be successful in managing this growth.

Our business plan calls for significant growth in business over the next several years through the expansion of our services in existing markets and the establishment of a presence in new markets. This growth will place significant demands on our management team, systems, internal controls and financial and professional resources. In addition, we will need to further develop our financial controls and reporting systems to accommodate future growth. This could require us to incur expenses for hiring additional qualified personnel, retaining professionals to assist in developing the appropriate control systems and expanding our information technology infrastructure. Our inability to effectively manage growth could have a material adverse effect on our financial results.

Future acquisitions or start-ups may be unsuccessful and could expose us to unforeseen liabilities.

Our growth strategy includes geographical expansion into new markets and the addition of new services in existing markets through the acquisition of local service providers. These acquisitions involve significant risks and uncertainties, including difficulties assimilating acquired personnel and other corporate cultures into our business, the potential loss of key employees or consumers of acquired providers, and the assumption of liabilities and exposure to unforeseen liabilities of acquired providers. In the past, we have made acquisitions that have not performed as expected or that we have been unable to successfully integrate with our existing operations. In addition, our due diligence review of acquired businesses may not successfully identify all potential issues. For example, we were unable to fully integrate one acquired business because we were unable to procure a necessary government endorsement. The failure to effectively integrate future acquisitions could have an adverse impact on our operations.

We have grown our business through start-up, or de novo, locations, and we may in the future start up new locations in existing and new markets. Start-ups involve significant risks, including those relating to licensure, accreditation, hiring new personnel, establishing relationships with referral sources and delayed or difficulty in installing our operating and information systems. We may not be successful in establishing start-up locations in a timely manner due to generating insufficient business activity and incurring higher than projected operating cost that could have a material adverse effect on our financial condition, results of operations and cash flows.

 

25


Table of Contents

We may be unable to pursue acquisitions or expand into new geographic regions without obtaining additional capital or consent from our lenders.

At December 31, 2012 and December 31, 2011, we had cash balances of $1.7 million and $2.0 million, respectively. As of December 31, 2012, we had $16.3 million outstanding on our credit facility. After giving effect to the amount drawn on our credit facility, approximately $7.4 million of outstanding letters of credit and borrowing limits based on an advanced multiple of adjusted EBITDA, we had $27.1 million available for borrowing under the credit facility as of December 31, 2012. Since our credit facility provides for borrowings based on a multiple of an EBITDA ratio, any declines experienced in our EBITDA would result in a decrease in our available borrowings under our credit facility.

We cannot predict the timing, size and success of our acquisition efforts, our efforts to expand into new geographic regions or the associated capital commitments. If we do not have sufficient cash resources or availability under our credit facility, our growth could be limited unless we obtain additional equity or debt financing. In the future, we may elect to issue additional equity securities in conjunction with raising capital, completing an acquisition or expanding into a new geographic region. Such issuances would be dilutive to existing shareholders. In addition, our credit facility prohibits us from consummating more than three acquisitions in any calendar year, and, in any event, does not permit the purchase price for any one acquisition to exceed $500,000, in each case without the consent of the lenders. The consideration we paid in connection with nine of the 12 acquisitions we completed exceeded $500,000. In addition, our credit facility requires, among other things, that we are in pro forma compliance with the financial covenants set forth therein and that no event of default exists before and after giving effect to any proposed acquisition. Our ability to expand in a manner consistent with historic practices may be limited if we are unable to obtain such consent from our lenders.

Access to additional capital and credit markets, at a reasonable cost, may be necessary for us to fund our operations, including potential acquisitions and working capital requirements. We currently rely on one financial institution for funding under our credit facility and any instability in the financial markets or the negative impact of local, national and worldwide economic conditions on that financial institution could impact our short and long-term liquidity needs to meet our business requirements.

Divestitures could negatively affect our continuing business.

We sold the Home Health Business to the Purchasers, effective March 1, 2013. We expect that the sale of the Home Health Business will enable us to realize certain long-term cost savings from reduced administrative overhead and headcount, however, there can be no assurances that these cost savings will be achieved in full or at all. Our assumptions underlying estimates of anticipated cost savings may be inaccurate and projected cost savings may therefore fall short of targets. In addition, future business conditions and events may impede our ability to continue to realize any benefits of our divestiture. Divestitures involve a number of risks and present financial, managerial and operational challenges, including diversion of management attention from running our core businesses, increased expense and potential disputes with the acquirers of the divested business. We may not successfully manage these or other risks we may confront in divesting a business, which could have an adverse effect on our continuing business.

As a result of the indemnification provisions of the Home Health Purchase Agreement pursuant to which we sold Home Health Business, we may incur expenses and liabilities related to periods up to the date of sale or pursuant to our other indemnification obligations thereunder.

As a result of the indemnification provisions of the Home Health Purchase Agreement pursuant to which we sold the Home Health Business, we have agreed to indemnify the Purchasers for, among other things, (i) penalties, fines, judgments and settlement amounts arising from a violation of certain specified statutes, including the False Claims Act, the Civil Monetary Penalties Law, the federal Anti-Kickback Statute, the Ethics

 

26


Table of Contents

in Patient Referral Act or any state law equivalent in connection with the operation of the Home Health Business prior to the Closing, and (ii) any liability related to the failure of any reimbursement claim submitted to certain government programs for services rendered by the Home Health Business prior to the Closing to meet the requirements of such government programs, or any violation prior to the Closing of any health care laws. Such liabilities include amounts to be recouped by, or repaid to, such government programs as a result of improperly submitted claims for reimbursement or those discovered as a result of audits by investigative agencies. All services that we have provided that have been or may be reimbursed by Medicare are subject to retroactive adjustments and/or total denial of payments received from Medicare under various review and audit provisions included in the program regulations. The review period is generally described as six years from the date the services are provided but could be expanded to ten years under certain circumstances if fraud is found to have existed at the time of original billing. In the event that there are adjustments relating to the period prior to the Closing, we may be required to reimburse the Purchasers for the amount of such adjustments, which could adversely affect our business and financial condition.

In addition, pursuant to the Home Health Purchase Agreement, we are obligated to indemnify the Purchasers for breaches of representations, warranties and covenants, certain taxes and liabilities related to the pre-Closing period (other than specifically identified assumed liabilities). Any liability we have to the Purchasers under the Home Health Purchase Agreement could adversely affect our results of operations.

Our business may be harmed by labor relations matters.

We are subject to a risk of work stoppages and other labor relations matters because our hourly workforce is highly unionized. As of December 31, 2012, approximately 73% of our hourly workforce was represented by two national unions, including the Service Employees International Union, which is our largest union. Our local labor agreements will be negotiated as they expire, which will occur at various times through 2013. Upon expiration of these collective bargaining agreements, we may not be able to negotiate labor agreements on satisfactory terms with these labor unions. A strike, work stoppage or other slowdown could result in a disruption of our operations and/or higher ongoing labor costs, which could adversely affect our business. Labor costs are the most significant component of our total expenditures and, therefore, an increase in the cost of labor could significantly harm our business.

We are subject to federal and state laws that govern our financial relationships with physicians and other health care providers, including potential or current referral sources.

We are required to comply with federal and state laws, generally referred to as “anti-kickback laws,” that prohibit certain direct and indirect payments or other financial arrangements that are designed to encourage the referral of patients to a particular medical services provider. In addition, certain financial relationships, including ownership interests and compensation arrangements, between physicians and providers of designated health services, such as our company, to whom those physicians refer patients, are prohibited by the Stark Law and similar state laws. Under both the Stark Law, there are a number of exceptions that permit certain carefully constrained relationships. Courts or regulatory agencies may interpret the federal Anti-Kickback Law, the Stark Law and similar state laws regulating relationships between health care providers and physicians in ways that will implicate our business. Provisions in the Health Reform Act make it easier to prosecute an Anti-Kickback Law violation as it is no longer necessary for the government to prove that a person had the specific intent to violate the statute. The Health Reform Act permits the government or a whistleblower to file an action under the False Claims Act if there an arrangement that violates the Anti-Kickback Law. In addition, the DHHS may withhold payments if it believes in its discretion that there is credible evidence of fraud. Violations of these laws could lead to fines and exclusions or other sanctions that could have a material adverse effect on our business.

We are required to comply with laws governing the transmission privacy, and security of health information.

HIPAA requires us to comply with standards for the exchange of health information within our company and with third parties, such as payors, business associates and consumers. These include standards for common

 

27


Table of Contents

health care transactions, such as claims information, plan eligibility, payment information, the use of electronic signatures, unique identifiers for providers, employers, health plans and individuals and security, privacy and enforcement. The HITECH Act amended HIPAA to impose new requirements for protecting the privacy and security of individuals’ health information, requirements to notify individuals and in some circumstances the media if there is a breach of individuals’ health information, and imposed a four-tier system of enhanced financial penalties. While we believe that we protect individuals’ health information, if our information systems are breached, we may experience reputational harm that could adversely affect our business. Recently, the OCR, which is charged with enforcement of HIPAA, has imposed substantial fines and compliance requirements on covered entities whose employees improperly disclosed individuals’ health information. On January 25, 2013, OCR issued long-awaited regulations implementing the HITECH Act requirements. The regulations became effective March 26, 2013, with a deferred compliance date for most provisions of September 23, 2013.

Violations of the HIPAA privacy and security standards may result in civil or criminal penalties depending upon the nature of the violation. The HITECH Act provides for increased civil penalties for violations under HIPAA. Civil penalties are tiered according to conduct, from $100-$50,000 per violation with a maximum penalty of $1.5 million per year for the identical violation. Criminal penalties can apply to employees of covered entities or other individuals who knowingly access, use or disclose protected health information for improper purposes with tiered fines of up to $250,000 and imprisonment for up to ten years. The OCR has stepped up enforcement of HIPAA violations and auditing of covered entities and has imposed significant financial and other penalties on entities that have violated the law. Failure to comply with HIPAA could result in fines and criminal and civil penalties that could have a material adverse effect on us.

Our operations subject us to risk of litigation.

Operating in the home and community based services industry exposes us to an inherent risk of wrongful death, personal injury, professional malpractice and other potential claims or litigation brought by our consumers and employees. Because we operate in this industry, from time to time, we are subject to claims alleging that we did not properly treat or care for a consumer that we failed to follow internal or external procedures that resulted in death or harm to a consumer or that our employees mistreated our consumers, resulting in death or harm. We are also subject to claims arising out of accidents involving vehicle collisions brought by consumers whom we are transporting or from employees driving to or from home visits. We operate five adult day centers which provide transportation for our elderly and disabled consumers. Each of our vehicles transports seven to 14 passengers to and from our locations. The concentration of consumers in one vehicle increases the risk of larger claims being brought against us in the event of an accident.

In addition, regulatory agencies may initiate administrative proceedings alleging violations of statutes and regulations arising from our services and seek to impose monetary penalties on us. We could be required to pay substantial amounts to respond to regulatory investigations or, if we do not prevail, damages or penalties arising from these legal proceedings. We also are subject to potential lawsuits under the False Claims Act or other federal and state whistleblower statutes designed to combat fraud and abuse in our industry. These lawsuits can involve significant monetary awards or penalties which may not be covered by our insurance. If our third-party insurance coverage and self-insurance coverage reserves are not adequate to cover these claims, it could have a material adverse effect on our business, results of operations and financial condition. Even if we are successful in our defense, civil lawsuits or regulatory proceedings could distract us from running our business or irreparably damage our reputation.

Our insurance liability coverage may not be sufficient for our business needs.

Although we maintain insurance consistent with industry practice, the insurance we maintain may not be sufficient to satisfy all claims made against us. For example, we have a $350,000 deductible per person/per

 

28


Table of Contents

occurrence under our workers’ compensation insurance program. We cannot assure you that claims will not be made in the future in excess of the limits of our insurance, and any such claims, if successful and in excess of such limits, may have a material adverse effect on our business or assets. We utilize historical data to estimate our reserves for our insurance programs. If losses on asserted claims exceed the current insurance coverage and accrued reserves, our business, results of operations and financial condition could be adversely affected. Changes in our annual insurance costs and self-insured retention limits depend in large part on the insurance market, and insurance coverage may not continue to be available to us at commercially reasonable rates, in adequate amounts or on satisfactory terms.

Inclement weather or natural disasters may impact our ability to provide services.

Inclement weather may prevent our employees from providing authorized services. We are not paid for authorized services that are not delivered due to these weather events. Furthermore, prolonged inclement weather or the occurrence of natural disasters in the markets in which we operate could disrupt our relationships with consumers, employees and referral sources located in affected areas and, in the case of our corporate office, our ability to provide administrative support services, including billing and collection services. For example, our corporate headquarters and a number of our agencies are located in the Midwestern United States and California, increasing our exposure to blizzards and other major snowstorms, ice storms, tornados, flooding and earthquakes. Future inclement weather or natural disasters may adversely affect our business and consolidated financial condition, results of operations and cash flows.

Our business depends on our information systems. Our operations may be disrupted if we are unable to effectively integrate, manage and maintain the security of our information systems.

Our business depends on effective and secure information systems that assist us in, among other things, gathering information to improve the quality of consumer care, optimizing financial performance, adjusting consumer mix, monitoring regulatory compliance and enhancing staff efficiency. We rely on an external service provider, McKesson, to provide continual maintenance, upgrading and enhancement of our primary information systems used for our operational needs. The software we license from McKesson supports intake, personnel scheduling, office clinical and centralized billing and receivables management in an integrated database, enabling us to standardize the care delivered across our network of locations and monitor our performance and consumer outcomes. To the extent that McKesson becomes insolvent or fails to support the software or systems, or if we lose our license with McKesson, our operations could be negatively affected.

We also depend upon a proprietary payroll management system that includes a feature for general ledger population, tax reporting, managing wage assignments and garnishments, on-site check printing, direct-deposit paychecks and customizable heuristic analytical controls. If we experience a reduction or interruption in the performance, reliability or availability of our information systems, or fail to restore our information systems after such a reduction or interruption, our operations and ability to produce timely and accurate reports could be adversely affected. The operation of this system is dependent on the knowledge and talents of a limited number of company employees. Should these individuals terminate their employment, our ability to adequately support or maintain the system could be materially affected.

Because of the confidential health information and consumer records we store and transmit, loss of electronically-stored information for any reason could expose us to a risk of regulatory action, litigation and liability.

If we experience a reduction in the performance, reliability, or availability of our information systems, our operations and ability to process transactions and produce timely and accurate reports could be adversely affected. If we experience difficulties with the transition and integration of information systems or are unable to implement, maintain, or expand our systems properly, we could suffer from, among other things, operational disruptions, regulatory problems, and increases in administrative expenses.

 

29


Table of Contents

We do not have full redundancy of all of our information systems. Should our support center become inoperable as a result of a natural disaster or terrorist acts, it would take substantial amount of time and resources to restore our business to the current state of operation. This risk is becoming even more critical as we are centralizing more of our business operations. The disruption to the business would be material and would affect our operational and financial performance.

Our business requires the secure transmission of confidential information over public networks. Advances in computer capabilities, new discoveries in the field of cryptography or other events or developments could result in compromises or breaches of our security systems and consumer data stored in our information systems. Anyone who circumvents our security measures could misappropriate our confidential information or cause interruptions in our services or operations. The Internet is a public network, and data is sent over this network from many sources. In the past, computer viruses or software programs that disable or impair computers have been distributed and have rapidly spread over the Internet. Computer viruses could be introduced into our systems which could disrupt our operations or make our systems inaccessible. We may be required to expend significant capital and other resources to protect against the threat of security breaches or to alleviate problems caused by breaches. Our security measures may be inadequate to prevent security breaches, and our business operations would be negatively impacted by cancellation of contracts and loss of consumers if security breaches are not prevented.

The agreements that govern our credit facility contain various covenants that limit our discretion in the operation of our business and we have agreed to negotiate new terms.

Our credit facility agreement requires us to comply with customary financial and non-financial covenants. The financial covenants require us to maintain a maximum fixed charge ratio and a maximum leverage ratio, and limit our capital expenditures. Our credit facility also includes non-financial covenants including restrictions on our ability to:

 

   

transfer assets, enter into mergers, make acquisitions or experience fundamental changes;

 

   

make investments, loans and advances;

 

   

incur additional indebtedness and guarantee obligations;

 

   

create liens on assets;

 

   

enter into affiliate transactions;

 

   

enter into transactions other than in the ordinary course of business;

 

   

incur capital lease obligations; and

 

   

make capital expenditures.

We have agreed, as a condition to receiving our lender’s consent to the sale of the Home Health Business, to renegotiate the terms of our current credit facility including a potential reduction in the amount of the maximum revolving loan limit and commitment. This could result in a reduction of our available credit or increases to our costs. These changes along with the restrictions in our current credit facility could impose significant operating and financial restrictions on our ability to take actions that may be in our best interests.

Our current principal stockholders have significant influence over us, and they could delay, deter or prevent a change of control or other business combination or otherwise cause us to take action with which you might not agree.

Eos Capital Partners III, L.P. and Eos Partners SBIC III, L.P., or the Eos Funds, together beneficially own approximately 37.2% of our outstanding common stock as of December 31, 2012. As a result, the Eos Funds have the ability to significantly influence all matters submitted to our stockholders for approval, including:

 

   

changes to the composition of our board of directors, which has the authority to direct our business and appoint and remove our officers;

 

30


Table of Contents
   

proposed mergers, consolidations or other business combinations; and

 

   

amendments to our certificate of incorporation and bylaws which govern the rights attached to our shares of common stock.

In addition, two of our directors are affiliated with the Eos Funds.

This concentration of ownership of shares of our common stock could delay or prevent proxy contests, mergers, tender offers, open-market purchase programs or other purchases of shares of our common stock that might otherwise give you the opportunity to realize a premium over the then-prevailing market price of our common stock. The interests of the Eos Funds may not always coincide with the interests of the other holders of our common stock. This concentration of ownership may also adversely affect our stock price.

We may not be able to attract, train and retain qualified personnel.

We must attract and retain qualified personnel in the markets in which we operate in order to provide our services. We compete for personnel with other providers of social and medical services as well as companies in other service-based industries. Competition may be greater for skilled personnel, such as regional and agency directors. Our ability to attract and retain personnel depends on several factors, including our ability to provide employees with attractive assignments and competitive benefits and salaries.

The loss of one or more of the members of the executive management team or the inability of a new management team to successfully execute our strategies may adversely affect our business. If we are unable to attract and retain qualified personnel, we may be unable to provide our services, the quality of our services may decline, and we could lose consumers and referral sources.

We may be more vulnerable to the effects of a public health catastrophe than other businesses due to the nature of our consumers.

The majority of our consumers are older individuals with complex medical challenges, many of whom may be more vulnerable than the general public during a pandemic or in a public health catastrophe. Our employees are also at greater risk of contracting contagious diseases due to their increased exposure to vulnerable consumers. For example, if a flu pandemic were to occur, we could suffer significant losses to our consumer population or a reduction in the availability of our employees and, at a high cost, be required to hire replacements for affected workers. Accordingly, certain public health catastrophes could have a material adverse effect on our financial condition and results of operations.

We depend on the services of our executive officers and other key employees.

Our success depends upon the continued employment of certain members of our senior management team. We also depend upon the continued employment of the individuals that manage several of our key functional areas, including operations, business development, accounting, finance, human resources, marketing, information systems, contracting and compliance. The departure of any member of our senior management team may materially adversely affect our operations.

If we were required to write down all or part of our goodwill and/or our intangible assets, our net earnings and net worth could be materially adversely affected.

Goodwill and intangible assets with finite lives represent a significant portion of our assets. Goodwill represents the excess of cost over the fair market value of net assets acquired in business combinations. If our market capitalization drops significantly below the amount of net equity recorded on our balance sheet, it might indicate a decline in our fair value and would require us to further evaluate whether our goodwill has been

 

31


Table of Contents

impaired. If as part of our annual review of goodwill and intangibles, we were required to write down all or a significant part of our goodwill and/or intangible assets, our net earnings and net worth could be materially adversely affected, which could affect our flexibility to obtain additional financing. In addition, if our assumptions used in preparing our valuations of our reporting units for purposes of impairment testing differ materially from actual future results, we may record impairment charges in the future and our financial results may be materially adversely affected. We had $50.5 million of goodwill and $6.4 million of intangible assets recorded on our consolidated balance sheet at December 31, 2012.

It is not possible at this time to determine if there will be any future impairment charge, or if there is, whether such charges would be material. We will continue to review our goodwill and other intangible assets for possible impairment. We cannot be certain that a downturn in our business or changes in market conditions will not result in an impairment of goodwill or other intangible assets and the recognition of resulting expenses in future periods, which could adversely affect our results of operations for those periods.

The market price of our common stock may be volatile and this may adversely affect our stockholders.

The price at which our common stock trades may be volatile. The stock market has recently experienced significant price and volume fluctuations that have affected the market prices of all securities, including securities of health care companies. The market price of our common stock may be influenced by many factors, including:

 

   

our operating and financial performance;

 

   

variances in our quarterly financial results compared to expectations;

 

   

the depth and liquidity of the market for our common stock;

 

   

we have a small base of registered shares of common stock consisting of the 5.4 million shares we issued in our initial public offering (“IPO”), which represents approximately 49.8% of our total common shares outstanding, that could result in significant stock price movements upward or downward based on low levels of trading volume in our common stock;

 

   

future sales of common stock or the perception that sales could occur;

 

   

investor perception of our business and our prospects;

 

   

developments relating to litigation or governmental investigations;

 

   

changes or proposed changes in health care laws or regulations or enforcement of these laws and regulations, or announcements relating to these matters; or

 

   

general economic and stock market conditions.

In addition, the stock market in general has experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of homecare companies. These broad market and industry factors may materially reduce the market price of our common stock, regardless of our operating performance. In the past, securities class-action litigation has often been brought against companies following periods of volatility in the market price of their respective securities. We have been and may become involved in this type of litigation in the future. Litigation of this type is often expensive to defend and may divert our management team’s attention as well as resources from the operation of our business.

We do not anticipate paying dividends on our common stock in the foreseeable future and, consequently, your ability to achieve a return on your investment will depend solely on appreciation in the price of our common stock.

We do not pay dividends on our shares of common stock and intend to retain all future earnings to finance the continued growth and development of our business and for general corporate purposes. In addition, we do not

 

32


Table of Contents

anticipate paying cash dividends on our common stock in the foreseeable future. Any future payment of cash dividends will depend upon our financial condition, capital requirements, earnings and other factors deemed relevant by our board of directors.

If securities or industry analysts fail to publish research or reports about our business or publish negative research or reports, or our results are below analysts’ estimates, our stock price and trading volume could decline.

The trading market for our common stock may depend in part on the research and reports that industry or securities analysts publish about us or our business. We do not have any control over these analysts. If analysts fail to publish reports on us regularly or at all, we could fail to gain visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. If one or more analysts do cover us and downgrade their evaluations of our stock or our results are below analysts’ estimates, our stock price would likely decline. In addition, due to the small number of analysts covering us, a single comment or report from one of the analysts whether positive or negative, could result in a significant increase or decrease in our stock price.

Provisions in our organizational documents and Delaware law could delay or prevent a change in control of our company, which could adversely affect the price of our common stock.

Provisions in our amended and restated certificate of incorporation and bylaws and anti-takeover provisions of the Delaware General Corporation Law, could discourage, delay or prevent an unsolicited change in control of our company, which could adversely affect the price of our common stock. These provisions may also have the effect of making it more difficult for third parties to replace our current management without the consent of the board of directors. Provisions in our amended and restated certificate of incorporation and bylaws that could delay or prevent an unsolicited change in control include:

 

   

a staggered board of directors;

 

   

limitations on persons authorized to call a special meeting of stockholders; and

 

   

the authorization of undesignated preferred stock, the terms of which may be established and shares of which may be issued without stockholder approval.

As a Delaware corporation, we are subject to Section 203 of the Delaware General Corporation Law. This section generally prohibits us from engaging in mergers and other business combinations with stockholders that beneficially own 15% or more of our voting stock, or with their affiliates, unless our directors or stockholders approve the business combination in the prescribed manner. However, because the Eos Funds acquired their shares prior to our IPO, Section 203 is currently inapplicable to any business combination with the Eos Funds or their affiliates. In addition, our amended and restated bylaws require that any stockholder proposals or nominations for election to our board of directors must meet specific advance notice requirements and procedures, which make it more difficult for our stockholders to make proposals or director nominations.

If we fail to achieve and maintain effective internal control over financial reporting, our business and stock price could be adversely impacted.

Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, requires our management to report on, and may require our independent registered public accounting firm to attest to, the effectiveness of our internal controls over financial reporting. Compliance with SEC regulations adopted pursuant to Section 404 of the Sarbanes Oxley Act requires annual management assessments of the effectiveness of our internal control over financial reporting. As a smaller reporting company, we have historically been exempt from the requirement under Section 404(b) of the Sarbanes Oxley Act that an independent registered public accounting firm attest to the effectiveness of our internal controls over financial reporting. However, it is probable that we will be required to comply with the reporting requirements under Section 404(b) of the Sarbanes-Oxley Act in the near future

 

33


Table of Contents

since the value of our publicly held shares, those not controlled by insiders, has increased and may cross the threshold for becoming an accelerated filer. Compliance with Section 404 of the Sarbanes-Oxley Act our legal and financial compliance costs makes some activities more difficult, time-consuming or costly and may also place strain on our personnel, systems and resources.

The NASDAQ is circulating a proposed rule change to require all registered companies to have an internal audit function. We do not currently have an internal audit function. If passed this rule change would require us to make additions to our staff and/or engage third party consultants to be in compliance with this requirement.

Compliance with public reporting and Sarbanes-Oxley Act requirements requires us to continually evaluate the adequacy of, and in some cases expand our compliance, accounting and finance staff. In connection with the implementation of the necessary procedures and practices related to internal control over financial reporting, we may identify deficiencies or material weaknesses that we may not be able to remediate in time to meet the deadline imposed by the Sarbanes-Oxley Act for compliance with the requirements of Section 404. Implementing any appropriate changes to our internal controls may require specific compliance training of our directors, officers and employees, entail substantial costs to modify our existing accounting systems, and take a significant period of time to complete. Such changes may not, however, be effective in maintaining the adequacy of our internal controls, and any failure to maintain that adequacy, or consequent inability to produce accurate financial statements on a timely basis, could increase our operating costs and could materially impair our ability to operate our business. Moreover, if we fail to satisfy the requirements of Section 404 on a timely basis, we could be subject to regulatory scrutiny and sanctions, our ability to raise capital could be impaired, investors may lose confidence in the accuracy and completeness of our financial reports and our stock price could be adversely affected. In addition, we could have undetected internal control weaknesses and deficiencies if we continue to not be required to comply with Section 404(b) of the Sarbanes-Oxley Act, which would require our independent registered public accounting firm to attest to the effectiveness of our internal controls over financial reporting.

Compliance with changing regulations including specific program compliance, corporate governance and public disclosure will result in additional expenses and pose challenges for our management team.

The state agencies who contract for our services require our compliance with various rules and regulations affecting the services we provide. We have a compliance officer who monitors and reports on our efforts for achieving the desired results. State agencies are recommending increased rules and regulations in an effort to control the growth of these programs and their overall costs. The implementation of these changes may require the Company to increase their efforts to remain compliant, may reduce the authorizations for services to be provided, may result in certain consumers no longer being eligible for our services all of which may result in lower revenues and increased costs, reducing our operating performance and profitability. If we continue to serve our consumers without addressing these increased regulations we are at risk for non-compliance with program requirements and potential penalties.

Changing laws, regulations and standards relating to corporate governance and public disclosure, including the Dodd-Frank Wall Street Reform and Consumer Protection Act and the rules and regulations promulgated there-under, the Sarbanes-Oxley Act and SEC regulations, have created uncertainty for public companies and significantly increased the costs and risks associated with accessing the U.S. public markets. We are committed to maintaining high standards of internal controls over financial reporting, corporate governance and public disclosure. As a result, we intend to continue to invest appropriate resources to comply with evolving standards, and this investment has resulted and will likely continue to result in increased general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance activities.

Declines in earnings could create future liquidity problems.

The availability of funds under the revolving credit portion of our credit facility is based on the lesser of (i) the product of adjusted EBITDA, as defined, for the most recent 12-month period multiplied by the specified

 

34


Table of Contents

advance multiple, up to 3.25, less the outstanding senior indebtedness and letters of credit or (ii) $55.0 million less the outstanding revolving loans and letters of credit. As of December 31, 2012 our total availability under our credit facility was $27.1 million.

The current Federal and state economic and reimbursement environments and state budgetary pressures to decrease or eliminate services we provide could negatively affect our future earnings. This decrease in earnings would reduce the availability of funds under our credit facility which could have a negative impact on our future operating results.

 

ITEM 1B. Unresolved Staff Comments

None.

 

ITEM 2. PROPERTIES

We do not own any real property. As of December 31, 2012, we operated at 118 leased properties including our National Support Center. Home and community based services are operated out of 96 of these facilities, while the Home Health Business, which was sold effective March 1, 2013, was operated out of 22 of these facilities. As part of the sale of the Home Health Business, nine of the leased facilities were assigned to the Purchasers and all or a portion of 13 of the facilities were subleased to the Purchasers. We lease approximately 27,462 square feet of an office building in Palatine, Illinois, which serves as our corporate headquarters, from a member of our board of directors and the former Chairman of Addus HealthCare.

 

ITEM 3. LEGAL PROCEEDINGS

From time to time, we are subject to claims and suits arising in the ordinary course of our business, including claims for damages for personal injuries. In our management’s opinion, the ultimate resolution of any of these pending claims and legal proceedings will not have a material adverse effect on our financial position or results of operations.

 

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

 

35


Table of Contents

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock has been trading on The Nasdaq Global Market under the symbol “ADUS” since our IPO on October 27, 2009. Prior to that time, there was no public market for our common stock. The holders of our common stock are entitled to one vote per share on any matter to be voted upon by stockholders. All shares of common stock rank equally as to voting and all other matters. The table below sets forth the high and low sales prices for our common stock, as reported by The Nasdaq Global Market, for each of the periods indicated.

 

     High      Low  

2012

     

Fourth Quarter

   $ 7.49       $ 5.25   

Third Quarter

     5.38         4.29   

Second Quarter

     5.30         3.67   

First Quarter

     5.05         3.21   

2011

     

Fourth Quarter

   $ 4.08       $ 3.25   

Third Quarter

     6.10         4.02   

Second Quarter

     6.09         4.98   

First Quarter

     5.23         4.15   

Holders

As of December 31, 2012, 46.8% of our shares were held by Company insiders. An additional 23.4% of the stock was held by 10 institutional investors. The total number of record holders as of December 31, 2012 was 30.

Dividends

Historically, we have not paid dividends on our common stock, and we currently do not intend to pay any dividends on our common stock. We currently plan to retain any earnings to support the operation, and to finance the growth, of our business rather than to pay cash dividends. Payments of any cash dividends in the future will depend on our financial condition, results of operations and capital requirements as well as other factors deemed relevant by our board of directors. Our credit facility restricts our ability to declare or pay any dividend or other distribution unless no default then exists or would occur as a result thereof, and we are in pro forma compliance with the financial covenants contained in our credit facility after giving effect thereto.

Equity Compensation Plan

The following table presents securities authorized for issuance under our equity compensation plans at December 31, 2012.

 

Plan Category

   Number of Securities to be
Issued Upon Exercise of
Outstanding Options,
Warrants and Rights (1)
     Weighted-Average
Exercise Price of
Outstanding Options,
Warrants and Rights (2)
     Number of  Securities
Remaining Available for
Future Issuance Under
Equity Compensation
Plans (Excluding
Securities Reflected in
the First Column) (3)
 

Equity Compensation Plans Approved by Security Holders

     638,629       $ 8.11         981,127   

Equity Compensation Plans Not Approved by Security Holders

                       
  

 

 

    

 

 

    

 

 

 

Total

     638,629       $ 8.11         981,127   
  

 

 

    

 

 

    

 

 

 

 

(1) Includes both grants of stock options and unvested share awards.

 

(2) Includes weighted-average exercise price of outstanding stock options only.

 

(3) Represents shares of common stock that may be issued pursuant to our 2006 stock incentive plan (the “2006 Plan”) or our 2009 stock incentive plan (the “2009 Plan”). We do not plan on issuing any further grants under the 2006 Plan. There are 435,068 shares of common stock that may be issued pursuant to the 2009 Plan.

 

36


Table of Contents
ITEM 6. SELECTED FINANCIAL DATA

The following table sets forth selected financial information derived from our consolidated financial statements for the periods and at the dates indicated. The information is qualified in its entirety by and should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.

 

     2012     2011     2010     2009     2008  
     (in thousands, except per share data)  

Consolidated Statements of Operations Data:

          

Net service revenues (1)

   $ 244,315      $ 230,105      $ 230,099      $ 219,921      $ 197,885   

Cost of service revenues

     180,264        168,632        170,376        162,734        147,293   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     64,051        61,473        59,723        57,187        50,592   

General and administrative expenses (4)

     46,362        45,858        47,042        45,137        38,564   

Revaluation of contingent consideration (6)

     —          (469 )     —          —          —     

Gain on sale of agency

     (495     —          —          —          —     

Depreciation and amortization

     2,521        3,167        3,408        4,144        5,159   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     48,388        48,556        50,450        49,281        43,723   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income from continuing operations

     15,663        12,917        9,273        7,906        6,869   

Interest income (7)

     (155 )     (2,263 )     (155     —          —     

Interest expense (2)

     1,723        2,524        3,159        6,773        5,755   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total interest expense, net

     1,568        261        3,004        6,773        5,755   

Income from continuing operations before income taxes

     14,095        12,656        6,269        1,133        1,114   

Income tax expense (benefit)

     4,807        4,244        1,902        (94     (454 )
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income from continuing operations

     9,288        8,412        4,367        1,227        1,568   

Less: Preferred stock dividends, undeclared subject to payment upon conversion; declared and converted in November 2009

     —          —          —          (5,387     (4,270 )
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) from continuing operations attributable to common shareholders

     9,288        8,412        4,367        (4,160     (2,702
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Discontinued Operations

          

Net income (loss) from home health business (5)

     (1,653 )     (10,393     1,661        2,375        2,455   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 7,635      $ (1,981   $ 6,028      $ (1,785   $ (247
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Basic and diluted income (loss) per common share:

          

Continuing operations

   $ 0.86      $ 0.78      $ 0.41      $ (1.54   $ (2.65

Discontinued operations

     (0.15     (0.96     0.16        0.88        2.41   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Basic and diluted income (loss) per common share:

   $ 0.71      $ (0.18 )   $ 0.57      $ (0.66 )   $ (0.24 )
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares and potential common shares outstanding:

          

Basic

     10,764        10,752        10,604        2,707        1,019   

Diluted

     10,784        10,752        10,606        2,707        1,019   

 

37


Table of Contents
     2012     2011     2010     2009     2008  

Key Metrics:

          

General:

          

Adjusted EBITDA (in thousands) (3)

   $ 15,786      $ 15,200      $ 16,293      $ 16,985      $ 17,212   

States served at period end

     19        19        19        16        16   

Locations at period end

     96        96        107        101        101   

Employees at period end

     13,836        12,463        11,716        10,940        10,371   

Operational Data:

          

Average billable census

     25,104        23,877        23,743        22,768        22,935   

Billable hours (in thousands)

     14,388        13,504        13,599        13,377        12,636   

Average billable hours per census per month

     48        47        48        49        46   

Billable hours per business day

     55,126        51,938        52,103        51,253        48,414   

Revenues per billable hour

   $ 16.98      $ 17.04      $ 16.92      $ 16.44      $ 15.66   

Percentage of Revenues by Payor:

          

State, local or other governmental

     95     94     93     94     95

Commercial

     1        1        1        1        1   

Private duty

     4        5        6        5        4   
     2012     2011     2010     2009     2008  
     (in thousands)  

Consolidated Balance Sheet Data:

          

Cash

   $ 1,737      $ 2,020      $ 816      $ 518      $ 6,113   

Accounts receivable, net of allowances

     71,303        72,368        70,954        70,491        49,237   

Goodwill and intangibles

     56,906        58,739        77,500        72,564        64,961   

Total assets

     149,857        154,692        166,924        161,315        135,748   

Total debt

     16,458        31,527        45,185        49,239        63,176   

Stockholders’ equity

     94,417        86,441        88,091        80,567        34,575   

 

(1) Acquisitions completed in 2010 included in 2011 accounted for $4.9 million of growth in net service revenues from continuing operations for the year ended December 31, 2011 compared to the year ended December 31, 2010, and included $4.6 million of growth in net service revenues from continuing operations for the year ended December 31, 2010 compared to the year ended December 31, 2009. Acquisitions completed in 2008 included in 2009 accounted for $3.7 million of growth in net service revenues from continuing operations for the year ended December 31, 2009 compared to the year ended December 31, 2008.

 

(2) During 2009 we incurred one-time charges relating to our IPO which included $1.2 million of separation costs related to the former Chairman of Addus HealthCare which was charged to general and administrative expenses; a charge to interest expense pursuant to a contingent payment agreement in which an amount equal to $12.7 million was paid upon the completion of our IPO, of which $1.8 million was deemed interest expense; and the write-off of $0.8 million in unamortized debt issuance costs relating to our former credit facility that was charged to interest expense.

 

(3) We define Adjusted EBITDA as earnings before goodwill and intangible asset impairment charge, revaluation of contingent consideration, net interest (income) expense, taxes, depreciation, amortization, and stock-based compensation expense. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

 

38


Table of Contents

Management believes that Adjusted EBITDA is useful to investors, management and others in evaluating our operating performance for the following reasons:

 

   

By reporting Adjusted EBITDA, we believe that we provide investors with insight and consistency in our financial reporting and present a basis for comparison of our business operations between current, past and future periods. Adjusted EBITDA allows management, investors and others to evaluate and compare our core operating results, including return on capital and operating efficiencies, from period to period, by removing the impact of our capital structure (interest expense), asset base (amortization and depreciation), tax consequences and non-cash stock-based compensation expense from our results of operations, and also facilitates comparisons with the core results of our public company peers.

 

   

We believe that Adjusted EBITDA is a measure widely used by securities analysts, investors and others to evaluate the financial performance of other public companies, and therefore may be useful as a means of comparison with those companies, when viewed in conjunction with traditional GAAP financial measures.

 

   

We adopted ASC Topic 718 “Share-Based Payment,” on September 19, 2006, the effective date of our 2006 Plan, and recorded stock-based compensation expense of $0.3 million per year for the years ended December 31, 2012, 2011, 2010, 2009 and 2008, respectively. By comparing our Adjusted EBITDA in different periods, our investors can evaluate our operating results without stock-based compensation expense, which is a non-cash expense that is not a key measure of our operations.

In addition, management has chosen to use Adjusted EBITDA as a performance measure because the amount of non-cash expenses, such as depreciation, amortization and stock-based compensation expense, may not directly correlate to the underlying performance of our business operations, and because such expenses can vary significantly from period to period as a result of new acquisitions, full amortization of previously acquired tangible and intangible assets or the timing of new stock-based awards, as the case may be. This facilitates internal comparisons to historical operating results, as well as external comparisons to the operating results of our competitors and other companies in the home and community based services industry. Because management believes Adjusted EBITDA is useful as a performance measure, management uses Adjusted EBITDA:

 

   

as one of our primary financial measures in the day-to-day oversight of our business to allocate financial and human resources across our organization, to assess appropriate levels of marketing and other initiatives and to generally enhance the financial performance of our business;

 

   

in the preparation of our annual operating budget, as well as for other planning purposes on a quarterly and annual basis, including allocations in order to implement our growth strategy, to determine appropriate levels of investments in acquisitions and to endeavor to achieve strong core operating results;

 

   

to evaluate the effectiveness of business strategies, such as the allocation of resources, the mix of organic growth and acquisitive growth and adjustments to our payor mix;

 

   

as a means of evaluating the effectiveness of management in directing our core operating performance, which we consider to be performance that can be affected by our management in any particular period through their allocation and use of resources that affect our underlying revenue and profit-generating operations during that period;

 

   

for the valuation of prospective acquisitions, and to evaluate the effectiveness of integration of past acquisitions into our company; and

 

   

in communications with our board of directors concerning our financial performance.

 

39


Table of Contents

Although Adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results of operations as reported under GAAP. Some of these limitations include:

 

   

Adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or other contractual commitments;

 

   

Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

 

   

Adjusted EBITDA does not reflect interest expense or interest income;

 

   

Adjusted EBITDA does not reflect cash requirements for income taxes;

 

   

although depreciation and amortization are non-cash charges, the assets being depreciated or amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for these replacements;

 

   

Adjusted EBITDA does not reflect any goodwill and intangible asset impairment charges;

 

   

Adjusted EBITDA does not reflect any revaluation of contingent consideration;

 

   

Adjusted EBITDA does not reflect any preferred stock dividends;

 

   

Adjusted EBITDA does not reflect any stock based compensation; and

 

   

other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.

Management compensates for these limitations by using GAAP financial measures in addition to Adjusted EBITDA in managing the day-to-day and long-term operations of our business. We believe that consideration of Adjusted EBITDA, together with a careful review of our GAAP financial measures, is the most informed method of analyzing our company.

The following table sets forth a reconciliation of net income, the most directly comparable GAAP measure, to Adjusted EBITDA:

 

     Year Ended December 31,  
     2012     2011     2010     2009     2008  
     (in thousands)  

Reconciliation of Adjusted EBITDA to net income (loss):

          

Net income (loss)

   $ 7,635      $ (1,981 )   $ 6,028      $ (1,785   $ (247

Preferred stock dividends

     —         —         —         5,387        4,270   

Goodwill and intangible asset impairment charge

     —         15,989        —         —         —    

Revaluation of contingent consideration

     —         (469 )     —         —         —    

Interest income

     (155     (2,263 )     (155     —         —    

Interest expense

     1,723        2,524        3,159        6,773        5,755   

Income tax expense (benefit) from continuing and discontinued operations

     3,708        (2,485     2,960        1,400        1,070   

Depreciation and amortization

     2,534        3,554        4,046        4,913        6,092   

Stock-based compensation expense

     341        331        255        297        272   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 15,786      $ 15,200      $ 16,293      $ 16,985      $ 17,212   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

The selected historical consolidated statements of operations data for the fiscal years ended December 31, 2012, 2011 and 2010 and the balance sheet data as of December 31, 2012 and 2011, were derived from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K. The

 

40


Table of Contents

selected historical consolidated statements of operations data for the years ended December 31, 2009 and 2008, and the balance sheet data as of December 31, 2009 and 2008 were derived from our audited consolidated financial statements which are not included in this Annual Report on Form 10-K.

 

(4) Adjusted EBITDA for 2009 includes a $1.2 million charge related to the separation agreement with the former Chairman of Addus HealthCare.

 

(5) During December 2012, in anticipation of the sale of the Home Health Business we reported the operating results of our Home Health Business as discontinued operations. On February 7, 2013, we entered into the Home Health Purchase Agreement with the Purchasers. In 2011, we determined that all of the $16.0 million allocated to goodwill and intangible assets for our home health reportable unit was impaired and recorded an impairment loss of $16.0 million.

 

(6) Adjusted EBITDA for 2011 includes a $0.5 million non-cash gain for the revaluation of contingent consideration originally estimated for the purchase of assets from Advantage.

 

(7) Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received. We recorded prompt payment interest income of $0.2 million, $2.3 million and $0.2 million in the years ended December 31, 2012, 2011 and 2010, respectively.

 

41


Table of Contents
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with our consolidated financial statements and the related notes included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements about our business and operations. Our actual results may differ materially from those we currently anticipate as a result of the factors we describe under “Risk Factors” and elsewhere in this Annual Report on Form 10-K.

Overview

We are a comprehensive provider of home and community based services, which are primarily social in nature and are provided in the home, focused on the dual eligible population. Our services include personal care and assistance with activities of daily living, and adult day care. Our consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Our payor clients include federal, state and local governmental agencies, commercial insurers and private individuals. We provide home and community based services through over 96 locations across 19 states to over 25,000 consumers.

Effective March 1, 2013, we sold substantially all of the assets used in our Home Health Business in Arkansas, Nevada and South Carolina, and 90% of the Home Health Business in California and Illinois, to the Purchasers for a cash purchase price of approximately $20 million. We retained a 10% ownership interest in the Home Health Business in California and Illinois. The assets sold included 19 home health agencies and two hospice agencies in five states. Through these home health agencies, we previously provided physical, occupational and speech therapy, as well as skilled nursing services, to pediatric, adult infirm and elderly patients. We are also holding as assets for sale two agencies located in Idaho and Pennsylvania. The results of the Home Health Business sold or held for sale are reflected as discontinued operations for all periods presented herein. Continuing operations include the results of operations previously included in our home & community segment and three agencies previously included in our home health segment. Following the sale of the Home Health Business, we manage and internally report our business in one segment.

We believe the sale of the Home Health Business substantially positions us for future growth. The sale allows us to focus both management and financial resources to address changes in the home and community based services industry and to address the needs of managed care organizations as they become responsible for state sponsored programs. We have improved our financial performance by lowering our administrative costs and concentrating our efforts on the business that is growing and providing all of our profitability and disposing of the business that was unprofitable. We have improved our overall financial position by eliminating our debt and adding substantial amounts in cash reserves to our balance sheet. A summary of our results for 2012 and 2011 are provided in the table below:

 

     2012     2011     Percent
Change
 

Net service revenues – continuing operations

   $ 244,315      $ 230,105        6.2

Net service revenues – discontinued operations

     38,822        42,995        (9.7 )% 

Net income from continuing operations

     9,288        8,412        10.4

(Loss) from discontinued operations

     (1,653     (10,393     N/A   
  

 

 

   

 

 

   

Net income (loss)

   $ 7,635      $ (1,981     N/A   
  

 

 

   

 

 

   

The home and community based services we provide are primarily social in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. We provide these services on a long-term, continuous basis, with an average duration of approximately 17 months per consumer. Our adult day centers provide a comprehensive program of skilled and support services and designated medical services for adults in a community-based group setting. Services provided by our adult

 

42


Table of Contents

day centers include social activities, transportation services to and from the centers, the provision of meals and snacks, personal care and therapeutic activities such as exercise and cognitive interaction.

We utilize a coordinated care model that is designed to enhance consumer outcomes and satisfaction as well as lower the cost of acute care treatment and reduce service duplication. Through our coordinated care model, we utilize our home care aides to observe and report changes in the condition of our consumers for the purpose of early intervention in the disease process, thereby preventing or reducing the cost of medical services by avoiding emergency room visits, and/or reducing the need of hospitalization. These changes in condition are evaluated by appropriately trained managers and referred to appropriate medical personnel including the primary care physicians and managed care plans for treatment and follow-up. We will coordinate the services provided by our team with those of selected health care agencies. We believe this approach to the provision of care to our consumers and the integration of our services into the broader healthcare industry is particularly attractive to managed care providers and others who are ultimately responsible for the healthcare needs of our consumers and over time will increase our business with them.

Our ability to grow our net service revenues is closely correlated with the number of consumers to whom we provide our services. Our continued growth depends on our ability to maintain our existing payor client relationships, establish relationships with new payors, enter into new contracts and increase our referral sources. Our continued growth is also dependent upon the authorization by state agencies of new consumers to receive our services. We believe there are several market opportunities for growth. The U.S. population of persons aged 65 and older is growing, and the U.S. Census Bureau estimates that this population will more than double by 2050. Additionally, we believe the overwhelming majority of individuals in need of care generally prefer to receive care in their homes or community-based settings. Finally, we believe the provision of home and community based services is more cost-effective than the provision of similar services in an institutional setting for long-term care.

We have historically grown our business primarily through organic growth, complemented with selective acquisitions. Our acquisitions have historically been focused on facilitating entry into new states.

On July 26, 2010, we entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which we acquired the operations and certain assets of Advantage Health Systems, Inc., a South Carolina corporation (“Advantage”). Advantage is a provider of home and community based services in South Carolina and Georgia, which expanded our services across 19 states. The total consideration payable pursuant to the Purchase Agreement was $8.3 million, comprised of $5.1 million in cash, common stock consideration with a deemed value of $1.2 million resulting in the issuance of 248,000 common shares, a maximum of $2.0 million in future cash consideration subject to the achievement of certain performance targets set forth in an earn-out agreement and the assumption of certain specified liabilities. In April 2011, we paid the first earn-out payment of $0.5 million to the sellers of Advantage. During the fourth quarter of 2011 we completed a revaluation of the remaining contingent earn-out obligation and recorded a reduction of approximately $0.5 million with a remaining obligation of $0.7 million as of December 31, 2012.

 

43


Table of Contents

Business

The results of the Home Health Business sold are reflected as discontinued operations for all periods presented herein. Continuing operations include the results of operations previously included in our home & community segment and three agencies previously included in our home health segment. Following the sale of the Home Health Business, we manage and internally report our business in one segment. The following table presents our locations (including the locations disposed of in connection with the sale of our Home Health Business), acquisitions, start-ups and closures for the period January 1, 2010 to December 31, 2012:

 

     Total  

Total as previously reported December 31, 2010

     129   

Home health offices reported as discontinued operations in 2012

     (22
  

 

 

 

Total at December 31, 2010

     107   
  

 

 

 

Closed/Merged

     (11
  

 

 

 

Total at December 31, 2011

     96   
  

 

 

 

Start-up

     1   

Closed/Merged

     (1 )
  

 

 

 

Adjusted Total at December 31, 2012

     96   
  

 

 

 

As of December 31, 2012, we provided our home and community based services through 96 locations across 19 states.

Our payor clients are principally federal, state and local governmental agencies. The federal, state and local programs under which they operate are subject to legislative, budgetary and other risks that can influence reimbursement rates. Our commercial insurance carrier payor clients are typically for profit companies and are continuously seeking opportunities to control costs. We are seeking to grow our private duty business.

For 2012, 2011 and 2010, our payor revenue mix for continuing operations was:

 

     2012     2011     2010  

State, local and other governmental programs

     94.9     93.5     92.7 %

Commercial

     1.0        1.3        1.2   

Private duty

     4.1        5.2        6.1   
  

 

 

   

 

 

   

 

 

 
     100.0     100.0     100.0
  

 

 

   

 

 

   

 

 

 

We derive a significant amount of our net service revenues from our continuing operations in Illinois and California, which represented 64% and 7%; 58% and 8%; and 53% and 11% of our total net service revenues from continuing operations for the years ended December 31, 2012, 2011 and 2010, respectively.

A significant amount of our net service revenues from continuing operations are derived from one payor client, the Illinois Department on Aging, which accounted for 57%, 51% and 45% of our total net service revenues from continuing operations for the years ended December 31, 2011, 2010 and 2009, respectively.

We also measure the performance of our business using a number of different metrics. We consider billable hours, billable hours per business day, revenues per billable hour and the number of consumers, or census.

 

44


Table of Contents

Components of our Statements of Operations

Net Service Revenues

We generate net service revenues from continuing operations by providing our services directly to individuals. We receive payment for providing such services from our payor clients, including federal, state and local governmental agencies, commercial insurers and private individuals.

Net service revenues from continuing operations are typically generated based on services rendered and reimbursed on an hourly basis. Our net service revenues from continuing operations were generated principally through reimbursements by state, local and other governmental programs which are partially funded by Medicaid programs, and to a lesser extent from private duty and insurance programs. Net service revenues from continuing operations are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate, which is either contractual or fixed by legislation, and recognized as net service revenues at the time services are rendered.

Cost of Service Revenues

We incur direct care wages, payroll taxes and benefit-related costs from continuing operations in connection with providing our services. We also provide workers’ compensation and general liability coverage for these employees.

Employees are also reimbursed for their travel time and related travel costs.

General and Administrative Expenses

Our general and administrative expenses from continuing operations consist of expenses incurred in connection with our activities and as part of our central administrative functions.

Our general and administrative expenses from continuing operations consist principally of supervisory personnel, care coordination and office administration costs. These expenses include wages, payroll taxes and benefit-related costs; facility rent; operating costs such as utilities, postage, telephone and office expenses; and bad debt expense. We have initiated efforts to centralize administrative tasks currently conducted at the branch locations. The costs related to these initiatives are included in the general and administrative expenses from continuing operations. Other centralized expenses from continuing operations include administrative departments of accounting, information systems, human resources, billing and collections and contract administration, as well as national program coordination efforts for marketing and private duty. These expenses primarily consist of compensation, including stock-based compensation, payroll taxes, and related benefits; legal, accounting and other professional fees; rents and related facility costs; and other operating costs such as software application costs, software implementation costs, travel, general insurance and bank account maintenance fees.

Depreciation and Amortization Expenses

We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks and non-compete agreements, principally on accelerated methods based upon their estimated useful lives. Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment, and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if applicable, their lease terms.

Interest Income

Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period

 

45


Table of Contents

of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the income statement caption, interest income. While we may be owed additional prompt payment interest, the amount and timing of receipt of such payments remains uncertain and we have determined that we will continue to recognize prompt payment interest income when received. The state amended its prompt payment interest terms, effective July 1, 2011, which changed the measurement period for outstanding invoices from a 60-day to a 90-day outstanding period. We believe this change in terms will reduce future amounts paid for prompt payment interest.

Interest Expense

Interest expense from continuing operations consists of interest costs on our credit facility and other debt instruments.

Income Tax Expense

All of our income from continuing operations is from domestic sources. We incur state and local taxes in states in which we operate. The differences from the federal statutory rate of 34% are principally due to state taxes and the use of federal employment tax credits.

Discontinued Operations

Discontinued operations consists of the results of operations, net of tax for our Home Health Business that was sold effective March 1, 2013 and the results of operations for assets held for sale.

 

46


Table of Contents

Results of Operations

Year Ended December 31, 2012 Compared to Year Ended December 31, 2011

The following table sets forth, for the periods indicated, our consolidated results of operations.

 

     2012     2011     Change  
     Amount     % of
Net Service
Revenues
    Amount     % of
Net Service
Revenues
    Amount     %  
     (in thousands, except percentages)  

Net service revenues

   $ 244,315        100.0   $ 230,105        100.0   $ 14,210        6.2

Cost of service revenues

     180,264        73.8        168,632        73.3        11,632        6.9   
  

 

 

     

 

 

     

 

 

   

Gross profit

     64,051        26.2        61,473        26.7        2,578        4.2   

General and administrative expenses

     46,362        19.0        45,858        19.9        504        1.1   

Revaluation of contingent consideration

     —          —          (469 )     (0.2 )     469        (100.0 )

Gain on sale of agency

     (495     (0.2 )     —          —          (495     *   

Depreciation and amortization

     2,521        1.0        3,167        1.4        (646     (20.4 )
  

 

 

     

 

 

     

 

 

   

Total operating expenses

     48,388        19.8        48,556        21.1        (168     (0.3 )

Operating income from continuing operations

     15,663        6.4        12,917        5.6        2,746        21.3   
  

 

 

     

 

 

     

 

 

   

Interest income

     (155     (0.1 )     (2,263 )     (1.0 )     2,108        (93.2

Interest expense

     1,723        0.7        2,524        1.1        (801     (31.7 )

Total interest expense, net

     1,568        0.6        261        0.1        1,307        500.8   
  

 

 

     

 

 

     

 

 

   

Income from continuing operations before income taxes

     14,095        5.8        12,656        5.5        1,439        11.4   

Income tax expense

     4,807        2.0        4,244        1.8        563        13.3   
  

 

 

     

 

 

     

 

 

   

Net income from continuing operations

     9,288        3.8        8,412        3.7        876        10.4   
  

 

 

     

 

 

     

 

 

   

Discontinued operations:

            

Earnings (loss) from home health business, net of tax

     (1,653     (0.7     (10,393     (4.5     8,740        (84.1
  

 

 

     

 

 

     

 

 

   

Net income (loss)

   $ 7,635        3.1   $ (1,981     (0.9 )%    $ 9,616        485.4
  

 

 

     

 

 

     

 

 

   

Business Metrics

            

Average billable census

     25,104          23,877          1,277        5.1

Billable hours (in thousands)

     14,388          13,504          884        6.5   

Average Billable hours per census per month

     48          47          1        2.1   

Billable hours per business day

     55,126          51,938          3,188        6.1   

Revenues per billable hour

   $ 16.98        $ 17.04        $ (0.06     (0.4 )% 

 

* 

Percentage information not meaningful

Net service revenues from state, local and other governmental programs accounted for 94.9% and 93.5% of net service revenues for 2012 and 2011, respectively. Private duty and, to a lesser extent, commercial payors accounted for the remainder of net service revenues.

Net service revenues increased $14.2 million, or 6.2%, to $244.3 million for 2012 compared to $230.1 million for the same period in 2011. The increase was primarily due to a 5.1% increase in average census increase and a related 6.5% increase in billable hours.

Gross profit, expressed as a percentage of net service revenues, decreased to 26.2% for 2012, from 26.7% in 2011. This decrease as a percent of revenue of 0.5% is primarily due to an increase in workers’ compensation costs as a result of an increase in average claim costs during 2012, partially offset by an increase in the average billed hours per census per month while leveraging the fixed wage cost for field staff.

 

47


Table of Contents

General and administrative expenses, expressed as a percentage of net service revenues decreased to 19.0% for 2012, from 19.9% in 2011. General and administrative expenses increased to $46.4 million in 2012 as compared to $45.9 million in 2011. In 2012, we had cost increases in administrative wages, telecom and technology related costs, an increase in management bonuses, an increase in corporate infrastructure and consulting expenses for business development initiatives which were partially offset by a decrease in bad debt expense due to improved collections and a decrease in legal related expenses.

Depreciation and amortization, expressed as a percentage of net service revenues, decreased to 1.0% for 2012, from 1.4% in 2011. Amortization of intangibles, which are principally amortized using accelerated methods, totaled $1.7 million and $2.2 million for 2012 and 2011, respectively.

Interest Income

Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the income statement caption, interest income. We received $0.2 million in prompt payment interest in 2012 and $2.3 million in 2011. While we may be owed additional prompt payment interest, the amount and timing of receipt of such payments remains uncertain and we have determined that we will continue to recognize prompt payment interest income when received. The state amended its prompt payment interest terms, effective July 1, 2011, which changed the measurement period for outstanding invoices from a 60-day to a 90-day outstanding period. We believe this change in terms will reduce future amounts paid for prompt payment interest.

Interest Expense

Interest expense was $1.7 million and $2.5 million for 2012 and 2011, respectively. Interest expense decreased $0.8 million primarily due to a reduction in outstanding debt.

Income Tax Expense (Benefit)

Our effective tax rates from continuing operations for 2012 and 2011 were 34.1% and 33.5%, respectively. The principal difference between the Federal and State statutory rates and our effective tax rate is the use of Federal employment opportunity tax credits. Our effective tax rate for 2012 does not include any earned 2012 Federal employment opportunity tax credits, which will be recognized in 2013 as the Federal employment opportunity tax credits were reinstated in January 2013.

Discontinued Operations

During the fourth quarter of fiscal year 2012, we announced that we were pursuing strategic alternatives for our Home Health Business, and in February 2013, we entered into the Home Health Purchase Agreement. Therefore, we have segregated the Home Health Business operating results and presented them separately as discontinued operations for all periods presented (see note 2 – “Discontinued Operations” of the Notes to the Consolidated Financial Statements included elsewhere herein).

 

48


Table of Contents

See the table below that depicts the results of discontinued operations.

 

     2012     2011     Change  
     Amount     % of  Net
Service
Revenues
    Amount     % of  Net
Service
Revenues
    Amount     %  
     (in thousands, except percentages)  

Net service revenues

   $ 38,822        100.0   $ 42,995        100.0   $ (4,173     (9.7 )% 

Cost of service revenues

     20,818        53.6        22,673        52.7        (1,855     (8.2 )
  

 

 

     

 

 

     

 

 

   

Gross profit

     18,004        46.4        20,322        47.3        (2,318     (11.4

General and administrative expenses

     20,743        53.4        21,068        49.0        (325     (1.5 )

Goodwill and intangible asset impairment charge

     —          —          15,989        37.2        (15,989     (100.0 )

Depreciation and amortization

     13        —          387        0.9        (374     (96.6
  

 

 

     

 

 

     

 

 

   

Operating income (loss) from discontinued operations

     (2,752     (7.1     (17,122 )     (39.8     14,370        (83.9
  

 

 

     

 

 

     

 

 

   

Income tax (benefit)

     (1,099     (2.8     (6,729     (15.7     5,630        83.7   
  

 

 

     

 

 

     

 

 

   

Net loss from discontinued operations

   $ (1,653     (4.3 )%    $ (10,393     (24.2 )%    $ 8,740        (84.1 )% 
  

 

 

     

 

 

     

 

 

   

The losses were primarily due to reduced sales, higher costs to treat consumers and our inability to reduce fixed general and administrative costs at a rate consistent with revenue declines. We recorded an impairment charge of $16.0 million as part of discontinued operations in 2011 to reduce the carrying value of the related goodwill and intangible assets.

 

49


Table of Contents

Results of Operations

Year Ended December 31, 2011 Compared to Year Ended December 31, 2010

The following table sets forth, for the periods indicated, our consolidated results of operations.

 

     2011     2010     Change  
     Amount     % of
Net Service
Revenues
    Amount     % of
Net Service
Revenues
    Amount     %  
     (in thousands, except percentages)  

Net service revenues

   $ 230,105        100.0   $ 230,099        100.0   $ 6        0.0

Cost of service revenues

     168,632        73.3        170,376        74.0        (1,744     (1.0
  

 

 

     

 

 

     

 

 

   

Gross profit

     61,473        26.7        59,723        26.0        1,750        2.9   

General and administrative expenses

     45,858        19.9        47,042        20.4        (1,184     (2.5 )

Revaluation of contingent consideration

     (469 )     (0.2 )     —          —          (469             

Depreciation and amortization

     3,167        1.4        3,408        1.5        (241     (7.1 )
  

 

 

     

 

 

     

 

 

   

Total operating expenses

     48,556        21.1        50,450        21.9        (1,894     (3.8 )
  

 

 

     

 

 

     

 

 

   

Operating income from continuing operations

     12,917        5.6        9,273        4.0        3,644        39.3   
  

 

 

     

 

 

     

 

 

   

Interest income

     (2,263 )     (1.0 )     (155     (0.1 )     (2,108     1,360.0   

Interest expense

     2,524        1.1        3,159        1.4        (635     (20.1 )

Total interest expense, net

     261        0.1        3,004        1.3        (2,743     (91.3
  

 

 

     

 

 

     

 

 

   

Income from continuing operations before income taxes

     12,656        5.5        6,269        2.7        6,387        101.9   

Income tax expense

     4,244        1.8        1,902        0.8        2,342        123.1   
  

 

 

     

 

 

     

 

 

   

Net income from continuing operations

     8,412        3.7        4,367        1.9        4,045        92.6   
  

 

 

     

 

 

     

 

 

   

Discontinued operations:

            

Earnings (loss) from home health business, net of tax

     (10,393     (4.5     1,661        0.7        (12,054     (725.7
  

 

 

     

 

 

     

 

 

   

Net income (loss)

   $ (1,981     (0.9 )%    $ 6,028        2.6   $ (8,009     (132.9 )% 
  

 

 

     

 

 

     

 

 

   

Business Metrics

            

Average billable census

     23,877          23,743          134        0.6

Billable hours (in thousands)

     13,504          13,599          (95     (0.7

Average billable hours per census per month

     47          48          (1     (2.1

Billable hours per business day

     51,938          52,103          (165     (0.3

Revenues per billable hour

   $ 17.04        $ 16.92        $ 0.12        0.7

 

* 

Percentage information not meaningful

Net service revenues from state, local and other governmental programs accounted for 93.5% and 92.7% of net service revenues from continuing operations for 2011 and 2010, respectively. Private duty and, to a lesser extent, commercial payors accounted for the remainder of net service revenues.

Net service revenues were consistent at $230.1 million for 2011 and 2010. Net service revenue included the Advantage acquisition, which contributed $4.9 million in service revenues for 2011 over 2010. Excluding $10.9 million and $10.5 million for 2011 and 2010, respectively, in revenue from the loss of certain programs, locations closed and the impact of the Advantage acquisition, organic revenue increased by $0.4 million, or 0.2%.

Gross profit, expressed as a percentage of net service revenues, increased by 0.7% to 26.7% for 2011, from 26.0% for 2010. This increase is primarily due to lower workers’ compensation and other insurance related costs.

 

50


Table of Contents

General and administrative expenses, expressed as a percentage of net service revenues, decreased 0.5% to 19.9% for 2011, and from 20.4% for 2010. Excluding the general and administrative expenses attributable to Advantage, general and administrative expenses decreased by $2.0 million, or 4.3%, to $44.3 million for 2011 compared to $46.3 million for 2010. The decrease was primarily due to a reduction in wage related costs due to our focus on administrative staffing requirements and cost controls, a decrease in bad debt expense due to continued focus on collections, partially offset by an increase expenses related to corporate infrastructure and an increase in 2011 management bonus expense.

Depreciation and amortization, expressed as a percentage of net service revenues, decreased by 0.1% to 1.4% for 2011, from 1.5% for 2010. Amortization of intangibles, which are principally amortized using accelerated methods, totaled $2.2 million and $2.5 million for 2011 and 2010, respectively.

Interest Income

Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the income statement caption, interest income. We received approximately $2.3 million and $0.2 million in prompt payment interest in 2011 and 2010, respectively.

Interest Expense

Interest expense was $2.5 million and $3.2 million for 2011 and 2010, respectively. The first half of 2010 included an existing interest rate agreement with a notional value of $22.5 million that expired on March 10, 2010. This agreement did not qualify as an accounting hedge under ASC Topic 815. As such, changes in the value of this agreement are reflected in interest expenses in the period of change. The mark-to-market adjustment included in interest expense was a decrease of $0.2 million. Excluding this mark-to-market adjustment, interest expense decreased $0.9 million during 2011 which was due to a reduction in outstanding debt.

Income Tax Expense (Benefit)

Our effective tax rates for 2011 and 2010 were 33.5% and 32.9%, respectively. The increase in our 2011 effective tax rate is principally due to a State of Illinois tax increase that became effective at the beginning of 2011. The principal difference between the Federal and state statutory rates and our effective tax rate is the use of Federal employment opportunity tax credits.

Discontinued Operations

During the fourth quarter of fiscal year 2012, we announced that we were pursuing strategic alternatives for our Home Health Business, and in February 2013, we entered into the Home Health Purchase Agreement. Therefore, we have segregated the Home Health Business operating results and presented them separately as discontinued operations for all periods presented (see note 2 – “Discontinued Operations” of the Notes to the Consolidated Financial Statements included elsewhere herein).

 

51


Table of Contents

See the table below that depicts the results of discontinued operations.

 

     2011     2010     Change  
     Amount     % of  Net
Service
Revenues
    Amount      % of  Net
Service
Revenues
    Amount     %  
     (in thousands, except percentages)  

Net service revenues

   $ 42,995        100.0   $ 41,633         100.0   $ 1,362        3.3

Cost of service revenues

     22,673        52.7        21,477         51.6        1,196        5.6   
  

 

 

     

 

 

      

 

 

   

Gross profit

     20,322        47.3        20,156         48.4        166        0.8   

General and administrative expenses

     21,068        49.0        16,799         40.4        4,269        25.4   

Goodwill and intangible asset impairment charge

     15,989        37.2        —           —          15,989        100.0   

Depreciation and amortization

     387        0.9        638         1.5        (251     (39.3
  

 

 

     

 

 

      

 

 

   

Operating income (loss) from discontinued operations

     (17,122 )     (39.8     2,719         6.5        (19,841     (729.7
  

 

 

     

 

 

      

 

 

   

Income tax expense (benefit)

     (6,729     (15.7     1,058         2.5        (7,787     (736.0
  

 

 

     

 

 

      

 

 

   

Net income (loss) from discontinued operations

   $ (10,393     (24.2 )%    $ 1,661         4.0   $ (12,054     (725.7 )% 
  

 

 

     

 

 

      

 

 

   

 

* Percentage information not meaningful

Our general and administrative expense reflects investments made in 2011 for our expanded sales programs and the expansion of regional management oversight. The net income loss in 2011 as compared to 2010 was primarily due to new regulatory requirements which reduced overall profitability of the Home Health Business. We recorded an impairment charge of $16.0 million as part of discontinued operations in 2011 to reduce the carrying value of the related goodwill and intangible assets.

Liquidity and Capital Resources

Our discussion below regarding our liquidity and capital resources includes discontinued operations.

Overview

Our primary sources of liquidity are cash from operations and borrowings under our credit facility. At December 31, 2012 and December 31, 2011, we had cash balances of $1.7 million and $2.0 million, respectively.

As of December 31, 2012 we had $16.3 million outstanding under the revolving credit portion of our credit facility. After giving effect to the amount drawn on our credit facility, approximately $7.4 million of outstanding letters of credit, borrowing limits based on an advanced multiple of adjusted EBITDA and the Fourth Amendment, we had $27.1 million available for borrowing under the credit facility as of December 31, 2012.

We used $16.3 million of the proceeds from the sale of the Home Health Business to pay down the outstanding amount of the revolving credit facility during the first quarter of 2013. In addition, in consideration for our lender’s consent to the sale of the Home Health Business, we agreed to work in good faith to negotiate an amendment to our credit facility to amend certain provisions of the credit agreement, including a reduction in an amount to be determined of the maximum revolving loan limit and revolving loan commitment.

Cash flows from operating activities represent the inflow of cash from our payor clients and the outflow of cash for payroll and payroll taxes, operating expenses, interest and taxes. Due to its revenue deficiencies and financing issues, the State of Illinois has reimbursed us on a delayed basis with respect to our various agreements including with our largest payor, the Illinois Department on Aging. The open receivable balance from the State of Illinois increased by $5.7 million, from $47.4 million as of December 31, 2011 to $53.1 million as of December 31, 2012.

 

52


Table of Contents

The State of Illinois continues to reimburse us on a delayed basis. These payment delays have adversely impacted, and may further adversely impact, our liquidity, and may result in the need to increase borrowings under our credit facility. Delayed reimbursements from our other state payors have also contributed to the increase in our receivable balances.

Our credit facility provides (i) maximum aggregate amount of revolving loans available to us of $55.0 million, (ii) maximum senior debt leverage ratio of 3.00 to 1.0 for the twelve (12) month period ending March 31, 2010 and each twelve (12) month period ending on the last day of each fiscal quarter thereafter and (iii) advance multiple of 3.25 used to determine the amount of the borrowing base.

On March 18, 2010, we entered into the first amendment (the “First Amendment”) to our credit facility. The First Amendment (i) increased the maximum aggregate amount of revolving loans available to us by $5.0 million to $55.0 million, (ii) modified our maximum senior debt leverage ratio, defined as senior indebtedness divided by EBITDA as adjusted by the bank, from 2.75 to 1.0 to 3.00 to 1.0 for the twelve (12) month period ending March 31, 2010 and each twelve (12) month period ending on the last day of each fiscal quarter thereafter and (iii) increased the advance multiple used to determine the amount of the borrowing base from 2.75 to 3.00.

On March 18, 2010, we also amended our subordinated dividend notes that we issued on November 2, 2009 in the aggregate original principal amount of $12.9 million. Pursuant to the amendments, the dividend notes were amended to (i) extend the maturity date of the notes from September 30, 2011 to December 31, 2012, (ii) modify the amortization schedule of the notes to reduce the annual principal payment amounts from $4.5 million to $1.3 million in 2010; from $3.3 million to $2.5 million in 2011; and provide for total payments in 2012 of $4.1 million and (iii) permit, based on our leverage ratio, the prepayment of all or a portion of the principal amount of the notes, together with interest on the principal amount. Our subordinated dividend notes were repaid in full during the fourth quarter of 2012.

On July 26, 2010, we entered into a second amendment (the “Second Amendment”) to our credit facility. The Second Amendment provided for a $5.0 million term loan component of the credit facility, the proceeds of which were used to finance a portion of the purchase price payable in connection with our acquisition of certain assets of Advantage effective July 25, 2010. The term loan will be repaid in 24 equal monthly installments, which commenced February 2011. Interest on the term loan under the credit facility is payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest will be paid monthly or at the end of the relevant interest period. The term loan was repaid when due on January 5, 2013. The total consideration payable pursuant to the Purchase Agreement was $8.3 million, comprised of $5.1 million in cash, common stock consideration with a deemed value of $1.2 million resulting in the issuance of 248,000 common shares, a maximum of $2.0 million in future cash consideration subject to the achievement of certain performance targets set forth in an earn-out agreement and the assumption of certain specified liabilities. In April 2011, we paid the first earn-out payment of $0.5 million to the sellers of Advantage. The second earn-out payment obligation was reviewed during the fourth quarter of 2011 and it was revalued at approximately $0.7 million. The sellers of Advantage disagree with our calculation of the second earn-out payment and the parties have agreed to have an arbitrator determine the amount of the second earn-out payment. The final payment is expected to be made during the second quarter of 2013.

On May 24, 2011, we entered into a Joinder, Consent and Amendment No. 3 to our credit facility to include Addus HealthCare (Delaware) Inc., a wholly-owned subsidiary of Addus HealthCare, as an additional borrower under our credit facility.

On July 26, 2011, we entered into a fourth amendment (the “Fourth Amendment”) to our credit facility. The Fourth Amendment (i) modified our maximum senior leverage ratio from 3.00 to 1.00 to 3.25 to 1.00 for each twelve month period ending on the last of day of each fiscal quarter beginning with the twelve month period ended June 30, 2011 and (ii) increased the advance multiple used to determine the amount of the borrowing base

 

53


Table of Contents

from 3.0 to 1.0 to 3.25 to 1.0. The Fourth Amendment resulted in an increase in the available borrowings under our credit facility.

On March 2, 2012, we entered into a fifth amendment (the “Fifth Amendment”) to our credit facility. The Fifth Amendment includes technical changes that are intended to comply with rules promulgated by CMS that restrict lenders from exercising any rights of set-off of funds on deposit in any lockboxes established for receiving payments from governmental authorities.

During the fourth quarter of 2011, the lenders under our credit facility permitted us to add back approximately $1.8 million to adjusted EBITDA for the purpose of determining availability under the credit facility. The effect of the add back was to increase availability by approximately $5.8 million until March 1, 2012. On March 1, 2012, the add back allowance was reduced by $0.2 million and will continue to be reduced by $0.2 million on the first day of each month thereafter until the add back is eliminated, which will result in a reduction in availability of $0.65 million on the first day of each month thereafter until the add back is eliminated. This add back was eliminated on December 1, 2012. During the second quarter of 2012, the lenders under our credit facility agreed to a modified interpretation of the credit facility as it relates to the calculation of the fixed charge ratio, which provides us with increased flexibility in meeting this covenant.

While our growth plan is not dependent on the completion of acquisitions, if we do not have sufficient cash resources or availability under our credit facility, or we are otherwise prohibited from making acquisitions, our growth could be limited unless we obtain additional equity or debt financing or unless we obtain the necessary consents from our lenders. We believe the available borrowings under our credit facility which, when taken together with cash from operations, will be sufficient to cover our working capital needs for at least the next 12 months.

Cash Flows

The following table summarizes historical changes in our cash flows for:

 

     2012     2011     2010  
     (in thousands)  

Net cash provided by operating activities

   $ 15,405      $ 15,947      $ 10,703   

Net cash used in investing activities

     (619     (1,051     (6,200

Net cash (used in) financing activities

     (15,069     (13,692     (4,205 )

Year Ended December 31, 2012 Compared to Year Ended December 31, 2011

Net cash provided by operating activities was $15.4 million for 2012, compared to $15.9 million in 2011. This decrease in cash provided by operations was primarily due to an increase- in working capital accounts of $2.8 million, which was offset by a decrease in our operating income of $3.3 million, of which $2.1 million represents a decline in prompt payment interest received with the remainder predominantly driven from declines in our Home Health Business offset by increases in our home and community based services.

Net cash used in investing activities was $0.6 million for 2012. Our investing activities for 2012 were $0.5 million in net proceeds received for the sale of a home health agency and the purchase of $1.1 million of property and equipment. Our investing activities for 2011 were $0.6 million for capital expenditures and a $0.5 million earn-out payment for Advantage.

Net cash used in financing activities was $15.1 million for 2012 as compared to net cash used of $13.7 million in 2011. Our financing activities for 2012 were primarily driven by net payments of $8.5 million on the revolving credit portion of our credit facility, $4.1 million in payments on our subordinated dividend notes and $2.5 million in payments on our term loan. Our financing activities in 2011 were primarily driven by $8.5 million

 

54


Table of Contents

in payments on the revolving credit portion of our credit facility, $2.5 million in payments on subordinated dividend notes, $2.3 million in payments on our term loan, and $0.4 million in payments on other notes.

Year Ended December 31, 2011 Compared to Year Ended December 31, 2010

Net cash provided by operating activities was $15.9 million in 2011, compared to $10.7 million in 2010. The improvement of $5.2 million for 2011 was primarily due to an increase of $2.1 million in net income after considering non-cash reconciliation adjustments and due to $3.0 million in improvements in working capital accounts.

Net cash used in investing activities was $1.1 million for 2011, compared to $6.2 million in 2010. Our investing activities for 2011 were $0.6 million for capital expenditures and a $0.5 million earn-out payment for Advantage. Our investing activities in 2010 included a $5.2 million payment relating to the acquisition of Advantage, payments of $0.4 million in contingent consideration made on previously acquired businesses, and $0.6 million in capital expenditures.

Net cash used in financing activities was $13.7 million for 2011 compared to net cash used of $4.2 million in 2010. Our financing activities for 2011 were primarily driven by net payments of $8.5 million on the revolving credit portion of our credit facility, $2.3 million in payments on our term loan, payments of $2.5 million on our dividend notes and net payments of $0.4 million on all other notes. Our financing activities for 2010 were primarily driven by $5.0 million in borrowings on our term loan which was offset by net payments of $5.3 million on our revolving credit facility, payments of $1.3 million on our dividend notes and net payments of $2.6 million on all other notes.

Outstanding Accounts Receivable

Our gross accounts receivable consists of $67.8 million from continuing operations and $8.0 million from discontinued operations which we retained. Outstanding accounts receivable, net of the allowance for doubtful accounts, decreased by $1.1 million as of December 31, 2012 as compared to December 31, 2011.

We establish our allowance for doubtful accounts to the extent it is probable that a portion or all of a particular account will not be collected. Our provision for doubtful accounts is estimated and recorded primarily by aging receivables utilizing eight aging categories and applying our historical collection rates to each aging category, taking into consideration factors that might impact the use of historical collection rates or payor groups, with certain large payors analyzed separately from other payor groups. In our evaluation of these estimates, we also consider other factors including: delays in payment trends in individual states due to budget or funding issues, billing conversions related to acquisitions or internal systems and resubmission of bills with required documentation and disputes with specific payors.

Our collection procedures include review of account agings and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount, not governed by amount or aging, is written off to the allowance account only after reasonable collection efforts have been exhausted.

 

55


Table of Contents

The following tables detail our accounts receivable before reserves by payor category, showing Illinois governmental payors separately, and the related allowance amount at December 31, 2012 and December 31, 2011:

 

     December 31, 2012  
     0-90 Days     91-180 Days     181-365 Days     Over
365 Days
    Total  
     (in thousands, except percentages)  

Continuing Operations

          

Illinois governmental based programs

   $ 38,339      $ 13,374      $ 1,076      $ 126      $ 52,915   

Other state, local and other governmental programs

     10,248        845        610        329        12,032   

Private duty and commercial

     1,936        360        127        401        2,824   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     50,523        14,579        1,813        856        67,771   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Aging % continuing operations

     74.5     21.5     2.7     1.3  

Discontinued Operations

          

Medicare

     4,751        955        188        —          5,894   

Other state, local and other governmental programs

     340        109        58        —          507   

Private duty and commercial

     965        211        164        30        1,370   

Illinois governmental based programs

     128        19        35        45        227   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     6,184        1,294        445        75        7,998   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 56,707      $ 15,873      $ 2,258      $ 931      $ 75,769   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Aging % of total

     74.9 %     20.9 %     3.0 %     1.2 %  

Allowance for doubtful accounts

           $ 4,466   

Reserve as % of gross accounts receivable

             5.9

 

     December 31, 2011  
     0-90 Days     91-180 Days     181-365 Days     Over
365 Days
    Total  
     (in thousands, except percentages)  

Continuing Operations

          

Illinois governmental based programs

   $ 33,233      $ 11,969      $ 416      $ 1,110      $ 46,728   

Other state, local and other governmental programs

     11,205        1,235        1,038        1,807        15,285   

Private duty and commercial

     1,690        502        583        916        3,691   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     46,128        13,706        2,037        3,833        65,704   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Aging % continuing operations

     70.2     20.9     3.1     5.8  

Discontinued Operations

          

Medicare

     6,109        2,991        991        17        10,108   

Other state, local and other governmental programs

     518        153        122        161        954   

Private duty and commercial

     1,225        393        355        149        2,122   

Illinois governmental based programs

     241        249        119        60        669   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     8,093        3,786        1,587        387        13,853   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 54,221      $ 17,492      $ 3,624      $ 4,220      $ 79,557   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Aging % of total

     68.2 %     22.0 %     4.6 %     5.2 %  

Allowance for doubtful accounts

           $ 7,189   

Reserve as % of gross accounts receivable

             9.0

We calculate our days sales outstanding (“DSO”) by taking the accounts receivable outstanding net of the allowance for doubtful accounts and deducting deferred revenues at the end of the period, divided by the total net service revenues for the last quarter, multiplied by the number of days in that quarter. The adjustment for deferred revenues relates to Medicare receivables which are recorded at the inception of each 60 day episode of care at the full requested anticipated payment (“RAP”) amount. Our DSOs from continuing and discontinued

 

56


Table of Contents

operations were 86 days and 94 days at December 31, 2012 and December 31, 2011, respectively. The DSOs for our largest payor, the Illinois Department on Aging, at December 31, 2012 and December 31, 2011 were 122 days and 125 days, respectively.

Indebtedness

Credit Facility

Our credit facility provides a $55.0 million revolving line of credit expiring November 2, 2014, and provided for a $5.0 million term loan, which matured on January 5, 2013. The term loan was repaid in full during the fourth quarter of 2012. The revolving line of credit includes a $15.0 million sublimit for the issuance of letters of credit. Substantially all of the subsidiaries of Holdings are co-borrowers, and Holdings has guaranteed the borrowers’ obligations under the credit facility. The credit facility is secured by a first priority security interest in all of Holdings’ and the borrowers’ current and future tangible and intangible assets, including the shares of stock of the borrowers.

The availability of funds under the revolving credit portion of the credit facility, as amended, is based on the lesser of (i) the product of adjusted EBITDA, as defined, for the most recent 12-month period for which financial statements have been delivered under the credit facility agreement multiplied by the specified advance multiple, up to 3.25, less the outstanding senior indebtedness and letters of credit, and (ii) $55.0 million less the outstanding revolving loans and letters of credit. Interest on the revolving line of credit and term loan amounts outstanding under the credit facility is payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest on the credit facility is paid monthly on or at the end of the relevant interest period, as determined in accordance with the credit facility agreement. We pay a fee equal to 0.5% per annum of the unused portion of the revolving portion of the credit facility. Issued stand-by letters of credit are charged at a rate of 2.0% per annum payable monthly. A balance of $16.3 million was outstanding on our credit facility as of December 31, 2012 and the total availability under the revolving credit loan facility was $27.1 million at December 31, 2012. The total availability under the revolving credit facility as of March 18, 2013 was $44.2 million.

The credit facility contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The credit facility also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum fixed charge coverage ratio, a requirement to stay below a maximum senior leverage ratio and a requirement to stay below a maximum permitted amount of capital expenditures, as well as restrictions on guarantees, indebtedness, liens, dividends, distributions, investments and loans, subject to customary carve outs, restrictions on Holdings’ and the borrowers’ ability to enter into transactions other than in the ordinary course of business, a restriction on the ability to consummate more than three acquisitions in any calendar year, or for the purchase price of any one acquisition to exceed $0.5 million, in each case without the consent of the lenders, restrictions on mergers, transfers of assets, acquisitions, equipment, subsidiaries and affiliate transactions, subject to customary carve outs, and restrictions on fundamental changes and lines of business. We were in compliance with all of our credit facility covenants at December 31, 2012.

During the fourth quarter of 2011, the lenders under our credit facility permitted us to add back approximately $1.8 million to adjusted EBITDA for the purpose of determining availability under the credit facility. The effect of the add back was to increase availability by approximately $5.8 million until March 1, 2012. On March 1, 2012, the add back allowance was reduced by $0.2 million and will continue to be reduced by $0.2 million on the first day of each month thereafter until the add back is eliminated, which will result in a reduction in availability of $0.65 million on the first day of each month thereafter until the add back is eliminated. This add back was eliminated on November 30, 2012. During the second quarter of 2012, the lenders under our credit facility agreed to a modified interpretation of the credit facility as it relates to the calculation of the fixed charge ratio, which provides us with increased flexibility in meeting this covenant.

 

57


Table of Contents

We used $16.3. million of the proceeds from the sale of the Home Health Business to pay down the outstanding amount of the revolving credit facility during the first quarter of 2013. In addition, in consideration for our lender’s consent to the sale of the Home Health Business, we agreed to work in good faith to negotiate an amendment to our credit facility to amend certain provisions of the credit agreement, including a reduction in an amount to be determined of the maximum revolving loan limit and revolving loan commitment.

Dividend Notes

Prior to the completion of our IPO, we had 37,750 shares of series A preferred stock issued and outstanding, all of which were converted into shares of our common stock on November 2, 2009. Shares of our series A preferred stock accumulated dividends each quarter at a rate of 10%, compounded annually. We accrued these undeclared dividends because the holders had the option to convert their shares of series A preferred stock into common stock at any time with the accumulated dividends payable in cash or a note payable. Our series A preferred stock was converted into 4,077,000 shares of common stock in connection with the completion of our IPO on November 2, 2009. We paid $0.2 million of the $13.1 million outstanding accumulated dividends as of November 2, 2009 with the remaining $12.9 million being converted into 10% junior subordinated promissory notes, which we refer to as the dividend notes. The dividends notes were subordinated and junior to all obligations under our credit facility. Our dividend notes were repaid in full during the fourth quarter of 2012.

Off-Balance Sheet Arrangements

As of December 31, 2012, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States. The preparation of the financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expense and related disclosures. We base our estimates and judgments on historical experience and other sources and factors that we believe to be reasonable under the circumstances; however, actual results may differ from these estimates. We consider the items discussed below to be critical because of their impact on operations and their application requires our judgment and estimates.

Revenue Recognition

The majority of our revenues for 2012 and 2011 from continuing operations are derived from Medicaid and Medicaid waiver programs under agreements with various state and local authorities. These agreements provide for a service term from one year to an indefinite term. Services are provided based on authorized hours, determined by the relevant state or local agency, at an hourly rate specified in the agreement or fixed by legislation. Services to other payors, such as private or commercial clients, are provided at negotiated hourly rates and recognized in net service revenues as services are provided. We provide for appropriate allowances for uncollectible amounts at the time the services are rendered.

Accounts Receivable and Allowance for Doubtful Accounts

We are paid for our services primarily by state and local agencies under Medicaid or Medicaid waiver programs, Medicare, commercial insurance companies and private individuals. While our accounts receivable are uncollateralized, our credit risk is somewhat limited due to the significance of governmental payors to our results of operations. Laws and regulations governing the governmental programs in which we participate are complex and subject to interpretation. Amounts collected may be different than amounts billed due to client eligibility

 

58


Table of Contents

issues, insufficient or incomplete documentation, services at levels other than authorized and other reasons unrelated to credit risk.

Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the income statement caption, interest income. We received approximately $0.2 million and $2.3 million in prompt payment interest in 2012 and 2011, respectively. While we may be owed additional prompt payment interest, the amount and timing of receipt of such payments remains uncertain and we have determined that we will continue to recognize prompt payment interest income when received.

We establish our allowance for doubtful accounts to the extent it is probable that a portion or all of a particular account will not be collected. Our allowance for doubtful accounts is estimated and recorded primarily by aging receivables utilizing eight aging categories and applying our historical collection rates to each aging category, taking into consideration factors that might impact the use of historical collection rates or payor groups, with certain large payors analyzed separately from other payor groups. In our evaluation of these estimates, we also consider delays in payment trends in individual states due to budget or funding issues, billing conversions related to acquisitions or internal systems, resubmission of bills with required documentation and disputes with specific payors. Historically, we have not experienced any write-off of accounts as a result of a state operating with budget deficits. While we regularly monitor state budget and funding developments for the states in which we operate, we consider losses due to state credit risk on outstanding balances as remote. We believe that our recorded allowance for doubtful accounts is sufficient to cover potential losses; however, actual collections in subsequent periods may require changes to our estimates.

Goodwill

Our carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions, including the acquisition of Addus HealthCare, Inc. In accordance with ASC Topic 350, “Goodwill and Other Intangible Assets,” goodwill and intangible assets with indefinite useful lives are not amortized. Goodwill and indefinite lived intangible assets are required to be tested for impairment at least annually. We test goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. We may use a qualitative test, known as “Step 0” or a two-step quantitative method to determine whether impairment has occurred. We can elect to perform Step-0 an optional qualitative analysis and based on the results skip the remaining two steps. In 2012, we elected to implement Step 0 and were not required to conduct the remaining two step analysis.

In 2011, the Company elected to evaluate the goodwill via the two step methodology. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. We used the combination of a discounted cash flow model (“DCF model”) and the market multiple analysis method to determine the current fair value of each reporting unit. The DCF model was prepared using revenue and expense projections based on our current operating plan. As such, a number of significant assumptions and estimates are involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. The cash flows were discounted using a weighted average cost of capital of 14.5%, which was management’s best estimate based on our capital structure and external industry data. As part of the second step of this evaluation, if the carrying value of goodwill exceeds its fair value, an impairment loss would be recognized.

In light of the current Federal and state economic and reimbursement environments and state budgetary pressures to decrease or eliminate services provided by us, we completed a preliminary assessment of the fair value of our two reporting units, home & community (continuing operations) and home health (discontinued operations), and the potential for goodwill impairment as of June 30, 2011. Our total stockholders’ equity as of

 

59


Table of Contents

September 30, 2011 was significantly greater than our market capitalization, which was approximately $43.6 million based on 10,774,886 shares of common stock outstanding as of September 30, 2011. While the market capitalization of approximately $43.6 million was below our stockholders’ equity, the market capitalization metric is only one indicator of fair value. In our opinion, the market capitalization approach, by itself, is not a reliable indicator of the value for our company.

Based on the above factors and updates to our business projections and forecasts, and other factors, we determined that the estimated fair value of our discontinued operations was less than the net book value indicating that its allocated goodwill was impaired. The preliminary assessment for our continuing operations indicated that its fair value was greater than its net book value with no initial indication of goodwill impairment.

As permitted by ASC Topic 350, when an impairment indicator arises toward the end of an interim reporting period, we may recognize our best estimate of that impairment loss. Based on our preliminary analysis prepared as of June 30, 2011, we determined that all of the $13.1 million allocated to goodwill for the discontinued operations as of September 30, 2011 was impaired and we recorded a goodwill impairment loss in the third quarter of 2011. The goodwill impairment charge was noncash in nature and did not affect our liquidity or cash flows from operating activities. Additionally, the goodwill impairment had no effect on our borrowing availability or covenants under our credit facility agreement.

The preliminary analysis prepared as of June 30, 2011 was subject to the completion of our annual impairment test as of October 1, 2011. We completed our annual impairment test of goodwill as of October 1, 2011 and determined that no additional impairment charges or adjustments were required. The goodwill for our continuing operations was $50.7 million. Continuing operations had fair values in excess of carrying amounts of approximately $9.1 million, or 8.9% as of October 1, 2011.

Long-Lived Assets

We review our long-lived assets and finite lived intangibles for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. To determine if impairment exists, we compare the estimated future undiscounted cash flows from the related long-lived assets to the net carrying amount of such assets. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset, generally determined by discounting the estimated future cash flows. No impairment was recorded in 2012. Based on our 2011 assessment of fair value discussed above, we determined that all of the $2.3 million allocated to the discontinued operations finite lived intangibles were impaired.

Indefinite-lived Assets

We also have indefinite-lived assets that are not subject to amortization expense such as certificates of need and licenses to conduct specific operations within geographic markets. Our management has concluded that certificates of need and licenses have indefinite lives, as management has determined that there are no legal, regulatory, contractual, economic or other factors that would limit the useful life of these intangible assets and we intend to renew and operate the certificates of need and licenses indefinitely. The certificates of need and licenses are tested annually for impairment. No impairment was recorded in 2012. Based on our 2011 assessment of fair value discussed above, we determined that all of the $0.6 million allocated to discontinued operations certificates of need and licenses were impaired and recorded an impairment loss for 2011.

Workers’ Compensation Program

Our workers’ compensation insurance program has a $0.35 million deductible component. We recognize our obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience,

 

60


Table of Contents

industry statistics and an actuarial analysis performed by an independent third party. We monitor our claims quarterly and adjust our reserves accordingly. These costs are recorded primarily in the cost of services caption in the consolidated statement of operations. Under the agreement pursuant to which we acquired Addus HealthCare, claims under our workers’ compensation insurance program that relate to December 31, 2005 or earlier are the responsibility of the selling shareholders in the acquisition, subject to certain limitations. In August 2010, the FASB issued Accounting Standards Update No 2010-24, Health Care Entities (Topic 954), “Presentation of Insurance Claims and Related Insurance Recoveries” (“ASU 2010-24”), which clarifies that companies should not net insurance recoveries against a related claim liability. Additionally, the amount of the claim liability should be determined without consideration of insurance recoveries. As of December 31, 2012 and December 31, 2011, we recorded $1.0 million and $1.8 million, respectively, in workers’ compensation insurance recovery receivables and a corresponding increase in its workers’ compensation liability. The workers’ compensation insurance recovery receivable is included in our prepaid expenses and other current assets on the balance sheet.

Interest Income

Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the statement of operations caption, interest income. We received approximately $0.2 million and $2.3 million in prompt payment interest in 2012 and 2011, respectively. While we may be owed additional prompt payment interest, the amount and timing of receipt of such payments remains uncertain and we have determined that we will continue to recognize prompt payment interest income when received.

New Accounting Pronouncements

We do not believe any recently issued, but not yet effective, accounting standards will have a material effect on our consolidated financial position, results of operations or cash flows.

Contractual Obligations and Commitments

We had outstanding letters of credit of $7.4 million at December 31, 2012. These standby letters of credit benefit our third party insurer for our high deductible workers’ compensation insurance program. The amount of the letters of credit is negotiated annually in conjunction with the insurance renewals. We anticipate our commitment will increase as we continue to grow our business and more years become our responsibility as responsibility shifts from the former owners of Addus HealthCare to us.

The following table summarizes our cash contractual obligations as of December 31, 2012:

 

Contractual Obligations

   Total      Less than
1 Year
     1 - 2
Years
     3 - 4
Years
     More than
5 Years
 
     (in thousands)  

Credit facility(2)

   $ 16,250       $ —         $ 16,250       $ —         $ —     

Term loan(2)

     208         208         —           —           —     

Contingent liability

     689         689         —           —           —     

Interest on all debt(1)

     1,432         780         652         —           —     

Operating leases

     10,280         3,024         3,803         2,245         1,208   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total contractual obligations

   $ 28,859       $ 4,701       $ 20,705       $ 2,245       $ 1,208   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) Interest is calculated at the applicable debt borrowing rate as of December 31, 2012.
(2)

Our credit facility was entered into on November 2, 2009 and matures on November 2, 2014. On March 18, 2010, we entered into the First Amendment to our credit facility. The First Amendment (i) increased the

 

61


Table of Contents
  maximum aggregate amount of revolving loans available to us by $5.0 million to $55.0 million, (ii) modified our maximum senior debt leverage ratio from 2.75 to 1.0 to 3.00 to 1.0 for the twelve (12) month period ending March 31, 2010 and each twelve (12) month period ending on the last day of each fiscal quarter thereafter and (iii) increased the advance multiple used to determine the amount of the borrowing base from 2.75 to 1.0 to 3.00 to 1.0. On July 26, 2010, we entered into the Second Amendment to our credit facility. The Second Amendment provided for a $5.0 million term loan component of the credit facility, the proceeds of which were used to finance a portion of the purchase price payable in connection with our acquisition of certain assets of Advantage effective July 25, 2010. The term loan will be repaid in 24 equal monthly installments which commenced in February 2011. Interest on the new term loan under the credit facility is payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest will be paid monthly or at the end of the relevant interest period. The term loan was repaid when due on January 5, 2013.

Impact of Inflation

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operation.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risk from fluctuations in interest rates. As of December 31, 2012, our weighted average interest rate on our credit facility was 4.8% on total indebtedness of $16.5 million. The impact on a 1.0% increase or decrease in interest rates would increase or decrease interest expense by $0.2 million.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Our consolidated financial statements together with the related notes and the report of independent registered public accounting firm, are set forth on the pages indicated in Item 15.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2012. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including

 

62


Table of Contents

its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December 31, 2012, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over our financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act. Under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control—Integrated Framework, our management concluded our internal control over financial reporting was effective as of December 31, 2012.

Our internal control system is designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of published financial statements. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the SEC that permit the Company to provide only management’s report in this annual report on Form 10-K.

Changes in Internal Controls Over Financial Reporting

There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

None

 

63


Table of Contents

PART III

Certain information required by Part III is omitted from this Annual Report on Form 10-K as we intend to file our definitive Proxy Statement for the 2013 Annual Meeting of Stockholders pursuant to Regulation 14A of the Exchange Act not later than 120 days after the end of the fiscal year covered by this Annual Report, and certain information included in the Proxy Statement is incorporated herein by reference.

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this item is incorporated by reference to the 2013 Proxy Statement to be filed with the SEC within 120 days after the end of the year ended December 31, 2012.

 

ITEM 11. EXECUTIVE COMPENSATION

The information required by this item is incorporated by reference to the 2013 Proxy Statement to be filed with the SEC within 120 days after the end of the year ended December 31, 2012.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by this item is incorporated by reference to the 2013 Proxy Statement to be filed with the SEC within 120 days after the end of the year ended December 31, 2012.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this item is incorporated by reference to the 2013 Proxy Statement to be filed with the SEC within 120 days after the end of the year ended December 31, 2012.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

The information required by this item is incorporated by reference to the 2013 Proxy Statement to be filed with the SEC within 120 days after the end of the year ended December 31, 2012.

 

64


Table of Contents

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

  (a) Consolidated Financial Statements. The consolidated financial statements as listed in the accompanying “Index to Consolidated Financial Information” in page F-1 are filed as part of this Annual Report.

Schedule II — Valuation and Qualifying Accounts

Schedules have been omitted because they are not applicable or are not required or the information required to be set forth in those schedules is included in the consolidated financial statements or related notes. All other schedules not listed in the accompanying index have been omitted as they are either not required or not applicable, or the required information is included in the consolidated financial statements or the notes thereto.

 

  (b) Exhibits

 

Exhibit

Number

  

Description of Document

    3.1    Amended and Restated Certificate of Incorporation of Addus HomeCare Corporation dated as of November 2, 2009 (filed on November 20, 2009 as Exhibit 3.1 to Addus HomeCare Corporation’s Quarterly Report on Form 10-Q and incorporated by reference herein)
    3.2    Amended and Restated Bylaws of Addus HomeCare Corporation (filed on September 21, 2009 as Exhibit 3.5 to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
    4.1    Form of Common Stock Certificate (filed on October 2, 2009 as Exhibit 4.1 to Amendment No. 4 to the Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
    4.2    Registration Rights Agreement, dated September 19, 2006, by and among Addus HomeCare Corporation, Eos Capital Partners III, L.P., Eos Partners SBIC III, L.P., Freeport Loan Fund LLC, W. Andrew Wright, III, Addus Term Trust, W. Andrew Wright Grantor Retained Annuity Trust, Mark S. Heaney, James A. Wright and Courtney E. Panzer (filed on July 17, 2009 as Exhibit 4.2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.1    Separation and General Release Agreement, dated as of September 20, 2009, between Addus HealthCare, Inc. and W. Andrew Wright, III (filed on September 21, 2009 as Exhibit 10.1(b) to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.2    Amended and Restated Employment and Non-Competition Agreement, dated May 6, 2008, between Addus HealthCare, Inc. and Mark S. Heaney (filed on July 17, 2009 as Exhibit 10.2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.3    Amendment to the Amended and Restated Employment and Non-Competition Agreement, dated September 30, 2009, between Addus HealthCare, Inc. and Mark S. Heaney (filed on October 2, 2009 as Exhibit 10.2(a) to Amendment No. 4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.4    Employment Agreement, dated November 29, 2010, by and between Addus HealthCare, Inc. and Dennis Meulemans (filed on December 1, 2010 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)

 

65


Table of Contents

Exhibit

Number

  

Description of Document

  10.5    Amended and Restated Employment and Non-Competition Agreement, dated August 27, 2007, between Addus HealthCare, Inc. and Darby Anderson (filed on July 17, 2009 as Exhibit 10.4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.6    Amendment to the Amended and Restated Employment and Non-Competition Agreement, dated September 30, 2009, between Addus HealthCare, Inc. and Darby Anderson (filed on October 2, 2009 as Exhibit 10.4(a) to Amendment No. 4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.7    Amended and Restated Employment and Non-Competition Agreement, dated October 8, 2008, between Addus HealthCare, Inc. and David W. Stasiewicz (filed on July 17, 2009 as Exhibit 10.6 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.8    Amendment No. 1 to Amended and Restated Employment and Non-Competition Agreement between Addus HealthCare, Inc. and David W. Stasiewicz (filed on October 2, 2009 as Exhibit 10.6(a) to Amendment No. 4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.9    Employment and Non-Competition Agreement, dated March 23, 2007, between Addus HealthCare, Inc. and Paul Diamond (filed on July 17, 2009 as Exhibit 10.7 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.10    Amendment to the Employment and Non-Competition Agreement, dated September 30, 2009, between Addus HealthCare, Inc. and Paul Diamond (filed on October 2, 2009 as Exhibit 10.7(a) to Amendment No. 4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.11    Addus HealthCare, Inc. Home Health and Home Care Division Vice President and Regional Director Bonus Plan (filed on July 17, 2009 as Exhibit 10.10 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.12    Addus HealthCare, Inc. Support Center Vice President and Department Director Bonus Plan (filed on July 17, 2009 as Exhibit 10.11 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.13    Addus Holding Corporation 2006 Stock Incentive Plan (filed on July 17, 2009 as Exhibit 10.12 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.14    Director Form of Option Award Agreement under the 2006 Stock Incentive Plan (filed on July 17, 2009 as Exhibit 10.13 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.15    Executive Form of Option Award Agreement under the 2006 Stock Incentive Plan (filed on July 17, 2009 as Exhibit 10.14 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.16    Form of Indemnification Agreement (filed on July 17, 2009 as Exhibit 10.16 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.17    License Agreement, dated March 24, 2006, between McKesson Information Solutions, LLC and Addus HealthCare, Inc. (filed on August 26, 2009 as Exhibit 10.17 to Amendment No. 1 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)

 

66


Table of Contents

Exhibit

Number

  

Description of Document

  10.18    Contract Supplement to the License Agreement, dated March 24, 2006 (filed on August 26, 2009 as Exhibit 10.17(a) to Amendment No. 1 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.19    Contract Supplement to the License Agreement, dated March 28, 2006 (filed on August 26, 2009 as Exhibit 10.17(b) to Amendment No. 1 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.20    Amendment to License Agreement, dated March 28, 2006, between McKesson Information Solutions, LLC and Addus HealthCare, Inc. (filed on August 26, 2009 as Exhibit 10.17(c) to Amendment No. 1 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.21    Lease, dated April 1, 1999, between W. Andrew Wright, III and Addus HealthCare, Inc. (filed on July 17, 2009 as Exhibit 10.18 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.22    First Amendment to Lease, dated as of April 1, 2002, between W. Andrew Wright, III and Addus HealthCare, Inc. (filed on July 17, 2009 as Exhibit 10.18(a) to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.23    Second Amendment to Lease, dated as of September 19, 2006, between W. Andrew Wright, III and Addus HealthCare, Inc. (filed on July 17, 2009 as Exhibit 10.18(b) to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.24    Third Amendment to Lease, dated as of September 1, 2008, between W. Andrew Wright, III and Addus HealthCare, Inc. (filed on July 17, 2009 as Exhibit 10.18(c) to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.25    Addus HomeCare Corporation 2009 Stock Incentive Plan (filed on September 21, 2009 as Exhibit 10.20 to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.26    Form of Incentive Stock Option Award Agreement under the 2009 Stock Incentive Plan (filed on September 21, 2009 as Exhibit 10.20(a) to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.27    Form of Restricted Stock Award Agreement under the 2009 Stock Incentive Plan (filed on September 21, 2009 as Exhibit 10.20(b) to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.28    Loan and Security Agreement, dated as of November 2, 2009, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation and Professional Reliable Nursing Service, Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions that are or may from time to time become parties thereto, and Addus HomeCare Corporation, as guarantor (filed on November 5, 2009 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.29    Consent and Amendment No. 1 to the Loan and Security Agreement, dated as of March 18, 2010, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation and Professional Reliable Nursing Service, Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions that are or may from time to time become parties thereto, and Addus HomeCare Corporation, as guarantor (filed on March 18, 2010 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)

 

67


Table of Contents

Exhibit

Number

  

Description of Document

  10.30    Joinder, Consent and Amendment No. 2 to Loan and Security Agreement, dated as of July 26, 2010, by and among Addus HealthCare, Inc., Addus HealthCare (South Carolina), Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation and Professional Reliable Nursing Service, Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions that are or may from time to time become parties thereto, and Addus HomeCare Corporation, as guarantor (filed on July 27, 2010 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.31    Asset Purchase Agreement dated as of July 26, 2010, by and among Addus HealthCare (South Carolina), Inc., Advantage Health Systems, Inc., Paul Mitchell as the Seller Representative and the Sellers set forth on Exhibit A thereto (filed on July 27, 2010 as Exhibit 99.2 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.32    Earn-Out Agreement dated as of July 26, 2010, by and among Addus HealthCare (South Carolina), Inc., Advantage Health Systems, Inc., Paul Mitchell as the Seller Representative and the Sellers set forth on therein (filed on July 27, 2010 as Exhibit 99.3 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.33    Joinder, Consent and Amendment No. 3 to the Loan and Security Agreement, dated as of March 24, 2011, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation and Professional Reliable Nursing Service, Inc., Addus HealthCare (South Carolina), Inc. Addus HealthCare (Delaware), Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions that are or may from time to time become parties thereto, and Addus HomeCare Corporation, as guarantor (filed on May 25, 2011 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.34    Amendment No. 4 to Loan and Security Agreement, dated as of July 26, 2011, effective as of June 30, 2011, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation, Professional Reliable Nursing Service, Inc., Addus HealthCare (South Carolina), Inc., Addus HealthCare (Delaware), Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions from time to time parties thereto, and Addus HomeCare Corporation, as guarantor (filed on July 29, 2011 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.35    Amendment No. 2 to Employment and Non-Competition Agreement, dated November 17, 2011, by and between Addus HealthCare, Inc. and Mark S. Heaney (filed on November 23, 2011 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)

 

68


Table of Contents

Exhibit

Number

  

Description of Document

  10.36    Amendment No. 5 to Loan and Security Agreement, dated as of March 2, 2012, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation, Professional Reliable Nursing Service, Inc., Addus HealthCare (South Carolina), Inc., Addus HealthCare (Delaware), Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions from time to time parties thereto, and Addus HomeCare Corporation, as guarantor (filed on March 16, 2012 as exhibit 10.41 to Addus HomeCare Corporation’s Annual Report on Form 10-K and incorporated herein by reference)
  10.37    Summary of Independent Director Compensation Policy (filed on March 16, 2012 as Exhibit 10.42 to Addus HomeCare Corporation’s Annual Report on Form 10-K and incorporated herein by reference)
  10.38    The Executive Nonqualified “Excess” Plan Adoption Agreement, by Addus HealthCare, Inc., dated April 1, 2012 (filed on April 5, 2012 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.39    The Executive Nonqualified Excess Plan Document, dated April 1, 2012 (filed on April 5, 2012 as Exhibit 99.2 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.40    Employment Agreement, effective June 18, 2012, by and between Addus Healthcare, Inc. and Inna Berkovich (filed on June 20, 2012 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.41    Separation Agreement and General Release, effective as of September 12, 2012, between Addus HealthCare, Inc. and Gregory Breemes (filed on September 21, 2012 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.42    Asset Purchase Agreement, dated as of February 7, 2013, by and among Addus HealthCare, Inc., its subsidiaries identified therein, LHC Group, Inc. and its subsidiaries identified therein (filed on March 6, 2013 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  21.1    Subsidiaries of the Addus HomeCare Corporation (filed on March 28, 2011 as Exhibit 22.1 to Addus HomeCare Corporation’s Annual Report on Form 10-K and incorporated herein by reference)
  23.1    Consent of BDO USA, LLP, Independent Registered Public Accounting Firm*
  31.1    Certification of Chief Executive Officer Pursuant to Rule 13-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
  31.2    Certification of Chief Financial Officer Pursuant to Rule 13-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
  32.1    Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
  32.2    Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101    The following materials from Addus HomeCare Corporation’s Annual Report on Form 10-K for the years ended December 31, 2012, formatted in Extensive Business Reporting Language (XBRL), (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Stockholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) the Notes to the Consolidated Financial Statements.

 

* Filed herewith
** Furnished herewith

 

69


Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Addus HomeCare Corporation
By:  

/S/    MARK S. HEANEY      

 

Mark S. Heaney,

President and Chief Executive Officer

Date: March 28, 2013

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated:

 

Signature

  

Title

 

Date

/s/    MARK S. HEANEY      

  

President and Chief Executive Officer (Principal

  March 28, 2013
Mark S. Heaney   

Executive Officer) and Director

 

/s/    DENNIS B. MEULEMANS      

  

Chief Financial Officer (Principal Financial and

  March 28, 2013
Dennis B. Meulemans   

Accounting Officer)

 

/s/    MARK L. FIRST      

   Director   March 28, 2013
Mark L. First     

/s/    SIMON A. BACHLEDA      

   Director   March 28, 2013
Simon A. Bachleda     

/s/    W. ANDREW WRIGHT, III      

   Director   March 28, 2013
W. Andrew Wright, III     

/s/    STEVEN I. GERINGER      

   Director   March 28, 2013
Steven I. Geringer     

/s/    WAYNE B. LOWELL      

   Director   March 28, 2013
Wayne B. Lowell     

/s/    R. DIRK ALLISON    

   Director   March 28, 2013
R. Dirk Allison     

 

70


Table of Contents

INDEX TO CONSOLIDATED FINANCIAL INFORMATION

 

     Page  

Report of Independent Registered Public Accounting Firm

     F-2   

Consolidated Balance Sheets

     F-3   

Consolidated Statements of Operations

     F-4   

Consolidated Statements of Changes in Stockholders’ Equity

     F-5   

Consolidated Statements of Cash Flows

     F-6   

Notes to Consolidated Financial Statements

     F-7   

 

F-1


Table of Contents

Report of Independent Registered Public Accounting Firm

Board of Directors and Stockholders

Addus HomeCare Corporation

Palatine, IL

We have audited the accompanying consolidated balance sheets of Addus HomeCare Corporation and Subsidiaries as of December 31, 2012 and 2011 and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2012. In connection with our audits of the financial statements, we have also audited the financial statement schedule listed in the accompanying index. These consolidated financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and schedule. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Addus HomeCare Corporation and Subsidiaries at December 31, 2012 and 2011, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2012, in conformity with accounting principles generally accepted in the United States of America.

Also, in our opinion, the financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

 

Chicago, IL     /s/    BDO USA, LLP

March 28, 2013

   

 

F-2


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

As of December 31, 2012 and 2011

(amounts and shares in thousands, except per share data)

 

     2012      2011  

Assets

     

Current assets

     

Cash

   $ 1,737       $ 2,020   

Accounts receivable, net of allowances of $4,466 and $7,189 at December 31, 2012 and 2011, respectively

     71,303         72,368   

Prepaid expenses and other current assets

     7,293         8,137   

Assets held for sale, net

     245         239   

Deferred tax assets

     7,258         6,336   
  

 

 

    

 

 

 

Total current assets

     87,836         89,100   
  

 

 

    

 

 

 

Property and equipment, net of accumulated depreciation and amortization

     2,489         2,251   
  

 

 

    

 

 

 

Other assets

     

Goodwill

     50,536         50,695   

Intangibles, net of accumulated amortization

     6,370         8,044   

Deferred tax assets

     2,328         4,089   

Other assets

     298         513   
  

 

 

    

 

 

 

Total other assets

     59,532         63,341   
  

 

 

    

 

 

 

Total assets

   $ 149,857       $ 154,692   
  

 

 

    

 

 

 

Liabilities and stockholders’ equity

     

Current liabilities

     

Accounts payable

   $ 4,117       $ 5,266   

Accrued expenses

     32,717         29,313   

Current maturities of long-term debt

     208         6,569   

Deferred revenue

     2,148         2,145   
  

 

 

    

 

 

 

Total current liabilities

     39,190         43,293   
  

 

 

    

 

 

 

Long-term debt, less current maturities

     16,250         24,958   
  

 

 

    

 

 

 

Total liabilities

     55,440         68,251   
  

 

 

    

 

 

 

Commitments, contingencies and other matters

     

Stockholders’ equity

     

Common stock—$.001 par value; 40,000 authorized and 10,823 and 10,775 shares issued and outstanding as of December 31, 2012 and 2011, respectively

     11         11   

Additional paid-in capital

     82,778         82,437   

Retained earnings

     11,628         3,993   
  

 

 

    

 

 

 

Total stockholders’ equity

     94,417         86,441   
  

 

 

    

 

 

 

Total liabilities and stockholders’ equity

   $ 149,857       $ 154,692   
  

 

 

    

 

 

 

See accompanying notes to consolidated financial statements

 

F-3


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

For the years ended December 31, 2012, 2011 and 2010

(amounts and shares in thousands, except per share data)

 

     For the Year Ended December 31,  
     2012     2011     2010  

Net service revenues

   $ 244,315      $ 230,105      $ 230,099   

Cost of service revenues

     180,264        168,632        170,376   
  

 

 

   

 

 

   

 

 

 

Gross profit

     64,051        61,473        59,723   

General and administrative expenses

     46,362        45,858        47,042   

Revaluation of contingent consideration

     —          (469 )     —     

Gain on sale of agency

     (495 )     —          —     

Depreciation and amortization

     2,521        3,167        3,408   
  

 

 

   

 

 

   

 

 

 

Total operating expenses

     48,388        48,556        50,450   
  

 

 

   

 

 

   

 

 

 

Operating income from continuing operations

     15,663        12,917        9,273   
  

 

 

   

 

 

   

 

 

 

Interest income

     (155 )     (2,263 )     (155

Interest expense

     1,723        2,524        3,159   
  

 

 

   

 

 

   

 

 

 

Total interest expense, net

     1,568        261        3,004   
  

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     14,095        12,656        6,269   

Income tax expense

     4,807        4,244        1,902   
  

 

 

   

 

 

   

 

 

 

Net income from continuing operations

     9,288        8,412        4,367   
  

 

 

   

 

 

   

 

 

 

Discontinued operations:

      

Earnings (loss) from home health business, net of tax

     (1,653     (10,393 )     1,661   
  

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 7,635      $ (1,981 )   $ 6,028   
  

 

 

   

 

 

   

 

 

 

Net income (loss) per common share

      

Basic and diluted

      

Continuing operations

   $ 0.86      $ 0.78      $ 0.41   

Discontinued operations

     (0.15     (0.96     0.16   
  

 

 

   

 

 

   

 

 

 

Basic and diluted income (loss) per share

   $ 0.71      $ (0.18 )   $ 0.57   
  

 

 

   

 

 

   

 

 

 

Weighted average number of common shares and potential common shares outstanding:

      

Basic

     10,764        10,752        10,604   

Diluted

     10,784        10,752        10,606   

See accompanying notes to consolidated financial statements

 

F-4


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the years ended December 31, 2012, 2011 and 2010

(amounts and shares in thousands)

 

     Common Stock      Additional
Paid-In
Capital
     Retained
Earnings
(Deficit)
    Total
Stockholders’
Equity
 
     Shares      Amount          

Balance at December 31, 2009

     10,499       $ 10       $ 80,611       $ (54   $ 80,567   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Issuance of shares of common stock under restricted stock award agreements

     4         1         —          —         1   

Stock-based compensation

     —          —          255         —         255   

Stock issued for acquisition

     248         —          1,240         —         1,240   

Net income

     —          —          —          6,028        6,028   

Balance at December 31, 2010

     10,751         11         82,106         5,974        88,091   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Issuance of shares of common stock under restricted stock award agreements

     24         —          —          —         —    

Stock-based compensation

     —          —          331         —         331   

Net loss

     —          —          —          (1,981     (1,981

Balance at December 31, 2011

     10,775         11         82,437         3,993        86,441   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Issuance of shares of common stock under restricted stock award agreements

     43         —          —           —         —    

Stock-based compensation

     —          —          341         —         341   

Shares issued

     5        —          —           —         —     

Net income

     —          —          —          7,635        7,635   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Balance at December 31, 2012

     10,823       $ 11       $ 82,778       $ 11,628      $ 94,417   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

 

See accompanying notes to consolidated financial statements

 

F-5


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the years ended December 31, 2012, 2011 and 2010

(amounts in thousands)

 

     For the Year
Ended  December 31,
 
     2012     2011     2010  

Cash flows from operating activities

      

Net income (loss)

   $ 7,635      $ (1,981   $ 6,028   

Adjustments to reconcile net income (loss) to net cash provided by operating activities

      

Depreciation and amortization

     2,544        3,554        4,046   

Deferred income taxes

     839        (4,663     447   

Change in fair value of financial instrument

     —         —         (191 )

Stock-based compensation

     341        331        255   

Amortization of debt issuance costs

     215        224        179   

Provision for doubtful accounts

     2,877        4,275        4,429   

Goodwill and intangible assets impairment charge

     —          15,989        —    

Revaluation of contingent consideration

     —          (469     —    

(Gain)/Loss on sale of assets

     (495     43        —    

Changes in operating assets and liabilities, net of acquired businesses:

      

Accounts receivable

     (1,812     (5,689     (4,892 )

Prepaid expenses and other current assets

     (18     1,433        (767 )

Accounts payable

     (1,149     1,962        (459 )

Accrued expenses

     4,425        934        1,676   

Deferred revenue

     3        4        (48 )
  

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     15,405        15,947        10,703   
  

 

 

   

 

 

   

 

 

 

Cash flows from investing activities

      

Acquisitions of businesses

     —          (500     (5,588 )

Net proceeds from sale of agency

     495        —          —     

Purchases of property and equipment

     (1,114     (551     (612 )
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (619     (1,051     (6,200 )
  

 

 

   

 

 

   

 

 

 

Cash flows from financing activities

      

Net borrowings (repayments) on term loan

     (2,500     (2,292     5,000   

Net (payments) borrowings on revolving credit loan

     (8,500     (8,500     (5,250 )

Payments on subordinated dividend notes

     (4,069     (2,500     (1,250 )

Debt issuance costs

     —          (34     (151 )

Net borrowings (repayments) on other notes payable

     —          (366     (2,554
  

 

 

   

 

 

   

 

 

 

Net cash used in financing activities

     (15,069     (13,692     (4,205 )
  

 

 

   

 

 

   

 

 

 

Net change in cash

     (283     1,204        298   

Cash, at beginning of period

     2,020        816        518   
  

 

 

   

 

 

   

 

 

 

Cash, at end of period

   $ 1,737      $ 2,020      $ 816   
  

 

 

   

 

 

   

 

 

 

Supplemental disclosures of cash flow information

      

Cash paid for interest

   $ 1,557      $ 2,337      $ 3,555   

Cash paid for income taxes

     1,758        2,005        1,457   

Supplemental disclosures of non-cash investing and financing activities

      

Contingent and deferred consideration accrued for acquisitions

   $ —        $ —        $ 1,615   

Tax benefit related to the amortization of tax goodwill in excess of book basis

     159        159        160   

See accompanying notes to consolidated financial statements

 

F-6


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)

1. Significant Accounting Policies

Basis of Presentation and Description of Business

The consolidated financial statements include the accounts of Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company” or “we”). The Company provides home and community based services through a network of locations throughout the United States. These services are primarily performed in the homes of the consumers. The Company’s home and community based services include assistance to the elderly, chronically ill and disabled with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. Home and community based services are primarily performed under agreements with state and local governmental agencies.

Discontinued Operations

On February 7, 2013, subsidiaries of Holdings entered into an Asset Purchase Agreement with LHC Group, Inc. and certain of its subsidiaries (the “Home Health Purchase Agreement”). Pursuant to the Home Health Purchase Agreement, effective March 1, 2013, the purchasers agreed to acquire substantially all the assets of the Company’s home health business in Arkansas, Nevada and South Carolina and 90% of its home health business in California and Illinois, with the Company retaining 10% ownership in such locations, for cash consideration of $20,000.

The Company’s home health services were operated through licensed and Medicare certified offices that provided physical, occupational and speech therapy, as well as skilled nursing services to pediatric, adult infirm and elderly patients. Home health services were reimbursed from Medicare, Medicaid and Medicaid-waiver programs, commercial insurance and private payors (see note 2).

Principles of Consolidation

All intercompany balances and transactions have been eliminated in consolidation.

Revenue Recognition

The Company generates net service revenues by providing services directly to consumers. The Company receives payments for providing services from federal, state and local governmental agencies, commercial insurers and private individuals. Our continuing operations, which includes the results of operations previously included in our home and community segment and three agencies previously included in our home health segment, are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate specified in agreements or fixed by legislation and recognized as revenues at the time services are rendered. Home and community based service revenues are reimbursed by state, local and other governmental programs which are partially funded by Medicaid or Medicaid waiver programs, with the remainder reimbursed through private duty and insurance programs.

Laws and regulations governing the Medicaid and Medicare programs are complex and subject to interpretation. As a result, there is at least a reasonable possibility that recorded estimates may change in the near term. The Company believes that it is in compliance in all material respects with all applicable laws and regulations.

Allowance for Doubtful Accounts

The Company establishes its allowance for doubtful accounts to the extent it is probable that a portion or all of a particular account will not be collected. The Company estimates its provision for doubtful accounts

 

F-7


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

primarily by aging receivables utilizing eight aging categories, and applying its historical collection rates to each aging category, taking into consideration factors that might impact the use of historical collection rates or payor groups, with certain large payors analyzed separately from other payor groups. In the Company’s evaluation of these estimates, it also considers delays in payment trends in individual states due to budget or funding issues, billing conversions related to acquisitions or internal systems, resubmission of bills with required documentation and disputes with specific payors. An allowance for doubtful accounts is maintained at a level management believes is sufficient to cover potential losses. However, actual collections could differ from estimates.

Property and Equipment

Property and equipment are recorded at cost and depreciated over the estimated useful lives of the related assets by use of the straight-line method except for internally developed software which is amortized by the sum-of-years digits method. Maintenance and repairs are charged to expense as incurred. The estimated useful lives of the property and equipment are as follows:

 

Computer equipment

   3 – 5 years

Furniture and equipment

   5 – 7 years

Transportation equipment

   5 years

Computer software

   5 – 10 years

Leasehold improvements

   Lesser of useful life or lease term, unless probability of lease renewal is likely

Goodwill

The Company’s carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions including the acquisition of Addus HealthCare, Inc. (“Addus HealthCare”). In accordance with Accounting Standards Codification TM (“ASC”) Topic 350, “Goodwill and Other Intangible Assets,” goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. Goodwill and indefinite lived intangible assets are required to be tested for impairment at least annually. The Company may use a qualitative test, known as “Step 0” or a two-step quantitative method to determine whether impairment has occurred. In Step 0, the Company can elect to perform an optional qualitative analysis and based on the results skip the two step analysis. In 2012, the Company elected to implement Step 0 and was not required to conduct the remaining two step analysis.

In 2011, the Company elected to evaluate the goodwill via the two step methodology. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. The Company used the combination of a discounted cash flow model (“DCF model”) and the market multiple analysis method to determine the current fair value of each reporting unit. The DCF model was prepared using revenue and expense projections based on the Company’s current operating plan. As such, a number of significant assumptions and estimates were involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. In 2011, the cash flows were discounted using a weighted average cost of capital of 14.5%, which was management’s best estimate based on the capital structure of the Company and external industry data. As part of the second step of

 

F-8


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

this evaluation, if the carrying value of goodwill exceeds its fair value, an impairment loss would be recognized. The Company recorded a $15,989 goodwill and intangible asset charge during the third quarter of 2011 (see Note 6) for its discontinued operations (see Note 2).

Intangible Assets

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-compete agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from two to 25 years.

ASC Topic 350 requires that the fair value of intangible assets with finite lives be estimated and compared to the carrying value. The Company estimates the fair value of these intangible assets using the income approach. Intangible assets with finite lives are amortized using the estimated economic benefit method over the useful life and assessed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company recognizes an impairment loss when the estimated fair value of the intangible asset is less than the carrying value. No impairment charge was recorded in 2012. The Company recorded a $2,273 impairment associated with discontinued operations in 2011. No impairment charge was recorded in 2010.

The income approach, which the Company uses to estimate the fair value of its reporting units and intangible assets, is dependent on a number of factors including estimates of future market growth and trends, forecasted revenue and costs, expected periods the assets will be utilized, appropriate discount rates and other variables. The Company bases its fair value estimates on assumptions the Company believes to be reasonable but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates. In addition, the Company makes certain judgments about the selection of comparable companies used in the market approach in valuing its reporting units.

Long-Lived Assets

The Company reviews its long-lived assets and indefinite lived intangibles (except goodwill and finite lived intangible assets, as described above) for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. To determine if impairment exists, the Company compares the estimated future undiscounted cash flows from the related long-lived assets to the net carrying amount of such assets. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset, generally determined by discounting the estimated future cash flows. No impairment charge was recorded in 2012. The Company recorded a $640 impairment associated with discontinued operations in 2011. No impairment charge was recorded in 2010.

Debt Issuance Costs

The Company amortizes debt issuance costs on a straight-line method over the term of the related debt. This method approximates the effective interest method.

 

F-9


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

Workers’ Compensation Program

The Company’s workers’ compensation program has a $350 deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The future claims payments related to the workers’ compensation program are secured by letters of credit.

Derivative Financial Instrument

The Company utilized a derivative financial instrument to minimize interest rate risk. The Company’s derivative instrument consisted of a three-year interest rate agreement designed to reduce the variability of cash flows associated with a portion of the Company’s term debt. As the hedge accounting criteria established in ASC Topic 815, “Derivatives and Hedging” have not been met, the Company accounted for the instrument at its fair value and recognizes any changes in its fair value in earnings for the period.

ASC Topic 820, “Fair Value Measurements,” establishes a three-tier fair value hierarchy, which categorizes the inputs used in measuring fair value. These categories include in descending order of priority: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

The fair value of the swap was calculated using proprietary models utilizing observable inputs (Level 2) as well as future assumptions related to interest rates and other applicable variables. These calculations were performed by the financial institution which is counterparty to the applicable swap agreement and reviewed by the Company. The Company used these reported fair values to adjust the asset or liability as appropriate. The interest rate swap agreement concluded in March of 2010.

Interest Income

Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the income statement caption, interest income. The Company received $155, $2,263 and $155 in prompt payment interest in 2012, 2011 and 2010, respectively. While the Company may be owed additional prompt payment interest, the amount and timing of receipt of such payments remains uncertain and the Company has determined that it will continue to recognize prompt payment interest income when received.

Interest Expense

The Company’s interest expense consists of interest costs on its credit facility and other debt instruments.

Income Taxes

The Company accounts for income taxes under the provisions of ASC Topic 740, “Income Taxes”. The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current

 

F-10


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its financial statements or tax returns. Deferred taxes, resulting from differences between the financial and tax basis of the Company’s assets and liabilities, are also adjusted for changes in tax rates and tax laws when changes are enacted. ASC Topic 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. ASC Topic 740, also prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. In addition, ASC Topic 740 provides guidance on derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions.

Stock-based Compensation

The Company has two stock incentive plans, the 2006 Stock Incentive Plan (the “2006 Plan”) and the 2009 Stock Incentive Plan (the “2009 Plan”) that provide for stock-based employee compensation. The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Stock Compensation.” Compensation expense is recognized on a graded method under the 2006 Plan and on a straight-line basis under the 2009 Plan over the vesting period of the awards based on the fair value of the options. Under the 2006 Plan, the Company historically used the Black-Scholes option pricing model to estimate the fair value of its stock based payment awards, but beginning October 28, 2009 under its 2009 Plan it began using an enhanced Hull-White Trinomial model. The determination of the fair value of stock-based payments utilizing the Black-Scholes model and the Enhanced Hull-White Trinomial model is affected by Holdings’ stock price and a number of assumptions, including expected volatility, risk-free interest rate, expected term, expected dividends yield, expected forfeiture rate, expected turn-over rate, and the expected exercise multiple.

Net Income (Loss) Per Common Share

Net income (loss) per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company’s outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.

Included in the Company’s calculation for the year ended December 31, 2012 were 596 stock options of which 501 were out-of-the money and therefore anti-dilutive and 57 restricted stock awards with 12 included in the weighted diluted shares outstanding for 2012.

For the year ended December 31, 2011 the Company had 10 dilutive shares but it reported a net loss and any potentially dilutive securities would be anti-dilutive, therefore, no additional shares were considered in the calculation of diluted earnings per share.

Included in the Company’s calculation for the year ended December 31, 2010 were 588 stock options which were out-of-the money and therefore anti-dilutive and 6 restricted stock awards with 2 included in the weighted diluted shares outstanding for 2010.

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. Accordingly, actual results could differ from those estimates.

 

F-11


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

Fair Value of Financial Instruments

The Company’s financial instruments consist of cash, accounts receivable, payables and debt. The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of the short-term nature of these instruments. The carrying value of the Company’s long-term debt with variable interest rates approximates fair value based on instruments with similar terms.

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets and also when determining the fair value of contingent considerations. To determine the fair value in these situations, the Company uses Level 3 inputs such as discounted cash flows or if available, what a market participant would pay on the measurement date.

New Accounting Pronouncements

The Company does not believe any recently issued, but not yet effective, accounting standards will have a material effect on the Company’s consolidated financial position, results of operations, or cash flows.

2. Discontinued Operations

During December 2012, in anticipation of the sale of substantially all of the assets used in its home health business (the “Home Health Business”), the Company reported the operating results of the Home Health Business as discontinued operations in accordance with ASC 360-10-45 “Impairment or Disposal of Long-Lived Assets.” On February 7, 2013, the Company entered into the Home Health Purchase Agreement, pursuant to which subsidiaries of LHC Group, Inc. agreed to acquire substantially all the assets of the Home Health Business in Arkansas, Nevada and South Carolina and 90% of the Home Health Business in California and Illinois, with the Company retaining 10% ownership in such locations, for cash consideration of $20,000. The transaction was consummated effective March 1, 2013. In addition, the results of operations for two home health agencies being held for sale are included in discontinued operations.

The Company has included the financial results of the Home Health Business in discontinued operations for all periods presented. Assets sold to the purchasers are presented as assets held for sale, net, on the accompanying consolidated balance sheet as of December 31, 2012 and 2011. In connection with the discontinued operations presentation, certain financial statement footnotes have also been updated to reflect the impact of discontinued operations.

The following table presents the net service revenues and earnings attributable to discontinued operations, which include the financial results for the years ended December 31, 2012, 2011 and 2010:

 

     2012     2011     2010  

Net service revenues

   $ 38,822      $ 42,995      $ 41,633   
  

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

     (2,752     (17,122     2,719   

Income tax expense (benefit)

     (1,099     (6,729     1,058   
  

 

 

   

 

 

   

 

 

 

Net income (loss) from discontinued operations

   $ (1,653   $ (10,393   $ 1,661   
  

 

 

   

 

 

   

 

 

 

 

F-12


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

The only class of assets for discontinued operations reflected as assets held for sale, net, as of December 31, 2012 and 2011 were as follows:

 

     2012      2011  

Property and equipment, net of accumulated depreciation and amortization

   $ 245       $ 239   

Pursuant to the Home Health Purchase Agreement, the Company is retaining $7,123 of accounts receivable, net as of December 31, 2012. In addition, the Company is retaining the related accrued expenses and accounts payable associated with the Home Health Business.

3. Sale of Agency

In February 2012, the Company sold an agency located in Portland, Oregon for approximately $525 with net proceeds of approximately $495 after the payment of closing related expenses. The Company recorded a $495 pre-tax gain on the sale of the agency.

4. Acquisitions

On July 26, 2010, the Company entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company acquired certain assets of Advantage Health Systems, Inc., a South Carolina corporation (“Advantage”). The total maximum consideration payable pursuant to the Purchase Agreement was $8,380, comprised of $5,140 in cash, common stock consideration with a deemed value of $1,240 resulting in the issuance of 248 common shares, and a maximum of $2,000 in future cash consideration subject to the achievement of certain performance targets set forth in an earn-out agreement and the assumption of certain specified liabilities.

On July 26, 2010, the Company entered into an amendment (the “Second Amendment”) to its credit facility. The Second Amendment provides for a new term loan component of the credit facility in the aggregate principal amount of $5,000 with a maturity date of January 5, 2013. The requisite lenders also consented to the acquisition, effective July 25, 2010, of certain assets of Advantage, by the Company, pursuant to the Purchase Agreement. The term loan was repaid in 24 equal monthly installments which began in February 2011. Interest on the term loan under the credit facility was payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest was paid monthly or at the end of the relevant interest period.

The Company’s acquisition of Advantage has been accounted for in accordance with ASC Topic 805, “Business Combinations” and the resultant goodwill and other intangible assets will be accounted for under ASC Topic 350 “Goodwill and Other Intangible Assets”. Assets acquired and liabilities assumed were recorded at their fair values. The total purchase price is $7,980 and is comprised of:

 

     Total  

Cash

   $ 5,140   

Issuance of 248 Addus shares at $5.00 per share (valued at a price per share equal to the average closing price of the Company’s stock for the three most recent trading days preceding the closing, subject to a floor of $5.00 per share)

     1,240   

Contingent earn-out obligation (net of $92 discount)

     1,600   
  

 

 

 

Total purchase price

   $ 7,980   
  

 

 

 

 

F-13


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

The contingent earn-out obligation was initially recorded at its fair value of $1,600, which is the present value of the Company’s obligation based on probability-weighted estimates of the achievement of certain performance targets, as defined in the Purchase Agreement. In April 2011, the Company paid the first earn-out payment of $500 to the sellers of Advantage. The second earn-out payment obligation was reviewed during the fourth quarter of 2011 and it was revalued at approximately $683 as of December 31, 2011 which resulted in a $469 gain on revaluation of the contingent consideration. The sellers of Advantage disagree with the Company’s calculation of the second earn-out payment and the parties have agreed to have an arbitrator determine the amount of the second earn-out payment. The final payment is expected to be made during the second quarter of 2013.

Under business combination accounting, the total purchase price was allocated to Advantage’s net tangible and identifiable intangible assets based on their estimated fair values. Based upon management’s valuation, the total purchase price has been allocated as follows:

 

     Total  

Goodwill

   $ 4,272   

Identifiable intangible assets

     3,631   

Property and equipment

     77   
  

 

 

 

Total purchase price allocation

   $ 7,980   
  

 

 

 

Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets acquired. Goodwill amounts are not amortized, but rather are tested for impairment at least annually. In the event that the Company determines that the value of goodwill has become impaired, the Company will record an impairment charge for the amount during the fiscal quarter in which such determination is made.

Identifiable intangible assets acquired consist of trade names and trademarks, certificates of need and state licenses, customer relationships, and non-compete agreements. The estimated fair value of identifiable intangible assets was determined by management.

As part of its annual review of goodwill and intangible assets, the Company determined that all of its home health business which is recorded as discontinued operations was impaired (see Note 6). As part of this impairment in 2011 the Company recorded a charge that included $544 of goodwill and $272 of intangible assets associated with the purchase of Advantage.

 

F-14


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

The following table contains unaudited pro forma consolidated income statement information assuming the Advantage acquisition closed on January 1, 2010.

 

     For the
Year Ended
December 31,
2010
 

Net service revenues

   $ 236,065   

Operating income from continuing operations

     9,793   

Net income from continuing operations, net of tax

     4,555   

Net loss from discontinued operations, net of tax

     1,617   
  

 

 

 

Net income

   $ 6,172   
  

 

 

 

Earnings per share

  

Basic and Diluted

  

Continuing operations

   $ 0.42   

Discontinued operations

     0.15   
  

 

 

 

Basic income per share from continue operations

   $ 0.57   
  

 

 

 

The pro forma disclosures in the table above include adjustments for interest expense, amortization of intangible assets and tax expense to reflect results that are more representative of the combined results of the transactions as if they had occurred on January 1, 2010. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operation that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information.

5. Property and Equipment

Property and equipment consisted of the following:

 

     December 31,  
     2012     2011  

Computer equipment

   $ 1,705      $ 1,412   

Furniture and equipment

     918        778   

Transportation equipment

     508        641   

Leasehold improvements

     1,496        1,209   

Computer software

     3,179        2,840   
  

 

 

   

 

 

 
     7,806        6,880   

Less accumulated depreciation and amortization

     (5,317     (4,629
  

 

 

   

 

 

 
   $ 2,489      $ 2,251   
  

 

 

   

 

 

 

Computer software includes $1,500 of internally developed software that was recognized in conjunction with the acquisition of Addus HealthCare. Depreciation and amortization expense predominantly related to computer equipment and software is reflected in general and administrative expenses and totaled $870, $941, and $903 for the three years ended December 31, 2012, 2011 and 2010, respectively.

 

F-15


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

6. Goodwill and Intangible Assets

The Company’s carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions including the acquisition of Addus HealthCare. In accordance with ASC Topic 350, “Goodwill and Other Intangible Assets,” goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred.

Goodwill is required to be tested for impairment at least annually. The Company can elect to perform Step-0 an optional qualitative analysis and based on the results skip the remaining two steps. In 2012, the Company elected to implement Step 0 and was not required to conduct the remaining two step analysis. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. The Company uses the combination of a DCF model and the market multiple analysis method to determine the current fair value of each reporting unit.

In performing its goodwill assessment for 2012, the Company evaluated the following factors that affect future business performance: macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, entity-specific events, reporting unit factors and company stock price. As a result of the assessment of these qualitative factors, the Company has concluded that it is more likely than not that the fair values of the reporting unit goodwill as of December 31, 2012 exceed the carrying values of the unit. Accordingly, the first and second steps of the goodwill impairment test as described in FASB ASC 350-20-35, which includes estimating the fair values of each reporting unit, are not considered necessary for the reporting unit and no goodwill impairment charges were recorded in 2012.

In 2011, the DCF model was prepared using revenue and expense projections based on the Company’s current operating plan. As such, a number of significant assumptions and estimates are involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. The cash flows were discounted using a weighted average cost of capital of 14.5%, which was management’s best estimate based on the capital structure of the Company and external industry data. As part of the second step of this evaluation, if the carrying value of goodwill exceeds its implied fair value an impairment loss would be recognized.

In light of the current Federal and state economic and reimbursement environments and state budgetary pressures to decrease or eliminate services provided by the Company, the Company completed a preliminary assessment of the fair value of continuing and discontinued operations and the potential for goodwill impairment as of June 30, 2011.

Based on the above and updates to the Company’s business projections and forecasts, and other factors, the Company determined that the estimated fair value of its discontinued operations was less than the net book value indicating that its allocated goodwill was impaired. The preliminary assessment for the continuing operations indicated that its fair value was greater than its net book value with no initial indication of goodwill impairment.

As permitted by ASC Topic 350, when an impairment indicator arises toward the end of an interim reporting period, the Company may recognize its best estimate of that impairment loss. Based on the Company’s preliminary analysis prepared as of June 30, 2011, the Company determined that all of the $13,076 allocated to goodwill for the discontinued operations as of September 30, 2011 was impaired and recorded a goodwill

 

F-16


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

impairment loss in the third quarter of 2011. The goodwill impairment charge was noncash in nature and did not affect the Company’s liquidity or cash flows from operating activities. Additionally, the goodwill impairment had no effect on the Company’s borrowing availability or covenants under its credit facility agreement. The analysis prepared as of June 30, 2011 was preliminary and subject to the completion of the Company’s annual impairment test as of October 1, 2011. The Company completed its annual impairment test of goodwill as of October 1, 2011 and determined that no additional impairment charges or adjustments were required. The goodwill for the Company’s continuing operations was $50,536 as of December 31, 2012.

Summary of goodwill and related adjustments provided below:

 

     Continuing
operations
    Discontinued
operations
    Total  

Goodwill, at December 31, 2010

   $ 50,820      $ 13,110      $ 63,930   

Adjustments to previously recorded goodwill

     (125 )     (34     (159

Impairment charge for discontinued operations

     —         (13,076     (13,076 )
  

 

 

   

 

 

   

 

 

 

Goodwill, at December 31, 2011

     50,695        —         50,695   

Adjustments to previously recorded goodwill

     (159     —         (159
  

 

 

   

 

 

   

 

 

 

Goodwill, at December 31, 2012

   $ 50,536      $ —       $ 50,536   
  

 

 

   

 

 

   

 

 

 

Adjustments to the previously recorded goodwill are primarily credits related to amortization of tax goodwill in excess of book basis.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-compete agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from two to 25 years.

In connection with the Company’s preliminary assessment of its fair value discussed above, it determined that all of its $2,273 allocated to finite lived identifiable intangible assets for the discontinued operations as of September 30, 2011 was impaired and recorded an impairment charge in the third quarter of 2011. The impairment charge was noncash in nature and did not affect the Company’s liquidity or cash flows from operating activities.

The Company also has indefinite-lived assets that are not subject to amortization expense such as certificates of need and licenses to conduct specific operations within geographic markets. The Company has concluded that certificates of need and licenses have indefinite lives, as management has determined that there are no legal, regulatory, contractual, economic or other factors that would limit the useful life of these intangible assets and the Company intends to renew and operate the certificates of need and licenses indefinitely. The certificates of need and licenses are tested annually for impairment. In connection with the Company’s assessment of its fair value discussed above, it determined that all of the $640 allocated to discontinued operations certificates of need and licenses were impaired and recorded an impairment loss in the third quarter of 2011, which is classified as discontinued operations.

 

F-17


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following for continuing and discontinued operations at December 31, 2012 and 2011:

 

     Customer  and
referral
relationships
    Trade names
and
trademarks
    State
Licenses
    Non-competition
agreements
    Total  

Balance at December 31, 2010

   $ 10,184      $ 2,407      $ 790      $ 189      $ 13,570   

Impairment charges for discontinued operations

     (1,754     (506 )     (640     (13 )     (2,913 )

Amortization

     (2,199     (350 )           (64 )     (2,613 )
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 31, 2011

     6,231        1,551        150        112        8,044   

Amortization

     (1,364     (248           (62     (1,674
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 31, 2012

   $ 4,867      $ 1,303      $ 150      $ 50      $ 6,370   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Amortization expense for continuing and discontinued operations related to the identifiable intangible assets amounted to $1,674, $2,613, and $3,143 for the three years ended December 31, 2012, 2011 and 2010, respectively. Goodwill and state licenses are not amortized pursuant to ASC Topic 350.

The estimated future intangible amortization expense is as follows:

 

For the year ended December 31,

  

2013

   $ 1,354   

2014

     1,093   

2015

     886   

2016

     717   

2017

     595   

Thereafter

     1,575   
  

 

 

 

Total

   $ 6,220   
  

 

 

 

7. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consist of the following:

 

     December 31,  
     2012      2011  

Prepaid health insurance

   $ 4,062       $ 3,672   

Prepaid workers’ compensation and liability insurance

     1,056         1,354   

Prepaid rent

     181         192   

Workers’ compensation insurance receivable

     953         1,866   

Other

     1,041         1,053   
  

 

 

    

 

 

 
   $ 7,293       $ 8,137   
  

 

 

    

 

 

 

 

F-18


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

Accrued expenses consisted of the following:

 

     December 31,  
     2012      2011  

Accrued payroll

   $ 11,539       $ 11,547   

Accrued workers’ compensation insurance

     12,452         10,173   

Accrued payroll taxes

     1,481         1,811   

Accrued health insurance

     3,469         3,039   

Accrued taxes

     1,223         223   

Accrued interest

     51         100   

Current portion of contingent earn-out obligation

     689         683   

Other

     1,813         1,737   
  

 

 

    

 

 

 
   $ 32,717       $ 29,313   
  

 

 

    

 

 

 

The Company provides health insurance coverage to qualified union employees providing home and community based services in Illinois through a Taft-Hartley multi-employer health and welfare plan under Section 302(c)(5) of the Labor Management Relations Act of 1947. The Company’s insurance contributions equal the amount reimbursed by the State of Illinois. Contributions are due within five business days from the date the funds are received from the State. Amounts due of $3,405 and $2,982 for health insurance reimbursements and contributions were reflected in prepaid insurance and accrued insurance at December 31, 2012 and 2011, respectively.

The Company’s workers’ compensation program has a $350 deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The future claims payments related to the workers’ compensation program are secured by letters of credit. These letters of credit totaled $7,410 at December 31, 2012 and 2011.

As part of the terms of the acquisition of Addus HealthCare in 2006, all 2005 and prior workers’ compensation claims are the obligation of the former stockholders of Addus HealthCare. Approximately $1,200 in cash escrows and deposits were set-aside from the purchase price of Addus HealthCare as collateral for these 2005 and prior claims as of December 31, 2012. The outstanding loss reserves associated with the 2005 and prior workers’ compensation policies approximated $608 at December 31, 2012.

8. Long-Term Debt

Long-term debt consisted of the following:

 

     December 31,  
     2012     2011  

Revolving credit loan

   $ 16,250      $ 24,750   

Term loan

     208        2,708   

Subordinated dividend notes bearing interest at 10.0%

     —         4,069   

Total

     16,458        31,527   
  

 

 

   

 

 

 

Less current maturities

     (208     (6,569
  

 

 

   

 

 

 

Long-term debt

   $ 16,250      $ 24,958   
  

 

 

   

 

 

 

 

F-19


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

Senior Secured Credit Facility

On March 18, 2010, the Company entered into an amendment (the “First Amendment”) to its credit facility. The First Amendment (i) increased the maximum aggregate amount of revolving loans available to the Company by $5,000 to $55,000, (ii) modified the Company’s maximum senior leverage ratio from 2.75 to 1.0 to 3.00 to 1.0 for each twelve month period ending on the last of day of each fiscal quarter thereafter and (iii) increased the advance multiple used to determine the amount of the borrowing base from 2.75 to 1.0 to 3.0 to 1.0. Our credit facility expires on November 2, 2014.

On July 26, 2010, the Company entered into the Second Amendment to its credit facility. The Second Amendment provided for a term loan component of the credit facility in the aggregate principal amount of $5,000 with a maturity date of January 5, 2013. The requisite lenders also consented to the acquisition, effective July 25, 2010, of certain assets of Advantage by the Company, pursuant to the Purchase Agreement. The term loan was to be repaid in 24 equal monthly installments which commenced February 2011. Interest on the term loan under the credit facility was payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest was to be paid monthly or at the end of the relevant interest period. The term loan was repaid when due on January 5, 2013.

On May 24, 2011, the Company entered into a Joinder, Consent and Amendment No. 3 to its credit facility to include Addus HealthCare (Delaware) Inc., a newly-formed, wholly-owned subsidiary of Addus HealthCare, as an additional borrower under the credit facility.

On July 26, 2011, the Company entered into a fourth amendment (the “Fourth Amendment”) to its credit facility. The Fourth Amendment modified the Company’s maximum senior leverage ratio from 3.00 to 1.00 to 3.25 to 1.00 for each twelve month period ending on the last of day of each fiscal quarter beginning with the twelve month period ended June 30, 2011 and increased the advance multiple used to determine the amount of the borrowing base from 3.0 to 1.0 to 3.25 to 1.0. The Fourth Amendment resulted in an increase in the Company’s available borrowings under the credit facility.

On March 2, 2012, the Company entered into a fifth amendment (the “Fifth Amendment”) to its credit facility. The Fifth Amendment includes technical changes that are intended to comply with rules promulgated by CMS that restrict lenders from exercising any rights of set-off of funds on deposit in any lockboxes established for receiving payments from governmental authorities.

During the fourth quarter of 2011, the lenders under the Company’s credit facility permitted the Company to add back approximately $1,800 to adjusted EBITDA for the purpose of determining availability under the credit facility. The effect of the add back was to increase availability by approximately $5,800 until March 1, 2012. On March 1, 2012, the add back allowance was reduced by $200 and will continue to be reduced by $200 on the first day of each month thereafter until the add back is eliminated, which will result in a reduction in availability of $650 on the first day of each month thereafter until the add back is eliminated. The add-back was eliminated on December 1, 2012. During the second quarter of 2012, the lenders under the Company’s credit facility agreed to a modified interpretation of the credit facility as it relates to the calculation of the fixed charge ratio, which provides the Company with increased flexibility in meeting this covenant. The Company was in compliance with all covenants as of December 31, 2012.

The availability of funds under the revolving credit portion of the credit facility, as amended, is based on the lesser of (i) the product of adjusted EBITDA, as defined in the credit facility agreement, for the most recent 12-month period for which financial statements have been delivered under the credit facility agreement multiplied

 

F-20


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

by the specified advance multiple, up to 3.25, less the outstanding senior indebtedness and letters of credit, and (ii) $55,000 less the outstanding revolving loans and letters of credit. Interest on the amounts outstanding under the revolving credit portion of the credit facility is payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest will be paid monthly or at the end of the relevant interest period, as determined in accordance with the credit facility agreement. The borrowers will pay a fee equal to 0.5% per annum of the unused portion of the revolving portion of the credit facility. Issued stand-by letters of credit will be charged at a rate of 2.0% per annum payable monthly. On December 31, 2012 the interest rate on the revolving credit loan facility was 4.8% (30 day LIBOR rate was 0.2%). The total availability under the revolving credit loan facility was $27,137 at December 31, 2012 compared to $21,810 at December 31, 2011.

Subordinated Dividend Notes

On November 2, 2009, in conjunction with the IPO, all outstanding shares of Holdings’ series A preferred stock were converted into an aggregate 4,077 shares of common stock at a ratio of 1:108. Total accrued and unpaid dividends on the series A preferred stock were $13,109 as of November 2, 2009, at which time a dividend payment of $173 was made and the remaining $12,936 in unpaid preferred dividends were converted into dividend notes. The dividend notes are subordinated and junior to all obligations under the Company’s new credit facility. On November 2, 2009, the Company made a mandatory payment of $4,000 on the dividend notes. Interest on the outstanding dividend notes accrues at a rate of 10% per annum, compounded annually. The outstanding principal amount of the dividend notes was originally payable in eight equal consecutive quarterly installments which commenced on December 31, 2009 and each March 31, June 30, September 30 and December 31 of each year thereafter until paid in full. Interest on the unpaid principal balance of the dividend notes is due and payable quarterly in arrears together with each payment of principal.

On March 18, 2010, the Company amended its subordinated dividend notes. A balance of $7,819 was outstanding on the dividend notes as of December 31, 2009. Pursuant to the amendments, the dividend notes were amended to (i) extend the maturity date of the dividend notes from September 30, 2011 to December 31, 2012, (ii) modify the amortization schedule of the dividend notes to reduce the annual principal payment amounts from $4,468 to $1,250 in 2010; from $3,351 to $2,500 in 2011; and amended total payments in 2012 to $4,069, and (iii) permit, based on the Company’s leverage ratio, the prepayment of all or a portion of the principal amount of the dividend notes, together with interest on the principal amount. The Company repaid the subordinated dividend notes in the fourth quarter of 2012.

Aggregate maturities of long-term debt as of December 31, 2012, are as follows:

 

     For the year ended
December 31,
 

2013

   $ 208   

2014

     16,250   
  

 

 

 

Total

   $ 16,458   
  

 

 

 

 

F-21


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

9. Income Taxes

The current and deferred federal and state income tax provision (benefit), for both continuing and discontinued operations are comprised of the following:

 

     December 31,  
     2012      2011     2010  

Current

       

Federal

   $ 2,325       $ 1,994      $ 2,178   

State

     544         184        335   

Deferred

       

Federal

     680         (4,267     388   

State

     159         (396     59   
  

 

 

    

 

 

   

 

 

 

Provision (benefit) for income taxes

   $ 3,708       $ (2,485   $ 2,960   
  

 

 

    

 

 

   

 

 

 

The tax effects of certain temporary differences between the Company’s book and tax bases of assets and liabilities give rise to significant portions of the deferred income tax assets at December 31, 2012 and 2011. The deferred tax assets consisted of the following:

 

     December 31,  
     2012     2011  

Deferred tax assets

    

Current

    

Accounts receivable allowances

   $ 1,784      $ 2,824   

Accrued compensation

     1,133        902   

Accrued workers’ compensation

     4,593        3,263   

Other

     395        146   
  

 

 

   

 

 

 

Total current deferred tax assets

     7,905        7,135   

Deferred tax liabilities

    

Current

    

Prepaid insurance

     (647     (799
  

 

 

   

 

 

 

Net deferred tax assets—current

     7,258        6,336   

Deferred tax assets

    

Long-term

    

Goodwill and intangible assets

     1,577        3,398   

Property and equipment

     96        112   

Stock-based compensation

     655        579   
  

 

 

   

 

 

 

Total long-term deferred tax assets

     2,328        4,089   
  

 

 

   

 

 

 

Total net deferred tax assets

   $ 9,586      $ 10,425   
  

 

 

   

 

 

 

Management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management

 

F-22


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

considers projected future taxable income and tax-planning strategies in making this assessment. Based on this assessment, management believes it is more likely than not that the Company will realize its deferred income tax assets as of December 31, 2012.

A reconciliation of the statutory federal tax rate of 34.0% to the effective income tax rate, for continuing and discontinued operations, for the years ended December 31, 2012, 2011, and 2010 is summarized as follows:

 

     December 31,  
     2012     2011     2010  

Federal income tax at statutory rate

     34.0     34.0     34.0

State and local taxes, net of federal benefit

     5.9        5.3        4.9   

Jobs tax credits, net

     (9.3     23.1        (7.9

Nondeductible meals and entertainment

     0.9        (2.0 )     1.0   

Tax asset adjustment—stock options

     0.3        (0.5 )     0.9   

Other

     0.9        (4.3 )      
  

 

 

   

 

 

   

 

 

 

Effective income tax rate

     32.7     55.6     32.9
  

 

 

   

 

 

   

 

 

 

The Company is subject to taxation in the jurisdictions in which it operates. The Company continues to remain subject to examination by U.S. federal authorities for the years 2009 through 2012 and for various state authorities for the years 2008 through 2012. As part of the acquisition of Addus HealthCare in 2006, the selling stockholders agreed to assume and indemnify the successor for any federal or state tax liabilities prior to the acquisition date.

The total amount of unrecognized tax benefits under ASC Topic 740 at December 31, 2012 was $115. If recognized, the entire amount would favorably impact the effective tax rate in future periods. Interest and penalties related to income tax liabilities are recognized in interest expense and general and administrative expenses, respectively. The Company does not anticipate a material change in its liabilities for uncertain tax positions during the next 12 months.

A summary of the activities associated with the Company’s reserve for unrecognized tax benefits is as follows:

 

     Unrecognized
Tax Benefits
 

Balance at December 31, 2010

   $ 115   

Increases related to current year tax positions

      
  

 

 

 

Balance at December 31, 2011

   $ 115   

Increases related to current year tax positions

      
  

 

 

 

Balance at December 31, 2012

   $ 115   
  

 

 

 

10. Stock Options and Restricted Stock Awards

Stock Options

The 2006 Plan provides for the grant of non-qualified stock options to directors and eligible employees, as defined in the 2006 Plan. A total of 899 of Holdings’ shares of common stock were reserved for issuance under the 2006 Plan. The number of options to be granted and the terms thereof were approved by Holdings’ board of

 

F-23


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

directors. The option price for each share of common stock subject to an option may be greater than or equal to the fair market value of the stock at the date of grant. The stock options generally vest ratably over a five year period and expire 10 years from the date of grant, if not previously exercised.

In September 2009, the Company’s board of directors and stockholders adopted and approved the 2009 Plan. The 2009 Plan provides for the grant of 750 incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units, restricted stock units, other stock units and performance shares.

A summary of stock option activity and weighted average exercise price is as follows:

 

     For The Year Ended December 31,  
     2012     Weighted
Average
Exercise
Price
     2011     Weighted
Average
Exercise
Price
     2010     Weighted
Average
Exercise
Price
 
     Options        Options        Options    

Outstanding, beginning of period

     775      $ 7.69         588      $ 8.63         607      $ 9.51   

Granted

     36        4.49         229        5.33         91        4.30   

Exercised

     (5     4.53         —             —          —     

Forfeited/Cancelled

     (209     6.02         (42     7.93         (110     9.95   
  

 

 

      

 

 

      

 

 

   

Outstanding, end of period

     596      $ 8.11         775      $ 7.69         588      $ 8.63   
  

 

 

      

 

 

      

 

 

   

The following table summarizes stock options outstanding and exercisable at December 31, 2012:

 

     Outstanding      Exercisable  

Exercise Price

   Options      Weighted
Average
Remaining
Contractual
Life In
Years
     Weighted
Average
Exercise
Price
     Options      Weighted
Average
Remaining
Contractual
Life In
Years
     Weighted
Average
Exercise
Price
 

$4.06 – $ 5.45

     166         8.4       $ 4.77         48         8.1       $ 4.77   

$9.26 – $10.00

     430         4.5         9.39         400         4.3         9.35   
  

 

 

          

 

 

       
     596         5.6       $ 8.11         448         4.7       $ 8.85   
  

 

 

          

 

 

       

The Company historically used the Black-Scholes option pricing model to estimate the fair value of its stock based payment awards under its 2006 Plan, but beginning October 28, 2009 under its 2009 Plan it began using an enhanced Hull-White Trinomial model. The determination of the fair value of stock-based payments utilizing the Black-Scholes model and the Enhanced Hull-White Trinomial model is affected by Holdings’ stock price and a number of assumptions, including expected volatility, risk-free interest rate, expected term, expected dividends yield, expected forfeiture rate, expected turn-over rate, and the expected exercise multiple. Holdings did not have a history of market prices of its common stock as it was not a public company prior to the IPO, and as such it estimates volatility based on the volatilities of a peer group of publicly traded companies. The expected term of options is based on the Company’s estimate of when options will be exercised in the future. The risk-free interest rate assumption is based on observed interest rates appropriate for the terms of the Company’s awards. The dividend assumption is based on the Company’s history and expectation of not paying dividends. The expected turn-over rate represents the expected forfeitures due to employee turnover and is based on historical rates experienced by the Company. The expected exercise multiple represents the mean ratio of the stock price to the exercise price at which employees are expected to exercise their options.

 

F-24


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

The weighted-average estimated fair value of employee stock options granted as calculated using the Black-Scholes model and the Enhanced Hull-White Trinomial model and the related assumptions follow:

 

    

For the year ended December 31,

    

2012

Grants

  

2011

Grants

  

2010

Grants

Weighted average fair value

   2.09    $2.54    $1.88

Risk-free discount rate

   1.59% – 1.95%    3.17%    2.89% – 2.99%

Expected life

   6.0 – 6.5 years    6.0 – 6.5 years    6.5 years

Dividend yield

   —      —      —  

Volatility

   42% – 51%    42% – 51%    42% –51%

Expected turn-over rate(1)

   5%    5%    5%

Expected exercise multiple(1)

   2.2    2.2    2.2

Stock option compensation expense, for continuing and discontinued operations, totaled $181, $254 and $241 for the three years ended December 31, 2012, 2011 and 2010, respectively. As of December 31, 2012, there was $349 of total unrecognized compensation cost that is expected to be recognized over a period of five years.

The intrinsic value of vested and outstanding stock options was $115 and $394 as of December 31, 2012. There were 5 stock options exercised in 2012 and the Company did not receive any cash from option exercises and did not realize any related tax benefits. There were no stock options exercised in 2011 or 2010.

Restricted Stock Awards

In 2012, management awarded 44 shares of restricted stock awards under the 2009 Plan with a weighted average fair value of $4.48 per share. As of December 31, 2012, $115 of unearned compensation related to unvested awards of restricted stock will be recognized over the remaining vesting terms of the awards.

The following table summarizes the status of unvested restricted stock awards outstanding at December 31, 2012, 2011 and 2010:

 

     For The Year Ended December 31,  
     2012     Weighted-
Average
Grant Date
Fair Value
     2011     Weighted-
Average
Grant Date
Fair Value
     2010     Weighted-
Average
Grant Date
Fair Value
 
     Restricted
Stock
Awards
       Restricted
Stock
Awards
       Restricted
Stock
Awards
   

Unvested restricted stock awards

     21      $ 5.95         6      $ 6.85         3      $ 10.00   

Awarded

     44        4.48         24        5.63         4        5.21   

Vested

     (20     5.14         (8     5.64         (1     10.00   

Forfeited

     (3     5.93         (1     5.93                
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Unvested restricted stock awards at December 31,

     42      $ 4.80         21      $ 5.95         6      $ 6.85   
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Restricted stock award compensation expense, for continuing and discontinued operations, totaled $160, $77 and $14 for the three years ended December 31, 2012, 2011 and 2010, respectively.

 

F-25


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

Shares available under the 2006 Plan and the 2009 Plan were 546 and 435, respectively, as of December 31, 2012. The Company does not plan on issuing any further grants under the 2006 Plan.

11. Operating Leases and Related Party Transactions

The Company leases its branch office space under various operating leases that expire at various dates through 2019. In addition to rent, the Company is typically responsible for taxes, maintenance, insurance and common area costs. A number of the office leases also contain escalation and renewal option clauses. Total rent expense on these office leases was $3,380, $3,495 and $3,441 for continuing and discontinued operations for the years ended December 31, 2012, 2011, and 2010, respectively. In connection with the sale of the Home Health Business, the Company entered into subleases for all or a portion of 13 of the Company’s leased properties and assigned nine leases to the purchasers Assigned leases are not included in the schedule below.

The Company leases its corporate office space from a member of its board of directors, who is also a stockholder of the Company, under the terms of an operating lease that expires in June 2013. The lease agreement provides for a renewal option of five years, commencing upon the expiration of the initial term of the lease. Rental expense relating to this lease amounted to $486, $409 and $367 for the years ended December 31, 2012, 2011 and 2010, respectively.

During 2011, the Company entered into a lease for its telecom system under a five year operating lease that expires in May 2016. Total expense on the telecom lease for continuing and discontinued operations was $285 and $62 for the years ended December 31, 2012 and 2011, respectively.

The following is a schedule of the future minimum payments, exclusive of taxes and other operating expenses, required under the Company’s operating leases. The payments owed with respect to the subleased properties have not been excluded from the table below because the Company remains liable for payments in the event that the sublessee does not make the required payment to the landlord.

 

     Non-Related Party Rent      Related Party Rent      Amount  

2013

   $ 2,784       $ 240       $ 3,024   

2014

     2,044         —           2,044   

2015

     1,759         —           1,759   

2016

     1,466         —           1,466   

2017

     779         —           779   

Thereafter

     1,208         —           1,208   
  

 

 

    

 

 

    

 

 

 

Total

   $ 10,040       $ 240       $ 10,280   
  

 

 

    

 

 

    

 

 

 

12. Stockholder’s Equity

Acquisitions

On July 26, 2010, in conjunction with the purchase of certain assets of Advantage by the Company, pursuant to the Purchase Agreement, the Company issued 248 shares of its common stock with a value of $1,240.

2009 Stock Incentive Plan

In September 2009, the Company’s board of directors and stockholders adopted and approved the 2009 Plan. The 2009 Plan provides for the grant of 750 incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units, restricted stock units, other stock units and performance shares.

 

F-26


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

13. Segment Data

The Company has historically segregated its results into two distinct reporting segments: the home & community segment and the home health segment. As a result of the sale of the Home Health Business, the Company has reported the operating results for the Home Health Business as discontinued operations. Therefore, all of the Company’s operations are reported as one operating segment.

14. Employee Benefit Plans

The Company’s 401(k) Retirement Plan covers all non-union employees. The 401(k) plan is a defined contribution plan that provides for matching contributions by the Company. Matching contributions are discretionary and subject to change by management. Under the provisions of the 401(k) plan, employees can contribute up to the maximum percentage and limits allowable under the Internal Revenue Code of 1986. The Company provided a matching contribution, equal to 6.0% of the employees’ contributions, totaling $44, $49, and $51 for continuing and discontinued operations for the year ended December 31, 2012, 2011, and 2010, respectively.

15. Commitments and Contingencies

Legal Proceedings

The Company is a party to legal and/or administrative proceedings arising in the ordinary course of its business. It is the opinion of management that the outcome of such proceedings will not have a material effect on the Company’s financial position and results of operations.

Employment Agreements

The Company has entered into employment agreements with certain members of senior management. The terms of these agreements are up to four years and include non-compete and nondisclosure provisions, as well as provide for defined severance payments in the event of termination.

16. Significant Payors

A substantial portion of the Company’s net service revenues and accounts receivables are derived from services performed for federal, state and local governmental agencies. One state governmental agency represented 57%, 51% and 45% of the Company’s net service revenues for 2012, 2011, and 2010, respectively.

The related receivables due from Medicare and the state agency represented 7% and 69% of the Company’s accounts receivable at December 31, 2012, respectively, and 11% and 58% of the Company’s accounts receivable at December 31, 2011, respectively.

17. Concentration of Cash

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash. The Company maintains cash with financial institutions which, at times, may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk on cash.

 

F-27


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

18. Unaudited Summarized Quarterly Financial Information

The following is a summary of the Company’s unaudited quarterly results of operations (amounts and shares in thousands, except per share data):

 

    Year Ended December 31, 2012     Year Ended December 31, 2011  
    Dec. 31     Sept. 30     Jun. 30     Mar. 31     Dec. 31     Sept. 30     Jun. 30     Mar. 31  

Net service revenues

  $ 63,775      $ 61,211      $ 60,440      $ 58,889      $ 58,304      $ 58,393      $ 57,200      $ 56,208   

Gross profit

    17,537        15,683        15,807        15,024        16,829        15,701        14,784        14,159   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income from continuing operations

    5,261        3,867        3,217        3,318        4,648        3,711        2,558        2,000   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income from continuing operations

    3,503        2,204        1,835        1,746        2,914        3,396        1,253        849   

Net income (loss) from discontinued operations

    242        (407     (371     (1,117     (418     (10,059     80        4   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

  $ 3,745      $ 1,797      $ 1,464      $ 629      $ 2,496      $ (6,663   $ 1,333      $ 853   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Average shares outstanding:

               

Basic

    10,772        10,761        10,761        10,756        10,754        10,746        10,746        10,746   

Diluted

    10,807        10,773        10,785        10,760        10,756        10,746        10,770        10,754   

Income (loss) per common share:

               

Basic and diluted

               

Continuing operations

  $ 0.33      $ 0.20      $ 0.17      $ 0.16      $ 0.27      $ 0.32      $ 0.11      $ 0.08   

Discontinued operations

    0.02        (0.03     (0.03     (0.10     (0.04     (0.94     0.01        0.00   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Basic and diluted net earnings (loss) per share

  $ 0.35      $ 0.17      $ 0.14      $ 0.06      $ 0.23      $ (0.62   $ 0.12      $ 0.08   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

19. Subsequent Event

On February 7, 2013, the Company entered into the Home Health Purchase Agreement with LHC Group, Inc. and certain of its subsidiaries. Pursuant to the Home Health Purchase Agreement, effective March 1, 2013, the purchasers acquired substantially all the assets of the Company’ s Home Health Business in Arkansas, Nevada and South Carolina and 90% of the Home Health Business in California and Illinois with the Company retaining 10% ownership in such locations, for cash consideration of $20,000. (see note 2). In addition the Company has two home health agencies that are being held for sale. The results of operations for assets sold or being held for sale are included in the financial statements as discontinued operations.

 

F-28


Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(amounts and shares in thousands, except per share data)—(Continued)

 

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II

(in thousands)

 

Allowance for doubtful accounts

   Balance at
beginning
of period
     Additions/
charges
     Deductions*      Balance at
end of
period
 

Year ended December 31, 2012

           

Allowance for doubtful accounts

   $ 7,189         2,877         5,600       $ 4,466   

Year ended December 31, 2011

           

Allowance for doubtful accounts

   $ 6,723         4,275         3,809       $ 7,189   

Year ended December 31, 2010

           

Allowance for doubtful accounts

   $ 4,813         4,429         2,519       $ 6,723   

 

* Write-offs, net of recoveries

 

F-29


Table of Contents

EXHIBIT INDEX

 

Exhibit

Number

  

Description of Document

    3.1    Amended and Restated Certificate of Incorporation of Addus HomeCare Corporation dated as of November 2, 2009 (filed on November 20, 2009 as Exhibit 3.1 to Addus HomeCare Corporation’s Quarterly Report on Form 10-Q and incorporated by reference herein)
    3.2    Amended and Restated Bylaws of Addus HomeCare Corporation (filed on September 21, 2009 as Exhibit 3.5 to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
    4.1    Form of Common Stock Certificate (filed on October 2, 2009 as Exhibit 4.1 to Amendment No. 4 to the Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
    4.2    Registration Rights Agreement, dated September 19, 2006, by and among Addus HomeCare Corporation, Eos Capital Partners III, L.P., Eos Partners SBIC III, L.P., Freeport Loan Fund LLC, W. Andrew Wright, III, Addus Term Trust, W. Andrew Wright Grantor Retained Annuity Trust, Mark S. Heaney, James A. Wright and Courtney E. Panzer (filed on July 17, 2009 as Exhibit 4.2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.1    Separation and General Release Agreement, dated as of September 20, 2009, between Addus HealthCare, Inc. and W. Andrew Wright, III (filed on September 21, 2009 as Exhibit 10.1(b) to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.2    Amended and Restated Employment and Non-Competition Agreement, dated May 6, 2008, between Addus HealthCare, Inc. and Mark S. Heaney (filed on July 17, 2009 as Exhibit 10.2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.3    Amendment to the Amended and Restated Employment and Non-Competition Agreement, dated September 30, 2009, between Addus HealthCare, Inc. and Mark S. Heaney (filed on October 2, 2009 as Exhibit 10.2(a) to Amendment No. 4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.4    Employment Agreement, dated November 29, 2010, by and between Addus HealthCare, Inc. and Dennis Meulemans (filed on December 1, 2010 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.5    Amended and Restated Employment and Non-Competition Agreement, dated August 27, 2007, between Addus HealthCare, Inc. and Darby Anderson (filed on July 17, 2009 as Exhibit 10.4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.6    Amendment to the Amended and Restated Employment and Non-Competition Agreement, dated September 30, 2009, between Addus HealthCare, Inc. and Darby Anderson (filed on October 2, 2009 as Exhibit 10.4(a) to Amendment No. 4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.7    Amended and Restated Employment and Non-Competition Agreement, dated October 8, 2008, between Addus HealthCare, Inc. and David W. Stasiewicz (filed on July 17, 2009 as Exhibit 10.6 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.8    Amendment No. 1 to Amended and Restated Employment and Non-Competition Agreement between Addus HealthCare, Inc. and David W. Stasiewicz (filed on October 2, 2009 as Exhibit 10.6(a) to Amendment No. 4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)


Table of Contents

Exhibit

Number

  

Description of Document

  10.9    Employment and Non-Competition Agreement, dated March 23, 2007, between Addus HealthCare, Inc. and Paul Diamond (filed on July 17, 2009 as Exhibit 10.7 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.10    Amendment to the Employment and Non-Competition Agreement, dated September 30, 2009, between Addus HealthCare, Inc. and Paul Diamond (filed on October 2, 2009 as Exhibit 10.7(a) to Amendment No. 4 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.11    Addus HealthCare, Inc. Home Health and Home Care Division Vice President and Regional Director Bonus Plan (filed on July 17, 2009 as Exhibit 10.10 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.12    Addus HealthCare, Inc. Support Center Vice President and Department Director Bonus Plan (filed on July 17, 2009 as Exhibit 10.11 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.13    Addus Holding Corporation 2006 Stock Incentive Plan (filed on July 17, 2009 as Exhibit 10.12 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.14    Director Form of Option Award Agreement under the 2006 Stock Incentive Plan (filed on July 17, 2009 as Exhibit 10.13 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.15    Executive Form of Option Award Agreement under the 2006 Stock Incentive Plan (filed on July 17, 2009 as Exhibit 10.14 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.16    Form of Indemnification Agreement (filed on July 17, 2009 as Exhibit 10.16 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.17    License Agreement, dated March 24, 2006, between McKesson Information Solutions, LLC and Addus HealthCare, Inc. (filed on August 26, 2009 as Exhibit 10.17 to Amendment No. 1 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.18    Contract Supplement to the License Agreement, dated March 24, 2006 (filed on August 26, 2009 as Exhibit 10.17(a) to Amendment No. 1 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.19    Contract Supplement to the License Agreement, dated March 28, 2006 (filed on August 26, 2009 as Exhibit 10.17(b) to Amendment No. 1 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.20    Amendment to License Agreement, dated March 28, 2006, between McKesson Information Solutions, LLC and Addus HealthCare, Inc. (filed on August 26, 2009 as Exhibit 10.17(c) to Amendment No. 1 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.21    Lease, dated April 1, 1999, between W. Andrew Wright, III and Addus HealthCare, Inc. (filed on July 17, 2009 as Exhibit 10.18 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.22    First Amendment to Lease, dated as of April 1, 2002, between W. Andrew Wright, III and Addus HealthCare, Inc. (filed on July 17, 2009 as Exhibit 10.18(a) to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.23    Second Amendment to Lease, dated as of September 19, 2006, between W. Andrew Wright, III and Addus HealthCare, Inc. (filed on July 17, 2009 as Exhibit 10.18(b) to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)


Table of Contents

Exhibit

Number

  

Description of Document

  10.24    Third Amendment to Lease, dated as of September 1, 2008, between W. Andrew Wright, III and Addus HealthCare, Inc. (filed on July 17, 2009 as Exhibit 10.18(c) to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.25    Addus HomeCare Corporation 2009 Stock Incentive Plan (filed on September 21, 2009 as Exhibit 10.20 to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.26    Form of Incentive Stock Option Award Agreement under the 2009 Stock Incentive Plan (filed on September 21, 2009 as Exhibit 10.20(a) to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.27    Form of Restricted Stock Award Agreement under the 2009 Stock Incentive Plan (filed on September 21, 2009 as Exhibit 10.20(b) to Amendment No. 2 to Addus HomeCare Corporation’s Registration Statement on Form S-1 and incorporated by reference herein)
  10.28    Loan and Security Agreement, dated as of November 2, 2009, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation and Professional Reliable Nursing Service, Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions that are or may from time to time become parties thereto, and Addus HomeCare Corporation, as guarantor (filed on November 5, 2009 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.29    Consent and Amendment No. 1 to the Loan and Security Agreement, dated as of March 18, 2010, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation and Professional Reliable Nursing Service, Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions that are or may from time to time become parties thereto, and Addus HomeCare Corporation, as guarantor (filed on March 18, 2010 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.30    Joinder, Consent and Amendment No. 2 to Loan and Security Agreement, dated as of July 26, 2010, by and among Addus HealthCare, Inc., Addus HealthCare (South Carolina), Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation and Professional Reliable Nursing Service, Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions that are or may from time to time become parties thereto, and Addus HomeCare Corporation, as guarantor (filed on July 27, 2010 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.31    Asset Purchase Agreement dated as of July 26, 2010, by and among Addus HealthCare (South Carolina), Inc., Advantage Health Systems, Inc., Paul Mitchell as the Seller Representative and the Sellers set forth on Exhibit A thereto (filed on July 27, 2010 as Exhibit 99.2 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.32    Earn-Out Agreement dated as of July 26, 2010, by and among Addus HealthCare (South Carolina), Inc., Advantage Health Systems, Inc., Paul Mitchell as the Seller Representative and the Sellers set forth on therein (filed on July 27, 2010 as Exhibit 99.3 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)


Table of Contents

Exhibit

Number

  

Description of Document

  10.33    Joinder, Consent and Amendment No. 3 to the Loan and Security Agreement, dated as of March 24, 2011, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation and Professional Reliable Nursing Service, Inc., Addus HealthCare (South Carolina), Inc. Addus HealthCare (Delaware), Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions that are or may from time to time become parties thereto, and Addus HomeCare Corporation, as guarantor (filed on May 25, 2011 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.34    Amendment No. 4 to Loan and Security Agreement, dated as of July 26, 2011, effective as of June 30, 2011, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation, Professional Reliable Nursing Service, Inc., Addus HealthCare (South Carolina), Inc., Addus HealthCare (Delaware), Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions from time to time parties thereto, and Addus HomeCare Corporation, as guarantor (filed on July 29, 2011 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.35    Amendment No. 2 to Employment and Non-Competition Agreement, dated November 17, 2011, by and between Addus HealthCare, Inc. and Mark S. Heaney (filed on November 23, 2011 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.36    Amendment No. 5 to Loan and Security Agreement, dated as of March 2, 2012, by and among Addus HealthCare, Inc., Addus HealthCare (Idaho), Inc., Addus HealthCare (Indiana), Inc., Addus HealthCare (Nevada), Inc., Addus HealthCare (New Jersey), Inc., Addus HealthCare (North Carolina), Inc., Benefits Assurance Co., Inc., Fort Smith Home Health Agency, Inc., Little Rock Home Health Agency, Inc., Lowell Home Health Agency, Inc., PHC Acquisition Corporation, Professional Reliable Nursing Service, Inc., Addus HealthCare (South Carolina), Inc., Addus HealthCare (Delaware), Inc., as borrowers, Fifth Third Bank, as agent, the financial institutions from time to time parties thereto, and Addus HomeCare Corporation, as guarantor (filed on March 16, 2012 as exhibit 10.41 to Addus HomeCare Corporation’s Annual Report on Form 10-K and incorporated herein by reference)
  10.37    Summary of Independent Director Compensation Policy (filed on March 16, 2012 as Exhibit 10.42 to Addus HomeCare Corporation’s Annual Report on Form 10-K and incorporated herein by reference)
  10.38    The Executive Nonqualified “Excess” Plan Adoption Agreement, by Addus HealthCare, Inc., dated April 1, 2012 (filed on April 5, 2012 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  10.39    The Executive Nonqualified Excess Plan Document, dated April 1, 2012 (filed on April 5, 2012 as Exhibit 99.2 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.40    Employment Agreement, effective June 18, 2012, by and between Addus Healthcare, Inc. and Inna Berkovich (filed on June 20, 2012 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated herein by reference)
  10.41    Separation Agreement and General Release, effective as of September 12, 2012, between Addus HealthCare, Inc. and Gregory Breemes (filed on September 21, 2012 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)


Table of Contents

Exhibit

Number

  

Description of Document

  10.42    Asset Purchase Agreement, dated as of February 7, 2013, by and among Addus HealthCare, Inc., its subsidiaries identified therein, LHC Group, Inc. and its subsidiaries identified therein (filed on March 6, 2013 as Exhibit 99.1 to Addus HomeCare Corporation’s Current Report on Form 8-K and incorporated by reference herein)
  21.1    Subsidiaries of the Addus HomeCare Corporation (filed on March 28, 2011 as Exhibit 22.1 to Addus HomeCare Corporation’s Annual Report on Form 10-K and incorporated herein by reference)
  23.1    Consent of BDO USA, LLP, Independent Registered Public Accounting Firm*
  31.1    Certification of Chief Executive Officer Pursuant to Rule 13-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
  31.2    Certification of Chief Financial Officer Pursuant to Rule 13-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
  32.1    Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
  32.2    Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101    The following materials from Addus HomeCare Corporation’s Annual Report on Form 10-K for the years ended December 31, 2012, formatted in Extensive Business Reporting Language (XBRL), (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Stockholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) the Notes to the Consolidated Financial Statements.
EX-23.1 2 d468078dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

Addus Homecare Corporation

Palatine, Illinois

We hereby consent to the incorporation by reference in Registration Statement No. 333-164413 on Form S-8, of our report dated March 28, 2013, relating to the consolidated financial statements and financial statement schedule of Addus HomeCare Corporation, which appears in this Form 10-K.

/s/ BDO USA, LLP

Chicago, IL

March 28, 2013

EX-31.1 3 d468078dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION

I, Mark S. Heaney, President and Chief Executive Officer of Addus HomeCare Corporation certify that:

 

1. I have reviewed this annual report on Form 10-K of Addus HomeCare Corporation (the “Registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the Registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting, to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: March 28, 2013

 

/S/    MARK S. HEANEY        

Mark S. Heaney
President and Chief Executive Officer
EX-31.2 4 d468078dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION

I, Dennis B. Meulemans, Chief Financial Officer of Addus HomeCare Corporation, certify that:

 

1. I have reviewed this annual report on Form 10-K of Addus HomeCare Corporation (the “Registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the Registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting, to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: March 28, 2013

 

/s/    Dennis B. Meulemans        

Dennis B. Meulemans
Chief Financial Officer
EX-32.1 5 d468078dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

(AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Annual Report on Form 10-K for the fiscal year ended December 31, 2012 of Addus HomeCare Corporation (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark S. Heaney, President and Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 28, 2013        By:  

/S/    MARK S. HEANEY        

            Mark S. Heaney
            President and Chief Executive Officer
EX-32.2 6 d468078dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

(AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Annual Report on Form 10-K for the fiscal year ended December 31, 2012 of Addus HomeCare Corporation (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dennis B. Meulemans, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 28, 2013        By:  

/s/    Dennis B. Meulemans        

            Dennis B. Meulemans
            Chief Financial Officer
EX-101.INS 7 adus-20121231.xml XBRL INSTANCE DOCUMENT 0001468328 us-gaap:AllowanceForDoubtfulAccountsMember 2012-12-31 0001468328 us-gaap:AllowanceForDoubtfulAccountsMember 2011-12-31 0001468328 us-gaap:AllowanceForDoubtfulAccountsMember 2010-12-31 0001468328 us-gaap:AllowanceForDoubtfulAccountsMember 2009-12-31 0001468328 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0001468328 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001468328 us-gaap:CommonStockMember 2010-01-01 2010-12-31 0001468328 us-gaap:RetainedEarningsMember 2012-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001468328 us-gaap:RetainedEarningsMember 2011-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001468328 us-gaap:RetainedEarningsMember 2010-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001468328 us-gaap:RetainedEarningsMember 2009-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2009-12-31 0001468328 us-gaap:CommonStockMember 2012-12-31 0001468328 us-gaap:CommonStockMember 2011-12-31 0001468328 us-gaap:CommonStockMember 2010-12-31 0001468328 us-gaap:CommonStockMember 2009-12-31 0001468328 adus:RangeTwoMember 2012-01-01 2012-12-31 0001468328 adus:RangeOneMember 2012-01-01 2012-12-31 0001468328 adus:RangeTwoMember 2012-12-31 0001468328 adus:RangeOneMember 2012-12-31 0001468328 adus:TwoThousandNineStockIncentivePlanMember 2009-09-30 0001468328 us-gaap:MinimumMember 2011-01-01 2011-12-31 0001468328 us-gaap:MaximumMember 2011-01-01 2011-12-31 0001468328 adus:TwoThousandNineStockIncentivePlanMember 2012-01-01 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:BeforeAmendmentMember 2011-07-26 0001468328 adus:SeniorSecuredCreditFacilityMember adus:AfterAmendmentMember 2011-07-26 0001468328 adus:SeniorSecuredCreditFacilityMember adus:BeforeAmendmentMember 2010-03-18 0001468328 adus:SeniorSecuredCreditFacilityMember adus:AfterAmendmentMember 2010-03-18 0001468328 us-gaap:FurnitureAndFixturesMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0001468328 us-gaap:FurnitureAndFixturesMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0001468328 us-gaap:ComputerEquipmentMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0001468328 us-gaap:ComputerEquipmentMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0001468328 adus:ComputerSoftwareMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0001468328 adus:ComputerSoftwareMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0001468328 us-gaap:TransportationEquipmentMember 2012-01-01 2012-12-31 0001468328 us-gaap:TransportationEquipmentMember 2012-12-31 0001468328 us-gaap:LeaseholdImprovementsMember 2012-12-31 0001468328 us-gaap:FurnitureAndFixturesMember 2012-12-31 0001468328 us-gaap:ComputerEquipmentMember 2012-12-31 0001468328 adus:InternallyDevelopedSoftwareMember 2012-12-31 0001468328 adus:ComputerSoftwareMember 2012-12-31 0001468328 us-gaap:TransportationEquipmentMember 2011-12-31 0001468328 us-gaap:LeaseholdImprovementsMember 2011-12-31 0001468328 us-gaap:FurnitureAndFixturesMember 2011-12-31 0001468328 us-gaap:ComputerEquipmentMember 2011-12-31 0001468328 adus:ComputerSoftwareMember 2011-12-31 0001468328 adus:RelatedPartyMember 2012-12-31 0001468328 adus:NonRelatedPartyMember 2012-12-31 0001468328 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0001468328 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0001468328 us-gaap:RetainedEarningsMember 2010-01-01 2010-12-31 0001468328 adus:TermLoanMember 2012-12-31 0001468328 adus:RevolvingCreditLoanMember 2012-12-31 0001468328 adus:TermLoanMember 2011-12-31 0001468328 adus:SubordinatedDividendNotesMember 2011-12-31 0001468328 adus:RevolvingCreditLoanMember 2011-12-31 0001468328 adus:TermLoanMember 2010-07-24 2010-07-26 0001468328 adus:TermLoanMember 2012-01-01 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:RevolvingCreditLoanMember 2011-12-31 0001468328 adus:TelecomSystemMember 2012-01-01 2012-12-31 0001468328 adus:OfficeMember 2011-01-01 2011-12-31 0001468328 adus:OfficeMember 2010-01-01 2010-12-31 0001468328 adus:CertificatesAndLicensesMember adus:HomeHealthSegmentMember 2011-09-30 0001468328 2011-09-30 0001468328 adus:StateLicensesMember 2011-01-01 2011-12-31 0001468328 adus:CertificatesAndLicensesMember adus:HomeHealthSegmentMember 2011-07-01 2011-09-30 0001468328 us-gaap:SegmentContinuingOperationsMember 2012-01-01 2012-12-31 0001468328 us-gaap:SegmentContinuingOperationsMember 2011-01-01 2011-12-31 0001468328 us-gaap:SegmentDiscontinuedOperationsMember 2011-01-01 2011-12-31 0001468328 adus:AdvantageMember 2011-01-01 2011-12-31 0001468328 adus:HomeHealthSegmentMember 2011-01-01 2011-06-30 0001468328 us-gaap:SegmentContinuingOperationsMember 2012-12-31 0001468328 adus:HomeAndCommunityMember 2012-12-31 0001468328 us-gaap:SegmentContinuingOperationsMember 2011-12-31 0001468328 us-gaap:SegmentDiscontinuedOperationsMember 2010-12-31 0001468328 us-gaap:SegmentContinuingOperationsMember 2010-12-31 0001468328 us-gaap:MinimumMember 2012-01-01 2012-12-31 0001468328 us-gaap:MaximumMember 2012-01-01 2012-12-31 0001468328 us-gaap:NoncompeteAgreementsMember 2012-12-31 0001468328 adus:TradeNamesAndTrademarksMember 2012-12-31 0001468328 adus:StateLicensesMember 2012-12-31 0001468328 adus:CustomerAndReferralRelationshipsMember 2012-12-31 0001468328 us-gaap:NoncompeteAgreementsMember 2011-12-31 0001468328 adus:TradeNamesAndTrademarksMember 2011-12-31 0001468328 adus:StateLicensesMember 2011-12-31 0001468328 adus:CustomerAndReferralRelationshipsMember 2011-12-31 0001468328 us-gaap:NoncompeteAgreementsMember 2010-12-31 0001468328 adus:TradeNamesAndTrademarksMember 2010-12-31 0001468328 adus:StateLicensesMember 2010-12-31 0001468328 adus:CustomerAndReferralRelationshipsMember 2010-12-31 0001468328 adus:HomeHealthSegmentMember 2011-12-31 0001468328 adus:HomeHealthSegmentMember 2011-01-01 2011-12-31 0001468328 adus:HomeHealthSegmentMember 2010-01-01 2010-12-31 0001468328 2012-10-01 2012-12-31 0001468328 2012-07-01 2012-09-30 0001468328 2012-04-01 2012-06-30 0001468328 2012-01-01 2012-03-31 0001468328 2011-10-01 2011-12-31 0001468328 2011-07-01 2011-09-30 0001468328 2011-04-01 2011-06-30 0001468328 2011-01-01 2011-03-31 0001468328 adus:ComputerEquipmentAndSoftwareMember 2012-01-01 2012-12-31 0001468328 adus:ComputerEquipmentAndSoftwareMember 2011-01-01 2011-12-31 0001468328 adus:ComputerEquipmentAndSoftwareMember 2010-01-01 2010-12-31 0001468328 adus:SubordinatedDividendNotesMember adus:BeforeAmendmentMember 2012-01-01 2012-12-31 0001468328 adus:SubordinatedDividendNotesMember adus:AfterAmendmentMember 2012-01-01 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:TermLoanMember 2012-01-01 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember us-gaap:LetterOfCreditMember 2012-12-31 0001468328 adus:TermLoanMember 2011-02-28 0001468328 adus:SeniorSecuredCreditFacilityMember adus:TermLoanMember 2010-07-26 0001468328 adus:SubordinatedDividendNotesMember adus:AfterAmendmentMember 2012-12-31 0001468328 adus:SubordinatedDividendNotesMember adus:BeforeAmendmentMember 2011-12-31 0001468328 adus:SubordinatedDividendNotesMember adus:AfterAmendmentMember 2011-12-31 0001468328 adus:SubordinatedDividendNotesMember adus:BeforeAmendmentMember 2010-12-31 0001468328 adus:SubordinatedDividendNotesMember adus:AfterAmendmentMember 2010-12-31 0001468328 adus:SubordinatedDividendNotesMember us-gaap:SeriesAPreferredStockMember 2009-11-01 2009-11-02 0001468328 us-gaap:SalesRevenueServicesNetMember adus:StateGovernmentalAgencyMember 2012-01-01 2012-12-31 0001468328 us-gaap:AccountsReceivableMember adus:StateGovernmentalAgencyMember 2012-01-01 2012-12-31 0001468328 us-gaap:AccountsReceivableMember adus:MedicareMember 2012-01-01 2012-12-31 0001468328 us-gaap:SalesRevenueServicesNetMember adus:StateGovernmentalAgencyMember 2011-01-01 2011-12-31 0001468328 us-gaap:AccountsReceivableMember adus:StateGovernmentalAgencyMember 2011-01-01 2011-12-31 0001468328 us-gaap:AccountsReceivableMember adus:MedicareMember 2011-01-01 2011-12-31 0001468328 us-gaap:SalesRevenueServicesNetMember adus:StateGovernmentalAgencyMember 2010-01-01 2010-12-31 0001468328 us-gaap:CustomerConcentrationRiskMember 2012-01-01 2012-12-31 0001468328 us-gaap:CashMember 2012-01-01 2012-12-31 0001468328 adus:HoldingsMember adus:TwoThousandSixStockIncentivePlanMember 2012-12-31 0001468328 adus:TwoThousandSixStockIncentivePlanMember 2012-12-31 0001468328 adus:TwoThousandNineStockIncentivePlanMember 2012-12-31 0001468328 2009-12-31 0001468328 adus:AdvantageMember 2010-07-24 2010-07-26 0001468328 2010-07-24 2010-07-26 0001468328 us-gaap:NoncompeteAgreementsMember 2012-01-01 2012-12-31 0001468328 adus:TradeNamesAndTrademarksMember 2012-01-01 2012-12-31 0001468328 adus:CustomerAndReferralRelationshipsMember 2012-01-01 2012-12-31 0001468328 us-gaap:NoncompeteAgreementsMember 2011-01-01 2011-12-31 0001468328 adus:TradeNamesAndTrademarksMember 2011-01-01 2011-12-31 0001468328 adus:CustomerAndReferralRelationshipsMember 2011-01-01 2011-12-31 0001468328 us-gaap:RestrictedStockMember 2012-01-01 2012-12-31 0001468328 us-gaap:RestrictedStockMember 2011-01-01 2011-12-31 0001468328 us-gaap:RestrictedStockMember 2010-01-01 2010-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2010-01-01 2010-12-31 0001468328 adus:HomeHealthSegmentMember 2012-12-31 0001468328 2012-06-30 0001468328 2013-03-18 0001468328 us-gaap:AllowanceForDoubtfulAccountsMember 2012-01-01 2012-12-31 0001468328 us-gaap:AllowanceForDoubtfulAccountsMember 2011-01-01 2011-12-31 0001468328 us-gaap:AllowanceForDoubtfulAccountsMember 2010-01-01 2010-12-31 0001468328 adus:SubordinatedDividendNotesMember us-gaap:SeriesAPreferredStockMember 2009-11-02 0001468328 adus:TwoThousandSixStockIncentivePlanMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0001468328 adus:TwoThousandSixStockIncentivePlanMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:RevolvingCreditLoanMember 2012-01-01 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:BeforeAmendmentMember 2011-07-24 2011-07-26 0001468328 adus:SeniorSecuredCreditFacilityMember adus:AfterAmendmentMember 2011-07-24 2011-07-26 0001468328 adus:SeniorSecuredCreditFacilityMember adus:BeforeAmendmentMember 2010-03-16 2010-03-18 0001468328 adus:SeniorSecuredCreditFacilityMember adus:AfterAmendmentMember 2010-03-16 2010-03-18 0001468328 2010-12-31 0001468328 adus:HomeHealthSegmentMember 2012-01-01 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:AdjustmentPermittedByLendersMember 2012-03-01 0001468328 us-gaap:SubsequentEventMember 2013-02-07 0001468328 adus:SubordinatedDividendNotesMember 2009-11-02 0001468328 adus:OfficeMember 2012-01-01 2012-12-31 0001468328 adus:TelecomSystemMember 2011-01-01 2011-12-31 0001468328 adus:StateGovernmentalAgencyMember 2012-01-01 2012-12-31 0001468328 adus:StateGovernmentalAgencyMember 2011-01-01 2011-12-31 0001468328 adus:StateGovernmentalAgencyMember 2010-01-01 2010-12-31 0001468328 adus:LhcGroupIncMember 2012-01-01 2012-12-31 0001468328 adus:TermLoanMember 2010-07-23 2010-07-25 0001468328 adus:SeniorSecuredCreditFacilityMember 2010-07-23 2010-07-25 0001468328 adus:SubordinatedDividendNotesMember 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:AdjustmentPermittedByLendersMember 2012-01-01 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:AdjustmentPermittedByLendersMember 2012-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:RevolvingCreditLoanMember 2010-03-18 0001468328 adus:SeniorSecuredCreditFacilityMember adus:AdjustmentPermittedByLendersMember 2011-10-01 2011-12-31 0001468328 2012-02-01 2012-02-29 0001468328 2011-01-01 2011-12-31 0001468328 2012-12-31 0001468328 2011-12-31 0001468328 2010-01-01 2010-12-31 0001468328 adus:AdvantageMember 2010-07-26 0001468328 adus:LhcGroupIncMember adus:HomeHealthSegmentMember us-gaap:SubsequentEventMember 2013-02-07 0001468328 2010-07-26 0001468328 adus:AdvantageMember 2011-12-31 0001468328 adus:AdvantageMember 2010-01-01 2010-12-31 0001468328 adus:AdvantageMember 2011-04-01 2011-04-30 0001468328 adus:AdvantageMember 2012-01-01 2012-12-31 0001468328 adus:AdvantageMember 2012-12-31 0001468328 adus:AdvantageMember us-gaap:MaximumMember 2010-07-26 0001468328 adus:SeniorSecuredCreditFacilityMember adus:RevolvingCreditLoanMember 2012-12-31 0001468328 2012-01-01 2012-12-31 xbrli:shares adus:property adus:segment iso4217:USD xbrli:shares iso4217:USD xbrli:pure adus:item 8 0.002 2000000 1600000 5.00 500000 0.42 0.15 4555000 1617000 9793000 683000 3631000 20000000 8380000 1615000 P5D 350000 350000 902000 1133000 4046000 3554000 2544000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">7. Details of Certain Balance Sheet Accounts</font></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid expenses and other current assets consist of the following:</font></p> <div> <table style="width: 850px;" border="0" cellspacing="0" cellpadding="0"> <tr><td width="69%"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="28%" colspan="4" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid health insurance</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,062</font></td> <td style="text-indent: 7px;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,672</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid workers' compensation and liability insurance</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,056</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,354</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid rent</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">181</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">192</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Workers' compensation insurance receivable</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">953</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,866</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Other</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,041</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,053</font></td></tr> <tr><td width="97%" colspan="5">&nbsp;</td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,293</font></td> <td style="border-bottom: #000000 3px double; text-indent: 7px;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8,137</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued expenses consisted of the following:</font></p> <div> <table style="width: 850px; height: 294px;" border="0" cellspacing="0" cellpadding="0"> <tr><td width="69%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="28%" colspan="4" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued payroll</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">11,539</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">11,547</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued workers' compensation insurance</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">12,452</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,173</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued payroll taxes</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,481</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,811</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued health insurance</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,469</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,039</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued taxes</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,223</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">223</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued interest</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">51</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">100</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Current portion of contingent earn-out obligation</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">689</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">683</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Other</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,813</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,737</font></td></tr> <tr><td width="97%" colspan="5">&nbsp;</td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">32,717</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">29,313</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company provides health insurance coverage to qualified union employees providing home and community based services in Illinois through a Taft-Hartley multi-employer health and welfare plan under Section 302(c)(5) of the Labor Management Relations Act of 1947. The Company's insurance contributions equal the amount reimbursed by the State of Illinois. Contributions are due within five business days from the date the funds are received from the State. Amounts due of $<font class="_mt">3,405</font> and $<font class="_mt">2,982</font> for health insurance reimbursements and contributions were reflected in prepaid insurance and accrued insurance at December 31, 2012 and 2011, respectively.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's workers' compensation program has a $<font class="_mt">350</font> deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The future claims payments related to the workers' compensation program are secured by letters of credit. These letters of credit totaled $<font class="_mt">7,410</font> at December 31, 2012 and 2011.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">As part of the terms of the acquisition of Addus HealthCare in 2006, all 2005 and prior workers' compensation claims are the obligation of the former stockholders of Addus HealthCare. Approximately $<font class="_mt">1,200</font> in cash escrows and deposits were set-aside from the purchase price of Addus HealthCare as collateral for these 2005 and prior claims as of December 31, 2012. The outstanding loss reserves associated with the 2005 and prior workers' compensation policies approximated $<font class="_mt">608</font> at December 31, 2012.</font></p> </div> -0.079 0.231 -0.093 0.009 -0.005 0.003 469000 495000 495000 525000 2982000 3405000 1800000 2273000 <div> <div class="MetaData"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Interest Income</font></i></b> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the income statement caption, interest income. The Company received $<font class="_mt">155</font>, $<font class="_mt">2,263</font> and $<font class="_mt">155</font> in prompt payment interest in 2012, 2011 and 2010, respectively. While the Company may be owed additional prompt payment interest, the amount and timing of receipt of such payments remains uncertain and the Company has determined that it will continue to recognize prompt payment interest income when received.</font></p></div> </div> 7410000 7410000 5000000 5800000 16458000 P60D 650000 200000 92000 495000 495000 3 8 P3D 2 24 24 9 13 1 1 1 2 596000 P5Y P5Y 4000000 0.90 0.90 P3Y 5.00 1354000 1056000 200000 469000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">3. Sale of Agency</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In February 2012, the Company sold an agency located in Portland, Oregon for approximately $<font class="_mt">525</font> with net proceeds of approximately $<font class="_mt">495</font> after the payment of closing related expenses. The Company recorded a $<font class="_mt">495</font> pre-tax gain on the sale of the agency</font><font style="font-family: ArialMT,Arial,Helvetica,sans-serif;" class="_mt" size="2">.</font></p> </div> <div> <table border="0" cellspacing="0"> <tr><td width="49%"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td width="49%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 3px;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td></tr> <tr valign="bottom"><td bgcolor="#c0c0c0" width="49%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net service revenues</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">38,822</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42,995</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">41,633</font></td></tr> <tr valign="bottom"><td width="49%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Income (loss) before income taxes</font></td> <td width="2%" align="right">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,752</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">)</font></td> <td width="2%" align="right">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(17,122</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">)</font></td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,719</font></td></tr> <tr valign="bottom"><td bgcolor="#c0c0c0" width="49%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Income tax expense (benefit)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,099</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(6,729</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,058</font></td></tr> <tr><td style="background-color: #ffffff;" width="93%" colspan="9">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#c0c0c0" width="49%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income (loss) from discontinued operations</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,653</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">)</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(10,393</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">)</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,661</font></td></tr></table> </div> 0.05 0.05 0.05 P3Y 3.0 2.75 3.25 3.0 3.25 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">10. Stock Options and Restricted Stock Awards</font></b></p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock Options</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The 2006 Plan provides for the grant of non-qualified stock options to directors and eligible employees, as defined in the 2006 Plan. A total of&nbsp;<font class="_mt">899</font> of Holdings' shares of common stock were reserved for issuance under the 2006 Plan. The number of options to be granted and the terms thereof were approved by Holdings' board of directors. The option price for each share of common stock subject to an option may be greater than or equal to the fair market value of the stock at the date of grant. The stock options generally vest ratably over a five year period and expire 10 years from the date of grant, if not previously exercised.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In September 2009, the Company's board of directors and stockholders adopted and approved the 2009 Plan. The 2009 Plan provides for the grant of&nbsp;<font class="_mt">750</font> incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units, restricted stock units, other stock units and performance shares.</font></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">A summary of stock option activity and weighted average exercise price is as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="23%"> </td> <td width="9%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="9%"> </td> <td width="10%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="10%"> </td> <td width="11%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="73%" colspan="12" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For The Year Ended December 31,</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td width="9%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="10%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td width="9%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="10%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td width="9%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td> <td width="10%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="9%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Outstanding, beginning of period</font></td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">775</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7.69</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">588</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.63</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">607</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.51</font></td></tr> <tr valign="bottom"><td width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Granted</font></td> <td width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">36</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.49</font></td> <td width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">229</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.33</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">91</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.30</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercised</font></td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(5</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.53</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="10%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Forfeited/Cancelled</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(209</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.02</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(42</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7.93</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(110</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.95</font></td></tr> <tr><td width="96%" colspan="13">&nbsp;</td></tr> <tr valign="bottom"><td width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Outstanding, end of period</font></td> <td style="border-bottom: #000000 3px double;" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">596</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.11</font></td> <td style="border-bottom: #000000 3px double;" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">775</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7.69</font></td> <td style="border-bottom: #000000 3px double;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">588</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.63</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The following table summarizes stock options outstanding and exercisable at December 31, 2012:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="2%" align="center"> </td> <td width="25%" align="center"> </td> <td width="10%" align="center"> </td> <td width="10%" align="center"> </td> <td width="2%" align="center"> </td> <td width="10%" align="center"> </td> <td width="11%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="25%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise Price</font></b></td> <td style="border-bottom: #000000 1px solid;" width="32%" colspan="4" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Outstanding</font></b></td> <td style="border-bottom: #000000 1px solid;" width="36%" colspan="4" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercisable</font></b></td></tr> <tr><td width="95%" colspan="10" align="center">&nbsp;</td></tr> <tr><td width="95%" colspan="10" align="center">&nbsp;</td></tr> <tr><td width="95%" colspan="10" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Remaining</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Remaining</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Contractual</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Contractual</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Life In</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Life In</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px double;" width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Years</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Years</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 1px;" bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.06</font></font>&#8211; $ <font class="_mt">5.45</font></font></td> <td style="text-indent: 3px;" bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">166</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.4</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.77</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">48</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.1</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.77</font></td></tr> <tr valign="bottom"><td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 1px;" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.26</font></font>&#8211; $<font class="_mt">10.00</font></font></td> <td style="border-bottom: #000000 1px solid; text-indent: 3px;" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">430</font></td> <td width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.5</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.39</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">400</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.3</font></td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.35</font></td></tr> <tr><td width="95%" colspan="10">&nbsp;</td></tr> <tr><td width="95%" colspan="10">&nbsp;</td></tr> <tr valign="bottom"><td width="2%" align="right">&nbsp;</td> <td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double; text-indent: 3px;" bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">596</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.6</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="10%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.11</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">448</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.7</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.85</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company historically used the Black-Scholes option pricing model to estimate the fair value of its stock based payment awards under its 2006 Plan, but beginning October 28, 2009 under its 2009 Plan it began using an enhanced Hull-White Trinomial model. The determination of the fair value of stock-based payments utilizing the Black-Scholes model and the Enhanced Hull-White Trinomial model is affected by Holdings' stock price and a number of assumptions, including expected volatility, risk-free interest rate, expected term, expected dividends yield, expected forfeiture rate, expected turn-over rate, and the expected exercise multiple. Holdings did not have a history of market prices of its common stock as it was not a public company prior to the IPO, and as such it estimates volatility based on the volatilities of a peer group of publicly traded companies. The expected term of options is based on the Company's estimate of when options will be exercised in the future. The risk-free interest rate assumption is based on observed interest rates appropriate for the terms of the Company's awards. The dividend assumption is based on the Company's history and expectation of not paying dividends. The expected turn-over rate represents the expected forfeitures due to employee turnover and is based on historical rates experienced by the Company. The expected exercise multiple represents the mean ratio of the stock price to the exercise price at which employees are expected to exercise their options.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The weighted-average estimated fair value of employee stock options granted as calculated using the Black-Scholes model and the Enhanced Hull-White Trinomial model and the related assumptions follow:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="45%"> </td> <td width="17%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="13%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="2%"> </td></tr> <tr valign="bottom"><td width="45%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="52%" colspan="8" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For the year ended December 31,</font></b></td></tr> <tr valign="bottom"><td width="45%" align="left">&nbsp;</td> <td width="17%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td> <td width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="45%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="17%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grants</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grants</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grants</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted average fair value</font></td> <td bgcolor="#cceeff" width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.09</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.54</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1.88</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Risk-free discount rate</font></td> <td width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1.59</font></font>% - <font class="_mt">1.95</font>%</font></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3.17<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></font></td> <td width="2%" align="center"> </td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.89</font></font>% &#8211; <font class="_mt">2.99</font>%</font></td> <td width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Expected life</font></td> <td bgcolor="#cceeff" width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.0 &#8211; 6.5 years</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.0 &#8211; 6.5 years</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.5 years</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Dividend yield</font></td> <td width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Volatility</font></td> <td bgcolor="#cceeff" width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42</font></font>% &#8211; <font class="_mt">51</font>%</font></font></td> <td bgcolor="#cceeff" width="2%" align="center"> </td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42</font></font>% &#8211; <font class="_mt">51</font>%</font></font></td> <td bgcolor="#cceeff" width="2%" align="center"> </td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42</font></font>% &#8211; <font class="_mt">51</font>%</font></font></td> <td bgcolor="#cceeff" width="2%" align="center"> </td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Expected turn-over rate(1)</font></td> <td width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></font></td> <td width="2%" align="center"> </td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></font></td> <td width="2%" align="center"> </td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></font></td> <td width="2%" align="center"> </td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Expected exercise multiple(1)</font></td> <td bgcolor="#cceeff" width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.2</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.2</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.2</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock option compensation expense, for continuing and discontinued operations, totaled $<font class="_mt">181</font>, $<font class="_mt">254</font> and $<font class="_mt">241</font> for the three years ended December 31, 2012, 2011 and 2010, respectively. As of December 31, 2012, there was $<font class="_mt">349</font> of total unrecognized compensation cost that is expected to be recognized over a period of five years.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The intrinsic value of vested and outstanding stock options was&nbsp;$<font class="_mt">115</font> and&nbsp;$<font class="_mt">394</font> as of December 31, 2012. There were&nbsp;<font class="_mt">5</font> stock options exercised in 2012 and the Company did not receive any cash from option exercises and did not realize any related tax benefits. There were no stock options exercised in 2011 or 2010.</font></p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Restricted Stock Awards</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In 2012, management awarded&nbsp;<font class="_mt">44</font> shares of restricted stock awards under the 2009 Plan with a weighted average fair value of $<font class="_mt">4.48</font> per share. As of December 31, 2012, $<font class="_mt">115</font> of unearned compensation related to unvested awards of restricted stock will be recognized over the remaining vesting terms of the awards.</font></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The following table summarizes the status of unvested restricted stock awards outstanding at December 31, 2012, 2011 and 2010:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="25%"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="78%" colspan="12" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For The Year Ended December 31,</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted-</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td style="text-indent: 2px;" width="2%" align="center"><b> </b></td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted-</font></b>&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted-</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grant Date</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td style="text-indent: 2px;" width="2%" align="center"><b> </b></td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grant Date</font></b>&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grant Date</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Fair Value</font></b></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td width="2%" align="center">&nbsp;</td> <td style="text-indent: 3px;" width="2%" align="center"><b> </b></td> <td width="11%" align="center">&nbsp;<b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Fair Value</font></b></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Fair Value</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Restricted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Restricted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Restricted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Awards</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Awards</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Awards</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Unvested restricted stock awards</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">21</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.95</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 5px;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.85</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10.00</font></td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Awarded</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">44</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.48</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">24</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td style="text-indent: 5px;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.63</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.21</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Vested</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(20</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.14</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(8</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="text-indent: 5px;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.64</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10.00</font></td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Forfeited</font></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(3</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.93</font></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 5px;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.93</font></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td></tr> <tr><td width="103%" colspan="13">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Unvested restricted stock awards at</font></td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td> <td style="background-color: #cceeff;" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 2px;" bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.80</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">21</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double; text-indent: 5px;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.95</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.85</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Restricted stock award compensation expense, for continuing and discontinued operations, totaled $<font class="_mt">160</font>, $<font class="_mt">77</font> and $<font class="_mt">14</font> for the three years ended December 31, 2012, 2011 and 2010, respectively.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Shares available under the 2006 Plan and the 2009 Plan were&nbsp;<font class="_mt">546</font> and <font class="_mt">435</font>, respectively, as of December 31, 2012. The Company does not plan on issuing any further grants under the 2006 Plan.</font></p> </div> P10Y P5Y 160000 159000 159000 P4Y 12936000 2519000 3809000 5600000 0.145 1866000 953000 false --12-31 FY 2012 2012-12-31 10-K 0001468328 10883632 Yes Smaller Reporting Company 28927673 Addus HomeCare Corp No No 5266000 4117000 7123000 72368000 71303000 223000 1223000 3039000 3469000 29313000 32717000 1811000 1481000 11547000 11539000 4629000 5317000 82437000 82778000 255000 255000 331000 331000 341000 341000 241000 14000 254000 77000 181000 160000 7189000 4466000 179000 224000 215000 3143000 2613000 2199000 350000 64000 1674000 1364000 248000 62000 588000 501000 154692000 149857000 89100000 87836000 239000 245000 683000 689000 5140000 5140000 20000000 1240000 1240000 7980000 1240000 248000 248000 248000 0.57 <div> <table border="0" cellspacing="0"> <tr><td width="62%"> </td> <td width="20%"> </td> <td width="12%"> </td> <td width="4%"> </td></tr> <tr valign="bottom"><td align="left">&nbsp;</td> <td align="left">&nbsp;</td> <td align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For the Year Ended</font></b></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td align="left">&nbsp;</td> <td style="border-bottom: #000000 1px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31, 2010</font></b></td> <td style="border-bottom: #000000 1px;" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="center">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net service revenues</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">236,065</font></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Operating income from continuing operations</font></td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9,793</font></td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income from continuing operations, net of tax</font></td> <td bgcolor="#cceeff" align="left">&nbsp;</td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,555</font></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net loss from discontinued operations, net of tax</font></td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,617</font></td> <td style="border-bottom: #000000 3px;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td></tr> <tr><td colspan="4">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,172</font></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Earnings per share</font></td> <td align="left">&nbsp;</td> <td align="left">&nbsp;</td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 16.078pt;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic and Diluted</font></td> <td align="left">&nbsp;</td> <td align="left">&nbsp;</td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 32.156pt;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Continuing operations</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.42</font></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 32.156pt;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Discontinued operations</font></td> <td align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.15</font></td> <td style="border-bottom: #000000 1px;" align="left">&nbsp;</td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic income per share from continue operations</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.57</font></td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td></tr></table> </div> 6172000 236065000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">4. Acquisitions</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On July 26, 2010, the Company entered into an Asset Purchase Agreement (the "Purchase Agreement"), pursuant to which the Company acquired certain assets of Advantage Health Systems, Inc., a South Carolina corporation ("Advantage"). The total maximum consideration payable pursuant to the Purchase Agreement was $<font class="_mt">8,380</font>, comprised of $<font class="_mt">5,140</font> in cash, common stock consideration with a deemed value of $<font class="_mt">1,240</font> resulting in the issuance of&nbsp;<font class="_mt">248</font> common shares, and a maximum of $<font class="_mt">2,000</font> in future cash consideration subject to the achievement of certain performance targets set forth in an earn-out agreement and the assumption of certain specified liabilities.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On July 26, 2010, the Company entered into an amendment (the "Second Amendment") to its credit facility. The Second Amendment provides for a new term loan component of the credit facility in the aggregate principal amount of $<font class="_mt">5,000</font> with a maturity date of <font class="_mt">January 5, 2013</font>. The requisite lenders also consented to the acquisition, effective July 25, 2010, of certain assets of Advantage, by the Company, pursuant to the Purchase Agreement. The term loan was repaid in&nbsp;<font class="_mt">24</font> equal monthly installments which began in February 2011. Interest on the term loan under the credit facility&nbsp;was payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of <font class="_mt">4.6</font>% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest was paid monthly or at the end of the relevant interest period.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's acquisition of Advantage has been accounted for in accordance with ASC Topic 805, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Business Combinations</font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">" and the resultant goodwill and other intangible assets will be accounted for under ASC Topic 350 </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Goodwill and Other Intangible Assets" </font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">. Assets acquired and liabilities assumed were recorded at their fair values. The total purchase price is $<font class="_mt">7,980</font> and is comprised of:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="86%"> </td> <td width="3%"> </td> <td width="10%"> </td></tr> <tr valign="bottom"><td style="align: left;">&nbsp;</td> <td style="align: right;">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 6.72pt;" align="left"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Cash</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5,140</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Issuance of&nbsp;<font class="_mt">248</font> Addus shares at $<font class="_mt">5.00</font> per share (valued at a price per share equal to the average closing price of the</font><br /><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Company's stock for the three most recent trading days preceding the closing, subject to a floor of $<font class="_mt">5.00</font> per share)</font></td> <td style="align: right;">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,240</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Contingent earn-out obligation (net of $<font class="_mt">92</font> discount)</font></td> <td style="border-bottom: #000000 1px;" bgcolor="#cceeff" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,600</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total purchase price</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,980</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <div>&nbsp;</div><br /> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The contingent earn-out obligation was initially recorded at its fair value of $<font class="_mt">1,600</font>, which is the present value of the Company's obligation based on probability-weighted estimates of the achievement of certain performance targets, as defined in the Purchase Agreement. In April 2011, the Company paid the first earn-out payment of $<font class="_mt">500</font> to the sellers of Advantage. The second earn-out payment obligation was reviewed during the fourth quarter of 2011 and it was revalued at approximately $<font class="_mt">683</font> as of December 31, 2011 which resulted in a $<font class="_mt">469</font> gain on revaluation of the contingent consideration.&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The sellers of Advantage disagree with the Company's calculation of the second earn-out payment and the parties have agreed to have an arbitrator determine the amount of the second earn-out payment. The final payment is expected to be made during the second quarter of 2013.</font></font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Under business combination accounting, the total purchase price was allocated to Advantage's net tangible and identifiable intangible assets based on their estimated fair values. Based upon management's valuation, the total purchase price has been allocated as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="59%"> </td> <td width="3%"> </td> <td width="37%"> </td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,272</font></td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Identifiable intangible assets</font></td> <td style="border-bottom: #000000 3px;" align="right">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,631</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">77</font></td></tr> <tr><td colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 19.8pt;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total purchase price allocation</font></td> <td style="border-bottom: #000000 3px double;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,980</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets acquired. Goodwill amounts are not amortized, but rather are tested for impairment at least annually. In the event that&nbsp;the Company&nbsp;determines that the value of goodwill has become impaired,&nbsp;the Company&nbsp;will record an impairment charge for the amount during the fiscal quarter in which such determination is made.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Identifiable intangible assets acquired consist of trade names and trademarks, certificates of need and state licenses, customer relationships, and non-compete agreements. The estimated fair value of identifiable intangible assets was determined by management.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">As part of its annual review of goodwill and intangible assets, the Company determined that all of its home health business which is recorded as discontinued operations&nbsp;was impaired (see Note 6). As part of this impairment in 2011 the Company recorded a charge that included $<font class="_mt">544</font> of goodwill and $<font class="_mt">272</font> of intangible assets associated with the purchase of Advantage.</font></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The following table contains unaudited pro forma consolidated income statement information assuming the Advantage acquisition closed on January 1, 2010.</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="62%"> </td> <td width="20%"> </td> <td width="12%"> </td> <td width="4%"> </td></tr> <tr valign="bottom"><td align="left">&nbsp;</td> <td align="left">&nbsp;</td> <td align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For the Year Ended</font></b></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td align="left">&nbsp;</td> <td style="border-bottom: #000000 1px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31, 2010</font></b></td> <td style="border-bottom: #000000 1px;" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="center">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net service revenues</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">236,065</font></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Operating income from continuing operations</font></td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9,793</font></td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income from continuing operations, net of tax</font></td> <td bgcolor="#cceeff" align="left">&nbsp;</td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,555</font></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net loss from discontinued operations, net of tax</font></td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,617</font></td> <td style="border-bottom: #000000 3px;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td></tr> <tr><td colspan="4">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,172</font></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Earnings per share</font></td> <td align="left">&nbsp;</td> <td align="left">&nbsp;</td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 16.078pt;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic and Diluted</font></td> <td align="left">&nbsp;</td> <td align="left">&nbsp;</td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 32.156pt;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Continuing operations</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.42</font></td> <td align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 32.156pt;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Discontinued operations</font></td> <td align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.15</font></td> <td style="border-bottom: #000000 1px;" align="left">&nbsp;</td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic income per share from continue operations</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.57</font></td> <td style="border-bottom: #000000 3px;" align="left">&nbsp;</td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The pro forma disclosures in the table above include adjustments for interest expense, amortization of intangible assets and tax expense to reflect results that are more representative of the combined results of the transactions as if they had occurred on January 1, 2010. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operation that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information.</font></p> </div> 77000 7980000 518000 816000 2020000 1737000 298000 1204000 -283000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">15. Commitments and Contingencies</font></b></p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Legal Proceedings</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company is a party to legal and/or administrative proceedings arising in the ordinary course of its business. It is the opinion of management that the outcome of such proceedings will not have a material effect on the Company's financial position and results of operations.</font></p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Employment Agreements</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company has entered into employment agreements with certain members of senior management. The terms of these agreements are up to four years and include non-compete and nondisclosure provisions, as well as provide for defined severance payments in the event of termination.</font></p> </div> 435000 546000 899000 0.001 0.001 40000000 40000000 10775000 10823000 10775000 10823000 11000 11000 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Workers' Compensation Program</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's workers' compensation program has a $<font class="_mt">350</font> deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The future claims payments related to the workers' compensation program are secured by letters of credit.</font></p></div> </div> <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">17. Concentration of Cash</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash. The Company maintains cash with financial institutions which, at times, may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk on cash.</font></p> </div> <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">16. Significant Payors</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">A substantial portion of the Company's net service revenues and accounts receivables are derived from services performed for federal, state and local governmental agencies.&nbsp;<font class="_mt">One</font> state governmental agency represented <font class="_mt">57</font>%, <font class="_mt">51</font>% and <font class="_mt">45</font>% of the Company's net service revenues for 2012, 2011, and 2010, respectively.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The related receivables due from Medicare and the state agency represented <font class="_mt">7</font>% and <font class="_mt">69</font>% of the Company's accounts receivable at December 31, 2012, respectively, and <font class="_mt">11</font>% and <font class="_mt">58</font>% of the Company's accounts receivable at December 31, 2011, respectively.</font></p> </div> 0.45 0.11 0.58 0.51 0.07 0.69 0.57 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Principles of Consolidation</font></i></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&nbsp;&nbsp;&nbsp;&nbsp; All intercompany balances and transactions have been eliminated in consolidation.</font></p></div> </div> 4077000 170376000 168632000 180264000 2178000 1994000 2325000 335000 184000 544000 1250000 4468000 2500000 3351000 4069000 0.046 0.046 0.046 0.1 0.02 2013-01-05 2012-12-31 2011-09-30 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Debt Issuance Costs</font></i></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company amortizes debt issuance costs on a straight-line method over the term of the related debt. This method approximates the effective interest method.</font></p></div> </div> 388000 -4267000 680000 447000 -4663000 839000 2145000 2148000 59000 -396000 159000 3398000 1577000 7135000 7905000 4089000 2328000 10425000 9586000 6336000 7258000 4089000 2328000 146000 395000 112000 96000 3263000 4593000 579000 655000 2824000 1784000 799000 647000 51000 49000 44000 0.060 0.060 0.060 903000 941000 870000 3408000 3167000 2521000 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Derivative Financial Instrument</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company utilized a derivative financial instrument to minimize interest rate risk. The Company's derivative instrument consisted of a three-year interest rate agreement designed to reduce the variability of cash flows associated with a portion of the Company's term debt. As the hedge accounting criteria established in ASC Topic 815, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Derivatives and Hedging" </font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">have not been met, the Company accounted for the instrument at its fair value and recognizes any changes in its fair value in earnings for the period.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">ASC Topic 820, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Fair Value Measurements," </font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">establishes a three-tier fair value hierarchy, which categorizes the inputs used in measuring fair value. These categories include in descending order of priority: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The fair value of the swap was calculated using proprietary models utilizing observable inputs (Level 2) as well as future assumptions related to interest rates and other applicable variables. These calculations were performed by the financial institution which is counterparty to the applicable swap agreement and reviewed by the Company. The Company used these reported fair values to adjust the asset or liability as appropriate. The interest rate swap agreement concluded in March of 2010.</font></p></div> </div> 1661000 4000 -10393000 80000 -10059000 -418000 -1117000 -1653000 -371000 -407000 242000 2719000 -17122000 -2752000 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Discontinued Operations</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On February 7, 2013, subsidiaries of Holdings entered into an Asset Purchase Agreement with LHC Group, Inc. and certain of its subsidiaries (the "Home Health Purchase Agreement"). Pursuant to the Home Health Purchase Agreement, effective March 1, 2013, the purchasers agreed to acquire substantially all the assets of the Company's home health business in Arkansas, Nevada and South Carolina and <font class="_mt">90</font>% of its home health business in California and Illinois, with the Company retaining <font class="_mt">10</font>% ownership in such locations, for cash consideration of $<font class="_mt">20,000</font>.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's home health services were operated through licensed and Medicare certified offices that provided physical, occupational and speech therapy, as well as skilled nursing services to pediatric, adult infirm and elderly patients. Home health services were reimbursed from Medicare, Medicaid and Medicaid-waiver programs, commercial insurance and private payors (see note 2).</font></p></div> </div> 1058000 -6729000 -1099000 239000 245000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2. Discontinued Operations</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">During December 2012, in anticipation of the sale of substantially all of the assets used in its home health business (the "Home Health Business"), the Company reported the operating results of the Home Health Business as discontinued operations in accordance with ASC 360-10-45 "</font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Impairment or Disposal of Long-Lived Assets.</font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">" On February 7, 2013, the Company entered into the Home Health Purchase Agreement, pursuant to which subsidiaries of LHC Group, Inc. agreed to acquire substantially all the assets of the Home Health Business in Arkansas, Nevada and South Carolina and <font class="_mt">90</font>% of the Home Health Business in California and Illinois, with the Company retaining <font class="_mt">10</font>% ownership in such locations, for cash consideration of $<font class="_mt">20,000</font>. The transaction was consummated effective March 1, 2013. In addition the results of operations for&nbsp;<font class="_mt">two</font> home health agencies being held for sale are included in discontinued operations.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company has included the financial results of the Home Health Business in discontinued operations for all periods presented. Assets&nbsp;sold to the purchasers are presented as assets held for sale, net, on the accompanying consolidated balance sheet as of December 31, 2012 and 2011. In connection with the discontinued operations presentation, certain financial statement footnotes have also been updated to reflect the impact of discontinued operations.</font></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The following table presents the net service revenues and earnings attributable to discontinued operations, which include the financial results for the years ended December 31, 2012, 2011 and 2010</font><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="49%"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td width="49%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 3px;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td></tr> <tr valign="bottom"><td bgcolor="#c0c0c0" width="49%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net service revenues</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">38,822</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42,995</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">41,633</font></td></tr> <tr valign="bottom"><td width="49%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Income (loss) before income taxes</font></td> <td width="2%" align="right">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,752</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">)</font></td> <td width="2%" align="right">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(17,122</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">)</font></td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,719</font></td></tr> <tr valign="bottom"><td bgcolor="#c0c0c0" width="49%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Income tax expense (benefit)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,099</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(6,729</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,058</font></td></tr> <tr><td style="background-color: #ffffff;" width="93%" colspan="9">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#c0c0c0" width="49%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income (loss) from discontinued operations</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,653</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">)</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(10,393</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="2">)</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,661</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The&nbsp;only class of assets&nbsp;for discountinued operations&nbsp;reflected as assets held for sale, net, as of December 31, 2012 and 2011 were as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="70%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr><td width="70%"> </td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center"> </td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center"> </td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td></tr> <tr valign="bottom"><td bgcolor="#c0c0c0" width="70%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment, net of accumulated depreciation and amortization</font></td> <td bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 1px;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">245</font></td> <td bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 1px;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">239</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Pursuant to the Home Health Purchase Agreement, the Company is retaining $<font class="_mt">7,123</font> of accounts receivable, net as of December 31, 2012. In addition, the Company is retaining the related accrued expenses and accounts payable associated with the Home Health Business.</font></p> </div> 13109000 7819000 0.57 0.08 -0.18 0.12 -0.62 0.23 0.06 0.71 0.14 0.17 0.35 <div> <div class="MetaData"> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Net Income (Loss) Per Common Share</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income (loss) per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company's outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Included in the Company's calculation for the year ended December 31, 2012 were&nbsp;<font class="_mt">596</font> stock options of which&nbsp;<font class="_mt">501</font> were out-of-the money and therefore anti-dilutive and&nbsp;<font class="_mt">57</font> restricted stock awards with&nbsp;<font class="_mt">12</font> included in the weighted diluted shares outstanding for 2012.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">For the year ended December 31, 2011 the Company had&nbsp;<font class="_mt">10</font> dilutive shares but it reported a net loss and any potentially dilutive securities would be anti-dilutive, therefore, no additional shares were considered in the calculation of diluted earnings per share.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Included in the Company's calculation for the year ended December 31, 2010 were&nbsp;<font class="_mt">588</font> stock options which were out-of-the money and therefore anti-dilutive and&nbsp;<font class="_mt">6</font> restricted stock awards with&nbsp;<font class="_mt">2</font> included in the weighted diluted shares outstanding for 2010.</font></p></div> </div> 0.329 0.556 0.327 0.340 0.340 0.340 0.010 -0.020 0.009 -0.043 0.009 0.049 0.053 0.059 P5Y 349000 115000 1200000 0.145 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Fair Value of Financial Instruments</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's financial instruments consist of cash, accounts receivable, payables and debt. The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of the short-term nature of these instruments. The carrying value of the Company's long-term debt with variable interest rates approximates fair value based on instruments with similar terms.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets and also when determining the fair value of contingent considerations. To determine the fair value in these situations, the Company uses Level 3 inputs such as discounted cash flows or if available, what a market participant would pay on the measurement date.</font></p></div> </div> 13570000 10184000 790000 2407000 189000 8044000 6231000 150000 1551000 112000 6370000 4867000 150000 1303000 50000 1575000 1354000 595000 717000 886000 1093000 6220000 P25Y P2Y -43000 495000 47042000 45858000 46362000 4272000 63930000 50820000 13110000 50695000 50695000 50536000 50536000 50536000 15989000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">6. Goodwill and Intangible Assets</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions including the acquisition of Addus HealthCare. In accordance with ASC Topic 350, "Goodwill and Other Intangible Assets," goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill is required to be tested for impairment at least annually. The Company can elect to perform Step-0 an optional qualitative analysis and based on the results skip the remaining two steps. In 2012, the Company elected to implement Step 0 and was not required to conduct the remaining two step analysis. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. The Company uses the combination of a DCF model and the market multiple analysis method to determine the current fair value of each reporting unit.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In performing its goodwill assessment for 2012, the Company evaluated the following factors that affect future business performance: macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, entity-specific events, reporting unit factors and company stock price. As a result of the assessment of these qualitative factors, the Company has concluded that it is more likely than not that the fair values of the reporting unit goodwill as of December 31, 2012 exceed the carrying values of the unit. Accordingly, the first and second steps of the goodwill impairment test as described in FASB ASC 350-20-35, which includes estimating the fair values of each reporting unit, are not considered necessary for the reporting unit and no goodwill impairment charges were recorded in 2012.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In 2011, the DCF model was prepared using revenue and expense projections based on the Company's current operating plan. As such, a number of significant assumptions and estimates are involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. The cash flows were discounted using a weighted average cost of capital of <font class="_mt">14.5</font>%, which was management's best estimate based on the capital structure of the Company and external industry data. As part of the second step of this evaluation, if the carrying value of goodwill exceeds its implied fair value an impairment loss would be recognized.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In light of the current Federal and state economic and reimbursement environments and state budgetary pressures to decrease or eliminate services provided by the Company, the Company completed a preliminary assessment of the fair value of continuing and discontinued operations and the potential for goodwill impairment as of June 30, 2011.&nbsp;</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Based on the above and updates to the Company's business projections and forecasts, and other factors, the Company determined that the estimated fair value of its discontinued operations was less than the net book value indicating that its allocated goodwill was impaired. The preliminary assessment for the continuing operations indicated that its fair value was greater than its net book value with no initial indication of goodwill impairment.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">As permitted by ASC Topic 350, when an impairment indicator arises toward the end of an interim reporting period, the Company may recognize its best estimate of that impairment loss. Based on the Company's preliminary analysis prepared as of June 30, 2011, the Company determined that all of the $<font class="_mt">13,076</font> allocated to goodwill for the discontinued operations as of September 30, 2011 was impaired and recorded a goodwill impairment loss in the third quarter of 2011. The goodwill impairment charge was noncash in nature and did not affect the Company's liquidity or cash flows from operating activities. Additionally, the goodwill impairment had no effect on the Company's borrowing availability or covenants under its credit facility agreement. The analysis prepared as of June 30, 2011 was preliminary and subject to the completion of the Company's annual impairment test as of October 1, 2011. The Company completed its annual impairment test of goodwill as of October 1, 2011 and determined that no additional impairment charges or adjustments were required. The goodwill for the Company's continuing operations was $<font class="_mt">50,536</font> as of December 31, 2012.</font></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Summary of&nbsp;goodwill and related adjustments provided below:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="51%"> </td> <td width="2%" align="center"> </td> <td width="13%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%"> </td></tr> <tr valign="bottom"><td width="51%" align="left">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Continuing</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Discontinued</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="51%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">operations</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">operations</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill, at December 31, 2010</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,820</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">13,110</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">63,930</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Adjustments to previously recorded goodwill</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(125</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(34</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(159</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr valign="bottom"><td width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Impairment charge for discountinued operations</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(13,076</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(13,076</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="100%" colspan="10">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill, at December 31, 2011</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,695</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,695</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Adjustments to previously recorded goodwill</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(159</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(159</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td style="background-color: #ffffff;" width="100%" colspan="10">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill, at December 31, 2012</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,536</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,536</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Adjustments to the previously recorded goodwill are primarily credits related to amortization of tax goodwill in excess of book basis.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-compete agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from two to 25 years.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In connection with the Company's preliminary assessment of its fair value discussed above, it determined that all of its $<font class="_mt">2,273</font> allocated to finite lived identifiable intangible assets for the discontinued operations as of September 30, 2011 was impaired and recorded an impairment&nbsp;charge in the third quarter of 2011. The impairment charge was noncash in nature and did not affect the Company's liquidity or cash flows from operating activities.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company also has indefinite-lived assets that are not subject to amortization expense such as certificates of need and licenses to conduct specific operations within geographic markets. The Company has concluded that certificates of need and licenses have indefinite lives, as management has determined that there are no legal, regulatory, contractual, economic or other factors that would limit the useful life of these intangible assets and the Company intends to renew and operate the certificates of need and licenses indefinitely. The certificates of need and licenses are tested annually for impairment. In connection with the Company's assessment of its fair value discussed above, it determined that all of the $<font class="_mt">640</font> allocated to discontinued operations certificates of need and licenses were impaired and recorded an impairment loss in the third quarter of 2011, which is classified as discontinued operations.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following for continuing and discontinued operations at December 31, 2012 and 2011:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="25%"> </td> <td width="2%"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%"> </td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Customer and</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Trade names</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">referral</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">and</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Non-competition</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">relationships</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">trademarks</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">State Licenses</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">agreements</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2010</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,184</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,407</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">790</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">189</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">13,570</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Impairment charges for discontinued operations</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,754</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(506</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(640</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(13</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,913</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Amortization</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,199</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(350</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(64</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,613</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="101%" colspan="16">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2011</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,231</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,551</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">150</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">112</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8,044</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Amortization</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,364</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(248</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(62</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,674</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="101%" colspan="16">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2012</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,867</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,303</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">150</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,370</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Amortization expense for continuing and discontinued operations related to the identifiable intangible assets amounted to $<font class="_mt">1,674</font>, $<font class="_mt">2,613</font>, and $<font class="_mt">3,143</font> for the three years ended December 31, 2012, 2011 and 2010, respectively. Goodwill and state licenses are not amortized pursuant to ASC Topic 350.</font></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The estimated future intangible amortization expense is as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="84%"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td style="text-decoration: underline;" width="84%" align="left"> </td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td style="text-decoration: underline;" width="84%" align="left"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For the year ended December 31,</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="84%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px;" width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2013</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,354</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2014</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,093</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2015</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">886</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2016</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">717</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2017</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">595</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Thereafter</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,575</font></td></tr> <tr><td width="98%" colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,220</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> </div> <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions including the acquisition of Addus HealthCare, Inc. ("Addus HealthCare"). In accordance with Accounting Standards Codification TM ("ASC") Topic 350, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Goodwill and Other Intangible Assets </font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">," goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. Goodwill and indefinite lived intangible assets are required to be tested for impairment at least annually. The Company may use a qualitative test, known as "Step 0" or a two-step quantitative method to determine whether impairment has occurred. In Step 0, the Company can elect to perform an optional qualitative analysis and based on the results skip the two step analysis. In 2012, the Company elected to implement Step 0 and was not required to conduct the remaining two step analysis.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In 2011, the Company elected to evaluate the goodwill via the two step methodology. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. The Company used the combination of a discounted cash flow model ("DCF model") and the market multiple analysis method to determine the current fair value of each reporting unit. The DCF model was prepared using revenue and expense projections based on the Company's current operating plan. As such, a number of significant assumptions and estimates&nbsp;were involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. In 2011, the cash flows were discounted using a weighted average cost of capital of <font class="_mt">14.5</font>%, which was management's best estimate based on the capital structure of the Company and external industry data. As part of the second step of this evaluation, if the carrying value of goodwill exceeds its fair value, an impairment loss would be recognized. The Company recorded a $<font class="_mt">15,989</font> goodwill and intangible asset charge during the third quarter of 2011 (see Note 6)for its discontinued operations (see Note 2).</font></p></div> </div> 13076000 13076000 544000 13076000 -159000 -125000 -34000 -159000 -159000 59723000 14159000 61473000 14784000 15701000 16829000 15024000 64051000 15807000 15683000 17537000 640000 272000 1913000 640000 2913000 1754000 640000 506000 13000 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Long-Lived Assets</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company reviews its long-lived assets and indefinite lived intangibles (except goodwill and finite lived intangible assets, as described above) for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. To determine if impairment exists, the Company compares the estimated future undiscounted cash flows from the related long-lived assets to the net carrying amount of such assets. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset, generally determined by discounting the estimated future cash flows. No impairment charge was recorded in 2012. The Company recorded a $<font class="_mt">640</font> impairment associated with discontinued operations in 2011. No impairment&nbsp;charge was&nbsp;recorded in 2010.</font></p></div> </div> 853000 1333000 -6663000 2496000 629000 1464000 1797000 3745000 6269000 12656000 14095000 4367000 8412000 9288000 0.41 0.08 0.78 0.11 0.32 0.27 0.16 0.86 0.17 0.20 0.33 1661000 -10393000 -1653000 0.16 0.00 -0.96 0.01 -0.94 -0.04 -0.10 -0.15 -0.03 -0.03 0.02 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">9. Income Taxes</font></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The current and deferred federal and state income tax provision (benefit), for both continuing and discontinued operations are comprised of the following:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="51%"> </td> <td width="2%"> </td> <td width="15%"> </td> <td width="2%"> </td> <td width="13%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="51%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="48%" colspan="7" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="51%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="15%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Current</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="15%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Federal</font></td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,325</font></td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,994</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,178</font></td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">State</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">544</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">184</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">335</font></td></tr> <tr valign="bottom"><td width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Deferred</font></td> <td width="2%" align="right">&nbsp;</td> <td width="15%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="13%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Federal</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">680</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(4,267</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">388</font></td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">State</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">159</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(396</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">59</font></td></tr> <tr><td width="99%" colspan="8">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Provision (benefit) for income taxes</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,708</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,485</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,960</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The tax effects of certain temporary differences between the Company's book and tax bases of assets and liabilities give rise to significant portions of the deferred income tax assets at December 31, 2012 and 2011. The deferred tax assets consisted of the following:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="66%"> </td> <td width="3%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td></tr> <tr valign="bottom"><td width="66%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="33%" colspan="6" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="66%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="3%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Deferred tax assets</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Current</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accounts receivable allowances</font></td> <td bgcolor="#cceeff" width="3%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,784</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,824</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued compensation</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,133</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">902</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued workers' compensation</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,593</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,263</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Other</font></td> <td style="border-bottom: #000000 1px solid;" width="3%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">395</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">146</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total current deferred tax assets</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,905</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,135</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Deferred tax liabilities</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Current</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid insurance</font></td> <td style="border-bottom: #000000 1px solid;" width="3%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(647</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(799</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net deferred tax assets&#8212;current</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,258</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,336</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Deferred tax assets</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Long-term</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill and intangible assets</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,577</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,398</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">96</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">112</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock-based compensation</font></td> <td style="border-bottom: #000000 1px solid;" width="3%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">655</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">579</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total long-term deferred tax assets</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,328</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,089</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total net deferred tax assets</font></td> <td style="border-bottom: #000000 3px double;" width="3%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9,586</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,425</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers projected future taxable income and tax-planning strategies in making this assessment. Based on this assessment, management believes it is more likely than not that the Company will realize its deferred income tax assets as of December 31, 2012.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">A reconciliation of the statutory federal tax rate of <font class="_mt">34.0</font>% to the effective income tax rate, for continuing and discontinued operations, for the years ended December 31, 2012, 2011, and 2010 is summarized as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="54%"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td></tr> <tr valign="bottom"><td width="54%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="41%" colspan="6" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="54%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Federal income tax at statutory rate</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">34.0</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">34.0</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">34.0</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td></tr> <tr valign="bottom"><td width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">State and local taxes, net of federal benefit</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.9</font></td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.3</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.9</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Jobs tax credits, net</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(9.3</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">23.1</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(7.9</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr valign="bottom"><td width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Nondeductible meals and entertainment</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.9</font></td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2.0</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1.0</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Tax asset adjustment&#8212;stock options</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.3</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.5</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.9</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Other</font></td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.9</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(4.3</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr><td width="95%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Effective income tax rate</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">32.7</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">55.6</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">32.9</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company is subject to taxation in the jurisdictions in which it operates. The Company continues to remain subject to examination by U.S. federal authorities for the years 2009 through 2012 and for various state authorities for the years 2008 through 2012. As part of the acquisition of Addus HealthCare in 2006, the selling stockholders agreed to assume and indemnify the successor for any federal or state tax liabilities prior to the acquisition date.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The total amount of unrecognized tax benefits under ASC Topic 740 at December 31, 2012 was $<font class="_mt">115</font>. If recognized, the entire amount would favorably impact the effective tax rate in future periods. Interest and penalties related to income tax liabilities are recognized in interest expense and general and administrative expenses, respectively. The Company does not anticipate a material change in its liabilities for uncertain tax positions during the next 12 months.</font></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">A summary of the activities associated with the Company's reserve for unrecognized tax benefits is as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="84%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="84%" align="left">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Unrecognized</font></b></td></tr> <tr valign="bottom"><td width="84%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Tax Benefits</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2010</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 9px;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">115</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Increases related to current year tax positions</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 9px;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td></tr> <tr><td width="98%" colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2011</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 9px;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">115</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Increases related to current year tax positions</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 9px;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td></tr> <tr><td width="98%" colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2012</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double; text-indent: 9px;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">115</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <div>&nbsp;</div><br /> </div> 1457000 2005000 1758000 1902000 4244000 4807000 2960000 -2485000 3708000 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Income Taxes</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company accounts for income taxes under the provisions of ASC Topic 740, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Income Taxes"</font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">. The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its financial statements or tax returns. Deferred taxes, resulting from differences between the financial and tax basis of the Company's assets and liabilities, are also adjusted for changes in tax rates and tax laws when changes are enacted. ASC Topic 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. ASC Topic 740, also prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. In addition, ASC Topic 740 provides guidance on derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions.</font></p></div> </div> -459000 1962000 -1149000 4892000 5689000 1812000 1676000 934000 4425000 -48000 4000 3000 767000 -1433000 18000 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Intangible Assets</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-compete agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from two to 25 years.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">ASC Topic 350 requires that the fair value of intangible assets with finite lives be estimated and compared to the carrying value. The Company estimates the fair value of these intangible assets using the income approach. Intangible assets with finite lives are amortized using the estimated economic benefit method over the useful life and assessed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company recognizes an impairment loss when the estimated fair value of the intangible asset is less than the carrying value. No impairment charge was recorded in 2012. The Company recorded a $<font class="_mt">2,273</font> impairment associated with discontinued operations in 2011. No impairment charge was recorded in 2010.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The income approach, which the Company uses to estimate the fair value of its reporting units and intangible assets, is dependent on a number of factors including estimates of future market growth and trends, forecasted revenue and costs, expected periods the assets will be utilized, appropriate discount rates and other variables. The Company bases its fair value estimates on assumptions the Company believes to be reasonable but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates. In addition, the Company makes certain judgments about the selection of comparable companies used in the market approach in valuing its reporting units.</font></p></div> </div> 2273000 640000 8044000 6370000 15989000 3159000 2524000 1723000 <div> <div> <p style="text-align: left;"> </p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Interest Expense</font></i></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's interest expense consists of interest costs on its credit facility and other debt instruments.</font></p></div> </div> -3004000 -261000 -1568000 155000 2263000 155000 3555000 2337000 1557000 100000 51000 155000 2263000 155000 3441000 367000 3495000 409000 62000 3380000 486000 285000 0.10 68251000 55440000 154692000 149857000 43293000 39190000 608000 21810000 27137000 2013-01-05 0.048 55000000 5000000 55000000 5000000 0.005 31527000 24750000 4069000 2708000 16458000 16250000 208000 6569000 208000 208000 16250000 24958000 16250000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">8. Long-Term Debt</font></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Long-term debt consisted of the following:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="67%"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="32%" colspan="6" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Revolving credit loan</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,250</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">24,750</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Term loan</font></td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">208</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,708</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Subordinated dividend notes bearing interest at <font class="_mt">10.0</font>%</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,069</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr><td bgcolor="#cceeff" width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,458</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">31,527</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Less current maturities</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(208</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(6,569</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Long-term debt</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,250</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">24,958</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Senior Secured Credit Facility</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On March 18, 2010, the Company entered into an amendment (the "First Amendment") to its credit facility. The First Amendment (i) increased the maximum aggregate amount of revolving loans available to the Company by $<font class="_mt">5,000</font> to $<font class="_mt">55,000</font>, (ii) modified the Company's maximum senior leverage ratio from&nbsp;<font class="_mt">2.75</font> to 1.0 to&nbsp;<font class="_mt">3.00</font> to 1.0 for each twelve month period ending on the last of day of each fiscal quarter thereafter and (iii) increased the advance multiple used to determine the amount of the borrowing base from&nbsp;<font class="_mt">2.75</font> to 1.0 to&nbsp;<font class="_mt">3.0</font> to 1.0. Our credit facility expires on November 2, 2014.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On July 26, 2010, the Company entered into the Second Amendment to its credit facility. The Second Amendment provided for a term loan component of the credit facility in the aggregate principal amount of $<font class="_mt">5,000</font> with a maturity date of <font class="_mt">January 5, 2013</font>. The requisite lenders also consented to the acquisition, effective July 25, 2010, of certain assets of Advantage by the Company, pursuant to the Purchase Agreement. The term loan was to be repaid in&nbsp;<font class="_mt">24</font> equal monthly installments which commenced February 2011. Interest on the term loan under the credit facility was payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of <font class="_mt">4.6</font>% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest was to be paid monthly or at the end of the relevant interest period. The term loan was repaid when due on January 5, 2013.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On May 24, 2011, the Company entered into a Joinder, Consent and Amendment No. 3 to its credit facility to include Addus HealthCare (Delaware) Inc., a newly-formed, wholly-owned subsidiary of Addus HealthCare, as an additional borrower under the credit facility.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On July 26, 2011, the Company entered into a fourth amendment (the "Fourth Amendment") to its credit facility. The Fourth Amendment modified the Company's maximum senior leverage ratio from&nbsp;<font class="_mt">3.00</font> to 1.00 to&nbsp;<font class="_mt">3.25</font> to 1.00 for each twelve month period ending on the last of day of each fiscal quarter beginning with the twelve month period ended June 30, 2011 and increased the advance multiple used to determine the amount of the borrowing base from&nbsp;<font class="_mt">3.0</font> to 1.0 to&nbsp;<font class="_mt">3.25</font> to 1.0. The Fourth Amendment resulted in an increase in the Company's available borrowings under the credit facility.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On March 2, 2012, the Company entered into a fifth amendment (the "Fifth Amendment") to its credit facility. The Fifth Amendment includes technical changes that are intended to comply with rules promulgated by CMS that restrict lenders from exercising any rights of set-off of funds on deposit in any lockboxes established for receiving payments from governmental authorities.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">During the fourth quarter of 2011, the lenders under the Company's credit facility permitted the Company to add back approximately $<font class="_mt">1,800</font> to adjusted EBITDA for the purpose of determining availability under the credit facility. The effect of the add back was to increase availability by approximately $<font class="_mt">5,800</font> until March 1, 2012. On March 1, 2012, the add back allowance was reduced by $<font class="_mt">200</font> and will continue to be reduced by $<font class="_mt">200</font> on the first day of each month thereafter until the add back is eliminated, which will result in a reduction in availability of $<font class="_mt">650</font> on the first day of each month thereafter until the add back is eliminated. The add-back was eliminated on December 1, 2012. During the second quarter of 2012, the lenders under the Company's credit facility agreed to a modified interpretation of the credit facility as it relates to the calculation of the fixed charge ratio, which provides the Company with increased flexibility in meeting this covenant. The Company was in compliance with all covenants as of December 31, 2012.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The availability of funds under the revolving credit portion of the credit facility, as amended, is based on the lesser of (i) the product of adjusted EBITDA, as defined in the credit facility agreement, for the most recent 12-month period for which financial statements have been delivered under the credit facility agreement multiplied by the specified advance multiple, up to <font class="_mt">3.25</font>, less the outstanding senior indebtedness and letters of credit, and (ii) $<font class="_mt">55,000</font> less the outstanding revolving loans and letters of credit. Interest on the amounts outstanding under the revolving credit portion of the credit facility is payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of <font class="_mt">4.6</font>% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest will be paid monthly or at the end of the relevant interest period, as determined in accordance with the credit facility agreement. The borrowers will pay a fee equal to <font class="_mt">0.5</font>% per annum of the unused portion of the revolving portion of the credit facility. Issued stand-by letters of credit will be charged at a rate of <font class="_mt">2.0</font>% per annum payable monthly. On December 31, 2012 the interest rate on the revolving credit loan facility was <font class="_mt">4.8</font>% (30 day LIBOR rate was <font class="_mt">0.2</font>%). The total availability under the revolving credit loan facility was $<font class="_mt">27,137</font> at December 31, 2012 compared to $<font class="_mt">21,810</font> at December 31, 2011.</font></p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Subordinated Dividend Notes</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On November 2, 2009, in conjunction with the IPO, all outstanding shares of Holdings' series A preferred stock were converted into an aggregate&nbsp;<font class="_mt">4,077</font> shares common stock at a ratio of 1:<font class="_mt">108</font>. Total accrued and unpaid dividends on the series A preferred stock were $<font class="_mt">13,109</font> as of November 2, 2009, at which time a dividend payment of $<font class="_mt">173</font> was made and the remaining $<font class="_mt">12,936</font> in unpaid preferred dividends were converted into dividend notes. The dividend notes are subordinated and to all obligations under the Company's new credit facility. On November 2, 2009, the Company made a mandatory payment of $<font class="_mt">4,000</font> on the dividend notes. Interest the outstanding dividend notes accrues at a rate of <font class="_mt">10</font>% per annum, compounded annually. The outstanding principal amount of the dividend notes was originally payable in&nbsp;<font class="_mt">eight</font> equal consecutive quarterly installments which commenced on December 31, 2009 and each March 31, June 30, September 30 and December 31 of each year thereafter until paid in full. Interest on the unpaid principal balance of the dividend notes is due and payable quarterly in arrears together with each payment of principal</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On March 18, 2010, the Company amended its subordinated dividend notes. A balance of $<font class="_mt">7,819</font> was outstanding on the dividend notes as of December 31, Pursuant to the amendments, the dividend notes were amended to (i) extend the maturity date of the dividend notes from&nbsp;<font class="_mt">September 30, 2011</font> to <font class="_mt">December 31, 2012</font>, (ii) modify the amortization schedule of the dividend notes to reduce the annual principal payment amounts from $<font class="_mt">4,468</font> to $<font class="_mt">1,250</font> in 2010; from $<font class="_mt">3,351</font> to $<font class="_mt">2,500</font> in and amended total payments in 2012 to $<font class="_mt">4,069</font>, and (iii) permit, based on the Company's leverage ratio, the prepayment of all or a portion of the principal amount of dividend notes, together with interest on the principal amount. The Company repaid the subordinated dividend notes in the fourth quarter of 2012.</font></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Aggregate maturities of long-term debt&nbsp;as of&nbsp;December 31, 2012, are as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="73%"> </td> <td width="2%"> </td> <td width="22%"> </td></tr> <tr valign="bottom"><td class="style1" width="73%" align="left"><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For the year ended December 31,</font></td> <td width="2%" align="left">&nbsp;</td> <td width="22%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="73%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px;" width="22%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="73%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2013</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="22%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">208</font></td></tr> <tr valign="bottom"><td width="73%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2014</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="22%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,250</font></td></tr> <tr><td width="97%" colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td width="73%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="22%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,458</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> </div> 0.10 -4205000 -13692000 -15069000 -6200000 -1051000 -619000 10703000 15947000 15405000 6028000 6028000 849000 -1981000 -1981000 1253000 3396000 2914000 1746000 7635000 7635000 1835000 2204000 3503000 <div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">New Accounting Pronouncements</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company does not believe any recently issued, but not yet effective, accounting standards will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.</font></p></div> </div> 1 50450000 48556000 48388000 9273000 2000000 12917000 2558000 3711000 4648000 3318000 15663000 3217000 3867000 5261000 10280000 10040000 240000 3024000 2784000 240000 779000 779000 1466000 1466000 1759000 1759000 2044000 2044000 1208000 1208000 <div> <div> <p style="text-align: left;"> </p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Basis of Presentation and Description of Business</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The consolidated financial statements include the accounts of Addus HomeCare Corporation ("Holdings") and its subsidiaries (together with Holdings, the "Company" or "we"). The Company provides home and community based services through a network of locations throughout the United States. These services are primarily performed in the homes of the consumers. The Company's home and community based services include assistance to the elderly, chronically ill and disabled with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. Home and community based services are primarily performed under agreements with state and local governmental agencies.</font></p></div> </div> 1737000 1813000 63341000 59532000 1053000 1041000 513000 298000 151000 34000 173000 5588000 500000 612000 551000 1114000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">14. Employee Benefit Plans</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's 401(k) Retirement Plan covers all non-union employees. The 401(k) plan is a defined contribution plan that provides for matching contributions by the Company. Matching contributions are discretionary and subject to change by management. Under the provisions of the 401(k) plan, employees can contribute up to the maximum percentage and limits allowable under the Internal Revenue Code of 1986. The Company provided a matching contribution, equal to <font class="_mt">6.0</font>% of the employees' contributions, totaling $<font class="_mt">44</font>, $<font class="_mt">49</font>, and $<font class="_mt">51</font> for continuing and discontinued operations for the year ended December 31, 2012, 2011, and 2010, respectively.</font></p> </div> <div> <div> <p style="text-align: left;"> </p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Allowance for Doubtful Accounts</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company establishes its allowance for doubtful accounts to the extent it is probable that a portion or all of a particular account will not be collected. The Company estimates its provision for doubtful accounts primarily by aging receivables utilizing&nbsp;<font class="_mt">eight</font> aging categories, and applying its historical collection rates to each aging category, taking into consideration factors that might impact the use of historical collection rates or payor groups, with certain large payors analyzed separately from other payor groups. In the Company's evaluation of these estimates, it also considers delays in payment trends in individual states due to budget or funding issues, billing conversions related to acquisitions or internal systems, resubmission of bills with required documentation and disputes with specific payors. An allowance for doubtful accounts is maintained at a level management believes is sufficient to cover potential losses. However, actual collections could differ from estimates.</font></p></div> </div> 8137000 7293000 3672000 4062000 192000 181000 -5250000 -8500000 -8500000 -2554000 -366000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">5. Property and Equipment</font></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment consisted of the following:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="67%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="13%"> </td> <td width="2%"> </td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="33%" colspan="6" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer equipment</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,705</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,412</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Furniture and equipment</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">918</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">778</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Transportation equipment</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">508</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">641</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Leasehold improvements</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,496</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,209</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer software</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,179</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,840</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,806</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,880</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Less accumulated depreciation and amortization</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(5,317</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(4,629</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="100%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,489</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,251</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer software includes $<font class="_mt">1,500</font> of internally developed software that was recognized in conjunction with the acquisition of Addus HealthCare. Depreciation and amortization expense predominantly related to computer equipment and software is reflected in general and administrative expenses and totaled $<font class="_mt">870</font>, $<font class="_mt">941</font>, and $<font class="_mt">903</font> for the three years ended December 31, 2012, 2011 and 2010, respectively.</font></p> </div> 6880000 2840000 1412000 778000 1209000 641000 7806000 3179000 1500000 1705000 918000 1496000 508000 2251000 2489000 <div> <div class="MetaData"> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and Equipment</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment are recorded at cost and depreciated over the estimated useful lives of the related assets by use of the straight-line method except for internally developed software which is amortized by the sum-of-years digits method. Maintenance and repairs are charged to expense as incurred. The estimated useful lives of the property and equipment are as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="38%"> </td> <td width="61%"> </td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer equipment</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3 &#8211; 5 years</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Furniture and equipment</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5 &#8211; 7 years</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Transportation equipment</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5 years</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer software</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5 &#8211; 10 years</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Leasehold improvements</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Lesser of useful life or lease term, unless probability of</font></td></tr> <tr valign="bottom"><td align="left">&nbsp;</td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">lease renewal is likely</font></td></tr></table></div></div> </div> <div> <table border="0" cellspacing="0"> <tr><td width="67%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="13%"> </td> <td width="2%"> </td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="33%" colspan="6" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer equipment</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,705</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,412</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Furniture and equipment</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">918</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">778</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Transportation equipment</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">508</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">641</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Leasehold improvements</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,496</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,209</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer software</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,179</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,840</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,806</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,880</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Less accumulated depreciation and amortization</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(5,317</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(4,629</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="100%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,489</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,251</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td></tr></table> </div> P5Y P10Y P5Y P5Y P3Y P7Y P5Y 4429000 4275000 2877000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">18. Unaudited Summarized Quarterly Financial Information</font></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The following is a summary of the Company's unaudited quarterly results of operations (amounts and shares in thousands, except per share data):</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="13%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="8%"> </td></tr> <tr valign="bottom"><td width="13%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="46%" colspan="11" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Year Ended December 31, 2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="44%" colspan="10" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Year Ended December 31, 2011</font></b></td></tr> <tr valign="bottom"><td width="13%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Dec. 31</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Sept. 30</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Jun. 30</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Mar. 31</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Dec. 31</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Sept. 30</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" colspan="2" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Jun. 30</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Mar. 31</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net service revenues</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">63,775</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">61,211</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">60,440</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">58,889</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">58,304</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">58,393</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">57,200</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">56,208</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Gross profit</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">17,537</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">15,683</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">15,807</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">15,024</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,829</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">15,701</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">14,784</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">14159</font></td></tr> <tr><td width="103%" colspan="22">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Operating income from continuing</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">operations</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5,261</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,867</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,217</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,318</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,648</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,711</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,558</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,000</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income from continuing operations</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,503</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,204</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,835</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,746</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,914</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,396</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,253</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">849</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income (loss) from discontinued</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">operations</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">242</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(407</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(371</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,117</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(418</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(10,059</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">80</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income (loss)</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,745</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,797</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,464</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">629</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,496</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(6,663</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,333</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">853</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Average shares outstanding:</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,772</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,761</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,761</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,756</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,754</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,746</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,746</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,746</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Diluted</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,807</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,773</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,785</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,760</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,756</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,746</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,770</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,754</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Income (loss) per common share:</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic and diluted</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 3px;" bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Continuing operations</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.33</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.20</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.17</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.16</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.27</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.32</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.11</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.08</font></td></tr> <tr valign="bottom"><td style="text-indent: 3px;" bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Discontinued operations</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.02</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.03</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.03</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.10</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.04</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.94</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.01</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.00</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic and diluted net earnings (loss) per share</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.35</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.17</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.14</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.06</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.23</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.62</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.12</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.08</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> </div> 3.00 2.75 3.25 3.00 -5000000 2292000 2500000 1250000 2500000 4069000 3993000 11628000 <div> <div class="MetaData"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Revenue Recognition</font></i></b> <p> </p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company generates net service revenues by providing services directly to consumers.&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company receives payments for providing services from federal, state and local governmental agencies, commercial insurers and private individuals. Our continuing operations, which includes the results of operations previously included in our home and community segment and&nbsp;<font class="_mt">three</font> agencies previously included in our home health segment, are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate specified in agreements or fixed by legislation and recognized as revenues at the time services are rendered. Home and community based service revenues are reimbursed by state, local and other governmental programs which are partially funded by Medicaid or Medicaid waiver programs, with the remainder reimbursed through private duty and insurance programs.</font></font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Laws and regulations governing the Medicaid and Medicare programs are complex and subject to interpretation. As a result, there is at least a reasonable possibility that recorded estimates may change in the near term. The Company believes that it is in compliance in all material respects with all applicable laws and regulations.</font></p></div> </div> 230099000 41633000 56208000 230105000 42995000 57200000 58393000 58304000 58889000 244315000 38822000 60440000 61211000 63775000 <div> <table style="width: 850px; height: 294px;" border="0" cellspacing="0" cellpadding="0"> <tr><td width="69%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="28%" colspan="4" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued payroll</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">11,539</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">11,547</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued workers' compensation insurance</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">12,452</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,173</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued payroll taxes</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,481</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,811</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued health insurance</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,469</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,039</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued taxes</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,223</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">223</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued interest</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">51</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">100</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Current portion of contingent earn-out obligation</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">689</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">683</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Other</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,813</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,737</font></td></tr> <tr><td width="97%" colspan="5">&nbsp;</td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">32,717</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">29,313</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="86%"> </td> <td width="3%"> </td> <td width="10%"> </td></tr> <tr valign="bottom"><td style="align: left;">&nbsp;</td> <td style="align: right;">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 6.72pt;" align="left"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Cash</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5,140</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Issuance of&nbsp;<font class="_mt">248</font> Addus shares at $<font class="_mt">5.00</font> per share (valued at a price per share equal to the average closing price of the</font><br /><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Company's stock for the three most recent trading days preceding the closing, subject to a floor of $<font class="_mt">5.00</font> per share)</font></td> <td style="align: right;">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,240</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Contingent earn-out obligation (net of $<font class="_mt">92</font> discount)</font></td> <td style="border-bottom: #000000 1px;" bgcolor="#cceeff" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,600</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total purchase price</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,980</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="67%"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="32%" colspan="6" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="67%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Revolving credit loan</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,250</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">24,750</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Term loan</font></td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">208</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,708</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Subordinated dividend notes bearing interest at <font class="_mt">10.0</font>%</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,069</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr><td bgcolor="#cceeff" width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,458</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">31,527</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Less current maturities</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(208</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(6,569</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="67%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Long-term debt</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,250</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">24,958</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="66%"> </td> <td width="3%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td></tr> <tr valign="bottom"><td width="66%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="33%" colspan="6" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="66%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="3%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Deferred tax assets</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Current</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accounts receivable allowances</font></td> <td bgcolor="#cceeff" width="3%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,784</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,824</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued compensation</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,133</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">902</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Accrued workers' compensation</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,593</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,263</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Other</font></td> <td style="border-bottom: #000000 1px solid;" width="3%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">395</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">146</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total current deferred tax assets</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,905</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,135</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Deferred tax liabilities</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Current</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid insurance</font></td> <td style="border-bottom: #000000 1px solid;" width="3%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(647</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(799</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net deferred tax assets&#8212;current</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,258</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,336</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Deferred tax assets</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Long-term</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill and intangible assets</font></td> <td width="3%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,577</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,398</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment</font></td> <td bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">96</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">112</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 11px;" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock-based compensation</font></td> <td style="border-bottom: #000000 1px solid;" width="3%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">655</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">579</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total long-term deferred tax assets</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="3%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,328</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,089</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr><td width="99%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td width="66%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total net deferred tax assets</font></td> <td style="border-bottom: #000000 3px double;" width="3%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9,586</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,425</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="70%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr><td width="70%"> </td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center"> </td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center"> </td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td></tr> <tr valign="bottom"><td bgcolor="#c0c0c0" width="70%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment, net of accumulated depreciation and amortization</font></td> <td bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 1px;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">245</font></td> <td bgcolor="#c0c0c0" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 1px;" bgcolor="#c0c0c0" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">239</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="54%"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td></tr> <tr valign="bottom"><td width="54%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="41%" colspan="6" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="54%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Federal income tax at statutory rate</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">34.0</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">34.0</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">34.0</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td></tr> <tr valign="bottom"><td width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">State and local taxes, net of federal benefit</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.9</font></td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.3</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.9</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Jobs tax credits, net</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(9.3</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">23.1</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(7.9</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr valign="bottom"><td width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Nondeductible meals and entertainment</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.9</font></td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2.0</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1.0</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Tax asset adjustment&#8212;stock options</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.3</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.5</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.9</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Other</font></td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.9</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(4.3</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr><td width="95%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="54%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Effective income tax rate</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">32.7</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">55.6</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">32.9</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="84%"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td style="text-decoration: underline;" width="84%" align="left"> </td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td style="text-decoration: underline;" width="84%" align="left"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For the year ended December 31,</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="84%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px;" width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2013</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,354</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2014</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,093</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2015</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">886</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2016</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">717</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2017</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">595</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Thereafter</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,575</font></td></tr> <tr><td width="98%" colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,220</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="45%"> </td> <td width="2%" align="center"> </td> <td width="17%" align="center"> </td> <td width="2%" align="center"> </td> <td width="13%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td width="45%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="17%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Non-Related Party Rent</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Related Party Rent</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Amount</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2013</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="17%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,784</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">240</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,024</font></td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2014</font></td> <td width="2%" align="left">&nbsp;</td> <td width="17%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,044</font></td> <td width="2%" align="left">&nbsp;</td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,044</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2015</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="17%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,759</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,759</font></td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2016</font></td> <td width="2%" align="left">&nbsp;</td> <td width="17%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,466</font></td> <td width="2%" align="left">&nbsp;</td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,466</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2017</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="17%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">779</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">779</font></td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Thereafter</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="17%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,208</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,208</font></td></tr> <tr><td width="93%" colspan="7">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="17%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,040</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">240</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,280</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="51%"> </td> <td width="2%" align="center"> </td> <td width="13%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%"> </td></tr> <tr valign="bottom"><td width="51%" align="left">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Continuing</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Discontinued</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="51%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">operations</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">operations</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill, at December 31, 2010</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,820</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">13,110</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">63,930</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Adjustments to previously recorded goodwill</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(125</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(34</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(159</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr valign="bottom"><td width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Impairment charge for discountinued operations</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(13,076</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(13,076</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="100%" colspan="10">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill, at December 31, 2011</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,695</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,695</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Adjustments to previously recorded goodwill</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(159</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(159</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td style="background-color: #ffffff;" width="100%" colspan="10">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill, at December 31, 2012</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,536</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50,536</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="25%"> </td> <td width="2%"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%"> </td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Customer and</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Trade names</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">referral</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">and</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Non-competition</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">relationships</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">trademarks</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">State Licenses</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">agreements</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2010</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,184</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,407</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">790</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">189</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">13,570</font></td> <td width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Impairment charges for discontinued operations</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,754</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(506</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(640</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(13</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,913</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Amortization</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,199</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(350</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(64</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,613</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="101%" colspan="16">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2011</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,231</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,551</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">150</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">112</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8,044</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Amortization</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,364</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(248</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(62</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,674</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td></tr> <tr><td width="101%" colspan="16">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2012</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,867</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,303</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">150</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">50</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,370</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="51%"> </td> <td width="2%"> </td> <td width="15%"> </td> <td width="2%"> </td> <td width="13%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="51%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="48%" colspan="7" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="51%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="15%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Current</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="15%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Federal</font></td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,325</font></td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,994</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,178</font></td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">State</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">544</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">184</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">335</font></td></tr> <tr valign="bottom"><td width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Deferred</font></td> <td width="2%" align="right">&nbsp;</td> <td width="15%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="13%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Federal</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">680</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(4,267</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">388</font></td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">State</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">159</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(396</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">59</font></td></tr> <tr><td width="99%" colspan="8">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="51%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Provision (benefit) for income taxes</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="15%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,708</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="13%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(2,485</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,960</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="73%"> </td> <td width="2%"> </td> <td width="22%"> </td></tr> <tr valign="bottom"><td class="style1" width="73%" align="left"><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For the year ended December 31,</font></td> <td width="2%" align="left">&nbsp;</td> <td width="22%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="73%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px;" width="22%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="73%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2013</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="22%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">208</font></td></tr> <tr valign="bottom"><td width="73%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2014</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="22%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,250</font></td></tr> <tr><td width="97%" colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td width="73%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="22%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,458</font></td></tr></table> </div> <div> <table style="width: 850px;" border="0" cellspacing="0" cellpadding="0"> <tr><td width="69%"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="28%" colspan="4" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></b></td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid health insurance</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,062</font></td> <td style="text-indent: 7px;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,672</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid workers' compensation and liability insurance</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,056</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,354</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Prepaid rent</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">181</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">192</font></td></tr> <tr valign="bottom"><td width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Workers' compensation insurance receivable</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">953</font></td> <td width="2%" align="left">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,866</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="69%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Other</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,041</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,053</font></td></tr> <tr><td width="97%" colspan="5">&nbsp;</td></tr> <tr valign="bottom"><td width="69%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,293</font></td> <td style="border-bottom: #000000 3px double; text-indent: 7px;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8,137</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="13%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="8%"> </td> <td width="2%"> </td> <td width="8%"> </td></tr> <tr valign="bottom"><td width="13%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="46%" colspan="11" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Year Ended December 31, 2012</font></b></td> <td style="border-bottom: #000000 1px solid;" width="44%" colspan="10" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Year Ended December 31, 2011</font></b></td></tr> <tr valign="bottom"><td width="13%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Dec. 31</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Sept. 30</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Jun. 30</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Mar. 31</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Dec. 31</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Sept. 30</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" colspan="2" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Jun. 30</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Mar. 31</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net service revenues</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">63,775</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">61,211</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">60,440</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">58,889</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">58,304</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">58,393</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">57,200</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">56,208</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Gross profit</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">17,537</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">15,683</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">15,807</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">15,024</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">16,829</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">15,701</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">14,784</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">14159</font></td></tr> <tr><td width="103%" colspan="22">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Operating income from continuing</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">operations</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5,261</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,867</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,217</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,318</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,648</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,711</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,558</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,000</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income from continuing operations</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,503</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,204</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,835</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,746</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,914</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,396</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,253</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">849</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income (loss) from discontinued</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">operations</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">242</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(407</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(371</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1,117</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(418</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(10,059</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">80</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income (loss)</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,745</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,797</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,464</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">629</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,496</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(6,663</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1,333</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">853</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Average shares outstanding:</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,772</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,761</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,761</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,756</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,754</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,746</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,746</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,746</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Diluted</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,807</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,773</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,785</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,760</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,756</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,746</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,770</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10,754</font></td></tr> <tr valign="bottom"><td width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Income (loss) per common share:</font></td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic and diluted</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="8%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 3px;" bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Continuing operations</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.33</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.20</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.17</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.16</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.27</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.32</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.11</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.08</font></td></tr> <tr valign="bottom"><td style="text-indent: 3px;" bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Discontinued operations</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.02</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.03</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.03</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.10</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.04</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.94</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.01</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.00</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="13%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Basic and diluted net earnings (loss) per share</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.35</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.17</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.14</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.06</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.23</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(0.62</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.12</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="8%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">0.08</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="59%"> </td> <td width="3%"> </td> <td width="37%"> </td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Total</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,272</font></td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Identifiable intangible assets</font></td> <td style="border-bottom: #000000 3px;" align="right">&nbsp;</td> <td style="border-bottom: #000000 3px;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,631</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">77</font></td></tr> <tr><td colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 19.8pt;" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Total purchase price allocation</font></td> <td style="border-bottom: #000000 3px double;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,980</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="25%"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="2%" align="center"> </td> <td width="11%" align="center"> </td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="78%" colspan="12" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For The Year Ended December 31,</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted-</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td style="text-indent: 2px;" width="2%" align="center"><b> </b></td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted-</font></b>&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted-</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grant Date</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td style="text-indent: 2px;" width="2%" align="center"><b> </b></td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grant Date</font></b>&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grant Date</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Fair Value</font></b></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td width="2%" align="center">&nbsp;</td> <td style="text-indent: 3px;" width="2%" align="center"><b> </b></td> <td width="11%" align="center">&nbsp;<b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Fair Value</font></b></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Fair Value</font></b></td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Restricted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Restricted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Restricted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Awards</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Awards</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Awards</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Unvested restricted stock awards</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">21</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.95</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 5px;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.85</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10.00</font></td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Awarded</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">44</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.48</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">24</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td style="text-indent: 5px;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.63</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="left">&nbsp;</td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.21</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Vested</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(20</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.14</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(8</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="text-indent: 5px;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.64</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">10.00</font></td></tr> <tr valign="bottom"><td width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Forfeited</font></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(3</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.93</font></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(1</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 5px;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.93</font></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td></tr> <tr><td width="103%" colspan="13">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Unvested restricted stock awards at</font></td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td> <td style="background-color: #cceeff;" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 2px;" bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">December 31,</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.80</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">21</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double; text-indent: 5px;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.95</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.85</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="2%" align="center"> </td> <td width="25%" align="center"> </td> <td width="10%" align="center"> </td> <td width="10%" align="center"> </td> <td width="2%" align="center"> </td> <td width="10%" align="center"> </td> <td width="11%" align="center"> </td> <td width="11%" align="center"> </td> <td width="2%" align="center"> </td> <td width="12%" align="center"> </td></tr> <tr valign="bottom"><td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="25%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise Price</font></b></td> <td style="border-bottom: #000000 1px solid;" width="32%" colspan="4" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Outstanding</font></b></td> <td style="border-bottom: #000000 1px solid;" width="36%" colspan="4" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercisable</font></b></td></tr> <tr><td width="95%" colspan="10" align="center">&nbsp;</td></tr> <tr><td width="95%" colspan="10" align="center">&nbsp;</td></tr> <tr><td width="95%" colspan="10" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Remaining</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Remaining</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Contractual</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Contractual</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td></tr> <tr valign="bottom"><td width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td width="10%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Life In</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Life In</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td></tr> <tr valign="bottom"><td style="border-bottom: #000000 3px double;" width="2%" align="center">&nbsp;</td> <td width="25%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Years</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Years</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 1px;" bgcolor="#cceeff" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.06</font></font>&#8211; $ <font class="_mt">5.45</font></font></td> <td style="text-indent: 3px;" bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">166</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.4</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.77</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">48</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.1</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.77</font></td></tr> <tr valign="bottom"><td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 1px;" width="25%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.26</font></font>&#8211; $<font class="_mt">10.00</font></font></td> <td style="border-bottom: #000000 1px solid; text-indent: 3px;" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">430</font></td> <td width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.5</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="right">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.39</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">400</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.3</font></td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.35</font></td></tr> <tr><td width="95%" colspan="10">&nbsp;</td></tr> <tr><td width="95%" colspan="10">&nbsp;</td></tr> <tr valign="bottom"><td width="2%" align="right">&nbsp;</td> <td width="25%" align="left">&nbsp;</td> <td style="border-bottom: #000000 3px double; text-indent: 3px;" bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">596</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.6</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="10%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.11</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">448</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.7</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.85</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="23%"> </td> <td width="9%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="9%"> </td> <td width="10%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="10%"> </td> <td width="11%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="73%" colspan="12" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For The Year Ended December 31,</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td width="9%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="10%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td width="9%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="10%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Average</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td width="9%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td> <td width="10%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td> <td width="11%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercise</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td> <td width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Price</font></b></td></tr> <tr valign="bottom"><td width="23%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="9%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="9%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="10%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="11%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Options</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Outstanding, beginning of period</font></td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">775</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7.69</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">588</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.63</font></td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">607</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.51</font></td></tr> <tr valign="bottom"><td width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Granted</font></td> <td width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">36</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.49</font></td> <td width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">229</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5.33</font></td> <td width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">91</font></td> <td width="2%" align="left">&nbsp;</td> <td width="2%" align="right">&nbsp;</td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.30</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Exercised</font></td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(5</font></td> <td bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4.53</font></td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="10%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">-</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Forfeited/Cancelled</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(209</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.02</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(42</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7.93</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">(110</font></td> <td style="border-bottom: #000000 1px solid;" bgcolor="#cceeff" width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">)</font></td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">9.95</font></td></tr> <tr><td width="96%" colspan="13">&nbsp;</td></tr> <tr valign="bottom"><td width="23%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Outstanding, end of period</font></td> <td style="border-bottom: #000000 3px double;" width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">596</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="9%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.11</font></td> <td style="border-bottom: #000000 3px double;" width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">775</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="10%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7.69</font></td> <td style="border-bottom: #000000 3px double;" width="11%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">588</font></td> <td style="border-bottom: #000000 3px double;" width="2%" align="left">&nbsp;</td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">8.63</font></td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="45%"> </td> <td width="17%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="13%"> </td> <td width="2%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="2%"> </td></tr> <tr valign="bottom"><td width="45%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="52%" colspan="8" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">For the year ended December 31,</font></b></td></tr> <tr valign="bottom"><td width="45%" align="left">&nbsp;</td> <td width="17%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2012</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2011</font></b></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">2010</font></b></td> <td width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="45%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="17%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grants</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="13%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grants</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Grants</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Weighted average fair value</font></td> <td bgcolor="#cceeff" width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.09</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.54</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1.88</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Risk-free discount rate</font></td> <td width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">1.59</font></font>% - <font class="_mt">1.95</font>%</font></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3.17<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></font></td> <td width="2%" align="center"> </td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.89</font></font>% &#8211; <font class="_mt">2.99</font>%</font></td> <td width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Expected life</font></td> <td bgcolor="#cceeff" width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.0 &#8211; 6.5 years</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.0 &#8211; 6.5 years</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6.5 years</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Dividend yield</font></td> <td width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td width="2%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td> <td width="2%" align="center">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Volatility</font></td> <td bgcolor="#cceeff" width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42</font></font>% &#8211; <font class="_mt">51</font>%</font></font></td> <td bgcolor="#cceeff" width="2%" align="center"> </td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42</font></font>% &#8211; <font class="_mt">51</font>%</font></font></td> <td bgcolor="#cceeff" width="2%" align="center"> </td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"><font class="_mt"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">42</font></font>% &#8211; <font class="_mt">51</font>%</font></font></td> <td bgcolor="#cceeff" width="2%" align="center"> </td></tr> <tr valign="bottom"><td width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Expected turn-over rate(1)</font></td> <td width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></font></td> <td width="2%" align="center"> </td> <td width="2%" align="center">&nbsp;</td> <td width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></font></td> <td width="2%" align="center"> </td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">%</font></font></td> <td width="2%" align="center"> </td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="45%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Expected exercise multiple(1)</font></td> <td bgcolor="#cceeff" width="17%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.2</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="13%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.2</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="center"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2.2</font></td> <td bgcolor="#cceeff" width="2%" align="center">&nbsp;</td></tr></table> </div> <div> <table border="0" cellspacing="0"> <tr><td width="84%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="84%" align="left">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Unrecognized</font></b></td></tr> <tr valign="bottom"><td width="84%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Tax Benefits</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2010</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 9px;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">115</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Increases related to current year tax positions</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 9px;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td></tr> <tr><td width="98%" colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2011</font></td> <td bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="text-indent: 9px;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">115</font></td></tr> <tr valign="bottom"><td width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Increases related to current year tax positions</font></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="left">&nbsp;</td> <td style="border-bottom: #000000 1px solid; text-indent: 9px;" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&#8212;</font></td></tr> <tr><td width="98%" colspan="3">&nbsp;</td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="84%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at December 31, 2012</font></td> <td style="border-bottom: #000000 3px double;" bgcolor="#cceeff" width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td style="border-bottom: #000000 3px double; text-indent: 9px;" bgcolor="#cceeff" width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">115</font></td></tr></table> </div> <div> <p style="text-align: center;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">ADDUS HOMECARE CORPORATION AND SUBSIDIARIES</font></b></p> <p style="text-align: center;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">VALUATION AND QUALIFYING ACCOUNTS SCHEDULE II</font></b></p> <p style="text-align: center;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">(in thousands)</font></b></p> <div> <table border="0" cellspacing="0"> <tr><td width="44%"> </td> <td width="2%"> </td> <td width="12%"> </td> <td width="12%"> </td> <td width="12%"> </td> <td width="2%"> </td> <td width="12%"> </td></tr> <tr valign="bottom"><td width="44%" align="left">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at</font></b></td> <td width="12%" align="center">&nbsp;</td> <td width="12%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Balance at</font></b></td></tr> <tr valign="bottom"><td width="44%" align="left">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">beginning</font></b></td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Additions/</font></b></td> <td width="12%" align="center">&nbsp;</td> <td width="2%" align="center">&nbsp;</td> <td width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">end of</font></b></td></tr> <tr valign="bottom"><td width="44%" align="left"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Allowance for doubtful accounts</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">of period</font></b></td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">charges</font></b></td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">Deductions*</font></b></td> <td style="border-bottom: #000000 1px solid;" width="2%" align="center">&nbsp;</td> <td style="border-bottom: #000000 1px solid;" width="12%" align="center"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">period</font></b></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="44%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Year ended December 31, 2012</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="44%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Allowance for doubtful accounts</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,189</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,877</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5,600</font></td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,466</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="44%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Year ended December 31, 2011</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="44%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Allowance for doubtful accounts</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,723</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,275</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3,809</font></td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">7,189</font></td></tr> <tr valign="bottom"><td bgcolor="#cceeff" width="44%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Year ended December 31, 2010</font></td> <td bgcolor="#cceeff" width="2%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="left">&nbsp;</td> <td bgcolor="#cceeff" width="2%" align="right">&nbsp;</td> <td bgcolor="#cceeff" width="12%" align="right">&nbsp;</td></tr> <tr valign="bottom"><td style="text-indent: 5px;" width="44%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Allowance for doubtful accounts</font></td> <td width="2%" align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,813</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">4,429</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">2,519</font></td> <td width="2%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">$</font></td> <td width="12%" align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">6,723</font></td></tr></table></div> <p style="margin: 0px;">&nbsp;</p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">* <font class="_mt">Write-offs, net of recoveries</font></font></p> </div> <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">13. Segment Data</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company has historically segregated its results into two distinct reporting segments: the home &amp; community segment and the home health segment. As a result of the sale of the Home Health Business, the Company has reported the operating results for the Home Health Business as discontinued operations. Therefore, all of the Company's operations are reported as&nbsp;<font class="_mt">one</font> operating segment.</font></p> </div> 255000 331000 341000 1000 3000 5.93 5.93 4000 24000 44000 44000 5.21 5.63 4.48 4.48 3000 6000 21000 42000 10.00 6.85 5.95 4.80 1000 8000 20000 10.00 5.64 5.14 2.2 2.2 2.2 P6Y6M P6Y6M P6Y P6Y6M P6Y 0.51 0.51 0.51 0.42 0.42 0.42 0.0317 0.0299 0.0195 0.0289 0.0159 750000 110000 42000 209000 91000 229000 36000 750000 1.88 2.54 2.09 394000 607000 588000 775000 596000 9.51 8.63 7.69 8.11 115000 4.53 9.95 7.93 6.02 4.30 5.33 4.49 <div> <div class="MetaData"> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock-based Compensation</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company has&nbsp;<font class="_mt">two</font> stock incentive plans, the 2006 Stock Incentive Plan (the "2006 Plan") and the 2009 Stock Incentive Plan (the "2009 Plan") that provide for stock-based employee compensation. The Company accounts for stock-based compensation in accordance with ASC Topic 718, "</font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock Compensation</font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">." Compensation expense is recognized on a graded method under the 2006 Plan and on a straight-line basis under the 2009 Plan over the vesting period of the awards based on the fair value of the options. Under the 2006 Plan, the Company historically used the Black-Scholes option pricing model to estimate the fair value of its stock based payment awards, but beginning October 28, 2009 under its 2009 Plan it began using an enhanced Hull-White Trinomial model. The determination of the fair value of stock-based payments utilizing the Black-Scholes model and the Enhanced Hull-White Trinomial model is affected by Holdings' stock price and a number of assumptions, including expected volatility, risk-free interest rate, expected term, expected dividends yield, expected forfeiture rate, expected turn-over rate, and the expected exercise multiple.</font></p></div> </div> 8.85 4.77 9.35 P4Y8M12D P8Y1M6D P4Y3M18D 4.06 9.26 448000 48000 400000 596000 166000 430000 8.11 4.77 9.39 P5Y7M6D P8Y4M24D P4Y6M 5.45 10.00 10499000 10751000 10775000 10823000 <div> <div> <p style="text-align: left;"><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1"><b>1. Significant Accounting Policies</b></font></p> <div> <p style="text-align: left;"> </p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Basis of Presentation and Description of Business</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The consolidated financial statements include the accounts of Addus HomeCare Corporation ("Holdings") and its subsidiaries (together with Holdings, the "Company" or "we"). The Company provides home and community based services through a network of locations throughout the United States. These services are primarily performed in the homes of the consumers. The Company's home and community based services include assistance to the elderly, chronically ill and disabled with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. Home and community based services are primarily performed under agreements with state and local governmental agencies.</font></p></div> <p style="text-align: left;"> </p> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Discontinued Operations</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On February 7, 2013, subsidiaries of Holdings entered into an Asset Purchase Agreement with LHC Group, Inc. and certain of its subsidiaries (the "Home Health Purchase Agreement"). Pursuant to the Home Health Purchase Agreement, effective March 1, 2013, the purchasers agreed to acquire substantially all the assets of the Company's home health business in Arkansas, Nevada and South Carolina and <font class="_mt">90</font>% of its home health business in California and Illinois, with the Company retaining <font class="_mt">10</font>% ownership in such locations, for cash consideration of $<font class="_mt">20,000</font>.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's home health services were operated through licensed and Medicare certified offices that provided physical, occupational and speech therapy, as well as skilled nursing services to pediatric, adult infirm and elderly patients. Home health services were reimbursed from Medicare, Medicaid and Medicaid-waiver programs, commercial insurance and private payors (see note 2).</font></p></div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Principles of Consolidation</font></i></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">&nbsp;&nbsp;&nbsp;&nbsp; All intercompany balances and transactions have been eliminated in consolidation.</font></p></div> <div class="MetaData"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Revenue Recognition</font></i></b> <p> </p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company generates net service revenues by providing services directly to consumers.&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company receives payments for providing services from federal, state and local governmental agencies, commercial insurers and private individuals. Our continuing operations, which includes the results of operations previously included in our home and community segment and&nbsp;<font class="_mt">three</font> agencies previously included in our home health segment, are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate specified in agreements or fixed by legislation and recognized as revenues at the time services are rendered. Home and community based service revenues are reimbursed by state, local and other governmental programs which are partially funded by Medicaid or Medicaid waiver programs, with the remainder reimbursed through private duty and insurance programs.</font></font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Laws and regulations governing the Medicaid and Medicare programs are complex and subject to interpretation. As a result, there is at least a reasonable possibility that recorded estimates may change in the near term. The Company believes that it is in compliance in all material respects with all applicable laws and regulations.</font></p></div><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font> <div> <p style="text-align: left;"> </p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Allowance for Doubtful Accounts</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company establishes its allowance for doubtful accounts to the extent it is probable that a portion or all of a particular account will not be collected. The Company estimates its provision for doubtful accounts primarily by aging receivables utilizing&nbsp;<font class="_mt">eight</font> aging categories, and applying its historical collection rates to each aging category, taking into consideration factors that might impact the use of historical collection rates or payor groups, with certain large payors analyzed separately from other payor groups. In the Company's evaluation of these estimates, it also considers delays in payment trends in individual states due to budget or funding issues, billing conversions related to acquisitions or internal systems, resubmission of bills with required documentation and disputes with specific payors. An allowance for doubtful accounts is maintained at a level management believes is sufficient to cover potential losses. However, actual collections could differ from estimates.</font></p></div> <div class="MetaData"> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and Equipment</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Property and equipment are recorded at cost and depreciated over the estimated useful lives of the related assets by use of the straight-line method except for internally developed software which is amortized by the sum-of-years digits method. Maintenance and repairs are charged to expense as incurred. The estimated useful lives of the property and equipment are as follows:</font></p> <div> <table border="0" cellspacing="0"> <tr><td width="38%"> </td> <td width="61%"> </td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer equipment</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">3 &#8211; 5 years</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Furniture and equipment</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5 &#8211; 7 years</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Transportation equipment</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5 years</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Computer software</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">5 &#8211; 10 years</font></td></tr> <tr valign="bottom"><td align="left"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Leasehold improvements</font></td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Lesser of useful life or lease term, unless probability of</font></td></tr> <tr valign="bottom"><td align="left">&nbsp;</td> <td align="right"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">lease renewal is likely</font></td></tr></table></div></div></div> <p style="margin: 0px;">&nbsp;</p> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Goodwill</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions including the acquisition of Addus HealthCare, Inc. ("Addus HealthCare"). In accordance with Accounting Standards Codification TM ("ASC") Topic 350, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Goodwill and Other Intangible Assets </font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">," goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. Goodwill and indefinite lived intangible assets are required to be tested for impairment at least annually. The Company may use a qualitative test, known as "Step 0" or a two-step quantitative method to determine whether impairment has occurred. In Step 0, the Company can elect to perform an optional qualitative analysis and based on the results skip the two step analysis. In 2012, the Company elected to implement Step 0 and was not required to conduct the remaining two step analysis.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In 2011, the Company elected to evaluate the goodwill via the two step methodology. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. The Company used the combination of a discounted cash flow model ("DCF model") and the market multiple analysis method to determine the current fair value of each reporting unit. The DCF model was prepared using revenue and expense projections based on the Company's current operating plan. As such, a number of significant assumptions and estimates&nbsp;were involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. In 2011, the cash flows were discounted using a weighted average cost of capital of <font class="_mt">14.5</font>%, which was management's best estimate based on the capital structure of the Company and external industry data. As part of the second step of this evaluation, if the carrying value of goodwill exceeds its fair value, an impairment loss would be recognized. The Company recorded a $<font class="_mt">15,989</font> goodwill and intangible asset charge during the third quarter of 2011 (see Note 6)for its discontinued operations (see Note 2).</font></p></div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Intangible Assets</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-compete agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from two to 25 years.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">ASC Topic 350 requires that the fair value of intangible assets with finite lives be estimated and compared to the carrying value. The Company estimates the fair value of these intangible assets using the income approach. Intangible assets with finite lives are amortized using the estimated economic benefit method over the useful life and assessed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company recognizes an impairment loss when the estimated fair value of the intangible asset is less than the carrying value. No impairment charge was recorded in 2012. The Company recorded a $<font class="_mt">2,273</font> impairment associated with discontinued operations in 2011. No impairment charge was recorded in 2010.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The income approach, which the Company uses to estimate the fair value of its reporting units and intangible assets, is dependent on a number of factors including estimates of future market growth and trends, forecasted revenue and costs, expected periods the assets will be utilized, appropriate discount rates and other variables. The Company bases its fair value estimates on assumptions the Company believes to be reasonable but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates. In addition, the Company makes certain judgments about the selection of comparable companies used in the market approach in valuing its reporting units.</font></p></div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Long-Lived Assets</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company reviews its long-lived assets and indefinite lived intangibles (except goodwill and finite lived intangible assets, as described above) for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. To determine if impairment exists, the Company compares the estimated future undiscounted cash flows from the related long-lived assets to the net carrying amount of such assets. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset, generally determined by discounting the estimated future cash flows. No impairment charge was recorded in 2012. The Company recorded a $<font class="_mt">640</font> impairment associated with discontinued operations in 2011. No impairment&nbsp;charge was&nbsp;recorded in 2010.</font></p></div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Debt Issuance Costs</font></i></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company amortizes debt issuance costs on a straight-line method over the term of the related debt. This method approximates the effective interest method.</font></p></div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Workers' Compensation Program</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's workers' compensation program has a $<font class="_mt">350</font> deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The future claims payments related to the workers' compensation program are secured by letters of credit.</font></p></div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Derivative Financial Instrument</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company utilized a derivative financial instrument to minimize interest rate risk. The Company's derivative instrument consisted of a three-year interest rate agreement designed to reduce the variability of cash flows associated with a portion of the Company's term debt. As the hedge accounting criteria established in ASC Topic 815, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Derivatives and Hedging" </font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">have not been met, the Company accounted for the instrument at its fair value and recognizes any changes in its fair value in earnings for the period.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">ASC Topic 820, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Fair Value Measurements," </font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">establishes a three-tier fair value hierarchy, which categorizes the inputs used in measuring fair value. These categories include in descending order of priority: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The fair value of the swap was calculated using proprietary models utilizing observable inputs (Level 2) as well as future assumptions related to interest rates and other applicable variables. These calculations were performed by the financial institution which is counterparty to the applicable swap agreement and reviewed by the Company. The Company used these reported fair values to adjust the asset or liability as appropriate. The interest rate swap agreement concluded in March of 2010.</font></p></div> <div class="MetaData"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Interest Income</font></i></b> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Legislation enacted in Illinois entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the income statement caption, interest income. The Company received $<font class="_mt">155</font>, $<font class="_mt">2,263</font> and $<font class="_mt">155</font> in prompt payment interest in 2012, 2011 and 2010, respectively. While the Company may be owed additional prompt payment interest, the amount and timing of receipt of such payments remains uncertain and the Company has determined that it will continue to recognize prompt payment interest income when received.</font></p></div><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font> <div> <p style="text-align: left;"> </p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Interest Expense</font></i></b></p> <p style="text-align: left;"><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's interest expense consists of interest costs on its credit facility and other debt instruments.</font></p></div> <p style="text-align: left;"> </p> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Income Taxes</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company accounts for income taxes under the provisions of ASC Topic 740, </font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">"Income Taxes"</font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">. The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its financial statements or tax returns. Deferred taxes, resulting from differences between the financial and tax basis of the Company's assets and liabilities, are also adjusted for changes in tax rates and tax laws when changes are enacted. ASC Topic 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. ASC Topic 740, also prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. In addition, ASC Topic 740 provides guidance on derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions.</font></p></div> <div class="MetaData"> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock-based Compensation</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company has&nbsp;<font class="_mt">two</font> stock incentive plans, the 2006 Stock Incentive Plan (the "2006 Plan") and the 2009 Stock Incentive Plan (the "2009 Plan") that provide for stock-based employee compensation. The Company accounts for stock-based compensation in accordance with ASC Topic 718, "</font><i><font style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Stock Compensation</font></i><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">." Compensation expense is recognized on a graded method under the 2006 Plan and on a straight-line basis under the 2009 Plan over the vesting period of the awards based on the fair value of the options. Under the 2006 Plan, the Company historically used the Black-Scholes option pricing model to estimate the fair value of its stock based payment awards, but beginning October 28, 2009 under its 2009 Plan it began using an enhanced Hull-White Trinomial model. The determination of the fair value of stock-based payments utilizing the Black-Scholes model and the Enhanced Hull-White Trinomial model is affected by Holdings' stock price and a number of assumptions, including expected volatility, risk-free interest rate, expected term, expected dividends yield, expected forfeiture rate, expected turn-over rate, and the expected exercise multiple.</font></p></div> <div class="MetaData"> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Net Income (Loss) Per Common Share</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Net income (loss) per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company's outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Included in the Company's calculation for the year ended December 31, 2012 were&nbsp;<font class="_mt">596</font> stock options of which&nbsp;<font class="_mt">501</font> were out-of-the money and therefore anti-dilutive and&nbsp;<font class="_mt">57</font> restricted stock awards with&nbsp;<font class="_mt">12</font> included in the weighted diluted shares outstanding for 2012.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">For the year ended December 31, 2011 the Company had&nbsp;<font class="_mt">10</font> dilutive shares but it reported a net loss and any potentially dilutive securities would be anti-dilutive, therefore, no additional shares were considered in the calculation of diluted earnings per share.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">Included in the Company's calculation for the year ended December 31, 2010 were&nbsp;<font class="_mt">588</font> stock options which were out-of-the money and therefore anti-dilutive and&nbsp;<font class="_mt">6</font> restricted stock awards with&nbsp;<font class="_mt">2</font> included in the weighted diluted shares outstanding for 2010.</font></p></div><font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1"> </font> <div> <p style="text-align: left;"> </p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Estimates</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. Accordingly, actual results could differ from those estimates.</font></p></div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Fair Value of Financial Instruments</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company's financial instruments consist of cash, accounts receivable, payables and debt. The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of the short-term nature of these instruments. The carrying value of the Company's long-term debt with variable interest rates approximates fair value based on instruments with similar terms.</font></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets and also when determining the fair value of contingent considerations. To determine the fair value in these situations, the Company uses Level 3 inputs such as discounted cash flows or if available, what a market participant would pay on the measurement date.</font></p></div> <div> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">New Accounting Pronouncements</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The Company does not believe any recently issued, but not yet effective, accounting standards will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.</font></p></div> <div> </div> <p style="text-align: left;">&nbsp;</p> </div> 86441000 94417000 80567000 80611000 10000 -54000 88091000 82106000 11000 5974000 86441000 82437000 11000 3993000 94417000 82778000 11000 11628000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">12. Stockholder's Equity</font></b></p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Acquisitions</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On July 26, 2010, in conjunction with the purchase of certain assets of Advantage by the Company, pursuant to the Purchase Agreement, the Company issued&nbsp;<font class="_mt">248</font> shares of its common stock with a value of $<font class="_mt">1,240</font>.</font></p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">2009 Stock Incentive Plan</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">In September 2009, the Company's board of directors and stockholders adopted and approved the 2009 Plan. The 2009 Plan provides for the grant of&nbsp;<font class="_mt">750</font> incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units, restricted stock units, other stock units and performance shares.</font></p> </div> 108 248000 5000 4000 24000 43000 1000 1000 5000 1240000 1240000 <div> <p style="text-align: left;"><b><font style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" class="_mt" size="1">19. Subsequent Event</font></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">On February 7, 2013, the Company entered into the Home Health Purchase Agreement with LHC Group, Inc. and certain of its subsidiaries. Pursuant to the Home Health Purchase Agreement, effective March 1, 2013, the purchasers acquired substantially all the assets of the Company' s Home Health Business in Arkansas, Nevada and South Carolina and <font class="_mt">90</font>% of the Home Health Business in California and Illinois with the Company retaining <font class="_mt">10</font>% ownership in such locations, for cash consideration of $<font class="_mt">20,000</font>. (see note 2). In addition the Company has two home health agencies that are being held for sale. The results of operations for assets sold or being held for sale are included in the financial statements as discontinued operations.</font></p> </div> 191000 115000 115000 115000 <div> <div> <p style="text-align: left;"> </p> <p style="text-align: left;"><b><i><font style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" class="_mt" size="1">Estimates</font></i></b></p> <p style="text-align: left;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" class="_mt" size="1">The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. Accordingly, actual results could differ from those estimates.</font></p></div> </div> 4813000 6723000 7189000 4466000 4429000 4275000 2877000 2000 10000 12000 10606000 10754000 10752000 10770000 10746000 10756000 10760000 10784000 10785000 10773000 10807000 10604000 10746000 10752000 10746000 10746000 10754000 10756000 10764000 10761000 10761000 10772000 6000 57000 10173000 12452000 Write-offs, net of recoveries EX-101.SCH 8 adus-20121231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements Of Income link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Discontinued Operations (Schedule Of Income Loss From Discontinued Operation) (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Acquisitions (Schedule Of Purchase Price Components) (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Acquisitions (Schedule Of Purchase Price Allocation) (Details) link:presentationLink link:calculationLink link:definitionLink 40404 - Disclosure - Acquisitions (Schedule Of Business Acquisition Pro Forma Consolidated Income Statement Information) (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Property And Equipment (Schedule Of Property And Equipment) (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - Goodwill And Intangible Assets (Schedule Of Future Amortization Of Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Details Of Certain Balance Sheet Accounts (Schedule Of Prepaid Expenses And Other Current Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - Details Of Certain Balance Sheet Accounts (Schedule Of Accrued Expenses) (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Long-Term Debt (Schedule Of Long-Term Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - Long-Term Debt (Schedule Of Long-Term Debt Maturities) (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Income Taxes (Tax Expense By Jurisdiction) (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Income Taxes (Deferred Tax Assets And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 40904 - Disclosure - Income Taxes (Reconciliation Of Effective Tax Rate, Percentage) (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Operating Leases And Related Party Transactions (Operating Leases And Related Party Transactions) (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Statements Of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Sale Of Agency link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Property And Equipment link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Goodwill And Intangible Assets link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Details Of Certain Balance Sheet Accounts link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Stock Options And Restricted Stock Awards link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Operating Leases And Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Stockholder's Equity link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Segment Data link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - Significant Payors link:presentationLink link:calculationLink link:definitionLink 11701 - Disclosure - Concentration Of Cash link:presentationLink link:calculationLink link:definitionLink 11801 - Disclosure - Summarized Quarterly Financial Information link:presentationLink link:calculationLink link:definitionLink 11901 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 12001 - Schedule - Valuation And Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - Summary Of Significant Accounting Policies (Policy) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Property And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Goodwill And Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Details Of Certain Balance Sheet Accounts (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Stock Options And Restricted Stock Awards (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Operating Leases And Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 31803 - Disclosure - Summarized Quarterly Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Summary Of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Discontinued Operations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Discontinued Operations (Schedule Of Disposal Group, Classes Of Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Sale Of Agency (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Acquisitions (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Property And Equipment (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Goodwill And Intangible Assets (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Goodwill And Intangible Assets (Changes In Goodwill By Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Goodwill And Intangible Assets (Schedule Of Carrying Amount And Accumulated Amortization Of Intangible Asset) (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Details Of Certain Balance Sheet Accounts (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Long-Term Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40905 - Disclosure - Income Taxes (Changes In Unrecognized Tax Benefits) (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Stock Options And Restricted Stock Awards (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Stock Options And Restricted Stock Awards (Summary Of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Stock Options And Restricted Stock Awards (Stock Option Awards) (Details) link:presentationLink link:calculationLink link:definitionLink 41004 - Disclosure - Stock Options And Restricted Stock Awards (Option Pricing Assumptions) (Details) link:presentationLink link:calculationLink link:definitionLink 41005 - Disclosure - Stock Options And Restricted Stock Awards (Summary Of Vested And Unvested RSU) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Operating Leases And Related Party Transactions (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Stockholder's Equity (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Segment Data (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Employee Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - Commitments And Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 41601 - Disclosure - Significant Payors (Details) link:presentationLink link:calculationLink link:definitionLink 41801 - Disclosure - Summarized Quarterly Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 41901 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink 42001 - Schedule - Valuation And Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 adus-20121231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 adus-20121231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 adus-20121231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 12 adus-20121231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations (Schedule Of Income Loss From Discontinued Operation) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Net service revenue $ 63,775 $ 61,211 $ 60,440 $ 58,889 $ 58,304 $ 58,393 $ 57,200 $ 56,208 $ 244,315 $ 230,105 $ 230,099
Home Health Segment [Member]
                     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Net service revenue                 38,822 42,995 41,633
Income (loss) before income taxes                 (2,752) (17,122) 2,719
Income tax expense (benefit)                 (1,099) (6,729) 1,058
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total                 $ (1,653) $ (10,393) $ 1,661
XML 14 R54.htm IDEA: XBRL DOCUMENT v2.4.0.6
Details Of Certain Balance Sheet Accounts (Schedule Of Accrued Expenses) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Details Of Certain Balance Sheet Accounts [Abstract]    
Accrued payroll $ 11,539 $ 11,547
Accrued workers' compensation insurance 12,452 10,173
Accrued payroll taxes 1,481 1,811
Accrued health insurance 3,469 3,039
Accrued taxes 1,223 223
Accrued interest 51 100
Current portion of contingent earn-out obligation 689 683
Other 1,813 1,737
Accrued expenses $ 32,717 $ 29,313
XML 15 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill And Intangible Assets (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended 6 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Jul. 26, 2010
Dec. 31, 2012
Home & Community [Member]
Jun. 30, 2011
Home Health Segment [Member]
Sep. 30, 2011
Home Health Segment [Member]
Certificates And Licenses [Member]
Dec. 31, 2012
Minimum [Member]
Dec. 31, 2012
Maximum [Member]
Weighted average cost of capital used for discounted cash flow     14.50%              
Common stock shares outstanding   10,823 10,775              
Goodwill impairment     $ 13,076       $ 13,076      
Goodwill   50,536 50,695 63,930 4,272 50,536        
Intangible assets, estimated useful lives                 2 years 25 years
Intangible assets excluding goodwill 2,273 6,370 8,044         640    
Impairment of intangible assets excluding goodwill 1,913             640    
Amortization expense   $ 1,674 $ 2,613 $ 3,143            
XML 16 R70.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholder's Equity (Details) (USD $)
In Thousands, unless otherwise specified
0 Months Ended
Jul. 26, 2010
Sep. 30, 2009
2009 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Business acquisition common stock shares issued 248  
Business acquisition issued common stock value $ 1,240  
Shares of incentive stock options provided for grant   750
XML 17 R55.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-Term Debt (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Dec. 31, 2012
Jul. 25, 2010
Senior Secured Credit Facility [Member]
item
Dec. 31, 2012
Revolving Credit Loan [Member]
Senior Secured Credit Facility [Member]
Dec. 31, 2011
Revolving Credit Loan [Member]
Senior Secured Credit Facility [Member]
Mar. 18, 2010
Revolving Credit Loan [Member]
Senior Secured Credit Facility [Member]
Jul. 25, 2010
Term Loan [Member]
item
Feb. 28, 2011
Term Loan [Member]
Dec. 31, 2012
Term Loan [Member]
Senior Secured Credit Facility [Member]
Jul. 26, 2010
Term Loan [Member]
Senior Secured Credit Facility [Member]
Dec. 31, 2011
Adjustment Permitted By Lenders [Member]
Senior Secured Credit Facility [Member]
Dec. 31, 2012
Adjustment Permitted By Lenders [Member]
Senior Secured Credit Facility [Member]
Mar. 01, 2012
Adjustment Permitted By Lenders [Member]
Senior Secured Credit Facility [Member]
Dec. 31, 2012
Subordinated Dividend Notes [Member]
item
Nov. 02, 2009
Subordinated Dividend Notes [Member]
Nov. 02, 2009
Subordinated Dividend Notes [Member]
Series A Preferred Stock [Member]
item
Jul. 26, 2011
Before Amendment [Member]
Senior Secured Credit Facility [Member]
Mar. 18, 2010
Before Amendment [Member]
Senior Secured Credit Facility [Member]
Dec. 31, 2012
Before Amendment [Member]
Subordinated Dividend Notes [Member]
Dec. 31, 2011
Before Amendment [Member]
Subordinated Dividend Notes [Member]
Dec. 31, 2010
Before Amendment [Member]
Subordinated Dividend Notes [Member]
Jul. 26, 2011
After Amendment [Member]
Senior Secured Credit Facility [Member]
Mar. 18, 2010
After Amendment [Member]
Senior Secured Credit Facility [Member]
Dec. 31, 2012
After Amendment [Member]
Subordinated Dividend Notes [Member]
Dec. 31, 2011
After Amendment [Member]
Subordinated Dividend Notes [Member]
Dec. 31, 2010
After Amendment [Member]
Subordinated Dividend Notes [Member]
Dec. 31, 2012
Letters of Credit [Member]
Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]                                                    
Line of credit facility increase in borrowing capacity         $ 5,000           $ 5,800                              
Maximum aggregate amount of revolving loans available     55,000   55,000       5,000                                  
Maximum senior leverage ratio                               3.00 2.75       3.25 3.00        
Specified advance multiple used to determine funds availability under credit facility     3.25                         3.0 2.75       3.25 3.0        
Debt instrument, maturity date               Jan. 05, 2013                   Sep. 30, 2011         Dec. 31, 2012      
Number of installments   24       24                                        
Interest rate margin over LIBOR     4.60%       4.60%   4.60%                                  
Increase to EBITDA for purpose of determining availiability under credit facility                   1,800                                
Reduction in EBITDA adjustment                       200                            
Monthly reduction in EBITDA adjustment until adjustment is eliminated                     200                              
Monthly reduction in availability under line of credit facility until EBITDA adjustment is eliminated                     650                              
Fee charged on unused portion of revolving credit facility     0.50%                                              
Interest rate                         10.00%                         2.00%
Interest rate on revolving credit loan facility     4.80%                                              
LIBOR rate     0.20%                                              
Total availability under the revolving credit loan facility     27,137 21,810                                            
Annual principal payments                                     3,351 4,468     4,069 2,500 1,250  
Common stock shares issued for conversion                             4,077                      
Stock conversion ratio                             108                      
Dividends payable 7,819                           13,109                      
Payments of dividends                             173                      
Unpaid dividends                             12,936                      
Mandatory payment of dividend note                           $ 4,000                        
Number of consecutive quarterly installments to pay dividends                         8                          
XML 18 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Property And Equipment (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Property, Plant and Equipment [Line Items]      
Property and equipment $ 7,806 $ 6,880  
Internally Developed Software [Member]
     
Property, Plant and Equipment [Line Items]      
Property and equipment 1,500    
Computer Equipment And Software [Member]
     
Property, Plant and Equipment [Line Items]      
Depreciation and amortization $ 870 $ 941 $ 903
XML 19 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2012
Income Taxes [Abstract]  
Tax Expense By Jurisdiction
  December 31,
    2012   2011     2010
Current              
Federal $ 2,325 $ 1,994   $ 2,178
State   544   184     335
Deferred              
Federal   680   (4,267 )   388
State   159   (396 )   59
 
Provision (benefit) for income taxes $ 3,708 $ (2,485 ) $ 2,960
Deferred Tax Assets And Liabilities
  December 31,
    2012     2011  
Deferred tax assets            
Current            
Accounts receivable allowances $ 1,784   $ 2,824  
Accrued compensation   1,133     902  
Accrued workers' compensation   4,593     3,263  
Other   395     146  
 
Total current deferred tax assets   7,905     7,135  
Deferred tax liabilities            
Current            
Prepaid insurance   (647 )   (799 )
 
Net deferred tax assets—current   7,258     6,336  
Deferred tax assets            
Long-term            
Goodwill and intangible assets   1,577     3,398  
Property and equipment   96     112  
Stock-based compensation   655     579  
 
Total long-term deferred tax assets   2,328     4,089  
 
Total net deferred tax assets $ 9,586   $ 10,425  
Reconciliation Of Effective Tax Rate
  December 31,
  2012   2011   2010  
Federal income tax at statutory rate 34.0 % 34.0 % 34.0 %
State and local taxes, net of federal benefit 5.9   5.3   4.9  
Jobs tax credits, net (9.3 ) 23.1   (7.9 )
Nondeductible meals and entertainment 0.9   (2.0 ) 1.0  
Tax asset adjustment—stock options 0.3   (0.5 ) 0.9  
Other 0.9   (4.3 )  
 
Effective income tax rate 32.7 % 55.6 % 32.9 %
Changes In Unrecognized Tax Benefits
    Unrecognized
    Tax Benefits
Balance at December 31, 2010 $ 115
Increases related to current year tax positions  
 
Balance at December 31, 2011 $ 115
Increases related to current year tax positions  
 
Balance at December 31, 2012 $ 115
XML 20 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 21 R73.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments And Contingencies (Details)
12 Months Ended
Dec. 31, 2012
Commitments And Contingencies [Abstract]  
Maximum term of employment agreements 4 years
XML 22 R57.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-Term Debt (Schedule Of Long-Term Debt Maturities) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Long-Term Debt [Abstract]  
2013 $ 208
2014 16,250
Total $ 16,458
XML 23 R76.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Event (Details) (Subsequent Event [Member], USD $)
In Thousands, unless otherwise specified
Feb. 07, 2013
Subsequent Event [Member]
 
Percentage of segment acquired 90.00%
Retaining ownership interest 10.00%
Business acquisition, cash paid $ 20,000
XML 24 R77.htm IDEA: XBRL DOCUMENT v2.4.0.6
Valuation And Qualifying Accounts (Details) (Allowance For Doubtful Accounts [Member], USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Allowance For Doubtful Accounts [Member]
     
Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at beginning of periood $ 7,189 $ 6,723 $ 4,813
Additions/charges 2,877 4,275 4,429
Deductions 5,600 [1] 3,809 [1] 2,519 [1]
Balance at end of period $ 4,466 $ 7,189 $ 6,723
[1] Write-offs, net of recoveries
XML 25 R71.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Data (Details)
12 Months Ended
Dec. 31, 2012
segment
Segment Data [Abstract]  
Number of operating segments 1
XML 26 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Valuation And Qualifying Accounts
12 Months Ended
Dec. 31, 2012
Valuation and Qualifying Accounts [Abstract]  
Valuation And Qualifying Accounts

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

VALUATION AND QUALIFYING ACCOUNTS SCHEDULE II

(in thousands)

    Balance at       Balance at
    beginning Additions/     end of
Allowance for doubtful accounts   of period charges Deductions*   period
Year ended December 31, 2012            
Allowance for doubtful accounts $ 7,189 2,877 5,600 $ 4,466
Year ended December 31, 2011            
Allowance for doubtful accounts $ 6,723 4,275 3,809 $ 7,189
Year ended December 31, 2010            
Allowance for doubtful accounts $ 4,813 4,429 2,519 $ 6,723

 

* Write-offs, net of recoveries

XML 27 R50.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill And Intangible Assets (Schedule Of Carrying Amount And Accumulated Amortization Of Intangible Asset) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Accumulated amortization, Balance at beginning of period $ 8,044 $ 13,570  
Impairment charges   (2,913)  
Amortization (1,674) (2,613) (3,143)
Accumulated amortization, Balance at end of period 6,370 8,044 13,570
Customer And Referral Relationships [Member]
     
Accumulated amortization, Balance at beginning of period 6,231 10,184  
Impairment charges   (1,754)  
Amortization (1,364) (2,199)  
Accumulated amortization, Balance at end of period 4,867 6,231  
Trade Names And Trademarks [Member]
     
Accumulated amortization, Balance at beginning of period 1,551 2,407  
Impairment charges   (506)  
Amortization (248) (350)  
Accumulated amortization, Balance at end of period 1,303 1,551  
State Licenses [Member]
     
Accumulated amortization, Balance at beginning of period   790  
Impairment charges   (640)  
Accumulated amortization, Balance at end of period 150 150  
Non-competition Agreements [Member]
     
Accumulated amortization, Balance at beginning of period 112 189  
Impairment charges   (13)  
Amortization (62) (64)  
Accumulated amortization, Balance at end of period $ 50 $ 112  
XML 28 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
0 Months Ended 3 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 1 Months Ended 12 Months Ended
Jul. 26, 2010
Sep. 30, 2011
Dec. 31, 2011
Jul. 26, 2010
Term Loan [Member]
Jul. 25, 2010
Term Loan [Member]
item
Dec. 31, 2012
Term Loan [Member]
Feb. 28, 2011
Term Loan [Member]
Jul. 26, 2010
Advantage [Member]
Apr. 30, 2011
Advantage [Member]
Dec. 31, 2012
Advantage [Member]
Dec. 31, 2011
Advantage [Member]
Jul. 26, 2010
Advantage [Member]
Maximum [Member]
Consideration payable for business acquisition               $ 8,380        
Business acquisition, cash paid               5,140   5,140    
Common stock consideration for business acquisition               1,240   1,240    
Business acquisition common stock shares issued 248             248   248    
Business acquisition, contingent earn-out obligation                   1,600   2,000
Principal amount of credit facility       5,000                
Credit facility, maturity date           Jan. 05, 2013            
Number of installments         24              
Credit facility, spread over LIBOR             4.60%          
Total purchase price for business acquisition                   7,980    
Business acquisition first earn-out payment                 500      
Business acquisition second earn-out payment revalued                     683  
Gain loss on revaluation of contingent consideration                     469  
Goodwill impairment     13,076               544  
Impairment of intangible assets excluding goodwill   $ 1,913                 $ 272  
XML 29 R75.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Quarterly Financial Information (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Summarized Quarterly Financial Information [Abstract]                      
Net service revenues $ 63,775 $ 61,211 $ 60,440 $ 58,889 $ 58,304 $ 58,393 $ 57,200 $ 56,208 $ 244,315 $ 230,105 $ 230,099
Gross profit 17,537 15,683 15,807 15,024 16,829 15,701 14,784 14,159 64,051 61,473 59,723
Operating income from continuing operations 5,261 3,867 3,217 3,318 4,648 3,711 2,558 2,000 15,663 12,917 9,273
Net income from continuing operations 3,503 2,204 1,835 1,746 2,914 3,396 1,253 849 7,635 (1,981) 6,028
Earnings (loss) from home health business, net of tax 242 (407) (371) (1,117) (418) (10,059) 80 4 (1,653) (10,393) 1,661
Net income (loss) from discontinued operations 242 (407) (371) (1,117) (418) (10,059) 80 4 (1,653) (10,393) 1,661
Net income (loss) $ 3,745 $ 1,797 $ 1,464 $ 629 $ 2,496 $ (6,663) $ 1,333 $ 853      
Average shares outstanding: Basic 10,772 10,761 10,761 10,756 10,754 10,746 10,746 10,746 10,764 10,752 10,604
Average shares outstanding: Diluted 10,807 10,773 10,785 10,760 10,756 10,746 10,770 10,754 10,784 10,752 10,606
Basic and diluted, Continuing operations $ 0.33 $ 0.20 $ 0.17 $ 0.16 $ 0.27 $ 0.32 $ 0.11 $ 0.08 $ 0.86 $ 0.78 $ 0.41
Basic and diluted, Discontinued operations $ 0.02 $ (0.03) $ (0.03) $ (0.10) $ (0.04) $ (0.94) $ 0.01 $ 0.00 $ (0.15) $ (0.96) $ 0.16
Basic and diluted net earnings (loss) per share $ 0.35 $ 0.17 $ 0.14 $ 0.06 $ 0.23 $ (0.62) $ 0.12 $ 0.08 $ 0.71 $ (0.18) $ 0.57
XML 30 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary Of Significant Accounting Policies (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
item
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2012
Transportation Equipment [Member]
Feb. 07, 2013
Subsequent Event [Member]
Dec. 31, 2012
Minimum [Member]
Dec. 31, 2012
Minimum [Member]
Computer Equipment [Member]
Dec. 31, 2012
Minimum [Member]
Furniture and Equipment [Member]
Dec. 31, 2012
Minimum [Member]
Computer Software [Member]
Dec. 31, 2012
Maximum [Member]
Dec. 31, 2012
Maximum [Member]
Computer Equipment [Member]
Dec. 31, 2012
Maximum [Member]
Furniture and Equipment [Member]
Dec. 31, 2012
Maximum [Member]
Computer Software [Member]
Summary Of Significant Accounting Policies [Line Items]                                          
Percentage of segment acquired                         90.00%                
Retaining ownership interest                         10.00%                
Business acquisition, cash paid                         $ 20,000                
Number of agencies in continuing operations                 3                        
Maximum length of care                 60 days                        
Allowances for doubtful accounts, number of aging categories                 8                        
Property and equipment useful life                       5 years     3 years 5 years 5 years   5 years 7 years 10 years
Recorded goodwill and intangible asset 15,989               15,989                        
Weighted average cost of capital, percentage                 14.50%                        
Intangible assets, estimated useful lives                           2 years       25 years      
Intangible asset impairment charge discontinued operations                   2,273                      
Impairment charges                   640                      
Deductible component of workers' compensation                 350                        
Period of interest rate agreement                 3 years                        
Interest income received                 $ 155 $ 2,263 $ 155                    
Number of stock options included in calculation 596               596                        
Diluted shares 10,807 10,773 10,785 10,760 10,756 10,746 10,770 10,754 10,784 10,752 10,606                    
Anti-dilutive stock option shares                 501   588                    
Shares of restricted stock awards                 57   6                    
Number of dilutive shares of outstanding stock options and restricted stock awards                 12 10 2                    
Number of stock incentive plans                 2                        
XML 31 R52.htm IDEA: XBRL DOCUMENT v2.4.0.6
Details Of Certain Balance Sheet Accounts (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Details Of Certain Balance Sheet Accounts [Abstract]    
Contributions due after fund received, period 5 days  
Health insurance reimbursement and contribution due $ 3,405 $ 2,982
Deductible component of workers compensation program 350  
Letters of credit secure compensation program 7,410 7,410
Cash escrow and deposit 1,200  
Loss reserve associated with compensation policies $ 608  
XML 32 R67.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options And Restricted Stock Awards (Summary Of Vested And Unvested RSU) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Stock Options And Restricted Stock Awards [Abstract]      
Restricted Stock Awards, Unvested restricted stock awards at beginning of period 21 6 3
Restricted Stock Awards, Awarded 44 24 4
Restricted Stock Awards, Vested (20) (8) (1)
Restricted Stock Awards, Forfeited (3) (1)  
Restricted Stock Awards, Unvested restricted stock awards at end of period 42 21 6
Restricted Stock Awards, Weighted Average Grant Date Fair Value beginning of period $ 5.95 $ 6.85 $ 10.00
Restricted Stock Awards, Weighted Average Grant Date Fair Value, Awarded $ 4.48 $ 5.63 $ 5.21
Restricted Stock Awards, Weighted Average Grant Date Fair Value, Vested $ 5.14 $ 5.64 $ 10.00
Restricted Stock Awards, Weighted Average Grant Date Fair Value, Forfeited $ 5.93 $ 5.93  
Restricted Stock Awards, Weighted Average Grant Date Fair Value end of period $ 4.80 $ 5.95 $ 6.85
XML 33 R61.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Reconciliation Of Effective Tax Rate, Percentage) (Details)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]      
Federal income tax at statutory rate 34.00% 34.00% 34.00%
State and local taxes, net of federal benefit 5.90% 5.30% 4.90%
Jobs tax credits, net (9.30%) 23.10% (7.90%)
Nondeductible meals and entertainment 0.90% (2.00%) 1.00%
Tax asset adjustment-stock options 0.30% (0.50%) 0.90%
Other 0.90% (4.30%)  
Effective income tax rate 32.70% 55.60% 32.90%
XML 34 R47.htm IDEA: XBRL DOCUMENT v2.4.0.6
Property And Equipment (Schedule Of Property And Equipment) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 7,806 $ 6,880
Less accumulated depreciation and amortization (5,317) (4,629)
Property and equipment, total 2,489 2,251
Computer Equipment [Member]
   
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 1,705 1,412
Furniture and Equipment [Member]
   
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 918 778
Transportation Equipment [Member]
   
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 508 641
Leasehold Improvements [Member]
   
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 1,496 1,209
Computer Software [Member]
   
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 3,179 $ 2,840
XML 35 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Sale Of Agency
12 Months Ended
Dec. 31, 2012
Discontinued Operations Including Sale Of Agency [Abstract]  
Sale Of Agency

3. Sale of Agency

     In February 2012, the Company sold an agency located in Portland, Oregon for approximately $525 with net proceeds of approximately $495 after the payment of closing related expenses. The Company recorded a $495 pre-tax gain on the sale of the agency.

XML 36 R62.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Changes In Unrecognized Tax Benefits) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]      
Unrecognized Tax Benefits, Beginning Balance $ 115 $ 115 $ 115
Unrecognized Tax Benefits, Ending Balance $ 115 $ 115 $ 115
EXCEL 37 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q M-S,S,F-B-C'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I7;W)K M3PO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D%C<75I#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!R;W!E#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1?1&%T83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5M<&QO>65E7T)E;F5F:71?4&QA;G,\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-I9VYI9FEC86YT7U!A>6]R#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D-O;F-E;G1R871I;VY?3V9?0V%S:#PO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E;G0\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DQO;F=497)M7T1E8G1?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O&5S7U1A8FQE#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7T]P=&EO;G-? M06YD7U)E#I7;W)K#I7;W)KF5D M7U%U87)T97)L>5]&:6YA;F-I86PQ/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O5]/9E]3:6=N:69I8V%N=%]!8V-O=6YT M,3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1I#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1I M#I7;W)K5]$971A:6QS M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D%C<75I#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E!R;W!E#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E!R;W!E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D=O;V1W:6QL7T%N9%]);G1A;F=I8FQE7T%S#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D1E=&%I;'-?3V9?0V5R=&%I;E]"86QA;F-E M7U-H930\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O&5S7TYA#I% M>&-E;%=O&5S7U1A>%]%>'!E;G-E7T)Y7TIU/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O&5S7T1E M9F5R%]!#I%>&-E;%=O&5S7U)E8V]N8VEL:6%T:6]N7T]F/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O&5S M7T-H86YG97-?26Y?56YR96-O/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I%>&-E;%=O#I.86UE/E-T;V-K7T]P M=&EO;G-?06YD7U)E#I7;W)K M#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/E-T;V-K7T]P=&EO;G-?06YD7U)E#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-E9VUE;G1?1&%T85]$971A M:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I7 M;W)KF5D7U%U87)T97)L>5]&:6YA M;F-I86PR/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T'1087)T7S4S,&9C83DW7SED,#%?-#!E,E\X M-C1F7S0W8C$W,S,R8V(V-PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]# M.B\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^9F%L'0^1&5C(#,Q+`T*"0DR,#$R/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!2 M96=I2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,30V.#,R.#QS M<&%N/CPO'0^+2TQ,BTS,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!796QL+6MN;W=N(%-E87-O;F5D($ES'0^3F\\2!0=6)L:6,@ M1FQO870\+W1D/@T*("`@("`@("`\=&0@8VQA'0^665S/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^3F\\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E"!A'!E;G-E7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#4R,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$#PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA2`H55-$("0I/&)R/DEN(%1H M;W5S86YD'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'1087)T7S4S M,&9C83DW7SED,#%?-#!E,E\X-C1F7S0W8C$W,S,R8V(V-PT*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T M-V(Q-S,S,F-B-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O M<&5R871I;F<@86-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@ M97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#$Q M-"D\6UE;G1S*2!O;B!T97)M(&QO M86X\+W1D/@T*("`@("`@("`\=&0@8VQA6UE;G1S*2!B;W)R;W=I;F=S(&]N(')E=F]L=FEN M9R!C'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S6%B;&4\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S"!B96YE9FET(')E;&%T960@=&\@=&AE(&%M;W)T:7IA=&EO;B!O9B!T87@@ M9V]O9'=I;&P@:6X@97AC97-S(&]F(&)O;VL@8F%S:7,\+W1D/@T*("`@("`@ M("`\=&0@8VQA7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/D)A6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#L\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2 M;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E2(@;W(@ M(G=E(BDN(%1H92!#;VUP86YY('!R;W9I9&5S(&AO;64@86YD(&-O;6UU;FET M>2!B87-E9"!S97)V:6-E2!P97)F;W)M960@:6X@=&AE(&AO;65S(&]F('1H M92!C;VYS=6UE2P@8VAR;VYI8V%L;'D@:6QL(&%N9"!D:7-A8FQE9"!W:71H(&)A=&AI M;F6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SX@/"]P/@T*#0H\9&EV/@T*#0H\<"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R<^/&(^/&D^/&9O;G0@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@ M3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R!!;&P@ M:6YT97)C;VUP86YY(&)A;&%N8V5S(&%N9"!T6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE2!I;F-L=61E9"!I;B!O=7(@:&]M92!A;F0@8V]M;75N:71Y('-E M9VUE;G0@86YD)FYB2!PF5D(&AO=7)S+"!D971E&5D(&)Y(&QE9VES;&%T:6]N(&%N9"!R96-O9VYI>F5D M(&%S(')E=F5N=65S(&%T('1H92!T:6UE('-E2!F=6YD960@ M8GD@365D:6-A:60@;W(@365D:6-A:60@=V%I=F5R('!R;V=R86US+"!W:71H M('1H92!R96UA:6YD97(@2!A;F0@:6YS=7)A;F-E('!R;V=R86US+CPO9F]N=#X\+V9O;G0^/"]P/@T* M#0H\<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^)FYBF4],T0Q/@T*/"]F;VYT/@T*/&1I=CX-"@T*/'`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`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`T*/'`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`Q M7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O M:'1M;#L@8VAA2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2!R971A:6YI;F<@/&9O;G0@8VQAF4],T0Q/E1H92!F;VQL;W=I;F<@=&%B;&4@<')E M65A3H@5&EM97-.97=2;VUA M;E!3+4)O;&1-5"Q4:6UE6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$ M)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/C(P,3`\+V9O;G0^/"]B/CPO=&0^/"]T M3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I M;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`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`Q7S0P93)? M.#8T9E\T-V(Q-S,S,F-B-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SX\8CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM M97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UEF4],T0Q/DEN($9E M8G)U87)Y(#(P,3(L('1H92!#;VUP86YY('-O;&0@86X@86=E;F-Y(&QO8V%T M960@:6X@4&]R=&QA;F0L($]R96=O;B!F;W(@87!P2`D/&9O M;G0@8VQA'!E;G-E M3PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86Q- M5"Q!F4],T0R/BX\+V9O;G0^/"]P/B`\+V1I=CX\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/&1I M=CX@/'`@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4] M,T0Q/C0N($%C<75IF4],T0Q/D]N($IU;'D@,C8L(#(P,3`L('1H92!#;VUP86YY M(&5N=&5R960@:6YT;R!A;B!!6%B;&4@<'5R&EM M=6T@;V8@)#QF;VYT(&-L87-S/3-$7VUT/C(L,#`P/"]F;VYT/B!I;B!F=71U MF4],T0Q/D]N($IU;'D@,C8L(#(P,3`L('1H M92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B!A;65N9&UE;G0@*'1H92`B4V5C M;VYD($%M96YD;65N="(I('1O(&ET2`U+"`R,#$S/"]F;VYT/BX@5&AE(')E<75I2`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`Q.2XX<'0[)R!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)VUAF4],T0Q/D=O;V1W:6QL(')E<')EF4],T0Q/DED96YT:69I86)L92!I;G1A;F=I8FQE M(&%S6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/D9O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4] M,T0Q/D1E8V5M8F5R(#,Q+"`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`S,BXQ-39P M=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O#LG/B9N8G-P.SPO<#X-"@T*/'`@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'!E;G-E+"!A;6]R=&EZ871I;VX@;V8@:6YT86YG:6)L92!A"!E>'!E;G-E('1O(')E9FQE8W0@2!H860@;V-C=7)R960@;VX@2F%N M=6%R>2`Q+"`R,#$P+B!4:&ES('!R;R!F;W)M82!I;F9O2!O8V-U2!V87)Y('-I9VYI9FEC86YT;'D@ M9G)O;2!T:&4@'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!! M;F0@17%U:7!M96YT(%M!8G-T'0^/&1I=CX@/'`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`Q M7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/&1I=CX@ M/'`@6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q M/C8N($=O;V1W:6QL(&%N9"!);G1A;F=I8FQE($%SF4],T0Q/E1H92!#;VUP86YY)W,@ M8V%RF5D+B!4:&4@0V]M<&%N>2!T97-T2!C:&%N9V5S('1H870@=V]U;&0@:6YD:6-A=&4@ M=&AA="!A;B!I;7!A:7)M96YT(&UA>2!H879E(&]C8W5R6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E2!C86X@96QE8W0@=&\@<&5R9F]R;2!3=&5P M+3`@86X@;W!T:6]N86P@<75A;&ET871I=F4@86YA;'ES:7,@86YD(&)A6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2!E=F%L=6%T960@=&AE(&9O M;&QO=VEN9R!F86-T;W)S('1H870@869F96-T(&9U='5R92!B=7-I;F5S2!A;F0@;6%R:V5T(&-O;G-I9&5R871I;VYS+"!C;W-T(&9A8W1O2!H87,@8V]N M8VQU9&5D('1H870@:70@:7,@;6]R92!L:6ME;'D@=&AA;B!N;W0@=&AA="!T M:&4@9F%I2P@=&AE(&9I6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE'!E;G-E('!R M;VIE8W1I;VYS(&)A'!E;G-EF5D+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@ M3F5W(%)O;6%N+%1I;65S+'-E2!T:&4@0V]M<&%N>2P@=&AE($-O;7!A M;GD@8V]M<&QE=&5D(&$@<')E;&EM:6YA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#L\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E2!!4T,@5&]P:6,@,S4P+"!W M:&5N(&%N(&EM<&%I2!R96-O9VYI>F4@:71S(&)EF4],T0Q/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.U-U M;6UA6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UEF4],T0Q/D1I3H@5&EM M97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O"!S;VQI9#LG('=I9'1H/3-$,B4@ M86QI9VX],T1C96YT97(^)FYB6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE MF4],T0Q/E1O=&%L/"]F;VYT/CPO8CX\+W1D M/@T*/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM M97,@3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/B0\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$R M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E6QE/3-$)V)O6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/D=O;V1W:6QL+"!A="!$96-E M;6)E3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/B8C.#(Q,CL\+V9O;G0^/"]T9#X-"CQT9"!B M9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#(E(&%L:6=N/3-$;&5F=#XF;F)S M<#L\+W1D/@T*/'1D(&)G8V]L;W(],T0C8V-E969F('=I9'1H/3-$,B4@86QI M9VX],T1L969T/B9N8G-P.SPO=&0^#0H\=&0@8F=C;VQO3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I M;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)OF4],T0Q/B@Q-3D\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`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`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`\+W1D/@T*/'1D('=I9'1H/3-$,B4@86QI9VX],T1C M96YT97(^)FYB3H@5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UEF4],T0Q/C6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E M6QE/3-$)V)O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F M8V$Y-U\Y9#`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`X-3!P>#L@ M:&5I9VAT.B`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`@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2!B87-E9"!S97)V:6-E65R(&AE86QT M:"!A;F0@=V5L9F%R92!P;&%N('5N9&5R(%-E8W1I;VX@,S`R*&,I*#4I(&]F M('1H92!,86)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M2!A;B!I;F1E<&5N M9&5N="!T:&ER9"!P87)T>2X@5&AE(&9U='5R92!C;&%I;7,@<&%Y;65N=',@ MF4],T0Q/D%S('!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`D/&9O;G0@8VQAF4],T0Q/D]N($IU;'D@,C8L(#(P,3`L('1H92!#;VUP86YY(&5N M=&5R960@:6YT;R!T:&4@4V5C;VYD($%M96YD;65N="!T;R!I=',@8W)E9&ET M(&9A8VEL:71Y+B!4:&4@4V5C;VYD($%M96YD;65N="!P2`U+"`R,#$S/"]F;VYT/BX@ M5&AE(')E<75I2!T:&4@0V]M<&%N>2P@<'5R2`R,#$Q+B!);G1E6%B;&4@96ET:&5R M(&%T(&$@9FQO871I;F<@"!M;VYT:',@<&QUF4],T0Q/D]N($UA>2`R-"P@,C`Q,2P@=&AE($-O;7!A;GD@96YT97)E9"!I M;G1O(&$@2F]I;F1E2UF;W)M960L('=H;VQL>2UO M=VYE9"!S=6)S:61I87)Y(&]F($%D9'5S($AE86QT:$-A2X\ M+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^ M)FYB2!O9B!E86-H(&9I2X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R<^)FYB2!W:71H(')U;&5S('!R;VUU;&=A=&5D(&)Y($-- M4R!T:&%T(')E&5R8VES:6YG(&%N>2!R M:6=H=',@;V8@2!L M;V-K8F]X97,@97-T86)L:7-H960@9F]R(')E8V5I=FEN9R!P87EM96YTF4],T0Q/D1U&EM871E;'D@)#QF;VYT(&-L87-S/3-$7VUT/C$L.#`P/"]F M;VYT/B!T;R!A9&IU2!U;F1E&EM871E;'D@)#QF;VYT(&-L87-S M/3-$7VUT/C4L.#`P/"]F;VYT/B!U;G1I;"!-87)C:"`Q+"`R,#$R+B!/;B!- M87)C:"`Q+"`R,#$R+"!T:&4@861D(&)A8VL@86QL;W=A;F-E('=A2!O9B!E86-H(&UO;G1H('1H M97)E869T97(@=6YT:6P@=&AE(&%D9"!B86-K(&ES(&5L:6UI;F%T960L('=H M:6-H('=I;&P@2!O9B`D/&9O;G0@8VQA2!A2!W:71H(&EN8W)E87-E9"!F M;&5X:6)I;&ET>2!I;B!M965T:6YG('1H:7,@8V]V96YA;G0N(%1H92!#;VUP M86YY('=AF4],T0Q/E1H92!A=F%I;&%B:6QI='D@;V8@9G5N9',@=6YD97(@ M=&AE(')E=F]L=FEN9R!C2!A9W)E96UE;G0L(&9O2!I2!,24)/4BP@<&QU2!U;F1E2!M861E(&$@;6%N9&%T;W)Y M('!A>6UE;G0@;V8@)#QF;VYT(&-L87-S/3-$7VUT/C0L,#`P/"]F;VYT/B!O M;B!T:&4@9&EV:61E;F0@;F]T97,N($EN=&5R97-T('1H92!O=71S=&%N9&EN M9R!D:79I9&5N9"!N;W1E2X@5&AE(&]U='-T86YD:6YG('!R:6YC:7!A;"!A;6]U;G0@;V8@ M=&AE(&1I=FED96YD(&YO=&5S('=A6%B;&4@:6XF M;F)S<#L\9F]N="!C;&%S6%B;&4@<75A6UE;G0@;V8@<')I;F-I<&%L/"]F M;VYT/CPO<#X-"@T*/'`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`Q7S0P93)?.#8T9E\T-V(Q M-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A M.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`\+V9O;G0^/"]B/CPO=&0^/"]T3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE M/3-$)W1E>'0M:6YD96YT.B`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`U<'@[)R!W:61T:#TS1#8V)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE6QE M/3-$)W1E>'0M:6YD96YT.B`Q,7!X.R<@=VED=&@],T0V-B4@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/C$L,3,S/"]F;VYT M/CPO=&0^#0H\=&0@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^)FYB6QE/3-$)W1E M>'0M:6YD96YT.B`Q,7!X.R<@8F=C;VQO6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UEF4],T0Q M/C0L-3DS/"]F;VYT/CPO=&0^#0H\=&0@8F=C;VQO6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I M;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE6QE/3-$)W1E>'0M:6YD M96YT.B`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`Q,7!X.R<@=VED=&@],T0V-B4@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)W1E>'0M:6YD96YT.B`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`\+V9O;G0^ M/"]B/CPO=&0^#0H\=&0@3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-E2!R871E/"]F;VYT/CPO=&0^ M#0H\=&0@8F=C;VQO3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-. M97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E&5S+"!N970@;V8@9F5D97)A;"!B96YE9FET/"]F;VYT/CPO M=&0^#0H\=&0@=VED=&@],T0Q,B4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2 M;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/C`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`Y<'@[)R!B9V-O M;&]R/3-$(V-C965F9B!W:61T:#TS1#$R)2!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O'0M:6YD96YT.B`Y<'@[)R!B9V-O;&]R/3-$(V-C965F9B!W:61T M:#TS1#$R)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)VUA'1087)T7S4S M,&9C83DW7SED,#%?-#!E,E\X-C1F7S0W8C$W,S,R8V(V-PT*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T M-V(Q-S,S,F-B-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=CX@/'`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`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`E(&%L:6=N/3-$F4],T0Q/C4N-CPO9F]N=#X\+W1D/@T* M/'1D(&)G8V]L;W(],T0C8V-E969F('=I9'1H/3-$,B4@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE3H@5&EM97-. M97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE6QE/3-$)VUAF4],T0Q/E1H92!#;VUP86YY(&AI2!U M'!E M8W1E9"!T97)M+"!E>'!E8W1E9"!D:79I9&5N9',@>6EE;&0L(&5X<&5C=&5D M(&9O2!P M2!T2!A;F0@97AP96-T871I;VX@;V8@;F]T('!A>6EN M9R!D:79I9&5N9',N(%1H92!E>'!E8W1E9"!T=7)N+6]V97(@'!E8W1E9"!F;W)F96ET=7)E&5R M8VES92!M=6QT:7!L92!R97!R97-E;G1S('1H92!M96%N(')A=&EO(&]F('1H M92!S=&]C:R!P'!E8W1E9"!T;R!E>&5R8VES92!T:&5I6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/D9O65A6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UEF4],T0Q/C(P,3(\+V9O M;G0^/"]B/CPO=&0^#0H\=&0@=VED=&@],T0R)2!A;&EG;CTS1&-E;G1E3H@5&EM97-.97=2;VUA;E!3+4)O M;&1-5"Q4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)OF4],T0Q/E=E:6=H=&5D(&%V97)A9V4@ M9F%I6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2 M;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE MF4],T0Q/B4\+V9O;G0^/"]F;VYT M/CPO=&0^#0H\=&0@=VED=&@],T0R)2!A;&EG;CTS1&-E;G1EF4],T0Q/D5X<&5C=&5D(&QI9F4\ M+V9O;G0^/"]T9#X-"CQT9"!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#$W M)2!A;&EG;CTS1&-E;G1E3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@ M3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/D1I=FED96YD('EI96QD/"]F;VYT/CPO=&0^#0H\=&0@=VED M=&@],T0Q-R4@86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q/B8C.#(Q,CL\+V9O;G0^ M/"]T9#X-"CQT9"!W:61T:#TS1#(E(&%L:6=N/3-$8V5N=&5R/B9N8G-P.SPO M=&0^#0H\=&0@=VED=&@],T0R)2!A;&EG;CTS1&-E;G1E6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/B4\+V9O;G0^/"]F;VYT/CPO=&0^#0H\=&0@ M=VED=&@],T0R)2!A;&EG;CTS1&-E;G1E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2 M;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@ M3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#L\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E M'!E;G-E+"!F;W(@8V]N=&EN=6EN9R!A;F0@9&ES8V]N=&EN M=65D(&]P97)A=&EO;G,L('1O=&%L960@)#QF;VYT(&-L87-S/3-$7VUT/C$X M,3PO9F]N=#XL("0\9F]N="!C;&%SF5D(&-O;7!E;G-A=&EO;B!C;W-T('1H870@:7,@97AP96-T960@ M=&\@8F4@65A6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE&5R8VES97,@86YD(&1I9"!N;W0@&5R8VES960@:6X@,C`Q,2!O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\8CX\:3X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3+4)O;&1) M=&%L:6--5"Q4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UEF5D(&]V97(@=&AE(')E;6%I;FEN9R!V97-T:6YG M('1E6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE3H@5&EM97-.97=2 M;VUA;E!3+4)O;&1-5"Q4:6UE6QE/3-$)W1E>'0M:6YD96YT M.B`R<'@[)R!W:61T:#TS1#(E(&%L:6=N/3-$8V5N=&5R/CQB/B`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`R<'@[)R!W:61T M:#TS1#(E(&%L:6=N/3-$8V5N=&5R/CQB/B`\+V(^/"]T9#X-"CQT9"!W:61T M:#TS1#$Q)2!A;&EG;CTS1&-E;G1E3H@5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE3H@5&EM97-. M97=2;VUA;E!3+4)O;&1-5"Q4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UEF4],T0Q/C(P,3(\+V9O;G0^/"]B/CPO M=&0^#0H\=&0@=VED=&@],T0R)2!A;&EG;CTS1&-E;G1E3H@5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE M6QE/3-$)V)O M#LG('=I9'1H/3-$ M,B4@86QI9VX],T1C96YT97(^/&(^(#PO8CX\+W1D/@T*/'1D('=I9'1H/3-$ M,3$E(&%L:6=N/3-$8V5N=&5R/B9N8G-P.SQB/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UEF4],T0Q/D9A:7(@ M5F%L=64\+V9O;G0^/"]B/CPO=&0^#0H\=&0@3H@5&EM97-. M97=2;VUA;E!3+4)O;&1-5"Q4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/E-T;V-K/"]F;VYT/CPO8CX\+W1D/@T*/'1D('=I9'1H/3-$,B4@ M86QI9VX],T1C96YT97(^)FYB3H@5&EM M97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UEF4],T0Q/D%W87)D M3H@5&EM97-.97=2;VUA;E!3+4)O M;&1-5"Q4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE#LG(&)G8V]L M;W(],T0C8V-E969F('=I9'1H/3-$,3$E(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/B@R M,#PO9F]N=#X\+W1D/@T*/'1D(&)G8V]L;W(],T0C8V-E969F('=I9'1H/3-$ M,B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E#LG(&)G8V]L M;W(],T0C8V-E969F('=I9'1H/3-$,3$E(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O M3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE6QE M/3-$)V)O6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O M3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M:6YD96YT.B`R<'@[)R!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#(U)2!A M;&EG;CTS1&QE9G0^/&9O;G0@F4],T0Q/D1E8V5M8F5R(#,Q+#PO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM M97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)OF4],T0Q/C0N.#`\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#-P>"!D;W5B M;&4[)R!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#$Q)2!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O#LG(&)G M8V]L;W(],T0C8V-E969F('=I9'1H/3-$,3$E(&%L:6=N/3-$6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O6QE/3-$)VUAF4],T0Q/E)E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=CX@/'`@6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UEF4],T0Q/C$R+B!3 M=&]C:VAO;&1E3PO9F]N=#X\+V(^/"]P/@T*#0H\<"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&(^/&D^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q M7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\ M8CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3 M+4)O;&1-5"Q4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#L\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E M2!S96=R96=A=&5D(&ET3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B M-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P M,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R65E($)E;F5F:70@4&QA;G,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@ M/'1H(&-L87-S/3-$=&@@8V]L65E($)E;F5F:70@4&QA;G,\+W1D/@T*("`@("`@("`\ M=&0@8VQA6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SX\8CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-. M97=2;VUA;E!3+4)O;&1-5"Q4:6UEF4],T0Q M/E1H92!#;VUP86YY)W,@-#`Q*&LI(%)E=&ER96UE;G0@4&QA;B!C;W9E2!A;F0@&EM=6T@<&5R8V5N=&%G92!A;F0@;&EM:71S(&%L M;&]W86)L92!U;F1E7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SX\8CX\:3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97-.97=2;VUA;E!3+4)O;&1)=&%L:6--5"Q4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2!C;W5R6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UEF4],T0Q/D5M M<&QO>6UE;G0@06=R965M96YT6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M6UE;G0@86=R965M96YT65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F M8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B M,3'0O:'1M;#L@8VAA6]R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\8CX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#L\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E2!R97!R97-E;G1E9"`\9F]N M="!C;&%S6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE2!R97!R M97-E;G1E9"`\9F]N="!C;&%S7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\8CX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4 M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#L\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E M2!E>&-E960@9F5D97)A;&QY(&EN2!B96QI979E'1087)T M7S4S,&9C83DW7SED,#%?-#!E,E\X-C1F7S0W8C$W,S,R8V(V-PT*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T M9E\T-V(Q-S,S,F-B-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/&1I=CX@/'`@6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UEF4],T0Q/C$X+B!5;F%U9&ET960@4W5M M;6%R:7IE9"!1=6%R=&5R;'D@1FEN86YC:6%L($EN9F]R;6%T:6]N/"]F;VYT M/CPO8CX\+W`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`S/"]F;VYT/CPO=&0^#0H\ M=&0@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^)FYBF4],T0Q/C(L,C`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`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`C,#`P,#`P(#%P>"!S;VQI9#LG M(&)G8V]L;W(],T0C8V-E969F('=I9'1H/3-$,B4@86QI9VX],T1L969T/B9N M8G-P.SPO=&0^#0H\=&0@F4],T0Q/B@P+C`T/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I M;65S+'-E6QE/3-$)V)O3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O M6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E6QE/3-$)V)OF4],T0Q/BD\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#-P>"!D;W5B M;&4[)R!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#(E(&%L:6=N/3-$;&5F M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I M;65S+'-E6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE#LG/B9N8G-P.SPO<#X@/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)? M.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@ M8VAA6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SX\8CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2 M;VUA;E!3+4)O;&1-5"Q4:6UE2!H87,@='=O(&AO;64@:&5A;'1H(&%G96YC:65S M('1H870@87)E(&)E:6YG(&AE;&0@9F]R('-A;&4N(%1H92!R97-U;'1S(&]F M(&]P97)A=&EO;G,@9F]R(&%S'1087)T7S4S M,&9C83DW7SED,#%?-#!E,E\X-C1F7S0W8C$W,S,R8V(V-PT*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T M-V(Q-S,S,F-B-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6EN9R!! M8V-O=6YT6EN9R!!8V-O M=6YT'0^/&1I=CX@/'`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`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`Q7S0P93)?.#8T M9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`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`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`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`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`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`@("`\+W1R/@T*("`@("`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`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`@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/DYE=R!!8V-O=6YT:6YG(%!R M;VYO=6YC96UE;G1S/"]F;VYT/CPO:3X\+V(^/"]P/@T*#0H\<"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R<^)FYB3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q M-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A M.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`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`Q<'@[)R!B9V-O;&]R/3-$(V,P M8S!C,"!W:61T:#TS1#$R)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/&1I=CX@/'1A8FQE M(&)O3H@5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/C4L,30P/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4] M,T0Q/E1O=&%L/"]F;VYT/CPO8CX\+W1D/CPO='(^#0H\='(@=F%L:6=N/3-$ M8F]T=&]M/CQT9"!B9V-O;&]R/3-$(V-C965F9B!A;&EG;CTS1&QE9G0^/&9O M;G0@F4] M,T0Q/D=O;V1W:6QL/"]F;VYT/CPO=&0^#0H\=&0@8F=C;VQO3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE M/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE M/3-$)V)O6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2 M;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O M'0^/&1I=CX@/'1A8FQE(&)O M3H@5&EM97-.97=2 M;VUA;E!3+4)O;&1-5"Q4:6UE6QE/3-$)V)O3H@5&EM97-.97=2;VUA M;E!3+4)O;&1-5"Q4:6UE#LG(&%L:6=N/3-$;&5F=#XF;F)S<#L\+W1D/@T*/'1D('-T>6QE/3-$ M)V)O6QE M/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E#PO9F]N=#X\+W1D/@T*/'1D(&)G M8V]L;W(],T0C8V-E969F(&%L:6=N/3-$;&5F=#XF;F)S<#L\+W1D/@T*/'1D M(&)G8V]L;W(],T0C8V-E969F(&%L:6=N/3-$6QE/3-$)V)O6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E M6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W1E M>'0M:6YD96YT.B`S,BXQ-39P=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-EF4],T0Q/D)A M3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E6QE/3-$)V)O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U M,S!F8V$Y-U\Y9#`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`Y/"]F;VYT/CPO=&0^#0H\=&0@ M=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^)FYB6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE6QE/3-$)V)O"!S;VQI9#LG(&)G8V]L;W(] M,T0C8V-E969F('=I9'1H/3-$,3,E(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O M3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE M/3-$)V)OF4],T0Q/B0\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#-P>"!D;W5B;&4[ M)R!W:61T:#TS1#$R)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM M97,@3F5W(%)O;6%N+%1I;65S+'-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q M7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`C,#`P,#`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`C,#`P,#`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`@/&AE M860^#0H@("`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`X-3!P>#L@:&5I9VAT.B`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`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`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`@("`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`U<'@[ M)R!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#4Q)2!A;&EG;CTS1&QE9G0^ M/&9O;G0@F4],T0Q/E-T871E/"]F;VYT/CPO=&0^#0H\=&0@8F=C;VQO3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM M97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W1E>'0M M:6YD96YT.B`U<'@[)R!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#4Q)2!A M;&EG;CTS1&QE9G0^/&9O;G0@F4],T0Q/D9E9&5R86P\+V9O;G0^/"]T9#X-"CQT9"!B M9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#(E(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O M3H@5&EM M97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)OF4],T0Q/BD\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`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`U<'@[)R!W M:61T:#TS1#8V)2!A;&EG;CTS1&QE9G0^/&9O;G0@F4],T0Q/D-U6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W1E>'0M M:6YD96YT.B`Q,7!X.R<@=VED=&@],T0V-B4@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/C$L,3,S/"]F;VYT/CPO=&0^#0H\ M=&0@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^)FYBF4],T0Q/CDP,CPO9F]N=#X\+W1D/@T* M/'1D('=I9'1H/3-$,B4@86QI9VX],T1L969T/B9N8G-P.SPO=&0^/"]T6QE/3-$)W1E>'0M:6YD96YT M.B`Q,7!X.R<@8F=C;VQO6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/C0L-3DS/"]F M;VYT/CPO=&0^#0H\=&0@8F=C;VQO6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W1E>'0M:6YD96YT.B`Q,7!X M.R<@=VED=&@],T0V-B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2 M;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O M6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE3H@5&EM97-. M97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E3H@5&EM97-. M97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)W1E>'0M:6YD96YT.B`Q M,7!X.R<@=VED=&@],T0V-B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)W1E>'0M:6YD M96YT.B`Q,7!X.R<@8F=C;VQO6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I M;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E"!A"!S;VQI9#LG(&)G8V]L;W(],T0C8V-E969F('=I9'1H/3-$ M,R4@86QI9VX],T1R:6=H=#XF;F)S<#L\+W1D/@T*/'1D('-T>6QE/3-$)V)O M3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM M97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/C(P,3(\+V9O;G0^/"]B/CPO=&0^#0H\=&0@3H@5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE6QE/3-$)V)O6QE/3-$)V)O"!S;VQI9#LG('=I9'1H/3-$,B4@ M86QI9VX],T1C96YT97(^)FYB6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/C4N,SPO9F]N=#X\+W1D/@T*/'1D('=I M9'1H/3-$,B4@86QI9VX],T1L969T/B9N8G-P.SPO=&0^#0H\=&0@=VED=&@] M,T0Q,B4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E M6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2 M;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I M;65S+'-E6QE/3-$)V)O3H@5&EM97-. M97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$ M)V)O3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q M/E5N3H@5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4 M:6UE3H@ M5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)W1E>'0M:6YD96YT.B`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`Y M<'@[)R!W:61T:#TS1#$R)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E'1087)T7S4S M,&9C83DW7SED,#%?-#!E,E\X-C1F7S0W8C$W,S,R8V(V-PT*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T M-V(Q-S,S,F-B-C'0O:F%V87-C3X-"B`@("`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`C,#`P,#`P(#%P>"!S M;VQI9#LG(&)G8V]L;W(],T0C8V-E969F('=I9'1H/3-$,3`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`S M<'@[)R!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#$P)2!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"CQT9"!B9V-O;&]R M/3-$(V-C965F9B!W:61T:#TS1#$P)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM M97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)W1E>'0M:6YD96YT.B`Q M<'@[)R!W:61T:#TS1#(U)2!A;&EG;CTS1&QE9G0^/&9O;G0@F4],T0Q/C0N-3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O M;6%N+%1I;65S+'-E'0M:6YD96YT.B`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`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`@("`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`S<'@[)R!W:61T:#TS M1#(E(&%L:6=N/3-$8V5N=&5R/CQB/B`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`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`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`U<'@[)R!B M9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#$Q)2!A;&EG;CTS1')I9VAT/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I M;65S+'-E6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!42!4'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/&1I=CX@/'1A8FQE(&)O3H@ M5&EM97-.97=2;VUA;E!3+4)O;&1-5"Q4:6UE2!296YT/"]F;VYT/CPO8CX\+W1D/@T*/'1D('-T>6QE/3-$)V)O6QE/3-$)V)O2!296YT/"]F;VYT M/CPO8CX\+W1D/@T*/'1D('-T>6QE/3-$)V)O6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3350L5&EM M97,@3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/C(L-S@T/"]F;VYT/CPO=&0^ M#0H\=&0@8F=C;VQO6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM M97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L M5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N M+%1I;65S+'-E3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W M(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA M;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$)V)O3H@5&EM97-. M97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-E6QE/3-$ M)V)O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q M7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O M:'1M;#L@8VAAF5D(%%U87)T97)L M>2!&:6YA;F-I86P@26YF;W)M871I;VX@6T%B'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`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`C,#`P,#`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`C,#`P,#`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`S<'@[ M)R!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#$S)2!A;&EG;CTS1&QE9G0^ M/&9O;G0@F4],T0Q/D-O;G1I;G5I;F<@;W!E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE3H@5&EM97-.97=2;VUA;E!3350L5&EM97,@3F5W(%)O;6%N+%1I;65S M+'-E3H@5&EM97-.97=2;VUA;E!3 M350L5&EM97,@3F5W(%)O;6%N+%1I;65S+'-EF4],T0Q/C`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`Q M7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&EM=6T@6TUE;6)E&EM=6T@6TUE;6)E2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S M(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-C`@9&%Y M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT('5S969U;"!L:69E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,R!Y96%R65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^-2!Y96%R65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q M7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S"P@26YC;'5D:6YG(%!O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P M93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4@9F]R(&)U'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S2!D871E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2P@'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F M8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B M,3'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^,R!D87ES/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA#PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S M,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=? M.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XD(#2!$979E M;&]P960@4V]F='=A2P@4&QA;G0@86YD($5Q=6EP M;65N="!;3&EN92!)=&5M2P@4&QA;G0@86YD($5Q M=6EP;65N="!;3&EN92!)=&5M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT+"!G2P@4&QA;G0@86YD M($5Q=6EP;65N="!;3&EN92!)=&5M2P@4&QA M;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%SF%T:6]N(&5X<&5N7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA2!396=M96YT*2`H1&5T M86EL'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S2!R96-O M7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAAF%T:6]N+"!"86QA;F-E(&%T(&)E9VEN;FEN9R!O9B!P M97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQAF%T:6]N+"!"86QA;F-E(&%T(&)E9VEN;FEN9R!O9B!P M97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M/B@Q+#,V-"D\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F%T:6]N+"!"86QA M;F-E(&%T(&)E9VEN;FEN9R!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M/B@V,BD\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA7,\ M7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'!E;G-E&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ M+#(R,SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y M-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA2!;365M M8F5R73QB2!, M96YD97)S(%M-96UB97)=/&)R/E-E;FEO2!;365M8F5R73QB3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S&EM=6T@86=G'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S2!U;F1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^4V5P(#,P+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^1&5C(#,Q+`T*"0DR,#$R/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!R961U8W1I;VX@ M:6X@879A:6QA8FEL:71Y('5N9&5R(&QI;F4@;V8@8W)E9&ET(&9A8VEL:71Y M('5N=&EL($5"251$02!A9&IU3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U M,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9? M-#=B,3'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)? M.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@ M8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'!E M;G-E("AB96YE9FET*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S"!E>'!E M;G-E("AB96YE9FET*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S"!E>'!E;G-E M("AB96YE9FET*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L-S`X/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R M7S@V-&9?-#=B,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&5S("A$969E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!!"!!"!A3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T M9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S+"!N970@;V8@9F5D97)A;"!B96YE9FET/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XU+CDP)3QS<&%N/CPO"!R871E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,BXW,"4\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D(%1A>"!"96YE9FETF5D(%1A>"!"96YE9FETF5D(%1A>"!"96YE9FET7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD M(#$X,3QS<&%N/CPO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N('!EF5D(&-O;7!E;G-A=&EO;B!C M;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU('EE87)S/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&5R M8VES960@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XS M('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2D@*$1E=&%I;',I("A54T0@)"D\ M8G(^26X@5&AO=7-A;F1S+"!E>&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S M&5R8VES960@&5R8VES92!0&5R8VES92!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^-2!Y96%R7,\&5R8VES86)L92P@3G5M8F5R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XT-#@\65A&5R8VES86)L92P@5V5I9VAT960@079E&5R8VES92!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0&5R8VES92!0&5R8VES92!065A&5R8VES M92!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0&5R8VES92!0&5R8VES92!07,\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!3 M:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65A2P@;6%X:6UU;3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'!E8W1E M9"!T=7)N+6]V97(@'!E8W1E9"!E>&5R8VES92!M=6QT:7!L M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S6UE;G0@07=A65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE M;G0@07=A65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V M-&9?-#=B,3'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B M-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P M,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!4'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^-2!Y96%R'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2!4'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T M9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q M7S0P93)?.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O M:'1M;#L@8VAA65E($)E;F5F:70@4&QA;G,@6T%B'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!M871C:&EN9R!C;VYT'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA6UE;G0@86=R965M96YT'0^-"!Y96%R7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6]R'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!;365M8F5R73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)?.#8T9E\T-V(Q-S,S,F-B M-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3,P9F-A.3=?.60P M,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%RF5D(%%U87)T97)L>2!&:6YA M;F-I86P@26YF;W)M871I;VX@6T%B'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U,S!F8V$Y-U\Y9#`Q7S0P93)? M.#8T9E\T-V(Q-S,S,F-B-C<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-3,P9F-A.3=?.60P,5\T,&4R7S@V-&9?-#=B,3'0O:'1M;#L@ M8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL M('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC'1087)T7S4S,&9C C83DW7SED,#%?-#!E,E\X-C1F7S0W8C$W,S,R8V(V-RTM#0H` ` end XML 38 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Schedule Of Purchase Price Components) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
0 Months Ended 12 Months Ended
Jul. 26, 2010
Dec. 31, 2012
Business Acquisition [Line Items]    
Business acquisition common stock shares issued 248  
Advantage [Member]
   
Business Acquisition [Line Items]    
Cash $ 5,140 $ 5,140
Issuance of 248 Addus shares at $5.00 per share (valued at a price per share equal to the average closing price of the Company's stock for the three most recent trading days preceding the closing, subject to a floor of $5.00 per share) 1,240 1,240
Contingent earn-out obligation (net of $92 discount)   1,600
Total purchase price   7,980
Business acquisition common stock shares issued 248 248
Business acquisition shares issued value per share   $ 5.00
Number of days before the closing   3 days
Per share price, floor   $ 5.00
Net discount of contingent earn out obligation   $ 92
XML 39 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Property And Equipment (Tables)
12 Months Ended
Dec. 31, 2012
Property And Equipment [Abstract]  
Schedule Of Property And Equipment
  December 31,
    2012     2011  
Computer equipment $ 1,705   $ 1,412  
Furniture and equipment   918     778  
Transportation equipment   508     641  
Leasehold improvements   1,496     1,209  
Computer software   3,179     2,840  
    7,806     6,880  
Less accumulated depreciation and amortization   (5,317 )   (4,629 )
 
  $ 2,489   $ 2,251  
XML 40 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2012
Acquisitions [Abstract]  
Schedule Of Purchase Price Components
    Total
Cash $ 5,140
Issuance of 248 Addus shares at $5.00 per share (valued at a price per share equal to the average closing price of the
Company's stock for the three most recent trading days preceding the closing, subject to a floor of $5.00 per share)
  1,240
Contingent earn-out obligation (net of $92 discount)   1,600
Total purchase price $ 7,980
Schedule Of Purchase Price Allocation
    Total
Goodwill $ 4,272
Identifiable intangible assets   3,631
Property and equipment   77
 
Total purchase price allocation $ 7,980
Schedule Of Business Acquisition Pro Forma Consolidated Income Statement Information
    For the Year Ended  
    December 31, 2010  
       
Net service revenues $ 236,065  
Operating income from continuing operations   9,793  
Net income from continuing operations, net of tax   4,555  
Net loss from discontinued operations, net of tax   1,617
 
Net income $ 6,172  
Earnings per share      
Basic and Diluted      
Continuing operations $ 0.42  
Discontinued operations   0.15  
Basic income per share from continue operations $ 0.57  
XML 41 R56.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-Term Debt (Schedule Of Long-Term Debt) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Debt Instrument [Line Items]    
Total $ 16,458 $ 31,527
Less current maturities (208) (6,569)
Long-term debt 16,250 24,958
Revolving Credit Loan [Member]
   
Debt Instrument [Line Items]    
Total 16,250 24,750
Term Loan [Member]
   
Debt Instrument [Line Items]    
Total 208 2,708
Subordinated Dividend Notes [Member]
   
Debt Instrument [Line Items]    
Total   $ 4,069
Interest rate 10.00%  
XML 42 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Schedule Of Purchase Price Allocation) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Jul. 26, 2010
Acquisitions [Abstract]        
Goodwill $ 50,536 $ 50,695 $ 63,930 $ 4,272
Identifiable intangible assets       3,631
Property and equipment       77
Total purchase price allocation       $ 7,980
XML 43 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill And Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets [Abstract]  
Changes In Goodwill By Segment
    Continuing     Discontinued        
    operations     operations     Total  
Goodwill, at December 31, 2010 $ 50,820   $ 13,110   $ 63,930  
Adjustments to previously recorded goodwill   (125 )   (34 )   (159 )
Impairment charge for discountinued operations       (13,076 )   (13,076 )
 
Goodwill, at December 31, 2011   50,695         50,695  
Adjustments to previously recorded goodwill   (159 )       (159 )
 
Goodwill, at December 31, 2012 $ 50,536   $   $ 50,536  
Schedule Of Carrying Amount And Accumulated Amortization Of Intangible Asset
    Customer and     Trade names                    
    referral     and           Non-competition        
    relationships     trademarks     State Licenses     agreements     Total  
Balance at December 31, 2010 $ 10,184   $ 2,407   $ 790   $ 189   $ 13,570  
Impairment charges for discontinued operations   (1,754 )   (506 )   (640 )   (13 )   (2,913 )
Amortization   (2,199 )   (350 )       (64 )   (2,613 )
 
Balance at December 31, 2011 6,231   1,551   150   112   8,044  
Amortization   (1,364 )   (248 )       (62 )   (1,674 )
 
Balance at December 31, 2012 $ 4,867   $ 1,303   $ 150   $ 50   $ 6,370  
Schedule Of Future Amortization Of Intangible Assets
   
For the year ended December 31,    
     
2013 $ 1,354
2014   1,093
2015   886
2016   717
2017   595
Thereafter   1,575
 
Total $ 6,220
XML 44 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Details Of Certain Balance Sheet Accounts (Tables)
12 Months Ended
Dec. 31, 2012
Details Of Certain Balance Sheet Accounts [Abstract]  
Schedule Of Prepaid Expenses And Other Current Assets
  December 31,
    2012   2011
Prepaid health insurance $ 4,062 $ 3,672
Prepaid workers' compensation and liability insurance   1,056   1,354
Prepaid rent   181   192
Workers' compensation insurance receivable   953   1,866
Other   1,041   1,053
 
  $ 7,293 $ 8,137
Schedule Of Accrued Expenses
  December 31,
    2012   2011
Accrued payroll $ 11,539 $ 11,547
Accrued workers' compensation insurance   12,452   10,173
Accrued payroll taxes   1,481   1,811
Accrued health insurance   3,469   3,039
Accrued taxes   1,223   223
Accrued interest   51   100
Current portion of contingent earn-out obligation   689   683
Other   1,813   1,737
 
  $ 32,717 $ 29,313
XML 45 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations
12 Months Ended
Dec. 31, 2012
Discontinued Operations Including Sale Of Agency [Abstract]  
Discontinued Operations

2. Discontinued Operations

     During December 2012, in anticipation of the sale of substantially all of the assets used in its home health business (the "Home Health Business"), the Company reported the operating results of the Home Health Business as discontinued operations in accordance with ASC 360-10-45 "Impairment or Disposal of Long-Lived Assets." On February 7, 2013, the Company entered into the Home Health Purchase Agreement, pursuant to which subsidiaries of LHC Group, Inc. agreed to acquire substantially all the assets of the Home Health Business in Arkansas, Nevada and South Carolina and 90% of the Home Health Business in California and Illinois, with the Company retaining 10% ownership in such locations, for cash consideration of $20,000. The transaction was consummated effective March 1, 2013. In addition the results of operations for two home health agencies being held for sale are included in discontinued operations.

         The Company has included the financial results of the Home Health Business in discontinued operations for all periods presented. Assets sold to the purchasers are presented as assets held for sale, net, on the accompanying consolidated balance sheet as of December 31, 2012 and 2011. In connection with the discontinued operations presentation, certain financial statement footnotes have also been updated to reflect the impact of discontinued operations.

The following table presents the net service revenues and earnings attributable to discontinued operations, which include the financial results for the years ended December 31, 2012, 2011 and 2010:

    2012     2011     2010
Net service revenues $ 38,822   $ 42,995   $ 41,633
Income (loss) before income taxes   (2,752 )   (17,122 )   2,719
Income tax expense (benefit)   (1,099 )   (6,729 )   1,058
 
Net income (loss) from discontinued operations $ (1,653 ) $ (10,393 ) $ 1,661

 

The only class of assets for discountinued operations reflected as assets held for sale, net, as of December 31, 2012 and 2011 were as follows:

2012 2011
Property and equipment, net of accumulated depreciation and amortization $ 245 $ 239

 

Pursuant to the Home Health Purchase Agreement, the Company is retaining $7,123 of accounts receivable, net as of December 31, 2012. In addition, the Company is retaining the related accrued expenses and accounts payable associated with the Home Health Business.

XML 46 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-Term Debt (Tables)
12 Months Ended
Dec. 31, 2012
Long-Term Debt [Abstract]  
Schedule Of Long-Term Debt
  December 31,
    2012     2011  
Revolving credit loan $ 16,250   $ 24,750  
Term loan   208     2,708  
Subordinated dividend notes bearing interest at 10.0%       4,069  
 
Total   16,458     31,527  
Less current maturities   (208 )   (6,569 )
 
Long-term debt $ 16,250   $ 24,958  
Schedule Of Long-Term Debt Maturities
For the year ended December 31,    
     
2013 $ 208
2014   16,250
 
Total $ 16,458
XML 47 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations (Schedule Of Disposal Group, Classes Of Assets) (Details) (Home Health Segment [Member], USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Home Health Segment [Member]
   
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Property and equipment, net of accumulated depreciation and amortization $ 245 $ 239
XML 48 R53.htm IDEA: XBRL DOCUMENT v2.4.0.6
Details Of Certain Balance Sheet Accounts (Schedule Of Prepaid Expenses And Other Current Assets) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Details Of Certain Balance Sheet Accounts [Abstract]    
Prepaid health insurance $ 4,062 $ 3,672
Prepaid workers' compensation and liability insurance 1,056 1,354
Prepaid rent 181 192
Workers' compensation insurance receivable 953 1,866
Other 1,041 1,053
Prepaid expenses and other current assets $ 7,293 $ 8,137
XML 49 R72.htm IDEA: XBRL DOCUMENT v2.4.0.6
Employee Benefit Plans (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Employee Benefit Plans [Abstract]      
Matching percentage for Retirement Plan 6.00% 6.00% 6.00%
Company matching contribution amount $ 44 $ 49 $ 51
XML 50 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Assets    
Cash $ 1,737 $ 2,020
Accounts receivable, net of allowances of $4,466 and $7,189 at December 31, 2012 and 2011, respectively 71,303 72,368
Prepaid expenses and other current assets 7,293 8,137
Assets held for sale, net 245 239
Deferred tax assets 7,258 6,336
Total current assets 87,836 89,100
Property and equipment, net of accumulated depreciation and amortization 2,489 2,251
Other assets    
Goodwill 50,536 50,695
Intangibles, net of accumulated amortization 6,370 8,044
Deferred tax assets 2,328 4,089
Other assets 298 513
Total other assets 59,532 63,341
Total assets 149,857 154,692
Current Liabilities    
Accounts payable 4,117 5,266
Accrued expenses 32,717 29,313
Current maturities of long-term debt 208 6,569
Deferred revenue 2,148 2,145
Total current liabilities 39,190 43,293
Long-term debt, less current maturities 16,250 24,958
Total liabilities 55,440 68,251
Commitments, contingencies and other matters      
Stockholders' equity    
Common stock-$.001 par value; 40,000 authorized and 10,823 and 10,775 shares issued and outstanding as of December 31, 2012 and 2011, respectively 11 11
Additional paid-in capital 82,778 82,437
Retained earnings 11,628 3,993
Total stockholders' equity 94,417 86,441
Total liabilities and stockholders' equity $ 149,857 $ 154,692
XML 51 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Schedule Of Business Acquisition Pro Forma Consolidated Income Statement Information) (Details) (Advantage [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2010
Advantage [Member]
 
Business Acquisition [Line Items]  
Net service revenues $ 236,065
Operating income from continuing operations 9,793
Net income from continuing operations, net of tax 4,555
Net loss from discontinued operations, net of tax 1,617
Net income $ 6,172
Earnings per share Basic and Diluted, Continuing Operations $ 0.42
Earnings per share Basic and Diluted, Discontinued Operations $ 0.15
Basic income per share from continue operations $ 0.57
XML 52 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities      
Net income (loss) $ 7,635 $ (1,981) $ 6,028
Adjustments to reconcile net income (loss) to net cash provided by operating activities      
Depreciation and amortization 2,544 3,554 4,046
Deferred income taxes 839 (4,663) 447
Change in fair value of financial instrument     (191)
Stock-based compensation 341 331 255
Amortization of debt issuance costs 215 224 179
Provision for doubtful accounts 2,877 4,275 4,429
Goodwill and intangible assets impairment charge   15,989  
Revaluation of contingent consideration   (469)  
(Gain)/Loss on sale of assets (495) 43  
Changes in operating assets and liabilities:      
Accounts receivable (1,812) (5,689) (4,892)
Prepaid expenses and other current assets (18) 1,433 (767)
Accounts payable (1,149) 1,962 (459)
Accrued expenses 4,425 934 1,676
Deferred revenue 3 4 (48)
Net cash provided by operating activities 15,405 15,947 10,703
Cash flows from investing activities      
Acquisitions of businesses   (500) (5,588)
Net proceeds from sale of agency 495    
Purchases of property and equipment (1,114) (551) (612)
Net cash used in investing activities (619) (1,051) (6,200)
Cash flows from financing activities      
Net borrowings (repayments) on term loan (2,500) (2,292) 5,000
Net (payments) borrowings on revolving credit loan (8,500) (8,500) (5,250)
Payments on subordinated dividend notes (4,069) (2,500) (1,250)
Debt issuance costs   (34) (151)
Net borrowings (repayments) on other notes payable   (366) (2,554)
Net cash used in financing activities (15,069) (13,692) (4,205)
Net change in cash (283) 1,204 298
Cash, at beginning of period 2,020 816 518
Cash, at end of period 1,737 2,020 816
Supplemental disclosures of cash flow information      
Cash paid for interest 1,557 2,337 3,555
Cash paid for income taxes 1,758 2,005 1,457
Supplemental disclosures of non-cash investing and financing activities      
Contingent and deferred consideration accrued for acquisitions     1,615
Tax benefit related to the amortization of tax goodwill in excess of book basis $ 159 $ 159 $ 160
XML 53 R59.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Tax Expense By Jurisdiction) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]      
Current federal tax expense (benefit) $ 2,325 $ 1,994 $ 2,178
Current state tax expense (benefit) 544 184 335
Deferred federal income tax expense (benefit) 680 (4,267) 388
Deferred state income tax expense (benefit) 159 (396) 59
Provision (benefit) for income taxes $ 3,708 $ (2,485) $ 2,960
XML 54 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Operating Leases And Related Party Transactions (Tables)
12 Months Ended
Dec. 31, 2012
Operating Leases And Related Party Transactions [Abstract]  
Schedule Of Future Minimum Payments
    Non-Related Party Rent   Related Party Rent   Amount
2013 $ 2,784 $ 240 $ 3,024
2014   2,044   -   2,044
2015   1,759   -   1,759
2016   1,466   -   1,466
2017   779   -   779
Thereafter   1,208   -   1,208
 
Total $ 10,040 $ 240 $ 10,280
XML 55 R65.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options And Restricted Stock Awards (Stock Option Awards) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options Outstanding, Number 596
Options Outstanding, Weighted Average Remaining Contractual Life In Years 5 years 7 months 6 days
Options Outstanding, Weighted Average Exercise Price $ 8.11
Options Exercisable, Number 448
Options Esercisable, Weighted Average Remaining Contractual Life In Years 4 years 8 months 12 days
Options Exercisable, Weighted Average Exercise Price $ 8.85
4.06 - 5.45 [Member]
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Stock Option, Exercise Price, Lower Range Limit $ 4.06
Stock Option, Exercise Price, Upper Range Limit $ 5.45
Options Outstanding, Number 166
Options Outstanding, Weighted Average Remaining Contractual Life In Years 8 years 4 months 24 days
Options Outstanding, Weighted Average Exercise Price $ 4.77
Options Exercisable, Number 48
Options Esercisable, Weighted Average Remaining Contractual Life In Years 8 years 1 month 6 days
Options Exercisable, Weighted Average Exercise Price $ 4.77
9.26 - 10.00 [Member]
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Stock Option, Exercise Price, Lower Range Limit $ 9.26
Stock Option, Exercise Price, Upper Range Limit $ 10.00
Options Outstanding, Number 430
Options Outstanding, Weighted Average Remaining Contractual Life In Years 4 years 6 months
Options Outstanding, Weighted Average Exercise Price $ 9.39
Options Exercisable, Number 400
Options Esercisable, Weighted Average Remaining Contractual Life In Years 4 years 3 months 18 days
Options Exercisable, Weighted Average Exercise Price $ 9.35
XML 56 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Concentration Of Cash (Cash [Member])
12 Months Ended
Dec. 31, 2012
Cash [Member]
 
Concentration Risk [Line Items]  
Concentration of Cash

17. Concentration of Cash

     Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash. The Company maintains cash with financial institutions which, at times, may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk on cash.

XML 57 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Quarterly Financial Information (Tables)
12 Months Ended
Dec. 31, 2012
Summarized Quarterly Financial Information [Abstract]  
Schedule Of Quarterly Results Of Operations
  Year Ended December 31, 2012 Year Ended December 31, 2011
    Dec. 31   Sept. 30     Jun. 30     Mar. 31     Dec. 31     Sept. 30   Jun. 30   Mar. 31
Net service revenues $ 63,775 $ 61,211   $ 60,440   $ 58,889   $ 58,304   $ 58,393   $ 57,200 $ 56,208
Gross profit   17,537   15,683     15,807     15,024     16,829     15,701     14,784   14159
 
Operating income from continuing                                          
operations   5,261   3,867     3,217     3,318     4,648     3,711     2,558   2,000
Net income from continuing operations   3,503   2,204     1,835     1,746     2,914     3,396     1,253   849
Net income (loss) from discontinued                                          
operations   242   (407 )   (371 )   (1,117 )   (418 )   (10,059 )   80   4
Net income (loss) $ 3,745 $ 1,797   $ 1,464   $ 629   $ 2,496   $ (6,663 ) $ 1,333 $ 853
Average shares outstanding:                                          
Basic   10,772   10,761     10,761     10,756     10,754     10,746     10,746   10,746
Diluted   10,807   10,773     10,785     10,760     10,756     10,746     10,770   10,754
Income (loss) per common share:                                          
Basic and diluted                                          
Continuing operations $ 0.33 $ 0.20   $ 0.17   $ 0.16   $ 0.27   $ 0.32   $ 0.11 $ 0.08
Discontinued operations   0.02   (0.03 )   (0.03 )   (0.10 )   (0.04 )   (0.94 )   0.01   0.00
Basic and diluted net earnings (loss) per share $ 0.35 $ 0.17   $ 0.14   $ 0.06   $ 0.23   $ (0.62 ) $ 0.12 $ 0.08
XML 58 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Event
12 Months Ended
Dec. 31, 2012
Subsequent Event [Abstract]  
Subsequent Event

19. Subsequent Event

     On February 7, 2013, the Company entered into the Home Health Purchase Agreement with LHC Group, Inc. and certain of its subsidiaries. Pursuant to the Home Health Purchase Agreement, effective March 1, 2013, the purchasers acquired substantially all the assets of the Company' s Home Health Business in Arkansas, Nevada and South Carolina and 90% of the Home Health Business in California and Illinois with the Company retaining 10% ownership in such locations, for cash consideration of $20,000. (see note 2). In addition the Company has two home health agencies that are being held for sale. The results of operations for assets sold or being held for sale are included in the financial statements as discontinued operations.

XML 59 R68.htm IDEA: XBRL DOCUMENT v2.4.0.6
Operating Leases And Related Party Transactions (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Rent expense $ 3,380 $ 3,495 $ 3,441
Office Space [Member]
     
Rent expense 486 409 367
Operating lease term 5 years    
Telecom System [Member]
     
Rent expense $ 285 $ 62  
Operating lease term   5 years  
LHC Group, Inc. [Member]
     
Number of properties under subleases 13    
Number of leases assigned 9    
XML 60 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 61 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Significant Accounting Policies
12 Months Ended
Dec. 31, 2012
Significant Accounting Policies [Abstract]  
Significant Accounting Policies

1. Significant Accounting Policies

Basis of Presentation and Description of Business

     The consolidated financial statements include the accounts of Addus HomeCare Corporation ("Holdings") and its subsidiaries (together with Holdings, the "Company" or "we"). The Company provides home and community based services through a network of locations throughout the United States. These services are primarily performed in the homes of the consumers. The Company's home and community based services include assistance to the elderly, chronically ill and disabled with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. Home and community based services are primarily performed under agreements with state and local governmental agencies.

Discontinued Operations

     On February 7, 2013, subsidiaries of Holdings entered into an Asset Purchase Agreement with LHC Group, Inc. and certain of its subsidiaries (the "Home Health Purchase Agreement"). Pursuant to the Home Health Purchase Agreement, effective March 1, 2013, the purchasers agreed to acquire substantially all the assets of the Company's home health business in Arkansas, Nevada and South Carolina and 90% of its home health business in California and Illinois, with the Company retaining 10% ownership in such locations, for cash consideration of $20,000.

     The Company's home health services were operated through licensed and Medicare certified offices that provided physical, occupational and speech therapy, as well as skilled nursing services to pediatric, adult infirm and elderly patients. Home health services were reimbursed from Medicare, Medicaid and Medicaid-waiver programs, commercial insurance and private payors (see note 2).

Principles of Consolidation

     All intercompany balances and transactions have been eliminated in consolidation.

Allowance for Doubtful Accounts

     The Company establishes its allowance for doubtful accounts to the extent it is probable that a portion or all of a particular account will not be collected. The Company estimates its provision for doubtful accounts primarily by aging receivables utilizing eight aging categories, and applying its historical collection rates to each aging category, taking into consideration factors that might impact the use of historical collection rates or payor groups, with certain large payors analyzed separately from other payor groups. In the Company's evaluation of these estimates, it also considers delays in payment trends in individual states due to budget or funding issues, billing conversions related to acquisitions or internal systems, resubmission of bills with required documentation and disputes with specific payors. An allowance for doubtful accounts is maintained at a level management believes is sufficient to cover potential losses. However, actual collections could differ from estimates.

 

Goodwill

     The Company's carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions including the acquisition of Addus HealthCare, Inc. ("Addus HealthCare"). In accordance with Accounting Standards Codification TM ("ASC") Topic 350, "Goodwill and Other Intangible Assets ," goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. Goodwill and indefinite lived intangible assets are required to be tested for impairment at least annually. The Company may use a qualitative test, known as "Step 0" or a two-step quantitative method to determine whether impairment has occurred. In Step 0, the Company can elect to perform an optional qualitative analysis and based on the results skip the two step analysis. In 2012, the Company elected to implement Step 0 and was not required to conduct the remaining two step analysis.

     In 2011, the Company elected to evaluate the goodwill via the two step methodology. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. The Company used the combination of a discounted cash flow model ("DCF model") and the market multiple analysis method to determine the current fair value of each reporting unit. The DCF model was prepared using revenue and expense projections based on the Company's current operating plan. As such, a number of significant assumptions and estimates were involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. In 2011, the cash flows were discounted using a weighted average cost of capital of 14.5%, which was management's best estimate based on the capital structure of the Company and external industry data. As part of the second step of this evaluation, if the carrying value of goodwill exceeds its fair value, an impairment loss would be recognized. The Company recorded a $15,989 goodwill and intangible asset charge during the third quarter of 2011 (see Note 6)for its discontinued operations (see Note 2).

Intangible Assets

     The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-compete agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from two to 25 years.

      ASC Topic 350 requires that the fair value of intangible assets with finite lives be estimated and compared to the carrying value. The Company estimates the fair value of these intangible assets using the income approach. Intangible assets with finite lives are amortized using the estimated economic benefit method over the useful life and assessed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company recognizes an impairment loss when the estimated fair value of the intangible asset is less than the carrying value. No impairment charge was recorded in 2012. The Company recorded a $2,273 impairment associated with discontinued operations in 2011. No impairment charge was recorded in 2010.

     The income approach, which the Company uses to estimate the fair value of its reporting units and intangible assets, is dependent on a number of factors including estimates of future market growth and trends, forecasted revenue and costs, expected periods the assets will be utilized, appropriate discount rates and other variables. The Company bases its fair value estimates on assumptions the Company believes to be reasonable but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates. In addition, the Company makes certain judgments about the selection of comparable companies used in the market approach in valuing its reporting units.

Long-Lived Assets

     The Company reviews its long-lived assets and indefinite lived intangibles (except goodwill and finite lived intangible assets, as described above) for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. To determine if impairment exists, the Company compares the estimated future undiscounted cash flows from the related long-lived assets to the net carrying amount of such assets. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset, generally determined by discounting the estimated future cash flows. No impairment charge was recorded in 2012. The Company recorded a $640 impairment associated with discontinued operations in 2011. No impairment charge was recorded in 2010.

Debt Issuance Costs

The Company amortizes debt issuance costs on a straight-line method over the term of the related debt. This method approximates the effective interest method.

Workers' Compensation Program

     The Company's workers' compensation program has a $350 deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The future claims payments related to the workers' compensation program are secured by letters of credit.

Derivative Financial Instrument

     The Company utilized a derivative financial instrument to minimize interest rate risk. The Company's derivative instrument consisted of a three-year interest rate agreement designed to reduce the variability of cash flows associated with a portion of the Company's term debt. As the hedge accounting criteria established in ASC Topic 815, "Derivatives and Hedging" have not been met, the Company accounted for the instrument at its fair value and recognizes any changes in its fair value in earnings for the period.

     ASC Topic 820, "Fair Value Measurements," establishes a three-tier fair value hierarchy, which categorizes the inputs used in measuring fair value. These categories include in descending order of priority: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

     The fair value of the swap was calculated using proprietary models utilizing observable inputs (Level 2) as well as future assumptions related to interest rates and other applicable variables. These calculations were performed by the financial institution which is counterparty to the applicable swap agreement and reviewed by the Company. The Company used these reported fair values to adjust the asset or liability as appropriate. The interest rate swap agreement concluded in March of 2010.

Interest Expense

The Company's interest expense consists of interest costs on its credit facility and other debt instruments.

Income Taxes

     The Company accounts for income taxes under the provisions of ASC Topic 740, "Income Taxes". The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its financial statements or tax returns. Deferred taxes, resulting from differences between the financial and tax basis of the Company's assets and liabilities, are also adjusted for changes in tax rates and tax laws when changes are enacted. ASC Topic 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. ASC Topic 740, also prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. In addition, ASC Topic 740 provides guidance on derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions.

Estimates

     The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. Accordingly, actual results could differ from those estimates.

Fair Value of Financial Instruments

     The Company's financial instruments consist of cash, accounts receivable, payables and debt. The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of the short-term nature of these instruments. The carrying value of the Company's long-term debt with variable interest rates approximates fair value based on instruments with similar terms.

     The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets and also when determining the fair value of contingent considerations. To determine the fair value in these situations, the Company uses Level 3 inputs such as discounted cash flows or if available, what a market participant would pay on the measurement date.

New Accounting Pronouncements

     The Company does not believe any recently issued, but not yet effective, accounting standards will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.

 

XML 62 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Condensed Consolidated Balance Sheets [Abstract]    
Accounts receivable, allowance for doubtful accounts $ 4,466 $ 7,189
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 40,000,000 40,000,000
Common stock, shares issued 10,823,000 10,775,000
Common stock, shares outstanding 10,823,000 10,775,000
XML 63 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholder's Equity
12 Months Ended
Dec. 31, 2012
Stockholders' Equity [Abstract]  
Stockholder's Equity

12. Stockholder's Equity

Acquisitions

     On July 26, 2010, in conjunction with the purchase of certain assets of Advantage by the Company, pursuant to the Purchase Agreement, the Company issued 248 shares of its common stock with a value of $1,240.

2009 Stock Incentive Plan

     In September 2009, the Company's board of directors and stockholders adopted and approved the 2009 Plan. The 2009 Plan provides for the grant of 750 incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units, restricted stock units, other stock units and performance shares.

XML 64 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document And Entity Information (USD $)
12 Months Ended
Dec. 31, 2012
Mar. 18, 2013
Jun. 30, 2012
Document And Entity Information [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2012    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2012    
Entity Registrant Name Addus HomeCare Corp    
Entity Central Index Key 0001468328    
Current Fiscal Year End Date --12-31    
Entity Filer Category Smaller Reporting Company    
Entity Common Stock, Shares Outstanding   10,883,632  
Entity Well-known Seasoned Issuer No    
Entity Public Float     $ 28,927,673
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
XML 65 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Data
12 Months Ended
Dec. 31, 2012
Segment Data [Abstract]  
Segment Data

13. Segment Data

     The Company has historically segregated its results into two distinct reporting segments: the home & community segment and the home health segment. As a result of the sale of the Home Health Business, the Company has reported the operating results for the Home Health Business as discontinued operations. Therefore, all of the Company's operations are reported as one operating segment.

ZIP 66 0001193125-13-132519-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-13-132519-xbrl.zip M4$L#!!0````(`'J&?$(/E)!XO!$!`)/:#@`1`!P`861UM5%%GK511=7@+``$$)0X```0Y`0``[%UO<^(XTG^_5?L==-S_ MJI#8!D+(3.:*)#.[J2>3I)+LW;U+"5N`;HS%6C8)^^D?2;;!@`T&;&,;;:5V MP$BRNONG5DO=:GW^U\?(!!-D4TRLJYIZJM0`LG1B8&MP57-I'5(=X]J_OOS\ MT^<_U>O_O7Z^!P;1W1&R'*#;"#K(`._8&8(;FU#:QS8"O2EXQA/D@!?2=]XA M>^*W#UJGS5-58R\!0\<97YZ=O;^_G]J\+/6+GNID5*_[;[N&E+7.ZHG7:J?J M[)<;_\W$N@2-,^WB3%/4!KBX5)1+I0.ZW[V"'SW;!(P^BU[50B_DCT^)/6"5 ME,89MJ@#+1W5O)*7)K9^K"G.?^ZQ?@7%/U;*OS=$:;73Z9R)7V=%64,&GI4- MMWM^YOT8%(6&N]AG:+`GM]\>'HB#*&<2IUA3M88:5&&R&D`XGM7J0]H3S?L_ MB`IU1:W/J_!WXBU8@REI:FI[70VO1%#!0$OD4J2?#LCDC/T0U1^*HSC)6E;/ M_OO]_D4?HA&LSWK%1`S`9\[A2RI^>D9](#A^Z4S'Z*I&\6AL\MZ+9T,;]:]J MG+/U@'>G']2H@3.O(0XK8CGH@P$7Z0[#JT`1^T7W'V/CJM:E;X_]-U5[:ZAO MO)DWG[UO_X:F"WFMKFF2=]Y!VK6,9T21/4'TE76H^X'IK/BLU#=BWQ*WY_1= MLZOKQ+4<^AV->LCVZ&.O9T,-.U/_&_N.#?ZDCY$-!-UH@6D!BV_N_J_V16&L M:YY?-+2+SV?S:O.F*!KPD3Q[P!YY0+Q$'V,3Z]CQ^@(,S,IY.L*GX#(9P;4O M0?G-%'\^BWSYO+MGB_W]?+;`FL]C9&-BA!@ED.)\$4AC?PWU\UGP+&@A5.?S MF2_HC5)7I=1+(74U5:DK4NJED+J2IM25CI1Z&:2N=/:3^JUK"U+?U#=?Q;^2 M*(7_XC##D_?PZ^\NZ]@-&8V)Q;[2!=FSQR-BO3A$_U$.4:\E:R[A%;K2%B@3 MG>W6Y"\)B5_`,EKR22OI2MY94'R MBI3\`22O)).\LI_D8U=QR43]C!R(+61\A;:%K4%)IO.$\HXFKC1KLVUEV34, MS)4`-)\@-NZL&SC&#C0K)=*U-)9&LML:87*4%GUJR5&:^RC==Z]J3UG*45H2RH;6P//?\@BA-_'U]9V4!`#ILZ'VA?/A+E$'F8,%]6"2G+U'AE?PTEZU"R^5@-GGS'%AZY MHW*(+C3&@D<+_:]@:-@6DH0?Y99DN/\5E&2:*]F"F>?M-.U\, M[,?^C8T,['R#.C99M^>2?T$6)O8+TEU68+&0QX*(\2\J7J,^L5&7\<3@?"D' M0.)XX8-E(S,VP61'A21>'LG03'>0E79=.]_/BLL-;MV^@VR)MM30%L7/HH.M M\:9>+'HKI&XK!]KRUFU*76G4U8N2P$WJME+KMCW!EMAJMPEKT)ERH]7I6@;W M@XUYCZ^G*\?ROKFVA1W&>U;N&_[@GV@L!DNY,$_`C?E"+YX=&<$P_[V"8CF6 MLL=JF;8>2H+5W'9#RHM5OF7OLLEE5N:(E6H,+Z1&+2-**ZM.#X12J4MC42J6 M/(%8@NQ91ZA'Q5(EF@]2AY8-G973GP=$I]2=&V?X5QM:=$QL1[2\-+=5`G]! MX;645@`=L>%2$@X'AT,.07';2/D>08J&Q#3N1F.;3$0P?$G.*&XEXS5T5ES" M\7L_E1+P[EM<)9=OS&*T4L+=<<%=4LF*Y<(=:\RVH&E.;]$$F:R6L6@Q5T+` M8D6PD=0JRSEZ.50=X>ZVW"N,1%5I.Q?2=LXJJ9*TG8MB.Q=!PM)VKK9\I>U< M-3 M%ARQ7*&M--;Q#I)\(%:5A1E)7G'EF6X*=YGKKHS>HG0O<)`8J,(IS_T2^DL, M5"JU_SVQ!LS:'-VBGK-H:+^RI_>D+"=YH^@(3O0N$%+<^7H'&3VC"3$G#*G> MB9E*B"N6IM)(3I6CJ_#KU"0R>G%[Q#:PQ2W^6SSA3#7$5:.E%]H&RBHE1:DC M"R&YF17:?M.:,S,T2`>@2)69E779KFO-S=:E?]H^VXA5*=OR[2#$:]R4SK97 M47,7Z*Q[16>1M$YNO"(3Z63T,J4.JMQQC`CB*J"1DNYI)L;`8[^/];B&R?M+=+`,X<(OE1EG0:_K;M M,!4X6(19T4?6%C0&:X!5(JLT2;=#F)#:6VKO7+7W,O#;B8#O*\.,+U`)N/3( MVF4UK$%7=_`$\P@DGR<+WG;_&0]-PI;+BOOUB%42S9B0X+D+?B/%1[2"E6@I M-EJ*E6]_1[3<8JI[[$/&L>!E'U8W;^\O>3G>RR#UI%N" M)4]=*]/%5B7-ZQ&D5HVUG[=Q4@9U'HBE\QMY'=0=V*A,&6*V+)+8VE MO9N\O3A!&QJ(7Q7)O6CBRPC:/ZHH;R]RN-0A(V0S:#^C M/K)M:(J\#MRJ'.)Q9<6=C.[2(&"W$",Y>^V=UV$_.WL6V MLM9^]BSMZ%D;>;N&/*FC!=`UN# M:/=NZ2/5\F'1`4_(I>HGC0M6E4`[2J`5(+0V[JBY1*1$9#['X.>(5")#$`Y^ MK'C)ER_8DE=41CO$DN"L:>$XDN@0HI;2(<1FB"/GA>5(,QE']HF2CXS<:11U MU"2,@%$::6J2)7.K6#Q1DVF23$^M%XTCN1YG;D8=+BH<1Y)HDCW/VT2N4AI% M'35)3R"EHTE22L6V@AS&Z>`]$JK; M]B62N^$[QE?96_13!MJ;=B'O0(4I(*.Z0>&Z9Q>%4<[$\SG*'5>G4U00[K'XQ+6N/P`VQ=-9YK_`SIC^N MI]?(TH?\".(B)*&)Z#.:(,M%C'43K"/Z@)PE:$!A&0B9A8FK@U MK;)XD3)D.#H_F0+-E@IB@\U$AT%.G`W3?8>VL>*] M>D;4L;'NE.HUY)8 MW")>#`V;71;Q!#&;$6_@&#O0+(?DUY(8"O):1^,1:76)B,,CHEBS@$3$X1&1 MSZP1ZX>6URT=Y75+:?O&BW,AS@)E_NT4^U#6>%-%SL)&D2AK\%LFU)U3_26U M(?\-35<4[)HF>>>HIV(7A")[@NC*\F%6ZANQ;XG;<_JN&438EV.H)R,X-&UL MI/B([$N)EF*CI5BVIT1+L=&2JUTJ\_]LAR69_V=33*27UB=;\VC7..R(I&C! MD^_8PB-W5`X49A:OO4TG0OG0@D<+3*R@`98G'N&'Q./>>`PS\8CPF'WF^&8$6P.OODPBG[(Q$ MR!>GI,"&27Q*=5I*EAS3;&9D9G&E_#I@)E[YLSVR((9>Z\[R MP+8)^]^*OW3I]W+`*8:HD#LIBJH,9=?@5VHJ[3WSAJ3GW2RZ`+/S2Y;`&V@3 MUJ`SY6X%/O_R@-.QF)>7LE`^]OM8+TFJE`1$^?(-4U4!HR!IT%-BJ;\B$S%S M[65*F;56->%'$%?!4*9=DGM6,N]L89*\%DL72!P<"@?%"FV4.#@4#HIQ!#,V M_^O]4!?;+G>67FQ9QV=P72&A2OJ=K;$;X?QXK:2WH+ZRIR4*/HE?I2T2DD/N MPT:R1'^MS&6[WVY?X46>\49="9`0>P12[L;DN!NS[W'#XL0>RMW[RN[>%^$2 M`0ED">0"Z=W%P]#IQ\G(&._*QW@OQ)"D='Y=6;\C)Y5G96!Z8"M`K8O-I;QV M&+60=:N]:9UBY-98MHNT1'81*Z9U,MI[+Q9+\MF&7C85#\Z#S*[+.;QX0Z2I MZ2Y<<[4HE"2^[A*%(\;S6#YU+TU6P#[#($ M'V]#3S5C#XMSR5/:NBABM2?GC?11F*W5(T57I7"(9FB)UO030LK1F7GD4S/1 MDI,5XZDPLXV$E#*NH`=*"K6@WIC]5LY5R?J4JDBW>7'>F9XRLZ!EQJ;JN$D. MX1]<7S=XBBXQX^%MTP_%,G;>\VL3G MLQ`%\00W5M@62T=\(UH,$,;L8](VHL6''32*;X&A]-4=FV@9INSY5U/L!"[_ MXDW#LYS'$=F,F8R8)GKL=P=<;['1,B`\:RSPA\7>>Q9^*!$%$$5W*R5)>H;82IK3-R-47\%Q"\%55I MLF/?1=8F.M7SK.CT;M$)8')'*=^QM_F_L&?U1#[9A&G,$?2` MXS+LS/TTO!WV@`;L8HH$ZUUF]V#3=9"Q%@>I[`=OP(%RVM3B6;$'9$TJ_V604):#2^.Z[D80>D-&/;ZXXF>,6S.[O%"YC1R[3+ M/7O,S69^WP2;Q4>K%WP_.D-DOPZA]0LAQCLVS766ZD:"&^<-=97B7/H=XM<- MI$.F22A;=GK(9D!Z@29;<(BZU]/NP$9HQ2B1\3R)5PN!A)-S.BR><`6&>HX` M5B]B?*2^:MI(WT7C(DQ>XIXNDN>O(_CT[M_QLM`26US;3*JLI5`+6TU-26:9 MU@(=.W5IB2H;]USQ_-9%(LGH-Y=?UJ0C/$'&D]C$VVI_XLM3ZS;4PP3-ASIT MBPQ7=[A"F-U?^MC_#[%_()LKG#&RZ.I2<\L=DU7]U@JA(VD/=N@TF_P&-AP= MON]^1Q9(\.#S"C\\3F647)M$_['=W/(W MT_EDX,G?!LXGP#^/`76F)KJJ\2;JT,0#ZQ*8J.]\JO$RO$@O^-!G+PJ*\\_U M/AQAB(>`_8G?&N!%T\FW7V;,P_ M_?S3SS\E)#,I=3L3]F2C,<0&0)Z:H@!:!B#<8`>ZR_07>ST4*HU+E&+JARE=X%*GW!!E\=;I@%)+UCPQE>@HN6,OY@G>0Y'9#-/1Y`1Z9) MQU!G+YA]'T/#\+][+8KV[."UC@%$>U>U\\Y?:S,PG3E&J/2LC/;7&A`LOZKQ M=%#,WMQ40]V^2B8O\3[:81:`B5^E1QR'C&K1+`G:Y1#SBL#1^)/5H^-/43WR M9>0)I>ZU?`G^["TJ@#K^`)28V&!R"ZB]8._0"9<;>TLSBHX##-U;9I6*0(2& M>K)N:!:=N9&X2/DE,>@[@-3XQ+!96I*=R=FII@W^WH"-=<+4]9]U':%^O[9^ M..0YFPW%9@O`%C-*^`R]2OJ2:&-IT0Y%RE]V[W,8=C8>#'/L=?-$.8\8M]$# M29@]V.*;BY>@[5D`4@ZI]+IQ@_K=V_+X.S,Q0LMX;J^:_A;T M=(L1OPY7:V>!PPM7/5%:Y]4FL-%JIH/>`D]2?'&5\L2T5JY%U%/J1819MTL7-5)[=<$"\$4 M=5<*+SVLS=+Q^%[15\6W+,S+Q1 M(V@/L'4)A$\F8K06SH?E!\3,?5B^JXH]RLQ9!8:("_H2:)WF(7Q7FXJH"7GYW4QB=I9AVS(8M-'^I>/P*&DGS=9FOVV9*51.U/8V^R2EGGB``S]01"#B MD7E63IK2O:2>7$297J76U%N']Y18<35.FN>;+9M2$ZC$FVZ54B5,3XN/&/PXSY,2JV,"1]X!V=XF=U`8*V M52>N`\@L$U&5)^WSBTK;).<7U=71,L0EPY76OLYSR=A(QK83^;AEB(L,F-B\ MW-1.VFHLFM(14.%\"*62D-8Y:<0KTM`(]3[F'],RKYKT4QYL>QTBP%-*0&L* MQC;AB7SIRDX94X(39,,!`@X!O[N,MCYFZS77XA8M&HU-,D6LFE>?F;9@R#.0 M\3,V.AF->/J!*>A!RJKP=!989V6Q!>Y,$UL$4^`,;>(.A@""5]AWZK]"VS'1 M%(QN=IKM4Q!BQ-_I`NFAO#4`<>I%NW#$C^T#&^%1 MS[4Y;;VI^$$DA^+M!O2=@H7<-X#WW'`1&S/.D+&ACR<(]/R$0\"`4PKZ-AF) MM@S>E`A%8E1Z-6T_7B*#E'1-'O[7V;P"8G>WQI46@OC1/`TMKQV MTKE8=/*`/K%7,3+C!.[W328JL=IG@/'.M,P;X;7@;#M@]M0! MX7@8P,,L1%$>('#"VJ1C+OX),J>GJQJ@6J.4@3/:Y3CV,PH-(6/^&O&W%I?6 MP)@E"A+MB4Q!"\.!0\Y+Z<;&!9/L?*U*>98'PI.%<$BW3B98A@4\QP7HZR%_-E,VM;@,E[%M1D0\8!%G%F MA4Z`.^;ZZ?_9>]/FMI$D`?3[1NQ_0&BWW[A?0!P"X-FSTQ&R;'=KGFUY+?5L MS"<'!!1)C$&`@T,RY]>_S"KV-'@/Y(J^MW'1Q()ML65R0,8;8)7L"`UB1:Q8>,MF.7NVX)7KN%:PS!VK M"XCKU2DJO54(X\#!U,-!ZV'0FFQS^`,,[LDZ.;/DY/Q$2 M7')T"U[FIKNQ*#F7-!&)\%-!U'7`;VSFFZV"W#:IEZ*:->X:5R$H1 M10<39&PH$SN#X`@AXHYLCMEXD;\ULG8$%]4W@XI+)Q5+BI1;>K]:L?./E:=\ ME']@*7NLQ&E@37VZS+^93UA@C-7*A^V14:Z[6-VO9$7]Z_%H/%]ZZSD)FK.N M)J?6UV%_`!&;F'1T,3GEO=)(LY0:7(U?SNY&_2<\,KRPH/*OM8"@9/E-`YD?*X3`!$C@(C?Q&7M M<%B`QB^6J1"BTLKJYP)I*D9!.C9K!#JF&=WYYNW7J.%\8ZA1;\$[]VB[G?RR ME2(8[R&$Y68^"\@%RMA.QM,:0`;Q81'02Q_-]T^:H\H?3.N+:X$R"R0!E0NT M>0W[-=P\RUI0">8/]"7%VQ%E[*1QJC1OL/M1*/J^X%+`QE/?[C^BP6G911L5 M+**5OFO"5XP"L8KN=]N=K%D(\>U&MM:D@:*MHCB7HBL\`9[X>EC;''HP?4&S M85]3[5+X[-L9G\`<>"<[\F'2C5;6F4ZS;^[`V->4DZU@?]$<6_6A71-`Q1)S M`%U]-OH_DK5F,P@YM0//C.='!_O<,7U_ M+2?CU]N=XWM[@F@G#BQ1$''[T"W%/.Q[-'$#?SFU3:G;%^Q8?PAG(Z/_:XM5 M95V#NE)E+*L.DT7`\_QOZ$8`%(RX&SOJP$;K&+['R3Q'`X5XY_L]T+#W_5-H MRZ/+36&&*D\?#]:AL<8CFATZ#,$4WQ`C]%GC9(%3SW,/>J_9?D\%3I&I&LMJNLHFZ&Y%S;&`=CZ#LQ0@, MZ$M6/=F/?DGD-\WA@BXB*"L])F<$/X(%2N48.V0Y2:(^DC2'R5$Y')'7'YGG MTS^'V7F;5X2_M(8UGPB14[3HG#6#F:]550:(0@:S;?3]5W8=AA7\J?H>U=[3R/('2':=60$A M&]S9[W6-MOX]WFFK9TPZBS9-.1>^CI(D^2(=K0#>BW87[049Q/%1,I3`4037 MGXE#C3H7>]]TJUGM,N*5*0IF?&7EW%MUN/Z.3%H%M!J<@04A"UI=PP\:L>^, MTMTURS7@]EW:Q29.@10=OK`ST4CX7U<&J\G2XN+%Y(8>^5@5\,";JX\?66:0+68@/&$^5-6$25. M.JKGWT0IN*B#/Z:U:O,Y_"5.$JN.PGN6Y61N%-0-LRV)BG!_1(48FV)J:Z/D MB5^\H64.S,L$R'&84H`&Z0NLA=T\J9+T@&'!LE=4K0'P9PGXA:3DS8(O92DT MG/(W#'@UZ!U#_J&:U4X7)"#63V(/?]7L[V_W"8$;GTK6V62%2"0D5I@*=BW+ MR[KCN)#E91T<'5V>J7R_HX#!N?I%EVO55Y+G2LIL63"QJ_?(L7,KZXJKYZO7 M29#F!UZ$9:2C8.$Y(W`&_:6I%$/9?1*[>R)DCVC`F\?WH$_L:!/@??)TT(D" M2NC>=L@V4"RF__"6<`C.Z;!F\6YA6.]7*TTA)8'T^EB#;A11$M.(+*`^/QXO MZ]<]4QI/1@W(5`BC*R`6,C4H?EX?8_O!U-.\&D.OZ*RH'1&C=I8!PE,1FH%Q M#T2_&_@QM+J?Q?->>](]PZNQ!XY,_;&2+?,$P MVP^ZB0&SY[:'$@B<)!`X'8TC"$Q`%P6=Y7FD=!^.=(+?!S$>?LY\I6L908KV M:ST-@K,NH8!7>CR=U;B$(^ZT],N:OKL1CRPXAI:2D8%5@U)B,7\E(_VBGJV+ M;9LKC3A<)TTEH"L]O"=^BM\8]SO1Y,[@/I`GRY6MO1N*+:3F@4Z@\=V^1-7`IQH;(Q;(_IF(B@H'F3!C$P1M\ZDA%]!<<;+), M)A32*!2:'>(%`F#VD>?%\[.<_,+KA\EFEHHQ#R7FVUGDVI%_<&L,8C!97(GM ML1"-BTAGHTS*WF!N%]"3_I?_G>C/Q-$4F;?!`KK.)J=(H2N3^Y&ZGZ/[7=F` M$,-GF#:)X<'HX4[5!Q\QJ?DDJ=`EG?500K%Z^MFE\H]7<9BIVD%+U+DG% M<36B[F-_H1TQ;Y)F`>I!?XO2D4E3Q%?>WTDZAY46E4=/% MD1;\0BSW)@#WZY-T_$("O-R2?KV4[C<^L`K6YJ?KS, M+[A]+NVJB24.C',6QIGQ4O7%:^KRW3-=1KNCQ8 M^XK^+W38+:5H5>YE756Y.WABHJ=,BQD'M.B>&KE7X\S@8JTB1\?*.5^@25ML M?>T>U[-IU4X`I:G8-?U]8-*.,^F8EY8#EPYHALUF1[I7LH]\*(#4^ MY_3XFV@4#T;&OL7R/K&P3/^F5@8+GPLS/1X&4T:!1W4ESPWG!U!R?&BFZ\2)<?C3] MXGGD`S9Q."@H4:3?/US] M*HW\V.8:T7+YR&8YYJ6Q+8[FTWZC>_Y-G`1A]/#'[#R5-&OB;7'`=G/,W7M1 MTGIEGL+ES]K@]4@.[\7FL@CC$4<7RGDKI346OQ+;L31:7)3]2/6C%!?>B7DN M>MM58V-+/ER65G6!W4SD>60M1V8=H6)8?^)LU$I9IV#S.W6-#Q0O49>M.\**TBK@4)/.W6Q9FP) M@!`M!DW^X9:Z2"L).?X`\L`\') MK#'P-CQ8=""61?888EED",HQ%YNVC-J<*RS M).(...GO&D^@:+0]U*3`1,*X M*6"*S(17)@U!D_),N9OH",'/G=LVC]VEHQ'0B4R8#R!+4JK^:`7#SE/X_3][FDS1MU_<+Z5D0]PKK&3F/'<9Z M9_+[BF-]$%\]$5\W3$LC6`]6Z( MK^8Q5++LRR!"<29:[+(^^=D*U"6R=ZE>4(%*,QTA>V<.D8)D;^H$ M*>WL[8S8S`P+R.3`3A63:G:24PR<\J7,.B-;!]ZH@6R76N=N8(XR9"LQ2[DS M*Y+RHQ"R6ET=/\5*L,?IG.$ZMB,;&!O$XT?;#-XZQ`!:@NVB#7'5;D3QLK MBLRJ<+5X'9:'RFGB2=.77?3!I9X6OGX18I/!]5+K98C(G;+"F9%HPT.IG\EJKT$16^VLK76C%^X,7:=3:%2YTKE8.4-5N$& M0^A8U1I6/`<>LA,EK,Q0@?'J4]%+$_J2[,3*=G"88]1LS9S4",BC!5ZFI5_) M",*M^943>JZ?`%?Y[O&--)ROO7U\-R-V,Y@/AWLJN_OKR9?DRJ8ZE5ZS)$8M MNTE'UA\QR\ZZ^%D7%_\^%.'YBR]FOD]CYONX2EQZGTTF5&MHI=-@=B=`2_3M3LN'<)1<'V70Z;6YA9$M6'%?67ZET:J6087>$4VL, MT!GQ=.:BBH-T.ITT'[45X>Z,5RJ9VJE2V!W1U`KU.R.6SE4ML=(E=R,B;"B< MU(_%8F.(_I[%:'(ZW%W>WEU$]F0TKU`OJL4`X$F%NFHM@KT8 MY>).>VJ9@+KVVG9#M!&]@)RR*'*[L8_-)L>&K13\U M@31,H[TUMW#^[[F-9CNFI2FRKN\YUR8JY\"O;W59^7[]H&Q,'<9G&;7<#A[# M9-JMJ1*=O5D1QX+&G/?>[J6-FG_TG#WF( MG*`!=0U=VRRT*>TPQ%=VF2,_FQ8P,]F[J,4#I[GK,T^_OURB($ M'H0%`\DX"TC&AT\C&B)_PK[00$L"(NTUHJN17U:L$I]KD8,A7,NX-I\!.O:# MCX'@`>)G;6Y=W=%V.AD%2X4)5#`TU3\!G*W/"F:2&G(C!W7^X99/"T[2H;?-/G8#N" M,X]C80Y\*_A>8R#`'`36N;9,=T=+XM`98>\XEJS":VQJ>)AQ60S+^+R?G0Z$ MC\WC[<<_V>&N@J=?-L0(7GG1=!W8/4"F"B1E7.LB4=B$&?2.\$QL:O,)A,4S M'2KR-##E;F>9@#Y\=84XA*%Q";:_4T)XV9;V-I7'/%G3Q=_T2A,3L*WQVZ.U#.;YSXBU/")(C3XF=?LO4IR>TUA1@D5'@D\^>"?$GL@6UHH#?H^65SED]&IA*:?C.\+I MWV_ESDK-[NQWVM6I_W&/S017=D;>#%3K8TAL MIZA63C9F^EK3I6431I>?L,SY!E=H9E5P'6<+YK,O2!P5Z+-0Q%-?>"^5':SK M?O]L^=P`\:;UQ+>^6N*U"+8PJJF?;X,*:1-X^1KX;E7-5DS78-[87%1U0)@& MD[01G"B,IBF2W/_C)^XZ,WM!2);__ZDHLCMG@I\=R])(F#WW_N6.KJUZJF'/1N,80\Q&4^HB M3K')NJ2YG=C$ID71_+H0W:+L;1:Q/5-?W_F7_S1PI!=:J[]GQ(IJQB7K??U! M4IM*V5F1U'MEYN]!=%4_-9G+5^S3^G664^NG\2O9DE9-D-^=M@.:P;216?K@$FWQ6!R(T($SH=]$Z+V) M]3XS`Z&().VDU26.4@[A"W!@MAHW<9DH;5'N-872B(1B'X=T5D:`ATAB#\V_ M(X;-$LDP0D5M'LM_;=`Q\REOP?`6H1F4F6!)D_AU+L@9$"J'-YDYA>L!R!5Z3EDE.3><8FNZ('`/_2L%=T@:.CQE?3RR/%<<. MDN;\Y'0_-1@XAB!CX'>*;&^XE65N_1WO#V-[V]I_!5CBW^P5/P?/D7\`_QED MI3EV=!WP0@YH`@<[$?=55:[4(U'06MDCBH9#W\'&TY0*?9=LX#ZZ&YGG10@?( MTV'1@A?-V8#0>\D.J,81,W?J9)2HC(+BDX%R1,X7EQ?POFN`!#:2,CW81B8\ MX$LLMLPT#/CIZDEQS[)BO>Y?5/+1G-MHNO8A<2MK/?!&K MH"=V)-\)L[!1'F%K!>Y]4UG8)R#\.`N<.TRDBGNU,^TS_&RLZWRJMHWVM)+* M8JRD\G&DFL.739M@=;5.@>:'7X]Z*O2HJUAFL?4#W^]_3ZYEDXJ[?7-)0$;7L MCG]-'"@QT`:>.C=/G;?$W*N7/!W1^9M'4GAQW7<&&_`^X/VUX_W5BC$:='.) M%!U0/J#\\E'>E-SJL0V0%5!8G[US0<5R3]GM`V^T3;:!-P;>Z`UOE#NRLC.5 M6LML_",G;/:090JGC;77)E+,;^!9)&FLH#I1;J@FUE^E='%[5)LFZ\7V!?!Z MNO/6R&U-9VGF\UO:+<4TIU%TBP0]TOBTTYR8W^Q]D'N=(YHP'HU3+G9JMXF; M6,N-E^V51X?VL3[);W%P\LZH^F*K';8+M`9O'TRQB]3+/N3:1]AT-,L_'-H' MLXMD;1\KTU&V1=-["_3OU/[LYQSP>S6+SL3#N6>,F+=#K:+8\0N4NV2#,T/IK4B6A'%H9+_O^E]E:^C5[DS MZ=I^JVYH2YYVL'%, MBMISJ.8(8ZPJ&Q:ED5YQ0``G._68+"493E:^KRW3-=1K.C;P'!N["C,WK>]W M::SN8RLBRP=T55UA.;F4G:7>08EUO`Y7J?-+@O-+-=TGG7348Y36.>4,*ZQ; M+Z@P:Q-8+1R_TENV&2WR;RIZOL8"07\7L34Z&]R5O\`TJ[2+K%0H$K'GVR4_ M:/$B=LMPD#06&1E1,=G'H8?&05GXB"7=2#>-6?S8/U*J?#Z//7F\F4;B_KR^ M7AJ'O'4!]']@E>SE9UG3:9GP6.'Z&2M<[[=GB)2R+]8%8C([)%S6PQ-IFN"' M*/;YHWTIPL81)BP&VT#L$$K@7/@K6?WUZIW+ M=LLW`?[!M7Q[-+_!OR7O+]>^7LOR[AM"]EG>DIL?FOT-Q_[V^&(^;DS7!GP^ M:#_H3'<&*E^`*WSZ$\51,,!7V5BSM_UO/LD_M*V[9<]=_?I%&/_C<%DAV+U9 MEF;$EC4MNJI'^<=;UB#D*VMV\&C>;$W+T?Y-EW*_@@=^,TT5>QO<&>]_*,2V M[U=O3?/[6]G6[*/K'\?6/[X"QM/8DW_`!T&ZXE2B:%M9A\UP+5W]"H(1_N)OT-R!XX`\8>QDS7UG?:L@;6DQO%V8W^[7WT#CA"_X7$1;,V/IK'&7A_O MR)/SN-]%=OV#BQJG9B!>_#$_FPZQ$]O]P8$G$*);/#CN5W1/Q[;_`VQK8M]\ ML,,BEE[B49B'%$DN,+![K-5&DWF#W#QGDDWUCJ*!'$>N9V.^( MZBKT3/A,G/O55Z)@[Q.`BM/4OU[=P0*N81+IJHS$"-9W?.H`J_[CP5,?3.L= M:.[.RM5O%,5TD:C%L").A0@;G[CTFI$G'D=>0A:UB#QI,>X<\H3CR,LZJYM' MWI2>@O4ASR\.[Q59OC5M>/)6WFE@IOQA$Q4A15L&0"3JK6QO/L!$50X],;HB M6-!X)$RFWG).`B:Z&-/Z3BS[-F*EW1DVP`>(^4I[IE%=/D4NESBC%[.(/"PV M8ZT@YI^QRZET&H0JT7ZY@:-$Q>/D@RZORYV:*X"`_,^?#T8)![]UX?R!+X&( MLHY]6=X;*I:Y+3?/];4@7DL"FREKR'#2=Z;B;H-'F([[`;XKI]C\^N$?;,+, MX;)F1*!.F`__G39C,-SA?`R8DW"*_XZB-77(PQE1Q)6;2!A?_W_Q*7",<.3W M8-8X^UOXWI)!Z5/)C_^/[,M-@?)\,EM(XH)-E#KDP8SF=FL:5#5BQO]]I/G8 MX7:4O@D+G$Y*[L9Y=#?>??Z`*UXLI)DDQH`Y,ML!9(S#OY(=JL;&^H$U4"N% MDG\0.S9]ZI#)B3]H.K%N@>YKTRI)@@=8/[S,!3/XKH@H%+'QDY-_<9]T30$! M+SLIZ)]]D\;YPG`,?+U8BO/97(K.&QDZ.>M7LM9L!QTA:(*76_.-"O*6^]W< MDEN@*"S8VD5GC0^=G/COI@ZGFFPQI)2D[F.!X+5CN,IZ)W&!^?I"H@^4?N1!#F M)P,2'L.@IQV%(]`D[PP%^"PP_=[*.I[G#QM"'%``@1,U))^LH[JDFW#<$_OM M'O[8F;:L_V:9[LZ&(707Y)$FL]-!^:C)3YH.(J(NEEE*0BJ5 M#B>J`9X"R!'GA^*X!#P@M"U3U^O;4\)"$-+@29FH#H`*;*O)HA)`#W#@6'6Q MCR!,)ZGD2LQ2%9(":!&FZ3L\#Q)WZU(']CNRLV!$>H3"9YU0YPRI#$L^'A?B?+XX!99_NK9#KT$>S8PWJ%W[)-M$C?J>OA+` MM*TYY(%8SYI"F'_A*^N)3N\A:DTL<+S`M]=5!W>&2'?4V_$#LPV M`#'NKDZ'MO`=R:M%>]E[7TD2!E3%KZ6:X-!7C/:RU_;29$!5P@73"(>VBW9= M-Q74J.B0;Y-#OF?QC_6>UD`JZ1AWPFPS[.#O(C`JDO-"LD(7;#U>*"%Q?(`WL)SGPGL M`E<;D^0=2P6P8]%]'S0#AM&,-09Z8."*']Q1<^#H/('V@D"<`?32TE:<=`7T MLG)(%*:U@WYG.+*QUH"[;FR;U,PFDC"1CD"/E0WR\M_M/\C]-BP:FAO>)MZ#"FEMBT4@UC$B5=1K^B[>.&VU7.`93 M6![;U]W'PZ,EJP1C`9#_Z1];V?I>.(IR.N[KZOUW/IL&3:AR2"2JNMCJ9\?D MXMD67UH7F\V[`&?K6U60.D&OMK:J.%GT=?5U;%7Q],4;CJ9JNHN)3@]$<2UZ M<_O^!P:N$/6#96Y1OW<=;[#WLF6`2F%_(1:U`&`J-Z']EE02Y@?W3HL$*>N` ML.E%YXBQPT6/A;,O^I"=RU\C3R>S98+9TI@J=ZHBU^?+Q71><*I:C,?%4AB/ M4R9,-[.*SEO@@G"^D&;EYOV=Z!BI_R#79#>+R2OYC%FJPU+`JIE,3X#EK6MK M!@&1JC`G+&R+6QIQM\:T+3A+-=4+N[MQ/LB:17VQM>!NMHC;"E4@:69-^328 M)=PH9UX3YJ#0+RRB>M'3LKU!EWO*,N;?Q%G<99PR9JA7W*C/,IR`:U(T^XKTB$G@L2.$ED/MDDW^Y>`OT[*4RQ%,OX[\751A9;9&& MU\WNL>ZP5!&Q'9O&<*N@[^*'C*2D,[.[()Y&_KR5-(6>1QU#'/WEH\X>K2`3J"M#7+T>*B%M"5@*;DN.SG8 M9Q=I<+]BR4KLUW0;`Y8X"2RKS/4>V!A)&[D>$-M>=BV%8,BL"8>TQ M59TE%,E3!\B2*94RX'$WG1U'<*#I*$&>%_\&O@DI%Y=+@ ML/Z15_Z(UD*B]=,X5BD.TP\YA>A8@1QONO#OXS7+9^)/5V%9I8Q>>./\9X0" MXTP.'RE7;[ALB)923#>3>K4A[Z02WMF%)FNFV9E'C-*_&2C+H?NP M6&<4-0WSTI*?5^Z*]!K$6BY7\9P!CYDK MSI%_G"Y)3F[)T5)E?WXZ'>10DE=T,`H9IV363B[!*TU+HQ3UM^E.H?Q,F)\' M+TV`SV6!GL+B$98.&GQ-+E9\]D;#.G,E_9:JY_/"/+^!3Q/F?A.K]4-U.)"Z MG(T>M7J6?LZG3SH#8UU-A-EH/%_LG+9D'W/B8A'X=QA55:!!\@4@71)'PG36 M'M)OT_31HHCOG&1M!Z[QJ$!SLU?"3^_2M=::MW+7M=`Q$*&B&G`V]VJ+LMTS MA(-3-682DTL00"54N[8X4N5>?=QZ?#7GS)7YD3O?W%BM)L/)L67JX'=_I";\WM$_:"@!?"FIXU MW5KGM6C2&[^\FXRX*(8.]VUX=7YOKK[GQ!GO-=AR(KV;Z"T:Z!2: MX9A@)'`TY)SSH]:X(!^'>X-O71W^3D8XV6C*9O8%+(7$,!DEB-AKKB`YSE6`I9[V-L8><%SL#5'/"=S#Z8+7]_*%B@>A@R<:.U, MQH#6%2?Q-0#NGR/:&CK`%(%D[N#C@+QI@0(;=#\"IJ('@F7YD M&H$7D]-8Q'9U[RJ&+AH[=&&2/0R4WU%,G"SBP_G`TI@EGMJ6JZ*#8!4U;:8!Q/2SK>9GMZ,I)"-EO MON")A`<"-%.YH"?#U<](+@V3H.`U#<@@*XB^/=NBR<>YG65BOQ^;]@R4.0.` MQY9%G&["9(I?]XBZYN'UQ)@^/\MK(.L:^Q+`/C04;0=B0&:Y:L=WY`$_>KL- M5"+,/-MS*@X*8V0-\3?9<&5KSTTI[N+W=FS%EE\<"3@!N]_9H.39)N5TQ*T: MTCU*/+R#N/-$9X!REGT6P$Q-@MXAT MB",05HLR&/[+X@Z3C4:<'R.)'02=&$1A MT\`$^4/H$&A?PA.-=AR488MS*ZS#CX+/0CHRV#Q,2.-K5=YS'^_>WG\%/.FN M3=E[M],UA8[#.I$>(_YD%.^U^!/GA7710=F@%+PR9[,7FO M028\8FL_&-)L#Y3(]##-3Q'\L+4">7PDFW2Q."\PF+]3+*(3Y`K@<;05-.7N&5KZQS$6T]17DM#=CI$`5'*-,OD-G67D,]^I-)]Z$6 M9&'[$HL^\$021&"[/,2[-!UW`>V_15=T3U<4YI4S?=F^2KE@;(X.(P^*4--& M4"-J"U-QX'OL(`O$0D['IZC,T"P0IYK%%$L[JD?O_*-B1Y-NM"-*\9Q?)I1B M"@-M[QBJQK_DB)Y$2^AJ\HNZL$J_E MNG"YF'M[-IJ+F<[MAJWS1^2]8S9YC^_=,8,RUTW8EXP0VQ^C^'4$#Q8XIY*59E!'>J8C]L[@;F#;Z]0C&G?#4X#X;X7*Y@YP_8/B%5@@>:/8KB6LT>=S);Q4==(/U@;@U#V_8=.G)5C=U2C%K95&MU0H:!W6\Q] M&>=Q1=855X^M)XO"ODMO!^1#U]$&]'UV:48O*MB?@%7K20,MV@&M6"7HW@;6 M9ILBN'4Y,@MC,M@.>-YY$\-N)3]V1/%N1)[0_ZZ2*&=Y@\4Y2TKQ9U^:<_L/ MZAE]\OV_2NC_]5VHU&)QLCQWN.EDOWP](C?@&N`-5%Q#!RWN4O0):2N->M\. MG;>!D&2^0U\JJG$O(JV/S[D[>`[6"3,AC6&V8%\=`3=TT@C?VG1&Z6\/^;#A!>S9%L%_[E`\S,;^D-A-,5WF1K$BTRRL;'Q@,60R[O["X(&'H MMA>EE.9ZP(ER-L8+]<5Z;*ABP&SHH;A,PM[8U)U'<8.$I+O7<][&]AT5*TF$ MQ?W0$#BOO_.Y-S8AW&<3.&#V M,\:Z!8MQ-IH=W>FP*`ID>:3^=?XJI!K5#;SVIC5ZCRD_E,_#MV3E;_Z=H. M*P'&JBUY!:DPW\>P">\'(@4)2BFWY1A<(O_P7\$D%HNL=$S09\E>7CP1[DX8 MC(015S*MHA9D<6'J#(AX_R7O>\>2#5M6Z";&``6-?KWG-C**/KUG7`@\4`VKG6SK0Q,L;06:3M5M[3J*PGQ)R*<3,1 MP"/P!N*&K?C%='75R\M2'!J6%8!,X[-D5?6*RGF%%OVQ<,)G7`UV<::1.H8# M+U/A%IW30W28NIBZWJR[]IR:Q,=+S^:6J_U*%!.`_S=1H]%+K!Z2WXG[QE`_ MAL60;E@M)#_(^8L.J\;VKWZ<S'HOCUL$4<\$4YM+\/&!^H>49[PS%(K)-WA'VWS*%QO-Q MO"S"K^F`G&D)0FP)^6PBB.-)U]:0K(&>MX9K<2'5M09SN]68;H4#F%Z2NH*I MVS]L[1=#TT'%M%QR579W_OD<$Z7AIOA$KZ`VO3`=<1$,4,4PAH-#+>LIKF^5 M"`L-WBQ?51,76;&RYD>REG4.U!J%T/);QVJ97E9)_DBQ6K029!K0O$>;1JYF*8KD-]'?`S37^(3DHCG]%"8<8&ULB&A0*\K%BU7[E"?`8M:`^R-)&4&!MZ/)(-3F=W>X?;#V#+_G0RZ_#R5:)]HZ?S>UB7LP]7_SN(23P*V"K/CZ;%.F%.[F!Y!-F)\^G=S)N6H!Z@!=YP4*F;(*EJCY.Y[/,R5G=)K*L!Q' M#H-E(4HUP'+O.K8#D@(5VG,C)S)7/5#5@J8B4-7@8A.$+##2G%0EIB[@-BLY M-=[R>'YA'272K6D[]A<3%/1]3;9_UBU>5^V+_S.M[Z`A_XF+8@?-Y[4E;U^C MG0$&YHN/$R6*DQW#";5#CE1_!`TTAC;@6-55'(WEKGI]IYCM$4TFII<4-K6O MPVJ8:>F\[&*00N+?FU&'GE=F7-:V:).#C>)=U;&"J2RO_LGT,H+I<[0?DVDY M7OZ\]YW_)JW=@&:Y_Q#O64/X?K@FGIGM?O<;"\5_4,L/@'7@#,,R"-[H>-%J M:6!^P(N:H>+%Y9YFZ,*3FL+L*ZP#B5>.U`D`YIJ^MS7;KW_*4NMIIR>5[`B- M\T&L6"IS=W@U(+W>;VS2P*JRV*[W5W&-XIB1K%Y5EAT7- ML&R;K(@D2HHOJNHR>?15L[]7]%L&>O;!P&_W;X%"&RRX0'7OX$'9WG@J=A]\ MGG/T>4:6AJ1+;Y5Q4;+L0^`>PRYIEKOUZL/(#KAU!:SR,$%C1?HMQ\;:5-2]EG_9BI')L%0-2;O<&]RLJ\P[S>UO1HLNAYF*DI`VS,Y45]*7U4HCVC$$0S,,)>TI[QMV% MX3G>J]'#%OV4WL[CO1([M`V8B8?Z&HM*&2A@\*3VO(III:L3.M*]$4\A\`8^ M'&X?!EP!+%G#)6+X?N*SGXR75/R)KB7KXC63P1#T"P2%`3W6*HXL>?W16H0R331XV.G(74F4Y_D;Q&1D2E`\MEB)HGG@*1L.+BP&(NS27%(\-;'<#XP7\^C_.,] MRXF#$X>L-*=6=82KK/-!Y^562!O4')6[(R+5(6)Y/);-$R M3H2.L0GCDDM%R6EL`G);:!DG8L?89#*>+6M%"=8'L1]V%I'5>^/O&`CSI).O M>%%R)%\Z1(IFD/O5+;W:_B`KM-]P!#$T#^*!!;;$'TJ@)ANYC_#M1S,KWEI, MBPZ>S++0D[G8NC`$-M:BZ%8JL3*I[76E[8>SD_XK>3;U9\U8L_?;Y8([K^0' M/L="S$,WTYD%2)'E"EF+/0;WF==;$X,\;$S+>4PB+IB%QLKY\Y3@#[%NC'V2 M'=<"\-\EMU!1'VSCPO17[#Y]/1:NQ],L9$07==[%-W*\XHK%:_@_*7/#]'?% MZ4H6+ADHO+R6,K6&XTM^U8YR1``7Y)S1R-F>.LBCD8M^VSQL(_:$P8M!3IV- M0>$&)W.8M(T%TJYUD$KEW<[R_Q!.YQY M70-IFK5&*VMY%;38HQ6F1U.BZ1Y6P2$VL$NZW*Z MGHBS>1<`+^MVFBV2MO/I8#?!'Y-).IK/#FAYCIC-I'9`+Q M[;DM*Y:#$B;35(CBDU0%I("[7IBDBZ,B@,1?!74`;9FV M78LLFPM2NBQ+G:LFL/*1-U^.:P;KL\ER$JLB;#)>I&^@K.GJ`Z[0_6W>1BD% M7'IUS3)WG>.)F$/(@^*89:'(1\MRNDB7V^6`J&7#S20I'Y9B?%T,I`*;39SF M<$T9D)K;:+')Z@*LCDU6!K![VMB^VB:;Y'`4G:,J'/F(D98Y6[T('&6*'Y>J M+R$>AZU@#>-ZX"T@LG)(>BJX\,'_SM/MHGGD,)"GZMFL9AR)_5Q1BQ,S+,YZ M@&MKX?FTG$R7?5@XC;I\BV47H@^@9[0:W:?S'#E>`X3MXJ"`'VN:(QK;P(%7 MF@Q+^MU@U0V`]D;7S1?T&'\PK7>F^^2L7-W/I*CH-%F(D[(H*`E@FP@H4IU[ MT1H"(B7IOUAD)VO^!!6).E]F;NWL*6N&LL#FRW#*EH,2JVQBY4M+>Z*%)O#D M]<2QA8FN%L%O96L??>AFBX2IUXV6C)RJ`EECJRSK:IL<,%8?5EG6&3S"!8C8UK- M3;2[4@F^"^N[9ME!R;Q$U)9;Y1/1DGG5'Y$-0,<]FS71(. M@A$:A[ET9M14S-X'16&VM&<9@V1>=[70$`]<6&8NC%E[C?5".3@P=5H26F;% MM!AZ5BE5^+`"'?;>V,+C8;"5A;&*6($N5LCN3W9TM,@8"BN[AP4V5S"EL[$( MN<;F!(D1@TX&,`Z6O&,%\"PLW$EHW-P2LR]U5DE].\\]]A*;""JT/8_EP:N).AHOGNK($CP886#A\KV>@AVJO4 MAK]$>$5V:$'9E:S1%K@N\1JE!.5F<01E@Q&KM.5$XF'XAOB]W_W16;'9RZQ> M%N%(<=P)COR`Q&!ULC\1&:MQT6J>?+LL&6YD.Y!`CD:L*.]LX&_94C9[GA7U M!/GBD#4M:&][;`J:GLVY-I,&6[H\E!?A(%0@8I,T[U7*I*SW"KP!8@UL%%I( MG7;F1>&T`^;$H.E?N(_DF>C84-5OLB)C865TR=$":M[LM!D1_/(OU\0M!*\K M;"?(+"(6*ZT0Q_Z+-YP8&\X;PZ2W;P[LHKQAPEZR1*,OJ1KL16R.2MO7AG\% M$ZH.*6Y8_6H7PP\$MSMCE;@N,R]3ZM&A^SK'73VB[SC7F2L M7*LK+@NI=FF+K!V8-,"1#K;'VIHJT6U/$:#\>$":-QX#_1SM!>15J8[@-EJA M.G:XE2=KA5&)QTL!=BD7C=;%Q3:NE=CW$T=-?B<6(% MO-O(03>$=3O"XOW>>LQU)0=3S$MTV+\]*&SFQ"=*HC M_^J!BH)5UW<,ZX`/-GA.C:=OWV)-X9]JR?K]*??`S<>Y7C_*/>FNDS&8),Z@6&!M? M-S59I1*Q*)>RYC+1KL)82EY<]VSED\C*9]^D<;&%)W,.>K;H>631R\*+!FJ/ MDZ'!/5LX2+,31?:#"M3`7Q`*;H0]TR+H?[04=Q/FT M+3*\\DNW"$JX$">OYK+MWN`^D"?+15?;G/:ZD'C:#D=3-9EZAX;=8OL'Q/6C'W^`C11B8ITKPUTGO7+P7L/\XOL):62GHN"71 MOD#ZGH-_A0XT^_"^;H-P;!@<3^C))#;U&]]8W['&LLT#=9YE5::(>#!=>.Q6 MMF#W&?+1-B;+>-/#GWSD9U96#Y' MY7:;O8W-(7G.5!1W)[-#CHYA[PA1*"-8\@[[[81><_N[INOPM@%;#-DB``TV MQ0ZFEAU+4^`-U=4=8("59FWID$0'8L,6P7GP$FW$-F7J`BVB;9]@?+\QEK\D MWOND15>JJ=5[V>&$PDHN^,J.^H\)]J0T83^_L0F] MW26<^',5MW214[/`08MIXU0291@2%ZOK"^-D'N4IZ#DWAGNMQ\_F8@%SJFT4 M]UI%%\;)I(Y:4!RNX?@2,L,\\W+1>X5E,5G3IAX$-8[U?O&VF*S;[I?9SAMMG!-0#`Y:=NUX]SV!G1S8L@)G?;-EY M,6-0Q62/W[29>R*(O0T8R73Q5*:A#:]%@J@RY$;SOI`N'171(+>-;(<(B\?: M%1'-V2BF-,'-RL*O;2[HDSSRA%VX:AM.?-_M&/4<8BQ@T%U9MOT]'R,YCRVM M>-XBW"_SMF[5: M#T[Z%Q_X8T-DVKZJ"H";#KI/O+YPH"Z:+%#>W:E^(*5%5CK,S**.83WP$<`] M$S,W%JMJ8C$!)(Q#XS(]E+'8ZLPV\$$XO^RP7$_Z+L;[IF/##][VPZ[3>=K/ M#<`L%'3`(_>G=-!&5@BZH1^@^8Q8$RG6?LFA;.):B*'FB8:6__5J#.,27;>! M>P!_^#=[ECYI^0,ZF#"C.IN_7DV6/UV%_CI'C3P=/"/^=,51!OKKE4)U@=PW M!*'T*^4GN1RP\E]A'ZTH+3$@F;[R9#J.N;U*IZT_+N[\Y"F6`I''UXR;KMG( MOW#_1;L+C3EA]X.CLA6X]^AJ:YXD@VYM&)H@((Z9E+U`Y^NCF3#0[,@D'%41 M-#@.#><73MK]B%`Q8]Y6J'AX%A]0L9RQO*@T:GA]TH)?B"F'QEEI6/MQ/S!.X^N; MB/QR.1T8IZ>,T][Z)@(_DZ2L1=9H2C2Q&';GQ[W13=O^F7MBR<`:^]*1?Q0X M'8_RVU$N;U\&O!'Y^33_\#BVCYMP6?Q\V400YKQ0X`A_#51H3ZK!3A"6]0BU M#NK]=X%$XPBK#LJ]>6+E>//)>K;3^-PZ0*N;FA\O,_GI[-I5$TL<&.MS3]H^JP>Q MH!J!!M5T41L0)_E7S`,9SD\&J0WX MZ!-%BRM(PCB9,YVZVI-14J)A]N*@J%L!4-Y[>1-?B.4W\=24&P-PJKO(5Q7J M-$^B$(K8O&LZ#Z'+F;@^*(]753X$/G>E-TS:PO(;%%Y".5<:&'S'"^,F[)Y M)BULGN-E;%.`;%:D%RLZ>PBF-*T)S+KK-?HJYR=0`]_)CGQ54LL.7`6M%'#$ M*U4_WO(CO5(%/*%VNP7CG>+K4/.\T%J.A[?+H"+3:FF`"GM#2ZQ%>JUXBO2:+@. M5C^@38-45N,CTM0JT7\M^K!-%'@<>TVS&G9;><_M0)'V"RFH=%?0P?S%4%`Q MZYI],KT.+ZQCBHU%ZA!4[[$7V5(OM+/.7:2"0+P89:1932R'."N%F#KQ\PL> M3)>SN#4:)P!P`TUJ+C#0..YU](H?NLZUN;I&8('.A'GKPH9*6%OCFK(#EG6` MWPK,,X]/D\$>U'K-'RWA<(Y5<(CM$M4[0U+V!E*#&N47R9$?\GE-B#D@-G(! M*B;RZ+B`!SS\/KG8C2\LW2-3;P@*0>:V,%(D"GT]%#TOIJNKW%."R2+MO'AL M^"4'!;O\J2G?^J5,0DZ([C]:$8'Q0U`D`$4S'>$RV:`VP30N*I@6BV."B95: M.).,F=4I8NJ3,%5Z<>4HG0D-U:^T$]0=_PH:QBWSU,$HH:NNBC/GL!.[)"XC M$!<&XBS`Y]C2A\!/I[/.`)]CS*1A?GXNX+\2@%31=*^KN/.!8(DH';VHKF-: M^]C#-?/39)RWJE+0-;O>=/*>W:M\(@`A%L[$ M&`"\A]DFW?"5V1H>*K?PPG"VA8*2K'X-.!`O#0>E^7\\SCTM&T/!/>I;-[0G M*6VZ7#>U)U*YI2;A.?.*SD^[Z@NBUY9`Z8\F:.S![0\NA=$R`-(F'!#0"P%$1Z8)GTS_(V$D7R^&(^;DS7!M/]LV80.B1L M"G15/1-\O&@S:5=_%HLK/^JA;A@WF6;QBECX6P^/?[/"\EC'F^5/#GLSDV1+8L6 M&9:W_CN>D]SW5&<6'[:#6MT94QZ&`QII@8.[G67^T+`J-[="TC]3TC\1179M M$E3ZWP!4UQAJQQE@;EO^#S:)XB*QIF>?B>(^9AW+U=.A$`\L,O%9MC0*HT9+ MPP,ZL!L0I&MQW#A$V1C:O[#R M,8;(.R:U-4WW1 M=-:Q#&.A86MH#KG6:1,"H*%LK#4O`A4YE7(>5JA^V1`#R([$"8-:([#C)J*N MR;5G88!K/!5;]WN\+ MX=+ZX+3X_0HSI;#-@K;BY&<9&(KNJ!>\`)>YK6Q])PYL*XNUQ,"6BO1^"C:: M?R._I??VK%0W;MX*WOY"9U3B6*/DH"TA[@)BL'+I-V$NQ4TD<^*81G!@*:;$ MN4[G<96@/`1G74&@XQT9]^W^D_Q/TZ*!P*$*>`M&.AA!%MA$7VD$L*Q_)>R& M#'LHV(7;K`F+R65BB)J,'UD?Q*+HF"\OE%T>+5DE:$2@'X[^@=*B*%K$9-?W M2\"+_P[8,]A5`01XD'11>/9Z(D7":"3I&. MU%MPB11;EXZ3Q:S+:D$%!%V>=*R` MC(K241I+%X>7&J1C@]P2>=PZO$WQRPR/4DSM'%0*@=[)R[YD-U/"'B M3P*;&!B\2KO,XU6([2!,SWXD7Y4XKD-XY^-)W$+,F;T^4,MRQ&2ZF"[:`;4T M%\RD616L^E=HAT)V_DV<%:2L.$^`X(U:>*X2;#23Z`%4SVR'!5CN_6;N-QBC M1M.^'L@:?TF48Z'?I24P%#8(%F)GUI%>-*=X>1FAKI7D[\WI>)84?*?/UBK] MZUM'`7M@/)5F=%MT$JEUL'H"JA M*-V%$1!U'G'"=)FXS2H"0E&@T^IM58M?*Q.PUDQ1S-F(^RT:@!*BP&\)?Z1B MYF7%_]"4W62X51"=H]E>T3A;4UU9]T.Q=G[QNYV%74'-9V*EQ.'X[=3]$!X% M%%E,H:9-$3!>RW2];VV-!=EJ?B4X^F[D)QSN1@6AY!6>N\7,:EKU3E%,2Z4Q M;30,Z>;AEGLT=YK"2=,QSUW%R$RS)@Z)S5\EPY&2T4=TZ#!*"2.!P`+B,%C) MIG4J#-/QRXB2>#$,SB$VC!!,@"%WD<@HV?$0C$%[N'#<^\!`&&1$RY/"_QF( M>1IUY1=KOE<<$Y.H!1Y#C#`DBB`)4F.O'$M;KXD%[RF*:_%!Q)(,'+$VM)6F M8/@1D!.,0XR!>O+.`V`>%M,',UADC5Y-T]I[#WJE/%C0$B`&!J$E/#"ZR8C. MCL4^-O(S8;,#]2\SH.ZWR(:QB,?GCHGU!AP:@9U"=YW(MN.15]_'F09HPA&L MWHV#P,$%;V^Y!X?LKL>(8);V#G3^%[RK.;*7RR[K>QJ:9ZCQXBZP?5T=@]6^ M:SOOBZU?$O+%!,20G4UW$\KO>,P;\4J(`Q@`O<["T1`0;DSG>0%.0N:/+AH. M"TPKRY@I@).M>*59ML-^\`)6"0H0V=_UH2@*D:<9SZ;^3#-=X,N@%(WB%3F, M2R$B`[\G]I=7S],B*#P`:/HP'Q$__JQQJM``0*].S1-6AO1@E+EWMQ^XK:D2 MW:\VX(?X;0'QVDZ/4(=5X$$0XI&(A:&_S!T$W.?Q.:Y3BXI,%,*V32GO%U=) M,"GC&,(PS\K4TT(),LA)RY-5,LU=XE8N#3X.I)PW*9X@OP#1%,O$;"9S"R<( M\K'FQ8&"C'/!&F?5)#S:QH-+>?C;=OPY>7HHRBCP@YCOR%0\AX+:V5_;.U#M M0`9SV%@;CJ(DI_I+P&D5;[FLZ@0]>D=PA`'[L0WNG[D1?`4QUE%!$8`8K]-" M[V&\:A048S`]\BM6S="U[T3?X]<&W>[T]_B);_O3)U80(6-ZGP'R0R$>Z>*: M2#`BY7KNAA[U\*N^9Z`ST8&8L9%F*A-D_DMI@@-E,8W6);9B:4\L2/[#S<-; MJC>`QG`MCJ^E*>_5$_&*<]@.#M`G(PHQ5V\]KO2L]KO MGJ-N9YG_Q%Q%5"MCAV%$[_4DKNE;E-Q.EPVZI5!)XC'R/:R"%E&6`%YW&ZE) MYK&'IPMZIU.0@$$#[)7@L(BO!HX!+$NCH"K@+V-MF2\.3,^4:T_AXO%KE%>6 MN=)04(10QTHXAU^'<>A^5D40ETZY*!*RSM`H'U:!HR*-YJ7L0'I0_3^SAM-D M%"_;_I._C9!B0'88#UD9$/^$V]!'6IPZ_D08G*Y$TD3"=`5*8S@X#9I%XTEE M579D2C@,J0]23D*IP+X":18J%SR&YA\*G9C.P42338\C5'\T5.3"\SFNZM)R M5$&9*2O(J+O8W:DCL_C(]C>35U.#B67TV7#!>RF2))C&?-,@V6 M?!.^\>2J:^*@H(2-;J,GPF;ZDH+%#*E%0L`XH;6Y@CX+&>/#-3DIY:%\#G6TB"S'-WR)B?8PBCQJ MUJ=J-8&*K88JBR]XU`2)<9-GT15%F(Z@4`W(=VP\F>;W('F(VL!,0Z"Z$X`* M>JA")PH8`,=A3."["3*8T-<0(GP7`<>WN-5PLLA:<)(U[!2'>F502,'O"7BI M1P-T#?1GL'Q$-7)&I3#L94JQ&VH`;#7'87(CX3ZBR69Q*>\A"L@#AB>U!TU, MKF:.=(9[Z*Z=*5GH.>[H7G/E`&S!^+(>I<53.THV7K65[3@V#*DPPD)>ORN2^ MRGQ]S)A,I*5J_W(UL!CWG)=6ZVE;U-\9ZF5R<&\Q0I^F5V_2-VK2P-K(U"X@ M;-(#LC^9EL4,7B_34--]($#&@O4)C.4:<"Q3%H,S5&6&)7M,]L,A&5H*\8VO MA$>X#D.(/9]FBF46=VZ&U#H\OZF$31\G*L%2Q_1R MJ./L'B__F6)[X9Z/5`#R3#'F]TKPE,_L$6,C59`C'C/W%DB@J93<6QD=8"I* MYR9D[0E'0/#IP=UND<_,5?A=S&R6F/[Y2F-F)-?41KGJ0[FSO2:K@X>W83JD*W:-!>JUY!XH6*[#S0H"*,,XE?2O73H)S`C?215@A9K:[:%\'1HMD8 MS&:19PS\U/>A']?WY.0B+W-YY5DZD;02S5^;P`#IH`^^=NT*V]K?]& MF@QDZR'9A&EFA_L^TJUGNOG=P;T;WIKX44G)^\%<0IW/YJG':],P<].5_-=" M%,248)(>H*X)ZK0I>@[OS<^'MFZ<)@,+O%862#F8#@\B83P&P.&PM7>R@7]> ML$UTU"TEY++$A9M!TS$_6]9M")V&AFO1=W=;J`BA^'-;)? M#9.VZE8J8.>>"Z]]TST[QC7].#3ZBM[71M/7*PF.FR#^DF7E^]HR74.]I@N# M5:_H_R(&XV"E>"''%?E(`CY23?=))YUDI/P;QSJ6UZZ1E0PN;Y2(%:3LP#J7 MHAD,_/,:^:>+HB=R6+./F/X1_)75@7,K6VO-^(4;[WXY>0(1FWW1V6 MLIIIO],*"#M+`\P`&%ZR6:SSGQPM]X^98?*/2-*;07/N;9KE1--5:=VKRTP^ MC5=ATU3,&%\%32P3)XA/K"L)0[+<%X3D'NS]P!O:"\/Z@K2!X M+\5>]SIF>#5'C&NO.4*8#HC9B5%2::S3U!B4ZWMC" M,ZS.D5]\P]UY:8MA]G6LB%I0.P8+XK!R5JPVFU=#PJ+ER6@F)1:2`CX2I]R> MR-:%\L8=;85AL*QWEJU])- MG$LQ7,<3?;W2>%X#S^/,?(Y@M`JP6JP*1K0\(XH)QJ2!Q%W%NB^G]=J-U@7` M8@:&2M%I$0/X(*PSY)6NRT5'B`F_TF'^.X@#KWBB7R0Q4461UBP\+B;K$HU' MBR#,)N,C@C%+R.5C@&:8%Q!W^24/@HIF-H,=YF69_1G`7:Y,2O1+]]46OVW3 M@7I*B[L=/<] M(D0\F%W*#Q_`N@"PVDORQ]U18QY-H43K="+@0T]EW3<54_PC-NBA2'H*D=JE M-/7.8.\Q-,[[CKPS3_NZ(.YL'857+>M\%UO?MVKSF+N`PZ'#TJ(S9/X<^(]I M];3>D/R2Q&TGLRLZPZ&QRY$2_-G-PB3-5#_I#/'"VZN!*#<4"^JP7I1Z>I/">Q5*%&OTUYR%UXM*B)BFJY4-.:%17ZUC%=0 MJ:@]&HC\9#QOD@0-KZ\/-)@OAW)=[0JB17XFS"L@0*LUZZ;SSM9+:T\%.2B+ M8X=U<4XHB]-($G9[V_B-P,^G0_6M/E)N.L[/`1CHUCVZ):/=!KKU@VZ"-)#M M5+*UF+(M\LO+HES/7$+1))A<,G3]%JYYYA66=58XN^.FT\7/#C2=V7!A<_;9I2CPL_FK.)X'EV)QE^)0++R.BKWM"?4)OYCE9PPT6K!WX)Q><`Y8 M:^.J-TP]X9S.9;GTG74J1X[TA'$&D5-S>?F!;7K+-NW)TQDO%4A':I1S(B8! M^S@T)3ATH`=UH4N46(VT(\`RK3G5REFE6/9X9@W@0[N7/U9+/1EWPU-X,U^0 M>&&2*+[NUU!W-A8AK!0^1PRL#7Q@?7G%T[T:LF,^4F8?RS'_%O1N,)#!X^T! MO*+<7EE<&'WG6K8K&[0^]\W#+?=H[C2%DZ;CJC6#FV"R"<9BGLDQ?K23(!T])FY M,RYAVS?1.;W3NW&QR,Q_[]]>S$_E[_%>G`N9EQ^7L!/S;W8N?"=.EYG"J&<[ M\1&[1\DKT!DK>K)>7>""P$_G9;C@D.K+1?2J7[I@I3VCO.3@[NZ5NUL4,]W= M$0YE'^MS/'/1(?[GSZY]O9;EW2^^#_+&4.\"=]P-];^^TVQ%-VW7(H_DA_-6 M-Y7OO_[G?W#<_Q1XU__I"\@9A3;H0I_-5[+ZZ]4[EWEMO@GP#WI)OSV:W^#? M$OOKZE<$U(.3BWPNX.]AEFG(RA?VU'Q(Y`"?BY+F`6X%X/]V@ MT1OK]6>N(EV&;;_9K*:ZX'%#^ MY=+V?+2_Y[-L86=D]JVML=L&C?:.1%#PWR@AT`::`5;7=X`W^[!FTI^@"\K\J6:@,65-99$"=Y_(2C M/=Q>_1SZZOG#?)+R/%J1/Z]B]P[WM'UEN'\YMH%3\EY*`WHRA/Q5I*\UP'AX M-41)$&GS&>MI?'!W$N\KBKTM[7"">&M+CK4"!1[=XS_ MR)IBL@;9O-CT_@1G"#N3>@_&.H\"8FA[2Z^39JQE MY5;>LR:I='8+D?-;'->QWJEIR$?\6L3;?H[)/07]0@]QJ1/9=H(^HG%"("A` M.%CXO^!7S9%I_VD^&^:+@5BY>G#(CAM?X:IE[$%];>,7_\*K,/\5UO*: M]OSTNX@B#2AG1\#!MJ_AJF%/LZ'Y6--50#Y'=*\/[HY8L*0MHM#&+O:VQUJVLX;;7;AMDG*L#KNSOVHY=%[Z8'(7`72= M-:QE@-)96'=D)T8`O]DNFW@K`_E0Z!W,>+BG+^#T85@4,K%(\`3Q.^8&N_Y9 MD^-D83P$ZN+:X]*59MD.^\WK\.J-Y!T@X:D6],3F MMJ8*TNS-U;O;#^PS'%%^\V'6BIG;`O=J.SW"XFF;K-3B&,C!G)23=_"(;`6= M[2V0FH;+FGW[M\`[R_PGZS-LQ[=81.7P0`B[?.]TV1C!44:%*PAISG#IC1M` M%A6RP%'N=N>U?\4YO2MJ.^1AU@N8T57U.4'>[73_F/=4DW!=V)/=!`JBX/,7 MM+;,%P<`81J.)[)Y_-I&))@KS8$_0_B]Q=N1EL_X==C6W)<>'M]'^IU3@"-D M9YB5X7LT=+#3+IQ,\AIYQ:;-F15Y!_*,:F/!ADT&64Q&<1O])[^Q\4NLLS;0 MX@EP&.`Q3C!_(MNQ0%IA!("'NZ!?.24[,!?*63B(7'ARSZFR(U-:`JFYI/Z_#,3M4GMB^!>PY4BK`] M])%`E2F_3-2^/J[E>&6(.=4-!$EJCVGNC4T(]QE4#6[V,SV!G;(R;?ND68UAK^2/B]YAY**!Y./LFC=D?WDC?:(<;'."MIQT]D#5M MF7+S0[._R<`ZWWXWMX2I\=YOG^BM^Q451G2N/^"#(%V!0%.`774@UK5T]:L@ MC>>S\7A\N-HXV/4L+;!\AEZPT&9L&BB,]+=&W!\^R[=Y%]=1]LJT8XZ]&2#9NU4[M1_PFRD?)[K1QV M+4R7J?"ESWTN.*L2Z3:(1BQ-HFM!G%X`!BJQZ;64OC//C(*D(["KS)J`LU5F MK8(!U#V_4-7SZ'+'L>6.\^7Z^\>-;#S(8'O17(G[U1G-CQFR<03X MFF!,6S@]15=)R_+]#\\+%CBL6S=BQ+F8@I."X->^\A/E]%*0NKZ(@'IWP?7$ M1[R=2,X!?"?_T[1NT?424O666`Z[ER/VC:'Z?7$9C9MP*:1OG=HQ_($BAEW; MU+GSQ3(<$@'B[)`'M/M0FB5`*09B6L`.,!&Q+%G_&NU57M2BGT\G%X89N@WB M6Z16_NX'%AZQ]_EG>4L%QF/0"+VH;VL\NQQ\^.]\-@V\UB(.N0D:5!=W?-6) M#HLI&K)^O_IH&FNZ#/8V$%<;S&""2\"^V<^-7,\8`(&@2B$ENQM">B-F*W5RP3FM[H&M[E$`9/8!R`=RN%=WH`T8A[C-[/:JLH M"`1V,T(;"W>@%]6$!68=9.BZ1MK]LWREUM]++N`,H0L.3MG7>#IMF1F[L@@=N;YFGO765FP$`?C0&10-5!E!I] MFN?60'`+HUY"@J@XFX]2_U+OR'I&W&V M346C0-%0JZSK1#:YD(`SW/TAP.%W"<@S\]<+7$.>+T58PY/O5BBAP:MW237QGA%&`7RS-4&C$1(V> MS,4T<7#6#FT[V#C1I2E)EXF.T^SVZ]EL=IGX.-7;*TZ6L\M$R$FNYUG"]7TI MV#C1!SV932X2'2Q/VF& M:6G._@ZK4X#>2,.OHJ.\_Y<+/S/?^YWQ3(K<9Y>]X)V)LRRY/7K>#01RBP[`Z0F5G;'"Y/$KB^LH`_B<&GBO/-+*^)-2&'&69\6EGW:':YL MT?F5%7)YI)"L\[Q8R'F1LLE*Z29MRH_2S"A)9UY:>F[`9^+U,):66?0](DSK&4:J99@B,Z4\Y9&N, M36!E5DM/%V%-*#BW3+DY7.D)?3(B==Y/;)0QK:_I1JUP26>!JU-+/*5U:\E^ M@I@5:#B_<--H3[CV6/\#4^%S6;\'_=!3]D_#,(J\).;WO>H1*J46^[4LE^=O M`-<'&K0'H\@+\T46G'5)P`ZJ`_3ZMGO*0--=LR;Y^Z]QQ:-I*;2H!P==57(: M1J6475^$L_ MM&:+S*9GK^;0>C/AQ5G=33^;`/SGCI"NQ0-R<79]NW5154R[KN*9+XF MFM9$I\N>XJQ%02@M\_M6U],GMQOBL9L,T&;CYQ+2]-"\6"ZCE\F+NA3+#JJ/ M7PYC-5AAN2"<(RUDY;P-@3OGD*NE(W![)XC$S\>9VL5`Q#)$;/%($_G)(O^* MH=>]N:N>+S5Q&NOET[I"]MB[LJP[5R@K+,6SN M;4-[C%LTM/=TUCR=3#7>F9=[L0%8JS.0(!R_;&^/I[R2N[0Y`M&>J?TAH_%" M&VS4+1>[X9+HHI]!X.>=CL\:*)?M(5J(35"N-BG4!9ECN;0+UW9'#)NFQS9[ MJ#6^N05)*KK"=H_0AC&S'*>8HL-QG;MU7DSK.['L/Y7;0XU;,0USTX2?+O/W M68]MIL:O6<59$_B\G*.--F_.Q5@5#^4EQK9(RZK7P$5CF\[FA#S7%&UJ+9.F M(LX*RH2(#$B-:IJ?WP?4097@T71D/:AIDW(]^>K5@CF_'.<+F$$M*(Y/(3OY MJ36UH/6-&+M7B$0F-&O:#O[:2Q;VE:M[#/=5G5_AY5A#7RRRDS4,M+)="R\4 M!LNH;(SL;)*?_3:D?5RL#?9FOCQOKE1'Z-^FM=?!8_XS2;?D<+'_M1`%\2]* M5Q6!QFT1<9J?"=)CM:/II'->DO+=/J_;MBOH5AG,NL&L*\A>'TUC?>T0:]L] M>=XAL3@8=ETQ['XS3?5%TUFU=,UP9&.MT@CNY193IORI_8M:".#I[_+'1#]XV_DX(WBA.K3K6A MAEE;#=F7Q*KE8PJM\9RRI%N3MAKU.U[4*=3.H@TU)N8Z(M2,C!N,:F2*E8OI M0:99^=6T:7;QTT75B,^T)=4MCW+F&)B@DKDXYB<%^GZ9M[F5#,.6`TQQ.L[FM:1%.U[X3?<\Y&]G@#-/!#P`85CKR M*B%QIH4YO@?UD"(5C:AS%U]^(IQ%`$/_)BJK?^3JCK;%]ICL:YD-N$H=!2!2 M"5C0:.%S[LYD]9W6Q/!Z8N)[*]=Q+5J$B>8>>S695-?"=IKX^`[08JHPF`&+ MU90-?&EBD:>,.E+L=:*ZBH,NZ1&7BK:=9?Z3*%BQ*7U^K^C4]4Z7#0,AL1T` MF:RQT!0`LI6_,_!@A;A6V\;Q1]Q;ZC:@ZXS]PL,;`11/1-?(,PZ40[-(,2Q& M$(\2\*)]M(H5+75U4,AJ=+BK+V!7W&#FNFDHFJX%/(6(PQZNKF,"?_B=71%# M2$1\(@`M,BSU84]&\6IO/V$U,1R/E3+#&F,1A.-PK!%LL1ZP[%D<;D]D8$/< M&NHAI>B_X;-7>6R,;&*[6Y!QN`^1OJS`F-ULT]A)L0:KOI@_7^DOH8E).E-? M#/%^;H_41(@:(Z^HOE@3R.U4&:G^E_[*V/[MH+,K5;DNA#L+=&AM!)TUN9;3 MI4L3:I'71">F'3H1I.+LN9->H MCS6Q#MK+AU65-A5F+L);U)&-;@I/GGHM)7+IU#X[34?YER*5H\W:$TW3T?DK M*K5YJ74&ZO5>J?F;^61354:QB*HY;'?V4M:_619@W^[)^@I=[5H4%:(T2C'3 M7E<8X)MY`8'2(X;KF7+QV33".PEN2V2=-;"@9BCVQ2@4^-L^&XTO6ZEX(Q90 MP3N[)SK$)T)%/%ZD^O+H7]%QLOI/UW;HG@]3>FV,/.;,';TIZJ56,ZY=J3GQ MG&U1@HQ'=9=&ZH9,Z2:_U:W3U!9_UYZ4.5,)RHZ3N9-A_BV*H4D!47P!=4-Z MR<^1,[]%ODX1:X=B;#EM-A>C/;'Y/BN^IR*).M_A4A)'54M,=;P):_YU4"TD M;-$7/AW5&KC]:DG8ZBZLJN3TE821HX-]'`*^PRZZ?OPOC0!]PIAE&I`J_V#! MKAH+J?ZG:VFVJBFLSVT0*:TY7NPIL5GPMC^:'YMJXV`6V6)CWLCPY`>LQ&`S M/.VY/T8/H^`"5':=C6FQEKOQ8%9Q/%["GY;IKC=AYUQ\YEFV--.U:?@).3[" M(C;"B+NQN9UL.7Y4KZS\R]5LS0_TO5%5&/9W(NO.YE:V\.S&068\"P$FNLYB MMTWE^\;4:>2WO+8(1JF;Z(IQO5!O3$+?&MIJS]YS8<_8-H"&X"&^_,7#GVP- MB1*_W`X6:/FAPE$@57CZ,@.O:8]GFNLE;[&%&-+#-3`8>VW0,&7:M)E=E]OP M"V"0NWFXY1[-G:9P\\DXO=ORBVQS_QTL(!&>+0AQY\J(NUMQX92,[`1X&UC! M@^K%='7@0OG9M$"NP$:"':`XB9#N(#0<^,=+"/#2#F`&=-$3VZ&,LB,&\!I2 MW"*Z[#!&BBB,49Y`?HR@0\/=Z@U%?F!=`<9[+!V"E=*15=AW<U0+"\QVP> MQK%W#%9]']_*J@E38=LU@K;< M`/S.9$QK1],O#.!)#NBR!91O[*JLW`1CWGBQ\OM0:`#B/)K`ME8T2K@7S=DD M^HT#EHGU3#S49+$RS>QH)0)_42`"7RP6I)]\YB0GUZ)\\'2%R-;.Q:O^$6&1 M0S9(QJTVA>$ARCC_%N:MMY?KIEJFUIU.QR:DX5M9Q\K;:8=M/=&&7=RP'N#)![QOT4CT.+^'/HDO!_^Y\^N?;V6Y=TO=]3%!J;;.\U6=--V+?(( M>'^KF\KW7__S/SCN?PZ>)/8765.QDP9ZN^'AKV3UUZMW+BO%\$V`?]`&^O9H M?A/$;Q+[ZXIS#8T]^0=\$*0K3B6*MI5UP.FU=/6K,)G.@0-2(`OFJP2/$(-' MR(5''(^GYX1'C,$CYN-G/EVM#EE9\DW$R:09 MR,H2S#*?-9OR,EX(1R\8 M>>X`:^7I6)&&5U$B7AVAXMD1RZX-37K)CY>+@"T/OWC5=X!AS8L-\"XXV$5: M<-'+GMG)>WJ?!>]:9`4TH7_Y=_HQ:Y<6QF=_9:^93+#VR(PO&&/N&AC M)^^B%2O<(48L>\X$P4O&!LKU(<]R3;FNW?.(97BGY)-DPK#U?,T\MA M$)RFEPI"6*`$NZVE$1S^E;0=S*#++[3>GQ$\AH,00\8Z=J/DW3J.;6%/"8MX MN$JKT$?+^ZFN`M\^P7Y#`]9E<1\R7F]2^U!;U5M=,*.X8&+KT@7L`'C%TIYP MK3Z%Z1S.!G[!D`Z*G2V1T2*@U?5`'F#P!D4GOF&I2$PM2;8(2V1=@COR=T)7 M@]?PBN?">2+>]_"X'&$EC!,`6JKT73Y!#"JC5%C$VM54BE.,#"&1!?%LVVHK M39'9WY&]Z4<.:-N@&*)?8XZ90CZAV7J.7.QG7=]'C:X\"RQQ)!\T934\83D[L$*:@[:L,GGSV.H$M M[2QJ#]32KH!Z0?4:R?MO>>Z$&T.ER8XW3)>MDR_FLP/GUPD@G7U9I9U,PD3* M(TTG%E;^3#K#JORVENS7#QK,3#Z"Z:PR%?BU.:."+I\W&:T\+M\C!0:]AA=] M8*=YU>(3K4]9B7F;^D@4L.O!9&*^#XLRGJRS<`"TQ3;:SN8YQY)5PADR`L+^ MV,K6=_C,\@R`8C0"G(YAF,8U;4F'(=Z8QD#M/;"Z7X-9NVK7/17G5M MOW0]WC5>ZYK!0L[!MB0ZS0M!V]G9H$7).MX%1?J)[=`R_S@(6;DZ0/),`O]& M&([NK9OW,DXL&FU.72?.BXD&LSAER1V-)T%PC3!':.A+TW'"X4(]#K)&PP)< MZG`[Y!<:A;ZBHL5#\5,4^4@M)*=L,?<#]:O)EK5'PM)AX]D`_IMVRN3PC9W& MLHQ+\'F_^<%N9YFRLJ&Y#[GPRBS7`CDP8+DX!V%]?G,+*/)"Z#V>X\QGSX<; ML-B*!+Y`V_9\8IBPH5G4MX/.+X(O>2[`N,=,T2S%W<*^H=XZS5#1ET)"4@1X M\]R86WD?>J$4!$:F#2.B^`R\BK@#HZ#HINTYX^)K/4#Y`<)QA^KHH:(NM#2" M?C:C,\$*+=A3F!?#_%G,P\G2HY*PTE_E[`0:D1?G\<(`T:F2V1$970R\Z87B MD(XO-P4JL6?XH$E)2!C79HEV/I>D"08'<48]J,`'J.S8Z;VU^7A3%734P2JFL.*:%!%)TESH^0X$0]EK!$P;X<&V9+T!DZEZV8#S6G8(H,G5'6YY5 MP"20C3,'?E#?"TGO!"(-8V`GN8ZFLU0LBI&=A>S$&`GW7.C1-FG;&LP,Q%V7 MR$]\HI%SU(D?HBFR%(,E[^T\1VWT3;^Y"O/5HO9G&BSIQG4\VJ#$7O M:'-[SME_NNJ:.6WE)]-U_*Q%HO@)CDSV>RX<'`$M=M=F&PN?]FCILQ]^C=BB M;N-#GJKD_\U1AX]KSY^)\_Z'QY1!]_BH`GUC?[M??5M^D\8%`U]`D"5T_OP9 MZX7QFS?0MSO8C*L0'\EQW^X_R?\TK5N4(C<_-/N;K+KVMUO@`>;O)S;8(1\] M3>\3#<0+AG[P[RG>XLD*Q\8#81P3#O0[R!^6`NO]QH;(Q>!LD@R9:`B!)0S6 MQ?@@/J9I(/.-SYDT/P,F[XQ:@12FRP-7<_ZJ[5XR()!WB`I'TPG'LBXPI"T&#K#E5?PNN#?8+G9'OK.X-YHP5F13#CW MW!.V9XRR'ZEZATH5:@RLM#9JDNB>WT=T-94\@?%BV([E,L=#)67B"*NFLS6[ M@/;>J#NL]QKV6?JF3TY;`W#E0P-G0E.PE;\FGLZ2OM?RP%$G;+T7?M/D1=3! M?-4`*GVJB+-T65X;1*5/EU-1A''<]9[]TPQ0<*8382A-'TE*7OE4AN$$BI2' M@89>W'JQ=I64;6%\H,:FS%$5CGPT3-.EW7$PP.:G!949]P:G^7EE2OJD-8!6 M@W0Y&VS5Y4P1T#[BO1W8Q5_A.5D_B\4QF<09+77*FJ$*#/LO%CI4G?T7738< M&/']OUQM1PW]_>-^1T+S_GZUTA12T*:7$O?69UE26>:4)LMIXU"=&=&3\;(' M2WI$7Z*Y?=C;#MD6=0N)YU]8Z7`2:3%N'*IS<]!BUH,EG<)!XN*$[8[7;VNB MOG7WINO+AC^1Q*64!4^J M8ET.@@*2?"DL,UGG*`3[#_0*1=LBXKP/01N5-%E8WH^?2%\L,W,29H/'E]/`JK\9?@'ZE=X_!TM M3?J%1B"]0KOL#>QG+. M>KJ0`TZ;!.ZE%+9KE%VR0,]?]!\&!C/Y2+HUMUN-:E4?"(%!L5`LV%<7)>;O M/G^@@C[OD"R$F02"`=1'#]1J=H(D3,6$7A(9^\19SZM)3>;3<0L0/[A/-,4< M@V;?:9CE;:B?3<>/XRK@1YPM6P"[I!00DY5=JD-9P'J>3::USWI6)A1F8NU, M>((BGE\S[!2TUN*`F$V/L'NZ^5\.A'RV.K;Z7`@^R8[+6I=\)3MVVMGWJ^#` MNS,^`UR/+T1_)I],;)AP/EA+@U)A5?\@LO7X8E;=S\=V1U$8LE?QV324.GA4 MG"R/R)UPEJJ05,58$4AJ"O\K$[W73!7_Q8C#=5[C0CEC]"CH*,M9 M4)T7E8=)-BQGB#47@2.HT?8BLWFA]B(I;1SRNHV4?*6)-\X"5KF:P!&TG[O' MAR1&JQK/.M**(UIV^-C^[3AR7UD#%3&U/G226AU'Y^NC64J#@U9H5FX;9Y;2 M3M_831S>@7WHQ\KK8'H=(O<2ND=TLI#YC`>MN!9\%SP0!M+5!+4XX>>-D*Y& M5:&1I!VT!`I)D:.,5[9[7M/4'R].6-_)?07+O=@F7OCY&3#3^V,VZEGG5,^U MC@4[:(T4V6*54?W>K$Y8[B79,W8\BHN<_%[B)07^:8='MWOEM'6.5AVJ1:Q. M^/$LOX?[60ZW(CMYN8RZ`.87+#D>L2MU+B&*VSAUBH,:9FU7]YY,\\^J>E%; MN]NF6Y.V2$Y)X*?BO%/D[)GF_A$+>?EW/=O@"JM&E#8A:MKGQ#=%C(-Z>B`V ML9R?&UK+Y=!_QD\+*$\7P`''M;=7IZO%;T(K,L`K:CO9386BH&^V9BK6(@\' MWFG;#3;AEY5MBYIY)R)>V1ROZTDO/6E93L?$4L'REA@JK8K[!A^[^J!9ML/=^-]>_8P% M2E/J;;$ZJ(FGN3?:SUC3E=:R5[VZGS3/@)/7:XNLL<9JV)S-"BXH\4[!YN1G M6=-I9)!703HHEKK/KA0\Y6$_Q:B+;V<_?O@\#V`#W%M3U5::!W98FLQ?@,W8 M2_=RJ3D:F4:KJJ80.%G->#2?'H`HC,;PG_R7I5'*^O!E+#I-L):J0X,G80&& ML_%JW@*=:5E=KTHZC$@QKLI[VID.WUIIMB+KW+]Z[VUHD!?+,*'%M0[* MQA',\6.E>C^;SRS*1Z0;9W*9M:!!/OS-U?><.,L5#_C#`Q9%5R-;_)@X.'C8 M:RC'"J3+G./?'](BP:9!0C9)TL4K&QR*C5V09Q3R5QFA0`N%R[[O8P];P:$5 MK;.&^)MLP,[8@+0-I.&$=?!EA3U':RS# M\>XU)&!4F/I4P"+*7K5EKU0UM@G%'4=3BY[V43KQW,ZU;%=F],`?OK@@\W&# MW?@-%QB0(T'0Y;M@1*9'J;Y*8*6D#R4.#Z*3;ID M6KO?4,.V%G`,(?&#>T4&1AK)/6+3%@"J2SLZ)EC[8N7<)V`$T-8I`Q[3@KB_ MF1KR(`^_T[U+3\!0BGTV1YR4(?CHU[0:,6P]504:LQ+7MUB\_9JSLE6L' MEF='*[&R=]#%DC9ZA!VG[K891P8T-77-`X(U+7;3P_L33R@+4UQ M`C61MN(@/XBE:+0+$6V*@TXLJD:`[G=MKE:L#XJAVJP',VV-S#AISV&BU).) MGE++4!J>&+X]`BW6K@GD\?\#L60X\0%/O(!G,<@?Y3OK+7)#]I813_BKQ#X M18IX#[JKOW][]_CN)F@O#VK^#ENVH"SV1"'E&"8Q&&C9DH(R.K,X?*$9@.OI MFX%4B@V)/=:++6=ZN!SL!J[[3BC>:P`5NJ6B^SM$7M#%G>FL0:OW[`Y1R6GQ M5`G:3V`KJ,#:.6$PT^_#COZMZ"G(#K>(LX2M-K88#?:EKFU92*#?:(F"QHX$ MUI.=PL5:X1EQ[!^S;&?3LT'*V`5^NPX8)/P1YPG2H`*J1C::S6S_^$83RV\T MVC"02E@Y5+*HG;.SB"/[#8?2S$496S&QQH6LL1)K6J8KKAY[;Z7]@#&]+F!4 M,_.)Y/DKXJV:J(@/]9653GYH3X&78DN(PW!`.QH^$T/V;>]@`)GU?<,30V-, M3IT1E%?9"S8"#^!%,\T8CB]20%-&2[`\.^Q"%K&2Z2NT0U0F]9E]M*7G,VT^ MQAI%^@HM]NFC7(DN:BI9+1/W'WZ5$+YT)-HH*6Q?E)SR@:C>FK9#SU_` MG2!>Q[1@?(9Q&(P*'*#!*6S['9-L;B.#VOQ$T$(GV*P059ULKT@PMZ\N:TRZ MT5VX(PK;,DF5FN?<'>Z)PLHM[W?_@]/'=;!=(;40/,L&#>8GP!FV>J*B5R=P M.EJ4B1G`O.]'_KF4-SY]UH.K@K09#YU,S&"P8T.=S&'(5*_&&^6UR3O=%^7M M(L]\8T:0@LT60P%XE+F9"/5='%[C/D`_(IQ$T)R%M_%HFL#;CEYM&&"=>Z"[ MM'11DNHA5QQG!\"6;6/#2N M-*E-DJ[1%@`X6ZF;\X(T3RB)3@JZHHUKLT<#Q5U(JIR'HPE5#^SV[]&C^2Q^ MJ2B.UHIZ39?H\=O`\9)G*ISQ3]=@6GL@PNZ^W/-4F8L=D[#C63/3WX$DZ-'Y M$X>SPG?T.&I!"3'=V1%$B3\=L3;">OU7&::64`UQ\< M6JFL'>_\BJB`_QBJ[)C6OA!2)X=ZG,<.R34&*D92Q4LNG+*:7>S(%#)/3)Y= M-;O4;8??`.(\QTAT\K3;Y4/H*:N8E@8Z$PX3G,9%;E().OC2+E/I?;'BTCMA MSWK.NUHU#P[]\9(R!C7\F9\%OP_<[@]DYWB/C^F#D=<#A\&>R+$P$.8O\*Z* MP3S3]4,%.V!X'WU/LDX5O'3\84]HKU>SC[OHDH';87(+;?>@U2P/Y6%T;Z1NY#1_Q9=$3$+@ MH+?YU,V$$M%?#KR"ECD0BAA^Y%@B4B-EB&)W/E'N9TK:@?\UZ]4#93$SFA[B+UMMYJ?)@X%>8J@1RCOA:FT/#/'HH(<9K'PD:(VY MZOFX`R@\%>-WLKSG#"(1^4+/5HQ72AB`:8=$G*9\0G)I"7&9'"'N)_1"-:@2 M=22IW'-)I=YL5/87-B'A;H*@KC`3#>'7XSD6P;ZFHB;\\V!/\E1+@J=8.3J[ MT6)T81^+)LUXV*:$$ZZBX%7*F*E6S^F#YZRBN@7;[\>+J=5= M9^-L!9^.XK=:OMM9D^DB@S=?#*LR-U8I+";E/H)3K[PTGUH'DXT;YS3+=W9VA)#J.L*[(#_XU]EOF;7C8$(*=.F^" M..5WFJWHINT"=&_W\,?.M&6=CFG?T:`[T+/Q&2]L1[T'`XYY-4,H?H>96"ST M`UEO@SZ837;1+('H.(4^$^=6MC=?O%R8M_L_P"Z],SZP2`!C?8/Y((?=+JNV MC;Z>B.-X?]/B@)QE`67;,5\+4K)I9LLK*-L.^%J8)MNFU+P"UK7UC$Q$NRP7 M6$`*(&=90'DF&B?:SK:\@-(\-!,*<="I\'O2]FP<)(SG8ZG(`E(`.MO`RN&BGK/,LA7*M5)AI%Y,#H5$3#*5D[W)Q('MK!Z,9 MJM:]EDED+;-OTKB@+!*G![*T`A#S"!#+PD!(TG)6)U7'IW&7N!0F]3.7&-UG M!63K?%(K+DZ3\/.9="#@:X>BF7U6\U(FD:7XVZP`51>U`C&/`+$L#(0HCFOE M[_%IO`68*"%R7FX4!2\VL=^S91KP46$Q[E],75/V[-\U-?O*#7//;D.?6A/G+!\ M!D^CR3U4TE`5V5*]*'&:3D%+?0`LLAYDP"4C`3#R"KWF])(]3,R@J9:T6`=+ MUV+A](%3BL?8``749PS\?\G,H(PZ]#*\>V6W2V*SN2A0[U>!UNYYQBH=+=/H M]A^#)(Q`FS5?'*S@Y_<_=L2P:[8FI^-)HM/@P7Q5P"FK@TP6T^GL?."4E=63 MA;18G`3.FK+,#5,:]`'KL_$P@G69DB--I!A-5 M!NA$@V,N"..3C-$)$EH`J!2;J?9[%R;_S2U7A+/MM-.4_&E MQ>Q<`)VJ[D_%V:E[[2/F1]L?7,>UR"?-P#HX7[RHSJ^T+`6-LZO6:)CYUM+` M*S3[V2`/S-XOLH5^TT?S%IZV9,5Q9?W&LK"0"(X7WFA^-HVO-%-=Q5?V13NW MCZE1>`D(.&'U8FMKKZ6CNS06)Q7@3VWZ7O\RFF)E<;ZX2&PTSM] M([9B:3O\"F-FP]L`]/PC"MJX*N-.2AML]W*-XA@O:J)8]E+=`Q3C[S[F7]6% M6\9-5Z0$F5_#FA6L5[RR64$9:G-+:$7K6]/:F8SYN#=7?FF3JY]935^6DLZ* M6&,4VYMX-JS_.,NYO?(NXJ[P/NWJA5S]',^KQ;)=J*[3\53-1A&D,H0^R*DP2E MO6P&/>4^5LG-Q'*[\1JU:V(H1PK4%KA>/:L\3HA^1-X-*X[S46-EK.#I`@Z& M`A=$IB$].D$5`(JXX+/1G0<`J&M*'4B8IC)>8HJ*4!2PG9:+LE#XRN3]"C.Z ML'X@2OY;T\Z)VB@==)_(>3@R;ST`EKT_E2:5X0LJ:Z7#Q0`;+RE@\)']X5L8 MF%CG^(EU?K(8-2FBY>_\.6CQNV3&F:\[W:+>=;]ZP!IG\9PS6@CM!HX95@R, M/E'8S2!E(!]FB\+.OD*3*8P/;8F8[^,K=Y,%1AA,N+>;W>Z MN2>$\];-(>Y2K/"+L[U#JW`R%MY\_YG[&K``Q0&M`4^;Q^F<81K7P)Q@G1$/ M79YIZ;VZP^:=/1GVG,D,)ZQ-/16=I0-K:$;>=A.M)0; M<9_2'T.C#LQ.!3D7[$EK3TTVL//_B4&UV`F%MDG!X0`Q\MJKWOQ'4)"2PF+3 ML3R[.;(:/EPIIU!D>',3KUXY*P7'NBKM@DQK9C9J6W0YL-X1&*`0%L&D2=IH M_'XESP1[0=R:*JW#)BP7LU0_@\HBA@\QP.?7FIX=5&SV%AJL[4]QI/*LZMG1 M$J.3>.$1_LB3:;70LFNN)ZJW(8=XN?>L&0WU,@39^)'(YZ#4?48U)Z\8ET@; MK.`X(JU>"&;VC@5MZYG-BS),^%,%:$(,HZO#W49P&Q$*:#_4PTVEGJB?5%IIVHPKJ$%JM5N,+O\,X$.YU8 M_E@L&8*E5V`Q'1TVH=_E)0(=;?'#8`LD=09LH6\/&P2M66,&?T_9',@V7?LW M?'M2-5PVG@+`K$TTG)@(P5X)>_P!X=MHM@._T=Y<;#W4D>FW>Z%U8F/#[$'0 MRM_IZX;#6K."J/?\URM9@=&\]EY;!(C3`"L*\Q*[K.O2L2D!1SMY#_]>TV(F M/'-K^EU<==I>ACZ`71]D??]OZBL%0K&>2K3.)G.[1H?!(KN)1!7R+.NN'"E% M";`%E..128+.LQIMM*,27=[32I%^64N0FV@K:]AMB-:3='W_/RO)B[V27'5- M'%P5MF*A2,,,')C@"1C).Q915:%G`6NSPVI1APUN*5(T__"U]S;8R#9+I'G: MPG#>$G!`SPM,N^C24MFFXFYC-S=P#.U<6BF6NHM9:Q/%0^F(NS%R-Y.&E;T! M')J)R$I)8_E//:*I^+E']&';7:W0S\MJV%+%##8;[D2\+H%#QD:%['?S!6N( M8@J2X\88`TU75T?(5V#S>XW>?$)5<&77=H(='(Q8<=3+#?%/V1J]E0LAX;LN M,&.M(!:(6!.74BT@WAF@@E!>K(0R:387T^`)AC]]\@()1./9"9-_K>[57J9. M^S4+UWDS%KJ\*#JCJ1"BVA]@+W_UJP3;]ZN/Z#2Z7]VR^OJUUMR9BHD/XBU?IOE8>$:?322&HHR#4#'1I#I$2,9(G MP9SN>'L%7K3IB/.73]6C8.VU.=&:L(UB2R!1_RT&0I"@KQBKY0U:9Z/5O&?S M6JIY"T4J?M#2XAY>"IF5X.OK3W,R7MK;(?-Y_7CI_5G[:,F&C?=R[/KB M7"?N:6=`BYMHFMT*IJUCL#(VV]MZLTF*"R?5_RWMP7G_&(\'(RIFB._6.2S\ZL[ M&#\2V\9P,7?KLG`VE>PLHFAA$%JTHW>GQ,&%G)IOIKPDS%O#;!-+_/ER^:8] M@?9FPL_$]M2M5ODF1>P>GOS">!R]2I^WKUB\\KZF+0I9D9\LJNZ5PO0Y'P]T M[@+K!"9HTZ(1I_GNPS,R043.L(_U]<_M=[[0@7O&+P]D9Z?Q"?QT'%?H,7+. M3[W0]Z#)/A/=W&'.B3\JS71YD3%Y0S'7AO9O5M=(,8U_N@;+;*&I%JP(5)#4 M$:D#15OP8B6H$??NF*;,$18^S\$S*I8FDFE+ETC2B'(0G,#R2@,,()0KEK.$ M0*Z)02R954&251A1LQT,Z7PF_EPV_8TF5I(C^8^+>1QM1Q(KEPEW>TYFY7(L MQ0GBYTLZ6/.19DW:Q],F:\J:+!$D6S"\]K`N0_E"/8M$Z?;CD]4&6%A5,&N, MM_MX"1!_.SYXO%BT;N1BTOT%^L_Z:PR>*5SG-EF:HL.+#((6X+D/V@_\5+@/ MW7S1FV4&%V!WD?NOXK4PE[U9:/R2O2SKSB;)E)\F5EH@`VTQ/DB+:`*PQ@2C M),S;X+$3%G@7J$_O?.VIY%J%E&RBSJVU\B$P3S24[O(B*QP"2Z&-0^"T958Z M!";+[DN@>@Z!Z?@,)/U,*N:_BF*R8M:1J>H!JD!]P\FBH-@N#E3=#6!]$^P3 M<>1WLB-?E7$&Z&W72RF:SG>A95(R4@'1^D<'A:6RF@V*:3/?0'`WAUF"SUZE M)[^\@HH5.[#X@ZX]AQ6:?8>#S*J^/NW]NA[X(SH0T`5WK6L&X;:T5@)'?BAD MYU#3_;@SY66C*1M:C(OY/>`WKZ*6[6ZOS=4UL_=5;8VE2]CH6&0+1S5HJCZN MB::=6ZS*EK+!DB'4.^*[3V1:*1JK#GB%6XXO=Y>-4=GV4BKM1A,JI45^?N), MJ)J@V)?TFI8"DSBZL?]K(0K"7[@I\1?V)@>3O8QT@FX!%0!`+%8$6P&I>.J^"PV#4/&K^. M`4^LGAR6Y]_#"V>BT-%KX'9PQ%!A$8.\R#JJ;KKVG>C[`@C(OJ^,?BY['Y.P MA@K:4#593T.AC*%0QE`H8RB4L1X*90R%,H9"&4.AC*%01F?C#+L8@#T4RA@* M90R%,H9"&4.AC*%01N<.IZ%0QE`H8ST4RA@*90R%,KIWU`V%,BXI$74J[Y%H; MW"W6]FB2:D!.K@`'UP$(8=Z;AA# MVKGFH8_1QJ`T]Q:3;6&E>S\#%L\=VBZ+`H0F?5L M?R-O&0/3`F0;4%#^#NGRH[\U2SIS71;6+.=B$6#B"V!'T7LH!U!E^+7PVE+-$"H4@ M-1LC@I4HX9EG3<'B*\_$<$E^UDGWHHPJI.DN6HMEF$G\?%YW@O6`[2QL"[R8 MYEP8TMD[3[DQ/RF0QM!:!N9`N*R\V06_*!"R-Q"N@X23QI.!<+TDW%(:"-<_ MPLUY<5SW&3=@.PO;,\!V9DV'V7^;AJDM=`E_KI,N'GBW[*L3:1)DPS94R*I9%B68QCY<1%,1M!Y2R7 M#EY'W;/(;PP@-Q1S2[B596YI.H!FN/!U)SP;BS,[22X)JA,T[OZN\.))."QP M6&"OH>K]`1FF1M6HAW6K'D^+;F%>G-5I=PQX]8M*+F;M5<=JL*AD_4[%3E)3 M;+'6V466"&V3F%*!#@%]Q>LK(^:$GTT&8EX(,25^7B!1D34)NG8_,YH:,9:-(7F8>T16@=07R.H M9[J,;%TNG^7J\36$@(F3_%[,`\;B?5$:BV-O8CEU]LYY%9D,;Z1Y4_&__:?_ M!6Y_@1=JO6(>&*!G##"I]5)Z('_/R"^,^7%VU/S``1?/`07:?`X(BX5^7*KS MKR(?7'Q#OE8#5";YMW8#>=J[.UQ6U:&'=HE]YX')K&K"9@=X8!`#%8KG5-3TB6FF0_9'%F:&A*$, MS`PY9BUBIJL+[+TWX)VFNTZ!7*&&]:H1+#^07#`X_55FWOK+PU3ZD_.G0HK@7H M\:A`$.V`ZYIP+7;#%=/EM+=.TJU`D9"AU7T'R=9A3_)`MFPI.>RV/I)-RH^3 M',C6/;(5:/XQX+HF7(\SJTU=L'WW+E)0N8R%-W0I.8'!ZJP`.J#52VL&O%;- M-#T=KTVLL,ZR84/_PH%M!F%3A6N$.HO2#5SS2KBF0,^G@6L&KDEPS7+@FH%K M2EL9E]LOM%6TUM1ALH,^@(-X*,X@#D=DR]",M1V-9J5AK!79*U8)IWM"J=9" M/YWDY`)=%@<*=IJ"E=LB5*!@7<7]>GG_W7O&J;4.;'<99Q`X-2L_M=8.'?CF MM?"-6&L-R(%O7@??O!F/9E6ORCI.PEI+UW9O>9?.H:!)73B#7CX%"X5[L(\R M+"/X2]6>&1X8)G8^F%O96FO&+]P80SU23J`=?L=%A_B?/[OV]5J6=[_\KRM; M#K'T_0?-D`U%D_4[8V5:6QJ,\4A^.&]U4_G^ZW_^!\?]C__.5_SQ?G5GJ.3) M(:I!;/O1_$R<6WFG.;(N&!^$.?R/:)6,$X7V5C M3<(7;U:PFILM,53X?X<]>\6YAL:@^0,^".(5IQ)%V\HZT.?N\X>K7Z71>!SB M)&]]_<'&6P*T)*71(8[FTP;1,?\FSA`=0E>90[Q(;)S(')7V"MG)>YS,OE^] M@Q=BRW_GLA"P;P+\0W?'H_E-$+])[*\D9%(4LFOIZM?K*3L!(L`EIJL`C!`# M1L@%1A27XKE@$6.PB/FP3$_&RX.+IRP<#4#;V@DF,,#2X4K.7!.,I>EX#'=G M@K$L?2?CV?)D&!T9I(OZWKMRN5$4=^OJ[.&5IFA.BH0J@3YIN902H.5-6">` M^;@3A)FXJ`CA,S%<\I4HYAJF`#I^,75-V0?*4RE:_XIJFJ>E<=YG7Y7\!)"] MDQTYT%6?_`]:6>WU^JVIJW<@H#7E9$766S@76?FA7AM`]N%NS>U.-O;#P9F.=>-IJRP8:=NJL"+,X& M$6V[.H!KKB)/PL#D63-=&S#L/:W"!\Z$H3=8-PDG1Z!06NQA<6L$&;]-(4$$ M?8@U9V.1^,UTL-#<:3=$UIV-/Q_/R19!',#+.UG7?4Z!EYYD&Z/D#4YVG8UI M`=%4&,&U``8NA0"?/,L*/<.QA6%P*?1[&1-[D[!U(P97&P)'7 ML`)&9*#Q2OO!AM+)6K-UBD"*'XOM%N&G%1 M6?A$=(T\4_D"(X'&`=/"&Q1LC9(<-Y&N-H0X-X9ZHZH45;*.:4BZB6>0_78/?P#GR/IOL,EW M]AT5V<#(T52E^^!0"2UIE&^_4U'^P"1YNBU]J+@+,TEJ!DW4[I$*Z^W3F3A> M-`A9&8M,`C)/6X&M7\PE+I?G1M,D@J;9-VE02R97'(%M+R M[!MR?!K?`VSC23-L+T:%1;X-/5TL%@U)^]*NK\E$$AH2%@G8>B4LI,5"%)L1 M%F)46.13<#:>3!H2%F)46!2`3!`%H2%A49;O9])\?@K;*QNBNCJY7]THB@4\ M]E&3J18-QNPC*J\U.;7HO:9OF=`;V5^XQ13O+\$DQNO87SAQ.6&9Z_26]Z]7 MH'4J1-?MG:S`/@C^WLFJZOT=#8./A+U[%[ZSY4]7H1:=6<$T[Q&AP#,G#E,N MFC^RK+.E0_CKPGD*, M=ARY/Z7BL]Y)A(Q9FJ<:RH-\:@WH+([.E*2K:LR?&3.3OAV:\#-YIQ$ZHRU3 MUW,CA/H8U92=GM5>7H(@\%-I60NZ.Y=1T55\3S)3;&H\PYK#A'/D'J;L(\6GU M[-JD.3]9U%T=KH=(6&27R.NII/:NHU^%:);XR2Q?L^GU`L?9JMO%".9!(%-9 M)!;(=[MP)!Q!P<5P.PV)(+;SVFD]'=2/NJK"M,[;MZYE8;#=SK2H86BNO&B_ M-7Z+M6"N3=?AS"<`3DX/,KV<0WNVN&B=9+:X7!E]CR%IN<3K:P&LEBVM]@JF M7C1BYU(99^/AJ;&<1V\&I]D8J_%,JJNZ0O=O!,HOIDUS4^3G]5:'ZL$=0J\H M)"YY*5N01G8H^^BGGF>$'1JZMJL_"I-MOGOK#>GR4*U8=U6[@V@!/U7 MF(B&J5.8)17\2/[ERCHF_&`*COP,4GY-.(R$Q10B]K"YPA\/:/!D<7]N;G>Q M;*`_`3(.[(KH/NKQXMY@*O$Q_EC&@PPX%>/$ M7<.IH=!YJO':8,.6MEAL=KZZVZVP&-5\N)UK*1O9)DRP]N8,[H^V,.>7BR*, M4]+(JFPL95EA6!/DSK`=RZ49X)TPKF;S0D'V*2&X>3'W)5]IXHVS@'6:OVU^ M_G!W28QZ#&<=":-N(I>@`>2^ON#W_N<2O#Z:%4A8:`2=5;6XHQN["57C*WDV M]6IG%V"N+QH1-^7""U MX2R'6Y&=O%Q&70#S"Y8<&9?-9XU<:["'>KNZ]V2:?U;U-2CPM44B2@(_%:L& MC]6+V9YI[A^);7.*%TJ_E1W7HI%8-:*T"5'3/B>^*6(<5$%:O[H]%5W+Y=!_ MQD\+*$\7P`''M;=7IZM]-(WU-=;^Y;"3244&&/K-MJ\?%O'-GJU1VM"KN+^\ M(T[X967;HF;>B8A7]K%PX$A6?$=V/,B*@!:I/LH_;FR;./:-<=XJD"<'B12+ MP.]"-,9%!8G,&@@2D5YKD$@3R'UU`0=#D$C_:'9I02*I&[L);<8_S[%2#B?3 M$SU7M^5-(P^O0OK'S1YJC6]N0"OO#C.KN">/>LF,;#O*;+;E3]O(RP.8D79TW@\W*.MKI+WIV^/_L48B`M MI_7CK(&HC,L._!`FLQ:IDB(3(C+@O,$8V3Z@#JH$K(J!'^BF]L&YV7P!@G&^ M@!G4@N+X%*0F\%ENT[:^$6/W"GH8(-"L:3OX:R]9V!>]`ACNJU[S?557K*$O M%MG)FEJB?ZQV--V/A)>D?+?/Z[;M"KI5!K-N,.O*IEIU3YYW2"P.AEU7 M#+O?3%-]T72=DPW:@D\VUAJ-'&M!,C8>RS&=YYMDG9##C=\62\NVBR7U*YKC MBV7NB.7LZ38B_W*UW7;0Z9V_+)M00%^+0B^D)?L,1UMV;3-L97'])-ME`Q0' MUV7"DIP.01W=H\ITWI0_L6M!'1T\_UGHAAZILU'>RU!#!:BS"J(NGHDB+XE# MJ;1+H>:$'Q?H$=URI;3&Q%Q'A)J1<8-1C4QI_4.[G&E6?C5MFEW\=%$UXK-P M/^'S]2P>F*"2N3CF)V)5Q;T2%T3$'?M8HK!/B4(]F=5^-'MGVK+^FV6Z._O. M4'07>Q6^P_9QV$_*)>K]SFLEA3^;6_+@R`Y!S\U;6<='EU%3/8YZQNY459,6*M%<(!8+U(8Y MV5@>XS]743;ODK.QW*^@\V0:)^^'3I4L3"M,'@EW$ M=4ZCF@7S:^.,LN,ZIK7G0',XI8-\^YJ@-!G5W?RQ";`K](N+RKL!V>=&]L#9 M=2&[1GVLB750TX[Z8,#0`LD)(A/>\ITV*T^>/A&#K+3"E4W;C)\9Y5\U5X[A M;4\T34?GKU/79JC`&:C7>Z7F;^:33549UC.=[ROHWRP+LVSU9GY\5W44M M1I1&*6;:ZPJN?C,O(%!ZQ'`]4RX^FX9*5%=Q:/+1ELBZS6Z'T`QU9,THE$[1 M/AN-+UNI>",64,$[NRI/KRZ`<7O)(P<'>QCX0#. M\O&3Z9&8YNJ#9F@.^0A#J7=!D2"6FO/!=5R+W$3BLM__P%H+I#N1F8L"D9EG MB8`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`MM'G?13D%]QU[):<]1 M,JO\1NQH,%MG-K<9M*\JP9[=1.HK"T,<*-=7RF6X-,Y"M,:D1@#V83:XV);I5O/=/.[[4[6+#P8.&4C6VO"K4R+4]'_Y7H.,.Z8 MR3K$6'2_('2GIVA5]$C\>%ZUP.Z%EU,?6.!"6"#E8#H\B(3Q.!JA)(POV"8Z MZI;J2%^Y5CU*L^RR6(UBX3(4W3*ZP(#5SK%I[\5=G2Z@XL=AC>Q7PZ2MNI4* MV+GGPFO?=,^.<4T_#HV^HO>UT?3U2H+C)HB_9%GYOK9,UU"OZ<)@U2OZOXC! M.%@IS$H1*_+1$)S?NI$UE5KL\%1!R@ZL4@ M[R0K087==QT6)^Y$PHI8K%9PWB/1AH5=2@49P+H`L-K+YQ'+5W2N&FN7001\ M*`C[;2B;Q[4!*Z#YRT9_,E(Z@[U'2U8)9\CP;-^1=^9I7Q?$G4V9>M6RSB(K M8EFE6M;'T?*-O+:(H0&Z`R4 M&U+#&TP-3U=_2F#O9,2]E7794,BE)X9'1$SSM<.$`@V*7D%2W68U-;T5E M4:YG+J&;K6DYVK_E])O-GMW"-<^\PK+.Y*+.,O7``5E5L*95^ST,].\Q_<^3 M,-H=(US#..@IY0J8(\.&ZQ[9"I26&,C6 M.>?E@A]/ZKZ*DJ>;J`_T[2/_!I=AEZKR952T" M-FS./KL4!7XV?Q7'\^!2+.Y2'.H"UE&^LT[ER)&>,,X@$I!,U2K$2>HB2 MS.2QO$>$FDJ=2K4,4V2FNLI8II>2K]!Y1ZHD1*W4PXW_%&*TV\AM MIK;%-'V6YJF6[DY(4JOKZ)0ZA,Z42):>H?.5E7=)KT9236!UL-7(K6M9@.=< MG:RD<7YB"ECYDGS-P"6=!:Y.+?%,<2`>[Z+F>JT9*K#:+]QT]^,O'6#]#P2$ M4EH)I_[66IFV!J/(2V)^2\8>H;*]!D$"OUPV6KVILS1H#T:1%^:9`3!U2<`. MJ@.TF&3WE(&FO9LU!536JG@T7KNIB:#2]I2?+'#2%:H?7T1"A[)SE5?WSG,1EBZLWH[1W\,@JJL9?^J$U6]23==/G0^O- MA!<+!-%T[^:OGA(\O3X@%V?7MUL75<6TZRJ>V:(<4.ENHO$8E?-6MSD?SEH4 MA-*R:I_/7@0(=YP!VA.GV7LF19H>FA?+9?0R>5&78ME!]?&+93YKMF8:W)LG M8I"5YOQ,:\%J-#"#<^0?:4TUABC'\F%'[9T@$C\?5TUG&XC8]I$F\I-%_A5# MKP,`JYYS`Y.V?F^PG&6:X9&SDGTL'FIX2L1@5OCA)]EQ+62F'"-<1<&K)!^J1:8`L3EG0[@]D2V.@(6KC M[.KV5Y:(!"J'[J/XK:::GS4W-#+XV7"3*>TJF7WY=,) MBVF5=2?3(K*KI$Y<3(W-4H+O08.RO'R=VO5>#YT4][]PB^F8W9UF:L/T[YVL MJH6TX]FRD':`" M\FNZA,X"^34UV5OIVZ&)D_2+17:RIG(;(NO.AM,,&XXG0ZDG7K-K.DX7O7L3 M?ER\\E8L`&%^/'IJH$/)^YS9/),.-9YQ36[J%]/Z3BS[3Z!B;'?$L*G>R.K^OC:[%G*CZ?YL0N]7J"4W4WS8@ZIVK(*>]Q73EATHX!] MFRA87HJ@_K]4`1V(9&!XA6C/U'UQP<)K.0*_F&4>/KV7S=3I551_ M+6`(-E:WJ="D[>HLDWQ1/R#V)&4P4^"D[,?#`R-^[3&M^=JC=M_8Q=]$M,A, M*U=S;1)`RTWDB&Y9]+'QUE'GYDW5;]+^N;#G$TO3KNY&:3&+H&'W:A MVAF$/I"=`Q@M4/^NXQA]763[FVL,5.L=U3[)UD5(K]=%M4LYGUD]8+L>;`N\F.9<:"$NI,N)X%VDW)B?3.HILG:6*N(#X;** MX2SXQ2*_B-1`N`X23AIWK@[M0+A"A"MPUSX0KG.$F_/BN.XS;L!V%K9G?-UY M_>V9<+]9IFUS.\M<:?F1WUW,[V^/#X0Y/\T.=!F0EE$7E)\MJL9SM51)HH'B MDZT29C'N)S=?^H89BSTMO7+1=)GQ"_&\-8X'NIRV7^;C.L/Z![K40Y<)/R_0 MG69`6AQI1^JHIU@:*9;%6(I=.HK9""IGN73P.NI^1S!RVUC[=:!7EKFEH=V: MX<+7G?!L+,[L)+DDJ.KLDM'Y%5X\"8<%#@OL-52]/R!-=D":1M7F"-U->VW1 M+`UPIX'6='S90S]EHW[3`4/]WKR96P M^D[F@]9I*?'3\?F+G+7)JV*!F,JJZSO!&FD=,P*_D/+S(&K$3%]81N#GD_/7 M9.TA8D1^6:"9S2M$#-AS!3H0OT+$"+S80`G-]M:WF)2Y9>Z)'O1&-VW[9Z8. MJ9KM:41$;9*.S>^,AF:L15-H'M8>H74`]36">J;+R-;E\EFN'E]#")@X*=R\ M9,`8G>3-I+$X]B:64[6]^*O+9'@CS9N*_^T__2]P^PN\4.L5\\``/6.`2:V7 MT@/Y>T9^8`Y8Y*?"#PB+A7Y:JS66]G6E-PS MK[_1SL*8G\_SHZKZO<`"M2@Z$0-\\:CI$]-,A^R/+,P,"4,9F!ERS%K$3%<7 MV'MOP#M-=YT"N4(-ZYG-$[E(4?"+1\)\WKFV*'7Z-5I`Z*+NUG5=L@;;T&D[ MW.*LC_@LH`D/^*Q7%QKP6>9`ZL9^[ZI1UC./VUTL8WU'+`[^WIH&NXS*OW^Z MX#S7;GFKAH3E`=0!U--F[+U/@-Z+<+*A67EKGE)_=.A07`O0XU&!(-H!US7A M6NR&*Z;+:6^=I%N!(B%#J_L.DJW#GN2!;-E2V0KT/QC MP'5-N!YG5INZ8/ON7:2@*V::7HZ7IM889UE MPX;^A0/;#,*F"M<(=1:E&[CFE7!-@9Y/`]<,7)/@FN7`-0/7E+8R+K=?:*MH MK:G#9`=]``?Q4)Q!'([(EJ$9:SL:S4K#6"NR5ZP23O>$4JV%?CK)R06Z+`X4 M[#0%*[=%J$#!NHK[]?+^N_>,4VL=V.XRSB!P:E9^:JT=.O#-:^$;L=8:D`/? MO`Z^>3,>S:I>E76\BZ=0T&3NG`&O7P*%@KW8!]E6`;^Q=$_5>T9 M__B?/[OV]5J6=[\\*!NBNCJY7_VO*UL.L?3]!\V0#463]3MC95I;&E3QB,,\ MDA_.6]U4OO_ZG__!+8-\J_7,V"OPSU MHR8_:;KF:,2&W]PM4>.#"^.W1_`;_EMA? M5[_BJKQ%T172]7*,L'^]&@,2B:[;.UG1C#7^'?5T13Q;'DVGRY^N0F2EYQI* M!1Z9'SY3SM.6RZ!_J5UK^$L:.]?D%?4&5H`IB!6L\ZGLCKE^:^KJR=OFT71D M_7#?/&7OH)-ZN5-8),(2`#UH*P"OE(V6DX1.+*176(X6.ZK4WKMZN'5^"7-^F=W"]'0CHQ8+(,`; MWK?`4NJMN=T1PZ;L])78#G"80]0'!U[^P]!@LA?94F\41WO6G'UWS`]QFF]; M",)/:?KTL5?$!MXX`:QA)>VOI-Q1$F'3LP70>'/,T;T2'(:PU;IA0WXP+>YQ M0[A_$-GBWL-IJG+OB$*V3\3B)(&OV[H\'>''6:!L-:8&7\V"N'E:_Q_!(Y>H MU_E4;1OM:3J>2&VDXX/Z2.4JK:J#I!GV1F?VQB#Q>D-5K_U<]^7=@/0!ZO:'I;Y8,T[R3G1[LI=>FL.739M@=;5.@>:%7VBO0'72B^Z^\F'GM3/A! MUBSN[[+NEA'1_>:2E*O".]UV6 M8II37KY%@HX6_>3$NAMO#7*OD6;BM=5I;%V=H'IF@=ZT[6-]DE]5[.2=4?7% M-M$RFF26F.@0F&(7J9=]R+6/L.EHEG\XM`]F%\G:/E:FHVR+IO<6Z-^I_=G+ MD_M-[=TWFX`ZOXQ7$TIBJ]NI0$G1+@+^)O]H?N7LUB\[$P[EGC)B'SO\O7JY M=TF&Y@?36A&MB.)0R?_?]+ZJL[M7]_=;/6LYW^U/\P[P,]"_V\?$P,YG86>N MHTZ("V-P2JS_6HB"^)<^<4=;\K3I>ZD"Y$E1>P[5'&&,;8["HC2UE6CKH#LF M+R"`D_,+!!92?DLRG*Q\7UNF:ZC7=&S@.39V%69N6M_OTEC=QU;1&I$#N@J, M54XN96>I=U!B':_#5>K\*E8`OLW[D18K^`^]2?K+-J/LFIZ7LL8"07\7L34Z M&]R5O\`TJ[2+K%0H$K'GVV5HCM;MO=)1KCD2&1E1,=G'PL6A:ZG?7*XX-/W6 MOG&=C6EA5>H_0"A9=)[['?[^19<-^^W^_0]B*9I-OF"I\J^RL>Y(O>C4X^!H M$>%IZ5>$<1.OG%#=^`2X.EK:60I177+,D1EV&DXZL_]YU;$SS#.E1*&@S_:RH]&[SC.L772ZQ96O(W*^"NHLHM-`. MVDN\.^S$SI8/'C9BW[$^[,,.[\.O9"MK1CDM]GP[L4]'TV5(A);HGU-+M8OT M'V13T[2YA9$M67'<(DV'+U(ZM=+9HCO"J34&Z(QX.G.7C4$ZG4Z:C]J*<'_YNN.:&]BGW1FL1>R3SIS,A;<)^6.Q2+Q60W'+YU6J4[H:NA[ M,$GD@<8FGXS&*4&$P1]^[I7P%^Z_N2Q`IZ-)2CQ96?I(.9&DX];X39A5*`[9 M(MR+487"%%W>WEU$]F0TGU<`O,6T@@KU:%H$>S&JIWQ)CYB[/:B/,7H`E*.JF3+'C:^B M2<"5?!0-XVPYDI:%2=OBZ9Y=+*I+4(X*US4]@:W:/S^!68IDW)2(\\U<]?F' M._5T+^L7KSO7+.V$Z*(E,5WVT]R$:#FVG9\RVFL$J_705(C/]1%_F/R+6\DB! MB5!>-P-,D9E00#4$3P_; M7N6.URRJ=NUV.L+#[7!R<$HKKV8`W#RE*X3E5P@N;*FS;V>"/-I)AF@)ZYT) M&3AW"L(@OKH;MCU(KRX@?1!>74U0&&17AV.[!^'5":P/TJMS>0SG$E_-8PA= M5N5Y\I6+T++!\IV31D#UE(N-;E*].U@[E>R=208`LJ=$*G24[)TY1,X2\M^@ ML[5W8X1>HI5H(] MZBC3RG-/9*T96.N(,U?<#MXT*W3+CLC?AD-$YO/\2.&&V^_T)TBF1;*-9OG! MRIV,*5S4W2W[%?%;JZF'L_R([BZ&[LW&]83NO4Z&:S/"?IH9#ENC]=O$4GZS M9*-(3^S63Q4I/][[Y(U1.9.@/;1,1I/BF4'MB6A1+`QE"^1K-8]!*IR-U.)) MM

IO0O#7MI/+ZIVW9L`NC\CO$E=;C3],$VC[-I%56^ M/3E^W6%%_L1.P>/ZX&KQY+I`PK1WW&4BL_=GW0?36A$-+*$_W\H&YB45./6* M>Z0[*&G?B.-\E;R&%0YG:6O>I=&X:N_O0A1N\=1]4[F[^<##W=:KYJ-EOD)8 M!Q.WIZ&\$=*"D08NOB"]:7FD/7B*ZA11E?Q3)-8>4Y#JNLEN7>^*W5L30RUQ M8UV^AGI[9W&1,BN5:L+7X6MK`A'Y%SZMTZKN8B<=.$0+!%(,W->1&X%"X1,G ML%]["DZ1N(J!_3IRHW$LF"*B6["/50O;XGAW+S(EAH=[^^R M[M));FS;W;+ONE/,9C(M4$AEWEC)E@*E= MONA(F#"6CW$VA-MC^1C25/F8$_`=X?1N8*Y/68""U"&L]2>+KC/I5&=/0NNL MU.S.?J?A;T,^13&J=4;>#%3K8\>H3E&MG&S,]"FG2\LF[#2_F!8GL\(TW$K6 MZ!+MGQN@'C3>MH_O5KB MM0BV,*HI\:E!A;0)O'S5[._7*XL03M5LQ71A.DMV\L5K!X1I,$D;O7N$T31% MDOM__,1=9S;W$Y+WI#\517;G3/"S8UD:"?-&)DJAP MUQ\DM:F4G15)O5=F_F[JLJ/IFK/OIR9S^8I]6F)#.;4^4:*BI!57\KQ,M>LN M7]$;^'#@PTX<=P,?=IV8V!(X.Q[6,:_.96-3K_4;(3^/I@&8P;626/KA$ M6SP6!R)TX$SH-Q%Z;V(%8I1X572XK:L[VDXO)$D[:76)H_QLZSXZ,%N-F[A, ME+8H]YI":41"L8\G),.RBEE_8U'C[+.X0YZ2NREIC`\1-4>IQILG^5M:Q/A,G.[&4)BX]F:):F8DFUI,?,NC-CD+Z6C-48+9?N.7NQ]%B M)NVM1Q#*%+HX56(TL9([0[$('-(V9Q%=I@X1DU-SK2UC)X< M-0JRFF4EE\),[;-.@3N[%!8Z9)GE(IJ365NIE'X)P_P*%H,P'(3A(`P'8?@* MA&'5(H&Q\B-]EIOYZTO;#?T5K24=,V6=)UE.F-!]8ZC_ZP*"5GO-6-\H-(?$ M?J?9BF[:KE67%V87.Q8I/7[AF%7ZE[;,TIMW[_YXX'Z___3^]N;K>^[V_NN7 M^Z\WCW?WG[F;S^^XAS_>/MR]N[OY>O?^X9C5NF-\? M-Q_O/OSC[O-OW,WM[?T?GQ\?N(?;W]^_^^/C>^[NKM=T.S%`#R'>$%5U%%0P,B*_+;_S*&3OH MYUD?7[>@$:@J,P[_W.SNO`@.8)5Q&]U=+7"(KILO5)"L3(L:),[*U3G9TYM+ ML,UP:70*+->'T^XL5]G(UIJ#?M*F8:]9ZWQ\.E%8EXFV*:[%`?YKVX93X18$*I<,)755Y MO.03NIX8Y2Z=A%T=:SBAAQ.ZZV)PPB^$?IS0$[$?MOY4&$[H\RN/$2''/OH1 M=O2O1,1/$,NTE:VU9OS"C5'`I0C0_`@HE"!_:0X'_V]F+9'_LS2'7)NKET-$76 M]3UGD[5%UC1.7W,P9M]V=?BO9C@FY[R86,\/0?`51)W]"^T3W.T@;CX'5:LMV`5UP8PGO= M-.P1!XBS"+Q->!"MN@^3-_.?[,BSG&R1$`S93J%P0BZ81KPT<`1N'SDE!4+^ M/DYL_-1&BT?W^CBVU\=7'%*:/OD'?!"D*TXEBK:5=5CHM73UJSB=CL?C"(RI M4U8&2XB!)>2")4E"$V`E)6,N6).ZP+JQ+-E8$^2'M_OT&@+O_^7")KTS;,=R MZ6Z^!]ZV'C>RX146^&!:*P)GEWIG?*$WVE5(,$^NM] M$O2!]++]]D4WK'L1[0T%IS;Y(&L6ZCZD"F-.HI@%Y64Z6DH-(K;0^GJ'\QQN M'G`>PL0ZG162$3F'[X&,F#0D(^)+Z"#BRIY-XH"Y$X^ER8"Y=,Q]\X#[]D67 MC<_REMS\T.QOLNK:WQY?S$81V]$CJF%M;-:(9O`*,%]2)YN,)HL!\^?`?/U'P4"[&%B?3>.9 MV`#)9Y?>IT=I\N=Y*C8/ZUOU2*RM4.J,_?7+[!^S3XGEGP6L3BP_<_^23_T+;NUO/S#VC*0I-F)-#T:I"4=9LT\-*I:.H*+]4G_MD\8>?VKZ`T M>=Q0Q102$UKA>#2M(RZB]!HZB;L<6V;`W>G6R.O%'1--]>[9R?G4SB-KZ"3N M2N_9`7>G[]F+P]U7S?[^P2+D#HM-$MO!66MCMPFB;"P)\S,A+0WXAG%5MT;" M4"8NEPVB[/PGPZF8*[,_&>:$6JY6.XZYFD]4C^<6C?)<*Y*M[C/!X[EI?S'' M8H2\'LWVS;.LZ5C-M%2-D;]KI"Z[J*C_(7Y\M^(>2,"83+FN)6SIDWU$`VH%@O1W0$ M#:4SSFN*[FX<"[]9IFUW+%>OML,Y>\7G1&FS`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`4#!=[@3$&A^U0Z%=8$P1;(+`>ZG['!1DEK&!SW-/KL,]D;5F&#CBO>*8 MZ&X5%SS#!$,,#A(B1J-OP`=L5[$&Q'+$V"!7J]SOKJY?_]]&`U`>P6HVMYJL M,S#9EE&)0ZRM9C!Z>CB*`QS=0!ZP0!^,H?XWSG:(%(8%?^._SP<%^4=>K:C= MSSWMN=_A`("A[3]YB-K1-QCRY^DZQ[0;H:+3[J!\5DO+Z`E"@U"5=)XI!.';_2&,8<0+ M_?/>($4KC\Z3"0L#`3M`P,<7LQ@!ER-IV('D*]G*&A[2MT`Z2U8<5]8Q:U:A$NQ6(M:P>Z>YCJG'`19@-E M.BI=I`:D2R'*U&5O'$YVS*_RUK]_>"OKZ+ROZK`]B++LR+)ZBO"V)5F##MV! MP-VPWJ1D'$Q'T-@F@>MR`$__,3^?T_#T5?0>M:WX?R>?Q,E`R[[2,NX`SJ^$ MVP5"UJ67_K';==S;6%@AF8XFN6D`]6#I5=.CL/Y0J!W*V0@23.?^6 MAM^:*^X+\!6P+`L,Q5#&=\16+(T%O,+O;S'8E-CVJPJIAXUB`\^H,HT$U0RP M03&*U?;WN^T%HK+`WR`.'=!UH\*QR?UN;LDM[%CNUK1V)MMHW)LK/^#5BY>G M(<+NDZVIFFP!>W)O''--L`L2"U/W'V?QRE=>P/(59UK#>\%TMO< M!B:GXRL@>%#2[+T09%CY,QRG-@QGF>YZ@V&VQ'DQK>\(.4@(F?EPO9]-UZ$3 MHXR"MZFPL^F<-@G'PE7N+!!>%E`!0[57IK6%QS46F8W`V'[`,:+5W1++CD'^ MIR(@^_@&FFDH`Q6"\='+>FL\ADE5WKJ`RA3[*S`83R MW-HRS2W]I`+[V_03@&Z;!E!YLU]KQ&#PP$HTAA;.(O`&3&6SB%^3T@E4=NU9 M428XOJ@LW+'@;WEM$8_;*/24^^B`2"J=6V,,LH$/P!]@ M3!@HXHJ$&I\NULJ?`>U*N7>:C6>>9KB`U7M`,./P5R/+[@WN`WFR7-G:VEFQP-[9-'.Z+:RD;X%ONQN='QHX??[_E?@-! ML>,QTV?$.)U8#ABT0?Y#7+BA$*.;XG>>]8-EL.ZDXJJR`N@9;#\$#4>)H5&3`OY@TQU4'(BLA MHS8,CB?O4$0I=V-]!X-%!K'PF3S+JDP1\0#"<\/!$0"GB,&^RLK(6HYC[/B3 MC[RL^6Z!^4!.&!H;]DZ'&4P-IJ=4B6:V6,1AWH7,N86#N5\,P-5&V^%,M@OH M#(X%GJ99*;*]H7(FQLDBP)U>^=EG*>>;0+I/T+;"[. MI$*()AFQ,QC$&^96J928G^AQ`X_A1@)%%C.<5BOOS`Z3Y51NM]G;>-3QG*DH M[HX20F9'GKTC1*&,8,D[.!9EG!F/0]B/W^%VI2[0(MKV"<9'Q.^3%EVIIEZ_ MR!JFTL#*UI:\!2[#TQ*-?UB.!NJ"1<]Z?`5.RF<\`7?RWH3]_,8FA#-,^$+\ MN&^LE3,0HSP MG__!>?0_T6#MO-3E0`&FHM5&H\872B".*+)LS#=DTC,F^%30`Q0'1!M(P-`Z M:7$5``X!@6B'*9AXZJ9`3H7KBN`I#*=`(=O@4+92O2@B6L'`P81(5]9!QM^[ MK/P?:,\XLQFHSZ!J;#0X8CR;S*9*!]A1<&I0&14^"0.39\UT;33)V--T5YHP M=(K-9Y,URY$UU`*9[!O0Y^*Y[/Y"BGU+)<5H8"'31`A!_AP*,7ET*?AS&1-_%P5MBYCFGIH8$'-%YI/]A0 M.EEKMAXZ9"(IU[(=,K3,K','6"QN45H$S4>BYEN@D<'B)S=`03F*]]@I-'AC MC.4?VAX_4"S*EJ=/K]"*I4,%!S^L,OA\<.X'ZJM%+\70`HY`Y*M+/J>J+BR& M.E$"'<$?*D7*7YJV^5%^L3W>6+NZM]<8:?Q<[11MRPIQ1&F%IZI.?C"MT7WZ M)TA"E(/TQ-VA\4#/3#`#.=G;WM2HLF@A`&`_GG6D6%?6LQ6M^BNP+(*3%0KL!,L?RS8-O`CV%2P]6";@:V( M]0SBFS+>`O$;AQ#0!$\GCGM[4`3!K MTZ+Z#:T=`3M^CS]0)TI0W,-?#W7E4OBQ?H>,QU9T&#BU'?D[?=WP=,+0T[$" M:P--3XK4+0+$:8`5A9W$KDWK:!R;$E4YM%[1`>WN_$//]YH!)=:!>2N#/;__ M-SVK@5#P-AZIJ/.Q.'R0!$FNKRG MXM4O5.)8M"Z&9D2T0J85P-,N=;\_N>H:=&U47EQV;:K9MHL3P!&@>]>H<"C9 M]'P"]8AY/CP/G*VQIT<..C#LO>T0U`;PO'G:PG#>$G!`3ZQ;A+KO5&`W MQ=W&[JY4S=ZY""!SF#-E2_%0"B>9D;N9-#R?`!R9*G9T[X!21_",,616_BL\ MES1T<:)_1B/,7ZG0LB`[$W$NDM>X`6+YUB(3X0Q,&+>U1'RU0I> MI10."%6'O=J;H^"+A7:#I]7AA?H.D?UJ3H#8\HF_?$\Q]W0H&:.#;(>Q.@$5 M#2PYW%%!Q22?FCQ@]3''94>Q M_Y&`BD.K!P:*P8J@H8$N*^(5`70-':_4F:G,7%;FZDP4BNF2W<`10P48>>1% MIJ49=>T[&)D%$,`^HB:4YBI+^WR@FF]!N=-`+1_O?AQHY7DZ6.+!#XIL6=0!$Y0677L(02[S[HJ8.\'7U/VP'E8!-#!G#LNZXM6>9[YX M43Q>F,&S;.&%3]RS$%8+96&:P4^12$UZ$W1+`Q1H&-.;J^0/&)1TEU)$.(PO M?L"@;%J5]O]O[VJ;VD:6]?=;=?^#+K>V=E,E!]N`#7MVMXI`LN%6-E`+>_*1 MDNTQUD9(7KU@.+_^3K_,FR1C&[!Q[%3E0[!E::;5T]/]]-,])\D`^TM1)X4'^:L MHXB9RK<+B3,&@1!FDO]B4%[L8(S\&JE-JH%ORX=M9C*29M6%@JPGY-+2WP#H M!MR=U">>50!9ELSBKYL4B69_]2/J-IRD*H>1I"J7PJCD!-$D0.SZU)>8Q+B-L,)S#TB"!'&B@^92(G`NOE[U=V'@OA;2H21*;EA+AV&: MY?0=YRE=5-WL:D;#PO@NB<`$(6,I55L/JIS\VMW0,/M0LC.#A\#, M$^@9'P64N@;CZCL-Q6TC:S47IV4D+2:(@^ M&#XUH9LTF>1R(.3AL,G&0@0*089A+O\TX^?)TZC,Q_H5:NO!>F^^(!JF]=JY M6[S\G&J/O8"*CPE+EJ/O!^,P)V]L6O:MM?_VP#$>/R@2$+Q$DQN1[Z('7==U M8WSGA:D'97DJK15@5B[+FE\[YX+D1E3(*Q^\09`'^"XA8ZGQ:@%&CY8G?A3: M62^Y8KCD9+HS"N"V&%`>T^BN7]HN(87#NVI/6%P<=_T9B'XZ%[IUX!\='KDI MS$>]',;`O4&A#8F<9CJ`'2C-29E!`X@*^QFHL)TWN`/G&2F`*GVP&%GFVLVF MS585D/4/:*PMCJ=Q,%*;T M^WVYGQ-OGG8AM1,48S8MLS)?R`M"CPWGK:P7GNE$$20X`M)RMQDC7;FOY*U$ M.`#VWA(^DPUI2V=?QC7!T]@DM?%^5J>RI"5P MO?2*D.$XEANH=#?>VE'LU/%B_D]G**6BAFS4LCFR$V.MN#`C;DYL-W`)BXG M6MV'<'_*:KYZVY]'C6_./M+F9D=)5=NRXXHI091WKHPT"?%V@D\@1";G07/H!W"1?N]EBX$0. MX-AFUHD]=(!49I?WH=,E5Q(QT,3`)XE(]QS9Q>P],VW+T)\!9D3J6HFI&F2B M[$C:4XF=0,.6M>&X)K2P-946#H@RO.HBEI&2M!!$0"!1`Q4WAN*%(F8*F=Q; MB6#$DE,@!)@.FV$DS9E-""-\#&R*L!SU5'IX) MQ7$#'P)M/XZ1:G:`C8_!*0=._"Z5^L''("W%UROIU"8[J)^2^*;Q"1&V[750 M8=F&8D)K)P*)$.:H@,;'\4@9S3!#R8FC'D3"UY0P"K"II= M-4BOU$R#`6JX4IJ*X#%HM^DQO0=KPZH9@S;Q M>A"S_!V\VN?R,:*WV84]2J15-[$RGZ5Z0IW]YI+\(+/ZS8#-9_-Z1IM@DD]% M+_?.,F@_T(>WDRW%**_:Q*I@!ZQ>+T>*-LX/O:2ZHSG+X0XLAS*'%&X%2FQP M8=S2[ZUHSC1FT(B M85+N$;NW=U"R>](6%5*ME(N)#=>F!L&P`R4]*36V@&5+B;"Q&@F[J'S<+&XP M41#>4MF9S3M6P'DOX9)%O$YYKPH&H<_4+]&?I[P=7>1[Q5CMNV9.OE7)'O3[ M:6$7H=JE)71W"''24,CE[!N\'*`X>678)P<*MF6("K!"3F=S3+$RSM5"+!_1+^F/AK;SJA-(=-5`-,8*4*JEW"@N4@!""`!1?T/:SR\;% M*KLK-Q/"+97VT&/:+4=B<*-;R6&J+PVQJM6J!T0GS""XAZV#M:`3&>TF@_-1 M3D7.8.=5*41H1BGDDJ;T5N1N),6"M@(,2U>PVMC!#X+;!W@9_\:7\8<(H-$%;EC^ZZJD7=BK+%`>`B9G M=&6PO:6PRI!!(<*.@7P0E$?+IBK/U3)(BOIMRCD?HA M*I0O^Q??KNW8$[NRY\I.TD1:=9.<36 M$U$BQK>@_02@3_,`WIKJB5V9,-&%D3<"=\'@;^GW6\@7U#EH%P6B*Y/9H)N[ M'D]I:-)1,AUSJ*4B\4P6A7[6M'W6F9K\&6;"9OK>IG76-[E`/UG=A$0<]+DO MFFH;2;8K0G`(W%U<1:H]D`K=N!U2FI$KC!VJP+M-I9+FNF&`UBH9^P61[C64 MQ,28'3XX_:M0*>_8_](]!ZAE#!!8(>.%[6N&P'0*[.%Q@`ZV1HI`>]`,`F-^ M$%K`W1C,2HYXG!M.@0Y@%5&<\UN^2H#3/#A5ZN+1F$-G&0Q4U3*M2\8/^&>Z M6330WIB3YMZY@EK0/1\AD+D'H7UAHJUC-PSN"T8 M!]\BV0#/^\LHC$0IE0CI3KDM@MPXV4A-I.H>XT]_I];[1$?$PB-`9^-+ZO&@MAZDA!YJSD],(?D0*^94<=OG<36A/3_I[8L]\^>`\$/C4I MQ8=F)"-C@A9]J<%\\#P)4`-V!?L`V@>B#(".=+^W"R_I#Z[IJ^!>;&."U\A="*,)+`"#GDOXE\*85!4$HIK4(P9(O+#/!?Q%W&S--D)RR=2$%C=01EP>WG/5,C;RR#8 M.[7&)+C14T02`9H"L93HT3V13P0S%LV]<4N7=^RI$TQ<9-5BCE@SIA:?V/.* MPB5V/"T0#T>I0T:4�,Q`U>7888!#G1;UW5IWN[?%I'_*KICF`LF?(NGJDH M,IVI@`>"M,M;0!JH+)N`$O!5\=89Z$VUJ1OEDLI/==JZI2*(J'ZAM'1Q`N.4 MB3'4\U$W&$:T*L/R?SH60X-J8`_Z0`\=HE("68"ZIY5>FZ42QCV#(8X35:Z; M!U\%SD83][BV$#\';\Y2I1)GS7T9^BR4FR*DDMT$@"]K0CXM6UVLZ]MK$WN> M`?A^JZF#W%VL'R598:H?38?>*7/:J@Y>>,15@Z(^._V]E5OIR";13`N[\DGB MAET9B!#V!0C+I:6%,C;F@+6;S8Z'(@;D@K^'P_+X9`W\'OZV:OG@M+L9OSE2 MO[$/&$"5SJS7*6['4?(@A)/:=>-7QW>P?^MD@\.:0GJS=%N'OE?=LU?N0Y#$ MYE3AY?L1.RZ91,4!+BZ!/)X;*,A1-3*6SZ9U@T*!*N6'-E/G!Z08A@5T!\PW M0'`-^@(>R@3['CAE?E4\.&$(W/NK.B0W+VI6&4$LB-T`<)BT9A4`X]:/N@.T%I/$-@Y17A4)2 M4`O__>RA8+<^I&B1+Z*.`?J1!465JN@I6HQ]"W2WJY+UCGV7`-8(4:>/R?G& M,!4EP-DBYE,C'OTGMAG%KJ,/H8@&UC?2I@P%M3DKWT+Z`@U44OI"24!?(/@H M45W1O%5[\F>A@&[OIT])EKWQ+J2HZ$A*#T^5W)K=&43!$==/$8IB#`1O$D4V MPA8P5KZ*C5F>HJ_[P*N"3"M6M3@VKU)<;=6;X]F=7F*=+FI5]#(QH,1AL2]& MTA3%;=1X.'@P?46`KQQ&!1L]-1D<*A*N\'^)5>$.RU"N;(3YZ3(T@9N9G3RS M4EENF&@E_'0(C'&SP%,+3D4?CVKU]N@XL38F!6<[=`='G3J'3KT`J0V8,)SC M1LV6>R,Z/:K(H9DJ%M(DL7A0UHZ3TM`1I8'J0+U)YCA%XZ#K/F:*>J"G-OMN MK78YB^#*7Z\2TME!W=J`MX$4^8W4R`^S=:U5REC,\19;98ZLT@&6+[@WH:&> MTL&?5!-*#-$:BX(_-Z9'MT!PE,RB1/A`FK#R.OQHU%O59]QH@KW^X.1,U@?- MFP+3C'?83#5X,6T.IV/L)B7,P"$]K_%_H:(Y<+9RGQN@:HGKIY94*XH7BS&^J;4UB*7 MRIVKCL^_70IM]JXZ\K[;8B;(1KY!"LU1,+Y*;3'2SM5EE1+/K,*V<8YJY_,A MI=$7*K?UR"/-*36<5N->,UAT8QIPF;HV&Z/IB7Y@'Y\PDJ-J(*T_#JS65IEP MTNWNG!R,S(@1RW-UA0`M><58K-`;[:H[>WAJG=MO@DY%":4*\'E;&QKV.;`T M<#!=V>2B/XK#?PKNS(!]BE+P=#$H)RBT7,NAFA34-O2D8UYL$NI-?4?-QM2. MFJ!YD(##=*/"!Q5&X$*#Q%.ZT44MZGBBK%1.7OHEK1>ICUF8%^H@1SO2P+8? MS)DN$[WK"\LAA3WT@KM`*A2NJ`F=-L74:3I@*AQ#HST*'^1"4X")G4*$Q;O) M.P9<;[4+ODB3.(&$X=;N%=X@$1EGI+'_B:<8D-C/!$^1&OBZ9/(!ROE5-;&3 MJ7W2)KW`3!^.=+T]G2J-N%G"@V-OY[;"SO]]J-IO6J"I/>,X(VC-'<"0'T'WF",Y49N.".!;'N0Q9 MI3J"F;M*/B`L/J$>H7\@RC&'U#JM6=JVB5*C!`Z.:TY)@92V M3DQ_"CK([SW#BG/*JG&P_^T+J]6%(.O#:'9_K[8D8\'<14_=M[F=HG:8(N2)5!T]I)CSV\"Z(H14W*(EN]P5KEOFLYU36]8X+=+ M#7&?F\I\=;6>6JRS-3H.)_*)<4X$-Q"'7\K;])(@'1!?$'H^P=$!05'+H:D'%M[M)`ZRZG:W;W7)W4E.ZY1#L@!P94QN4 M4//>]'=,@Y.#%9!SAM6,AP%3>:Q#EO--?2?]"OOD5Z]3GU/9O_41RH6;&S%7 M`E;CM-4S+=,T[^XZSZ:,GUZ.HS`_2>([^944P)\@ABE;,^W-S2/EJ=GR1\KMXQ%6TO9^SSQ\`B#^<)<>I`JF1YAE:X5,L*+C`6@*LZLCL3?)1 M%Z?IN#@O#@IVR^Z?W`ZJSM\\LUA@\M+PX%>/S[SDW"U]Y@?SSUM/8(%)_ZE- M`"DLL&I_Q_,%U^GUUX"<"T]HZ4)I.4)Y<DZOVGFM)!PN!!B^X+]0.9J[) M(&'YJ4[!;$P'+=CL651&L?RQKQ0Q?2DY%#WJP)._1S;^YH)51V\],UD/9_MB M0-5Z!KGGL?=!]-(".N!V$?PAOG6:"_6$;=E#5Y`3A-]] M/I8>'I<'JJ00&A3I#K65MDU>YCS_';14@)Y"T.X^_1K$62!#V<_B+A@$.+/+ MI)"7G01I$LEP#C^:%J$?N0'Z#^K1TYYW`C%ZDL8AW5;W2=7PFNG7"<(%$NJ< M59D_0$=H*:)1B`?*([5:KFG%+57%"BZI^U$0K-WTI;%Q43`ZX#GF`Y[M)DF5 M1IAPXNT(Q#`B,00W(N[K,G,H2>H)F-](1-0M*PO4>:.U_%B\AE]P!JVBY)\U M=\`[E^OVZJNBIAYCO2A<,NF;WKUAUQ_I=OEIHEW`>VX<;O.B.66)>S7AV M=:"J\\M5!6H9Z2D6VUU#[OKZM^J9>*Q:)F;'\4"&?2*5EO(=UP#.12-^ M_%8:/M;!@;I*AI*G2='+AT7$E1;S9K_W#ULNK#'7;%Y6`%90M'H!=+KMUQ=` MZQ4%T&T='KVZ`-JON03V.YWE"N`$#S(=7"5PAJ?\_+UIG;TP;/`:\FDOHB!3 M)KML>4W#R%]!7NWNP?K+:QIZOGIYM0^[W9>6UQ?NNW),[<\^8_>S4^K!0M#E MN>G`=23UQ1,N?5FGAS`5]?POS6A3V;JWJ?9T/I]WFA;,Y MG5)=T(*C6=Y44.7V%M"X;JD";KUFLM#BZ1[,H6[PWOSEN=COKIE]/W5F:W<-ULU_[UE34 MHI]O)@=K-I.N-9.C16;2W5NSF:A%O[A^'3:[2Y]+Y5?O@BSLO[C+,M="J1_+ MLJ:QN+LRWW[R"K-8AJNRHFD\V4U9JY>Q9!=E52KU#/=D#1?XXJ[)?$[6*\QB M,;>DLTXOX\DN2:>U1K-XLCNR5K-XNBO2[:YFTRC1*E_4#UE@<9>&L:0)+$SA MG,L=G&<&2?I5I)E]X,\G=9;W"9_O]SQN1;-5]L-G/_)%QS@'ZZ*]7_:$YAWC M_S0:'Y(D1_[3I<#*R$:#OHK"^.O/0_[RD_S#N\>/\H>Q^'5'#A8[K._PIVD" M^?]1GH]_WMV=3"9O[WMI]#9);W;ER/9VX>M=N'`';ZYN'R5]YZ[([TI2==-1 M"I/^W[-WD?^=,6R^ M8G<8]/.&NJ/Z.:3P*X/@1R6_[BBY-II2RY)T(%(@-)1&N9@`VE,$T%X'`;17 M((#6%`&TUD$`K2<)0-W3&:(T>TF1]L4BJZL\.!:1,XC[VTA^'M_(]1LW_KK< M^>U+"FUVD^$02BY%SL>%P_E0HH9\0ATDY:]^%0``&$D!`!4`'`!A9'5S+3(P,3(Q,C,Q7V-A;"YX M;6Q55`D``V>M5%%GK511=7@+``$$)0X```0Y`0``[5U9<^,XDG[?B/T/7,]+ M3\2ZK,-VV155.^&SUQUV66&[9V>?.B@2DKA-D1J`M*WY]9O@(8$B00(4:0*2 M7ZHL"4<>'Q*)!)#X_K?WN6N\(DPG%<4 M&,_^)'@SX9ND?>/DR_&7_@`Z,69!L/AV=/3V]O8%T[(D*?K%\N>'ATEOER:! MUJ%>U.W@2W_URU72L^]],X9'@[.C0:\_-,Z^]7K?AB?&Q<.JX`-P,G$J2[J. M]^<8>C-`&A[Y<<"0]S[&[A__S\_"CZ%8H2YQN)ZM_[EAE$^JFDR^"6H)\.TV*' M]*O#_N!PV/_R3NP#D(%A?,>^BY[0Q(@(^!8L%^C'`7'F"Y<2'GTWPVCRX\"T M`1@@QT%_$-?_RW,`ZJ"8N/(]&WF@-OB#^*YC4S5=FB[E_GF&0-$'!NWF]Z>[ M##>F#6U>W_[\Z0>(4!`MT0R_5)B!']R_<"QPN1_;A`.!HDA(XY.W11*LA[L$NWV)\7 MEKY&@>FX5L)X%Z77TL MKQ>NFQC0UGDMZ*IU7B]#XGB($.;7$?9O?3PWV>$88W$U*.^\"2W1EE2:(ZI! M^0$%,.R"Y85GWP!9"]HEH\B"7[<3S1;]->"&3)VQBRX( M@3ES3Q85E^:'' M4CG":&$Z]LW[@DYZ!#AZ#&8(7X48@PZ;$%:+]'0F-?@&P\R74OF1`N)UW:`L M[GUO^H+P_!J-F3'.?KL=PQ+M?RA7#R:,6+#OVRJT5D\-5*F@W;XND83!!;!A@^Q30!#<>^88\=M0'\U^FF'RR<$3K8% M?273Q\UD@D"ZK_37)_`S1@A;8!7-*6J,X1I=-LA[LI3PIO?(C*W_$W*I1+SD=J)IE:)$Y)1(BQ+2>%R!50YZ#Q#4L%?? M.@'ML=?K]WK&H;%J%_Y>-6VP;1M)XT;2>L0-\`/KADQ'T3K"QUD8)(Q%@9V) M2<91=`>0,37-!0UL#8Z0&Y#TFP@PA[U^$N3Y2_+U'_&@3%MVS3%RHU!?YL>C MS@A+W)92^I(R?YP.3WJ]WLGQ\;!_-AR<#$][#.4,1"YPE@D36VG[\&<.-=G( M65+BB(3S>&URZ("2T_H36-GGQ9=TYLL0[F,;X1\'_0,C)$"/OZ!]F>Z!\8:< MZ2R(?EE@QX=))47Y_5!`4# MI5&0\^8JQWM)C=W0N"R#B9Z'2NLY&T1(8P@B4[)`S=W0>UU&$_T?*ZW_F(W_ M1JY]Z^-G,&(B?EB^^&YH6HJ[1+TG2JLWC3:/8/41L"%GL%W<<M M)!]:S,N,[>'HCRFAD[JJR-9B-DUW.SBJ27]63R]5TL_KJY07N87.L!ME;>XP M@5VX>;?P["ZH M6)PQ.0M\HLZZM5*YY95V0^\*W/A!"8O1,HIK9Y: M!554X#E)<*B%>WSES^>^%\FC])#/1K$=4JD0:UH,UB=Z<-9#]HV)/<>;$G#S MPWD8';(%A]"Q'-[D6EUQA_1=D]F:?O+WHXWCR^V?:2ZZ8,RJA'NP>2!ZL'G= M@_$X,9(^.@!\JL(1PL\S$Z-+DS@6S-/7CAL&:P8WT%Y9JYN-2?;^\%5\>1BH M7-\U!G(W*(VHY^Y6UFPO"_X3`/^PXY$NJ.7L'F:3W&LQD0M<0*<;0(^3%_-] M&RC5:GD'0=6<'+3P+8"Q-?\O#SPB>F^S@I+)AJ MCQ+:$Z9CS(RL*W$ M*Z<'%,Q\^.45BD1N?6UH-D:!>GC]0#C6&0OM2EX+,[VZ8ESIJ124U!%P[>H\ MCT)1L6F!EE]I%L,1]B?46G MKFIRJ\6,^ROR0"PTJ=^%/7<\AP142*\H$1+/ARJOE17'*8BC\WL6-95?A]&6 M[7D^E13]Y@\:N'OTZ+SS.+F8(L_:/*##*:6_KF08J]SOW=(VHEC)^N^(G6)U-L1!=9FM?)4I!+3;;IVCWV.1#!\UYA77#UEJQ?/ MD)*=%LYWRE'YI+Q12D6H2"B&KU>!N5=TF=S1U=8UIF-15.X=%1??00U+,*K% MQ?25U4OSQ8(_R0]-XWB_WFA8*DF.CIA0ZD;8?\5W%C[ MZ5F`_0N:9[CLHKAX`]D!\!4&P$G'9J*.AMF1OB7O6@1@1N8R&?3TJM`=(2'- M+DQW!'B(**FA'@2V5&$>$[+@U" M=?Y&0D]_HE$<)6W6.`5(I!B]O4+$?/X1AH!D%%UU_&_!M" M_"I[@`=I]O4(-;)L"2I_#Q5>I61^-E@EE,R131Q!V6)=4="`>L!H:5TARGLW M&WQ`-#N!5>WTE1173Z%;*F1C*TF6=;EUXG&WZ\07/WJ2,+16;1\H6@I",6$I/+IV?43H# M/D]W1>';R4`/1V+3--YY&_E$^?O9Y?5V&!?;R4!NIE`)%ALI2&60L5%U7\$A M(@:Y5)#*X&,C@ZDP.#;J[24R1&0@]Y*5,K!(WF5+.2Q\GTT8*R*-[26`:@LF M0=6IVDZ*="Z;/0!!-;^);K\J;3$B@1`@[-;'UWXX#B:AFWI1_"UO;I4]4+PT M^PD.SI3&09K3BQZ@O%$Z^=*:YV_@EH_URV]`%U7W0-$ MU!9#&HKJJ3WULU=Q'R>K\P'1H<`H5Q\IG2M$JV=%=`XB^KIK2-E*%"E:U-Y( M3?U?N:L9%;7V`!IU))`B0NU+.K][8!5=YU_(9K(?(@QVD5[UYEF-BEI[@(@Z M$D@1(;I+VI&12)]$C:ZF9EY.O9O#(AJ7;8$)5-T#<-060XH0P=BFM,W@;'^Q M:3XVLGNL[K(59P3'>=G,K:W[/25]FA$71KK/CN>L-+SH@SE<9+/Y#RI M?0/:#Y89@7&&5+VF&O&)"[M.#S?1MS8>P^!Q[#I3[N$PN1;4,P3;Z''E\C8@ M!"TF$D%A18L)T^$]Y"39RNYAIDE!:'&S69#1."M8FBR&T*O_R*;A!9H#@+\' MU%#K>X^S6@)2Z7T]*>_EPHT`+[T./^X-:WLOZSX5\5[`G1K3*]%`T1.R_*E' M8[UW-LQ:SL0QTW@>27'"A/S8%W8!'W-D\W,=MM9;HSZ0)'6%5&T$0DET\.IE M9GHI+V4NU(<0H*Z5:PF+.2>M.S%KY>,U(2;9&ZP?TO=>CH#N):R%H\HQTYL_ M[S6$1$R<%NY@@5L,D+[U\=QD4RK&H<)57L4[;T)+U'$Z'R6"W>?6D6 MK;7ZR(JO#^([_\2K,%Z;$[D6KF.!)$@J"I&;2Q+UVQZ0F>YX:)(<@$)M:C'@ MRK4J,C+JRT(YVYUC1?P$W?:M[BM<)*11TW2VO!Y+(P=LT(`)TQ?\*K?4.LF? M,$@;-:!58]7L1K2^L$S'2RANE(4?;R^K`B@Y/O\Z/.L-AX`4`$KF,M1'7NFQ MK'!.P433L58_P"<;2FRJ>?5LC+1V\R&<5H6C33[V8IY*$^>55MI)J-1@6G)QU9BA(R6;6DV38F`<+_BTQ\ M"Q7D&:]J43T;4T.+>2O3M$2TV&F58_HGF)B7-^2^H@?P_6>\*6J[1C_A)2H4 M+6)2Q-.GBJ-RM,N MC<4JGEI>:W(.#_R/C_]$F+"9*E<(XZ9WE*BIO?JVY;7E51]'K0F3!70S9\F7 M*QZ*)\@M6MH-M3?(>\TEFU*.=O(V0NK+ROK4N8N9-7WJA(R53]VQZYQ_,:+< MW2PIW]%!#TI.A2FH**W><*_4RL:!"V&NM/"5$X9&YA($YKZ8[X*@+*B0%<(0 MA-#74+6BC&GA/R<\/8.MQ*+F9J/P;FA5A"DMMG#2K`[)DU3E&BTNK+E&)9C2 M8A\E]BXE78/R2IIKN`9S6NQS%*P.5DN#G@OYMN6&':MVE2 M]`7A^34:,]=EV&_E(B9G^5U(VM@A;L"N2/#O2)/C0(M3!\E-N.PM*ZJV^Y@(90V5,Y(,9A#B:+62- M92Z\+&XLC76OM>TF9R,FSYLWO?/HF1SRZ-%MB/R17HEZ70^XM=R>T,)$\QY1`^))=C,FET91W&7'PAZS"FO='/::X(>MF# MZ;%CQS$G#W[NA^*B70[S%2518I/*:&U5-?6&[1Q!#0]YV>$$'X-'-?.'Z2X1*(-=.)[N%P`^4D9[>$]`0B?5RUN M53'\,''UC010U7KGU]4`!MNXUI*,5\Y&G%SQ'[?'0U]1]"Q@*6KU<7(SF2`K M<%[IKT]F@$8(6R`I<&SVSW9CNF1TE77T0X0[?P_C77W'>_]K(A; MR8X2*'%F2*:!+BQ#,7U9+5VD9V7HGF<(A"PSA:4XEVI9/:LBCP?6HK0EDFY6 M32+L6WG`TN M;RHKN%,0W+&6,&I,:/+-D2\I-0*O]_/ MWP!:=67$?47G-Y/>C*@[@^W/^$6R0L,P_GH^2>&#?E:]U& M.LF])$5C14JF.FVI9Z7JZ3Z3OJDQ06BQ<2_'[IU'7UB(KFDV@B.FO4\L50E# MBSU3:9;]$#>*I[2]3SQ5"4.+R(`LR]&S5$T":MW@)Z(JI:'%YJHTSV]^HX!* MFON$4X4LM(@LR''\,D,8F?3=V$;`M&[N$TP5LF@P//#]B)(Z!IK@P_\#4$L# M!!0````(`'J&?$(H<@=CP"P``(\/`P`5`!P`861U&UL550)``-GK5119ZU4475X"P`!!"4.```$.0$``.U]69/;N)+N^XV8_Z#K M>9@S$6/7[K8[NN^$5(M;$>52G:KJ/C-/'2P2DGA,D6J`5%GGUU^`BT1*6+FF M9#ZY+&+)+S,!)!*)Q"___7WA#58($S?P?WUW]N'TW0#Y=N"X_NS7=Q%Y;Q'; M==_]]__[M__SR_]]__Y_1D_W`R>PHP7RPX&-D14B9_#FAO/!-0X(F;H8#5[7 M@R=WA<+!S<]K)8!Z&RY]/3M[>WCY@5I:D13_8P>+] M^[2WD45HZ[1>W.WYA[/-E^NTY\#_>7!Q?3TY\OK@;#KYN" M7RF2J:LLZ;G^MU?:VX!RPR>_OLN1]_T5>Q\"/*,53R].LH+ODI(_?R=NH?3; M15;V[.1_OMX_VW.TL-Z[/@DMW][68LWPZIU]_OSY)/ZZ*4J[=\)-V3PU5R?) M1UJ4N#^3N*O[P+;"6)1*"`-A"?:_]UFQ]^RG]V?G[R_./GPGSCO*KL'@%QQX MZ`E-!S&M/X?K)?KU'7$72X]AC'^;8S3]]9WE4!VB+#\_.T_J__MS2"7'U.\6*\>*LM:>9-UZD*T M6%AX375N*\RA;0<1ZWSV2+73=A&Y0:'E>J7UQ*R/QB7S8&'VUPI5@Z7;>.-X MV*3N1!Z:3,=TI5R@>[KPW>%@P2W=!.9R!+3(%_I]&1#+^X*#:'GM680@.LT. MZ3]A1=VNI><:.3&TZ7I!W#KU7-YD0[1O.?@887M.U_U'[-IT*E\L`Y^MDO5A MTN^J<:RCB+@^(B3W]1$'=P%>6'E;(1EE&XMA[$]9B>JCNVFB:N0?I8".MG`] M]!UF(2U9ES7INU[3#6/)*27G:_T`-?NK$?67('#>7,^C_8Q]NAN9N=2X22;& MF@1IU$,[R*[G]+^(C/VLS&C]C&;515JMRW:P;U7LFG)_34V_X8+9@+0HM0:C M1>2Q:83^AD/W7ZFMOM-&8TRJD[8:N7D?^+,7A!9$.T;]F;_[4^ M((KVZ]POL:WY9!DOD50YGA`)J;$0[]_IA^&;A9VZIJ]R7;6,-5?&;&(ILO"(D62?GF6:#LN49.I+L:?W:/J&FL.43RZYS MOU&EPTYPZY=LBS$E**I[["3NR^?$?5G#B."WUZ17M"+1PN9J]=Z]$O171&VY MVU5E&U+46&5ZL]7Y#\N+8MN)ZN/?(\MSI[&AE7@"2[';L.44B85M73""(XGL MI(.=15S%&.>T"6Q'K^B]XU+;FITNO1ND'>7!;%IQ_?"$%CU)RYQP&VB0X$TO M[YU@8;F&U.[7;H=4-+4B+RQ-:U:]26)C?KQ?H,4KPH:$%JLV2*3E>6:DQ152 M@B@773]V`]W3KE,"6*GF#\'R#$#?0T2;<#:_NB$CX?3TXO1T\'ZP:8K^O>EK MD.]L6X0,)M-!OK__&*0]QH@I9B^P"YU[[%@SP%SVQTR<6N0UYB2=#&>6M63' MO.](B\^`.<6.NF2T(176W_I M\+M+5'3SZVQ@;'5LB(N`J$9F;:?*67)N#3"5]*_OSK+6ICA8B!FKEA<*A'P#WAX[C)OT_6JXS]J^MI1M:GE02BCJM2N6\HE046`!(Z(EMM'SD MW%K8I_LO(A6-J'"K,KFH*!,1"`#"V$S%U$I'8_JGTB;+%6Q("/$V0G,%V2.; M:WREYMD.OY/]SL\L,H-N$VZ]N"C=,R7G7MOO7D`W!;^^"W'4F0V]N\D9^[87 M.7%<%([9'H;8?8U"AO,E>`A\!HHRDY(R&U-X&)%0*-AZ&HG!R8?HT)B9!S$V&F58A2 MZ"24\TYJ'E`XF=X%>(K<,,)(/`57;K=5.5]6'J35P!Z\7GQAEQ/J4H:TL58U MX*I5#4@10A/[T/EG1,+8@_@2",SS&!2[M^`P4Q-*A9X17KHT2 M!CPA.Y@EDF,G&B+G7_/=MJI*'ZNH4O.\@*9T@L$34YL/X#2;73C56U6"GQJ8 M3SB8#D28R4Q87IJ\^JV*\U-CR\,!R_,!O<6?2@DS5[E527YN3)(Y1-#$2"W. M[4T6@;1VRK3KX#VM(I4=RM7,_^6D>.9;PSFP]!:AQC'OV=G'T[/!^\&V'7;F MNVUJD+;5R2E![KKADTN^R0YR186[.=[8H66T?J%]2HYSI37@'.;*)5(\^9`` M`C`Q[2.A/4K/$*4U@!SO:BB>5$AY2,SJ\NSSW".>^L3'!Z?(#8%4M",?!&FI:$)X*$P1I[=*F.ON25>CN#$P-0SZJ#OM,;`_/ MUL9[H92/:-??=,7)K0KA/*NBB+FX.C;DN6DVM$SYG_9-^4)C+#PS;@Z"-AZP M-3]"OCU?6/B;F4F_4^U([/H=5!!7KPV)9L;C7C6X9CY7(^6"VP5WO((KVL3G M5Y?GIZ!-_\K"Y`*&(%^Z]LCM_5P!D*:]0"$+PLEA@,#SWI3O3?G>E._&E)>G MG].PZ2].ST\O=FWZ?*N#;;.#OR4-_V=_VTI"Z$YZI9'EL02>SW.$XB0EF\B' M+V. MQ+S*E>9<;E92=7VP7_[\C?+E-V1YX3S-7,;= MC,F+0MB651P#3&1RD-#B:/H[2(UNT@3#Q2@=;TR\:#-6O3D(&S2Y.*MC!#?J M^-F'51-.B?5'M8GOA)(#NO'4!7NZ#O M!EE7@[^EG1GZ'T23KQ8^GK?!O'HG=[Q9-EF)JR#WO?O=?%F)%*YX;P$!F-MC M:N3WZO,E@&R9]Y1FC\&`3AZ,6%S<`UW2/=`YG!VE+MNY(`!(XBMEWB):2&6Q M4P;"-H^C0'G&[U`,@<_6=S6?BV4@V/4J/AD.UM7S^M=5 M(3R8@I*Z(R7E@:S`"M53"`:0'[DVT107O2NZZ%W`6;GK$!<7(#P)2E<=05D( MJ[Q2$25"`K0F9<^]/'I6_-S%YLT7Y>4OK9H=K%47]:]56E`A"U,Y36K5!+*6 M&:BLEA"!K7"-"A'TJM><8*&NA2PA210BO"%9E5>47QK">FB@MCNY1OF8`$CG M+L)^G'**PKESO\?)IZ0"DE6`L&,N*2,9+`!BBM\S608XC(]'](:2H@Z$,Z22 MPE(@:R(^(QO#V?OJXO`,44D(V>L,^2W%4]^1<*5CIKW31_.CIOLN`S*J0-V> M[9O8_F"".![I_H9V89KK656U@7:N*S2D[Y[Y,_".5LAXH2>+^X"#3TO>$,. M73\>*37)DKTG,*/J7:9&K45J1F@;%UW<)PM?(W=G#?5L%H\BN MK1#-*#%[Z1,KM--EBM-:A%D.-K2%4[CS^IT@BN?>G8INYFG5[#+S:5T+I!90 M:'+=?64]23R9A+9FC[$+!*M7M62Z.\RN/_644DCA0F8)^ MHK.,R#F52RH79EV80'J21P:*,VH1LYR5+Q$HQ0(0.PT(;7/Y`[FX=T\4V.A#(D-ZX7L9?! M--]#-&ZE79DWY"LR1@U-^$.*U6'4TGW7,[(C2AO%?/L]T5QV+S^)NT@S#6>/ M[](5)`:7V&$"E:BI[785I2'74TV\@*8^`OWG/B]H-G$(FF@WOJ(A[Y49Y(.0 MN6C&VSX::")^G=;:U82&G%ZET;=K^HWC1)ITZF)G(M*3>&[Q=D75A$]+"@]D M!M$'"[._5L@LO\?Y?GX/82[131?_63:QQZ'DZY1E+&VM]SX5ZM&G0FU9D_L< MJWV.UY M&)I8`N[G=CS(Z!@33_Z<0EU.^R)]V,SC''JA.90.-U>3X#IIAV9\G^JI3_74 M)PHZ\$1!S<\?>Y[.UETO]Q"RSW?`Z'9]+I"O6B?!?L^!I[QEG2\)(;='1VHC MY0LTH^ZKZ\?T;&X49U>,MP!&ZT<+BT\&C5J`D$6DX]G$B%^-GQ^R^\/7E&37 M28F_"S"+W$VU=K26AF":U(:0T*3+&<&$5ZT=&_^&/">E8WMG.0N'T[]$4:FY M+F]]0U",2LR#MIYD-VV?D(W<%3-K'I`P\(Q?MLO[Y$#6"`%G0$8P&#T49!KE M<*X=Y9"1P=XW20@9,$H&C!1!K3X>HH^'Z.,A^GB(/AZBCX?HXR'Z>(@C6Z)Z MYS$$4_Z(G<Q30D;O+.V=I;VSM'>6]L[2WEG:.TM[9^F1+5&]LQ2.4=\[2_66-3E487YT ML7.UMM9[9VQ]O.QXZYI[?Z9LLI++_60E^5;A9"C9*(ML+[A;",B[2I(]EK`T MG$T1G_.*]Y#`;#9XM"6O-,FW%1KU@&P@%`JG$M0.J&,66?$:]-75Y06@YZ3K M%",7:",/(CDK*[X6(=ZM[16!L$O35K'MVT6[,*#MP^X#?Q8BO+A!KZK[W_RB M<))\J%<S,NR2#FUA>++\F6PUR'V'D_]#O03DR(;"9&G. MAT()(#/\GFKL,1A02H?T*5`IDW?*0)A%.)I1N')@*5P0$YQA M*#YFD7S55Y12C4,(6BVM)Z40-Y[&@ZO0\5L)+%V:A?U)%$Y>/7?J@Q.,UR'(-C;[TLW38]!&7!F(,^]FJV*\5/=8MR#TUH>I+%/0KK_8U1+ M$QP5R[7*[<^E)T,^\=!&!O.`,@IQE(3K$)<\+S&RG(G_AX5=MLHF[\9S1X=V M[7;=-:=5AH@V)FBBU+2S'R-LSRV"Z'1M5]RE[#35KI`K.8O*`>S"LKQS,*E#RAE>7M[^;*-='IL_75A"0'UKBT MOE"`[';BQ$\Z35\,W>Y""KY'GK!,6^CT-7H#69GB@K:Z?0D"Y\WUO/%B:;DX MQDK1"-8O4>%.7Z#?T97G49S"_UCG&`(G44,CN+$#C3ZBJAGU$'B?:E"/@XFM*A*Z2^&83LWYWJA%"#$Z5>=_(\"MA7_<6&N2I*R]IAL)NC[)8D`XA2&$W1A)1H*E M<:9G\HUG_CLO"+C."5XI"/$V1FSF@6A>J5$8IYF)F*O?T"35KPLBCL9,Y[6Q M@3S\X&!]Q,%=@!<6.S`-/->Q0O947"'MT=B?LA)Q3)WA,]*4; M?5GOUSR2TY-]8%UX1S(BTKR6_BRQ]#0](<+:AW2*80RN2SG1_5#Q$8UD3Q11 M\N2O?5=O\QA.,@PA@Y(T/Y]M55F+6CVD4XS:0!^`N42XH$JLISOUC^180@2O MRY',FUN8`XO^0#)G([LH9@]]Y\;UHE#['DBE'H[A9*(2`[K4"?X,5*]6E.SC MX,Y%ZF?!`:P#&4*U&9,>%J]@>S-& M](2$WCF%JGH7$Y60IM%:D7I:JR;$8G`"VH`%8=,3)5PF2MFD#.+PQ4 M5DN(M26Z%AB5<1@.;4%$.W_"AD"N&7ZC6&_,>PWAOW&$/K&L!XA[EGH MTO6^<^=^9W\1J8!D%4`;I7(9R6`!$-,+MGRR MI`97;&[I#25%'="&J%Q8"F0`Y'6/+(+F@>>,%TL7)V>GEY=7EZ'5Y==F&/-#4BKRP68%PH37A"/TM6+#3C.M@L8@HM]9B1ZBH)(05EZLZ&Y>G MB/*F^/D;LKQPGM(D9RBW*(2U5> M163+KG$K'2S$JL>NA`NQ,3CX8MU2_&`MY&$?I5H"LLR75&X#X?/A_^@*4%R/ M?Z+K\14<4Z,;I>"RI)&S6H1#=^K2"HC09?S>M2E[!`$H.A4@&"P5E'E[DBN' M"JOW-MKNFMO^F:Q@\/P#N;-YB)SA"F%KAI(\ZM?6T@TM M[W?:V5V`LY2FR&'O9=QYP1MO4)5L"(0MJWY1LB0Z:&.,;7$"_SD,[&])KO-) M%!(ZM3C[":GUJD`X.]4;@7("^`EGJM584`JE@4@H`1_67&>GC,OA/: M/W3&G4;>O3L5';+J586014I/2'IXH`EP+R(`A=JOY&I5A9`42O-M7"T\X`1X MY.\="_(Y=?3<<;G`L'T`HJ`[124(&8[TI*="`C>N:I-.*2LS6F?.>,-` MJ[W;J*I`J[1K^FE;=+0>I-UW'7VU"8C.:-.[@+I3NE/7QR9[[]`.W155(Y0= M"^I$`*AJ`XKEDLN*ZSE1H0,PIZ;T<"C5.;265`-RNF"HIYS3:PG&XY5?T1/^ M^>KRZB1D+I2%N&O4@G!WH:C%'E#)H<`3'SY.J(SIY31"^ MZ/+"DX,#(+YLK5<=\'#*=7>^(R2:?QEOQYXYU+MW,!V=@C&C)2*X._&-RK`+ MZ5Z2&;`^-U$9]1 M$#U'C+H!6*=0NJ&B1BU`]-'H2E;OQ`IF^*B$7H/(0>-6@#AV2BBYIK#!AHMV M(O""1^2"_GOU"8XGJ%TEX+*BD?!0:DL&"X3IPOJ$I@ACRWM"B:%)YNY2%B>J M61."TZ>D.F^#136Q-IZ=G.X#',0(93&K\7\6%OXFD9*B`H0-:E7A*"`V+I/8 M1ZR.J^86@[`1K^58JU!Q[Y=A_XLQ>$%S?HM>P[>Y_V4XBQ5M^S9@>L73@IPQ@U M8Y_0%4R5-XQ;LA.C94[U)Y.0XCD$05DX3DX)_PNV#!\'@,ELCS)YI)*H-!`_ MI%2WI`(!Y%FL121%]]CYU>7'4SB>PJIBXH(#(+E[%(8(3Z;7&#FN/"\^OR@$ M3Z!"_8IIU7D@``@"=H)*P5Y(3)9*@3LT>=9Z2$EVY!F'DN=*!Y8OG'$EA"-.Y7%&:WOF3\,2TYH=6I!\$!K/Z\2L<[LIU:/^Q=U-R4*ZJ`L&;K"D#)18(*ZGKHVR7>V?9KD?U M06;8"(MW8-P(I*-KW`BA`!5+,GKEIHZR&A2C1Z%V*D$501VOP(KNP,NKRX_G M<'R==0J1"[21-0GY=-5[1G9$:2G2(UF5U)5`F+J:2KA=H=2XH.W"-R>Y<8S3 M9!JGK=-)`;%?OH,E2Y"/3/>L38P%@&3R1$DG/5Y!(.N24KL*>1,Y.`Y;#J"7 MFXJRJ7^%J>OF/G81&3[B.+8<.3')BAO[DAH0UB&Q!A;OYDM@`!!,<5*^5\2A M"DMW%XRJ`)"7!7OQ_XHP#AX8YX[:TD_AFN>!6?@@<4 MIDG"SP0255>#X`LTD*(:4/,>V26RW:F+G*&SLGP;?:5VE[OT$$O4_A+<(.;5 MI!#N(M\APY7E4I'$RO8[VT06]8^[3ZZS>0B)HG5GX%J!0QN_129\M<*(47=# MK7$M6ZA8`4)FZ=*&41%*XZ/U(6)HV(Q!Z/S@\9+>2,I!2`&M.W[X"&`/A)%% M7/*\I%:6,_'_L+#+K.8GW5$AJ0TAT7/I(2+!U?AXR6S>E^#VU0T=ZR[`CQ%> MTOW(9)K-P2SK#9N`7;.5K;:F(>2!UAV5M8%N7/)/R(ELUN+83TC=GG_S0U8D MQ=OUH)Q6$Y$42>-L_QKXX=Q;2XCXW0]=;_O?,;GUW$5R),X33,4&VQ5=>;=+ M'5@[$.Z>YNQ3DP*1D%F+\6&/HQ2[20/MRKFZ MN\@$&S3!\CW26P0W=!OMSR@"-Q#E!3!KHEWAEO<6E4/7^%H_BD\*MMWSUNC] M,NTRO;PS1T#^(0R:ZPACMJNN<`HB;J)=^95W$95#!TV\1:!#WX\L[Y&.S:E:U77'6[3@2H8(FQNO`7R%,XA0AN3=3QX1$R!&=9:DJM2NZ\FXA M73S0A!;3.`\\=OWA]J^(4L8"\1/*EW0:V>*)#^F$L82&K;0;1%#>E50:(#0Y M9]SY9T@?.H;9VDJR*T][D&%H[;B; MKC($V1'+0?;WR,)TR^:M\P?#+P&E4*K>95MJ5TP58T[*@@24Q6Z;"#7_JVE* MN[W'6G=3VN4?%2E^ZW/<&3LI#C`+1K4,=WT6C#X+1I\%H\^"48FQK6?!./C< M"]7R7QQ"[H7^@M&!YK;/&ZN2Y79;!,)$97+.4B`>F@\I3YWUI9(O?&"W>40PH,GF>&-LJD=AU!MBTZC;)#Z$F<0]DO@E,DJU M:X?IM>GAFX4=4NY1@+/3_40/JFZ4ZB3 M1S88XQ2NDYTR<'PF?"X7'M$HD@Y@!HS/IEGXCW/-7KSR2?*4-E5;?Y8\?#5: M;\NDWN\8QA:+[SQZEJ]\]+*9KH#X:+B*6\QIWP3Z7H.J=E5(?7)Y<77Y4X,A M)Z9I73K1*BY'`"C:SK(NSS[/+PO!V]CD>"GS`((@#_&9!O7BWK_0<#`O M--3#XJ^448MH(67R3AD($Y#@M0$!Q1#XG&1SD?.Y6`:"4U'%YR+%`/BK9N4@Y(&Y++5Z@NQV>IO"8#6B;4H+=14/XDAK"@#(^FHF`"Z61 M@^JWX&4>1,3RG6?W>VQYCGWF)W17B)$D.<#6K`EA"15;WT90F@\;V!+RX/JH MI#CD52$LM?KRD&.I;9XBR/XP"U8G#G*3*8K^L3LST9_^O$.G.3SKD3_O[GCE=6B3)D#"W2V\1T\5O@.:X_DX3![);H)A7;Z*'YX6W0R%0XUE8OHC`CY>,-!=EH(0?Z,Y[S8!'YHV#;VX M<>3PT=Y^9W^*9F+=RA#B=?1DKHL(FAAO%TLO6"/T3!<)UT9\ZA_8O6I"P25! M-2\!75WRWZ\#$CX$X?^B\`G9P>*4*+=""EOJ&D-)73XE:8L@/HX/) M!$HMG_0G5DZ4`J-M(B"D/^Y8*P6<:=XL%2#(C9+;[PC;+LEHY-JL)5J!D#I9 MQZ`M`0W:I%+5"/LCT6;?84LW"^%X"=A/DR@DH>4SI\9P-L-H1IDY]D/L^L2U M_["\2!C:V1T]$'(ZMV,Y5V#2L>EO#G,K^BGI#T3&ZG844,(%<`H6'\'$&;'R MV1P3KU'>8-Q,]4+7J'E#(#)AZWI1S>&!DW5%M:8VVA2YS'NX<4LT-(UP>P*1 M)+N="82+_VC4*4G:MKW21";A'.&7N>5S75]UZYAQ]R!R;S>L>,9,^5&U\1_( MG;E"V)JA^"-[:>G.5+AB MF2^:_MCU9B?KBY_^@@GJ/YP%9/+UD82_[$^)S[_:B&W!(2`_0:'S#8_ MX`[NYA]VC)?@MT`ABEP)$!&%;8DBA_LPO`8E>;"WDVUR$K\'$8'<*/L*,W7# MEO.A1D77*X'@#>%4%@M7E!JMV2Z/;F8LX=^JBY='/=O^OERVK:Q[78((33], M9=WCY5$K:_8,0BXR0!X5VUKO(`+J#U.%96P%J+84JK1A*QB2!N'5SI.-BE]<'$*&7`J:_LUM(A$2+I+QI MH-YEA4"]-$0O)6*0HP)XO)Y.:N8JH7D&[??9FFN*>#.6:9_HN4_TW"=Z[A,] ME^$SN$3/I:\WE`LU,6L86EA)&;:8A)`8+$7'%2U2-B=5ZU>A#N+"DU%,266= M;IN5(!T.91BPP93;_SRYY-L=1BC_QEZZ.->MRL;=PPTUZ4R'C7GXPREO5UH+ M.:P$O+K^@'J:6N:=3;)9]W##/\!K[8:'()5WSR>]C_Q5!_DFHQ3""[,#AWHZ MA!MG48N"-L0UD"I9UV#,L/X1>+09C\)LV6Q5$``W3@+4G*K@XH^HPNT9!0H" MX`8W'((*UV\8&&5T+0=FLX)$V)^LV$V%O=U42WW"C2`HJWPM,>[(I\Q<[$,[ M4V2A0QC9/`]A3BRPK>,0E*Q]PH>+1RN7RA"8MDQW0\6 M9B57R"PRY>ST;#A*@>& M'-=+=:IDJ_U+=8A-SUF0ZI<:8>+HJ?H<00&:@1YM)K(BB^1>.D8>HQ?F\)G3L2EXSYA6# M$)]1AL5<,."VG?WCIO`#L^*M4;P=\T-JT$F?S1.4A3"(](0F`-#X%)5=.TR' MNHM(;U+ M?N,<+OIWV.DGU[[AE`(1^:#F+(_T@_&IZ94N\M2A M8PV%1.\2F*QJ)YM%*YZ67X+<-=^I"<@):""]PH91!R8`BUM!I_16 MC69=*#M_?94U$"0DGUO3HBRDB[ZZO+K\U&`R!=,LW$V*EPN\$:LS\//+K-@U M(2@(PO]CHH9;,Y0/J/ETV%KL[IS7(D=0*5XWR^AZ)C/N:JOR"JDJ=>TL[VXB]C[@6D`81JF0)Z0C=P5PWD=89S0KY:Z=EL0QJ^Y6I0$ M"WMXJV",_9>WX'^1A?4&ODES$#QB36M!'N_!*P+M'-6J"KD&(;CL6E"&'.)# M5X>[(,)U:D.N/0A>QN:5(0?XX'7!7=4Z,^3:@W"5J05=V`(^;%UXF2.,K&DH M='>4;P["#:&F-2&/][`5H1;QP[A3T[30.S^;BA/_S0./'?0F+R*;G2R=[X=S MYYK\#S)(&H5R&-2G#>2YL#W+?[`6TOC00A&(!T4-)`\L@@8P#6<$R>-"=PI! M.0CB*!F/V4V&==(-^"V;\, M:Q;7E22T3KX*=*ZNQB%XU)O1P+HX!&T:4^+:A95=&>5%0];5*`27?$=JI.`, M-/4IS:7BZ!BNZ'Z,P;T+<)S'L>ZU4=D=!,<_L`OB2IYU[2Z@8\*=NC:EA9(= M8,,XU(\<;\&VQ4'29+>^@NL@MH1Q+#&6QDRV\1<5[F):V*-EM!XAWYXO+/Q- MLK-75X.SVY?+)C\`U:@`3.3[1&8D2C?XZFI`MORZ&BD7W"XX`()[MCQ$GM`* M^1%Z1GCEVH@\('FLIZ(.!+>!KCX65CHY+`#"&MIV$!6<[E(YB8M#V&B5$9$8 M$0#I<.8(1:H":0TX*0HJK56@4A3L(U&E)I#6@+LXR5(12"$UX:O^BAQJ%&-) M$H+=$B"7$,G=^%WZ&TGXQRX,?@E6"/N+^"[Q<$8G3$G,N:("R#5`PF,%'&BN MC3UH*L>]K$)W#GDU#/G4TI777'$K>T>9$E7B#2)%!9"#B"LB'33@Q]`C-5W8 MV)\)'T"55X'@&:XXH@IXNG:A1:\$_1511.KG?BU\6PF9%J6$2B0!RH1QW^B[N3`;&--X:%M0^3+J+CYDQ/VN1M#@$ MLU@CP8X4`S1C^!XE#Q4ZHV@=1.'DS4>8S-UE=O0_F3Z@M[&_HG\&PBLLIHU` M,)AU\ZR9(8,F7DYHQW7`R,XT\C9.XGMMD?FCY1J$SLA;`1&XH"5@8VB=;(ZR M4$,6>)-$2OC.WR/+NVC8_R-KO=N.D MP+[9\A4?D(2K33G0NA-&C^J-5: MH@_U+HM<_T>6QWXJ-:=OZD)P8-2L$E*\T';#&UL550)``-GK5119ZU4475X"P`!!"4.```$.0$` M`.V]>W/D1I(G^/^9W7>(ZQV[ELRR))7Z,:/>F3U+DD4U=UE%#DEU[YAL;0Q, M1))H(8%L`,DJ]J>_>.`12,0+0"`\DII_NE7,<`__!=P]/%[N__K_?=FEZ`47 M99)G__:;]]]\]QN$LTT>)]G3O_WF4+Z+RDV2_.;_^Q__]__UK__/NW?_^^SN M&L7YYK##684V!8XJ'*//2?6,SHN\++=)@='C*[I+7G"%[O-M]3DB?ZGYHS]\ M\_MOWG]/.D'/5;7_T[???O[\^9N"MBWKIM]L\MV[=W5O9U%)N!,ZUNWWW[QO M?SFO>\ZS/Z'???O]OWS[_7?O?X?^Y4_???>GW_T!K3^V#3\2)-O$V#)-LE\> M26^(C$96_MMO!/&^/!;I-WGQ1`B_^]VW3T??_M__YX M?;]YQKOH79*5591M.BK*1D;W_H[*R6@ M'WJ\:J)OO4GYD%=1.DE4D;*6-Z7_NB9R]23&7RJ6 MDV^+?#=*L%J,?`31?Z:/Z3&B'IP"E_FAV.`QW[%QH*RGJ>/,)2/^A%!27XVS M=S_=_^9_-*0HRF+$B9%`C7YNZ/_/OW[+NG0+K?>!7$-:CX5D8R(U'H9E&Y6/ M#!"QFJ?_O"7Y'_+$W`A(;`.C`06:H' M;2LX73@20:2!L MCX`-?_9K:RKQJ(4=_^;-KN0=JZ=4"MA\ MSMZ/7K^GI.?!!VW;(-K(MW7>XB+)2=P77Q`?H]'(HW9P]BH5^-AP>XU`+%@B M@=J4>6,20,>(-O>M`Y=)N8E2+L0E^=MQD&1H"Z<+2L&/]6'0$$0G%%*H]8(3 M-.K!2&!TXS]P5-AIAM`26B\&0LNUHFT&J!-',A@U@K;WJP]\<7^'GQ*ZH,^J M3]%.-EW(F_G7!)VXC1K(VGC5`;4``P6H]U:ZMH@V]OOQSXD"%E%ZE<7XR__" MKTI`@W90GU\AB.%RGS?O30J^8TBNEI=)BHMSTNU37J@=PU$K*+<@%;;O%'I- M`%R"I'^50V!-4=/6\XR0[W9Y=E_EFU_NGR,R##>'BAZGTB-JM;O3$H'-%190 MCB8.#07$+&(41SFE,$K$2%>($R.!VJ]._16GZ?_*\L_9/8[*/,/Q55D><*'$ MK6P/I4D&`'TE4C0&T!^M)"K5H43O?J%4J"%#G,ZOTMP>'M-DN[P/B\JXIWHX8AT7T+?'&R>T8I_ M-,-(VT+,+1I!E+-*'9RV1(A3^=66O^3I(:NB@D=4:C49M(/2#X7`?<4X:@2@ M$5()5*K0-N;!ZFP5<'`?X&9[F611MDFB]#8O$\WMJG&DP'<&+&!);Q%HZ.#N M%1B%&BZ(\RS&&;V92OZKS-,D9E=1SZ*47O$DH2W&51G$I:1U61)1#"IWW`A& MN>2BBFK4;^%=863=#T]96:.E[]A97.88(2V<>LHODJRK\Z@H7LE<_IE?]$5))+PNQJZCL/P3R%8HJU'!`C,4BQK)OCLAUYC(7 M(0.#"?"!(PR M-IN<1-[E'=Y@(O=CBC_AJEZ8J:8G+0E0!&(!HQ>/:-K[CTZ,P@QG_YH$=30K M1*A6S:(:YN[L'"2%@"3#%?5<49KFGVE<7M)__=,?5W_XX5^81R#_^<_?_PY% M[.\?B9X\H]^]7R&BX^_9[Q>$U^X1%\U?OUL1]N4>;ZKD!:>#(Q`_OG")SPSL M]Y;]WK]?_?Z/?^3?^Y]7[__E!^KVC[_L]^QW^N'UG]B?1[TM\#Y*X@]?]G2= M26:%F^H9%SQUMKF0:J6U.BFI1I'B-&G'IAYVOR M+_.!84Y:,F0Y0[:I]V@CZ7+3EY\!@.9[H^?/.(TO\^*>A(Z&\$O9''+S1RW^ M63 MU6[6`F!6],H?W2JI3SD@M[<6@7?6;GB[S;0,:1 MIP'#(FJ38`!O("S$92%.L$L76Z+G/C]ZO66 MR,B2@_S]D.SIP3RQ-.523D<"M;MAAM'?UE"W!]C/,`DC611SDA5B1#S;3$/& M)E>X^&<1."%%0`L!#"0&0FO4,SIL.!#M5^S//X_>5?>?L>##]O\ M#!<;L%O.(T1^DR\R+2@Z,9@P%IHT//XB0KKSPM=9141*'E, M<;LC\^'+)CW0X-S@H>Q(8;S7&%BB9[.A\^[U[(4:*%A'6L]W"#>4Z&E);VE< ME\P`17M0P^!K8DSD!64I7+&$L4&2; MTUU(.6)'6R0*Y^AP",5T>MA1!'&`>"S.B'.ICC2<`QPG<(!]PCQ<(1SI2)>/ M8Y::0>U"6.\^A+'K,'*W`<9V74@.;*;C(01DEF9,`9B@P?`@S?PN9!**]6;V%55JVM0(JJ_:CR%[5^5,Y"VZ#U[#J)'I,T MJ1)'T=6Q\$1MMJ7UKN_C!!LHGD#>GLI6 MKP$/=6OHBX9.9`_D[>DX$'O> M&M1&BP..AXY/5'LQ2]0".C%7>&,)>=9+(-(:V%QT[O-5.0M`\?00T5*=R M>XS$\NSI`1>["_QH>-`E;0D4>ZF%[@5=PV;^HRV5#,.(G;1\5Y&FB+9M#1%] MC*I#(8VZY@DO+6$[%P,NR_;F_FXAP6V=B.N0 M]F:L-Q+"V8NQVX,)8._%O'T';(K6(O>?[:4A;!:)TZ;Q,H*J,7R(J[^.(&\) M&N@:S\2/`Z[NH=1NJ0$R;YI=:0`S MI6&*A)P;S9,B^%RHG02#F/QH0:.DHH\:Z0'B>9[1\A,XVZCU4TL!E*G:#**7 MGUK=W']6:I,LDL3]+05/"BS2_!8L\>\<'"NT$0F$U'3$95?`53!&7N\([T+' MN"L<`5W:&'V=X;YW?:&^I+&NJB)Y/%3TM`M5.;J-`GE".Q,>].T,H8B>ML3! MH!G<'"$3]WAB$-N`S`9#`:2NLZM"6.=]9[7DEGS/:JH^,%OVD)*3N$`32":2 M<5#8%;!W__3-=]^]1_NH0"^4Y+^CWW^W^NZ[[U!TJ)[S(OD'?3U&)NGWWZW^ M^9__T/[G']ZCDI?$3-@0\(F\JXY9YRD_3EW]ODE='41V?1/B%?4'6.KVH-=`]%+WSO%HJ\J?\[ M*#HYAO<@VM:(-D=)AFH"N-G.%8*0YCQWF#S-?,:+0LX`P5[PFPJ#)GQ_1V!L MY-;BS[_>X2I*,AQ_B`JJ%>6Z>X5^@;?))E&MIFT(8;RN/231`9NIO/MB6Y$& MBM80HH82?270HIKX:S@?O32RD'SW\E@#\>G+`P7U]?/AX9HRI#U3ZQVPAET`3DE=>!E\@GM@:'#_N#/9MH?3AI/EL5T$&?F*OA3/F ML6YPCW1'/0-#TT8AS`SYNG02LYM/8T,@@K8G*7Z_8\U`Q^2`%N M-2H0"FLY;@YI)7)9#-;!B5!'!6X1XV#4EE`?LD=*&(`6P:\\V`)O6@=B"7WA MM5;`F\);@"B'E?8O>C-LO.K;R-]7^V1!\4=0=0;KJ+.K;H>R2! MV+`$AM:0A?;PUCP0QE*G!+H@;GPZ0Q/2JGD9?($LB:>#ZWOG?&%-''?A<0H4 M"R0^Z\)L\AUF2Z:=.>&ALC54]1>M\/V"+]*F`#5>-')(U":+:2HF]NJJS-,D M9LONEKQ$-UO$66H>F'@\B8]27-:9)>YQ\9)L<*FN2*ML#70FKQ>^=S`O;^K_ M=%XGQ_#0E[;N\I$T!,O5G35."N/DIQ5S2MZJ24@"].36W;@#7_^9_0$@UQ=E M=;-MA%9.U?U&4&L(F:C]58/8`F"=,.Q>,AF5K*13TPPJCAPA:AC>8M+H@J_? M?RSRLKPM\JWRLG2O!5#UTJ&0O0*FW<_^:Y@>]SVLS4%;(-X$QIAL9=PO**.Q M`.@L&3W:"\YP$:7K+%['NR1+:#!.WYE]X-E45>A,5$!V90>F9VMZ$O_V9R// M4)6,W*FVV;9Z2BZ_$DQ@7[X0CD"#J_UCT:$+5O:Z)%+#S.-P>ZTS%KG)5/ M&%I2&GFU.6$J^I\=]3>+F(C,=7D"Y#MC\TG",CGF4P:EV1@`@C7#0?\8)=E- M1C:)?" M5MZZ*G$K-7P!I59R?CG@.B^-.BRV!-;BH=!2/>Z:P6GRL0P:7:[O:7Q%&R^3 MI<0X%4T1.V%-@0UPM+R(JE:]_#S0/]?621:A4&?M7L#XO#GV@DN63YGCN4U33+3QM7\%5B M(Q!W"K54ZMNNZN:P!J<27V9YQVW!3%`NB%IGFMB[IOAZ@3NO_3GPP5;I+9'P M)69R9*\KE"UU=1=.?M^/'V@@?DE,X[R-KV_:\/H,;_,"\W8/T1=G8^X>L[C+G!0K;Z]2@#Y2,/K(`\??GCI'N@QB4=L$@/!/ZKQD4S*6GMO:J(\B).LJAX15<5WM'[\D3;"'S(R1^K;(7Y*2'H)]]5@/-LOL MI+-87_N5<\>_@P3MKQ&(!?W]$^"].QD<>CF0XKW) MR,_[O(S2FZVT80-;=1/)$7.@NWM.AZ9WN\\)9__W_QR*K3>-EFB%V$75>A(E M,V/3":LBIR"A.J!8^QHFP_KQ!,]TU>:+/HC+9K+/X(DD/%8X- M:RIK:A@/,A*<9RNI?MA-" MAN%H!'2)]F?P"V$?8,(`C-MD5#`+PX/S;7W'R]$S7>@1L](0_'7:/N+C9#A*QNZ$%F_$`AE!1,IN$"[H/BF6`#J8P$? M&+J`W:"5.%&Y0H*[4G$=:%&S:C27H-RI":R%0U6Q",6EZN63G/SSN)TK;%#N M9%LRL3HML<"5WG.!5?UF.=GZ8`$9D-:$FKYSR-B5+SYTN& M19A6!;`C]UP>REVI:[2F1ZV^;UWU!5*)JQ.0RG>>[?9Y1J==? M$M6]'P,-L$;J@$@U448`IX%J:8;UDAJ:5:-1'1E1+D((J%A'."[R792HL$[^V@RQKZWS=72S&\M7JD)>AGWGR@)I[VQ9<0':1P[T=,8Q<%3$D[ M\!*]?8$5=7EY(\ABO*($VIJNZ&?>%$B3G8KL3X/7<9S08]@HO8V2^"H[C_8) M61!HM=E``Z/95D!$+=<2>-=X"VF&ZYZ6!E$B=)6AF@S8%AR`>6:A:@QC%WK118.0M_1N"3HQ)#4T>&/4OL:!U?R%A/>Y&#Q>^SI\ M]>^*.=3RTN70]->A+C@#+%C=B2U9V0ZW2T)[H;_'19+''S)M&M=%1^DL(O_< M+'-%AJ.[KZ*B>I/XS*6K3TB_P5-\VAX"!G/,9W60!W]49WL(PMNMQ%,>0)]G M*71MWJLECQ!MW9@;D3U':E=E><#QQ:&@/HD#96+=$9=0)!MZB$:;K3]'1L]UALI(KDPK?X^(EV6`^@'=XDS]EC,M?HO2@ M>G>Z?+=09S-^AK-_O+-LGP`G1#X`2MRT M+"$/*E94PK.(#@>TH<2#"L%&18",QPJ)7(**]\9A3#A&FHL]ZFB",S8>4TZW M-AE]4.:F!FB]&@O1X%2235IS!6MR(U'*;0Y^X:1%]PE_9C]-,CR!.$"K&T"S M-KF6,BQ[.Q)KDK$1'KQ%B*9F!,AW++BA!?`XXV9['I7/EVG^N;1_-20A`7\L MI(2A>",T:`_Y-$@AS+0709098MR">`?T"5=4(E9G)\;QV>M/1/ZKK*VPO=Y4 MR0N99[!)`:AP*C:M%^D3"I,:;ET9L\I1VSD[?.]GU4Z1_^<\+O"=2 M)6RG>)W%ZQV]4_D/]L_VHJ4\Z>712,_FYM>%.0)//=-,5HLXG#C?'*C:L2[< M?BE5?A"!(B53A%@"`"+AN$M+@H.A=)4N$A>B%=Z4>ZR&ZE@K-\2C&C]!A+OUF\EST#7.JI!R;2.UJWQ_,"Q M9/B)[DKJS&<:I/-G\B],+W!LHZ1`+_0XF=[]VR991)8(44I^(DL+%L3!^#7_ MN#R_Q#H[OJFCVMM6-`9\DZ44??`P:]`2YG660@SYD9+D$A/0Z=@HT8.ZK^9D MU,&G;W%5SK/RZID:>;)^N205:IYW)X<:/]T)+S>/J@EK?_]S%&" M#;?,Q(4S??33,$",0UT6IN8!M)GH%F&,'RMVB,Y>`FPH%Z`[KAZ_'+AK89N[ M)1'U,B\N\L-CM3VDZXW6G>A)8%R(#0S1;>C:>W<59F$&2M:2L(M=#1%JJ&`< MPFP<<8,C4N#P9Q<_YGG\.4E38O!7645$3AY3O"Y+7%WM]B2DIX&[8ACL2&'L M9`PLT5YLZ+S;C;U0`[UK2)DW[H@1HT8=.8PAN0*6=,`B2EVBI*5'&Q+M/@'E M2_'PY[=ZWR()3&0%QD%K>='K"C]>Y(1 M8@TULK\71SG0N*_A@1@3U'*!VJ";A?$K2OWUMY2>8BQKC-RK`#G)$\-C](D> M=1#<.5YEFP)');[`_/^%6R7U2S[#7;(Q#,#JZXZ$>%1&UY(:HEKN*-%DQ2H9 M(?JJ8?$UW2GO;DRUZ5R!KTO-1LJ/`4J*3KC`Q$,Q&K^D2?28I.PR$V#YNR', M9M5VAS:$)Y:Q'2$8:B@&J8>E-;T@7@-&IA+(UMX8>=0R@0I,9X%H4A1(% MI"'=%I@L2.+FED!],X`L>VZJ9URP-8MJFVTJLU",;0QTO?G9<`K`(.W%M#71 MFF-[H81.&8P97^V"G?4[Q=Z`Q)R&3XPY0[DY$&8D;H5<9KPEK*8E2`@Z'>#2 MI)EC;J/72:%02Q>*:U8`L@N":J(`'*Y4HM'A3TT=BG>Q`]5*OU]2^O'^PNDG M"=,5%`UU47,),!W>&UA-.[QVN@\7^7UTJ@X<9P3<:R&W-"U%$NDNG? M?KM_(B8Q126]C/+84@%=3UX:QHS\(\1C$6^UP3@N+XE1\!M`ZR><;5Z/T)B; M`V00L1"_31&B:0N3`\0HD'1.W-QZ?KO&`:!3-9&B-II6TD-/X$;1+.:RAL>*WX1<\5. M/<%O!,^'2H1ZCDI>KF??W#6EV/`RV"9/]2>#S+0O`:">X!OL]LNYV>O!\/X$>5=0Z;P=B>2ES1LH[; M>+<;N0`#Q>B:T7"2-H0*^2T%IF;\F!=%_IEH;XF^*EHR]KR,F-0.I7D$E(_( M$D0;Z=+4`DJ1O:;::+X%B9B-.2%BSYACVPHRP<9D*(=!RV M4LGR60C[45_U#/]KQ#A0%\!Y@&7IF`R/^H6O.E<@N`CB%0K\DJ@CC*MG7)P1?&XOH[@_D@\0DZ""3@.4,/R2!G^U5,%0S_W%[T"A`+HPA(A") M@@D/+)&TLRQ]1B_BB!,:3FQZB`2$[`)$T!SOQ4,JB42F^FD$-$4]Q!WV>80_DPE?. M0=L#"Z>BPR]M/E'/HG\V9T<:UL)&!LMF72/2!;.L&0HU,B1F#&"?TOP$J746_#*S\?/K!1#-(X%C"5.@2G:XAAZ[]8X7CCYJ1V] M\,+^0^"RJLN4(\F#0!B+=("6V61;G(1:)V09VIA=JX[2IECVAY37O"8@[P_[ M/?]7]_-5MLV+':_59BHUZX(U5#E9=\/2+QD[GR]`65A70DNJDC:LN_KJJ.'. M/(+(7V@C=+'TY06+F'G!$>KAIS4;T[P\%/S\8]-<=B!^I.4'^0B?+!)Q6=U& M2:P8J'X3J*?U0S'[K^B[WP$>S!]W+GD;SYL@V@8JJ<0X*8&7M!;B,L_"DF+1 MFPI)30":T()70*1K[B0F(8,2V[`A6,H*A39+LS M5(])8[`\+G.$!K=`2^F/[5!=D=3C5E%=IKV]19S%[0*GO.@G595Z(;X./!F@F+X!'O'.!MR]\IS*" M>?X[3]KA)-*R8\H:-WF7-B)'6N"*Y3&C$TTD,/7[_.0X:_PP71F*= MNO3X'4[IK8F'O%_4D#1HZBA=91^^;'!9WFS/\OR7LZA,I)YL-DL`A^9H&%J_ M-I,?C'MS(O1`U6F9^T?.%A6<+WU06CUC%!W5OR0!-'IJBG8E&<*L"Y9)@W2" M'FDOGA,F+#$=H)8+P#^\"1T!?"\@ND\U\4(V)+#*-HXZ")2F='Z5T!QX@U7ADI`\0X@*WDEP0(9V*L MTC85AH3<=?).$FOS,M[[O(S2'XO\L#(=;-V+>.Y7EZAH";+-H16XW M3Z2M8+9$-*(,`YNC>6!IS5;N680LM'Y78;KD<'-MDQKV/-\]TN>2+,C0QXAZ M$I@YT@:&./_IVGN?V\S"Z'/UAA"S23#81V:VQ,'HEF6494<9@K[91P8-,1*H MPPJ)9L%;SSRHC`'IC:`3IZ7:HG@GA::B.1[&$B3ZRZ%O.- M!N&XE9#LW?':/OV"&>$S5DC$>>* MK.>RI^0QQ;Q,<`?*X/M'\H`QPTE`13L5'YJLH MR=DUHKK/3W@8D?3Z!E6D/*F,'&W3FPQNI:U\QY#JX48:`QM^HZV MY?DD0UC-B=*;%FV*MO`ZHEV"21N":HG)L3`UJ3HU">#:Y&CQ6RT/X(&_]2Z: ME@+XR;_=#IFF.5P2`.O=K][#^A"\HP2"R4GJ28)1(JW+U+4/08U,'JC3HS"" M3R=0G#[_OJ](ES?[YEKQ'2:FEFPJ'+,?UI^C(M;N+(VCA[BN-P%@=XMO!#'0 MY;[1$@XOH=&6J.;!MC([+HC_R/DLG7]!N6`-!*0C,]/?O.RI`^`UUW!E-MQRG2RXQO8`GR92*9[S-":@Z4V`ZI7FX#:L$DQ$0$\1 MK:#TGB!J*?P_/;001ZYC-=%O$2<+8N4@1V._C!A!'Y*^62XPK(D#T4+[>%VJ MD)1%6"L1AS!_6]8P`8T-/]$0X0[O::*%[,GDP)7-@4S)('[/G6]-CD(9D.C5@18 M4B+?[7%6\M1A=%U>)07NW\$U>.!1'(`*2HP'V:LG84_NOYS$6-D&>OAAMT_S M5XQ1DPF*7L<.8\O^EB#CN&YH,:3;G$C4`JS%'7%1=3H[H*<.,^'WGCU,Y.7_ M"<0L08RV&C1XRNB M1,3[$+*0E(E*=9'OHN1XJK"B"$29AB#TCJAM#J],Q[+8*!/7)$X%M%^Q/`Z/ M-G$HJWR'BP&FCWCWB`O5")BH@&S##DS//O0D_FW$1IZA?M542#:'LDPZRXEJW_$`@" MF50&$+1S2ML:?DHY$L4JR*4TO&);2%HT9K?-AC00S;+>63/3P6O;F#VE@=X% M=08S`]IPGP%N]\_1]\FWK)XXG#>@PM,=S)^(5.R%=F4N9V.@@;%_*R"BX6L) MO%N\A30&5;KAJA3$UMN_'Z*">(+TM:X!&J5"L7GKL\C17&`T;R)841='LO"N MG9/DD]1XW>VB(OD'CE'+$+4S#"U;G;#,W![I5;!"_=Y58T=;__6&M(!(U:IHC MUCX('WV,P7@S7=T^#,W1WT)7-0;7';,/ZBL/Y#--5QC@M/XO47IH[B83EYXF MVU?ZOD2?[W(L,8P]C(,F&H<=I7=+&2/60.5:8G8AJB-WE?#1D1/>/./X0(O[ MZ,&.>$`TAR.0(Y\_"#U7/YV=_\E@KJQ#5UMSI/MC9AL(:G_3_6!T`["6#P"< MY=\43U%6U^T^S[,R3Y.8_8/5`;_9WI(A;B[)G=5U9RYPN2F2?3TPX^L=+]PG MC/?P,I"B?UFT0^\>R`.:@5F*?:Y0K]<58OU2[R7V3/[<5(<2.F=N#:08M-&7 M00PK'[F;_L@QSR>.&?F]Z3"TFM(,J+)FYTC:D.I'*X"9JT8?$092*UHJE6VE MUQ4WTU?T<_W_X+:Z`$C0.PJ=L[$S*#T)V)T$(XRCNPC*]A!W$`S"R`XDQ4G0 MLXG8G=N/Q71;)-DFV:>8IS$7&0">VN,73(SU#F_RIRRQ-Q(+.J#3>UM`O1-\ M$Y'_4WP[B09*5M,A@3"\&<8A.,AZCGB7''8E$08G+_31R3I-\\^T)L%E7ESD MA\=J>TB;E?6'LDKXT=A'7#WG<9[F3Z\(#Z92(=,0>H(>E4 M\77R@F.M#5G0057YL`34+_5A(`*H]V$E MD:12QE$AUA7BI.\8;7ASDS.@@#:TVT=)0>?$F^(B*?=Y&:4W6UH`BL'@XMD% M@]-8`5G:#-@]XYO`Q[\]3A9RJ+DM*T07,C4S>I#(:H8Q?JWQ!F>N[L9A@!;P ME`\_6J[6I"V!3O#40O?.ZX;-_)_.J620E!-]#'`!-4Y^=%66![93<9Z7D&HM MIKB]PVE4X9A)9'O:9DD-GYK8`IPJ+;&&%#0EL5$N6::YEAK5Y%P#PS.H>4C_ MFA>_L,H2/J^^RJHX3-VK4^29).LN3#!7O"2C7L]M"`#R35I!:'-.:EO#Y)VT M$$FV7F8TJ*ZEZ4O7949[`<(`'=`&2"?/A"9U*#0=L2@6W]64`YVO?3 M4$!L^AG%46M2317>;.8$5@#EKVUM0]4@YWW30?>>]8UG MX_\YWU09A\_X**=WCY15;SF^JFO>LKL1+;^Z1%)H-NIP.&A)R'=G@^&`,^4/ M49$EV5-YBPL&TVX6,U+!F*@E&-$<#23>3<]*GF$=HIH*$3+$Z$*\>S\-VR?< M+NB^NL[+\FL&DA;.(.Z#\8&SGI]*?+.M+RMB50[6XT8PMB$7532%?@OOFB_K M?J`,I!$]"FV;A1?06<%H?X=3WB[D?_<8`&47>PU MG@V,'4Z%*YKD6![>K7.:@)(8YW,O`4"/47@FZ@.UR^)G;4(6'D?2*/*2Z*KT MP30K0Z0]LIK%#J*`VGSX78FUZ;R`BK#-%5B=F8C,,/6ZA#)%E"N2OZ.OBUO! MG:;]JD9!?QP7Q%"$D*FMN9_Y8Y$?]B41/#W$Q`W+LTAP7*PT"JN4'*7T!MO] M,\;TQ=`ZCMFCWBCM,V@QV[35N+LP* MM>(H'`1O0EU)*Q--*<6D0DPLGC2J%4Q(@5>".]J`/\;-\<=8H?,T*DN>W`/Z MIGDW8$UNJ_7F[X>D9(#+LU?A7VVEX(IF)$GB9L:R]KH.>H#VILX&2>XE9[,' M]'Z.9-=ZM3:7G=@)+<$I_'O5E;2N4*^G`+W4XH-&D]H1^9^C$I/E;L+>`.SV M>0:[,=4-0)V@Y1\XOHKIF>8V:1[ML$$HR+^R^#J)'I,T8>5IRI(LOV+MFGFQ M7J"]C]/!DGL@)UT`>B&'\FL]4=T0,F(XCNCN<`XDXE@16)6/R8_T6QC(>T/DS^1=9)UQE'9ZS5W2/GT(Q#9YO`P_22]F;B@4' M:-.Q!BDW)2,YH&E9RJ8UM88'&N0\"F;J=0B8U3@N"E[]9D>OCK`):[W9''8' MGM2`_+FHZIH5_$RV/R[PAIMOA3Q6@Q17AXH6TA5`U&_<1NVRN>D"UO1=#I/, M-[C@#^8\W`FO]2YB>KBAAUDAWE/?YNJ^@G,_/H:,7CN5#(G$#06QX7]3/>.B M=L'C-O$UE-`!@Q&4/%!0D@$&"`:9))D^MK@HNLP^Y]$^J:*4[B33[3),9E_R M'W2!SC@W@4*O?EY81CM^#/J+6P:Y<4DE"Q8X]/,#&2@:/@1CC"2(*0Y8W-T82+(>Y!3<5T4^>!?<#%CJ$+P7@^1B3B M9;Z`)WNEPE'91DY?MFR@#6L<7+F9V?$`-+HQ`FI-L&/4)C&N&N4-<'YS@WM@ MIL(PA&"Q_'3X#&_S`K_*D?PSEC"NT/<\:#,6F\Q26 MD!O1T^75;T[S6PB/C''S+Y:(J6'.%J,U^R!G:I=#0RC;W;&S5_0_B4O>`B%G?-LMFK$9'IYO;5T?.DR M1!-W,0XR[.L^]A!,_,-VBS_WP!1>;I,3L;=D==9"S_8F#C@/U-\Z&=)0_FMUK>/[* M$:2I_HQUC[K^T8$*T+=P)L.*/I1OQ*C?7S)!3LGW+3;8/8=(P[#`PJ?;Z)6> MVS+1Q!F`YIYD0\->Y/*_30ZEYG02CIN;/U0FES:]AR#ZOJJW1'KC7NH4UP-.AJ[;FGX0AC2-TU93(:F M_L?=_4\.L^/6>=>RIVM,T-"CK[KDZFU4$'D+$L)%&[Z\?23@R'\?C#;5/@CF!LQ@##CYSY9:_VZ0/X*K MV2/.OUF!E&B;%VA@9N$=#RTX1C>#,6HXA^!$_OU`W!PNTE>A!$>7LFB9JY%\-^(^,DZX$`,COZQRVOLLJ0% M7R&094CRE"7;9$,3`'4E.6CYC>;BFBQ4&D4.4;)B/+RN1(4]+5!)BK$":H\. M.QZ]6BHUE]KD?)>;"`"AOUF3G6BLOR2J^G_"[S"SVT!`<<9J?_0^"QWU/+Q+ MQT_#:`OHK_L1[QYQH8C`CYI$_T3)1G1FUJ%,A@:YL#F)6%^*T) M:=K"F(M1H&&J[I:"[M>5G`9%-9%?"S@)Z?7%))>&X"]LN\8ON"!2Q6>'U_Q0 MW7S."/#G9'^5D1'`976S_80_7[$;"'FAVND8RP0F\)L&58P,QW'P'CI.$6^@ MJ"T3Q+FL4,L'-8RH"M,BSBTOF`#4"=X[7)&%/9TQ\Q9G4C,(JAH.S>Q(T[!Q MC_&!S/+5ZWE4/M]&R?&,.YE+,-5P;,`:JN'H6(10#<@BF\CPA#,:^U_5 MA0L/Q+UUQY&R@,:6$B!2'P>J#=KMR&#B]S&R#72&$U.#CVIR,E^A3Y(?':GM( MZXW$LG-\Q%&=1Q5^R@OBP&10I_$!N&9& M0G/.;84R8:ZC4]NF9>G9ORR#FO!"#;-FLYV@KF=XFN*Y8`KB<0+YW@+5& M?RHQD?XZV1[?C1Q%&5BUT2$HJW*C'5DX]4:/91I7<'2%.#VB#`(K-6J-C$'" M;0W5`T>42A#YLZ?CBDF?<'65;=)#3`R^J8^H&!`[4AB+&@-+-"D;.N\V92_4 M0/4DQ;T(-?JJI6^+8'X-8U4SL-&TC$5,5@%/31U/:E])ASB2%09T`RNOHG0A M6",^V0H]4$'@O,=EE!0T+0.^RO:'JJ05IVCL0!-B*@9&2P'C*RQ`B"Y"T]R[ M9S#*,M`N2L&R@M"4KI1FA1HJ:1Y3/UY@/(Z_XN3IF3[=C?@Q(=K4!R4;7AQM M1;<_ZD-Y0/M0EB8TAJMVI$`6,P)6SW0LZ/S;D+500V/2U=$,(&2=`>WJ:!HE M?H+61MBQY_)MY/HR;2FHV*PZDI&7%::A\OES5#QAYA78OCJ.]0=>$QD!;%?- M@MSN5TWB`K-A-4-4HXZBI.6&-HP=B@5^8&=G;QBS?K%]=U8?2ZSFE^ M1B'O\Y+`W9Z]?L35#T M5O%N6/M?Z+N4>VA!-?>FD$F5HT>,FAYH[/SXBG@G=37=BG2#:#\KQ'MBU9\Z MNZ.=`6T;>!@IP;6XC'(N<'S85-21T1QC>8:I6'_-BU\(9C'KF,RAVM,"Q#)C M@;7ABRTA3,0R3CI)":&&G"Q1:WIJ1I\YA]^ROS8\_,8E)X],'WU`PIOW]B8A MSFO;7'2FFR#KIP+CG>(VCX$`YOV-&8+X`D?=&NP-CDDDV2,00D,UI+EAC@I: M*2EJZ+P_Q#D1",;7.,OC\'K>Q@3B-:E8B*(^0ABV!#M-4PE]='AVW`SBK$PN M@VQ!R56#-UWQF!?L%&RLU`DOR%;@#:;[>PM<-!=S;_/#)[J->!ZEFT-JO/UL M00QXW=P:VN#&N9$2]M*YI7B::\PER]BW[*X.RNH`,A M]#?]K;,JB9/T0&LGWN--73S]PQ2"9VEYN:K M>(43=<0;9HIU.C#BI.R$L?=IW*'4PXN/`F_4,4<-=T2_#!+XLTJH=0_LRCGK MH]D3@XD8EAZ@=^T(B1X%E:PX$)S_:([]U_S4O_6;3*RC//V*D1O'`L8;3($I M&OT8>N^V/5XX]>V/F@?J)D#.9EB$`L9,'6"MJX\1:$4'B1ME!%Q$2XKN@CH. M`HF)?7.HRBK*Z+6U=?RW0UE)-K%FIX!F3.DP>@R[`[@?U]):KI2MP,RJFRZX!J<6,&[$VNR%D348Z M(1^*%4$TKN2.FT/O>,C%E^]Q]-L&L*LA$TAE4FWYW9:(U^<$W+<(5OP1.Q-C M,+1[$4F+82_#X'/KG>Z8WA-U8V<`9U%*7[_=/V-,G_.LXY@E^HA2>BTISJ(P.O@]H\=O'0-<)3A$9?DH(&= M+[3=KU`M`&(2L"BDDP$)0M!K1(T8B,NQ0MWK%5$4H8Z&JY3_)=Y\\Y2_?!OC MA+L&\A_''H'\Z3^O\5.4\CP^DC3_TA9^+4LC)-5^R<_>-%39MR3A'&E5YZQR ME/7?]@/S3GEJ=XG\_9_]?UJ9>,UW%7_S^E&''0^^:/,M%3GSEPU)W,@X8S5P M_;QA'HVX,VDR=%4C@,A?*6H;[P]:P$3Y"C&&ON3/YWPZ8;/)-\LF2%<&]=;2 M/F^XM%18H&3NBPSO6PK8KQ4)Y$$D>*N!^V"0_0;OUXMFOX<-X*\-F>3]!_'7 MB^>CYU?^[_/4F(I>;`F%AI&855[06S*C<&Y@%;=FPNU0SH)]7];0_W5]M13#V^5U6]0U9AD.@>[13Y&\$"3/H%),NAAS M\`224E_$=RUI?@[ZCD':Y`P33X1YPX?HBV*(G'&'<0*.!T=T&XY8>W MIGR0[FJOZA?"Z"O:Q=?\>9"JZ2/KJ*$@7<&XM67'J1F/E(U'#;E^D%Q%7Y;* MC&_RB*>G'&'Z7R+8A^T6;ZJ;K?3W,<-OYA60;[4%;O2D)D9A^$T[*:T-@;!# MG!]=+LA;!>0-)Z*_:MT*KI>HND2%>==4#EC9H\43W'V)S8*22^F8Z/F=5_+7%'A]!0#W"/V+A/I M[Q(IR]NH=\R<<0<+`5T.SE%0Z((U1)CH3FY9<"'<)S-?)UNAHYI0J^.B4&#; MALL.E+Q@%-MK9&>)F\UA1U/YD,&*\;[`FX0?.-+FT8[ZJ'^XSDI)@)8ED6N# M<9]>U4(,7V.0IN]H6T0;DT"2-'?T@,Z=CD@?UYD:AZ$GPX=W^I;@ MNJ)]\-8T9LI2ZPK(`[W)T@]UW?WCO0?2Q74>9>J7>\CS4/LMALF7B^=OP& MP!GN',,B]!F'1#?Z1IBZ/L];=EG3Z,>C/Z M]XHX)(QV]"O1ZY=9A:HB8IO'.:\PJ5A\>_T4-KTG.$MFF> MLZO,1Z(O[0GFMQH:_J@_Y_^N%[ M?@GKD`TOEWH\]B&`;[;G)!Y-JLMHDZ1D-N$E]I+-;?1*[?VV2+)-LH^4YP&C M6``=$4V`V3LX&D'O_SAIM'##8QJ:VHEH)6>"&BXKU/!!-2-Z;Z=F!73Z-!]L M^SN]4%-7OMYPX-N:8U@&^>'+/N&KNXNHPN]'C,R`,ASS4X`R6=T161#&)I7) MWL8ZV2.-C+S`H=JV7V>-\Y3;L$2, M9S#[\U/1L\=E:-^`XL>H?N^WF%[M+8QVV0.&RZ0HFRV]>MO`_V8?><`_AYP>F@>\X`6:6U]PCXFMQ7V9[S"_ M\F*)6L\B#.]@`U/G)G3TP?@+LY!V>E@R/@-%1$7-"]R%G#30T5X%"NV<5[51 MDM%L!#<9%Y1I\![![BCB('>ID[0<;AZU#"!-'T M&W3KI.CXL*.G[L"X=Y//\^/=-P73\+XW%*S^-E]^S//XD` M*%9VJL8P&RAZT<4M$GE+[YL@.C&&:E0W7J&N.:+MW=K%#USL##_1U!*Z9?TH MZ069R=*]&-;,\+/Q$J#,%ON\D_0$)6UKP&QLK0ST**LB:%CCY\J3.F M-!(KT(_D`92/;0K07D*V,0S\9V0;+YW.G')ZOMIP09P-^JIEA!I."R53-&95 M@ M`QB&L\ZV?0AGFD?"6)U=+E4_U?@HZ/A-T%_H3MR"V0P?+;/#%W-L/[5[APN^7_[6QV+TEKK#`>GML(N/!$W('5P&OHA> M2U[DX9P_#)?!US0&O!:L%'UP-WC0$O:"L$("_9'IRPQEKM+B6>,Z?AZJ)^$BJ>1ED]@;>GA9CQ1@+K)D!+0J#Y<)1T M0]^,J_8)\-&I(;V@@"`?N9\^-,,\"HG/P6K_/-\])AGC?H+!UH.7WF%W*CQ"'%9-;5]^#\YP5I)#G!5?XQ8\!QI+=":L>>D[UV]@=C@@ MQ[!=_PM"K%`G!A+E:`Z-VH<;-,>>(`NJA5D-#YI6B$E$ACW*VI,FP$T4R#'O M#>E`=>$/*ER,C;*JBF&#?N&^88].O`RL[`QFT8[!#G,\H/+E+_6%E&!?PD$, ML[S"TLFYQF8BD(Z)NG#;8KV=E/NS'3P'#L_4U:FX.#L<;IW:"G777Y7^;;%" M<+8/7/T,I/3%;Y0RQP1Z=5QVYX;XV,N\V$5W^`5GAQ'/](>4P=Q(48$R7$PY M)@OA?HI<)LL3;4*+&#&JJ8-Y3&\)BV[.E;AXH094\):35D;V%VX:N>K"D-D3 M+T=K>1*OI`[C(HT!G.[2C((TF`LR6OE&FTO+!7$VX'=>3A#>Z&LLXS!V&.J: MV*Q.8UW8E?Y970I[&8]!?%6_^O5Y*TM7LGKD4%CR#,N[C!H(&Y]CQ3`X3S1" MZM$&3.=%29UT*^T'\UUO>D`F>[LYHT)1&[U?6Y"ZBKX`>4)IQ>W9OE#%-7!O MJ!^,2?Y0SC)\CZB3VY4+B,6B]:?@%=_:H+CSC*-&AB)G;_IU@.?ZQN6W97J# M,&%]?40?WA:-%*#M1DV/.*CM&HED\XTWO.T;&YA=E!),=D-'\B\3/LD"0'J; MC?RA;&ZXTE2RFW467R3IH;+.;3:KA[#"JAF#9!-B36`?7+@U&<-H1]7UA+JN M4-.74&"2=%PIGCG7_6`3?;0+D?-SD9>L->R1"FM"K:U^J(LJ+.,FBXI5E@B#+A)OM0_2E-Z[V2Q+/8@6S M$0#R.0S["UYE"F';`@#P:+\LV<:4A]+UR^A:1K)T1YV4_$:M*"=/X\+NIM&- M0"(L*Y7(JT/S8CF;8/9=@OA.S.W7QT[=;"`>0.'%]Y0G[/F\@;&#R+VFO+-M MEW/-1`Z=:\T.GCS'FIX6,+>:C6#:G&I'#Q'Z[Q#@?M&X+G2UYO-87=(:440$4(+X`C]V+P,[MC#^!G7 MPR,Z)5>\O7LPMX(/\_)T[)&]6?E,@6!?26?AH;KFJ7>[\8J]^U*K]QTXT/IBXY205!71)%XAZS+A^]E>;1/ MR*C^5.+X,B^:-)I`)1M> M*.+,T(9P8PE,.3]T(`S1-B_:[*;DGQO"D^8Z_NSW9M<;QZV_H!4N>(_+4\'W M#JN8J7RZ@0AH*6D%I;=`U%+X7_99B"-+LMH224O(@:W,YJ(!"F?#%-L8F"ZB M.]"QXVQ0^,L>9^6DYV&NK^LT*<%,B30P19T'X5%:(&J'.T+_)+D MAS)]107>Y$5,5C6JHLP0D^YEDB45ODY>AMG@[>9A,P/HJ=D6HGRV-E$#3N!V MHFGG=,[B'>,A*:X-/M-K()Z]?HS^EA?G:526ZR^)RL^/X@"CJA-`BKHZ@MR[ MLHZ6;:"M!@U]?$6,#6)\T,^44YCZVJ']%.WP1;Z+$M5UI]%<@M-;'5A+W96Q M"$E_U?(I=!BI=%A48,H+_1H'JCUJLB.#.5L:(]M`SQIB1*A10XYZ].AG MSF$9>U(>'9TV+/W)$!BV&>Z`+.-B3'U-2?IE_]A%Q2\:+V`@`#!^*PBMS6M; MPYBZA4C#FA2T&9LD2J8Q'1F089\2"+T9>T(RPVCOB2Z16&1##RDTIBIM!F"@ M&G%;LY2T@3%&I2##+0/:$C5-@@-4"V M7-,JN(2TK-6*.')W9H7$VX?+W0&POW/A#+@(+(P;[HM#6S77J&GU84QF_GR+ MN&20-]/]PGYLKY0O"W[.)DW`BFQQI<4[,'\SZM5N'R4%#OB,TQ?\,<^JYPGG_59,PUMYV@^%[2K4 MS#&H%:FMN`/+^`\<%>A]>`'Z9$#$D'YW*O9*!__A<^YD>%I>IV"=1\"G&V7- M*'!;[$DI-\'O3\$$]3B(2?S^I"R/=*^ZO#F9V\E8GPA^IOU15J=@@9V<"5).)V"!G9AR`QQ,'Z$:H`8( M,8P_GI3]D;;NQH4Q.QG[$Z#/M#_2]A3LKQ53;G^#B2-8^U,#(8;QSZ=B?^LM M&1NG1GC$\10L43H(T\VQQRYPFY3(.KQ+]HR+B+8[!=NT!82EB((PTT]8=5A@ M(@K.V`0HEO9$*$(RF5:9@,+I,03$YNK'I3E&=5D3P>V$N%BP.?%"X/]!G$!E/1;MDW/H(PCA3B5=$X M6-VS(CLZH'=%8X0;OE(1J5%\("9`Z=&6,*!O^1F'U9(V+9M8W@0PP]LB.'0S M',.?<916SU=9>2BH[[_#R>[Q0&!2#5UGL2@6P23#/98#@)N8!K+U%N/(89S& M%!D'2LB9H*3A0A1/8,/2SVX$1E1-_7J0-X52[TY"@3K#MUQ@5JR!A#OG^6Z? M9^S:T%_SXA<"G/Z%K$Z;W,!/1;23C<)H%@#>92+,UKV,I(?Q+Y.$E!3[:+@0 MO:O9T!7&9\Z(_;'AA/:)EK7%&4-]OS`L=)=8\WAP); MNA=[6@"_,A98ZU!L"6$\R3CI))4[&#E+P`A.=O&_I# M2:SS\P7>YV6BVG4^:@.SR2P55-Q3[C7POH4LZ7V@$KP-JAO!;##:R$ESQ"/, MA:4QLERVN4[&@BA/H_VD2.]?F/`OKGM!X, MCM'GA*QO^S-(GB:;9*DW7:;=?I"O"EX,\;;`^RB)V]T*Q>`,FT%5XI:+VZ^] MW6\#4&U;)H"D2BYKAMIV4!681TG[?+0QY7`]6'J/JM_TX@LZX:0M_EJ=R.LG>J8L&]UJ`3JUW6%ZZ5_@9:D*],RO$W5+J;3N- M6L@H,\$YQ1"'%B6# M#0//U0J=@.I-7MUT=;<<'O M[,G7"[J&,!.Q6F1Q/AZV\CXMJT08*`IKV-XF7C(*-4[3XV0&K`*ZV10''-]' M:50DV*"[JL9`53^UHO>J?4I;^J_RJ1%#EN6--D9-:V!]GB3[/GHEW`%W'273 M3KL$U*NZ%26,WH\`)1J!!9EWB["6R3*F:XF7M1:+;(_3D37&(]]S"&"7H1;P MEAOW0_3%D\)0G+THR$`^_>KC"##944F*+JII%=W56.@;+-:T7OI9*4M M_>>+U8@A>[7+&J.Z-;!ZCY*]T>VD)H)3[[-#F62X+->;OQ^2,J'+"OI6*,F> MB/3DO\HDQ@4_,:TNHZ3X2Y0>#$8PCR6,J;@8!M&@YO#S;G;SA1TH>,,2"3R) M@;9<48_MBN80H)P18PULR0L,1_TKVM-T*V3A3B^U=V.!HR)[EQ\JE#^FR1-P M^0:^5\W]4[-)8=P+-A%!GFF8H`S/-U040&<=>G%4YQ[U#".0!7$(,@4,G#%< MX,>*K-6J@IVR/TCN-&A;PJB]1FA1UR7-O"NX4H9AX;C-,XX/*::N\SK/GMX1 M?=LA2H\Z!B7ZF?$`S/9__TQ<_`.1C8KV0'H3Z]D?H5>TA=$:K>"BWD@;>M<< MC11#W:%M.X59(=H>_4PI0M*4?OUX$]ZF=2#:TA=>JR]`1>ZU1M%;&U.V MA#$T@S@#-6C;-[$+I0"RN1.076]^RP*8,[VU3^]OR3HL(?%J?/9Z34R?P-%, M=A94$%.?-9AN(C22`$V+EG(-O7>72Z&E1&>OJ*:%FC1/$HYA2O6-:8:9WQ\> M\R).,IIAY")Y26+2U:>\PAH;-Y(`&+@EC-:Z#>UA3-M*J.%FF4"%XIH,993. MKRD[$+\A0XP.TH;]@?&92BO#S?;49;1A5_@U1SSJYE`ILO3B]]-AR=L"I+[2 M"2))B)1A85>PH0`_\)'!X+.2]N3'3!:.*LG@F%1*I`E"M88"R57L9JABG!3X MG&@.IJ'9K$R@Y@1..$OR@F<&C?L":T(G,Q%$\&0+I0N?3!1``92=6,-IF]'5 M25KC)F?KMB;]QG,8-0]$33B<00!C*;^(H*Y842=T5>&=*IY2M@[AJM5`>/5U MJ[8I\)6K(SDDR=I[%ZS0SVR68!0N)P+9E'65$1\2E?@J.\N+(O],]_>B/?FQ M>I49R&@6$"G:I\'L,K6/HP=*V#Y%2.L(J^%$_@.UO%##S',"][>&U)#0W1W< M+JE[$R"@I(&;9.BQA;M1P(5=M7V,OB2[P\[DEZ:Q"&F% MLU\=U7S`3=0AUO.^::Y0]/14X*>HPFA?$#M-]E&*HEU^@,NHX0!E\^$ZT*8YE%6HN@E2E+8G&)W=,*]V5Z1M?ACA6/Z0.DA_X0K@C*IHO2]8J#, M9##^QA:.Z&-,--[]BIU`P_-G2D:G?)$0/>2TY#&J:=%[&/TBK9I_BG$LSWR2"HM_S$UL"[?D-1Y!M_24NQ M0KN:!L6$""8V&0WB:"&CQS`C*FEV01[R#X])%4>7>7%[*/9D#7.S;1P!64PP M+Y",BTB12.SZ(>SJX>+-2(=H+H'NN80 M^D"]3D*(/OYK<$Q1AZ<1JMH1HD7%]O4(Y=LVX*`C%/5&R%FTH7S6P.H&TUSQ M''IWTU,V4-KF($\;C.(+CQN4;:&>-Q@$DMRQKRGH\46M2AV1[P<.)R"]Z8G# M=`A)"R%20IAAEQ_SK'I.7S42_I152=K]\ZK\D"8[?L%3AG4F0P#;=C($K?7/ MX@;C'QR(/-Q2Y#R1WA818RS^X:I$'6^_CN;7-0QZC[7D6!1:WT8B$3H6PA^2 M$F'E6#AU?8.-'ME!%0-^/!KCO:*KOH)PF&X'3N-+W704BIMUB<;.]4CV8J\5 M-UBX3QKZJJ`\]'^-H!/G[F48>WY?LM6=*NX6'<1A=#DO+'?%Z*>,;O$W5QC. M\]TN83)?8GR+R;Z&3Z#G8TT^\3OBF^XK MZJ",=C^&00CG9S80U>=I.FK@\S6S:*:+]BO4IK>G3%:(LUG:4D<>P4W`V<(J MZ(T[NKDL),+>1Z_,)Q4X96BK'.V)H2;YH411EXT;RDFY!1]6O"&BN3@4Y(,0 M-$E^O!2=QB*NI81N(Q)$*0;NUDO;XZN[D+<.ZJ2PC,>8ZC9A'.W&6":9J[5/1!S%UZX>SGKJ;2BJ?G M.!.7MB/1/N3T18!DPZMZQ@M,9$LL9]=9=HC2V^;YT"V/]*T";15I"$M8/2SU MXE5.![QLU0EE7K!R:M22HYH^C-7:*&PUE.ZQ6[TP!2Q#>)YG!'-)8J*;[7V5 M;WZY?X[(P%V5Y0''JL=?)B(8"[*#(MJ.GL*[U=B(,[R+W!+1>8N1K1`G1)P2 M9FTU$O"E&9S07H'(LT\#VRK2,8^&_?,L4^89/:@0NOT6<#\LMN.(FB1@O5JFP ML=8[V1-&/[;I$+-@D],?93H*#.NM`ZNI.E7[/F\.I>1UBEC?;5B@%1&E+&/76""VJMJ29=[56RC!0BJ8E#;S: MMC#:/$WH>%FAZ>Z">Z';MBO$]B\<;JG_E.VC)%:9E;P)P(:Z0LQV/_WH=YCM M=*D0@P_+6RVLB,J]](!DU&^DNQ%TAF74!MA9*@T899(J&@)8B5;DUE:DK6`L M1B.*RB&*3IREE?=K/\%*K+>F,6)_C+*86LEK>XG$!&"&E7TZT*2I-UM:#!YO M#E7R@O_]$!4$3?I*MQRC-&73X$-.(&BGJ:F<`.QT'NC6D*>Q@;'T.;(.-)0S M8]>3.W;H[PT_EFRA8M]SKA@O=XRIYG3TVE8=6Q9J\)T"FY M1,S>*;CPN_]3[D'GPU/L7B%[F,6=A9C2Y9NWX_.)\L$82YV4)L'E'=ZWR^;V MV/$J^X2_5`^?3SAS7'R0*CL=S1#4(.?**W!0]!LLPW?%>HX MT_FE.W=/,D2Y(\X>8",3AH(@!B0.VWN,39S(/%+_EC'AK1)KS5V!][BL4T9?CK`/4]G!,!!.] M+#)M4JLT496L83V807O1.BJ;>/8Y6#LGY=M>:.8.F_2)FLF?//C]DL\H7&;I]G M?'W<>M@/7_8X*W$-YIRE.CB0H;XA'YEYYW+]6%9%M%$=L\SF"O7&P\E@]!^! MS&()\$K$@;RREQ.L@8 MC(MJ1$U40+IN!Z:GRWH2_[IJ(\]0%^NWMDVL*%5#H%=-LP")X3UN`#TJ`'FW M&I9L9DWB'=+36-LQT8):D!TPB1WI":&LR48JI0HR8K9[QL@#M*U9\$H&+S#[ MNL!;3,2+:Z^AF+05HV)+#/5J?0RT_KMU&TJ`E^OV8DG>KG/B=N;2Q5%0B=9< MX-L.=W$"M+>>)YEF=78L8&UO#$R9!=K0@]FAO7!J;3V>\\*U2A=H^108IF6. M6*\J1FH4!QB[G`!2-,L1Y-ZMRV+1 MF28&O(H]`E]WKM,_`-+O,+KL('A#MARBB79NX!ZR&[`2W8676/5.B7N=!;$U MV*J)/_1_*W&>(=+7+S@D@0`Z\VF.$1IN4[3_#,].[G,BXO\\%AM M#RGY+3]DRE/))3J"#7#=#YDL#';7"UBP[!J".LBD1L:[6K'_;G^HNZ.W4'F' M+.YNNERAME,V%3;=HJ9?V/`;9OSJO:M5.PBHP!NZ%J;9RWA M;5<0PTZ;&$%`RO)CD9>E(8FFGB80U9$!T6J02`"O2$-I[/2)T2V<9=.TB^X, M#"]5L*FO><1-$WJ^%;$F01C.=<+K*"2XO"TPS<963T`6FW4Z6G!#,@-3&)2: M$-*P3%+I=5*@7J&:O@F:'.]@_4PQ_\G:^>I8@/L8:YCZN5M-'\!4;A+.H_AW<,IUB;9^#'\%..M@!!0!KTE\"J"G^;8WVOK$MDS",1, MC1"U1JJDAC=1@VAV2MLP(?]%V3"%;1D%8I].@`K6V2'%*J2GL"O+RM30PH6Q MV.`\+ZV-UTE7@9BYPV%SLT^K[@?>=3@#L=">+>OVW2/MM]^,]AR(5_(\AH+_ M8N5LZM$)=/N6;9Y\(F8\85-.)`O$N2C@F+?F.AIXHY<*-&J#KB,.:8_."(GO MR*5MMJ90]^0XID_8VEQ8TT!,1!!;:Q:D';PIM$+8J3]I'HC"JP7G2I[AP+:< M;?+SR-^2*'>BY[$,-W>7:1C&)NU2\0LR6Y=>V!EINM1/JESO@+M,SS5R.#J0 M*0-9T;8KY@WR;?L&01I M)<,45CQ"%A0QC@^DV6.*Z[7]1TSOT6?QAXP,714EF6:3W'$?X48LHP=J;`AC MW4&0,NATVUAG?TA>["S?LF3MB_7'8M?"Q#O["\4^S=EO'?SN4 MU8[ECLA![>A#1+OM1U+)?H9+50,_W M_I^E_%H'9'Z,-654'B1@WXE8`]\,8G>+.\!S-H&&K,(-I52PQT9,QWR"#(SD M0LZ(?QA#)'`,-\2QQ`Y\Q5Z.9$3VFS$,0K)*V]PW]M2!6."(=#!*NPLJ[8U# MF$?Q`YS9K3]'1?Q`>EE_2526==0&QGBD@HKVT6O@W00DO0\^/VN#:"/T,VT& MF'%%?D-D711$7LQFB;/7KDU=%)S)WP'-8GJM[5.TPQ?YCJQT%2.S3%[PV55))N*)I(D2]./F!8)5PRZHBV,S]$*+CH-:4/O5J^1 M8J!Q75M^PQ#]S)L#V=HLT;GJ+PK`HCC5*`CW/Y5*@;W6<-G1ZP=$W/-HGY`8 MG/F7LDZ/$E_FQ>6A.A3XJBP/]-V9`OH$/F!U6J8!/JK,,HX)1"V6*1+*JJ\0 M/MS*R'*0L^)S4-DD_XE9QC3.#C7\@#+UNX7-]U%+CK80T28*F#,.EX2]WK\0 M1W++BF+)MI(5#0$.@;0BMP<[TE8PAS4:4227K+I-=/1"6B->I\SO:4JP$NN/ M.Y80.Z`%NBKLYXC+'TG#JKS*.&QV:WWJ"F-*3X$NSZ;^L6WC4UM$)BS)D\?K$X>!7CL6Z<9O"<+FV2#Y6@_Y1D-RC#?TRR9 MR, M@(_DD>=E7M1_HNW>^_XP"B'>F-?4#K47]RF5X.WX40T\.(?*A6+;M8)8;\RS MCAGYAHJ/V[X;GH-SWZO:XU;@%N:'#U]PL4G*!IET'JJRB+$ZRI_734\'RZ5YE59%D9;+Y2Y0>5)MX@/*\TO:]Q`%UZ5V5G)^<]#4@6]8X]!_@FW-[8 MT92XM;QC$8QOHV+0&VTXOC@0>9]X[,VOOHE;KVUPKAK>"8R`O-%DR#TW,YJ+ M?_\Q443%42OGA#BK]AX'YW9T!(%:CE"50YQA;SU:V["^QP'DQ4X3E\4->&?( M/AWHQ7B:S:[G8[OM@-.-)"_S8HL3>@FYO7ZTT&PG[>DTHT?-H+F,&R7=G%S$ MJ,2P:*PH]-K=$`2;.+P-X3%^''][3M\%I"GT'//FA\!F.O)G2KU9:MN,A`+_ M"4Q6M.A*]7J5E57!CGYXU="'YRB37J!U_0%&=W]BT]K$X74RUXWL^W0FP$G` MEI@5N2!(D*1.65016=07ZD]LIG`SW/*WO&1TV/^[7GQZF#N<#PM?`45L6'XU M$\I?*GC#[\8+$?9=14BRR[^Y>OK<])5E_((@YRRC.ZI8/) MCX?V1-G9!`TX/V^><7Q(\:'UT/4&]^<\7<__SD M5O+A_%+SIUOZ-G--J9ULT,^LKY!S^*D&Z3K)\%6%=\XS`@B,3RSR'`R)DY"Q MY7HZL=Z1R.Z#-/0S[0*Q/D[1>(;7./A!X?+719I^3LRT3`.VT*4KWLGI&)X> M@;]+5KS716)Q?GW^0[;HP9GM`,K1XRRFX4'],&G!HR/>PWT5%56XH_&(GY(L MH]=TO(R)A^,TV_%07/XXW?EJV;.RMW$BMORYUXF?;GD^P]+LUWWB=4:%T_$3 MVYL;,Y3]<5CX5H0^!+EH"&9Z@G]B8QJA!!.H% M1PIQHHYPTE`[]86C)#@]=S@!WJ2877_B+@3MK4#:.UP>@O?E?:V+L3>Z6^4[ MVQ-RN)*7,A`N=[08)^IT)PZW4[<[4H;3<[R3`"[K>J6O+-^J\W4S_D;W*WFV M&.[U3?;7;H1QS M^W->C\%="74!9](]T29A">KZ1@?:>2^!"2N`2GPF<:U]DT=,B%"OD$X>54T- M\45Z"BET!!$`.,`Q3>DOM*\@JZU;PA^`G%%F?V=/)F9=IT!R9 MEZJ;4S(O/0;[VN##:?`GQ32HF`(#K*[^)@9P1HI\QO@FP](:Z=(6`*GMY4*V M:>O[/\.DI)?),'S=Q[XB:;5L[7"9&PE.2'WJ=RM)?__-=W]$[]`?OOG]'V;5 M-M>9QL/GW&`:0@LHTQ@(V3>-]F=`TSB20:%UI!6D:00BI(5IF"3]X9OOJ6F\ M_^Z;[[Z;91L!!L?7DYXTSN_L#83(@Z%;+$J^#NPYI!L8UMOMX_:,Y,'>=;AO M)Z>.9OX9%_6X[I+*RP<\[O(M6+%\&)>SY7Y_)V[1,C`>[7J%F`2UD3,9WL!Z MV')4A3$Z'AU?XS+YX>&B(\-1Y]NC02F;49&.QXG.`C_M][YG@4&7;V`64`SC M8K/`47^G/0M(P7B=!9@$;VP6L!Q5[2S@9UQ\SP)V(Z.>!?BHO*59@+^ZO]D* M+V/JBS@^OH>N]S)X\N984@3G-O+[27BV]^P`D1 M__=9E-([?>&]@_3U"0S#=-8^?%QRI'S/[:-'J?[5)A>3Y\G]T=&0#(?BZ"KM M':8'V>3G\SRKBFA3':+T`1>[[W4?+`3I`(.#$.`K@@=XT6""BU!P>YT+I:Y] M<.^]E1@)(B,J,^!"-]CO)9T2+,?T.MG2,M'H/W!4P"9K._'A90-(@Q?U./]: MYN<>21NVU5';^R!TP"3BKV&FMOM,<-.U7KXW/F?;@`]PXC[>D/6S:+/?7_BO M[S?N^WW@*9H6K/DU9FOBO[[>5.M;]AL&%^)-^GYV<9[^N?*)GZ?4O]#'A@#G M*;+>W]!YBGIP%S]/&7;]-LY35+B`MO<%<=[H>4KX`_[FSU-.X1.\[;,:ZR_0 M1!0"P1L[JQD.14AG-7.D>P,[0/,_SF*;/]-%.^U]G[FXO3IYJ6O_=9W5./]> M[910"E."B[.:MSJ!]$B\'!Z,%NG7,%7(/P/<_-"7YXU/"C*P`M3*;4$I0MII7'RPERM29EF\''SG<6%\GBM5#9P) M:X*H8(A*AIAH(;T2\CW^[0A%]0AMZ;"\R(;E!%QMBW9=EH<='Z>[I/SELL#X M*B.?!)?5'1F5CV05L3OL7'^9T=V?F'.=.+Q.O.K(OD_'G4X"MH0?[1PB$D19 M(2H,HM*@1AQ$Y5FA6J(35#BF)W_CSJC<=!C2"93+ M(32?+[GH+9#3(W=0?+J]IOO@3OP7',X6]OTGE"+:,USO/-K*.G#'G/>4Y?/"O*E;B$UT;0AR*[>:&9*P='*9[Z M!"BIXFL@VR(M2W<(4_;%#RI%\2WNKS:B7XOZ?JT4VNUKOQ;1[H5;)2AJ)4"X M<6H5D>%=3H20'ATL-G'\UY@N-#U`#NP'NP$XV9!:N%CK9U+N=?@F0F;)$"X8 M(@N]G7I(/(#B-P1>_!Z][WC7/)ZM-\,-^MTAK9)]>HH.[/BX3G*ZCNMG_+L!9<$+G\-[/HCC.__Q-S=U`%VXOW&=GXZSG`:LB5\ M(Y<$":(@)@NJB##=3?A6'M6[>B=C/2/?AK]!OR--B'^E+I0_[&+,:?F'FAH5 M78N2M6#A=8FB"F&>YVL?1IZO4QW%1S'?EGPLW\+D]1G>\'EUN7^P$4VL(YZ##V``'38(2R1SCU M>RFG`KLQ_57M($*-\:]R?S&\27JT?&]MII[X@2"V,']-<_8DY`%M@K[1-%:> MOMO,R>57L+]X('H1WFPR3KBW-I5,^31>-RRM)'M#D\AXV/#;G%387^ODX>![ MS9XY`M@MO,9DY-99?$?&*$KI9<*L5/ER15L8UZH57/1TTH;>'8]&"DG:8Z(U M%5VN,BJ:(X6:>$T$8XACY&?2XB6ES8D,KJ35C_8*/=#.'#X9:ZKAW!8YZ;E* M<,ES:A\>4]:_[*6$F0;@R98MD/;)E8D`YLF4G50#M>DJ.>U;PCH_?-F0^GVG M=&I`](^#/*)Q8,S<=:S+,GG*\/$U#&U+0,.5"STPUWXS6".5R:+1`?Z]Z>LW MUA[&'@.4V<[TW`H^P\K:*9I)1#,,R<26M0*P+K6PK64-F\!8E4H.38S$/C*J MELI9I32F\$35VY!3>3WN)6Z><7Q(\9=_ZQE&JA?38FJO%>?3]S>_)F2AZM\'['FV:DE;9`* MV`7:'4WJE MF?;_*C4374.(5;!.Y&X1+&L%M`96BS)79N[HQ8JV7U6CU&GBS;BF,[UNO4M)42,,ACU*B\/]"9"G0:XOL=0WN$-3E[H M:OS\4!3D+U;#8\TK!&4<"5RMHY:,@%5WE)06)]6<79,>N[D,5**.XPK5/&%6 M,B[A$TOZW:D8[%7V\#G_#QP5=C/%&':G8+9#^-,MM^,5N/$>"^K(?I,,$;Z( M,3X%(S8.`S&PWY^0'9/.L5-+%AB>B"T/AF"6-;?G<[3`[T3,^7@`9IESPRQ\<^Y+ZM"<">.3,F?#0!`[^^=3,>>'9US@:%LI MS]FGLSL%8Q["GV[+':_`3?E84$>6W+$]!3,V#H(:3JBV[&1<3L-NYUMKX#;J MT#)A7H4Y@3OY.9@;\SL[E$F&RW*]^?LA*1-6^J9^ZLIKBU^5Y0''-P7]?PJC MJ2DA>YCBBBF,>;H9"M%*<45Z@AO>JJ\@" M\&[%SY!$'5>4\!'8Y+L=^1?/:/\B>RA_`HE`F@<_[-=R_1(E*1V;R[Q@#]<5 M8[U<=R>6K,-R^)RDWS#T=3H)-:R`+)$BHWNPQKM&;=]H2_P9Z_W$DEW,&,N2 M#D1";".KZ)8']V,Y3Y%!G]"^)#$90CHP3[*!\>?<&HQM$'>/GUC$IAA,37L8 M]V($(/H'96/O!FZ01/,>M%L8-"0P9C4=0=XB*!4(_.G_!=Z2("1F=_J3QP,U MT%LB]H?=/LU?[[C8J&^-S6$(8T'SAT`TL>GYWY+SCM(;S!M M/&CH'66O:-=XAHT(-Y+"G?&LAV8&N-ERD5D\_U1@YG?*C]$7NC%YA-V6".#1 MCS64]@V0D0+F29"E6,.M84*';K:HHT0=*:II_3X8.CTH^N=$4_'4O[+L&C2R MQQVNJ&4!-\N?YVP%7C"5O$O*7\Y>SW"V>=Y%Q2^:?`=F,IB9VA:..!>;:+S/ MMG8"2>8/@0Q1.KH?U5*")S@8PFI$XZ_"K4?CF"P459/#T:M:GR8`59,)9*-J M@IXI'OG["S>26!H=^Z$]O"[=@-A;/:W.B+T/I"]NK$X"D*S$FY0P)G% M5;;)=_@Z+\LSO,T+_.$+D3$OXH0>`;.47^LL/C_L#FE$KSM^V&[QIKK9GC_3 M&Y976;VT3+*GVR+)-LE>^8!IB8Y@3'"Y(1,-UWTOWLU]*0@#X^(=H:]H5U\C M^K6:JY3T3NXCZQSU>N?9[&`>57D;%KK#F=1#D]*A600OF>$?<[V_#`>QQY./ MPV.)_WX@_OW#"_D?;1T(:5.@JXH';KON,3DN:F:?XY(@I0LLJ1)2Y>D09@%_0T6/47M*Q(PU1%]67=6SH`M-#[147J1:N12V$ MO;GC&EID`\WC#85&LLN\N,@/C]7VD#;3DOZN@@4AT*T%:TB]^PM&*O\W&2Q% M&EX):`AI1774D';A!O#]!M^PPHOZKPUU$R;P@9[%1@*>L@*X!BNX,%'"F2N! MZQ`*,^CGO[,HI7^:-'>VM-"J:P',/@*K"0,+P7I2C0]45JAFL,B,L<=%DL1_R49!EU(0VJ(:Q0G,7YJX\C>G-QL4"EMJA\UN[!B0V`+JP-1.Q=3VM_]7\9[:CKX94MT@!X(VR>C+YOD;&; MHBSK'E]]W#]C3$.!)GZ)TF[OHCQ[)?_8YV64_ECDAWU)6*2'F"Q3:)N-O,UM,,;:$OW#'0KS0^LX:11\T&,$?H4[>"/3T=AHQ)K M3U0GB1[:)#L#*/P4H_ M"#,6LG\FONW/.$JKYSIGI_K!H;(IP$+4(':[T%2T@UE(:H49:`EMC7CS)KTK MT)/"P.76+^*6$Q[N;K#^QIRR=1@WA#5WXA1-P>\)ZV^]#:X*!W')38)!&X=I MV@>C-^I82MDX!-W1!@,*[0$-=Y;%`&8#^BQ2\K9!Z+XF:Y2L(;3.ZY_H#QY6 MP.:&6D)T?QI^6]`,^M4KS)E\H?^E?RRB(X#1>S,$4?75K;UKOTF4@0:U!,Q[-B3` M1C`#12^T"L`8'HHH*_=YP7>2[28!`PV,25@!$:U"2^#=,"RD&99UZ-$$,T5X M@3+C&*J9E.[S;?59FQ-6U1+@$$HO='L&)6\&TK*UL&4+U?M'2F:AE!P7+-'=":I)`Z^*22#0/^SP/HM(0NZ<-1( M"LBD4#VB(%1+(I&=DC64P-M`+C&MS*!F!#CK^"5BJ1O5DR27!:<.RV#[QA\K=*O,91B9_S-+[:[8O\I:XP MJ]OAUE+`K`PM0(AK0DUS[ZM!HRP#G6HID$@"O*^].`R/EQ7;%V;UXK2^?ZY[ MRFB@`;J\:`.D=XE11^#_,J-9&GG=(7XQJ]U::,C`-^1J0?2WO_MM@!1')FA/ M4<0&_A5CV+ND;&C]9@3V_K8#26>^*:,)^O/=[I`EE::&G:HET(LRM="]!V7# M9G#OR52RR%\VT2"P;0[XFBQ8J9^J%&&\3(@R^3EYP M?$7T*WM*'E.\+DMO'Z._Y<5Y&I7Z'`HCN4`E0Y@$MI_58!0+@/0$$^23 M[`HU7-ZEE`WJ^"#."#V^(L8*,5[@48T!=X?:F(%@$J<@]5D'>H1.R]B$IM=J M&36ZC:X5NBTJ=@#I!L+$/F)2])E>!F M^\1F%\M$#;R?90=.NK.E)X7;X[*12[?;U=*CCD&7.".,C2\)1IN],`T9Z/:8 M$8YDQTQ)`[6)9A!(N5LEU;<@-MLF(E*8$/P;Q%J^SL1X])>SIC`4HV9F- MA@SL),#+)*HF5*@-6II&F4"#I<7!^(Q%QL1E![?Z5+^]9H`95>3B-E+HR;\[C]? MVJ#S8?HP\J\PRC`TPNKS[!TU@OWHFNQYO19@'UZ?.:[[]+"Y[]P(.^,X_^%S M_O"<'\HHB^^3+\P#7A$ER*KD!=..U>?ZMI0`!_SC0+4G_79D,$?^8V0;IO_Y MG*.&&A'R>J9K&;`$BD`7`4X=F/YVP"QTI),_CD/DQA%\2C(\T1/H26%=@0TL MF2_0T8$[`[-P>J.A](&Z@Q.%9NT0)N`CO?S@S2/\.4]I(2/-U;[C%B!O/61" M"F\\Q)^AWG8,99`\,>"-P%YR!".CZ=V&"T%G6,7-=IML--D.^K\#6(1,P-8> MQ!]AK&$HP>#S\29`EA"(?'HKL!?R?A]I1)T3+^(4;_+=_6M9X9TF-I0U@X@# MU>)V,=^P#5!\IQ)D&/#PEH@WA8K9@A37$(>YE+G^[VO2"?DW^1?YC\>HQ.0? M_S]02P,$%`````@`>H9\0K6.'32-7```]Z@&`!4`'`!A9'5S+3(P,3(Q,C,Q M7W!R92YX;6Q55`D``V>M5%%GK511=7@+``$$)0X```0Y`0``[;U9<^LXEB[Z M?B/N?]#)\]#5$2$QRSW\=YRV=Y9IY\J:!&2V4F1*@ZV5;_^+G"0 M2)&82$``(55&U)8E3.M;'Z:%A87_^-]?AT=MR].Q]H&3T$DZ33P>^*D^2Q9]__?7S M\_.7"*>-BZ2_3,+YSS\7M5T[,90.^;)JCWXY7/UR4]0'?]Z=/'KT<'A M\>CBSP<'?SX^'5U]6R7\!I),/69*WPO^>(/:1H!&$/_EITKSOMXB_YT&<.,%DG0L7TY;O\/+R M\M?L5T@:>W^.L_R/X<1),OTPVS4BIL!__5PF^QE_]?/AT<_'A[]\Q>Y/@,%H M]!]1Z*-G-!UE#?ASLER@O_P4>_.%CQN>??<>H>E??G)<(`;@>'1XE.?_G[<% M)8+E;M-*9Z@CP7) M.TJ\B>.K$FFC$L7RK7Z-Q],'&+KF2*)<;85O49Z7))S\\1[Z+@R@=_],@?^* M9&NK:(MRWCCQ^[T??LKL983R>TMUZ\43/XS3"+UXLP!FEXD#X]-D$J8P0`6S M)ZA_XB$Q2;C+E-AZ_"G$Q:?('2]0E(VI79M-*DPFVHZ/QM.K&2Q/Q'H!J0B) M;;N:0)^)O3X(UHN0V+:G*`2%)$L\A4(5"]PE.K:QO2B);?TM#-U/S_>A@H<` MEDPS[\U'5W$L.O]REBBS-Z'$\7P\U`!`CA=4)\2B(W?N6UQ%2Y3E,0QFKRB: MWZ*WKDRI%R&Q;?DD_.I\=1YA:R7(')_P%#I>9!T8V/:,XB3R)ME$!#]

M54QQK^=W&LF=1; MXI-4)@NAJSV2&F&QE+5['+3'S&])81-UA!2XI@XO*DKC9@E?%J;I__4S9.A_ ME6*O?VY4=B?&5D>T'UG1&)549AZ#![ZB$\6:V"^&3^CP$T4%`G./]$RORBK- M(_?V>*6:U!Q(*YWRC;KLV!'$'XO%MGO(1I7['J*LA_`@K7119$,/R3WVQM/* M*49AB-Q&9R'7ON\WROJ-(.B2`I^2KCF>:>Q$;Y(0;2*Y<1+XC/!&#W[&CZ=C M*W[J^*\HFA_1.IG^UNT[8:,3&JH4I1%F=FG*!+NEIA8J@; M66-7$TF3UJ;=6[?OA,JF.\E*41K%>">Z:"W+5M:B@DW:=T9]G9%#$Y*NFS#7 MFD;X&Q=HPO],^AZ)Q;[%/>#Q5SW89;3+\'C3Z.ZMZ.Q)D/H2!BNX58'M)84QFF9CCI! M2Q19M'N*RE'J-]B/S-,Y5:VU-&8JEM*VIFK9\MBB7.>+K=QJ&AN4RY1G=QP^ M.2YC=G/N%"G8.$YM>[Y7!.$`_#.[1K3<>BSQ;JTPC]EJF":1TA*!5NK$.;1@ M_2NH*B:39R_^XSY"^.TO!%Q,G@'28NDCN_\(5K_O.%H05KKP,>J"IT1`=765 M?1_9+K1*WZDWRJM$YFB3;[:T32=Y]?NNH@5AI;Z3.J>3QA%D$]`W'D!7S[*B M:"YV^BRCPKK.SD%GI[O4*[:'J22/1'LW(B6$OX<^%..#7%O>BE`;L./]1!_& MDIP0S9L_%$.ZO347M0'[?J,)8Z5^@<+]AN1?(Q&CU12<1L'X`]]=;6S+MU+G M[C%>'ZP*(CT/]Y"N?=Q0&-B66>'N=05-F"H(\&RJ`^KJJ=3?X5?D0K(?P4?V M\3E.1;U03^6\E9HW)4M>-F;T_/)C[XVZM;&/^2;Q][!0C)JWK$3K-V9DU!OD M6PIL^U=7.[S*O?4.0'N-=,__'JC9\H:K,@SSV5D;\>O5[XDO#;7]*[-,%(O' M8S2RO]&"NBHO0)5G^P[0&;C]:[7#7OGO^=\'MOVKMR)`;MU?6F+3]KUF*XCN MUF.ZDG9EYO6K7H[S^\ZE$M9=>:97TL;/O+XEV+Y]W]H>K+OR[F_?/25^2]:\ MCB72N'VOVA*FN_YR\,[NKG;RS6'ED`[\0>(QU`NE!+-'!-#ENO&QX?`)=GK+ M5P`A!I5D0#D13OF!Q#PR#@\.-STR5G6.\DH+IXRLVE%6[ZA:\>A/JZIENU_P M2T]SPNA2BI8A$_B2=19J=*]:(K-FY>[JJHTE;`E5QV**T>276?CQJXN\7'WP M85-K\-4_'M',\>\"Z$S+E@A;+2GJTER"-.>:W?/88*\UQ"L043WJ-9*WK/5! MV,V?C=$%+ZQU13!%T1XKB3"H/[Y/?HO"=/$03,BO9C82&:4M)O8;GMI\TFA7 MF)QI["D*81Y(ECC^:P)S`%[B+?(UX"O430E%R)'3&!IT&D#["DIQ/-(<@Y`H M$9:'^CXW1T[CE-Y5?P),8$BO?:P@K=BG4V]">0V[^OMPU,I0QL9HSY315.6] M(A_!'O1E"?OM]N"$I&2VJI)75%L\0LO)[)$5?;"1T#@&=)J8.>4B^D'J4%JV MV<[VV@"PCR_R!3')>M":UES5T;705!^_>$J#U,FZJUL^'E0,9AZ*\S<64B`T M-K"T#*@ M-6Q3-4YEB3HY!5,:NNK0P%,;_I2BQSI'O8]U!#/L#W_DO`I3;[$+0Q]*8KX' M7\A9:[WM[`!ZV\7P#XJZRFWN4QY8?EC+O(:5A^@JI^@TVRD[IS$]A4!TBR<:YUH1#4S6EU9O; M!&YQE>[X9>T2^'2\2PH6TZXA6WLY,T#KI,BRS-(S&<<3B4N`#I(;]53+QJ+X M/L5.Q$6.3^;6=H-;OH8\=@O(+IF*'YT?- M.Y&5(O\M'N6%=CWOEN6KN6I1G+<'XT$X"N?-I/?DFWF+F/[L,_-XO&?YQ@T; M?!1H/S)7@87!Y^J^$WQWYM3+1Y4DYFE:J=Y:#E!98)BO:OJEHUHBX]3-A)^L M,8I$IIYMOWZ&K^]A&CN!^QW6/-FH]A!,`"/8BF&Y*%=1^+(:JV"*MC;.0?M( MJEWQFD/*L,Y,);]18P+!MCUA*(+0J`/:ZS2&QL;QU0366K&'FU*&K\D?YHT? MXCA%[CC"_V+P2B?V3/3B5P('Y11N'@_5\*))0(7XF757:$M_I5Q^.YV,4[\,HBR(F>U7`J*ZNKZ/3T\N#'>'Y5A'= MSEFU>ELFFF$8;IW$$3-B'K<8,?.R1K@PS<;+O"7/:!%&V&3-,EL2D^L8ATHV MK@SN1?-(VPMB>O-&`H9:JIU93"IE6U#E'?!NOO##)4+7*$!3+\%;;<&[>"?- MGE@6.BI*'67%ZNV3M3$9W\A*O"@;E=B.$:\+&LJB^2B?K`#+N9=DTS!`B<6%/H>"B8<$YZS3YIQ5*3N[ M"5XK7?O4111;8/+B+P-H7%R>79P?*EG;@?2XN5+ ME.GRV8O_H#FAM"@E[M,G[W(G^H'B/L+(9 MH^D.RN+0-(^TYH9::(I3"D-U(F%E,U_G/&KCT3Z'W)9LZ%X<'\7/Z`,%*7I! MT8 M2V+LM@S"C+#XE!SF$Z/GLH(JJ+GA\)LPL,+@4W*8KV2&GGBV"G1IM:\>"%O: M;\B%_5)$"7A?3V&^*AF*V+"Z<$AGJNJR.*:_A1\H"K"9R/&OL/V)$G6)FL$V MQ8H+:^OT_,AP'B9GJ,-T`C`=F<:)/I,S74Y)(?(90;(W:)J3M*WS4C.8KR@Z MUAM]5UQ6&[=>#0R+XV9GA@YYNW(EBSTTE'@/3X5 M+`4?*5P<'YY'1\?:1HF"'8J,5.><8.##&UPV_2V-:7HH,=O41C' M3U$X]4B4J*38$1JP)+9D)[!R;'T(8!9!CR`T@0(M*7>$"KR22W+&AZ7L6ZB5 M%##<,>E02[,C1&#++"ETFZ_1F1/`R1R5\%VLG/AA\)OC!5CF,<9N$<:./YZV M)@2$QM-7YXODU"FE\!UAFT*P%`1XVW.5%W[--M.!D?506D`X_?/J>O*X1@`Y MNOL"B$$Z#[MM9U8-["::SE/?P0$O[J93-`%@;M[QU<&'H#A(AH7(4^2!YA9$ M1SSY%>W(F+LEX"2%H-//Z+\C;_:>(/<*FN+,-J(-C-,D3IP`P)M=.[$W(9!5 MJ(PZG*<`Y[&-/.R/24&Q"ULI=NOY*7S;0$2,9*12=IMF0J@41+L#'Q/4T>E=;44B5'AWY><.=$`714W#_+4"95``C\8^3:$6YU0:'D3=_#AII9 M<0M'T&\Q^F<*9=U]X(O.0D?-EVU'S65YHZQ`S<%=ZM*1KOFQDI>L.3X].;HX M.3PZ.M3T1M9&`ZFQIEN2&M=[A0!O.07FE='<2WZ;(M#][PFI3=7KB M`WNMI4X2VO@4[2/*3:WN=;H,TV3\&4#KWKU%&01W//V./A^"#_@8$A^_$RMD M^.R1*/=VW+NUA[F^"3$:9>^Z"V!?O;QQXOU;<& MRF<4<,#M,D#=WU+']Z9+'!ZUN+XN9+\!D;#]IBP9/JX*S\*JK8L?E>7K->?0 M96<8=_@REY:'HZ/+BX.#DX-#73&=&'I>V=QH-B"A,HP;*WHHK#E^](?"7&/# M6C;?#S^=8(+B+'IEC"*891DF);[,`R,'CSYI'!&&PMR(4G2AJ$8IGJP&$T-8 MB:*,H"!@B=EB)?9]&-V&Z5LR3?VRC]'#!S$S#HPX%%TW:=-1>DM(PSLTLTQA MPN483"D5DU0?5,R-5T3OAM>.C[_J-&$5>0?+$M$MED[9'V MC"8X%HJ'-J>^/D75L3L'[$[M8I9T<+;S+I=)`YSTZ=-"FO5'0]+]XGSZO`M< M05OS?_R*97ES8@1__/]02P,$%`````@`>H9\0OE"%\@`%@``N?L``!$`'`!A M9'5S+3(P,3(Q,C,Q+GAS9%54"0`#9ZU446>M5%%U>`L``00E#@``!#D!``#M M75MSX[BQ?C]5^0\\?LFD:FU9]GBS,S63E"W;NT[9EF)["#P)^5L7)Q]/AF=0B;7PO-7GP>#M[>U$(JT* M24]LL3P^#FN[(@JX0SE=[=G),'XS"FL6_+-U/CC[:7!V.CRW?OI\>OKY_,*Z M?(@)'Z`E,U9)J>P%71(+^H*KKT`?#_?/FNXH(/S\/I4N MRY#CDZC`^8!QY1%NTXC>9?R[@1Q?3Z'),?L/XZOKV\5%X5&'/8N//AF?GPZ@*[B^+!7(\.?#6*SH`"BJ9'1<0 MO$89P8_C?N!J6(XMXGF13WZ,9`I^G2)+.=KRX MYG3770R"EQ$I@68W[`C0=!0]*38C:JKY1V]TD>/3X3$4`I6QK"^$<^$1#Q1; M_XU/5BO&9R+\$QX@1I^E<.D+L+#PQ[>GNPK1D&KP#(QUOXT$=RB'<0`_E'"9 M@WI_15S4J^<%A9%S9#'GZU&3`K%\D80.G3'.=$M`T4]/K6,KY@>_8Y96FJ<5 M,K4"KE\&FZPV:_&!PYC_2?]>2:J`N>Z]>W@0E@Y)3"5MXMJ^VZ)@(EEYN?!I MA-C>@8S?JO'L#LSNDM9!LZ"4&=*SNI`FG*WQS`IX]\!N">R(J,6M*]YJC=3B M@F9X/[:#%]E;FG\/<2'$UTS9KE"^I/A+<(]Q'ZI<4:F;H-`;<'R71J/P'CR@ M6RF6A=37U"/,#75@+YQ-2O(1;,`9*$92M>)@UY&-> M0]*U9-4BJLG255E)7;TB[%01+EU7V"8#THI'E2*$;95A"M?,4Z5 M2KV=2($+)9*>U@,+'<_M=[`"`8K&*K.SVJJ4ZV-]Y8ID2I.`H@E+BY5U;L*) M*GJ+UNEA?%Z%[85+WUI?LVHKQD_"^&\,=>%#KR#EO,YF[KT4BE8_2>XWOH>FIBED![[MVXD M.K%9ZA*%V3E_LQ[]F+=$D01:1Q*N5L`VJT^!(%9:DL!?WBC5:UB#=5;04;#T MA9%*&$_'K2YM6_@\K0H325>$.3?O*USK*L!L["VH'/E20K\956U_%9EU[H\% MJ["@H%Z1!\)D(VM6),^F.=,R69%06F6U6%8H5Z]_>]8_>")A$1PAL!-5*^%9 MI54YA[VE5H75QUK5*T]]Y;D7?/Y"<1=CFO)STD]+-*1^0;,:_)0W+LCD&+E8 MR":+=?9=C_0ND7X@X!R`A*56H0V+*O1S1J`^^E926Z\(]14A6'.^D'>JX'^A MT;Q:_P6Z4CG,-JS!&Y0TP_XI/^C#E;!F;GV`?R)S;EVMK70-/=2MH+ZF,PH> ME@-_!"X6N%[WC$R9:QKQS1E4`9\;[UG@HUKP[V@%@TYBJJ9>`5HIP!.U!;>A M#\/UY\UL1F%`O>+;)^+1"94V]LZ<5NM"_@I/X9G- M.9O!4.%1$!`FPPGTL`UN^>9<;R8V@3J$\3SYT;4.EW9D3."\8/"8/ENGP/1(/D%E,J2@40 M'_-`I$OW,+3(ZZB3LE$!RT4>EN),BQZ@]ND5#3(E*N#Z,0^7.>FAAVT'>\9M M]H0K@/QC@:=0=\^WQ[3!!I]IYZX"HY_R&&6WW7H@Z@?=#3'T"A@^Y6%(A\1[ M$*H\:5S@CU?:S=+18^5)9NMH`[RX?"/2R2]9ZY0QPC8\+?"\L;`5L@UCQA'C M\&7`NL=T9SL5[3<>*O`MB$PTW!;H4:XSA,CX-'#4CF8..;TR##3",__YP=1GL0, M34$<(L,DNFF@1Z=JT/C+)9'LW]3YJP^>+I7N^I9Q`A:'N/DDCL;%S"@61"H2 MQE;,V8I9]^D=C:"=*OJK#ZV^>2V(NF^^-D-5$,U(&%B:0P](C=76I#5"=19$,.*L^V,KYJ:=BH1?'YEM9B77XYDQ)T+_ MFU_K-BEK0A;6P/D^B:[/H7`U9`88:I\EZ2'IOVJ0#%&!DHS5A=Y+$JNZ2A1VWK_(!B M\*H+F#'\,8]AU04)/9:[2QHHF>;JES2CN]VA\1[HYID$Q8`64)B!JW'0MT>G MQ?G=(G#R!&9L*@]E]LCL+N>@&+(&)8U8#D_S6-;./^B!WGTB0C'[>QNY+SSLT*F_#^6'@FJD'TKC^* MO%7X[I%(_/5:=CE"S5)FB.L?I+(^Q*S[8^:[NQ(=WJ^$(N[/4OBKD4L4S)SC MF?E2OAVPK-**^H'>]&5)4F;$O(#$C6WE,KP>H M5>B^RE@;:-RZI+>8HIO\)8Z0/:-O^J?3\K?Q21EXENE M0CGOMMTL%8B@R2,AK*?G;[TJ[2.YL,K]W8*365VVOP6I=X7;FYG,S4S_=U+99:RC,Z,7*V;F'JX=GT&PI@47[NT&=JM[@#J(6][&U`I MM(549@AKW`W4`[636X(RJ#4K8H2PQ9U!_Z\0Q?]-85'\1&?6NW[B`='7(\7` M#:1'X;.%I+.O1P3P/895V-GP['SX+ZC[Y'WI1B3(/Z,.[U/IG@@Y'P`$YX$J M9,4-JXT8$&GG>+R=:P[#3Y\^#3358!4DP8(/,XA$CQAXS,/BUW$E%M:B?K"( M"U(.=M9PP+EIPS=58T]-GZ2JV5/C73)MVG@H0MT]MOH>^>^IN3`RFS9W8S#O MJ=&CI);"IG\9D-6*@3^A_X:_.!>!8@0/H.5">A8G2ZI6Q#:UBG'E8>;6D:7` MBB[)O;`U(T,1_.LX*G>,CXZ'9\?GPY-WY40R-A$AZ81F(D3E&HN@>2EJG\S% M*Y@M-D"-.#X=`H-2&0K+X(_CI'"+#G`\.4!U'7!_226SZ_7!9BGL@4_8`\,? MMY)!\..6<@C^N`M1L'`PT#B=8P2WGARNE)E2C85("W"A_W*\VNH8%7Z*=`(\'3!D8^-%O'#PX?EC1#:C&@BB9.@[?O-N4Z7& MLRLAOE\1Q534]NW9&+IE*3BXHW)=NV-,'1&\FP:IN/""3IE7WCT/Y)TM_>4] MY7-O,9X]4_G*;/K"EO32=<4;=2943H"SOH,UZ(IF10S-CF3>2;/+&JAEPJY0 MMT)>"W_JS7PWSH+VEU,J\=@DJ.4(8)T+J>])#UK:LJRAR2N!1_5>Z1T'>BKW MVO*_"_F=2C42RQ7E*NAI#DM<;-`3M2E[12FCMM:FWJ\>!QZ%UU2-ZUUU`%X4 M1=EB@)L7.RSC5D_^ES3.S8ILWUS'^[R`]]+VI[H3=]/P!^J`Y)(^4!R$L67: M?%HH/K@IX-]\=L22L/W:GF?*F9#/U/8E=4;P'_-NBNQZ1OY4J;FOM:E M#])J_B)@SL;=J.72YSFE+'W;,8)/]%6XKSCIZH%R+PC/"FXBZ%AV/%63%SCW MM&,I<<(;S[)VZ([;$E-K[OB5D%*\::<'EC/Z`UE!,YH7ZV94V%I"@ZGSP'K] M+%ZIY/B"N,%U&!N&KH*H8PA_A@K&//M![T#PPC<=+4ZJD*ASDC&W2FU6YK`< MND?J3:2P*774K13+(OS,)(>YR@3F2E4UK(KH,)N&MGL\"S)J='!D+JDF4>$Z M.6WDJPB[7BQ':UJ=='>G/TD$B]7P&V^A^AE)#F3I>T5G0M)+>.C@BZSE+GO9 ML<6^G'E4EHA<\JYCB:_TO`Z24>4]P6P8=W#^>;&D(":N#('I+F;YTNE\16U8 MZ%+GTGG%(?W@NQY;N?2;PB@>3!X(O?AOW*$RZ\W$D_]. M69HXFW>NR;C.G:7,Z-1$Z+MWY8(-:^(W%!>'<@ECI:'[R(&YAF'7(KY,27(`%>7AB.(TP(P4'$J@?F M[M@=J$?\(+BW<-=/U/'M($:;LR]%R[!O,$N[09=<.O_C*YTU>J=N7+8,8C5Q M"&U__`\R!))O[V8K=-.:=EHS)H?IV1J:DT1:3"0'"7@BX02M@0<(7*WO*2KV M1BBS%F774=G4`;W'LQ.%M)Y2N>!@B' ME(*%_GCV1&V,,:4V)=L7/U0S\QJU"&:5Z`B#![\42_I:UZCU6Y0_3.BC16)PE4WPA<><%:LBZMZ:38(U M+)E3S(;0)^%T]\O$0S"3=+DZQCTL'WKX6]T,R!!"@A:#`' M8U>P*Y^O['.*X21Q!36F8DZCJ\F`[HYKV5DI?=C^_DGL[` M!MT+I>/3A9?OZ\R)?..V8M%]%^!>\"^4N-XBM%[YK>+BUUWO]J?L;GCIJG`+ MK7+F;9<&^7YA:T:@*-E.+GK1.B%ID'!#P/,)QC-UYM M'*(/O&"KC>5];>JN4T8D<>@C)H^#I/J/)9'?-QI31=1YF`(\D7L&IE/E$L8* M7W6M23`G2S;5+-6U3_7^&^[F!)FP.L49V*479O7(N_;`@DDZE=C+EE-?*AJ. MZ'1#KOUX0Z]QJ2EP?I,T5[D.CY@1;AYF)\ M.4)Z7_)%0+-R>+4N;>@+MO7>9J4C?S.;43O81PUO@\;U.$9D.6Z:Z1'T%S%5 M\"(88!BRC=K5R[5LTL=H>&A]O23W974-D63UE4<#2J.(??"U#^D3MR1RM0-.!VT4-C)I-[(=*XCV.L1K..=OXF4A?$7`_C). M\TEQ&VYZ;?+.<^R33;7-Y/J"-QU+^RAXN3R;P:(G*^K&LZXES&RU M8OIJ\29L^*;KI,OSB2SZ& M^2:=V?H;U--EZ#DU/3VS]P:3F9FZ:^5(W$*\'SH;NBE[V;4U*]:T1Y&2]^8= M-(*IS6!4JY)=-_<7X3HPGZC-;:6-IUV?BTM]9NN!>+Y.'>+_I$0J,-D8>7T3 MN:X2I@+!U;*]1WJW/'4 M%4N%YULJ"ICRRG`4JGT:Z[]3-E_@A?LP=Y`Y'0GEX8=L<1_ M47SMV<%0U\TXV(::YIFWYD3NA+\,@N%T2]B72U\TZVPD=&^)FL5'.\; MN0*Z?[YIU8L(NO9]'JD7V=IT4FOI(&M`?]##"]S3*1Z!8!B@B3Y8>.?@`F+& M2/R5Y"A/,G7!!O@9>AU%B>3YDD\-QN\0ZW M.*031-P-1JR\Q(%N>QK:`$,IFX\7#"#4N=9B-CQ8H9\0@^4D'B\$0$`D]H.`!$`&````````0`` M`*2!`````&%D=7,M,C`Q,C$R,S$N>&UL550%``-GK511=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`>H9\0ATDY:]^%0``&$D!`!4`&````````0```*2! M!Q(!`&%D=7,M,C`Q,C$R,S%?8V%L+GAM;%54!0`#9ZU4475X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`'J&?$(H<@=CP"P``(\/`P`5`!@```````$```"D M@=0G`0!A9'5S+3(P,3(Q,C,Q7V1E9BYX;6Q55`4``V>M5%%U>`L``00E#@`` M!#D!``!02P$"'@,4````"`!ZAGQ"I[HB9^B!``"M"0@`%0`8```````!```` MI('C5`$`861U&UL550%``-GK511=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`>H9\0K6.'32-7```]Z@&`!4`&````````0`` M`*2!&M`Q0````(`'J&?$+Y0A?(`!8``+G[```1`!@```````$` M``"D@?8S`@!A9'5S+3(P,3(Q,C,Q+GAS9%54!0`#9ZU4475X"P`!!"4.```$ :.0$``%!+!08`````!@`&`!H"``!!2@(````` ` end XML 67 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Condensed Consolidated Statements Of Income [Abstract]      
Net service revenues $ 244,315 $ 230,105 $ 230,099
Cost of service revenues 180,264 168,632 170,376
Gross profit 64,051 61,473 59,723
General and administrative expenses 46,362 45,858 47,042
Revaluation of contingent consideration   (469)  
Gain on sale of agency (495)    
Depreciation and amortization 2,521 3,167 3,408
Total operating expenses 48,388 48,556 50,450
Operating income from continuing operations 15,663 12,917 9,273
Interest income (155) (2,263) (155)
Interest expense 1,723 2,524 3,159
Total interest expense, net 1,568 261 3,004
Income from continuing operations before income taxes 14,095 12,656 6,269
Income tax expense 4,807 4,244 1,902
Net income from continuing operations 9,288 8,412 4,367
Discontinued operations:      
Earnings (loss) from home health business, net of tax (1,653) (10,393) 1,661
Net income (loss) $ 7,635 $ (1,981) $ 6,028
Net income (loss) per common share, Basic and diluted      
Basic and diluted, Continuing operations $ 0.86 $ 0.78 $ 0.41
Basic and diluted, Discontinued operations $ (0.15) $ (0.96) $ 0.16
Basic and diluted income (loss) per share $ 0.71 $ (0.18) $ 0.57
Weighted average number of common shares and potential common shares outstanding:      
Basic 10,764 10,752 10,604
Diluted 10,784 10,752 10,606

[& M[3PIMO'CI4B5Z MB]$_4P#M[J/[PJ=12O^]T>0=N:F/?G?\-),:^@F@XGO3)7253BL&WB*E\V4) M^T?:MB7[M_,,(E2%\OW1JP/K1[F[I+)(1?N17BUN*TCQWJ17>VD%;F>?TJOY M'.5N><_2C^\"%2C:O_1J?UM!:O8RO9K94LZ6]S6]FB]2@42YB@$XF#TB)T9Y MS3XV'#[!VF3Y&L$JVYGT'T'%J]G^>JZ?^L3JV/KJHQB$E"X_5G4H7W]\=R+\ MZ0/U$XNW<.7RE(O6\GCE,8SC^RB-9N7I8FH]]JR/3 MRKRM`A5YC5*\%Y74M_F*5BQ+A90MO\H7D+.^[>S*)2E2J(;M2';S#G^B^"$H MTUPORS,-5:)R5+D=V=<4NP'T,ROG'*_,(2FLT=-YFFVTX+LH\?Y5V,PWRE`& MDLRV;1O-^S3!8S>M;3U7!O*;L66[F*Q]6*>JMBQK=21'"\=S[[X6V-T*&S/& MR3N*;M((>_Q)V9.H:X\VU.";"+9892NW"1"I:D765DF]@EZDHK:O0:M^*T\0 M1OE;E>J;`R,KK+O[DK%336HLZ)*H1RU1E>W_J^B?U\O_!+!BUYOTWWF)5*!& MKELT13`.N_!'/A+#\/SH.6^>+X%Y'>I1(^4SFH3!!.HJ%BAWTRF:8-;`K\^P MQ'M"$7;9<&;RB-FA2C6RKS8"/X((VC0+\"D`_%)X*LE3,7=%6S[WDC3H=*MJ MR[*N3T+6B:\P[;RDK[565NW;1J32E.R++K\OOO*T5[8EKS`NS1>L.1"DD6$8KQSQ!D>H>%%\W&)\F[M5V%"7PD*7.2N MOO427-7!P<'EP>CG45E0]2,4.LI+'56+S00`$?QP4JLA.W(/(Y8F\#?_H+7[ MZ@T67S!)E@7YSAOR\Y(X\_TJU,0"[2R(0XPFO\S"CU]=Y.'X%4?X0];\GP\. MBQ`._Q.^6K7C%8K=:.?FS_\X.SX%E$]/3HX/+\\O3D\/SBHMK/+@*JJWUHDF M9=GPL4&->M2)(L6OBRPDP,^3=\]?Z7H:A7,A`(M6A)S2A!$L$/[RT^%/HS2& M-H;9.GH=D$"E(JZ@82YNW+WOS%HT4?N]WOA+:/SYP%3!%J?0Q9$&790"/:'( M"T$F%Q9BM-Y12S=\W?"+5>CH6*..[F'*=?R\J??P74S14R.M/;KB$ZW0UXEV M??T7Y!]IT^7?D^_\G"#^#%^3$88#+KGC$*I5$ M,EW\QZ^;!Q%2CB>$HO)RG5(<'N!3BE6Y\'E5]*A:]J@H?%24WIF*4R=^RY29 MQC_/'&>1\Q'Y25Q^LTG,XNM_K!HYGJ[.X)["_/(=X6Q#+&OW_M5=J,+?D][\ M>J(Z(0^!D)=Z^ED7Q>"N)B`6\00$Q,Q]9A]SJ(AB9#)\H.@MC%&65H^><:`S M?)(/_V"'CP_'1_AL/RFO5N%3SLW=N%#>.GQ'IZ=X0:V3%1S:;5*BNZA*F+*( MO#""*2$[4]`R/!3'W,]H@@"--Q]]1TFQF"`-%I0L=I!$6$+BV9T<;ISKX4;] MZEAY*P!Y-,[K\BW[T/(QQ@A#&0$)+;00TAZ8@' ME6)\2&`[T63#B1XV-"X=,6<62@X[."$J(/%4U()A@F=LL$KYW+-"\XQ5%DKNOB9_B@UT&%7BR MUI$\!B0/AT^3SH(KMEAHHE#;^GJ-K<"N8YW)2MIT$-E.BT4KF"(K#ROIP2^I M)+N%N:Q@<\%V!M#TWM'DS6X<-[J>FO<26,FZ4C-K;K@,$^0,QC&CEX:IA.&1G+)[+4>*([V' MX4_.$A_Z\AV#UQ.;K&L>Y9`/PSGD5&R7T,<*'""T"229&.WIK>2&@*B*;0Z: MCCFKH3SIQ&A):1\E>(54;$_0?.;]C#Y0D#)FD/;$]E%"0$[%]@1=0P3OU,$: M2$\`I2-CV*!F[=@JL:2IPZQ]:36$-\OXV)[8>G;P2VVG?;J")WO(L)X-#%%E M.=&9-$A0GXEO)00EA^T$$17=3O8;QI7*AGGI):".9 M<=P05&;[\,&44+&-2]-5CRO7]7)!GAS/?0ANG(67."1W&T)J^Q@A(JB='C7/ M./QI@-P[)PI@,HTK#[/!MMZ;>*1)A9W1/KITE-G.K4L33>[EAWW,X)31QAT, M:\G6\=B]CM\IX'=LU=*TD_R2K@DP^*,_]L13IHUWE'B3]2*%&8CBM$L@BM&? M:I7]^SXPA:PEI^^'GQCH^S"Z#=.W9)KZS8O7C*-6D3*,&S$ZA[7H+;6D34SU MNJGFG2MTTG&4`>IF>[,DO8HQI$A"SW(380\M;TDH,BG($*!$00@AU7ER6(O%5A"RKH! MT."#EMW%ZM=X/,T?5>7<51SQAK=;US`:3T=%'5IN6>*:5ZUA;!^(J;58E!P? MO^R;.1&]H.C#FZ"8'$6`D+I.YC,@\XG>'LM02,V*)""2-4O\&(:R4ECB"%U- M-&0-"E5.RYV;NYZU<+ M"PUSYQNBCOL)UW?I?)EK.4`SO+*4J>??'"\8!WB9,9Y>8<^IS=,90JK!ZI!3 ME+Z./Q(T)NM^`K08]H2X_?#91YE.8(B:X[#Q_VKKR")9A\B#WO+).G33O"!; M/8!>3%#$T`>;Z8:L=#YA)(77TKU$6PF;`_0(ZU*6CMB_%I&^Z-E(-6\]L4$I)";;/TG);5`WETSD%ZHZ=>M7[:-Z.7?=`WSY?C.%.:V8W>8VF M883R=*_.%XJ_>4'FNU7"!JO9>BFY*]DWE+R'[GK()*T*MMB"89-4+TSD][V& MMHPI\"GZ^34*$-E:3$@]?"+QB41^+VQHDQRK\T"*/+[I$]Z7@]Z2)/+>T@3[ MO+V&^)8P9`)9_&R]SUCYJJBLKI]ST,_IP"BW%41*QLJ,(:B?L;=>/,E10^X: M-%BBC*\)9=DOD[?P\C:)@BV-&-)QP'\O`ACQQ]/6Q.6 M`I/,L%(*-Y0U$JC08MA5AY@")POM]W5`8*9]L);&4"YQC4!L04H5R[Q3HT.M MY9W$TN7[VHF]">PS;CT_A=TM8V;BS#UD*O01L21)\X1`_XJD;1$',FZ(1[LL MT;D\X^C01\==%LLBN-@XEXC,ZGTXV:GDG6*G/(04^!]JYRD#^6Z3HN7\ZB*] M`E]'[=SY._)F[QB^#^A5,_0]G;^A:#QMW*+(\:$OLSJ591S/!!9=\@0NI\_F MX;WQI)!!ACHF%X#)F5X2R--L3]:T(J-TL:4IRBP!E>J$SG';3;"4/>\$L5&Z M?%HQ3_LE.G*<%\:%NN-N%^JJ]?W;J*A1;ZB.#G$8N?+J">94-.T5G_.PVI\E M,FYD$%)-/7@34RYSWS19-3Z7\R:<+\(`]YJK+X]DWJ7F,5>O9/50=,HM(H>* M-3U<5KF[_0WA*8F@UD8Z` MJX3F$J#3NH\N%W'\-R.2KD0?2#F%FTL.NI[;"*(,#TEKS@6"#0:2`'<;_+X<;=IA'M+WL8,EF?H$I$WR6R$D.SJ MTXG<[.SY/HRFR$O2B'C=N'>Y%E%,"1061Y\7P2H+TR.+@UEA.TP\LOP*UM': MN7;E_G=:7,AZ#0FVA@RK-R<[,9GCVSR9XI\1K#!B+RFCN>6X/J-).`NR4F@/ M\JBNUA[^:D%*08!,[4PG#`09"%>3'"KL5R8VCC:RV\.\7A)+>FYL"`PJ8E!W MIE`SO_4?LIE+QPRR13BT3M.4\UZ=A>XQMC.))I/#X?*&S[99`5SXN"`=A_* M&R=^O_?#S]4TQ7"=/.GF.HFK&>7UZ'687,G+[R?9DD73H@*WY"D*/SS0S/7R M!V#^$*SB#EY-$N\C?\N/+IIX0;5N3"D!&`HM"-58D,D2UQZ.JW/#5! M_Y+T*;)\5<@![?N5BNT2+Y4`V6Q6?0VQ$3*8>#ZJX?(:RAF(5%>[.[35@J19 MEW0)T>:K$;'$63B3. M7S8G;50XL^_91]B>],'/1A^7#.(8Y+@/H]LP?4NFJ7\UH7*0EF7/NW;>"6.F MU!M&TV+NMS!T/SW?S^*])TXP\]Y\=!7'H(#YPO$BK"4"YWBR[KG7SKW.V)GE M3*/[L<;+0T#ES@8W2+\G\K(!=^W^R0_)P%[#G9SLF>",IR^C%JC]'$ MI%SZ@FZ0]T$)LL23U3@J]N0`#ZDX4>A[#L$8YHSATU.$8"7KEE;SPE@."]YQ M\HZB;*U+>>:K0V&[R+G.N/0]F&"P\-P4%I:=\LE9=AK2BGR[R"T>"!3$IC%P M*`,DHA1$\9PWS\]6("(\VLBZHU3B0<'&PX4F&.5@#9MV%!#OUC+S[2*/>""P M\42`WS6LMU>O<;12ZSP%V`_ MJR1A8J>G(3_:O5<_N\.TGIC(,@VTKK8UC6@$2%8><'U7VY2"C..=I-6VJ,B6 MQ-9^1HMB(!]/;]$;B2>;R8QC@22M-NG");EIJV=IWJ2KA6,5AD>\FX#>!F(1 M;PIQY=T=%G6'P\8%>16!E_0-1`2`@?B<`]!FEMVAD3`*BI?99WHW=/F(C(.` M`:XH<_MG[.!:T1!Z+MR-O.DGS049Z%NZ(?]/%GK2!X#DIJC&FU]3F.B M(>F6#,S7-O M`M-$BC".:Z+[_=["*C`@F<.;*^A?4;2$KD0+U\Z5UU*F\$@I:49K/HVR*T39 M$:;(FY(V8T#J?<"S!.W.ST,S`C8OZ6*1_[7^^2&8AM$\5RPKA%?_H@<_'BD# M0=)5T/H"7(^+9!YR%[^&0?2&7"4EJ%7,);4@^_ M*D7VFMU(6$?I!%`ZVB&V<*$AR3AM&&?*&X>K`^;`76TXLVN(K$-5WOS&,4SX M++67I)*>:.@S#1'D8\-XJ]A/7X1)"B#>SP$=U\3%,?CZ748_G'MQ%XKM7H6 M:3?#5("C]#!V!;ZBX/TX')8?QFF$7KQ9X$V]"7;4RZ_J92]<^-ZD8IVF!NP_ M/(#_1C^/UF7BZ/WK8D?KK@G5L41OBL3:>E`Q:8A?25/4*VKF&RO\@",.7 MN<[T4V#ZL>9U+E-IM1"$W854LN794A^F!Y=F=-ZC9N>MEC>J%*@C-G&K:'E` MOT48._YO49@N6#U9N!0M89AK;6$$IU[KB]7Q^Q9KW)#0D1*U(,PJ,%'VJD@E(.M]NU60L8W>ZD MV>UJI6CH=.6-PIMP_H8]$#,]TWL8+0OH^.3B^!`4C(4]`7UK\N%I:23_I,N7 MV;A>*ZR8YM3:0_+A]N3ROEO;_4%&CSYM]NBRM!$4-UJ7I\<_LOT>'Z.#,_.5 M9#HZ/3\Z.+XX.[_4]/8)L:7\?5VDB#KOSX#W)WI[?#=--;M];Q"&V_G)49AY M9_6SYAA0%IJ-`>MB1T6Y1L7XKNR0&.."4!DKYIV?P\+GXOCL2-,9(%>K6:.$ M6"'&C1/]-=<<,R1`,MQ1XQ8ECN?C^UXP;#I><.WX^`;&RSM"R>8S#8SAX[S% M@I>7GCV+FY<_*BH8936,5E7(>0"/+0MA9.B07]*;?>PJV9V[3U'&=/'.*JR\ ML2'VZ,5@S.?M277,T=66 ML*;BUK3&=$<>-51G47YIAGS$57%"X^Q;E\V^E1P[4/=7;$45UT.RBPN(.=Q)\24"F\:*T]C\C M`,J;),C-?KCZ="*7LP,?'K0<,>%"1D7QV=9X74'Q8U&%E",9#EEHRUJQ_'). MD2I5TD^1VA(:T_4ZP[\^/^*6;^!][3WTH?TOV-Z6'K:X?%3*^K=X5)2F MP\=IW8XX;P46GS%+TC.M!NF+4U@37!S"=EF3_U9K,_EG3>[\QO3C'@IJSJ+] MQ!]P-T>SS)#N)`YG_VYSSL@+&66EZ.!^7O\S6F"WVV#&ZM'$Y%HZ[D9K!+HL M.Z=YG96AJEJ?["C?D+>B=_.%'RX1*CS*\8D7[Y*VQ7VC+&U4%#?*R]-QU[OR M:G>VWDJ\"-6/\!B]5J"$B^Y@%YRIG<4Z*O+EB-BF=`,=SH'8.=>4E[57-U]XK]N<=CB,E(I M--L6UXO5,YB0I!093D3*T!(?@Z>)K#%#K!`31PIQ5=A`%J MO`WGCA=P=]95#O.5S-`33T^F2ZML@;QE6J1Q$LY1U!#_&YJ_H8A$#7HN\^G! M4&X+/3I(;`M%-D6&U1C*0@3P#ARK#`,@1I_)@2XG):!!(RR!9@V+[*W86>MH M7`(:YX9IG:XX#LWS2JTT>LK)%FTL%?GS^$6]:'F*0UW%Y=G1Y?'%^?GEP>&=/"^FS0#.K$X\MVV;^R>:][V M[1H%D_>Y$_TAMH>K93-.X0+*XMK(L:4=T&YN)8S8EFXCF_DZYU$;C_8YY+9E M^0ZS*7TSMTHP`/5SZ*U%_70);5&TJGV:B43H-?;3Y=SOTXS5.EUQYNW32,%V MM[=3>TGG,%QZ_T+NWU(G@B'*7Q9A'AV_$K*8<_?6& M'D,5FON@7+@4'8,#M9&LX8$OLW$#1$?U5H>('I(K->9L,4)I^A:C?Z90UMT' MXHVKOBL$?;/?B@DZ-'>VE\D[>1_X4.C*]\-/'![M/HQNP_0MF:9^N+,/GDH]Q)3TI+-NIE!"LY8_487M9-EDW)[SV8YM&C]X%<*DF8^09.CF[R27H)53LI MY@O'B[+W8Z/RS9?Q%`>KS`#($>&;=[H4-73JR!*Y8-/EP-F$@YMRFER:*0?. M!5Z)2GO;PA/&O(,%9^Z!#H&`E`?097@EQ)F#!A`#K)(^72UVHNGMU*?G=%Q[@ M&"3@RS10(O00KB3#T*VGJ\#9O#1H3SYX`@B(5:I^Z+;*EW=`\=J)\<)FO=89 MEX?1#YGC/,QX6;A$JIFA0TD#)XPLB4LN#=V:>>=$`4`7/Z$H@X9O-&'D&CA' MNDA7\J&OP5+_6>V/&(VGQ2D0(MT_JR<:N+XYA"G5.W33X[WC1=B9$@2N7)H` M:-(LQB!ULN#*6T?OZ/3T^&!(5.@N8\F0H9L3OZ//"F11&,#'":I(SS=#B!8S M<-Y($;=T^I)OI53_9&.KIUMVTY?OJL/QP='!<>.IQDJIHW6QHS_E!6OQ/FZ7 M%):.Y5G$;U&8+E@NR<*EZ'F4`^9#S&%:R)EZ(N.Z<4=UU1_78$K($6U$ZPMD M*Q%JST\&[I7K>GE3U_TNOE[6L8$B_-0M7C!HP9(2\>=6D-RD-+ M:AR'9*IMXX!&!`+M&I>\4GIDQ.UI)C2.&9UF+TZYB-=:Y+SPN+HOFH^0CV$< MWX-LK:3.I*._`]F].'.52M?/1D^6C8#2J!NZ7BY<820TI':8P_GOD6^M)^)6H).F%:A:EE;33WGW]R:+RM_K9X;2O#-1<\M!WKN<:AW#?4NOG M%4S%5PYE8>5FR>D]2:"UTVEP+E65F MT;]6I6I=%1'OA#*61ASYC+H(W/D*L+G]F5MU7'>`-:U4E/=CRD56H>Y\UNS. M9=%9=UX7/LI+U]JM*5)S!]\5*@,'A;L\/[XXPD]_G)P>G9UJ.G1:+XO*]O,O M+!LYC.OS_75"6TCRR:_P25I=5,EOI:+F",%-'68).T:E;GA8LM\H80BGE9OQ MC4OS:8(!GH=14D2O*^[!".V&95115\4)J.+(7FHJ`VRX6YU;E#B>'X^G-_E[ M7C4[>!%82&BM=-[B#)C7D;TRE]4519V?)/7L2!/8']_#]]Z,[@\IJ53CNKVH)JGV*FF(6#B[W!8-!T@*OX*@Q^9! MJ+0ZQ*<`\;$]I.N/A*3)R"2RW4VG:(*#>*R0?G:2+,AZ,`%@V.[?,HJTFG:2 MX+#F?8,U,C^":.5+!;!20%#V?,)ZI\! M2T"F/%81'NB?86D1>9,$N=D/5UA^H77YX4%S79X5-2HJR?P2UM44/^85R36S M\XA&,[.+Y=<[1K3'H*I)@`=7+UD*CA5="S9FS.A,A?;A0BH>%J[*"?C@;^.K M-'D/L\?!?\#0$55`RT*C72_OOE`T\6+T!,I!STXPZT_4WA7O&)'5X&7ACF"- MWY.SS!P<,?A5_:Q?&,6N[8OUQ:4NI.Y>B?T$EHR-A5N(]LZ^`?Z/`-:]&8A2 MUPJ"M=A/5]G@2-I\M/%5^?:CN/8:S!X10)-#G,77?W(B$#Z"V0:0%;WR>7C8 MW(2L:AKE517[D*RR45;;J%J=W*T(OYBT#4F74O2..[GKVC5@J5@>]S%\>')Q>GQQGQD?:@ M&FPN\`]"`F75^]89]*T3O594&9JDC4-]L1GZN+.$19\W"[RI-\'7VAK!7PL/ M0*YQY^3@\."P?=Q98O?E2D6C=4VCLJK1GXK*M`P\[+BW&_V+ED%.6"%00G<>^\+?XJIK"!GL)@8@D);$M@H.R%?A%&N M-+Y!@YK'8H:(RZTL@E#/(YQR$'P)I\DG($A^/Z<]I85*%I56V:V5K9S./1+> MQ>E2A#%DD+RUD(8%D2I2%/Z$(OQ&NC/#?I+Y`T]ED/`VY5*2#U&1=.0WE"DJ MNXWOXSRB#Q0!`NYUN@S39/P90.O>O<5#`,U$<3*>?D>?#\$'?`PCDL%!K!"; M>241$:7'&<=ZV-82X.4$^6-T[\_N1XFP-6QU)V@6\R(%&P.FUY MVZCG]/8]Q4LPD&N&`@S40_$P2PK@K=]]:IOI^'+:3):^,"A8X_:8_P@$*!/TZLW1E>^'G\B%6?\)A`38VU@BD+V.T05@=&875?IB4?#E MU(P9C,"73!0<+1([]-^&Z5LR3?TR:.2ZLP"&-TZ"9E`[:AU>NI1C/8.D@5)0 MZ!3IUQ*/AT81.?[ATOPG>^T4.P2/.H_!A>'$>*=$I$SK$+[!$5OR#-I56D M(3Z\P)S2>++N!(VZXE`:)P_,(!1AM;TA4_Z(#)ZR;]Z=:(;:7W%N6VYW*LAF M`DE&I:235<;N\LVBXF&(\!KEKXD#&M/KY3>4O(=N]G+$Z[L3O#@^?B@&M%$^ M=I0]7![&)"NXI-)M)NDVH"J9:XCAG/ANC9M.$MQ3\2%S&"`LW=_#Z`^HM1K4 MI&WLX\U;A^<2X#FWADG]@2AYHL;>+'K\X/CO!Z\FH6(30G&#"I M&:QGA+CT)0T,L6I+LP9DXN?!7;.1E+SYWTQ9@^GPY/3T1.?;/LKV^EQBE^PP MVX9=6E*K$;9RTP7>1=PX_B3UB;,)=V:;>2$!B9(J:FS4F@:2OR-O]I[`0BUW M9R@1NO7\%,=9RR)\1"!244G9="Z>@ M!:WQ%)404QU0)5VMLI,3^G'>@3^-1$DV-;5W3X-B*"FFZ MN'+_.XV3EBUBS])VEGX=H2E].-48Y67[U&4]"A:\(`T,_EEX._UL4I@M6,#[A4O08C[!-Y`58DUG-:H\I!^Z5ZWHYA]<*C*^7=0%6 M?A/M`K<%`]QR[?7>>@:]57.0E(X$JQNU]$%G;GQ"]:A00G%LIW+CR*R3B3KZ M!5$)'-WB5$^W$)+ONS.GQQCI6-H.$I=(E29O98*J/78%8>_Q5X#[K\CQD_?B M!B;Y[CDAJ7$V'"`3:-5X=IV(T^646?OSJ(B\?HN##YL@$7_WC$;*SH1U,P-1:@F4JT);!'1 M#Y=V31[T38Q4:R@)N.8/<2DMH8#Z,?:1$)]*0PN,HZM9,YQN36PON%9^=^$E M]#?#U%!2[B!YZ.K:6'T+H&;C$OR;%V0-6$6)*L-&K7&Y7CYE2B4,A`(EU%$] M!U0U!VTTAXNRT#0KA!&F$'+M_?;L,<,8Y[=GP)`Y5+^]^JBY]]O3[[=G`)EU M,M$,OSW^;J'IPIF!?GL[05PB513Y[;&):)7?G@$" M%Z!(33&[=G4BIVM"@9=C#X<)Q\?7F#\02%"$5(_)=B-"ZATD'%W%+6X8`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` M)!U2DJ['FT/05G3&40E._2GZ_%=^?G8HW&IZRL)#:6A966^LMW;/[!UR`//. MB8)QFHS??&_6=AF]0PG#9XXLH97&A=4T=&$,Q],;:+N7W#L3SX?&/"%HE>M- M8%&+87Z*O&#B+;"@[=9J@2*&3R9I4A=L.K.=37=?"Z^()@Q0'PJ0:".GW=SA M$;:@S+D9E&%$YG\(XL3Q?8P/->1^-5U=ZD.0^G)@*A83K5#HA4T11_!Q$A8\ M2O/+#+$7OX`XCCL.?G*LH=8TJ0O+94'2FAVJFY;=.]%<;FT+Y9DG-NAEIS#)T9?84L> M&'+TQ,^#%S0)`[H2)@)+ MA,JPASS]Q2XY-?2WNZJ7U]8A$6MK]9MPO@@#;%H0O2K7>*6K?E6N&@*QK'&4 M53E:U[F_1B?![6FEV):U5WR]K/Q%O6@G6$R]XQR=GIX>F'$GA/LJG@R!=^FR MG@E*EJ(T+BL'4?QAJ5S^=3X3:""B+SYML^75[@^MYCJ?J>ID*V1C8\DCI'8= M*NOHJT4R?Q\GK*L-X,/V1GDZ!D9%13/`+=8`:@CKL/.1!A4"Q0_TF..!:+J+ M[$Y1LA,T9OER&^F..&P2R1)?L5?UWA-@Z$23CL-VWJ#1SC>SO?BMY:0L9)0Z M;`NSE'\"K366<;Y`XXW M?@A0S&C>N(W$=?F/0?[#8=-!3%*E+M>R-%UR-9NO[_TP;+4E-E-9IUM.$96Z M74OKOBC)(L>F^#1<<$O%F]@\9(BM^_` MNLZ][X`\IS.&FYFQ'9SWK)\JB!);KM1%?47,9S0)9X'W+^0^N`"2-\WN=N3. M3>7V^RIP'^%K?"',0S'\ELXA^88GU#AY1]'KNQ,0.+#]!@R6989`I3T$O[*! MM3.0Q&=E^$=H^74/EN?Z45+V.L$@*%[V_E8@R0]>*:IM5VG<"1<%EFZM^X"6 M'1;TY/LPFCOX_D;H>ZZ3X(FL]B;90S#%*;KL&$[X=PQEVZI)8/<0CK+FC:KM M&^4-'*U:.*HT<;_!L,0Y^03ZX-&PQB8I`@_+4[6G<[(!2I:B-*ZC+:+XYK[* MO27G9`-H(*(O/FVSY=7NV*K(.=E0=;(5LF$=X!%2NPX'X)QL`!^V-\K3,3#= M.3DN-P3/Z`,%J8!3U69.XR@@K"LN=7.)K33@LT)OSE*VXNG*8);OO#@=3PBY M;2*&#-&5NOHJ#*U2RO@=);ET^+8_?G8V/WM-0>KUDZ>"E.$J(U!T0!=97 MO?1J?U.W+\':2]UIB@E`HC1ZLJ;8+K3)OH95AS52+;]-)),CO"SGW587\S/U M8U;;X(S]D."+N/13P^$>)]E+X'Z:<`\19.W._XL;7X(;B:9.Z?D`0[)7PED0.(>8$3+3,] MPL0SGKXZ7S7(^6?OK3;+I@YB-*:R',+I:PWE)_ZE2T[5&^>[$V'P/I#8N?WI MP>'FN7U9^@B*'ZW*'_UI58/F8W>B0Q+C[)TCG]X#>&(#^0[>Z=GK_0&ZP^FQ MWC&&6XWMI^X=I#7WM)THS/62\1@\1T[C--]+B4U.=(5@@'1@OBC/D=,X.G35 MGP`3&-)K/]EH,.)3/SF6K]CM*;LF5#"*(+,<.=D;C"+.MY0,=`:.<.X@R M_!:1SRSHF8Q3>T<]"2B<++?B8'+:7O""YD^\7(F!>S4/H\3[5]ME6L:6TU20+"3R_/CBX/CX]/CLXN+ MTY.#';)2G4&'.C%T%*%J2);AJ@!@@)8*^88K`\C02XD2#%?\=-!TOK=%PY4! M=.BJ/PF&*S83AK1[;>S=6PTLUC\B)T7OHNP_S M111^9+$#Z",()8?%!!&56H'WM]3S$OXS$MKI@!4J%I5601AEHS8ALL]"#"#) MMG:D=`1VZRS$`+5WU%._LQ!U&XRUW>)<#V>N)I-TGOHXX%#5V@^??=1B]A<- M6B>K>'MYJ!2AOMN>RYRQ`9KA]IGR%!01`W*<.5H6>[DE++6L'5"KE_CV#O`J M8?`VPY5V=!8_:SJ+EY5DQW'K:D9Y/>8XC5/`J$32HY_6"9:AY9BN#)-'/8RK M):IW@7-\B*VWXW=25>VLC2V?N2=JS_C."^7<;/6[<7KC@+VI*[HXAJN):DZJ MI#!.5734"5JBR&+)H<,W+_#FZ9RJUEH:,Q5+:5M3M6QY;%&N\\56;C6-#4&1?A1%\B` MXNS]E@D*8H+K'SO#T$C!K;Y-)P]A$+3K7_)6C^7;T4Q8A^4"4#D;X(S"*1?1 M:TM*I_T[\F;O"7*O/E#DS-!-&.-769V%ESC^CQBY]V%4OM:*W!LG?K_WP\^V MSMRI(',52=?)1A^6)[M2#PU--AV\3PJ#ER2<_)'%^(K':1+#X.DVWSGGR3)\ MSG264M(NQ+"[S.6AX<-\X7A1!B39VZL]L3V<$)!/DJ^#H6Q@Z-\^C8M-_MIW MC/?$I3#,>-/4?_2F)"<&GJSVZ+>SM`I\NK7W[H8W$TKNOB9^BJ<\1L_GR6H/ M:SI+*RD4MF\*85;SX'BZB0DWX-1,]E"F M@YR2XC(S5Z$Z?6Y7T:S+--?+\K1)T`FW$3>'Y81;5`T_K9->+T=%];OFF5M& M;#DZ/+ZXO,!>W[J<&%:7M\KV\X70J:6N]Z=+Z$_G>L>-_KIHL7(*R&ZNS^AJ M1%V]%'"C1S;':0VF`EYRUMDXO%H(F8S3_<] MM$=T=Q(3WY:#KESVMLS,.DEOI#./#[U6''SR&17RH--QAP&*XH.:][1#[A`./=\+75C`1(DI M5J<5FW%,)S]7E/O?:9QD?N,,Y;=GLHX2`F)N)T[SP(_!+:`$AWA]3\$9$2*$ M7Z'5/2T<#EOC[1))BER63PQW05/-1IB9UXN?&R>*EG@Y/,<^8SB"RCK("M5& M+VJ//A:U1U?CN9>M'.7-S+)4&CJJMA2GWRQNMZW7IR98K\G."3&?09M50*T_ M'Q]`?[XP8X#JKC&:C;L3'.8:.RGB<-X5$BC!.*KT5*N(*Q`?&.9&CZ=()G!W M2+`4XPC35[]"C.%&1+MAE'1?"+9XX1Q%,!(_9PUQ_&>4[__B=V]!NSC$E7-( M].!6YIHB?9$PZZH!@2.OD>,B#`F^&Y7],7>B/RC4H&;8!4:(`V!6'!$"$;+C M2/:5PI9DNZ!T7K$5!(C7OO3X'@:PS5Z@!%W-(L01+)Z]AXL^Z; MFL`+Z3L33IF-.CJCB$XPEXEO.P@%F4<(/OT);3!$9+?WY([F19^#YV/P.EP] MJ.2VAT]]!%8<[/M4#X%47S@8-%TZR*GXP$\32\R:S#0?(NJ=S7;PO/$^S5ZB MHW9&T:/%DSY'BWF#F">(L>8C1*$K=HRCQ$YEU0ZH+H_U'2G2>EY%B7=?"VRC M^`Z\>?U$_@?Z%@;)>X?#(XY"ZUW[$+KVI>8(4M(T+#;R=81*^[F!#F;^%W*B MU\]0"B&+LO8\[(20);[9'0"!ZL5#9U!+VU.P(T:6O*@J#LE]F!*?:^Y4V)Z" MW2"RQ/K>`1%(*X^!D';/P&X06?*VK!@B5U-HKU0:UDK<<[$'3I)"'!E,2/([ MD/1,>UK1H9`5T*CR/.26S'B%E6L\Q?&B'2^X=GPGF*"7=X22JTD66K;KTY#G MS:.52(+'#X_$!)-:A_R2'K(/DLA[2S/WN]LT M'\KN4^R;-T&8IT^90;C5I9$O:YW51Z>G9P=Z.GAG%55>M^\NL7;3%.E9E>PY MD8<`NA$&XAEY\[<4ZLBB9>`78]8B@\1M/!`KP2(Z2!!PZBF?QIY%SKQ],!,JPB)>R)!\H`E,OYR,X,UK$15ZB6R)'>4N!IP_;]$BC#W2'J&6Q@[]\XMFB;7BT7/> M/-]+EO>9EZ\WQ^[\Q8=5<(1BQTR@@4@1=K&DM^3*+`Q&[!/7?A]/$8+]N5M` M@5$:)^\HNDDCK)\N?A_GS1"G`IO)J@M(T;91V;C,;21KWJAH7U\?D`%N/.4, M+@6TJ\4V80#93&;7(,$EG:D;S:+Q+>O@[`VQ8OA;R59TF#:V=BO)#BK(!D#) M^SP:!XCG)F=:4MC!!5[!3-U+MO"W8DS!%K66>!X".>W0TB]??P;"%5 M1+=OG1S(">O`'`,PFMS%I?1W3ODLV5;6%_SE>I^'!QPY[2)&5X%E[1W-/&-< M[QWAFRA%J[VCZ#:Q$7FLXS:Q:,9JF[C?#0I?4,L1?(&&11YB#`/MB>WJ^0(R M:M\?RJ%`RXIHM?.A\X$CIUWDZ"JP-7O#HG<\.4MHD/_J?'$.&2T9[&*&H)S: M-Y)2Z<`P-3%26TD$+B$M.99@.+Z:_#/U8@\+D;_F,T/9NSZQYQ:OLUPE]XX7 M_>[X*8,H?8JTBT[2D5#PS*L^DV8^XI9+HC?8,;EM:XW3'JY.F-OGE,S>0?T,&^JNV[:F-TRF_9CBT2I'1DN.`W-&^ M]+.G!E-N2VJ^^BDJ;!*`6T1+M/_LP$Z2,HRO?C=.S]V';KI,E+,;S=-OUFYJ M!ZVD,$Y?=-0)6C*Y`Q)\"*[1-,3A%6%K@8E)?KZ@-:&9:J.T;:TX0:$&\21) M=D^90Y=MZ8:N2FZ9S'I31-Z^.N';Z;0E-4[WW6=+;O$H9]R:)\Y-$:C;G/;$ MQBF46RULC9J\QR&,R\_H(_0_O&"6K],?0R<@#\[$Q'613T'D8[.4RK5UZ2"C MJ6K%VS:Z+NLI+%(@AV"FAKQ87[-]`B$\V$"[U\M';%J/**]WL7-9I-V.PIKU MA!?IM;;T#=KI!3C:_JWWX;D@5G8Z0WFYC9[%(L5WD=02-[%'+T"E(>W>F61. ML[1E-"&Y<63HL906$9'"`MU[HQ8Q\K&,OK!F9#-.T4+JXM,V4UY35V8O*`#6 MY5%XW+I,E&&>E6D0*F?J;'/([R2U6>8P2>>+Y=,^V=.5X^E+$D[^H)T9D](; MQY,>Y\9",E*\A#7;5*K-IP[[S83&:5-,)TV=BQ%R6$<%SAUV=*Q!86TA`WUD?"1\=PN(74=H#,`Z&2HX[N(A,0+`'("3K:L M91Z"282<&#T$UV$4A9_88.@LX,=DV;:`$RS"<#72E;&QBI,ANM(UG:8G9\>?-TSJ)4ER(LH90TT97<+-;^(.HSUB!^-,`%=)&++[R\AM]1`E!XB>,? M$MU=Z-DL(T\G<96:D$]D61<6:.)-/>1>N1_X4L.WU$^\A8]^Q,A]#6\1MKT" M6#A@?'SUX7A^<0?_!]Z9UWM3JQU"7O&64&HKL"BP8_>@GHKE[CY/R&FLT1)8O(IN)BL?=U: MQ^W:B;WX!<1QW''PNQ-Y>(?WS-N+B;DM88L,J27=,R8M5(591!@;RBW=:WCW MYB6N/K?M+BFP_@L3SUW\^Q'>^-\]= M1=K(T*M`F^@B'XC24':@0HY*BUAN3?P0@ MGUL:06_"^=S+$+I'Z`E%$TR/&?D5G([E64)+-3B4U%-E=#;"E%/&[<(;FLP? MP&6RC;\`R^C54_"23WUMTB0^79@SF%6QN4TCV-NTO@K;I0C+.-5;]))5AIB; M2;>#L^/CM5AM:Z_--'5Q+T#"#LVRQ+(EDM8Q%G44NV6.,.5N2$V\8 M0(MB$*7P>'QY!PW$#W&<(I?D=4'/9!EC.@A;KJ`@$*(E91VF2X#I?,ADX)6P)((:([&L/?"/`+^U M1M)J6Q)+U,DM6JE'0T(JD=XESEFY)B6>SMJTV9K0)IWR"UAJUNR0#J6G&'Y@ M`$U2'.?Z;ZD30:7^LNH]]AJ"Y-2.W*TDF[@A$8&2/&I,G"OR;#5$^_J-R>JW MHO':CUCQVJNO2-9_VP=PUQG`_>0`J'VAMW/+"N!>RF)N`'>940U-T!RO1EKL MR;SBF1N]77940Q,4RJT6MD8I$FJ_>KV]J(8F*I6BF8VUDYB,IJJU5U3#82N0 M0S!3HQHJ#FLW;+UVD=22-W#E![PP@0K=5U(B$A+[NJ[U4[GLY]AQ&:XR.O#M MRR6J:+)FT\H+<.LE\Z5^E=,/F5I26DP`FH1]Y^?+G`O>U-VOT6LDG]%B=22_@0.M&E_ETD MC_E/TD.=EV*V@U"T80UU035%#"8Y9+$XP!=!6Z3"-SY M!J?U?I+)6K)N_SWSAP"^1*_.%XH[/F=^V7S./"]TE)5JSF/F*U'7;66L$Z@Y M=(SE=],IFF`H5RW#"^%G-($=%8YIDG6HY!X!&QT?KX]3:,BREI@@JH22C>OS M'`JO#OBJ(+!D'?$CB`"*6>#]"[D@[C4*T-1KA#ICI!XZ1T3$4C;O;W-2@/^[ M^UJ@($;7R_^$"3%VO2P:A>@,F:5GJ<"WD\OSDX/CD_/#R\/CBZ-+37:M MPK1;#(H-&4C2TW/5>]/1Z>GY@>:H_0JTU1Q;NJ!BR=Q2B)Y9]&"9_0@UB9*) MGG>W*=4!&^V;5EEV][RQ1:-\BF62N_JQC">(G:< M9YTALN2]2P&$6=8,=@D[RK6^"%&BC@_'#%AV./CC*HY1$N-.5X3+%3Y;O&R> M+=8W?F5M^.]17M\(*AQ5:C3%;,@FQ=H65#<:<5H9>U=0T/SLY/CD[.CPXO#\ M1---D`:'L(&E^*Z0\AF8&WT@S*ZKR21*'3^^\OWP$S\5<1]&MV'ZEDQ3'WX+ MTV9$?745&3?T*:8'><95C*GVK2OA6*R;^'B"@I\RO-L.S?J7NKO$5`F@9?M< M"CI5*`"ATG1]-U_XX1(A"H'55+*[?-XBGI9MM5=(C9-WXGNP[8GW=!/`A;AG M-D+YOT5A'#.B.-'R[*D@#H^RK:TV+E5VF$\1PE%S"O0Y]AKDO'MN=8>I[\-@ MK7=!C!BQ\#.:8N/5.L>>4:+@2'HQHD%U&'\AB@/-QUGHFBI>"1,".(]Q2%`'6R?/(='-?8Q>%%%]38S[P%[$G7 M$RL%CY4903GNK7`6,1G'_7>K"6["F)N<$JK:TWAKJ*IX3,T(QF=;,.9E85:V M/1,[(23M_3/3UHRP5!;8O;U:+G_B?T M<_]ZQ?A>\:KJS!4`5_Z_1NOJ]U[@9*^6H].SPY.S\_-+70"!?9*;OSC]YJ-"']\0]N\*W#LUCAUC M[?8PU.X3WV.0+'=FZ]?-LS>NQ@N2ZUWO0G>,A@I!D^5%,("!-'.N62/39\FX M650=VA.`]LAF/DJ'JJ^?@=$L%+@0Q%_`GG%=`%+FA[!-"^'-NQ/,4/P0$$)? MB-H%3^EVP:(Z^'94K3"S"995[FV!K!MNYQ?'!YK>#5$0)L:>\::FG>9X(X*& M)#L<--4+\>7:*+$KME`&DQWK=&FLD6<>RVES%[C;G994R8MR1W@GAD)@PLW3(K^?M M;UA3L1YZJR>J4?OT`*BM*<1U9Q75'^YFRF;NFV^9>(S'WFIIC-&=`/Q-G;%% MXE"9IO?0VQVNKF``@Y5WMFN^7J[3%(_/9@*OI0Y<[)[XW9G3WX53495Q!&)S MH:7/;PL8[;>LY7!V8U!M?22+FM8XUFR-`4WR\0-D"WLPII0):O6[>2SI,CG1 MQ:'L`#1/3%F[Z5U[G<(X5=%1)VC)_K[WS0N\>3JGJK66QDS%4MK65"U;'EN4 MZWRQE5M-4P?C$,#0'/^Y@W*9\BAP0=+^''2YT*#,HM4DQNFYTT3*E(CB&*1Y M+N7:GM%6CP;HC`D_66,4B;0/O:1WG#_#U_&4TD/0`6C]NQ>@CFJG9;5+[\*2:O<'KH[G,9K\,@L_?G61 MEP_E\&%S!(>O_O&(9HY_!^(ERY8)MR6%<4H6FF]Y!5(0EHA7(WG+6F?3S9^- MT04OK'5%,$4Q=2C]:^B[7C"+R2-F/851>F*BOC$D$ MCZU/S`YN5!24B^A;J^5!CW`^QQ=W8**^<19>XOB9+3LN0G2Z]V%TGR;8TRR. M4QPUENP5)5:.N2JG:Z^I=CFB*Q@$>NQMV4X.OZ,X>#.N$PU>YH&PV MVI>8QV&DT[#"\>(W2)C$#T$.6Q;RH>N9M'A-=2T=G9Y>:`[1UGG0V18X"F[4 M:3>YX0CH$QQYL!W$PN^/Y"/#E=D>HO605\'E->W<*0,ZO\#4[DU0.RC?P^`# M9@:4>P#$K_A>P&;,I.]A\E\H>5XYA%:=TTC70+91MSW,U0>7@MMS]A(_GX%@ MD5Q\A=,=;KL'M#9BWQ4DXJ;@+I^"_0T!F$J/O_M"T<2+2]%;-S_"I0R?:3(% MEW4=SZ9MT^]YSPRR&(W8(_`UQ%^-TR1.G`!;&*]FLR@+J/T0))$7Q-[D=\=/ MB7[ZNMHS?*J;":&"D,;:UQQ]$:Y`N95.0:QO3_IN$"D(FJR?U-FA>!RGR+U- M`8!9/A/F-N/JUF(U51*/440+LHB&/M",COS%#VXRWPX-[Q(B5+ M9MGMVW>C[4!:]K.^)X+,)9,1,2I>TOG9-=PU9.5Y`FK1%.S3"-[R MP2/)%:P]C.-@>;MA>B@GK2=0X!;.9FFU[SDN"S1)#E\#V7,1@X#QF-ZD\%]> M"W:L#R@&3H$WVR![0(F4UDX@U(A]/Y",G0(?M4%VA98MCX[.(-B,?7>0CIX" M_S8C.X2E.X-=-MOT0DV6WYW!KQM4#XRS+T2/BX_['!?7SHBS+_P.!"H"E_AP

XML 68 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill And Intangible Assets
12 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets [Abstract]  
Goodwill And Intangible Assets

6. Goodwill and Intangible Assets

     The Company's carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions including the acquisition of Addus HealthCare. In accordance with ASC Topic 350, "Goodwill and Other Intangible Assets," goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred.

     Goodwill is required to be tested for impairment at least annually. The Company can elect to perform Step-0 an optional qualitative analysis and based on the results skip the remaining two steps. In 2012, the Company elected to implement Step 0 and was not required to conduct the remaining two step analysis. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. The Company uses the combination of a DCF model and the market multiple analysis method to determine the current fair value of each reporting unit.

     In performing its goodwill assessment for 2012, the Company evaluated the following factors that affect future business performance: macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, entity-specific events, reporting unit factors and company stock price. As a result of the assessment of these qualitative factors, the Company has concluded that it is more likely than not that the fair values of the reporting unit goodwill as of December 31, 2012 exceed the carrying values of the unit. Accordingly, the first and second steps of the goodwill impairment test as described in FASB ASC 350-20-35, which includes estimating the fair values of each reporting unit, are not considered necessary for the reporting unit and no goodwill impairment charges were recorded in 2012.

     In 2011, the DCF model was prepared using revenue and expense projections based on the Company's current operating plan. As such, a number of significant assumptions and estimates are involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. The cash flows were discounted using a weighted average cost of capital of 14.5%, which was management's best estimate based on the capital structure of the Company and external industry data. As part of the second step of this evaluation, if the carrying value of goodwill exceeds its implied fair value an impairment loss would be recognized.

     In light of the current Federal and state economic and reimbursement environments and state budgetary pressures to decrease or eliminate services provided by the Company, the Company completed a preliminary assessment of the fair value of continuing and discontinued operations and the potential for goodwill impairment as of June 30, 2011. 

     Based on the above and updates to the Company's business projections and forecasts, and other factors, the Company determined that the estimated fair value of its discontinued operations was less than the net book value indicating that its allocated goodwill was impaired. The preliminary assessment for the continuing operations indicated that its fair value was greater than its net book value with no initial indication of goodwill impairment.

     As permitted by ASC Topic 350, when an impairment indicator arises toward the end of an interim reporting period, the Company may recognize its best estimate of that impairment loss. Based on the Company's preliminary analysis prepared as of June 30, 2011, the Company determined that all of the $13,076 allocated to goodwill for the discontinued operations as of September 30, 2011 was impaired and recorded a goodwill impairment loss in the third quarter of 2011. The goodwill impairment charge was noncash in nature and did not affect the Company's liquidity or cash flows from operating activities. Additionally, the goodwill impairment had no effect on the Company's borrowing availability or covenants under its credit facility agreement. The analysis prepared as of June 30, 2011 was preliminary and subject to the completion of the Company's annual impairment test as of October 1, 2011. The Company completed its annual impairment test of goodwill as of October 1, 2011 and determined that no additional impairment charges or adjustments were required. The goodwill for the Company's continuing operations was $50,536 as of December 31, 2012.

      Summary of goodwill and related adjustments provided below:

    Continuing     Discontinued        
    operations     operations     Total  
Goodwill, at December 31, 2010 $ 50,820   $ 13,110   $ 63,930  
Adjustments to previously recorded goodwill   (125 )   (34 )   (159 )
Impairment charge for discountinued operations       (13,076 )   (13,076 )
 
Goodwill, at December 31, 2011   50,695         50,695  
Adjustments to previously recorded goodwill   (159 )       (159 )
 
Goodwill, at December 31, 2012 $ 50,536   $   $ 50,536  

 

     Adjustments to the previously recorded goodwill are primarily credits related to amortization of tax goodwill in excess of book basis.

     The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-compete agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from two to 25 years.

     In connection with the Company's preliminary assessment of its fair value discussed above, it determined that all of its $2,273 allocated to finite lived identifiable intangible assets for the discontinued operations as of September 30, 2011 was impaired and recorded an impairment charge in the third quarter of 2011. The impairment charge was noncash in nature and did not affect the Company's liquidity or cash flows from operating activities.

     The Company also has indefinite-lived assets that are not subject to amortization expense such as certificates of need and licenses to conduct specific operations within geographic markets. The Company has concluded that certificates of need and licenses have indefinite lives, as management has determined that there are no legal, regulatory, contractual, economic or other factors that would limit the useful life of these intangible assets and the Company intends to renew and operate the certificates of need and licenses indefinitely. The certificates of need and licenses are tested annually for impairment. In connection with the Company's assessment of its fair value discussed above, it determined that all of the $640 allocated to discontinued operations certificates of need and licenses were impaired and recorded an impairment loss in the third quarter of 2011, which is classified as discontinued operations.

     The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following for continuing and discontinued operations at December 31, 2012 and 2011:

    Customer and     Trade names                    
    referral     and           Non-competition        
    relationships     trademarks     State Licenses     agreements     Total  
Balance at December 31, 2010 $ 10,184   $ 2,407   $ 790   $ 189   $ 13,570  
Impairment charges for discontinued operations   (1,754 )   (506 )   (640 )   (13 )   (2,913 )
Amortization   (2,199 )   (350 )       (64 )   (2,613 )
 
Balance at December 31, 2011 6,231   1,551   150   112   8,044  
Amortization   (1,364 )   (248 )       (62 )   (1,674 )
 
Balance at December 31, 2012 $ 4,867   $ 1,303   $ 150   $ 50   $ 6,370  

 

     Amortization expense for continuing and discontinued operations related to the identifiable intangible assets amounted to $1,674, $2,613, and $3,143 for the three years ended December 31, 2012, 2011 and 2010, respectively. Goodwill and state licenses are not amortized pursuant to ASC Topic 350.

The estimated future intangible amortization expense is as follows:

   
For the year ended December 31,    
     
2013 $ 1,354
2014   1,093
2015   886
2016   717
2017   595
Thereafter   1,575
 
Total $ 6,220

 

XML 69 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Property And Equipment
12 Months Ended
Dec. 31, 2012
Property And Equipment [Abstract]  
Property And Equipment

5. Property and Equipment

Property and equipment consisted of the following:

  December 31,
    2012     2011  
Computer equipment $ 1,705   $ 1,412  
Furniture and equipment   918     778  
Transportation equipment   508     641  
Leasehold improvements   1,496     1,209  
Computer software   3,179     2,840  
    7,806     6,880  
Less accumulated depreciation and amortization   (5,317 )   (4,629 )
 
  $ 2,489   $ 2,251  

 

     Computer software includes $1,500 of internally developed software that was recognized in conjunction with the acquisition of Addus HealthCare. Depreciation and amortization expense predominantly related to computer equipment and software is reflected in general and administrative expenses and totaled $870, $941, and $903 for the three years ended December 31, 2012, 2011 and 2010, respectively.

XML 70 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Quarterly Financial Information
12 Months Ended
Dec. 31, 2012
Summarized Quarterly Financial Information [Abstract]  
Summarized Quarterly Financial Information

18. Unaudited Summarized Quarterly Financial Information

The following is a summary of the Company's unaudited quarterly results of operations (amounts and shares in thousands, except per share data):

  Year Ended December 31, 2012 Year Ended December 31, 2011
    Dec. 31   Sept. 30     Jun. 30     Mar. 31     Dec. 31     Sept. 30   Jun. 30   Mar. 31
Net service revenues $ 63,775 $ 61,211   $ 60,440   $ 58,889   $ 58,304   $ 58,393   $ 57,200 $ 56,208
Gross profit   17,537   15,683     15,807     15,024     16,829     15,701     14,784   14159
 
Operating income from continuing                                          
operations   5,261   3,867     3,217     3,318     4,648     3,711     2,558   2,000
Net income from continuing operations   3,503   2,204     1,835     1,746     2,914     3,396     1,253   849
Net income (loss) from discontinued                                          
operations   242   (407 )   (371 )   (1,117 )   (418 )   (10,059 )   80   4
Net income (loss) $ 3,745 $ 1,797   $ 1,464   $ 629   $ 2,496   $ (6,663 ) $ 1,333 $ 853
Average shares outstanding:                                          
Basic   10,772   10,761     10,761     10,756     10,754     10,746     10,746   10,746
Diluted   10,807   10,773     10,785     10,760     10,756     10,746     10,770   10,754
Income (loss) per common share:                                          
Basic and diluted                                          
Continuing operations $ 0.33 $ 0.20   $ 0.17   $ 0.16   $ 0.27   $ 0.32   $ 0.11 $ 0.08
Discontinued operations   0.02   (0.03 )   (0.03 )   (0.10 )   (0.04 )   (0.94 )   0.01   0.00
Basic and diluted net earnings (loss) per share $ 0.35 $ 0.17   $ 0.14   $ 0.06   $ 0.23   $ (0.62 ) $ 0.12 $ 0.08

 

XML 71 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Employee Benefit Plans
12 Months Ended
Dec. 31, 2012
Employee Benefit Plans [Abstract]  
Employee Benefit Plans

14. Employee Benefit Plans

     The Company's 401(k) Retirement Plan covers all non-union employees. The 401(k) plan is a defined contribution plan that provides for matching contributions by the Company. Matching contributions are discretionary and subject to change by management. Under the provisions of the 401(k) plan, employees can contribute up to the maximum percentage and limits allowable under the Internal Revenue Code of 1986. The Company provided a matching contribution, equal to 6.0% of the employees' contributions, totaling $44, $49, and $51 for continuing and discontinued operations for the year ended December 31, 2012, 2011, and 2010, respectively.

XML 72 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
12 Months Ended
Dec. 31, 2012
Income Taxes [Abstract]  
Income Taxes

9. Income Taxes

The current and deferred federal and state income tax provision (benefit), for both continuing and discontinued operations are comprised of the following:

  December 31,
    2012   2011     2010
Current              
Federal $ 2,325 $ 1,994   $ 2,178
State   544   184     335
Deferred              
Federal   680   (4,267 )   388
State   159   (396 )   59
 
Provision (benefit) for income taxes $ 3,708 $ (2,485 ) $ 2,960

 

     The tax effects of certain temporary differences between the Company's book and tax bases of assets and liabilities give rise to significant portions of the deferred income tax assets at December 31, 2012 and 2011. The deferred tax assets consisted of the following:

  December 31,
    2012     2011  
Deferred tax assets            
Current            
Accounts receivable allowances $ 1,784   $ 2,824  
Accrued compensation   1,133     902  
Accrued workers' compensation   4,593     3,263  
Other   395     146  
 
Total current deferred tax assets   7,905     7,135  
Deferred tax liabilities            
Current            
Prepaid insurance   (647 )   (799 )
 
Net deferred tax assets—current   7,258     6,336  
Deferred tax assets            
Long-term            
Goodwill and intangible assets   1,577     3,398  
Property and equipment   96     112  
Stock-based compensation   655     579  
 
Total long-term deferred tax assets   2,328     4,089  
 
Total net deferred tax assets $ 9,586   $ 10,425  

 

     Management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers projected future taxable income and tax-planning strategies in making this assessment. Based on this assessment, management believes it is more likely than not that the Company will realize its deferred income tax assets as of December 31, 2012.

     A reconciliation of the statutory federal tax rate of 34.0% to the effective income tax rate, for continuing and discontinued operations, for the years ended December 31, 2012, 2011, and 2010 is summarized as follows:

  December 31,
  2012   2011   2010  
Federal income tax at statutory rate 34.0 % 34.0 % 34.0 %
State and local taxes, net of federal benefit 5.9   5.3   4.9  
Jobs tax credits, net (9.3 ) 23.1   (7.9 )
Nondeductible meals and entertainment 0.9   (2.0 ) 1.0  
Tax asset adjustment—stock options 0.3   (0.5 ) 0.9  
Other 0.9   (4.3 )  
 
Effective income tax rate 32.7 % 55.6 % 32.9 %

 

     The Company is subject to taxation in the jurisdictions in which it operates. The Company continues to remain subject to examination by U.S. federal authorities for the years 2009 through 2012 and for various state authorities for the years 2008 through 2012. As part of the acquisition of Addus HealthCare in 2006, the selling stockholders agreed to assume and indemnify the successor for any federal or state tax liabilities prior to the acquisition date.

     The total amount of unrecognized tax benefits under ASC Topic 740 at December 31, 2012 was $115. If recognized, the entire amount would favorably impact the effective tax rate in future periods. Interest and penalties related to income tax liabilities are recognized in interest expense and general and administrative expenses, respectively. The Company does not anticipate a material change in its liabilities for uncertain tax positions during the next 12 months.

A summary of the activities associated with the Company's reserve for unrecognized tax benefits is as follows:

    Unrecognized
    Tax Benefits
Balance at December 31, 2010 $ 115
Increases related to current year tax positions  
 
Balance at December 31, 2011 $ 115
Increases related to current year tax positions  
 
Balance at December 31, 2012 $ 115

 

 

XML 73 R60.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Deferred Tax Assets And Liabilities) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract]    
Deferred Tax Assets, Current, Accounts receivable allowances $ 1,784 $ 2,824
Deferred Tax Assets, Current, Accrued compensation 1,133 902
Deferred Tax Assets, Current, Accrued workers' compensation 4,593 3,263
Deferred Tax Assets, Other 395 146
Deferred Tax Assets, Total current deferred tax assets 7,905 7,135
Deferred Tax Liabilities, Current, Prepaid insurance (647) (799)
Net deferred tax assets-current 7,258 6,336
Deferred Tax Assets, Long-term, Goodwill and intangible assets 1,577 3,398
Deferred Tax Assets, Long-term, Plant and equipment 96 112
Deferred Tax Assets, Long-term, Stock-based compensation 655 579
Total long-term deferred tax assets 2,328 4,089
Total net deferred tax assets $ 9,586 $ 10,425
XML 74 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Details Of Certain Balance Sheet Accounts
12 Months Ended
Dec. 31, 2012
Details Of Certain Balance Sheet Accounts [Abstract]  
Details Of Certain Balance Sheet Accounts

7. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consist of the following:

  December 31,
    2012   2011
Prepaid health insurance $ 4,062 $ 3,672
Prepaid workers' compensation and liability insurance   1,056   1,354
Prepaid rent   181   192
Workers' compensation insurance receivable   953   1,866
Other   1,041   1,053
 
  $ 7,293 $ 8,137

 

Accrued expenses consisted of the following:

  December 31,
    2012   2011
Accrued payroll $ 11,539 $ 11,547
Accrued workers' compensation insurance   12,452   10,173
Accrued payroll taxes   1,481   1,811
Accrued health insurance   3,469   3,039
Accrued taxes   1,223   223
Accrued interest   51   100
Current portion of contingent earn-out obligation   689   683
Other   1,813   1,737
 
  $ 32,717 $ 29,313

 

     The Company provides health insurance coverage to qualified union employees providing home and community based services in Illinois through a Taft-Hartley multi-employer health and welfare plan under Section 302(c)(5) of the Labor Management Relations Act of 1947. The Company's insurance contributions equal the amount reimbursed by the State of Illinois. Contributions are due within five business days from the date the funds are received from the State. Amounts due of $3,405 and $2,982 for health insurance reimbursements and contributions were reflected in prepaid insurance and accrued insurance at December 31, 2012 and 2011, respectively.

     The Company's workers' compensation program has a $350 deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The future claims payments related to the workers' compensation program are secured by letters of credit. These letters of credit totaled $7,410 at December 31, 2012 and 2011.

     As part of the terms of the acquisition of Addus HealthCare in 2006, all 2005 and prior workers' compensation claims are the obligation of the former stockholders of Addus HealthCare. Approximately $1,200 in cash escrows and deposits were set-aside from the purchase price of Addus HealthCare as collateral for these 2005 and prior claims as of December 31, 2012. The outstanding loss reserves associated with the 2005 and prior workers' compensation policies approximated $608 at December 31, 2012.

XML 75 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-Term Debt
12 Months Ended
Dec. 31, 2012
Long-Term Debt [Abstract]  
Long-Term Debt

8. Long-Term Debt

Long-term debt consisted of the following:

  December 31,
    2012     2011  
Revolving credit loan $ 16,250   $ 24,750  
Term loan   208     2,708  
Subordinated dividend notes bearing interest at 10.0%       4,069  
 
Total   16,458     31,527  
Less current maturities   (208 )   (6,569 )
 
Long-term debt $ 16,250   $ 24,958  

 

Senior Secured Credit Facility

     On March 18, 2010, the Company entered into an amendment (the "First Amendment") to its credit facility. The First Amendment (i) increased the maximum aggregate amount of revolving loans available to the Company by $5,000 to $55,000, (ii) modified the Company's maximum senior leverage ratio from 2.75 to 1.0 to 3.00 to 1.0 for each twelve month period ending on the last of day of each fiscal quarter thereafter and (iii) increased the advance multiple used to determine the amount of the borrowing base from 2.75 to 1.0 to 3.0 to 1.0. Our credit facility expires on November 2, 2014.

     On July 26, 2010, the Company entered into the Second Amendment to its credit facility. The Second Amendment provided for a term loan component of the credit facility in the aggregate principal amount of $5,000 with a maturity date of January 5, 2013. The requisite lenders also consented to the acquisition, effective July 25, 2010, of certain assets of Advantage by the Company, pursuant to the Purchase Agreement. The term loan was to be repaid in 24 equal monthly installments which commenced February 2011. Interest on the term loan under the credit facility was payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest was to be paid monthly or at the end of the relevant interest period. The term loan was repaid when due on January 5, 2013.

     On May 24, 2011, the Company entered into a Joinder, Consent and Amendment No. 3 to its credit facility to include Addus HealthCare (Delaware) Inc., a newly-formed, wholly-owned subsidiary of Addus HealthCare, as an additional borrower under the credit facility.

     On July 26, 2011, the Company entered into a fourth amendment (the "Fourth Amendment") to its credit facility. The Fourth Amendment modified the Company's maximum senior leverage ratio from 3.00 to 1.00 to 3.25 to 1.00 for each twelve month period ending on the last of day of each fiscal quarter beginning with the twelve month period ended June 30, 2011 and increased the advance multiple used to determine the amount of the borrowing base from 3.0 to 1.0 to 3.25 to 1.0. The Fourth Amendment resulted in an increase in the Company's available borrowings under the credit facility.

     On March 2, 2012, the Company entered into a fifth amendment (the "Fifth Amendment") to its credit facility. The Fifth Amendment includes technical changes that are intended to comply with rules promulgated by CMS that restrict lenders from exercising any rights of set-off of funds on deposit in any lockboxes established for receiving payments from governmental authorities.

     During the fourth quarter of 2011, the lenders under the Company's credit facility permitted the Company to add back approximately $1,800 to adjusted EBITDA for the purpose of determining availability under the credit facility. The effect of the add back was to increase availability by approximately $5,800 until March 1, 2012. On March 1, 2012, the add back allowance was reduced by $200 and will continue to be reduced by $200 on the first day of each month thereafter until the add back is eliminated, which will result in a reduction in availability of $650 on the first day of each month thereafter until the add back is eliminated. The add-back was eliminated on December 1, 2012. During the second quarter of 2012, the lenders under the Company's credit facility agreed to a modified interpretation of the credit facility as it relates to the calculation of the fixed charge ratio, which provides the Company with increased flexibility in meeting this covenant. The Company was in compliance with all covenants as of December 31, 2012.

     The availability of funds under the revolving credit portion of the credit facility, as amended, is based on the lesser of (i) the product of adjusted EBITDA, as defined in the credit facility agreement, for the most recent 12-month period for which financial statements have been delivered under the credit facility agreement multiplied by the specified advance multiple, up to 3.25, less the outstanding senior indebtedness and letters of credit, and (ii) $55,000 less the outstanding revolving loans and letters of credit. Interest on the amounts outstanding under the revolving credit portion of the credit facility is payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest will be paid monthly or at the end of the relevant interest period, as determined in accordance with the credit facility agreement. The borrowers will pay a fee equal to 0.5% per annum of the unused portion of the revolving portion of the credit facility. Issued stand-by letters of credit will be charged at a rate of 2.0% per annum payable monthly. On December 31, 2012 the interest rate on the revolving credit loan facility was 4.8% (30 day LIBOR rate was 0.2%). The total availability under the revolving credit loan facility was $27,137 at December 31, 2012 compared to $21,810 at December 31, 2011.

Subordinated Dividend Notes

     On November 2, 2009, in conjunction with the IPO, all outstanding shares of Holdings' series A preferred stock were converted into an aggregate 4,077 shares common stock at a ratio of 1:108. Total accrued and unpaid dividends on the series A preferred stock were $13,109 as of November 2, 2009, at which time a dividend payment of $173 was made and the remaining $12,936 in unpaid preferred dividends were converted into dividend notes. The dividend notes are subordinated and to all obligations under the Company's new credit facility. On November 2, 2009, the Company made a mandatory payment of $4,000 on the dividend notes. Interest the outstanding dividend notes accrues at a rate of 10% per annum, compounded annually. The outstanding principal amount of the dividend notes was originally payable in eight equal consecutive quarterly installments which commenced on December 31, 2009 and each March 31, June 30, September 30 and December 31 of each year thereafter until paid in full. Interest on the unpaid principal balance of the dividend notes is due and payable quarterly in arrears together with each payment of principal

     On March 18, 2010, the Company amended its subordinated dividend notes. A balance of $7,819 was outstanding on the dividend notes as of December 31, Pursuant to the amendments, the dividend notes were amended to (i) extend the maturity date of the dividend notes from September 30, 2011 to December 31, 2012, (ii) modify the amortization schedule of the dividend notes to reduce the annual principal payment amounts from $4,468 to $1,250 in 2010; from $3,351 to $2,500 in and amended total payments in 2012 to $4,069, and (iii) permit, based on the Company's leverage ratio, the prepayment of all or a portion of the principal amount of dividend notes, together with interest on the principal amount. The Company repaid the subordinated dividend notes in the fourth quarter of 2012.

Aggregate maturities of long-term debt as of December 31, 2012, are as follows:

For the year ended December 31,    
     
2013 $ 208
2014   16,250
 
Total $ 16,458

 

XML 76 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options And Restricted Stock Awards
12 Months Ended
Dec. 31, 2012
Stock Options And Restricted Stock Awards [Abstract]  
Stock Options And Restricted Stock Awards

10. Stock Options and Restricted Stock Awards

Stock Options

     The 2006 Plan provides for the grant of non-qualified stock options to directors and eligible employees, as defined in the 2006 Plan. A total of 899 of Holdings' shares of common stock were reserved for issuance under the 2006 Plan. The number of options to be granted and the terms thereof were approved by Holdings' board of directors. The option price for each share of common stock subject to an option may be greater than or equal to the fair market value of the stock at the date of grant. The stock options generally vest ratably over a five year period and expire 10 years from the date of grant, if not previously exercised.

     In September 2009, the Company's board of directors and stockholders adopted and approved the 2009 Plan. The 2009 Plan provides for the grant of 750 incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units, restricted stock units, other stock units and performance shares.

A summary of stock option activity and weighted average exercise price is as follows:

  For The Year Ended December 31,
        Weighted       Weighted       Weighted
        Average       Average       Average
        Exercise       Exercise       Exercise
  2012     Price 2011     Price 2010     Price
  Options       Options       Options      
Outstanding, beginning of period 775   $ 7.69 588   $ 8.63 607   $ 9.51
Granted 36     4.49 229     5.33 91     4.30
Exercised (5 )   4.53 -       -     -
Forfeited/Cancelled (209 )   6.02 (42 )   7.93 (110 )   9.95
 
Outstanding, end of period 596   $ 8.11 775   $ 7.69 588   $ 8.63

 

The following table summarizes stock options outstanding and exercisable at December 31, 2012:

  Exercise Price Outstanding Exercisable
 
 
 
      Weighted       Weighted    
      Average       Average    
      Remaining   Weighted   Remaining   Weighted
      Contractual   Average   Contractual   Average
      Life In   Exercise   Life In   Exercise
    Options Years   Price Options Years   Price
$ 4.06– $ 5.45 166 8.4 $ 4.77 48 8.1 $ 4.77
$ 9.26– $10.00 430 4.5   9.39 400 4.3   9.35
 
 
    596 5.6 $ 8.11 448 4.7 $ 8.85

 

     The Company historically used the Black-Scholes option pricing model to estimate the fair value of its stock based payment awards under its 2006 Plan, but beginning October 28, 2009 under its 2009 Plan it began using an enhanced Hull-White Trinomial model. The determination of the fair value of stock-based payments utilizing the Black-Scholes model and the Enhanced Hull-White Trinomial model is affected by Holdings' stock price and a number of assumptions, including expected volatility, risk-free interest rate, expected term, expected dividends yield, expected forfeiture rate, expected turn-over rate, and the expected exercise multiple. Holdings did not have a history of market prices of its common stock as it was not a public company prior to the IPO, and as such it estimates volatility based on the volatilities of a peer group of publicly traded companies. The expected term of options is based on the Company's estimate of when options will be exercised in the future. The risk-free interest rate assumption is based on observed interest rates appropriate for the terms of the Company's awards. The dividend assumption is based on the Company's history and expectation of not paying dividends. The expected turn-over rate represents the expected forfeitures due to employee turnover and is based on historical rates experienced by the Company. The expected exercise multiple represents the mean ratio of the stock price to the exercise price at which employees are expected to exercise their options.

     The weighted-average estimated fair value of employee stock options granted as calculated using the Black-Scholes model and the Enhanced Hull-White Trinomial model and the related assumptions follow:

  For the year ended December 31,
  2012     2011     2010  
  Grants     Grants     Grants  
Weighted average fair value 2.09   $ 2.54   $ 1.88  
Risk-free discount rate 1.59% - 1.95%     3.17%   2.89% – 2.99%  
Expected life 6.0 – 6.5 years     6.0 – 6.5 years     6.5 years  
Dividend yield          
Volatility 42% – 51%   42% – 51%   42% – 51%
Expected turn-over rate(1) 5%   5%   5%
Expected exercise multiple(1) 2.2     2.2     2.2  

 

     Stock option compensation expense, for continuing and discontinued operations, totaled $181, $254 and $241 for the three years ended December 31, 2012, 2011 and 2010, respectively. As of December 31, 2012, there was $349 of total unrecognized compensation cost that is expected to be recognized over a period of five years.

     The intrinsic value of vested and outstanding stock options was $115 and $394 as of December 31, 2012. There were 5 stock options exercised in 2012 and the Company did not receive any cash from option exercises and did not realize any related tax benefits. There were no stock options exercised in 2011 or 2010.

Restricted Stock Awards

     In 2012, management awarded 44 shares of restricted stock awards under the 2009 Plan with a weighted average fair value of $4.48 per share. As of December 31, 2012, $115 of unearned compensation related to unvested awards of restricted stock will be recognized over the remaining vesting terms of the awards.

The following table summarizes the status of unvested restricted stock awards outstanding at December 31, 2012, 2011 and 2010:

  For The Year Ended December 31,
        Weighted-     Weighted-        Weighted-
        Average       Average       Average
        Grant Date     Grant Date        Grant Date
  2012     Fair Value 2011    Fair Value 2010     Fair Value
  Restricted       Restricted       Restricted      
  Stock       Stock       Stock      
  Awards       Awards       Awards      
Unvested restricted stock awards 21   $ 5.95 6   $ 6.85 3   $ 10.00
Awarded 44     4.48 24     5.63 4     5.21
Vested (20 )   5.14 (8 )   5.64 (1 )   10.00
Forfeited (3 )   5.93 (1 )   5.93    
 
Unvested restricted stock awards at                        
December 31, 42   $ 4.80 21   $ 5.95 6   $ 6.85

 

     Restricted stock award compensation expense, for continuing and discontinued operations, totaled $160, $77 and $14 for the three years ended December 31, 2012, 2011 and 2010, respectively.

     Shares available under the 2006 Plan and the 2009 Plan were 546 and 435, respectively, as of December 31, 2012. The Company does not plan on issuing any further grants under the 2006 Plan.

XML 77 R64.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options And Restricted Stock Awards (Summary Of Stock Option Activity) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Stock Options And Restricted Stock Awards [Abstract]      
Options, Outstanding, beginning of period shares 775 588 607
Options, Granted shares 36 229 91
Options, Exercised shares (5)    
Options, Forfeited/Cancelled shares (209) (42) (110)
Options, Outstanding, end of period shares 596 775 588
Weighted Average Exercise Price, Outstanding, beginning of period $ 7.69 $ 8.63 $ 9.51
Weighted Average Exercise Price, Granted $ 4.49 $ 5.33 $ 4.30
Weighted Average Exercise Price, Exercised $ 4.53    
Weighted Average Exercise Price, Forfeited/Cancelled $ 6.02 $ 7.93 $ 9.95
Weighted Average Exercise Price, Outstanding, end of period $ 8.11 $ 7.69 $ 8.63
XML 78 R66.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options And Restricted Stock Awards (Option Pricing Assumptions) (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average fair value $ 2.09 $ 2.54 $ 1.88
Risk-free discount rate, minimum 1.59%   2.89%
Risk-free discount rate   3.17%  
Risk-free discount rate, maximum 1.95%   2.99%
Expected life     6 years 6 months
Volatility, minimum 42.00% 42.00% 42.00%
Volatility, maximum 51.00% 51.00% 51.00%
Expected turn-over rate 5.00% 5.00% 5.00%
Expected exercise multiple $ 2.2 $ 2.2 $ 2.2
Minimum [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life 6 years 6 years  
Maximum [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life 6 years 6 months 6 years 6 months  
XML 79 R63.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options And Restricted Stock Awards (Narrative) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Stock option compensation expense $ 181 $ 254 $ 241
Unrecognized compensation cost 349    
Recognization period for unrecognized compensation cost 5 years    
Share based compensation, no stock option exercised period 3 years    
Intrinsic value on vested stock options 115    
Intrinsic value on outstanding stock options 394    
Number of stock options exercised 5    
Stock options forfeited shares 209 42 110
Restricted stock awards shares 44 24 4
Restricted stock weighted average fair value per share $ 4.48 $ 5.63 $ 5.21
2006 Stock Incentive Plan [Member]
     
Common stock shares reserved for issuance 546    
2006 Stock Incentive Plan [Member] | Holdings [Member]
     
Common stock shares reserved for issuance 899    
2009 Stock Incentive Plan [Member]
     
Common stock shares reserved for issuance 435    
Stock options shares granted 750    
Unrecognized compensation cost 115    
Restricted stock awards shares 44    
Restricted stock weighted average fair value per share $ 4.48    
Minimum [Member] | 2006 Stock Incentive Plan [Member]
     
Stock option vest period 5 years    
Maximum [Member] | 2006 Stock Incentive Plan [Member]
     
Stock option vest period 10 years    
Restricted Stock Award [Member]
     
Stock option compensation expense $ 160 $ 77 $ 14
XML 80 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options And Restricted Stock Awards (Tables)
12 Months Ended
Dec. 31, 2012
Stock Options And Restricted Stock Awards [Abstract]  
Summary Of Stock Option Activity
  For The Year Ended December 31,
        Weighted       Weighted       Weighted
        Average       Average       Average
        Exercise       Exercise       Exercise
  2012     Price 2011     Price 2010     Price
  Options       Options       Options      
Outstanding, beginning of period 775   $ 7.69 588   $ 8.63 607   $ 9.51
Granted 36     4.49 229     5.33 91     4.30
Exercised (5 )   4.53 -       -     -
Forfeited/Cancelled (209 )   6.02 (42 )   7.93 (110 )   9.95
 
Outstanding, end of period 596   $ 8.11 775   $ 7.69 588   $ 8.63
Stock Option Awards
  Exercise Price Outstanding Exercisable
 
 
 
      Weighted       Weighted    
      Average       Average    
      Remaining   Weighted   Remaining   Weighted
      Contractual   Average   Contractual   Average
      Life In   Exercise   Life In   Exercise
    Options Years   Price Options Years   Price
$ 4.06– $ 5.45 166 8.4 $ 4.77 48 8.1 $ 4.77
$ 9.26– $10.00 430 4.5   9.39 400 4.3   9.35
 
 
    596 5.6 $ 8.11 448 4.7 $ 8.85
Option Pricing Assumptions
  For the year ended December 31,
  2012     2011     2010  
  Grants     Grants     Grants  
Weighted average fair value 2.09   $ 2.54   $ 1.88  
Risk-free discount rate 1.59% - 1.95%     3.17%   2.89% – 2.99%  
Expected life 6.0 – 6.5 years     6.0 – 6.5 years     6.5 years  
Dividend yield          
Volatility 42% – 51%   42% – 51%   42% – 51%
Expected turn-over rate(1) 5%   5%   5%
Expected exercise multiple(1) 2.2     2.2     2.2  
Summary Of vested And Unvested RSU
  For The Year Ended December 31,
        Weighted-     Weighted-        Weighted-
        Average       Average       Average
        Grant Date     Grant Date        Grant Date
  2012     Fair Value 2011    Fair Value 2010     Fair Value
  Restricted       Restricted       Restricted      
  Stock       Stock       Stock      
  Awards       Awards       Awards      
Unvested restricted stock awards 21   $ 5.95 6   $ 6.85 3   $ 10.00
Awarded 44     4.48 24     5.63 4     5.21
Vested (20 )   5.14 (8 )   5.64 (1 )   10.00
Forfeited (3 )   5.93 (1 )   5.93    
 
Unvested restricted stock awards at                        
December 31, 42   $ 4.80 21   $ 5.95 6   $ 6.85
XML 81 R51.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill And Intangible Assets (Schedule Of Future Amortization Of Intangible Assets) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Impairment of Intangible Assets (Excluding Goodwill) [Abstract]  
2013 $ 1,354
2014 1,093
2015 886
2016 717
2017 595
Thereafter 1,575
Total $ 6,220
XML 82 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Significant Payors (Medicare And One State Governmental Agency [Member])
12 Months Ended
Dec. 31, 2012
Medicare And One State Governmental Agency [Member]
 
Concentration Risk [Line Items]  
Significant Payors

16. Significant Payors

     A substantial portion of the Company's net service revenues and accounts receivables are derived from services performed for federal, state and local governmental agencies. One state governmental agency represented 57%, 51% and 45% of the Company's net service revenues for 2012, 2011, and 2010, respectively.

     The related receivables due from Medicare and the state agency represented 7% and 69% of the Company's accounts receivable at December 31, 2012, respectively, and 11% and 58% of the Company's accounts receivable at December 31, 2011, respectively.

XML 83 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary Of Significant Accounting Policies (Policy)
12 Months Ended
Dec. 31, 2012
Significant Accounting Policies [Abstract]  
Basis Of Presentation And Description Of Business

Basis of Presentation and Description of Business

     The consolidated financial statements include the accounts of Addus HomeCare Corporation ("Holdings") and its subsidiaries (together with Holdings, the "Company" or "we"). The Company provides home and community based services through a network of locations throughout the United States. These services are primarily performed in the homes of the consumers. The Company's home and community based services include assistance to the elderly, chronically ill and disabled with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. Home and community based services are primarily performed under agreements with state and local governmental agencies.

Discontinued Operations

Discontinued Operations

     On February 7, 2013, subsidiaries of Holdings entered into an Asset Purchase Agreement with LHC Group, Inc. and certain of its subsidiaries (the "Home Health Purchase Agreement"). Pursuant to the Home Health Purchase Agreement, effective March 1, 2013, the purchasers agreed to acquire substantially all the assets of the Company's home health business in Arkansas, Nevada and South Carolina and 90% of its home health business in California and Illinois, with the Company retaining 10% ownership in such locations, for cash consideration of $20,000.

     The Company's home health services were operated through licensed and Medicare certified offices that provided physical, occupational and speech therapy, as well as skilled nursing services to pediatric, adult infirm and elderly patients. Home health services were reimbursed from Medicare, Medicaid and Medicaid-waiver programs, commercial insurance and private payors (see note 2).

Principles Of Consolidation

Principles of Consolidation

     All intercompany balances and transactions have been eliminated in consolidation.

Revenue Recognition
Allowance For Doubtful Accounts

Allowance for Doubtful Accounts

     The Company establishes its allowance for doubtful accounts to the extent it is probable that a portion or all of a particular account will not be collected. The Company estimates its provision for doubtful accounts primarily by aging receivables utilizing eight aging categories, and applying its historical collection rates to each aging category, taking into consideration factors that might impact the use of historical collection rates or payor groups, with certain large payors analyzed separately from other payor groups. In the Company's evaluation of these estimates, it also considers delays in payment trends in individual states due to budget or funding issues, billing conversions related to acquisitions or internal systems, resubmission of bills with required documentation and disputes with specific payors. An allowance for doubtful accounts is maintained at a level management believes is sufficient to cover potential losses. However, actual collections could differ from estimates.

Property And Equipment
Goodwill

Goodwill

     The Company's carrying value of goodwill is the residual of the purchase price over the fair value of the net assets acquired from various acquisitions including the acquisition of Addus HealthCare, Inc. ("Addus HealthCare"). In accordance with Accounting Standards Codification TM ("ASC") Topic 350, "Goodwill and Other Intangible Assets ," goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. Goodwill and indefinite lived intangible assets are required to be tested for impairment at least annually. The Company may use a qualitative test, known as "Step 0" or a two-step quantitative method to determine whether impairment has occurred. In Step 0, the Company can elect to perform an optional qualitative analysis and based on the results skip the two step analysis. In 2012, the Company elected to implement Step 0 and was not required to conduct the remaining two step analysis.

     In 2011, the Company elected to evaluate the goodwill via the two step methodology. The first step in the evaluation of goodwill impairment involves comparing the current fair value of each reporting unit to the recorded value, including goodwill. The Company used the combination of a discounted cash flow model ("DCF model") and the market multiple analysis method to determine the current fair value of each reporting unit. The DCF model was prepared using revenue and expense projections based on the Company's current operating plan. As such, a number of significant assumptions and estimates were involved in the application of the DCF model to forecast revenue growth, price changes, gross profits, operating expenses and operating cash flows. In 2011, the cash flows were discounted using a weighted average cost of capital of 14.5%, which was management's best estimate based on the capital structure of the Company and external industry data. As part of the second step of this evaluation, if the carrying value of goodwill exceeds its fair value, an impairment loss would be recognized. The Company recorded a $15,989 goodwill and intangible asset charge during the third quarter of 2011 (see Note 6)for its discontinued operations (see Note 2).

Intangible Assets

Intangible Assets

     The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-compete agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from two to 25 years.

      ASC Topic 350 requires that the fair value of intangible assets with finite lives be estimated and compared to the carrying value. The Company estimates the fair value of these intangible assets using the income approach. Intangible assets with finite lives are amortized using the estimated economic benefit method over the useful life and assessed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company recognizes an impairment loss when the estimated fair value of the intangible asset is less than the carrying value. No impairment charge was recorded in 2012. The Company recorded a $2,273 impairment associated with discontinued operations in 2011. No impairment charge was recorded in 2010.

     The income approach, which the Company uses to estimate the fair value of its reporting units and intangible assets, is dependent on a number of factors including estimates of future market growth and trends, forecasted revenue and costs, expected periods the assets will be utilized, appropriate discount rates and other variables. The Company bases its fair value estimates on assumptions the Company believes to be reasonable but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates. In addition, the Company makes certain judgments about the selection of comparable companies used in the market approach in valuing its reporting units.

Long-Lived Assets

Long-Lived Assets

     The Company reviews its long-lived assets and indefinite lived intangibles (except goodwill and finite lived intangible assets, as described above) for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. To determine if impairment exists, the Company compares the estimated future undiscounted cash flows from the related long-lived assets to the net carrying amount of such assets. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset, generally determined by discounting the estimated future cash flows. No impairment charge was recorded in 2012. The Company recorded a $640 impairment associated with discontinued operations in 2011. No impairment charge was recorded in 2010.

Debt Issuance Costs

Debt Issuance Costs

The Company amortizes debt issuance costs on a straight-line method over the term of the related debt. This method approximates the effective interest method.

Workers' Compensation Program

Workers' Compensation Program

     The Company's workers' compensation program has a $350 deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The future claims payments related to the workers' compensation program are secured by letters of credit.

Derivative Financial Instrument

Derivative Financial Instrument

     The Company utilized a derivative financial instrument to minimize interest rate risk. The Company's derivative instrument consisted of a three-year interest rate agreement designed to reduce the variability of cash flows associated with a portion of the Company's term debt. As the hedge accounting criteria established in ASC Topic 815, "Derivatives and Hedging" have not been met, the Company accounted for the instrument at its fair value and recognizes any changes in its fair value in earnings for the period.

     ASC Topic 820, "Fair Value Measurements," establishes a three-tier fair value hierarchy, which categorizes the inputs used in measuring fair value. These categories include in descending order of priority: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

     The fair value of the swap was calculated using proprietary models utilizing observable inputs (Level 2) as well as future assumptions related to interest rates and other applicable variables. These calculations were performed by the financial institution which is counterparty to the applicable swap agreement and reviewed by the Company. The Company used these reported fair values to adjust the asset or liability as appropriate. The interest rate swap agreement concluded in March of 2010.

Interest Income
Interest Expense

Interest Expense

The Company's interest expense consists of interest costs on its credit facility and other debt instruments.

Income Taxes

Income Taxes

     The Company accounts for income taxes under the provisions of ASC Topic 740, "Income Taxes". The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its financial statements or tax returns. Deferred taxes, resulting from differences between the financial and tax basis of the Company's assets and liabilities, are also adjusted for changes in tax rates and tax laws when changes are enacted. ASC Topic 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. ASC Topic 740, also prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. In addition, ASC Topic 740 provides guidance on derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions.

Stock-Based Compensation
Net Income (Loss) Per Common Share
Estimates

Estimates

     The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. Accordingly, actual results could differ from those estimates.

Fair Value Of Financial Instruments

Fair Value of Financial Instruments

     The Company's financial instruments consist of cash, accounts receivable, payables and debt. The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of the short-term nature of these instruments. The carrying value of the Company's long-term debt with variable interest rates approximates fair value based on instruments with similar terms.

     The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets and also when determining the fair value of contingent considerations. To determine the fair value in these situations, the Company uses Level 3 inputs such as discounted cash flows or if available, what a market participant would pay on the measurement date.

New Accounting Pronouncements

New Accounting Pronouncements

     The Company does not believe any recently issued, but not yet effective, accounting standards will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.

XML 84 R49.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill And Intangible Assets (Changes In Goodwill By Segment) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Jul. 26, 2010
Goodwill [Line Items]      
Goodwill, at Beginning of Period $ 50,695 $ 63,930 $ 4,272
Adjustments to previously recorded goodwill (159) (159)  
Impairment charge   (13,076)  
Goodwill, at End of Period 50,536 50,695 4,272
Continuing Operations [Member]
     
Goodwill [Line Items]      
Goodwill, at Beginning of Period 50,695 50,820  
Adjustments to previously recorded goodwill (159) (125)  
Goodwill, at End of Period 50,536 50,695  
Discontinued Operations [Member]
     
Goodwill [Line Items]      
Goodwill, at Beginning of Period   13,110  
Adjustments to previously recorded goodwill   (34)  
Impairment charge   $ (13,076)  
XML 85 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Sale Of Agency (Details) (USD $)
In Thousands, unless otherwise specified
1 Months Ended 12 Months Ended
Feb. 29, 2012
Dec. 31, 2012
Discontinued Operations Including Sale Of Agency [Abstract]    
Gross proceeds from sale of agency $ 525  
Net proceeds from sale of agency 495 495
Gain on sale of agency $ 495 $ 495
XML 86 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Stockholders' Equity (USD $)
In Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2009 $ 10 $ 80,611 $ (54) $ 80,567
Balance, shares at Dec. 31, 2009 10,499      
Issuance of shares of common stock under restricted stock 1     1
Issuance of shares of common stock under restricted stock, Shares 4      
Stock-based compensation   255   255
Stock issued for acquisition   1,240   1,240
Stock issued for acquisition, Shares 248      
Net income (loss)     6,028 6,028
Balance at Dec. 31, 2010 11 82,106 5,974 88,091
Balance, shares at Dec. 31, 2010 10,751      
Issuance of shares of common stock under restricted stock, Shares 24      
Stock-based compensation   331   331
Net income (loss)     (1,981) (1,981)
Balance at Dec. 31, 2011 11 82,437 3,993 86,441
Balance, shares at Dec. 31, 2011 10,775      
Issuance of shares of common stock under restricted stock, Shares 43      
Stock-based compensation   341   341
Shares issued 5      
Net income (loss)     7,635 7,635
Balance at Dec. 31, 2012 $ 11 $ 82,778 $ 11,628 $ 94,417
Balance, shares at Dec. 31, 2012 10,823      
XML 87 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions
12 Months Ended
Dec. 31, 2012
Acquisitions [Abstract]  
Acquisitions

4. Acquisitions

     On July 26, 2010, the Company entered into an Asset Purchase Agreement (the "Purchase Agreement"), pursuant to which the Company acquired certain assets of Advantage Health Systems, Inc., a South Carolina corporation ("Advantage"). The total maximum consideration payable pursuant to the Purchase Agreement was $8,380, comprised of $5,140 in cash, common stock consideration with a deemed value of $1,240 resulting in the issuance of 248 common shares, and a maximum of $2,000 in future cash consideration subject to the achievement of certain performance targets set forth in an earn-out agreement and the assumption of certain specified liabilities.

     On July 26, 2010, the Company entered into an amendment (the "Second Amendment") to its credit facility. The Second Amendment provides for a new term loan component of the credit facility in the aggregate principal amount of $5,000 with a maturity date of January 5, 2013. The requisite lenders also consented to the acquisition, effective July 25, 2010, of certain assets of Advantage, by the Company, pursuant to the Purchase Agreement. The term loan was repaid in 24 equal monthly installments which began in February 2011. Interest on the term loan under the credit facility was payable either at a floating rate equal to the 30-day LIBOR, plus an applicable margin of 4.6% or the LIBOR rate for term periods of one, two, three or six months plus a margin of 4.6%. Interest was paid monthly or at the end of the relevant interest period.

     The Company's acquisition of Advantage has been accounted for in accordance with ASC Topic 805, "Business Combinations" and the resultant goodwill and other intangible assets will be accounted for under ASC Topic 350 "Goodwill and Other Intangible Assets" . Assets acquired and liabilities assumed were recorded at their fair values. The total purchase price is $7,980 and is comprised of:

    Total
Cash $ 5,140
Issuance of 248 Addus shares at $5.00 per share (valued at a price per share equal to the average closing price of the
Company's stock for the three most recent trading days preceding the closing, subject to a floor of $5.00 per share)
  1,240
Contingent earn-out obligation (net of $92 discount)   1,600
Total purchase price $ 7,980

 

 

     The contingent earn-out obligation was initially recorded at its fair value of $1,600, which is the present value of the Company's obligation based on probability-weighted estimates of the achievement of certain performance targets, as defined in the Purchase Agreement. In April 2011, the Company paid the first earn-out payment of $500 to the sellers of Advantage. The second earn-out payment obligation was reviewed during the fourth quarter of 2011 and it was revalued at approximately $683 as of December 31, 2011 which resulted in a $469 gain on revaluation of the contingent consideration. The sellers of Advantage disagree with the Company's calculation of the second earn-out payment and the parties have agreed to have an arbitrator determine the amount of the second earn-out payment. The final payment is expected to be made during the second quarter of 2013.

     Under business combination accounting, the total purchase price was allocated to Advantage's net tangible and identifiable intangible assets based on their estimated fair values. Based upon management's valuation, the total purchase price has been allocated as follows:

    Total
Goodwill $ 4,272
Identifiable intangible assets   3,631
Property and equipment   77
 
Total purchase price allocation $ 7,980

 

     Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets acquired. Goodwill amounts are not amortized, but rather are tested for impairment at least annually. In the event that the Company determines that the value of goodwill has become impaired, the Company will record an impairment charge for the amount during the fiscal quarter in which such determination is made.

     Identifiable intangible assets acquired consist of trade names and trademarks, certificates of need and state licenses, customer relationships, and non-compete agreements. The estimated fair value of identifiable intangible assets was determined by management.

     As part of its annual review of goodwill and intangible assets, the Company determined that all of its home health business which is recorded as discontinued operations was impaired (see Note 6). As part of this impairment in 2011 the Company recorded a charge that included $544 of goodwill and $272 of intangible assets associated with the purchase of Advantage.

The following table contains unaudited pro forma consolidated income statement information assuming the Advantage acquisition closed on January 1, 2010.

    For the Year Ended  
    December 31, 2010  
       
Net service revenues $ 236,065  
Operating income from continuing operations   9,793  
Net income from continuing operations, net of tax   4,555  
Net loss from discontinued operations, net of tax   1,617
 
Net income $ 6,172  
Earnings per share      
Basic and Diluted      
Continuing operations $ 0.42  
Discontinued operations   0.15  
Basic income per share from continue operations $ 0.57  

 

     The pro forma disclosures in the table above include adjustments for interest expense, amortization of intangible assets and tax expense to reflect results that are more representative of the combined results of the transactions as if they had occurred on January 1, 2010. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operation that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information.

XML 88 R58.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Taxes [Abstract]      
Statutory federal tax rate 34.00% 34.00% 34.00%
Unrecognized tax benefit $ 115 $ 115 $ 115
XML 89 R69.htm IDEA: XBRL DOCUMENT v2.4.0.6
Operating Leases And Related Party Transactions (Operating Leases And Related Party Transactions) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Operating Leased Assets [Line Items]  
2013 $ 3,024
2014 2,044
2015 1,759
2016 1,466
2017 779
Thereafter 1,208
Total 10,280
Non-Related Party [Member]
 
Operating Leased Assets [Line Items]  
2013 2,784
2014 2,044
2015 1,759
2016 1,466
2017 779
Thereafter 1,208
Total 10,040
Related Party [Member]
 
Operating Leased Assets [Line Items]  
2013 240
Total $ 240
XML 90 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations (Tables) (Home Health Segment [Member])
12 Months Ended
Dec. 31, 2012
Home Health Segment [Member]
 
Schedule Of Income Loss From Discontinued Operation
    2012     2011     2010
Net service revenues $ 38,822   $ 42,995   $ 41,633
Income (loss) before income taxes   (2,752 )   (17,122 )   2,719
Income tax expense (benefit)   (1,099 )   (6,729 )   1,058
 
Net income (loss) from discontinued operations $ (1,653 ) $ (10,393 ) $ 1,661
Schedule Of Disposal Group, Classes Of Assets
2012 2011
Property and equipment, net of accumulated depreciation and amortization $ 245 $ 239
XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 194 373 1 true 51 0 false 7 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.addusDFNNotes.com/role/DocumentDocumentAndEntityInformation Document And Entity Information true false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.addusDFNNotes.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.addusDFNNotes.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Condensed Consolidated Statements Of Income Sheet http://www.addusDFNNotes.com/role/StatementCondensedConsolidatedStatementsOfIncome Condensed Consolidated Statements Of Income false false R5.htm 00300 - Statement - Condensed Consolidated Statements Of Stockholders' Equity Sheet http://www.addusDFNNotes.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements Of Stockholders' Equity false false R6.htm 00400 - Statement - Condensed Consolidated Statements Of Cash Flows Sheet http://www.addusDFNNotes.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements Of Cash Flows false false R7.htm 10101 - Disclosure - Significant Accounting Policies Sheet http://www.addusDFNNotes.com/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies false false R8.htm 10201 - Disclosure - Discontinued Operations Sheet http://www.addusDFNNotes.com/role/DisclosureDiscontinuedOperations Discontinued Operations false false R9.htm 10301 - Disclosure - Sale Of Agency Sheet http://www.addusDFNNotes.com/role/DisclosureSaleOfAgency Sale Of Agency false false R10.htm 10401 - Disclosure - Acquisitions Sheet http://www.addusDFNNotes.com/role/DisclosureAcquisitions Acquisitions false false R11.htm 10501 - Disclosure - Property And Equipment Sheet http://www.addusDFNNotes.com/role/DisclosurePropertyAndEquipment Property And Equipment false false R12.htm 10601 - Disclosure - Goodwill And Intangible Assets Sheet http://www.addusDFNNotes.com/role/DisclosureGoodwillAndIntangibleAssets Goodwill And Intangible Assets false false R13.htm 10701 - Disclosure - Details Of Certain Balance Sheet Accounts Sheet http://www.addusDFNNotes.com/role/DisclosureDetailsOfCertainBalanceSheetAccounts Details Of Certain Balance Sheet Accounts false false R14.htm 10801 - Disclosure - Long-Term Debt Sheet http://www.addusDFNNotes.com/role/DisclosureLongTermDebt Long-Term Debt false false R15.htm 10901 - Disclosure - Income Taxes Sheet http://www.addusDFNNotes.com/role/DisclosureIncomeTaxes Income Taxes false false R16.htm 11001 - Disclosure - Stock Options And Restricted Stock Awards Sheet http://www.addusDFNNotes.com/role/DisclosureStockOptionsAndRestrictedStockAwards Stock Options And Restricted Stock Awards false false R17.htm 11201 - Disclosure - Stockholder's Equity Sheet http://www.addusDFNNotes.com/role/DisclosureStockholderSEquity Stockholder's Equity false false R18.htm 11301 - Disclosure - Segment Data Sheet http://www.addusDFNNotes.com/role/DisclosureSegmentData Segment Data false false R19.htm 11401 - Disclosure - Employee Benefit Plans Sheet http://www.addusDFNNotes.com/role/DisclosureEmployeeBenefitPlans Employee Benefit Plans false false R20.htm 11501 - Disclosure - Commitments And Contingencies Sheet http://www.addusDFNNotes.com/role/DisclosureCommitmentsAndContingencies Commitments And Contingencies false false R21.htm 11601 - Disclosure - Significant Payors Sheet http://www.addusDFNNotes.com/role/DisclosureSignificantPayors Significant Payors false false R22.htm 11701 - Disclosure - Concentration Of Cash Sheet http://www.addusDFNNotes.com/role/DisclosureConcentrationOfCash Concentration Of Cash false false R23.htm 11801 - Disclosure - Summarized Quarterly Financial Information Sheet http://www.addusDFNNotes.com/role/DisclosureSummarizedQuarterlyFinancialInformation Summarized Quarterly Financial Information false false R24.htm 11901 - Disclosure - Subsequent Event Sheet http://www.addusDFNNotes.com/role/DisclosureSubsequentEvent Subsequent Event false false R25.htm 12001 - Schedule - Valuation And Qualifying Accounts Sheet http://www.addusDFNNotes.com/role/ScheduleValuationAndQualifyingAccounts Valuation And Qualifying Accounts false false R26.htm 20102 - Disclosure - Summary Of Significant Accounting Policies (Policy) Sheet http://www.addusDFNNotes.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy Summary Of Significant Accounting Policies (Policy) false false R27.htm 30203 - Disclosure - Discontinued Operations (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureDiscontinuedOperationsTables Discontinued Operations (Tables) false false R28.htm 30403 - Disclosure - Acquisitions (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureAcquisitionsTables Acquisitions (Tables) false false R29.htm 30503 - Disclosure - Property And Equipment (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosurePropertyAndEquipmentTables Property And Equipment (Tables) false false R30.htm 30603 - Disclosure - Goodwill And Intangible Assets (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureGoodwillAndIntangibleAssetsTables Goodwill And Intangible Assets (Tables) false false R31.htm 30703 - Disclosure - Details Of Certain Balance Sheet Accounts (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureDetailsOfCertainBalanceSheetAccountsTables Details Of Certain Balance Sheet Accounts (Tables) false false R32.htm 30803 - Disclosure - Long-Term Debt (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureLongTermDebtTables Long-Term Debt (Tables) false false R33.htm 30903 - Disclosure - Income Taxes (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) false false R34.htm 31003 - Disclosure - Stock Options And Restricted Stock Awards (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureStockOptionsAndRestrictedStockAwardsTables Stock Options And Restricted Stock Awards (Tables) false false R35.htm 31103 - Disclosure - Operating Leases And Related Party Transactions (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureOperatingLeasesAndRelatedPartyTransactionsTables Operating Leases And Related Party Transactions (Tables) false false R36.htm 31803 - Disclosure - Summarized Quarterly Financial Information (Tables) Sheet http://www.addusDFNNotes.com/role/DisclosureSummarizedQuarterlyFinancialInformationTables Summarized Quarterly Financial Information (Tables) false false R37.htm 40101 - Disclosure - Summary Of Significant Accounting Policies (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary Of Significant Accounting Policies (Details) false false R38.htm 40201 - Disclosure - Discontinued Operations (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureDiscontinuedOperationsNarrativeDetails Discontinued Operations (Narrative) (Details) false false R39.htm 40202 - Disclosure - Discontinued Operations (Schedule Of Income Loss From Discontinued Operation) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureDiscontinuedOperationsScheduleOfIncomeLossFromDiscontinuedOperationDetails Discontinued Operations (Schedule Of Income Loss From Discontinued Operation) (Details) false false R40.htm 40203 - Disclosure - Discontinued Operations (Schedule Of Disposal Group, Classes Of Assets) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureDiscontinuedOperationsScheduleOfDisposalGroupClassesOfAssetsDetails Discontinued Operations (Schedule Of Disposal Group, Classes Of Assets) (Details) false false R41.htm 40301 - Disclosure - Sale Of Agency (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureSaleOfAgencyDetails Sale Of Agency (Details) false false R42.htm 40401 - Disclosure - Acquisitions (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureAcquisitionsNarrativeDetails Acquisitions (Narrative) (Details) false false R43.htm 40402 - Disclosure - Acquisitions (Schedule Of Purchase Price Components) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureAcquisitionsScheduleOfPurchasePriceComponentsDetails Acquisitions (Schedule Of Purchase Price Components) (Details) false false R44.htm 40403 - Disclosure - Acquisitions (Schedule Of Purchase Price Allocation) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureAcquisitionsScheduleOfPurchasePriceAllocationDetails Acquisitions (Schedule Of Purchase Price Allocation) (Details) false false R45.htm 40404 - Disclosure - Acquisitions (Schedule Of Business Acquisition Pro Forma Consolidated Income Statement Information) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureAcquisitionsScheduleOfBusinessAcquisitionProFormaConsolidatedIncomeStatementInformationDetails Acquisitions (Schedule Of Business Acquisition Pro Forma Consolidated Income Statement Information) (Details) false false R46.htm 40501 - Disclosure - Property And Equipment (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosurePropertyAndEquipmentNarrativeDetails Property And Equipment (Narrative) (Details) false false R47.htm 40502 - Disclosure - Property And Equipment (Schedule Of Property And Equipment) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails Property And Equipment (Schedule Of Property And Equipment) (Details) false false R48.htm 40601 - Disclosure - Goodwill And Intangible Assets (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails Goodwill And Intangible Assets (Narrative) (Details) false false R49.htm 40602 - Disclosure - Goodwill And Intangible Assets (Changes In Goodwill By Segment) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureGoodwillAndIntangibleAssetsChangesInGoodwillBySegmentDetails Goodwill And Intangible Assets (Changes In Goodwill By Segment) (Details) false false R50.htm 40603 - Disclosure - Goodwill And Intangible Assets (Schedule Of Carrying Amount And Accumulated Amortization Of Intangible Asset) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetDetails Goodwill And Intangible Assets (Schedule Of Carrying Amount And Accumulated Amortization Of Intangible Asset) (Details) false false R51.htm 40604 - Disclosure - Goodwill And Intangible Assets (Schedule Of Future Amortization Of Intangible Assets) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfFutureAmortizationOfIntangibleAssetsDetails Goodwill And Intangible Assets (Schedule Of Future Amortization Of Intangible Assets) (Details) false false R52.htm 40701 - Disclosure - Details Of Certain Balance Sheet Accounts (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureDetailsOfCertainBalanceSheetAccountsNarrativeDetails Details Of Certain Balance Sheet Accounts (Narrative) (Details) false false R53.htm 40702 - Disclosure - Details Of Certain Balance Sheet Accounts (Schedule Of Prepaid Expenses And Other Current Assets) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureDetailsOfCertainBalanceSheetAccountsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails Details Of Certain Balance Sheet Accounts (Schedule Of Prepaid Expenses And Other Current Assets) (Details) false false R54.htm 40703 - Disclosure - Details Of Certain Balance Sheet Accounts (Schedule Of Accrued Expenses) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureDetailsOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails Details Of Certain Balance Sheet Accounts (Schedule Of Accrued Expenses) (Details) false false R55.htm 40801 - Disclosure - Long-Term Debt (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureLongTermDebtNarrativeDetails Long-Term Debt (Narrative) (Details) false false R56.htm 40802 - Disclosure - Long-Term Debt (Schedule Of Long-Term Debt) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails Long-Term Debt (Schedule Of Long-Term Debt) (Details) false false R57.htm 40803 - Disclosure - Long-Term Debt (Schedule Of Long-Term Debt Maturities) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtMaturitiesDetails Long-Term Debt (Schedule Of Long-Term Debt Maturities) (Details) false false R58.htm 40901 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureIncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) false false R59.htm 40902 - Disclosure - Income Taxes (Tax Expense By Jurisdiction) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureIncomeTaxesTaxExpenseByJurisdictionDetails Income Taxes (Tax Expense By Jurisdiction) (Details) false false R60.htm 40903 - Disclosure - Income Taxes (Deferred Tax Assets And Liabilities) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails Income Taxes (Deferred Tax Assets And Liabilities) (Details) false false R61.htm 40904 - Disclosure - Income Taxes (Reconciliation Of Effective Tax Rate, Percentage) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureIncomeTaxesReconciliationOfEffectiveTaxRatePercentageDetails Income Taxes (Reconciliation Of Effective Tax Rate, Percentage) (Details) false false R62.htm 40905 - Disclosure - Income Taxes (Changes In Unrecognized Tax Benefits) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureIncomeTaxesChangesInUnrecognizedTaxBenefitsDetails Income Taxes (Changes In Unrecognized Tax Benefits) (Details) false false R63.htm 41001 - Disclosure - Stock Options And Restricted Stock Awards (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureStockOptionsAndRestrictedStockAwardsNarrativeDetails Stock Options And Restricted Stock Awards (Narrative) (Details) false false R64.htm 41002 - Disclosure - Stock Options And Restricted Stock Awards (Summary Of Stock Option Activity) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureStockOptionsAndRestrictedStockAwardsSummaryOfStockOptionActivityDetails Stock Options And Restricted Stock Awards (Summary Of Stock Option Activity) (Details) false false R65.htm 41003 - Disclosure - Stock Options And Restricted Stock Awards (Stock Option Awards) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureStockOptionsAndRestrictedStockAwardsStockOptionAwardsDetails Stock Options And Restricted Stock Awards (Stock Option Awards) (Details) false false R66.htm 41004 - Disclosure - Stock Options And Restricted Stock Awards (Option Pricing Assumptions) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureStockOptionsAndRestrictedStockAwardsOptionPricingAssumptionsDetails Stock Options And Restricted Stock Awards (Option Pricing Assumptions) (Details) false false R67.htm 41005 - Disclosure - Stock Options And Restricted Stock Awards (Summary Of Vested And Unvested RSU) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureStockOptionsAndRestrictedStockAwardsSummaryOfVestedAndUnvestedRsuDetails Stock Options And Restricted Stock Awards (Summary Of Vested And Unvested RSU) (Details) false false R68.htm 41101 - Disclosure - Operating Leases And Related Party Transactions (Narrative) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureOperatingLeasesAndRelatedPartyTransactionsNarrativeDetails Operating Leases And Related Party Transactions (Narrative) (Details) false false R69.htm 41102 - Disclosure - Operating Leases And Related Party Transactions (Operating Leases And Related Party Transactions) (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureOperatingLeasesAndRelatedPartyTransactionsOperatingLeasesAndRelatedPartyTransactionsDetails Operating Leases And Related Party Transactions (Operating Leases And Related Party Transactions) (Details) false false R70.htm 41201 - Disclosure - Stockholder's Equity (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureStockholderSEquityDetails Stockholder's Equity (Details) false false R71.htm 41301 - Disclosure - Segment Data (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureSegmentDataDetails Segment Data (Details) false false R72.htm 41401 - Disclosure - Employee Benefit Plans (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureEmployeeBenefitPlansDetails Employee Benefit Plans (Details) false false R73.htm 41501 - Disclosure - Commitments And Contingencies (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments And Contingencies (Details) false false R74.htm 41601 - Disclosure - Significant Payors (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureSignificantPayorsDetails Significant Payors (Details) false false R75.htm 41801 - Disclosure - Summarized Quarterly Financial Information (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureSummarizedQuarterlyFinancialInformationDetails Summarized Quarterly Financial Information (Details) false false R76.htm 41901 - Disclosure - Subsequent Event (Details) Sheet http://www.addusDFNNotes.com/role/DisclosureSubsequentEventDetails Subsequent Event (Details) false false R77.htm 42001 - Schedule - Valuation And Qualifying Accounts (Details) Sheet http://www.addusDFNNotes.com/role/ScheduleValuationAndQualifyingAccountsDetails Valuation And Qualifying Accounts (Details) false false All Reports Book All Reports Element us-gaap_DebtInstrumentBasisSpreadOnVariableRate had a mix of decimals attribute values: 0 3. Process Flow-Through: 00100 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Jul. 26, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Condensed Consolidated Statements Of Income Process Flow-Through: Removing column '1 Months Ended Feb. 29, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2011' Process Flow-Through: 00400 - Statement - Condensed Consolidated Statements Of Cash Flows adus-20121231.xml adus-20121231.xsd adus-20121231_cal.xml adus-20121231_def.xml adus-20121231_lab.xml adus-20121231_pre.xml true true XML 92 R74.htm IDEA: XBRL DOCUMENT v2.4.0.6
Significant Payors (Details)
12 Months Ended
Dec. 31, 2012
item
Dec. 31, 2011
item
Dec. 31, 2010
item
State Governmental Agency [Member]
     
Concentration Risk [Line Items]      
Number of state government agency 1 1 1
Service Revenues, Net [Member] | State Governmental Agency [Member]
     
Concentration Risk [Line Items]      
Concentration risk, percentage 57.00% 51.00% 45.00%
Accounts Receivable [Member] | Medicare [Member]
     
Concentration Risk [Line Items]      
Concentration risk, percentage 7.00% 11.00%  
Accounts Receivable [Member] | State Governmental Agency [Member]
     
Concentration Risk [Line Items]      
Concentration risk, percentage 69.00% 58.00%  
XML 93 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
segment
Dec. 31, 2012
Home Health Segment [Member]
Feb. 07, 2013
Home Health Segment [Member]
LHC Group, Inc. [Member]
Subsequent Event [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Percentage of assets sold     90.00%
Ownership percentage     10.00%
Cash consideration for sale of asset by agreement     $ 20,000
Number of held for sale agencies included in discontinued operations 2    
Accounts receivable, net   $ 7,123  
XML 94 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments And Contingencies
12 Months Ended
Dec. 31, 2012
Commitments And Contingencies [Abstract]  
Commitments And Contingencies

15. Commitments and Contingencies

Legal Proceedings

     The Company is a party to legal and/or administrative proceedings arising in the ordinary course of its business. It is the opinion of management that the outcome of such proceedings will not have a material effect on the Company's financial position and results of operations.

Employment Agreements

     The Company has entered into employment agreements with certain members of senior management. The terms of these agreements are up to four years and include non-compete and nondisclosure provisions, as well as provide for defined severance payments in the event of termination.